Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Neurons,0.7708167445740131,1.9948972240613196,0.0,0.0,0.0,81/259,10.90%,NPY;CDH22;SLITRK1;SLC32A1;CCK;SPOCK3;CA10;IGF1;PROX1;RGS7BP;TAGLN3;STMN2;TESC;NCALD;SH3GL2;VSTM2B;TMEM191C;CNTN2;RIT2;PCSK2;SNCB;GAP43;SYT4;SCN3B;OPCML;ZDHHC22;NRGN;OLFM3;CNTNAP2;PCP4;ELAVL4;C11ORF87;SCN1A;RIMS3;SYT5;VSNL1;STMN4;GAD2;SCN2A;ATP2B3;KCNK1;ARHGDIG;SRRM4;GABBR2;GRM5;SYNPR;RAB3C;PDE1A;CDK5R2;GNG2;ST8SIA3;ZIC1;HPCA;SYP;GABRA1;CPLX2;TCEAL5;MAP7D2;RYR2;MATN2;MEG3;GRIA3;NRN1;VGF;LUZP2;GABRG2;SULT4A1;VSTM2A;BEX1;KCNQ2;NECAB2;CELF3;KIF5A;PCLO;KCNC1;CPLX1;TMEM130;DNER;ADAM12;LY6H;PACSIN1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.7830423959867888,1.9364369128056096,0.0,0.0,0.0,46/123,10.32%,SLITRK1;CA10;SLC24A2;PROX1;ZNF536;STMN2;VSTM2B;CNTN2;CNTN4;PCSK2;SYT4;SCN3B;OPCML;ZDHHC22;OLFM3;SV2B;VWC2L;CNTNAP2;CNTNAP5;CACNG3;C11ORF87;SCN1A;STMN4;GAD2;SCN2A;ATP2B3;PAK3;SRRM4;GRM5;SYNPR;RAB3C;B3GALT2;ST8SIA3;GRIA1;SYP;GABRA1;TCEAL5;NTRK3;GABRG2;VSTM2A;FAM135B;CELF3;KCNC1;TMEM130;GRM6;HCN1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.8139906028403275,1.91571099731728,0.0,0.0,0.0,44/117,9.31%,NPY;CDH22;SLITRK1;CCK;CA10;RGS7BP;TAGLN3;ZNF536;STMN2;SH3GL2;VSTM2B;CNTN2;RIT2;SNCB;GAP43;SYT4;SCN3B;OPCML;NRGN;OLFM3;KCNC2;PLP1;PLPPR4;ELAVL4;C11ORF87;STMN4;GAD2;SCN2A;ATP2B3;ARHGDIG;GRM5;SYNPR;RAB3C;ST8SIA3;HPCA;GABRA1;CPLX2;TCEAL5;GFAP;GABRG2;SULT4A1;VSTM2A;CELF3;KCNC1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7862988879864767,1.8708525585929248,0.0,0.0,0.0,41/114,10.94%,NPY;RIMBP2;CDH22;SIX3;CA10;CHGB;PROX1;STMN2;SH3GL2;NPTX2;CNTN4;PCSK2;SYT4;SCN3B;KCNB2;PCP4;ELAVL4;PLPPR1;GAD2;FGF12;IGSF21;PAK3;ABCC8;RAB3C;UNC5D;NKX6-2;ST8SIA3;SYP;CPLX2;TCEAL5;MEG3;SYT13;ROBO2;PIR;SULT4A1;VSTM2A;CELF3;KCNC1;ASXL3;LY6H;HMGCLL1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6950959552237781,-1.868110152055904,0.0,0.633641067458815,0.38,27/85,13.55%,RPS24;RPL35A;RPL34;RPL39;RPL37;RPL13;RPL18;RPS28;RPL12;RPL31;RPL23;RPL41;RPL6;RPS26;RPL29;RPL30;RPL22;RPS13;RPL14;RPSA;RPL15;RPS2;ZFAND2B;RPL23A;RPL11;RPS21;RPS23
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.7803625571694046,1.863262408061469,0.0,0.0,0.0,50/121,9.31%,CDH22;SLITRK1;SLC32A1;CCK;SHISA7;CA10;GRIN2A;SPINK8;TAGLN3;STMN2;GRIN2B;GRIN2D;VSTM2B;CNTN2;RIT2;SNCB;GAP43;SYT4;OPCML;NRGN;OLFM3;KCNB2;KCNC2;PCP4;ELAVL4;CACNG3;C11ORF87;STMN4;GAD2;IGSF21;ATP2B3;SRRM4;GRM5;SYNPR;RAB3C;OXTR;ST8SIA3;HPCA;GRIA1;GABRA1;KCND3;CPLX2;TCEAL5;GRIA3;GFAP;GABRG2;VSTM2A;KCNQ2;CELF3;KCNC1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.6935248922785419,-1.857130331870949,0.0,0.3940938346390191,0.42,29/78,19.77%,MRPL10;MRPS21;MRPL52;MRPS7;MRPS22;MRPL15;MRPL36;MRPL18;MRPS16;MRPS10;MRPL47;MRPL40;MTRF1L;MRPS9;MRPS26;MRPL21;MRPS33;MRPS34;MRPS18B;MTRF1;MRPS12;MRPL19;OXA1L;MRPS5;MRPL50;MRPS31;PTCD3;MRPL3;MRPL17
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6893407656719633,-1.850254018965198,0.0,0.30651742694145934,0.47,30/97,13.55%,RPS24;RPL35A;SRPRB;RPL34;RPL39;SRPRA;RPL37;RPL13;RPL18;RPS28;RPL12;RPL31;RPL23;RPL41;RPL6;RPS26;RPL29;RPL30;RPL22;RPS13;SPCS1;RPL14;RPSA;RPL15;RPS2;ZFAND2B;RPL23A;RPL11;RPS21;RPS23
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.7712554676668409,1.8469578135358145,0.0,0.0,0.0,53/143,10.87%,CDH22;SLITRK1;SLC32A1;CA10;SLC24A2;PCDH8;STMN2;VSTM2B;CNTN2;RIT2;SNCB;GRID2;SHISA8;GAP43;SYT4;OPCML;ZDHHC22;OLFM3;PLP1;CNTNAP2;PCP4;ELAVL4;C11ORF87;STMN4;GAD2;IGSF21;ATP2B3;SRRM4;GRM5;SYNPR;RAB3C;PDE1A;ST8SIA3;HPCA;SYP;GABRA1;ITPR3;CPLX2;TCEAL5;GRIN1;GRIA3;GABRG2;SULT4A1;VSTM2A;HIVEP2;KCNQ2;CELF3;KIF5A;KCNC1;CPLX1;HCN1;NRIP3;LY6H
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.736334638602051,1.8444282940778607,0.0,0.0016316468356373877,0.01,44/160,8.06%,ENPP2;CDH22;ANLN;MOBP;ST18;HAPLN2;MYRF;CA10;MOG;ADAMTS4;RGS7BP;TMEM235;CREB5;VSTM2B;MBP;SRCIN1;CNTN2;SNCB;FAM163B;ZDHHC9;OPCML;ADCY5;OPALIN;PLP1;FA2H;EFNB3;STMN4;IGSF21;BCAS1;VLDLR;PLLP;MCAM;GRM5;SYNPR;NINJ2;NKX6-2;ST8SIA3;HPCA;FAM107A;CPLX2;TCEAL5;PHYHIP;MAG;GFAP
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.6846063017705728,-1.8368244110034428,0.0,0.2646610556154197,0.49,28/78,20.33%,MRPL10;MRPS21;MRPL52;MRPS7;MRPS22;MRPL15;MRPL36;MRPL18;MRPS16;MRPS10;MRPL47;MRPL40;MRPS9;MRPS26;MRPL21;MRPS33;MRPS34;MRPS18B;MRPS12;MRPL19;OXA1L;MRPS5;MRPL50;MRPS31;PTCD3;MRPL3;MRPL17;TSFM
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7443520016358944,1.8346740616872614,0.0,0.001427690981182714,0.01,35/110,10.60%,RIMBP2;KCNT2;PCDH18;CHGB;PDGFRA;ZNF536;ZNF385D;STMN2;CNTN4;PCSK2;SULF1;PDZRN4;GAP43;SYT4;OPCML;OLFM3;TCEAL7;PLPPR4;C11ORF87;THY1;GAD2;PAK3;RAB3C;UNC5D;ST8SIA3;GRIA1;TCEAL5;GRIA3;ROBO2;CACNA1C;CELF3;PTPRD;ASXL3;TMEM130;SCN3A
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7906311266617677,1.8286938589071657,0.0,0.0012690586499401904,0.01,36/101,9.31%,CDH22;SLITRK1;CA10;GRIN2A;STMN2;GRIN2B;CNTN2;RIT2;GAP43;SCN3B;OPCML;OLFM3;KCNC2;CNTNAP5;CACNG3;C11ORF87;SCN1A;STMN4;GAD2;SCN2A;ATP2B3;SRRM4;GRM5;SYNPR;ST8SIA3;HPCA;GRIA1;GABRA1;CPLX2;NTRK3;GRIN1;DIRAS2;GABRG2;VSTM2A;CELF3;KCNC1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7803707067707812,1.8275176741101562,0.0,0.0011421527849461712,0.01,54/155,12.25%,SLITRK1;ELAVL2;CNR1;FLRT3;EDIL3;KCNH7;PCDH8;TAGLN3;EPHA7;ZNF536;STMN2;SH3GL2;NLGN1;CLSTN2;ATRNL1;SYT1;CNTN2;SLITRK5;SNCB;GRID2;GAP43;CAMKV;PLPPR5;SYT4;NEFL;OPCML;ZDHHC22;OLFM3;CNTNAP2;LINGO2;RELN;TCEAL7;ACHE;EFNB3;STMN4;NAP1L3;ST8SIA3;FSD1;NRG1;MAP1B;SULT4A1;KCNQ2;CELF3;KIF5A;KCNC1;PNMA2;KIF5C;ADAM12;SMAD1;HMGCLL1;RGMB;DPYSL5;CRMP1;NEFM
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.700195351108383,-1.8243490852321547,0.0,0.26272922309267943,0.55,21/74,13.96%,NDUFAF3;UQCRFS1;NDUFS5;COX18;TMEM126A;DMAC2;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;COX20;NDUFV3;NDUFA8;SLC25A33;LYRM7;FOXRED1;NDUFS3;NDUFC1;SAMM50;SMIM20;COX19
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.8048933473675628,1.8192382830086589,0.0,0.0010383207135874286,0.01,41/104,12.39%,RIMBP2;CDH22;MYT1;SLITRK1;PCDH8;STMN2;ATRNL1;SRCIN1;CNTN2;SNCB;GAP43;PRKCG;CAMKV;SYT4;ZDHHC22;OLFM3;KCNB2;STMN4;GAD2;SCN2A;PRR36;ABCC8;CDK5R2;ST8SIA3;HPCA;SYP;CPLX2;SYT13;GABRG2;SULT4A1;VSTM2A;KCNQ2;CELF3;KIF5A;KCNC1;SMAD3;LY6H;HMGCLL1;MAPT;DPYSL5;NR4A2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.6841593912694964,-1.811533466093925,0.0,0.2717444415321341,0.66,30/84,19.77%,MRPL10;MRPS21;MRPL52;MRPS7;MRPS22;MRPL15;MRPL36;MRPL18;MRPS16;MRPS10;MRPL47;MRPL40;MTRF1L;MRPS9;APEH;MRPS26;MRPL21;MRPS33;MRPS34;MRPS18B;MTRF1;MRPS12;MRPL19;OXA1L;MRPS5;MRPL50;MRPS31;PTCD3;MRPL3;MRPL17
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7230624689433096,-1.8110296779422883,0.0,0.23402771132625225,0.66,29/87,13.55%,TMA7;RPS24;RPL35A;RPL34;RPL39;RPL37;RPL13;RPL18;RPS28;RPL12;RPL31;RPL23;RPL41;RPL6;RPS26;FTSJ1;RPL29;RPL30;RPL22;RPS13;RPL14;RPSA;RPL15;RPS2;RPL23A;RPL11;RPS21;RWDD1;RPS23
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.661522554646166,-1.8098171369163378,0.0,0.20574016367184086,0.66,58/191,15.37%,TMA7;MRPL10;RPS24;RPL35A;RPL34;RPL39;RPL37;MRPS21;MRPL52;RPL13;RPL18;KARS1;MRPS7;RPS28;RPL12;VARS1;RPL31;AIMP1;RPL23;MRPL36;MRPL18;MRPS16;RPL41;MRPL47;FASTKD2;ASMT;RPL6;RPS26;GATC;FTSJ1;RPL29;RPL30;RPL22;RPS13;RPL14;EEFSEC;RPSA;RPL15;APEH;RPS2;EPRS1;RPL23A;NOA1;NARS1;RPL11;EEF1B2;IGF2BP3;EEF1A1;MRPS33;MRPS34;MRPS18B;RPS21;RWDD1;RPS23;WARS2;AIMP2;YARS2;MRPS12
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7854339229329554,1.8057758393317227,0.0,0.0019035879749102855,0.02,43/97,12.05%,CDH22;CCK;MOBP;ST18;MOG;SLC24A2;PROX1;SLC4A10;CNTN2;PCSK2;XKR4;PRKCB;SCN3B;SV2B;KCNC2;CNTNAP5;CACNG3;SCN1A;KCNQ1;STMN4;RPH3A;GAD2;KCNT1;SRRM4;SYNPR;UNC13C;ST8SIA3;SYP;GABRA1;CPLX2;KCNH2;MYT1L;CACNA1E;VSTM2A;FAM135B;ADCY2;CELF3;CNDP1;HCN1;MYO15A;PDE1B;FGF13;TCEAL6
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.7221387438366118,1.8055065985676706,0.0,0.0017571581306864174,0.02,59/229,10.91%,NPY;RIMBP2;SLC32A1;CHRNA5;HTR2C;CHRM3;GRIN2A;GRIK1;TBC1D24;HRH1;GRIN2B;CHRM1;GRIN2D;NPTX2;NLGN1;MBP;GABRB2;SYT1;GRIK2;RIT2;SNCB;GRID2;RPS6KA1;APBA2;NRGN;CBLN2;PLP1;CDH8;GABRG3;SYT5;GAD2;GLRA2;KCNMB4;GABRD;GABBR2;GRM5;PRKAR1B;UNC13C;PTCHD1;GRIA1;GABRA1;DVL1;GRIN1;GRIA3;NPTX1;GABRA5;SNCA;HCRTR2;CACNA1E;DTNA;GABRG2;KCNQ2;KIF5A;CPLX1;PDLIM4;HOMER1;DNAJC5;FCHSD1;MINK1
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7792952219092215,1.8048478694414793,0.0,0.0016316468356373877,0.02,35/116,10.08%,NPY;RIMBP2;CDH22;CHGB;TTLL7;RGS7BP;TAGLN3;STMN2;PLD1;DOC2B;SERPINE1;CNTN2;GAP43;SYT4;OPCML;TCEAL7;PLPPR4;ELAVL4;SYNPR;RAB3C;UNC5D;ST8SIA3;CPLX2;TCEAL5;PHYHIP;MAP1B;GUCY1A2;SULT4A1;VSTM2A;CELF3;PCLO;PTPRD;PLD2;KALRN;ASXL3
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7861882833222429,1.8028257446674125,0.0,0.0022843055698923424,0.03,40/103,10.94%,NPY;ENPP2;RIMBP2;CDH22;CCK;CA10;CHGB;VWA5B2;TAGLN3;STMN2;SH3GL2;PCSK2;GAP43;SYT4;OPCML;OLFM3;KCNB2;ELAVL4;PLPPR1;GAD2;ABCC8;RAB3C;UNC5D;CDK5R2;ST8SIA3;HPCA;GLP1R;SYP;CPLX2;TCEAL5;SYT13;SULT4A1;VSTM2A;CELF3;KCNC1;SCG5;ASXL3;SCN3A;LY6H;HMGCLL1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6925400992158282,-1.801567021591993,0.02857142857142857,0.19919339790033208,0.67,27/88,13.55%,RPS24;RPL35A;RPL34;RPL39;SRPRA;RPL37;RPL13;RPL18;RPS28;RPL12;RPL31;RPL23;RPL41;RPL6;RPS26;RPL29;RPL30;RPL22;RPS13;RPL14;RPSA;RPL15;RPS2;RPL23A;RPL11;RPS21;RPS23
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6640925009235111,-1.7978553892399984,0.0,0.1885468542194523,0.69,48/179,13.06%,IMP4;PAK1IP1;RPS24;FCF1;RPL35A;RIOK2;RPL34;RPL39;RPL37;ZNF658;EXOSC8;RPL13;RPL18;RBIS;RPS28;DDX52;RPL12;RPL31;RPL23;MRPL36;POP5;PIH1D2;NOP56;RPF1;NOC2L;RPL41;RPL6;EXOSC4;RRP1B;NOL8;RPL29;IMP3;RPL30;RPL22;RIOK1;SNU13;RPL14;EXOSC5;URB2;RPL15;DCAF13;RPS2;MDN1;RPL23A;NIP7;RPL11;RRP36;UTP20
prerank,PanglaoDB_Augmented_2021__Interneurons,0.7244444142927201,1.7875920840932888,0.0,0.004996918434139499,0.07,77/265,9.38%,NPY;CDH22;SLITRK1;CCK;L1CAM;SPOCK3;CA10;SHISA9;RGS7BP;PCDH8;TAGLN3;STMN2;NCALD;SH3GL2;GRIN2D;ZIC4;VSTM2B;SYT1;CNTN2;RIT2;ELMO1;PTPRO;PCSK2;SNCB;SHISA8;PRKCB;GAP43;PRKCG;CAMKV;PLPPR5;SYT4;OPCML;ZDHHC22;NRGN;OLFM3;SV2B;KCNC2;RELN;ELAVL4;C11ORF87;STMN4;GAD2;FGF12;IGSF21;ATP2B3;VLDLR;GABBR2;GRM5;SYNPR;KCNQ5;RAB15;RAB3C;PDE1A;CDK5R2;ST8SIA3;LHX6;HPCA;RAMP3;SYP;CPLX2;PDP1;TCEAL5;NRN1;SYT13;GABRA5;CACNA1E;VGF;ADGRL2;GABRG2;SULT4A1;VSTM2A;HIVEP2;KCNQ2;CELF3;KIF5A;KCNC1;CPLX1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.8084097128981087,-1.7863187466659152,0.0,0.19810064415009518,0.79,3/31,2.38%,ACP3;ATP10B;TPP1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.6849630932130172,-1.7842855404617295,0.0,0.18867564305430165,0.81,36/93,20.61%,MRPL10;MRPS21;MRPL52;MRPS7;MTIF2;MRPS22;MRPL15;MRPL36;MRPL18;MRPS16;MRPS10;MRPL47;FASTKD2;MRPL40;GATC;MTRF1L;MRPS9;MTIF3;MRPS26;NOA1;MRPL21;MRPS33;MRPS34;MRPS18B;MTRF1;MRPS12;MRPL19;OXA1L;MRPS5;MRPL50;MRPS31;PTCD3;MRPL3;MRPL17;TSFM;QRSL1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7563781909485783,1.7806536407837017,0.0,0.005374836635040806,0.08,46/133,12.76%,SLITRK1;SCN9A;CA10;RGS7BP;TAGLN3;ZNF536;STMN2;SH3GL2;CNTN2;GAP43;SYT4;SCN3B;OPCML;OLFM3;PLP1;TCEAL7;ADD2;PLPPR4;ELAVL4;C11ORF87;STMN4;SCN2A;ATP2B3;GRM5;SYNPR;PIEZO2;RAB3C;ST8SIA3;TCEAL5;MAP1B;SULT4A1;VSTM2A;CLGN;KIF5A;KCNC1;PTPRD;DHCR24;ASXL3;LY6H;VWA5A;NACAD;FGF13;TCEAL6;CRMP1;NEFM;FAM13C
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7321316727326032,1.773812157895132,0.0,0.005710763924730857,0.09,46/178,9.38%,NPY;CHRNA5;HTR2C;CHRM3;GRIN2A;GRIK1;HRH1;GRIN2B;CHRM1;NPTX2;NLGN1;MBP;GABRB2;SYT1;GRIK2;RIT2;SNCB;RPS6KA1;APBA2;NRGN;PLP1;GABRG3;SYT5;GAD2;GLRA2;KCNMB4;GABRD;GABBR2;GRM5;PRKAR1B;UNC13C;PTCHD1;GRIA1;GABRA1;GRIN1;GRIA3;NPTX1;GABRA5;SNCA;HCRTR2;CACNA1E;DTNA;GABRG2;KCNQ2;KIF5A;CPLX1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.7488506846017277,1.7715846026917028,0.0,0.006011330447085112,0.09,26/80,9.47%,ECM2;COL4A1;PRRX1;PCDH18;DCN;PDGFRA;ABCA8;COL4A2;ACTA2;CALD1;SULF1;ITGA8;SLIT2;ASPN;THY1;PODN;ANGPTL2;MYH11;SLIT3;POSTN;COL12A1;SEMA3D;FAP;C1R;BGN;ITGA11
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.7745394042347103,1.7666898084228106,0.0,0.007423993102150112,0.12,42/105,12.05%,CDH22;SLITRK1;SLC32A1;CA10;RGS7BP;ZNF536;STMN2;SH3GL2;VSTM2B;CNTN2;SNCB;GAP43;OPCML;OLFM3;KCNC2;PLPPR4;C11ORF87;SEMA3C;STMN4;GAD2;IGSF21;ATP2B3;GABBR2;GRM5;SYNPR;ABCC8;CDK5R2;ST8SIA3;HPCA;TCEAL5;PHYHIP;GFAP;GABRG2;SULT4A1;VSTM2A;CELF3;KCNC1;LY6H;HMGCLL1;SYN2;LGI3;TCEAL6
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7310167872434412,1.7575478789185892,0.0,0.008702116456732734,0.15,47/146,12.76%,RIMBP2;CCK;CA10;RGS7BP;TAGLN3;ZNF536;STMN2;NMNAT2;ATRNL1;CNTN2;GAP43;SYT4;OPCML;CASZ1;OLFM3;TCEAL7;PLPPR4;ELAVL4;STMN4;ATP2B3;GFRA2;CDK5R2;ST8SIA3;CPLX2;TCEAL5;CACNA1E;MAP1B;GUCY1A2;SULT4A1;VSTM2A;CELF3;PCLO;ARHGAP26;KCNC1;KALRN;MFSD6;ASXL3;AHDC1;SCN3A;LY6H;HMGCLL1;RGMB;NACAD;VSTM2L;CRMP1;NEFM;FAM13C
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.8183834002913903,1.7561960754485266,0.0,0.008825726065493143,0.16,2/52,0.15%,LEF1;CDKN2A
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7320502052652856,1.754202641340717,0.0,0.008441998845254308,0.16,30/105,10.94%,RIMBP2;FLRT3;PROX1;RGS7BP;STMN2;CNTN4;PDZRN4;SYT4;SHC2;PCP4;RCAN2;PLPPR4;PLPPR1;FGF12;ATP9A;ABCC8;ST8SIA3;ABCC9;SYT13;SYBU;MAOB;GUCY1A2;ADGRL2;LIMCH1;PCLO;PTPRD;ATP1B1;KALRN;ASXL3;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.8084621017209023,1.7495522450299275,0.0,0.009042042880823857,0.17,27/53,14.48%,SHISA7;SHISA9;GRIN2A;GRIN2B;NPTX2;NLGN1;PSCA;SHISA8;NEFL;DLGAP3;RELN;APP;CACNG3;NETO1;GRIA1;GRIN1;GRIA3;NPTX1;CACNG8;SHANK1;CAPN1;CACNG4;MINK1;DLGAP1;DLG3;DLGAP2;CAMK2B
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.65784659529135,-1.7443369777162927,0.0,0.27045655318364054,0.92,47/161,13.65%,IMP4;RPS24;FCF1;RPL35A;RIOK2;RPL34;RPL39;RPL37;EXOSC8;RPL13;NSA2;RPL18;RPS28;DDX52;RPL12;RPL31;RPL23;POP5;PIH1D2;NOP56;RPF1;RPL41;RPL6;EXOSC4;RRP1B;THUMPD1;NOL8;RPL29;IMP3;RPL30;RPL22;RIOK1;SNU13;RPL14;EXOSC5;RPL15;DCAF13;RPS2;RRP15;MDN1;RPL23A;RPL11;SRFBP1;RRP36;UTP20;MAK16;NOL6
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.773732171181385,-1.7340132904254637,0.0,0.2853592612162086,0.97,2/29,2.38%,ACP3;TPP1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7459417952944168,1.7303211213418082,0.0,0.016903861217203334,0.26,35/121,9.31%,SLITRK1;PROX1;PCDH8;EPHA7;ZNF536;STMN2;ATRNL1;CNTN2;GAP43;CAMKV;SYT4;SCN3B;OPCML;ZDHHC22;OLFM3;ELAVL4;STMN4;GAD2;ATP2B3;PAK3;SRRM4;SYNPR;RAB3C;ST8SIA3;LHX6;NTRK3;ROBO2;SULT4A1;VSTM2A;HIVEP2;KCNQ2;CELF3;KIF5A;PCLO;KCNC1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.7349781060049456,-1.73016945059252,0.02702702702702703,0.2792141939533966,0.97,4/36,7.21%,RITA1;NXT2;AAAS;GEMIN4
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.7613163316342103,1.727084111007136,0.0,0.017571581306864172,0.26,1/66,0.01%,LEF1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.8637711917162954,1.7230666960903966,0.0,0.017343801549182598,0.27,11/26,10.41%,CALD1;DMTN;ADD2;BAIAP2L1;NEDD9;BAIAP2;FAM107A;PAWR;RHOD;MYO1B;FSCN1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.7050721071755097,1.7230202775939605,0.0,0.01672438006528322,0.27,34/106,16.30%,LEF1;ARHGAP39;CEP170B;APP;DAB2IP;EFNB3;ARHGEF17;NUAK1;PTPN21;PHYHIP;LARP6;MAP1B;GFAP;SCARA3;SEMA3B;NYAP1;MAPK8IP1;SH3PXD2B;SRRM3;TNFRSF19;YAP1;CMTM4;NACAD;TEAD1;EPB41L1;LGI3;CAP2;MEIS3;GPR37;SLC13A4;BCAR1;MTCL1;SEZ6L2;RBFOX2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.7617848175923858,1.7222120765170097,0.0,0.01654152309232386,0.28,38/100,10.94%,RIMBP2;KCNT2;CDH22;CHGB;PROX1;RGS7BP;STMN2;NPTX2;CNTN4;PCSK2;SYT4;KCNB2;SHC2;RCAN2;PLPPR4;ELAVL4;PLPPR1;GAD2;IGSF21;BAIAP3;ABCC8;RAB3C;UNC5D;ST8SIA3;CPLX2;TCEAL5;GRIA3;SYT13;MAOB;GABRG2;VSTM2A;CELF3;PTPRD;ATP1B1;KALRN;ASXL3;LY6H;HMGCLL1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.7096866474092703,1.718655592578623,0.0,0.017513009369174624,0.3,31/118,8.58%,C1QL1;HAPLN2;CSPG4;CA10;PDGFRA;TAGLN3;ZNF536;STMN2;VSTM2B;CNTN2;SNCB;GAP43;OPCML;ADCY5;PLP1;TCEAL7;PLPPR4;C11ORF87;STMN4;IGSF21;NKX6-2;ST8SIA3;FYN;HPCA;TCEAL5;LHFPL3;PHYHIP;NNAT;GFAP;VCAN;NYAP1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.765289723465542,1.7140254792627798,0.0,0.020264001023238522,0.34,35/94,10.87%,SLITRK1;SLC32A1;SHISA7;PCDH8;TAGLN3;STMN2;GNG3;VSTM2B;CNTN2;SNCB;ARHGAP39;GAP43;PRKCG;CAMKV;OPCML;CAMK2N2;C11ORF87;EFNB3;PRR36;GRM5;CDK5R2;B4GALNT4;HPCA;PHYHIP;GRIN1;SULT4A1;NYAP1;KCNQ2;MAPK8IP1;CELF3;KIF5A;KCNC1;SRRM3;DNER;LY6H
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.7236535815949889,1.706773092843276,0.0,0.02177228746303639,0.35,26/117,10.90%,LEF1;GGT5;ANXA1;SP100;IL1RAPL1;TIMP2;IRAK2;APP;IL1R1;PLSCR1;OSMR;NLRP12;CIITA;CHI3L1;PID1;CDK9;SNCA;PML;MYD88;MX1;BCL2L1;IKBKE;PTPN9;SMAD3;HDAC4;STAT3
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.8644871321231945,1.7007901316129945,0.0,0.02561191093515657,0.39,4/23,3.41%,NR4A3;C3;IGF1;IRS2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.8643768434595827,1.7001321548593333,0.0,0.024858619437063727,0.39,11/26,10.41%,CALD1;DMTN;ADD2;BAIAP2L1;NEDD9;BAIAP2;FAM107A;PAWR;RHOD;MYO1B;FSCN1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.7513411104154571,1.6988354377213837,0.0,0.025127361268815766,0.41,17/65,8.31%,ENPP2;CSPG4;IGF1;EPHA7;IL15;DMTN;PTPRC;TEC;RELN;APP;EFNA1;CD44;TNFRSF14;FYN;GHR;PDGFA;RAP2B
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7437324305416542,1.6983554194618122,0.0,0.02506390833631876,0.42,34/96,13.06%,STMN2;SH3GL2;CNTN2;GRID2;GAP43;NEFL;SCN3B;OPCML;ZDHHC22;PLP1;TCEAL7;PAK3;SRRM4;SEMA5B;RAB3C;UNC5D;ST8SIA3;GJC1;GRIA1;TCEAL5;NTRK3;ROBO2;MAP1B;GUCY1A2;SULT4A1;KCNQ2;PTPRD;PNMA2;ASXL3;DCX;NACAD;CRMP1;NEFM;RUNX1T1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.6869630801144245,1.6977667903260145,0.0,0.024695195350187486,0.43,51/211,11.15%,TGFBR2;SIX3;C3;COL4A1;HAPLN2;MYRF;IL1RAPL2;CA10;CHST8;MOG;PCDH18;GRIN2A;GRIK1;PROX1;TAGLN3;EPHA7;GRIN2B;SH3GL2;GRIN2D;ZIC4;MBP;CNTN4;SH3GL3;UGT8;CNTNAP2;RELN;LSR;CIC;SOX4;SHROOM4;ZIC1;MFSD2A;APOD;GRIN1;NNAT;EIF2B2;ZBTB16;NPTX1;GLIS2;THOC6;ROBO2;SYNJ2;ADGRL2;VCAN;AATK;PBX3;KLK6;DNER;DCX;STAT3;TPPP
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.942285659899395,1.6964241418495074,0.0,0.024646454833048954,0.44,2/11,0.09%,LEF1;TGFBR2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6562708924165502,-1.693194795124143,0.0,0.39071312772422356,0.99,29/105,13.55%,RPS24;RPL35A;RPL34;RPL39;RPL37;RPL13;RPL18;RBM8A;RPS28;RPL12;RPL31;RPL23;RPL41;RPL6;RPS26;RPL29;RPL30;RPL22;RPS13;RPL14;RPSA;RPL15;RPS2;RPL23A;PYM1;RPL11;EIF3E;RPS21;RPS23
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7249469626567024,1.6909013988441612,0.0,0.026357371960296264,0.47,22/95,9.50%,SIX3;PCDH8;TAGLN3;ZNF536;SNCB;GAP43;CAMKV;OPCML;ZDHHC22;EFNB3;LGR5;SEMA5B;UNC5D;CDK5R2;HPCA;MAP1B;SULT4A1;KCNQ2;CELF3;PCLO;KCNC1;SRRM3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.8171756414727676,1.6884907097779884,0.0,0.028553819623654282,0.52,1/38,0.01%,LEF1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6853384118918552,-1.6874592637531192,0.0,0.3730583249469582,0.99,13/50,13.21%,NDUFAF3;NDUFS5;TMEM126A;DMAC2;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;NDUFA8;FOXRED1;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6853384118918552,-1.6874592637531192,0.0,0.3730583249469582,0.99,13/50,13.21%,NDUFAF3;NDUFS5;TMEM126A;DMAC2;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;NDUFA8;FOXRED1;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.7267222390626165,1.6815472703429248,0.0,0.03315028814843766,0.58,18/74,11.17%,OPTC;COL4A1;COL11A2;COL4A2;COL8A1;P4HA2;COL21A1;TLL1;COL12A1;COL27A1;COL23A1;SCX;CYP1B1;LOXL1;P3H2;TGFB2;COL9A1;COL4A4
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.731018632846901,1.68060928262229,0.0,0.03344876013056645,0.59,33/101,10.08%,RIMBP2;KCNT2;CHGB;EDIL3;PROX1;RGS7BP;STMN2;SH3GL2;CNTN4;PCSK2;SYT4;KCNB2;SHC2;DEPP1;TCEAL7;RCAN2;PLPPR4;PLPPR1;ABCC8;RAB3C;ST8SIA3;GLP1R;RAI2;LDB2;FAP;PGR;GRIA3;SYT13;CELF3;PTPRD;SCG5;PKDCC;ASXL3
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6436011592147114,-1.6792774087667734,0.0,0.38229948871071,0.99,41/149,13.65%,IMP4;RPS24;FCF1;RPL35A;RPL34;RPL39;RPL37;NIFK;EXOSC8;RPL13;RPL18;RPS28;DDX52;RPL12;RPL31;RPL23;POP5;PIH1D2;NOP56;RPF1;RPL41;RPL6;EXOSC4;RRP1B;NOL8;RPL29;IMP3;RPL30;RPL22;SNU13;RPL14;EXOSC5;RPL15;DCAF13;RPS2;MDN1;RPL23A;RPL11;RRP36;UTP20;NOL6
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.8432357195109407,1.6789647861634556,0.0,0.03399896662165347,0.61,1/27,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8984975473857589,1.6768456720199116,0.0,0.037119965510750565,0.7,6/13,6.50%,SHISA7;SHISA9;SLC4A10;GRIK2;SHISA8;SYP
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.725027921648768,1.6757559090122462,0.0,0.03756413603822963,0.72,25/73,10.91%,SHISA7;ANK3;SHISA9;GRIN2A;CTSS;GRIN2B;NLGN1;SHISA8;NEFL;RELN;APP;CACNG3;FGF12;NETO1;HPCA;GRIA1;GRIN1;GRIA3;JPH4;CACNG8;SHANK1;CAPN1;CACNG4;HOMER1;MINK1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.7399612344745968,1.6752382227137734,0.0,0.03823728888732834,0.74,37/111,12.49%,MYT1;ELAVL2;CNR1;PCDH8;TAGLN3;EPHA7;STMN2;DRAXIN;GRID2;GAP43;CAMKV;PLPPR5;SYT4;ZDHHC22;EFNB3;PRR36;VLDLR;SEMA5B;GRM5;UNC5D;CDK5R2;B4GALNT4;CCKBR;MAP1B;SULT4A1;NYAP1;KCNQ2;CELF3;KIF5A;KCNC1;KIF5C;C2CD4C;DCX;DPYSL5;CRMP1;NEFM;EPHA4
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8820836700853372,-1.6741281445171183,0.0,0.3902301695935385,0.99,2/10,1.07%,EYS;REEP6
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7719279762427601,1.6739968215609378,0.031746031746031744,0.038395774472658524,0.74,9/32,7.20%,HTR2C;GRIN2A;SLC24A2;GRIN2B;GRIN2D;PTPRC;ITPR3;GRIN1;RYR2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.8157849859646374,1.667830792856864,0.0,0.045448162900983066,0.79,7/28,8.58%,CDKN2A;THBS1;SERPINE1;DMTN;APOD;FAM107A;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.7497665587831467,1.6669442063110071,0.0,0.04498683418257368,0.79,19/62,8.14%,SHISA7;RIMS2;GRIN2A;SLC24A2;PLK2;GRIN2B;GRIN2D;NLGN1;CLSTN2;SYT1;GRIK2;RELN;APP;CACNG3;RIMS3;BAIAP3;SHANK3;CACNG8;NPTN
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.9287658858519515,-1.6646075437902144,0.0,0.4154359844140547,1.0,1/12,0.08%,SLC2A5
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.6687559900073893,1.6623891622788365,0.0,0.050026291980642304,0.81,52/211,10.96%,SLITRK1;CCK;L1CAM;ANK3;SCN1B;EPHA7;DRAXIN;CNTN2;SLITRK5;CNTN4;PTPRO;SHTN1;SLIT2;EPHA2;IRS2;RELN;APP;DOK6;PLPPR4;EPHA5;SEMA3C;EFNB3;EFNA1;PAK3;EMB;VLDLR;SH3KBP1;NRP2;SEMA5B;GFRA2;SHANK3;UNC5D;SLIT3;BAIAP2;ANOS1;FYN;RAP1GAP;SEMA3D;PARD3;ROBO2;MAP1B;NPTN;SEMA3B;LAMA5;DCC;KIF5A;GAB2;NEXN;KIF5C;NRXN3;GLI2;SLITRK4
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.8797739434173921,1.6621125145043805,0.0,0.049269335821207384,0.81,2/27,0.37%,LEF1;HPN
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.7700975280714382,1.661708485989417,0.0,0.048541493360212275,0.81,2/54,0.15%,LEF1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.7436101471832528,1.6605606115862857,0.0,0.04827211770338535,0.81,20/63,14.38%,NR4A3;HPN;IGF1;SGPP2;NR4A1;ZFP36;DAB2IP;DUSP10;TGFA;EPB41L4B;LAMB1;CDK6;NLRC3;YAP1;CDKN1C;TGFB2;B2M;FUT2;DEAF1;FGF2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7915038784962585,1.6594927897499145,0.0,0.04822422869772723,0.81,9/31,8.25%,GRIN2A;GRIN2B;GRIN2D;GRID2;GABRG3;GABRA1;GRIN1;GABRA5;GABRG2
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6843444155492449,1.6585043651580522,0.0,0.049008737681326624,0.81,35/137,13.14%,LEF1;COL4A1;TEAD2;CD24;COL4A2;FBLIM1;EPHA2;THY1;FRAS1;ZIC1;GJC1;LAMB1;PAWR;PTPN21;PARD3;PML;ADGRL2;KITLG;MYO1B;NR6A1;CTNNB1;SH3PXD2B;LMNA;SMAD3;YAP1;RBPMS;GLI2;SMAD1;STAT3;PODXL;TEAD1;ENAH;COL4A5;CD276;CTNNA1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.927551435925832,-1.6583899204719672,0.0,0.4228957013416926,1.0,3/10,3.58%,H1-2;ATAD2;H1-4
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.8506365293585585,1.6546220459105898,0.0,0.05200874288594173,0.84,6/25,10.90%,GGT5;ANXA1;WNT8B;RAMP3;CTNNB1;STAT3
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.8436018610506114,-1.65450974364123,0.05128205128205128,0.419963591900063,1.0,1/17,0.09%,NGF
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.8314313335646356,1.6535842481934626,0.0,0.05269933025277948,0.86,13/35,6.50%,HLA-DRA;GPNMB;TLR2;CTSS;PLEK;PRKCB;NAPSB;MYO1F;PTPRC;SIGLEC1;ACHE;AHR;CIITA
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.6634872090300136,1.647652929295544,0.0,0.058879945292914695,0.88,27/146,16.65%,TGFBR2;VRK2;SBK1;PLK2;PRKCB;PRKCG;CAMKV;RPS6KA1;STK32B;GRK2;IKBKE;PRKCE;PRKCH;HIPK3;STK32A;GAS6;PRKCD;CDC7;HIPK1;RPS6KA6;MAPKAPK5;STK32C;RPS6KB2;HIPK2;CAMK1D;NEK6;PINK1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.7102679578574215,1.6459846880653262,0.0,0.05981783229633337,0.89,17/71,8.77%,SLITRK1;CCK;L1CAM;ANK3;SLITRK5;CNTN4;SHTN1;GAP43;PLP1;RTN4RL1;APP;PLPPR4;PAK3;BAIAP2;PARD3;MAP1B;DCC
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.7368763032454573,1.6456070283908821,0.0,0.059011227222218854,0.89,8/63,7.57%,GGT5;NPNT;ZFP36;YBX3;DAB2IP;ERBIN;CHI3L1;PID1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.7213903309241296,1.6449372241886344,0.0,0.058980020861974417,0.89,25/118,8.71%,TGFBR2;SIX3;COL4A1;CA10;PCDH18;GRIN2A;PROX1;EPHA7;GRIN2B;GRIN2D;CNTN4;CNTNAP2;RELN;CIC;SHROOM4;SHANK3;ZIC1;MFSD2A;APOD;GRIN1;NNAT;ROBO2;SYNJ2;ADGRL2;AATK
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.9180997574257,1.6431641794070317,0.0,0.062081530407558025,0.92,2/16,0.37%,LEF1;HPN
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8435960243700832,1.642825281954729,0.015873015873015872,0.06109610928997774,0.92,8/27,1.80%,NPY;CNR1;NPY1R;ANXA1;HTR2C;CHRM3;HRH1;CHRM1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.7812711416725946,1.641775829026541,0.0,0.0613907121908567,0.94,1/46,0.01%,LEF1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.6830296319925722,1.6388374104943075,0.0,0.06466341920926016,0.94,33/93,16.68%,COL4A1;TEAD2;CSPG4;BOK;AMH;COL4A2;EPHA2;DAB2IP;ARHGEF17;MCAM;NUAK1;COL12A1;LAMB1;PTPN21;LARP6;RHBDF1;GLIS2;SCARA3;YAP1;GLI2;TEAD1;CAP2;MEIS3;ENAH;COL4A5;CD276;BCAR1;SMARCA1;MTCL1;SEZ6L2;FSTL1;RBFOX2;FZD7
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.6921369149457371,1.6376446917179797,0.0,0.06506809805147885,0.94,34/112,13.22%,KCNT2;PCDH18;EDIL3;RGS7BP;STMN2;GAP43;OPCML;SLIT2;ADCY5;SHC2;TCEAL7;RCAN2;PLPPR4;THY1;EFNB3;SEMA5B;COL23A1;CCDC3;LDB2;RASL12;BOC;MAP1B;GUCY1A2;ADGRL2;VCAN;PTPRD;ASXL3;PCDHB15;TGFB2;NACAD;CRMP1;FAM13C;RUNX1T1;PRICKLE2
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.7092274375887462,1.6372283926270608,0.0,0.06443787353875415,0.94,18/84,11.07%,ARHGAP4;SPOCK3;TMEFF2;SERPINE1;SULF1;SLIT2;WAS;THY1;DUSP10;PODN;CLIC4;FOXO3;CYP1B1;RAP2B;LIMCH1;DUSP22;DLG5;LDLRAD4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.8863902046256373,1.6370714641756519,0.0,0.06349025775141952,0.94,4/13,5.34%,SHISA7;RELN;APP;SHANK3
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.8893028974437468,1.6335593390404441,0.0,0.06753599076203448,0.95,4/13,6.55%,HPN;COL4A1;CTSS;LAMB1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5778749815802943,-1.6332775043604153,0.0,0.5013105396511053,1.0,58/179,19.63%,SLC25A5;UQCRFS1;PHYH;TIMM8B;LRPPRC;COX7C;NDUFB4;RETSAT;UQCRB;OAT;MRPS22;MRPL15;ATP5PF;TIMM13;SLC25A4;NDUFB1;ALAS1;ATP5MC1;VDAC2;GLUD1;NQO2;COX7B;ATP5PB;ATP6V1G1;ECH1;ATP5PD;NDUFA8;ETFB;ATP5MC3;CS;PDHA1;NDUFS3;ISCU;HTRA2;MPC1;NDUFC1;MTRF1;ETFDH;IDH1;COX5B;ATP6V1F;COX11;ATP5F1B;TIMM10;TIMM50;MRPS12;ECHS1;SUCLA2;OXA1L;ATP5F1A;AFG3L2;IDH3G;DECR1;PRDX3;SLC25A11;TIMM17A;ATP5MC2;CYC1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.8149336482620845,1.629763763035065,0.0,0.07016081393240765,0.96,6/26,3.34%,TGFBR2;MET;COL4A1;NPNT;SLIT2;EPHA2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6849695348420364,-1.6297139226669775,0.05405405405405406,0.5035128287270292,1.0,17/56,15.46%,PAK1IP1;RPS24;RPL35A;RIOK2;ZNF658;RBIS;RPS28;MRPL36;NOC2L;RIOK1;RPL14;URB2;NIP7;RPL11;RRP36;NOM1;RPF2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.9233205034328373,-1.6281913626773117,0.0,0.4948463308250126,1.0,3/10,3.47%,AR;CEBPA;ZC3H8
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.617182422605576,-1.6269171343728717,0.0,0.4822426371581316,1.0,46/188,15.01%,IMP4;RPS24;FCF1;RPL35A;TRPT1;RPL34;RPL39;RPL37;EXOSC8;RPL13;RPL18;KARS1;RPS28;DDX52;RPL12;RPL31;RPL23;POP5;PIH1D2;NOP56;RPF1;RPL41;RPL6;EXOSC4;RRP1B;NOL8;RPL29;IMP3;RPL30;RPL22;METTL3;SNU13;RPL14;EXOSC5;RPL15;DCAF13;RPS2;MDN1;RPL23A;RPL11;RRP36;UTP20;NOL6;LAS1L;ADAT1;KRR1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8737575841528614,-1.6254942830977517,0.02564102564102564,0.47385092022072545,1.0,2/16,5.96%,SLC2A5;SLC5A10
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.8301232709985347,1.6245395361269623,0.0,0.07802029587308354,0.96,2/32,0.09%,LEF1;TGFBR2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.8085207583342424,-1.6233702372544583,0.025,0.4695019179404677,1.0,5/20,7.02%,ASIP;BLOC1S4;BLOC1S2;PMEL;SNAPIN
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8484198343043152,1.6228713649425062,0.01639344262295082,0.08026795960871705,0.96,7/19,10.74%,TGFBR2;SEMA3C;NRP2;TBX20;ROBO2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.7999349555369616,1.6200784778242083,0.014705882352941176,0.08448801422889486,0.96,4/35,3.17%,CDKN2A;THBS1;PTPRO;DMTN
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.7771669375563354,1.6182992189902925,0.0,0.08627883875471754,0.96,4/38,3.34%,LEF1;PDGFRA;NR4A1;EPHA2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.9530215780711415,1.6168928723396376,0.0,0.08665132461791619,0.97,3/11,1.60%,APOLD1;MAFF;CD24
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.8246754463449598,1.6168454483515196,0.0,0.08454897239211917,0.97,6/15,12.41%,THBS1;DMTN;APOD;FAM107A;DUSP22;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.8246754463449598,1.6168454483515196,0.0,0.08454897239211917,0.97,6/15,12.41%,THBS1;DMTN;APOD;FAM107A;DUSP22;PHLDB2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.8210026530292057,1.6165949473678083,0.0,0.08390430074027644,0.97,12/34,10.23%,GRIN3A;GRIN2A;GRIK1;GRIN2B;GRIK2;GRID2;APP;GRM5;GRIN1;GRIA3;HOMER1;GRM6
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.6872567526779272,1.613349125755379,0.0,0.08963730717299065,0.97,41/118,13.22%,COL4A1;EDIL3;COL4A2;CALD1;GAP43;SLIT2;ADCY5;SHC2;TCEAL7;PLPPR4;DAB2IP;THY1;EFNB3;IL1R1;ARHGEF17;ANGPTL2;ASIC3;GFRA2;ABCC8;NUAK1;PTPN21;LARP6;BOC;TNFRSF1A;MAP1B;GUCY1A2;ADGRL2;SCARA3;LIMCH1;BGN;SRRM3;PKDCC;HMOX2;NACAD;TEAD1;EPB41L1;CRMP1;CAP2;MEIS3;FAM13C;PRICKLE2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.85678070459261,1.6124464119749669,0.0,0.0893734554220379,0.98,5/16,5.58%,GRIK1;GRIK2;GRID2;CDH8;UNC13C
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8066629020794249,1.6096320204228252,0.0,0.09391034009557409,0.99,8/27,6.50%,SHISA7;SHISA9;SLC4A10;GRIK2;SHISA8;APP;NETO1;SYP
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.8264592190454767,1.6091588270968284,0.0,0.09401867437056899,1.0,7/21,8.58%,TLR2;THBS1;DMTN;APOD;FAM107A;ROBO2;DUSP22
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.9311812983470096,-1.6090965182194763,0.0,0.5202238032205142,1.0,1/5,3.00%,SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.9311812983470096,-1.6090965182194763,0.0,0.5202238032205142,1.0,1/5,3.00%,SMYD5
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.8888125349713598,1.6080949509202938,0.0,0.09481244202745928,1.0,6/15,5.34%,CACNA1H;CACNA1G;DOC2B;NLGN1;SYT4;RAB15
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.9248337804839034,1.6076580391675548,0.0,0.09463551646696848,1.0,3/13,1.74%,NR4A3;C3;ACSL5
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.8423984085808071,1.6072551333602991,0.0,0.0945971247767182,1.0,1/30,0.01%,LEF1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.8734833588008691,-1.6067287129150998,0.023809523809523808,0.516523720767685,1.0,4/11,9.13%,CSKMT;SMYD2;METTL18;KMT5A
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.64406333202584,-1.6066092883840157,0.043478260869565216,0.5011056483229358,1.0,33/92,20.33%,MRPL10;MRPS21;MRPL52;MRPS7;MRPS22;MRPL15;MRPL36;MRPL18;MRPS16;MRPS10;MRPL47;MRPL40;MRPS9;MTRES1;EEFSEC;MRPS26;MRPL21;EEF1B2;EEF1A1;MRPS33;MRPS34;MRPS18B;MRPS12;MRPL19;OXA1L;MRPS5;MRPL50;MRPS31;PTCD3;MRPL3;EEF2;MRPL17;TSFM
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.9335454005082852,1.60648213490008,0.015625,0.09509085976993706,1.0,6/11,5.58%,RIMS2;DOC2B;SYT1;RIMS3;SYT5;UNC13C
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.8643933003005957,-1.6061633196835885,0.0,0.4888672654605134,1.0,2/9,6.10%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.9636557351331233,-1.6055096031194007,0.0,0.4777697804811414,1.0,1/6,0.08%,SLC2A5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.8146838975196112,1.6054551379249995,0.0,0.09609837225064338,1.0,11/29,12.57%,ANK3;SCN1B;YWHAH;SCN3B;FGF12;NETO1;HECW2;PRKCE;FGF13;FXYD7;HECW1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.9805667453128225,1.6048955202679878,0.0,0.0959148759176387,1.0,1/5,0.34%,ANLN
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.6477082650648365,1.6033681693228774,0.0,0.09843047034311386,1.0,56/175,16.37%,L1CAM;SCN1B;EPHA7;DRAXIN;CNTN2;CNTN4;PTPRO;GAP43;SLIT2;EPHA2;IRS2;RELN;DOK6;EPHA5;SEMA3C;EFNB3;EFNA1;EMB;VLDLR;SH3KBP1;NRP2;SEMA5B;GFRA2;SHANK3;UNC5D;SLIT3;ANOS1;FYN;RAP1GAP;SEMA3D;ROBO2;NPTN;SEMA3B;LAMA5;DCC;KIF5A;GAB2;NEXN;KIF5C;NRXN3;GLI2;VSTM2L;EPHA4;ENAH;OPHN1;PLXNA4;KLF7;LAMA2;PLXNA1;ROBO4;GAB1;PLXNA2;NOTCH3;PIK3CD;PALLD;LAMA3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.9588675541081108,1.6029994012818842,0.0,0.09822513950537073,1.0,1/8,0.56%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.8428145160448901,1.6024462479314008,0.0,0.09752227625309616,1.0,7/24,7.59%,CACNA1H;CACNA1G;DOC2B;SYT1;SYT4;SYT5;SYT13
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.8137687452986339,1.6004404251177147,0.0,0.09931763347358011,1.0,12/26,10.60%,CACNA1H;SCN1B;SCN9A;CACNA1G;YWHAH;SCN3B;SCN1A;SCN2A;KCNH2;CACNA1E;CACNG4;SCN3A
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.6557521109007395,1.600421366557983,0.014925373134328358,0.09837251405826701,1.0,35/92,18.57%,COL4A1;COL4A2;SLIT2;EPHA2;DAB2IP;NUAK1;COL12A1;LAMB1;PTPN21;LARP6;RHBDF1;ADGRL2;SCARA3;KITLG;MYO1B;PKDCC;TANC1;YAP1;GLI2;TEAD1;CAP2;ENAH;CD276;FN1;CCND1;PLOD2;BCAR1;SMARCA1;FSTL1;RBFOX2;FZD7;WNT5A;MESP1;WWTR1;MAGI1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.9501753497784176,1.5999927887397616,0.02127659574468085,0.098055031643783,1.0,2/6,1.03%,CDKN2A;IGF1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.7341988923914334,-1.5997164024612802,0.0,0.49562236611192545,1.0,4/24,6.33%,DAO;IDO1;THNSL2;ACMSD
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.7843236876457037,1.5987805060548137,0.030303030303030304,0.09966785881267116,1.0,6/28,12.33%,CHST8;IGF1;PXYLP1;UGDH;B4GALT7;HS3ST3B1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.8421919333521081,1.5980491490914728,0.0,0.10017631717965378,1.0,11/23,10.91%,SHISA7;SHISA9;NLGN1;SHISA8;RELN;CACNG3;SHANK3;CACNG8;SHANK1;CACNG4;MINK1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.9670511957451415,1.5975751045748483,0.0,0.10067429186896663,1.0,2/5,2.14%,THBS1;ATF3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.7038712650079304,1.5948157791685351,0.0,0.10559085950624807,1.0,9/50,9.13%,S100A10;THBS1;DMTN;THY1;APOD;FAM107A;LIMCH1;DUSP22;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.95548908349949,1.5945280490036928,0.0,0.10510113000868303,1.0,4/8,3.00%,ANK3;SCN1B;PKP2;SCN3B
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.745845679992353,1.593938749090668,0.0,0.10507805621504776,1.0,2/53,0.98%,TGFBR2;SBK1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.9142379830407464,1.592889471673736,0.017857142857142856,0.10641245253805418,1.0,1/10,0.03%,GGT5
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.919653849989488,1.5921161264327255,0.0,0.10637697506851596,1.0,2/12,0.54%,NR4A3;MET
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8210957904966457,1.5905937335487315,0.0,0.10789462716044898,1.0,5/21,7.13%,GRIN2A;GRIN2B;GRIN2D;GRID2;GRIN1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.8399047771752874,-1.5899407254805742,0.023255813953488372,0.5419573401633571,1.0,1/12,1.05%,PTCD2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6511090563344042,1.5885519399891186,0.0,0.10938309363522948,1.0,50/147,16.17%,NR4A3;FOSB;CXCL2;FOSL2;KLF2;TLR2;SOCS3;MAFF;PLK2;ATF3;SERPINE1;NR4A1;PLEK;ZFP36;DUSP1;ICAM1;IRS2;EFNA1;BTG3;CD44;PMEPA1;NFIL3;BCL6;KLF10;BIRC3;LDLR;SMAD3;TRIP10;NAMPT;CD83;GADD45A;NR4A2;CDKN1A;B4GALT5;SPSB1;KLF6;RELB;TNFAIP6;KLF9;PER1;TNIP2;CCL2;FOS;CCND1;IFIH1;GPR183;IER5;PFKFB3;SLC2A3;KLF4
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.7009872453278474,1.588415953952995,0.0,0.10866767925345003,1.0,25/80,10.05%,CACNA1H;RIMBP2;TMEM74B;STMN2;SYT1;FAM163B;SYT4;ADCY5;SHC2;PLPPR1;PRR36;DUSP8;SEMA5B;ABCC8;ST8SIA3;RAP1GAP;CPLX2;FAAH;KCNH2;SYT13;CELF3;CPLX1;FTCD;C2CD4C;CACNG4
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.7236918084057057,1.585201180624364,0.0,0.1143230287573479,1.0,17/92,10.90%,LEF1;TGFBR2;CACNA1H;IL1RAPL1;SLIT2;SLIT3;RAMP3;NLRP12;GHR;PID1;CDK9;ROBO2;CYP1B1;CTNNB1;PTPN9;SMAD3;STAT3
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.9291773383961182,-1.5850535527561533,0.0,0.532799409771772,1.0,3/8,3.58%,H1-2;ATAD2;H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.9291773383961182,-1.5850535527561533,0.0,0.532799409771772,1.0,3/8,3.58%,H1-2;ATAD2;H1-4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.9291773383961182,-1.5850535527561533,0.0,0.532799409771772,1.0,3/8,3.58%,H1-2;ATAD2;H1-4
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.762500465858498,1.5848579974814294,0.015873015873015872,0.11421527849461713,1.0,8/29,14.57%,LZTS1;YWHAH;IL1RAPL1;HECW2;PTPRD;CDKL5;HECW1;SS18L1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.8251637357877533,1.5827254935799668,0.0,0.11749368000696261,1.0,4/24,3.17%,ANXA1;THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.6432593360810038,1.5796025868799697,0.0,0.12385546713819948,1.0,47/186,11.84%,CACNA1H;SLC6A15;HPN;SCN1B;SCN9A;CACNA1G;SLC24A2;KCNH7;KCNH8;KCNJ2;KCNV1;KCNK10;TRPC3;SCN3B;KCNB2;KCNC2;SLC39A14;SCN1A;KCNF1;KCNQ1;SCN2A;KCNK1;TRPM4;ASIC3;ASIC4;ABCC8;KCNQ5;SLC9A9;SLC39A11;KCND3;KCNH2;ABCC9;LRRC55;ATP1A1;KCNQ2;CACNA1C;SLC9A1;KCNC1;ATP1B1;SLC4A11;HCN1;SCN3A;ATP1B3;ORAI1;KCNK12;KCNAB3;GAS6
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6192905787081097,1.5787728354587311,0.0,0.12470231770185015,1.0,47/163,16.37%,MET;COL4A1;COL4A2;CALD1;PTPRO;SULF1;DAB2IP;ARHGEF17;ANGPTL2;NUAK1;COL12A1;LAMB1;TDRD5;PTPN21;RHBDF1;ADGRL2;SCARA3;RHPN1;KITLG;LIMCH1;ITGA3;MYO1B;ENPEP;TANC1;YAP1;CDKN1C;COL4A4;PODXL;TEAD1;EPB41L1;MAPT;CAP2;ENAH;COL4A5;STARD13;PRICKLE2;WSB2;PARD3B;OPTN;NEBL;PLOD2;BCAR1;SMARCA1;FSTL1;PALLD;RBFOX2;LAMA3
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.8682011761343533,-1.5776035982978207,0.02857142857142857,0.5723878411280254,1.0,3/12,4.71%,ID2;TNFAIP3;FOXJ1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.7939709934295067,1.5765344422846643,0.0,0.1281063258790976,1.0,8/34,11.61%,GGT5;ANXA1;WNT8B;CYP1B1;CTNNB1;STAT3;ALPL;ABCA2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7937488951646295,1.5741630396455308,0.013888888888888888,0.13338712881335643,1.0,6/25,8.44%,SOCS3;EGF;PTPRC;GHR;CYP1B1;OCIAD2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6451022367542287,1.5738097878912696,0.0,0.1330153154857665,1.0,33/115,13.45%,COL4A1;PRRX1;CSPG4;GPNMB;COL4A2;CALD1;PPFIBP1;ANGPTL2;NRP2;OSMR;AHR;POSTN;COL12A1;LAMB1;MLANA;PTPN21;FAP;RHBDF1;TYR;EMP1;SH3PXD2B;SRPX2;TANC1;MMP14;YAP1;PXDC1;THBS2;TEAD1;KLC2;STARD13;PPARG;PRICKLE2;FN1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.7135529840475214,1.5736821995333252,0.01639344262295082,0.1323494586766572,1.0,13/59,8.61%,LEF1;EPHA7;GRID2;CAMKV;ZDHHC22;CNTNAP2;EFNB3;SEMA5B;UNC5D;FRAS1;ADAMTS19;CCKBR;KCNQ2
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.681942848893104,1.5716380792532887,0.0,0.13517129915754253,1.0,30/95,11.45%,KCNT2;HPN;SLC24A2;KCNH7;KCNH8;KCNJ2;KCNV1;KCNK10;KCNB2;KCNC2;KCNE4;KCNF1;KCNQ1;KCNK1;ABCC8;KCNQ5;SLC9A9;KCND3;KCNH2;ABCC9;LRRC55;ATP1A1;KCNQ2;SLC9A1;KCNC1;ATP1B1;HCN1;ATP1B3;KCNK12;KCNAB3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.7038226870525663,1.5701911440598502,0.0,0.13774756432238738,1.0,20/70,13.80%,SLITRK1;CCK;ANK3;SLITRK5;CNTN4;SHTN1;APP;PLPPR4;PAK3;BAIAP2;MFSD2A;DVL1;PARD3;MAP1B;DCC;MINK1;SLITRK4;CDHR1;OPHN1;KLF7
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.7745430618316207,1.5695827610936817,0.05,0.1375464336742868,1.0,15/34,16.53%,LZTS1;CSMD3;DAB2IP;VLDLR;HECW2;MFSD2A;DCC;PACSIN1;CDKL5;HECW1;BCL11A;ALK;COBL;CAMK1D;KIAA0319
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6645900902444577,1.5681261664524355,0.0,0.13986531985145909,1.0,17/89,10.36%,GGT5;CSPG4;PAPSS2;DCN;OGN;B3GNT2;CHSY3;CHST15;GGCT;CHPF2;CHST6;VCAN;UGDH;BGN;GSS;OMD;UST
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.5956775563078538,1.5674285403166033,0.0,0.14099348244419543,1.0,62/290,15.87%,LEF1;CXCL2;IL13RA1;TLR2;ANXA1;SOCS3;IL1RAPL1;NPNT;IL27RA;STAT4;ZFP36;NUMBL;CSF2RA;DUSP1;SLA;ICAM1;TEC;IRAK2;YBX3;PIM1;DAB2IP;FOXO1;ERBIN;IL1R1;MYLK3;OSMR;FYN;BCL6;NLRP12;GHR;CHI3L1;PID1;CDK9;TNFRSF1A;FOXO3;LAMA5;GAB2;BCL2L1;PTPN9;SMAD3;SHMT1;FSCN1;SYK;STAT3;INPPL1;PDE1B;IL4R;GAS6;CDKN1A;STX4;TYK2;CDKN1B;FN1;CCL2;FOS;FGF2;BCL2;CCND1;CD4;INPP5D;IL12A;PIK3CD
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.8282981833068067,1.5672867623629765,0.0,0.13981853675716047,1.0,3/18,3.77%,TMEM204;PRKCB;DAB2IP
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6546793886720813,1.5672526917351957,0.0,0.13875740445213816,1.0,37/124,12.05%,NPY;HAPLN2;CNTN2;GAP43;OPCML;ADCY5;SHC2;PLP1;TCEAL7;RCAN2;PLPPR4;DAB2IP;THY1;BCAS1;CTHRC1;PRIMA1;APLNR;APOD;FAM107A;SEPTIN9;PHYHIP;RASL12;MATN2;NRN1;MAG;GFAP;TMEM132C;SEMA3B;BAG3;ART3;NDRG1;ZCCHC24;NACAD;SORBS1;EPB41L1;LGI3;TCEAL6
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.8009453280392755,1.5672391328199047,0.0,0.1376200486779403,1.0,6/29,4.37%,ANK3;SCN1B;YWHAH;PKP2;SCN3B;FGF12
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6946043013056273,1.5663980326683322,0.0,0.13826548754348367,1.0,35/101,16.29%,CACNA1H;ANK3;RAPGEF5;CD24;SRCIN1;ADCY5;SHC2;CP;PLPPR1;KCNQ1;ATP9A;BAIAP3;EPB41L4B;RAP1GAP;RAI2;ZNF704;FAAH;SYT13;SYBU;MAOB;ZBTB7C;HOOK1;KALRN;SLC22A23;TPPP;PODXL;SORBS1;PLEKHH1;DLG3;NEBL;COBL;CAMSAP3;USP54;TOX3;PATJ
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.8432598092097464,-1.5662552177748175,0.05263157894736842,0.6255457692682844,1.0,6/13,11.71%,CHAMP1;IK;KNL1;SPDL1;MIS12;CENPA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.8076782592779193,1.5650704978424017,0.0,0.14009793434702633,1.0,7/24,8.73%,SOCS3;PTK6;SRCIN1;DMTN;PTPRC;THY1;MVP
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6692366256547615,1.5634543461294896,0.0,0.1420838064473037,1.0,22/73,11.54%,COL4A1;PRRX1;PCDH18;DCN;PDGFRA;ABCA8;ACTA2;CALD1;THY1;PODN;ANGPTL2;POSTN;IGFBP7;TNS1;LDB2;FAP;C1R;BGN;ITGA11;SPARC;ZCCHC24;THBS2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7013276014551023,-1.5632498904206267,0.02702702702702703,0.6327425407040522,1.0,13/38,15.30%,RPS24;RIOK2;MRPS7;RPS28;DDX52;RPS27L;RIOK1;SNU13;RPSA;SRFBP1;RRP36;NOM1;LOC102724159
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.6316911275182618,1.561362565998067,0.0,0.14766403862518357,1.0,34/141,12.05%,CA10;SOCS3;GRIN2A;RGS7BP;TMEM235;STMN2;VSTM2B;CNTN2;GAP43;OPCML;ADCY5;OPALIN;PLP1;TCEAL7;RCAN2;PLPPR4;C11ORF87;IGSF21;GRM5;SYNPR;FAM107A;TCEAL5;PHYHIP;GRIA3;GFAP;LUZP2;TMEM132C;ALDH1L1;LY6H;NACAD;SORBS1;TEAD1;LGI3;TCEAL6
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.691949815966295,1.561089591137024,0.029411764705882353,0.14785032901192957,1.0,23/64,17.94%,L1CAM;SNCB;PPFIBP1;FBLIM1;CBLN2;APP;TJP3;PAK3;GRM5;AGRN;DVL1;SNCA;SMAD3;SDK2;TGFB2;MAPT;OPHN1;MYO9A;SLC8A3;SLC8A2;TJP2;VASP;NLGN4X
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.6620480768365897,-1.560704999131231,0.037037037037037035,0.6369778690890029,1.0,15/53,14.10%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;UQCRHL;NDUFV3;COX7B;NDUFA8;NDUFS3;NDUFC1;COX5B;COA6
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.639510915826891,1.5603877823999708,0.0,0.1485690927293262,1.0,29/157,14.31%,LEF1;GPNMB;IGF1;PDGFRA;EGF;THBS1;FLT1;SEMA3C;SEMA5B;NEDD9;FAM107A;LAMB1;SEMA3D;NTRK3;RHOD;MGAT5;PDGFA;MYO1C;SEMA3B;MMP14;STAT3;PODXL;CFAP20;STX4;PDPN;WASHC1;CEMIP;PAK1;TRIM32
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6478200983468757,1.5593609380960716,0.0,0.15016210257896948,1.0,34/115,16.32%,SLITRK1;L1CAM;ANK3;FLRT3;NLGN1;CNTN2;SNCB;ARHGAP39;PPFIBP1;CBLN2;APP;ACHE;PAK3;GRM5;SHANK3;UNC13C;AGRN;DVL1;KIRREL3;SNCA;DOK7;PTPRD;SDK2;DNER;MAPT;LRRC4;PCDHB2;DCTN1;CAST;SLC8A3;PCDHB5;PDZRN3;LRFN5;SLC8A2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.6972394898141323,1.5591774560625467,0.0,0.1494462990148798,1.0,2/70,1.32%,LEF1;SP100
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.7420203412491275,-1.5564169577043618,0.05263157894736842,0.6496108829801347,1.0,4/27,7.16%,AR;RNF6;TRIM68;HEYL
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.6812901292208724,1.555599962105966,0.0,0.1561523387663048,1.0,26/99,14.24%,GGT5;CXCL2;TLR2;ANXA1;ADGRE5;HRH1;THBS1;TRAF3IP2;SIGLEC1;NOD1;ACKR1;TPST1;CD44;CIITA;CHI3L1;TNFRSF1A;HDAC4;STAT3;APOL3;HDAC9;PXK;RELB;ITGAL;TNFAIP6;CCL2;FOS
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.6618787207219209,-1.555531507316455,0.037037037037037035,0.6410324266762562,1.0,14/52,13.74%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;UQCRHL;NDUFV3;COX7B;NDUFA8;NDUFS3;NDUFC1;COX5B
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.7434111585073847,1.5554587274239309,0.0,0.1554885268597174,1.0,16/46,13.96%,ANXA1;RIMS2;IL1RAPL1;SYT1;SEPTIN5;RAB15;RAB3C;SEPTIN4;CPLX2;SNCA;CPLX1;SYTL4;RAB27B;LGI3;STX4;HAP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.8768299087989689,1.5549583743282336,0.017857142857142856,0.1556934585795044,1.0,3/9,8.14%,RFTN1;IL15;MYD88
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.674819897889659,1.5547478562114274,0.01282051282051282,0.15555439048707184,1.0,22/87,12.49%,ENPP2;CSPG4;IGF1;SOCS3;IL15;PTK6;SRCIN1;PTPRC;TEC;RELN;EFNA1;CD44;GRM5;NEDD9;TNFRSF14;GHR;TNFRSF1A;DOK7;STAT3;PARP9;GAS6;EPHA4
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6822122048327885,1.5544125270851747,0.0,0.15533277875267928,1.0,27/86,11.45%,HPN;SLC24A2;KCNH7;KCNH8;KCNJ2;KCNV1;KCNK10;KCNB2;KCNC2;KCNF1;KCNQ1;KCNK1;KCNMB4;ABCC8;KCNQ5;SLC9A9;KCND3;KCNH2;ABCC9;LRRC55;KCNQ2;SLC9A1;KCNC1;HCN1;ATP1B3;KCNK12;KCNAB3
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.614519525536492,1.5536629674180198,0.0,0.15629017152829594,1.0,60/217,13.72%,OPTC;ECM2;COL4A1;ADAMTS4;DCN;CTSS;COL11A2;NPNT;ADAMTSL2;THBS1;SERPINE1;COL4A2;COL8A1;P4HA2;TIMP2;ITGA8;ICAM1;ITGA2;APP;COL21A1;TLL1;ADAMTS10;CD44;POSTN;AGRN;COL12A1;COL27A1;ADAMTS19;COL23A1;LAMB1;SCX;CYP1B1;PDGFA;VCAN;LAMA5;ITGA3;CAPN1;SH3PXD2B;BGN;ITGA11;LOXL1;SCUBE3;MMP14;ITGA9;P3H2;ADAM12;TGFB2;ADAM19;COL9A1;COL4A4;SPARC;GAS6;MMP16;MMP17;ITGB8;COL4A5;FN1;COL5A1;ITGAL;WASHC1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.6887343494864733,1.5532399518993825,0.013513513513513514,0.1564832684192674,1.0,9/56,10.91%,CDKN2A;THBS1;THY1;SKAP1;LIMCH1;PLEKHA2;SLC9A1;CDK6;MINK1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.8301575141626586,1.5529432625227597,0.0,0.15625974333176604,1.0,6/29,3.87%,TLR2;CTSS;P2RY13;PLEK;MYO1F;SIGLEC1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.9244312328518147,1.5528423822170905,0.0,0.15538208031174172,1.0,5/10,2.96%,CACNA1H;CACNA1G;DOC2B;SYT1;SYT4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.7105743000144343,1.5523293136165646,0.014705882352941176,0.15598543748693422,1.0,13/58,10.49%,CLIC1;SLC4A10;GABRB2;GABRG3;GLRA2;GABRD;CLIC4;GABRA1;GABRA5;GABRG2;ANO9;TTYH3;CLCN4
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.7494809934529727,1.5519723560519265,0.03076923076923077,0.1556081914809642,1.0,8/37,9.08%,MTMR7;SGPP2;PLPPR5;PLPPR4;PLPPR1;MTMR11;SYNJ2;PLPP4
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.7662439313442732,1.5515451389775325,0.0,0.15563842527259447,1.0,10/35,14.96%,CLIC1;SLC4A10;CLIC4;ANO9;TTYH3;SLC4A11;CLCN4;SLC26A8;ANO7;SLC13A4
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9117361923574493,-1.5506610437176218,0.0,0.6610977509735069,1.0,2/9,3.58%,H1-2;H1-4
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.7630219961372066,1.550468924961459,0.0,0.15782474846528913,1.0,5/30,10.85%,PROX1;SULF1;ITGA8;TGFB2;GLI2
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.7854546164425632,1.5501134629574802,0.0,0.1577598534206899,1.0,7/28,8.54%,EPHA7;SLIT2;SEMA3C;SLIT3;SEMA3D;PDGFA;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.7639780451262542,1.5476755910609161,0.0,0.1626583104078513,1.0,5/33,3.00%,ANK3;SCN1B;CHRM1;PKP2;SCN3B
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.6045098459421537,1.5469886628208722,0.0,0.16349995346147247,1.0,61/268,15.63%,OPTC;COL4A1;KIF14;COL11A2;STMN2;COL4A2;COL8A1;CORO6;ELMO1;P4HA2;MYO1F;NEFL;CORO7;APP;COL21A1;STMN4;TLL1;MYH11;SHROOM4;COL12A1;COL27A1;COL23A1;FSD1;CLRN1;SNCA;RHOD;SCX;POF1B;GFAP;TPM4;CYP1B1;MYO1C;MYO1B;HOOK1;CLIP2;LOXL1;TLE6;B4GALT7;MYO15A;P3H2;TGFB2;COL9A1;TPPP;COL4A4;ACTN1;INPPL1;FGF13;MAPT;TSPAN14;COL4A5;B2M;COL5A1;KATNAL1;DCTN1;ARHGAP17;PLOD2;PPP1R9B;MTM1;BCAR1;RHOBTB2;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.6253127607119404,1.5446441214331608,0.0,0.1690696911593788,1.0,37/202,14.31%,LEF1;ENPP2;GPNMB;IGF1;PDGFRA;EGF;THBS1;SHTN1;DMTN;PTPRC;DAB2IP;FLT1;SEMA3C;SEMA5B;NEDD9;FAM107A;LAMB1;SEMA3D;NTRK3;RHOD;MGAT5;PDGFA;MYO1C;SEMA3B;ARHGEF7;PRKCE;MMP14;TGFB2;STAT3;PODXL;STX4;FN1;PDPN;WASHC1;CEMIP;PAK1;TRIM32
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6625912689160691,1.5442460860143041,0.0,0.16862188075049894,1.0,31/119,13.08%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTN4;PLP1;CNTNAP2;BICDL1;APP;EPHA5;STMN4;SRRM4;LAMB1;MYT1L;TENM4;FRY;UGDH;MICALL1;PBX3;DCX;TGFB2;GLI2;GPRIN1;HS6ST1;MAPT;ATP8A2;B4GALT5;OPHN1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.7753894338959875,1.5439570119327304,0.01694915254237288,0.16848669941689157,1.0,5/30,4.37%,SCN1B;CHRM3;YWHAH;SCN3B;FGF12
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.9321923958789485,1.5438073406420671,0.0,0.16759188531110153,1.0,1/11,0.61%,PTP4A3
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6346655025368783,1.5436466887357523,0.0,0.16686020156233466,1.0,23/92,8.22%,ENPP2;CA10;GRIN2A;RGS7BP;OPCML;OPALIN;PLP1;RTN1;IGSF21;TGFA;GRM5;SYNPR;APLNR;RAMP3;FAM107A;TNS1;KCND3;CHI3L1;GRIA3;PID1;MAOB;GFAP;TMEM132C
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.6193004789256245,1.5435851743152385,0.0,0.16591272033954907,1.0,34/195,11.84%,C3;KLF2;TLR2;RIMS2;IGF1;P2RY6;CCBE1;NLGN1;SULF1;PRKCB;DMTN;PTPRC;SLC39A14;RELN;DAB2IP;SHANK3;FAS;NTRK3;GRIN1;MGAT5;NPTN;MYO1C;NECAB2;SHANK1;CTBP2;HOMER1;KLK6;YAP1;DLG5;TGFB2;STAT3;ASXL1;SORBS1;GAS6
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6933093768374111,-1.5435806254106568,0.02564102564102564,0.6975525267528063,1.0,17/44,16.94%,TIMM8B;ATP5PF;TIMM13;ATP5MC1;ATP5PB;ATP5PD;APOO;DMAC2L;ATP5MC3;MICOS10;SAMM50;ATP5F1B;TIMM10;TMEM11;LETM1;ATP5F1A;AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.8943460828828662,1.542637282382951,0.014705882352941176,0.16714248924800507,1.0,3/13,4.07%,HPN;CCBE1;MYH9
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.6439370033070885,1.5425232683299772,0.0,0.1663538114697573,1.0,24/120,12.62%,MRAP2;ANK3;TESC;S100A10;PKP2;FYB1;SCN3B;ZDHHC22;KCNB2;EPHA2;KCNIP4;RAB15;RAB3C;RAMP3;TNFRSF1A;MRAP;RAB40B;ATP1B1;PLEKHF1;PACSIN1;ATP1B3;GAS6;FGF13;TSPAN14
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.6728572630129014,1.5424188146027333,0.0,0.16564899745541892,1.0,17/69,9.74%,ENPP2;GRIN2A;DCN;PDE1C;PROX1;PDGFRA;ABCA8;CNTN4;THY1;ANGPTL2;PIEZO2;SLC38A11;GRIA3;ALDOB;PTPRD;BGN;KALRN
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6864127029017407,1.5417770376366118,0.0,0.16656394780464998,1.0,35/126,12.06%,TGFBR2;CDH22;CDH6;SLITRK1;L1CAM;CDH9;FLRT3;IL1RAPL1;CDH19;CDH23;NLGN1;CLDN16;CNTN2;CNTN4;GRID2;ICAM1;CDH8;IGSF21;EMB;FAT2;CDH7;UNC5D;CDH18;KIRREL3;MAG;ROBO2;NPTN;TENM4;PTPRD;NEXN;SDK2;TGFB2;CLDN18;LRRC4;VSTM2L
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.9731263523415659,1.5413792817851952,0.0,0.16652151113005006,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.9274679675777996,-1.5412256163310945,0.0,0.6989291216967318,1.0,1/6,1.45%,HEY2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.8236441490028434,1.541173923583849,0.0,0.16633503532665445,1.0,7/18,7.13%,TGFBR2;GRIN3A;GRIN2A;GRIN2B;SLIT2;SLIT3;GRIN1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.6326189700653821,1.5402759634341667,0.0,0.16787490933454102,1.0,33/145,17.11%,SCN1B;IL1RAPL1;STMN2;CSMD3;PTK6;SRCIN1;RIT2;PTPRO;PLPPR5;RTN4RL1;RELN;DAB2IP;PAK3;SHANK3;MFSD2A;NTRK3;MAG;NPTN;DCC;ZNF804A;PTPN9;SIPA1L1;CDKL5;CRMP1;EPHA4;KIF13B;PAK1;CAMK2B;LPAR1;STX1B;CAMK1D;PTPRS;WNT5A
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.8540744007541156,1.5398875192009462,0.019230769230769232,0.1676109211908506,1.0,5/15,7.13%,GRIN2A;GRIN2B;GRIN2D;GRID2;GRIN1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.7324040745257722,1.5389092808543265,0.014705882352941176,0.16962032973952146,1.0,7/43,7.37%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINF1;SERPINE3;BIRC3
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.9511876278128941,-1.538872882035876,0.025,0.7016415722592733,1.0,1/5,0.03%,ACP3
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.8810833641107219,1.5374568804048112,0.017543859649122806,0.17301499594184594,1.0,1/14,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.5946822717030251,1.5373145117504259,0.0,0.172444049309971,1.0,67/304,15.63%,LEF1;ENPP2;ARHGAP4;GPNMB;ANXA1;IGF1;KIF14;PDGFRA;TMEFF2;EGF;THBS1;SERPINE1;SRCIN1;SULF1;SLIT2;MGAT3;TMSB10;THY1;FLT1;SEMA3C;DUSP10;PODN;SEMA5B;CLIC4;NEDD9;FAM107A;DOCK10;LAMB1;SEMA3D;NTRK3;LDB2;RHOD;MGAT5;FOXO3;CYP1B1;PDGFA;RAP2B;LIMCH1;MYO1C;SEMA3B;DUSP22;NEXN;LMNA;GNA12;MMP14;DLG5;STAT3;MINK1;LDLRAD4;PODXL;CYRIB;EPHA4;STX4;PLXNA4;PDPN;WASHC1;CEMIP;PAK1;TRIM32;FGF2;PHACTR1;CAMK2B;BCAR1;PLXNA1;ROBO4;PLXNA2;CAMSAP3
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.8426315812475282,1.537300383554775,0.0,0.17146220466691914,1.0,7/17,4.87%,CACNA1H;ANK3;SCN9A;CACNA1G;SCN1A;SCN2A;KCNMB4
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6299885567322175,1.5355270147433844,0.0,0.17602997164352205,1.0,17/93,8.39%,COL4A1;PCDH18;COL4A2;CALD1;PPFIBP1;SLIT2;THY1;MCAM;SLIT3;GJC1;LAMB1;PTPN21;LARP6;MAP1B;GUCY1A2;ADGRL2;LIMCH1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.6177691166234931,-1.534788378651989,0.029411764705882353,0.7181871496305078,1.0,7/51,8.91%,H1-2;ATAD2;H1-4;POLR2K;POLR1F;TAF1D;SMARCD1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.8128966904016834,1.5345161267140741,0.03508771929824561,0.1777217255130097,1.0,4/15,8.51%,CCBE1;DCN;DAB2IP;MYO1C
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),0.9881649718371597,1.5344424114615478,0.0,0.1768627007108263,1.0,1/5,0.01%,LEF1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.6404206857012579,1.5331947323435304,0.0,0.18009301948347667,1.0,44/123,20.74%,GAS2L3;PROX1;CORO6;ELMO1;MYO1F;WAS;DMTN;CORO7;BAIAP2L1;SHROOM4;NEDD9;BAIAP2;CLRN1;FHOD1;RHOD;POF1B;TPM4;MYO1C;MYO1B;TLE6;TCAP;MYO15A;ACTN1;INPPL1;ENAH;NEBL;ARHGAP17;PPP1R9B;BCAR1;SPIRE1;COBL;RHOBTB2;NEB;ERMN;SPIRE2;CGNL1;FHOD3;DSTN;FLNA;MPRIP;RHOBTB1;MYO1E;SAMD14;EMP2
prerank,PanglaoDB_Augmented_2021__Pericytes,0.6342983838545408,1.531681587865531,0.0,0.182676862586361,1.0,37/111,11.65%,ECM2;COL4A1;PRRX1;CSPG4;PCDH18;DCN;PDGFRA;ABCA8;COL4A2;ACTA2;ICAM1;ASPN;THY1;PODN;ANGPTL2;MCAM;SLIT3;POSTN;APLNR;ZIC1;SLC38A11;TNS1;COLEC11;LDB2;RASL12;ABCC9;FAP;STEAP4;C1R;MYO1B;BGN;ADGRF5;PDZD2;ALPL;SPARC;THBS2;LHFPL6
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.8136088269277122,1.5315552142153839,0.0,0.18200540555406927,1.0,11/26,13.08%,NPY;PROX1;DRAXIN;GRID2;MDGA2;SOX4;CTNNB1;AGTPBP1;MAPT;NR4A2;OPHN1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.7827204881806779,-1.5300115307188549,0.024390243902439025,0.7398918562095309,1.0,3/15,8.96%,DAO;THNSL2;CTH
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6245931486450116,1.5290163847064724,0.0,0.1876870950701018,1.0,32/107,13.22%,COL4A1;PCDH18;EDIL3;COL4A2;SLIT2;PLP1;TCEAL7;DAB2IP;THY1;EFNB3;GFRA2;NUAK1;TUSC3;PTPN21;LARP6;OLFML2A;BOC;MAP1B;ADGRL2;SCARA3;SEMA3B;YAP1;PCDHB15;GLI2;TEAD1;EPB41L1;CAP2;MEIS3;ENAH;FAM13C;RUNX1T1;PRICKLE2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7747770539973678,1.5289195883643258,0.0,0.18686150795572826,1.0,6/27,8.93%,EGF;PTK6;PTPRR;ERBIN;NRG1;NRG2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.7176805213295766,1.5288048665181937,0.0,0.185979444808865,1.0,4/43,4.45%,GGT5;CXCL2;CD24;ERBIN
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.87693367642638,-1.528092402684274,0.03773584905660377,0.7391993124749638,1.0,2/9,4.45%,RTRAF;SIDT1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.7789093499794225,1.5275558625068468,0.016666666666666666,0.18970238784450774,1.0,3/20,4.12%,SLC24A2;PLK2;ACHE
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.9492378938944352,1.5274702145147387,0.0,0.18887943769338397,1.0,1/10,0.03%,GGT5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.7895118974256733,1.5274266809664516,0.0,0.18793604915932458,1.0,7/23,4.15%,DCN;SP100;THBS1;SLIT2;DAB2IP;PTPRR;DUSP10
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6662258641068186,1.5272386230592963,0.015151515151515152,0.18751954763014542,1.0,8/52,6.03%,ELMO1;SULF1;SHC2;DAB2IP;FLT1;NRP2;BAIAP2;FYN
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.8279279639214505,1.5268711038322442,0.028985507246376812,0.18794188242176044,1.0,2/11,6.50%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.7946226008937406,1.5267773304144325,0.0,0.18733857969843346,1.0,8/19,8.65%,GRIN2A;GRIN2B;GRIN2D;ITPR3;GRIN1;RYR2;JPH4;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.9212386869495377,1.5267765205759274,0.018867924528301886,0.18425058113197576,1.0,2/8,3.21%,EGF;MGAT3
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.9212386869495377,1.5267765205759274,0.018867924528301886,0.18425058113197576,1.0,2/8,3.21%,EGF;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.9212386869495377,1.5267765205759274,0.018867924528301886,0.18425058113197576,1.0,2/8,3.21%,EGF;MGAT3
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.7365223097022436,1.5253793881894184,0.029850746268656716,0.18705092330511888,1.0,5/34,4.00%,ECM2;NPNT;PTPRO;DMTN;THY1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.7111807180163925,1.5250990749867757,0.0,0.18659300388848862,1.0,18/80,5.54%,NR4A3;CXCL2;HLA-DRA;GPNMB;TLR2;P2RY6;CTSS;ADGRE5;SLC15A3;PLEK;SLA;MYO1F;GPR34;PTPRC;SIGLEC1;MARCHF1;NRP2;AHR
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.6239881488934149,1.5247636180359432,0.012987012987012988,0.18638698690554004,1.0,20/107,12.49%,ARHGAP4;TMEFF2;SERPINE1;SULF1;SLIT2;DAB2IP;THY1;PTPRR;DUSP10;PODN;CLIC4;FOXO3;CYP1B1;RAP2B;LIMCH1;DUSP22;DLG5;LDLRAD4;PHLDB2;EPHA4
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.8587985840328216,-1.5244376832462438,0.0392156862745098,0.7495510188232324,1.0,2/8,5.27%,DAO;THNSL2
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.8276374880287073,-1.5231295366458137,0.0,0.7463195898761034,1.0,3/9,7.30%,PGP;ACMSD;MST1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.6434199115366381,1.5227686261495983,0.0,0.19263082184817953,1.0,33/88,18.70%,C1QL1;SLIT2;DAB2IP;TRAM1L1;EFNB3;TUSC3;PTPN21;LARP6;BOC;MAP1B;ADGRL2;SCARA3;B4GALNT1;CNN3;YAP1;GLI2;TEAD1;EPB41L1;IGDCC4;CAP2;MEIS3;ENAH;CD276;BCAR1;SMARCA1;KIAA1549;SEZ6L2;RBFOX2;PFN2;FZD7;CTXN1;MAGI1;FHOD3
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.735605952375118,-1.5226816842538882,0.05555555555555555,0.7360281911640505,1.0,8/22,14.09%,MT1E;MT1A;AKR1C3;MT1G;MT1F;HSF1;MT2A;MT3
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.8432183259987288,1.5224866909992698,0.0,0.19318873041629628,1.0,7/18,10.20%,PTK6;SRCIN1;PTPRC;THY1;DUSP22;MVP;ZFYVE28
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.8356283463365477,1.5209601731904525,0.05,0.19756813067260368,1.0,3/13,5.32%,HPN;SCN1A;PIEZO2
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.6636108217740284,1.520492306130055,0.014492753623188406,0.19785228666210394,1.0,19/83,13.96%,RIMS2;PLD1;CD22;SYT1;RIT2;PTPRC;SEPTIN5;ATP9A;RAB15;RAB3C;SEPTIN4;CPLX2;CPLX1;SYK;PACSIN1;LGI3;STX4;OPHN1;HAP1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7420681660026669,-1.5203818809562117,0.05405405405405406,0.7389767776461277,1.0,8/21,14.09%,MT1E;MT1A;AKR1C3;MT1G;MT1F;HSF1;MT2A;MT3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8203457105879518,1.5202858215444075,0.05084745762711865,0.19735197857780423,1.0,6/19,10.74%,PROX1;PKP2;NRG1;RYR2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.73231260078742,1.519242876563136,0.014925373134328358,0.19978703950288787,1.0,12/36,4.87%,CACNA1H;ANK3;SCN9A;CACNA1G;YWHAH;KCNJ2;SCN3B;KCNE4;SCN1A;KCNQ1;SCN2A;KCNMB4
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.7832387714352679,1.5190684196376731,0.0,0.19916289187498862,1.0,8/29,7.59%,RIMS2;SYT1;SYT4;SEPTIN5;RIMS3;SYT5;RAB15;SYT13
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.9154079917686765,1.5190232948271511,0.0,0.19824931759428363,1.0,1/8,0.92%,BOK
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.8607456796050215,-1.5186750270939533,0.02631578947368421,0.7387594026617178,1.0,5/11,11.10%,CHAMP1;IK;KNL1;SPDL1;MIS12
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5893675612409529,-1.5185848037835616,0.0,0.7267619436397199,1.0,18/90,17.21%,RP9;PDCD7;SF3B4;DHX16;SCNM1;ZCRB1;RBM8A;U2AF1;PRPF18;RRAGC;YJU2;SNRNP25;LSM4;PRPF8;SRSF2;PRPF3;RNPC3;LSM1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.8090290725828025,1.5182732695705923,0.046153846153846156,0.19905250339706212,1.0,4/18,4.13%,RIMS2;NLGN1;SEPTIN5;RIMS3
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.7833357810781886,-1.5178237890540955,0.07317073170731707,0.7188992761290867,1.0,1/9,1.38%,MID1IP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.8125221964915434,1.51770622847549,0.0,0.1997303075213561,1.0,4/19,4.37%,SCN1B;YWHAH;SCN3B;FGF12
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7788036476691013,1.5176132763613894,0.015873015873015872,0.19929400635285233,1.0,7/30,7.74%,ANK3;P2RY6;CTSS;RELN;SHANK3;STAC2;LRRC55
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.9064199559452021,1.5166331848196681,0.0,0.2014131357818781,1.0,3/9,5.59%,TGFBR2;PDGFRA;EIF4A3
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.9566984692912374,1.5164715235292339,0.0,0.20091505807916743,1.0,2/8,1.88%,RECQL4;BLM
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.7831705937133062,-1.5163004589251081,0.0,0.7172482454921653,1.0,6/16,16.24%,COX18;COX20;SMIM20;COX19;COA6;OXA1L
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.9567560209347725,1.516195013900302,0.0,0.2013402999794557,1.0,2/7,1.88%,RECQL4;BLM
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.8400834239514811,1.515909654383763,0.029411764705882353,0.20158996654299924,1.0,6/20,9.13%,NR4A3;KCNQ1;GNG2;RYR2;SNCA;SLC9A1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7734125880477231,1.5151740325827145,0.0,0.2028599722516334,1.0,14/25,8.65%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNE4;SCN1A;KCNQ1;FGF12;GJC1;KCNH2;RYR2;ATP1A1;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7735823767513939,1.514903139745255,0.014925373134328358,0.20259076378525406,1.0,6/23,13.96%,P2RY6;THY1;APLNR;SNCA;CEMIP;HAP1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.8547002820622978,1.5145387159441186,0.018518518518518517,0.20277431709093602,1.0,2/14,1.03%,CACNA1H;IGF1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8722876739556433,-1.5140959963658647,0.04878048780487805,0.7217575573670334,1.0,1/12,0.09%,NGF
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.6451481902598482,1.5140361774857418,0.0,0.20368391331540053,1.0,35/118,16.40%,HPN;MET;SCN1B;TLR2;HRH1;KCNJ2;IL15;RASGRP1;SLC7A2;SERPINE1;CD55;ICAM1;IRAK2;IRF7;IL1R1;OSMR;AHR;APLNR;LDLR;MMP14;NAMPT;SLC7A1;IL4R;ITGB8;CDKN1A;KLF6;TNFAIP6;PDPN;CCL2;LPAR1;CHST2;CD70;GPR183;RGS16;P2RX7
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.7916408991732173,1.51401377666982,0.0,0.20269033325044736,1.0,4/29,7.40%,TGFBR2;APLNR;RYR2;TBX20
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.6771268366477817,-1.5135243232043845,0.02857142857142857,0.7148393614305022,1.0,4/30,4.71%,CFAP53;PKD1L1;ENKUR;FOXJ1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.8003219296011044,1.5132907300096146,0.06153846153846154,0.20370239475205015,1.0,6/18,8.86%,RIMS2;NLGN1;RELN;SHANK3;GRIN1;SHANK1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.9146392834643124,1.5130693862874094,0.0,0.2033804427686757,1.0,3/8,5.59%,TGFBR2;PDGFRA;EIF4A3
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.6663692094107684,1.512470502418335,0.0,0.20443436626704786,1.0,22/74,13.55%,COL4A1;PRRX1;TEAD2;CSPG4;PCDH18;COL4A2;CALD1;SLIT2;DAB2IP;COL12A1;LAMB1;PTPN21;RHBDF1;PDGFRL;BOC;SCARA3;YAP1;GLI2;TEAD1;ENAH;PPARG;COL5A1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.8954542574616886,1.512193826067116,0.03636363636363636,0.20498636824560235,1.0,4/9,4.07%,ANXA1;MSMP;PTPRO;FLT1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.6125025738122478,1.511767604791887,0.0,0.20498923078391046,1.0,36/168,13.98%,MRAP2;ANK3;RFTN1;TESC;S100A10;PKP2;FYB1;NLGN1;SCN3B;ZDHHC22;KCNB2;EPHA2;THY1;KCNIP4;SHANK3;RAB15;RAB3C;AGRN;RAMP3;DVL1;TNFRSF1A;MRAP;RAB40B;SH3PXD2B;ATP1B1;PLEKHF1;PACSIN1;ATP1B3;GAS6;FGF13;LRRC4;TSPAN14;SYNE3;ITGAL;DLG3;PICK1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.758861768307597,1.5117638539099825,0.06060606060606061,0.20407184830554814,1.0,12/29,13.72%,EGF;SRCIN1;RELN;TGFA;EFNA1;GRM5;NEDD9;FYN;DOK7;GAS6;EPHA4;DLG3
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.9612324003857333,-1.5102871117230816,0.02127659574468085,0.7302326935958295,1.0,1/7,0.09%,NGF
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.6239078893777307,1.50820170065303,0.0,0.2146385233596956,1.0,36/127,13.55%,COL4A1;PRRX1;TLR2;PCDH18;EDIL3;PDGFRA;RGS7BP;KCNJ2;COL4A2;OPCML;PLP1;TCEAL7;RCAN2;PLPPR4;THY1;ANGPTL2;CD44;SYNPR;POSTN;APLNR;FAM107A;LDB2;PTPN21;RASL12;BOC;ADGRL2;SCARA3;PTPRD;BGN;COL9A1;SPARC;THBS2;DBI;FAM13C;PRICKLE2;COL5A1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6987141966707207,1.5079172853597542,0.028985507246376812,0.2141670527265262,1.0,23/73,12.25%,MYT1;PCDH8;STMN2;GAP43;CAMKV;PLPPR5;SYT4;ZDHHC22;KCNB2;ACHE;EFNB3;CDK5R2;VGF;SULT4A1;NYAP1;KCNQ2;CELF3;KIF5A;C2CD4C;CACNG4;DPYSL5;CRMP1;NEFM
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.6767797212071814,1.5077031739706224,0.0,0.21380673161188607,1.0,16/85,7.35%,CDH22;CDH6;SLITRK1;CDH9;FLRT3;CDH19;PKP2;NLGN1;FBLIM1;CDH8;ACHE;SHANK3;CDH7;CDH18;GJC1;KIRREL3
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7532903464714145,1.507432407402046,0.029411764705882353,0.21382162601899252,1.0,10/29,18.48%,NLGN1;SRCIN1;RELN;EFNA1;SHANK3;SIPA1L1;EPHA4;CAMK2B;CUX2;NGEF
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.853602773641492,-1.5070755707088273,0.05405405405405406,0.7407537507196766,1.0,4/7,13.86%,NUDT16L1;TFIP11;HSF1;ERCC6
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6781545893974077,1.5066869616508676,0.014285714285714285,0.2156342156023373,1.0,14/51,15.54%,ANXA1;PLEK;DMTN;THSD7B;MYH9;NEDD9;PDLIM4;MKLN1;MINK1;SIPA1L1;PAK1;PHACTR1;BCAR1;GAB1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.8142271035195714,1.5063435445871143,0.017543859649122806,0.21574581868637585,1.0,10/17,16.32%,HTR2C;TYMP;NPTX2;DLGAP3;APP;NPTX1;DLGAP1;DLGAP2;SLC8A3;SLC8A2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.7841042887950237,1.5061423192645762,0.0,0.2155420439114013,1.0,6/25,7.18%,LEF1;HLA-DRA;DUSP10;SOX4;BCL6;TESPA1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.9154998576359947,1.5055825417015685,0.0,0.21659180437814837,1.0,3/10,2.61%,SIX3;KIF14;NUMBL
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.627796663690458,1.5054290030789068,0.0136986301369863,0.21612645653322327,1.0,35/120,19.39%,TGFBR2;KIF14;SRCIN1;PTPRC;RELN;DAB2IP;INCENP;AGAP2;EFNA1;PAK3;GRM5;NEDD9;PAK4;SNCA;DOK7;MMD;TGFB2;MINK1;GAS6;EPHA4;CDKN1A;PRKCD;DLG3;PAK1;IQGAP1;CD4;SLC8A2;NOX4;STK3;CALM3;SYAP1;TELO2;MAP2K3;RAP1A;STK11
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.6918411622346814,1.5053064555433577,0.04838709677419355,0.2157686822239939,1.0,13/42,15.37%,YWHAH;STMN2;GRIN2B;PTPRO;RTN4RL1;FYN;MAG;DCC;PTPN9;CRMP1;EPHA4;LPAR1;STX1B
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.8157867292352312,1.5051117465920765,0.014925373134328358,0.21551702775403206,1.0,8/18,16.40%,TRPC3;THY1;APLNR;RAMP3;GRIN1;SNCA;CEMIP;P2RX7
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.9553648104444363,1.5045080327798086,0.017543859649122806,0.21670172345772426,1.0,1/6,0.37%,HPN
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.8838461193902449,1.5041167420189594,0.0,0.21665210639447688,1.0,1/10,0.18%,NR4A3
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.7941652819345499,1.5028980073420175,0.028985507246376812,0.2194456217476577,1.0,9/22,11.93%,TESC;SERPINE1;EPHA2;ADA;EFNA1;CYP1B1;TGFB2;SYK;P2RY12
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.9492363598733224,1.5027605930615326,0.0,0.2189800007598124,1.0,1/7,0.12%,ENPP2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6976915646486903,1.5026132316375387,0.043478260869565216,0.21846816705886676,1.0,17/61,13.45%,KIF14;PROX1;TMEFF2;ATRNL1;SRCIN1;ITGA8;EPHA2;RELN;EFNA1;LAMB1;POF1B;LAMA5;ACTN1;PXN;RADIL;OPHN1;FN1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.9469910473719614,1.5025354295921276,0.0,0.21776044544565817,1.0,2/8,0.95%,CDKN2A;ANXA1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.8173356305364347,1.5022341576805547,0.03125,0.2178569154866758,1.0,11/21,8.65%,CACNA1H;SCN1B;SCN9A;CACNA1G;YWHAH;KCNJ2;SCN3B;SCN1A;SCN2A;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.8889993006526518,1.5021938606570715,0.0,0.21715800558998288,1.0,2/12,1.03%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7800109230399184,-1.5019873829709982,0.0851063829787234,0.7676985364610959,1.0,5/14,16.24%,COX18;COX20;SMIM20;COX19;OXA1L
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.8780310238195813,1.5019086275933518,0.017241379310344827,0.2173551360443017,1.0,2/10,2.21%,CDKN2A;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.874623016080947,1.5013326012302615,0.015384615384615385,0.2185351815679334,1.0,3/16,1.12%,NR4A3;IGF1;P2RY6
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.801889626292742,1.5012621815985217,0.01694915254237288,0.21794039836354842,1.0,5/16,10.74%,THBS1;SLIT2;SLIT3;YAP1;TGFB2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.6299069627489979,1.5005670016108055,0.02857142857142857,0.2191078569069813,1.0,21/123,8.31%,CDKN2A;ARHGAP4;RASGRP2;IGF1;PLK2;RASGRP1;PLD1;RIT2;ELMO1;SHTN1;CDC42EP3;WAS;SHC2;ARHGDIG;WASF1;ARHGEF3;CDC42EP1;EPS8L2;RHOD;MRAS;RAP2B
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.7871537420830291,1.5001809807012787,0.0,0.21929333470966486,1.0,7/27,8.54%,THBS1;SLIT2;SEMA3C;SEMA5B;SEMA3D;ROBO2;SEMA3B
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.6742029814372221,1.4991685375702277,0.0,0.22136469653999097,1.0,31/70,21.39%,NPNT;SH3GL2;CEP170B;PCP4;APP;PRR36;ARHGEF17;CYS1;ABCC8;CDK5R2;GLIS2;SCG5;GLIS3;EPB41L1;INPP5J;CRMP1;STARD13;CD276;BCAR1;SPP1;CAMSAP3;SEZ6L2;PDZRN3;SLC8A2;SCAMP5;SLC7A8;LRP2;CAMK1G;TMEM151A;ARNT2;FGFR1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.5975794881967083,1.4987835035149177,0.0,0.22134631819653014,1.0,33/175,14.63%,TGFBR2;BOK;TLR2;ELMO1;APP;FOXO1;SCN2A;PLSCR1;SEPTIN4;AHR;FAS;PAWR;FAP;ZBTB16;PAK4;MYD88;HK2;DCC;CSRNP1;CASP10;MX1;BCL2L1;TNFRSF19;DHCR24;PRKCE;PDE1B;GADD45A;BBC3;PRKCD;TNFRSF10B;FADD;RNF152;BCL2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.749094067225752,1.4986928883632904,0.08196721311475409,0.22070422932636313,1.0,3/20,7.37%,TLR2;IRF7;BIRC3
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.8143877216536655,1.4985460045730221,0.0,0.22001972476536286,1.0,2/25,1.32%,LEF1;SP100
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.6836923368475487,1.4978714530107342,0.013333333333333334,0.2217204093776755,1.0,28/65,19.55%,TYMP;ADGRE5;TC2N;ZFP36;PIM3;CD55;RPS6KA1;IRF7;OSTF1;ANO9;IL4R;DTX2;ST6GALNAC2;PRKCD;FRAT2;ABTB1;RHBDF2;TFAP2C;HLA-E;IFIH1;JUNB;B3GALT4;VASP;TBC1D10A;MAP2K3;IFI35;LITAF;SBNO2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.7324761743597962,1.4966972992995409,0.031746031746031744,0.22468657068173434,1.0,3/17,10.05%,YBX3;SCN2A;SLC4A11
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.6371597189945658,1.4941842160265424,0.0,0.2330086074082334,1.0,24/123,12.62%,MRAP2;ANK3;TESC;S100A10;PKP2;FYB1;SCN3B;ZDHHC22;KCNB2;EPHA2;KCNIP4;RAB15;RAB3C;RAMP3;TNFRSF1A;MRAP;RAB40B;ATP1B1;PLEKHF1;PACSIN1;ATP1B3;GAS6;FGF13;TSPAN14
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7610901508491632,1.493999627534883,0.046153846153846156,0.23280175900569489,1.0,13/26,18.36%,RIMS2;NLGN1;RELN;APP;SHANK3;GRIN1;SHANK1;SLC8A3;STX1B;SLC8A2;CUX2;NLGN4X;MTMR2
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.7513380668118574,1.493543346333167,0.056338028169014086,0.233626415969932,1.0,1/17,0.12%,ENPP2
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.6154554319959274,1.492936819402757,0.0,0.23491052585076558,1.0,29/156,16.65%,TGFBR2;VRK2;SBK1;PLK2;PRKCB;PRKCG;CAMKV;RPS6KA1;STK32B;GRK2;GALNT16;IKBKE;PRKCE;PRKCH;HIPK3;STK32A;GAS6;PRKCD;CDC7;HIPK1;RPS6KA6;MAPKAPK5;STK32C;RPS6KB2;HIPK2;CAMK1D;NEK6;HPF1;PINK1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.7482328387334622,1.4929297326264586,0.014925373134328358,0.23395560501397386,1.0,11/37,11.89%,HPN;ADAMTS4;CTSS;TIMP2;TLL1;CD44;CAPN1;SH3PXD2B;SCUBE3;MMP14;MMP16
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.9627318218818227,1.492734199011772,0.0,0.23379451338817173,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.66324225232192,1.4920527130884467,0.015625,0.23570717553848808,1.0,20/72,17.31%,CACNA1G;GRIN2A;SLC24A2;GRIN2B;GRIN2D;TRPC3;ATP2B3;TRPM4;GRIN1;MCUB;CACNA1C;ORAI1;GAS6;MCOLN2;STOML2;SLC8A3;SLC8A2;P2RX7;SLC8A1;SLC24A1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.7006902415832629,1.4919732406933048,0.015873015873015872,0.23512751709373791,1.0,16/47,16.07%,LEF1;TGFBR2;IL15;EPHA2;MYH9;PIR;PML;GAB2;PDE1B;CDKN1A;PPARG;HLA-DRB1;CD4;GPR183;PIK3CD;RARA
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9117083152266295,-1.4917271126897649,0.07142857142857142,0.8376656485171776,1.0,1/6,0.72%,BUD23
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.9548346352796115,1.4915669899924977,0.0,0.23574033481288975,1.0,2/6,0.95%,CDKN2A;ANXA1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7411293322225813,1.4913191565449035,0.028169014084507043,0.23580222038211393,1.0,13/38,14.10%,GRIK1;NLGN1;SYT1;RELN;CACNG3;GRM5;SHANK3;CACNG8;CACNG4;HOMER1;GRM6;OPHN1;CCL2
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.7766046008919989,1.4904800749787808,0.0,0.2376312322013006,1.0,13/29,14.48%,GRIN2A;GRIN2B;NLGN1;NEFL;RELN;APP;GRIA1;GRIN1;GRIA3;CAPN1;DLG3;CCL2;CAMK2B
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.904541801214831,1.4894059174603074,0.01818181818181818,0.24003266235410248,1.0,3/8,7.84%,NPNT;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.660544477316664,1.4891592973428447,0.02857142857142857,0.2399420181288492,1.0,15/74,13.51%,CDKN2A;SH3GL2;SLIT2;IRS2;DAB2IP;NTRK3;PID1;CDKN1C;HDAC4;NIBAN1;MAPT;TERF2IP;CDKN1A;CDKN1B;FBP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.8083284204724706,1.4887873469433728,0.03333333333333333,0.239896875143988,1.0,3/21,1.03%,NR4A3;MLIP;IGF1
prerank,MSigDB_Hallmark_2020__Apoptosis,0.6182729568155325,1.4879246228298206,0.0,0.2412351604767167,1.0,22/123,13.34%,LEF1;ANXA1;DCN;ATF3;TIMP2;APP;PLPPR4;BTG3;CD44;NEDD9;FAS;BIRC3;EMP1;CTNNB1;BCL2L1;BGN;LMNA;TGFB2;GADD45A;CDKN1A;ENO2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8646135003476062,-1.487913621195173,0.058823529411764705,0.8548927099161883,1.0,2/5,9.71%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.9261058045505319,1.4875930406979214,0.038461538461538464,0.24158531280028744,1.0,2/5,1.74%,LEF1;TESC
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7672595605143652,1.4872764981946918,0.029411764705882353,0.24140151691129733,1.0,4/23,7.82%,NPY;GLRA2;MCHR2;HCRTR2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.8655075290740109,1.4867320725511366,0.0,0.24218930868433874,1.0,3/15,2.94%,NR4A3;IGF1;TRPC3
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.768597892590538,1.486353349242626,0.030303030303030304,0.2426635378477943,1.0,12/31,12.75%,RIMS2;DOC2B;SYT1;RIMS3;SYT5;UNC13C;CPLX2;SNCA;PCLO;CPLX1;DNAJC5;STX4
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.915425787707618,1.485558846995721,0.015384615384615385,0.24449071300744285,1.0,1/7,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.7823843558779625,1.4855255252897714,0.047619047619047616,0.24368832320034728,1.0,3/30,1.12%,NR4A3;IGF1;P2RY6
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.788470719618327,1.4843406332538254,0.05,0.24636626422051822,1.0,7/24,9.13%,PLEK;WAS;SHANK3;FHOD1;SYNPO2L;SHANK1;SLC9A1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.9170625024478707,-1.4840889773056753,0.0,0.8708365041639706,1.0,2/7,3.61%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.7867982585593644,1.4839419753700354,0.05405405405405406,0.24686074965541113,1.0,4/18,10.74%,EPHA7;FOXO3;CTNNB1;TGFB2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7931040169678886,1.4838220364690866,0.0,0.24653260112800374,1.0,3/27,7.40%,TGFBR2;APLNR;TBX20
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7096248977060364,-1.4837166883784105,0.07317073170731707,0.861818086001911,1.0,11/24,15.46%,NIFK;NSA2;DDX18;RPF1;RPL7L1;SNU13;ZNHIT3;RRP15;MAK16;LAS1L;RPF2
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.8544504511434692,1.4834328704263693,0.03508771929824561,0.24655042447973366,1.0,3/10,11.37%,CACNA1H;ADAM12;ERVW-1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.747572917433508,1.4831252500186272,0.047619047619047616,0.2465681143232109,1.0,3/28,5.67%,GGT5;AWAT1;ALOX12
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.7455287197814553,1.4822238813548987,0.030303030303030304,0.24837561308456294,1.0,11/37,11.55%,SLC32A1;RIMS2;SYT1;GAD2;CPLX2;DVL1;SNCA;PCLO;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.6743362512048818,1.4818492138438977,0.0,0.24855622316263515,1.0,18/61,11.03%,SLC6A15;SCN1B;SCN9A;SLC24A2;SCN3B;SCN1A;SCN2A;KCNK1;TRPM4;ASIC3;ASIC4;SLC9A9;ATP1A1;SLC9A1;ATP1B1;HCN1;SCN3A;ATP1B3
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.7402322899756865,-1.4807672830518628,0.046511627906976744,0.8725352864681073,1.0,9/28,13.43%,LSM7;LSM3;EXOSC8;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.6098510039752563,1.4806521704895417,0.0,0.25220425569811383,1.0,50/156,16.50%,CDH6;ECM2;COL4A1;PRRX1;EDIL3;DCN;THBS1;IL15;SERPINE1;COL4A2;ACTA2;CALD1;SLIT2;ITGA2;THY1;CTHRC1;CD44;PMEPA1;SLIT3;OXTR;POSTN;COL12A1;FAS;FAP;MATN2;TPM4;VCAN;BGN;BASP1;PDLIM4;LOXL1;MMP14;ADAM12;SPARC;THBS2;GADD45A;CAP2;ENO2;FN1;COL5A1;LAMA2;FGF2;PLOD2;RGS4;SPP1;CD59;FSTL1;PFN2;LAMA3;TNFRSF11B
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.7481117324487526,1.4805437184544505,0.0,0.25186365471728117,1.0,15/32,13.72%,PTK6;SRCIN1;PTPRC;RELN;APP;THY1;EFNA1;GRM5;NEDD9;RAP2B;MVP;DOK7;GAS6;EPHA4;DLG3
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9375071561455545,1.4798959077908962,0.0,0.2527852854917629,1.0,1/5,0.07%,NPY
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8233368429956207,-1.4798263523553727,0.11904761904761904,0.8690026631460069,1.0,3/12,6.17%,RPP25L;TRMT10C;POP5
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7537539938628575,-1.4794554476674797,0.08108108108108109,0.8601682783445259,1.0,2/19,1.59%,BUD23;TFB2M
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.6898627281987829,1.4793940199035933,0.0,0.253825675687488,1.0,9/42,8.65%,HTR2C;KCNC2;ABCC8;GIPR;GLP1R;ITPR3;CACNA1E;HADH;CACNA1C
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.7776505585173857,1.4793208901597161,0.0,0.2531077266493851,1.0,8/25,11.22%,MET;COL4A1;SLIT2;RYR2;TBX20;CTNNB1;GLI2;PODXL
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.9255466529082829,1.4790494435450219,0.03773584905660377,0.2531010571440716,1.0,1/6,1.34%,PROX1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.6837481125155279,1.4785252580833694,0.028985507246376812,0.25404622995596177,1.0,17/60,11.97%,SLC6A15;SCN1B;SCN9A;SLC24A2;SCN3B;SCN1A;SCN2A;KCNK1;ASIC3;ASIC4;SLC5A4;ATP1B1;SLC4A11;HCN1;SCN3A;ATP1B3;FGF13
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.6999076864384406,1.4783249819939424,0.028985507246376812,0.25387128869724107,1.0,15/56,13.83%,ANK3;YWHAH;KCNJ2;CHRM1;SYT1;SYT4;SYT5;SYT13;SNCA;ATP1A1;TF;PXK;SYT12;B2M;PER1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.5580210860299952,1.4777151196954714,0.0,0.25525882204570366,1.0,80/376,16.84%,CXCL2;ST18;HLA-DRA;IL13RA1;ANXA1;SOCS3;SP100;IL15;IL27RA;STAT4;NUMBL;CSF2RA;SLA;ICAM1;LMNB1;IRS2;TEC;IRAK2;TRAF3IP2;PIM1;IRF7;NOD1;FOXO1;IL1R1;TRIM5;MAP3K14;CD44;OSMR;TNFRSF14;FYN;BCL6;CIITA;SAMHD1;GHR;BIRC3;TRIM22;TCP1;TNFRSF1A;PML;FOXO3;MYD88;LAMA5;GAB2;MX1;BCL2L1;FSCN1;YAP1;SYK;STAT3;INPPL1;IL4R;CDKN1A;PRKCD;STX4;TYK2;EIF5A;IL17RE;CDKN1B;HLA-DRB1;FN1;B2M;TNIP2;CCL2;FOS;FGF2;CAMK2B;BCL2;CCND1;CD70;HLA-E;CD4;INPP5D;IL12A;PIK3CD;ADIPOR2;TNFRSF11B;TAB1;JUNB;IKBKG;TP53
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.8860909797563205,-1.477654325306559,0.09090909090909091,0.8638946194935361,1.0,1/5,0.03%,ACP3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.7990305078603156,1.4768300727488581,0.04477611940298507,0.25708672005239985,1.0,6/17,9.81%,MRAP2;PID1;MRAP;TMBIM1;BCL2L1;PKDCC
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6827869987188773,1.4759575119201829,0.0,0.25918709984099897,1.0,9/64,5.13%,DCN;SP100;PROX1;EGF;THBS1;SLIT2;EPHA2;DAB2IP;NRP2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6941140479208759,1.4757734835546434,0.015151515151515152,0.2589557079321017,1.0,18/50,17.01%,STMN2;NLGN1;PTPRO;RTN4RL1;THY1;EFNB3;EFNA1;MAG;DCC;MCF2;PTPN9;CRMP1;EPHA4;BCL11A;LPAR1;STX1B;KIAA0319;PTPRS
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.8239351554823181,-1.475733784333912,0.03125,0.8664912808664447,1.0,4/21,3.75%,AR;CEBPA;ZC3H8;BRF2
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.6027103077693814,1.4754219358089846,0.0,0.25949549266489785,1.0,22/105,14.38%,LZTS1;GPNMB;SP100;SRCIN1;EPHA2;WTIP;PAK3;SHANK3;HECW2;BCL6;PID1;CTNNB1;SIPA1L1;CYRIB;SPARC;MAPT;PHLDB2;EPHA4;HECW1;KIF13B;PAK1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.797312089774063,1.4752030063074557,0.03076923076923077,0.2596682338637338,1.0,5/16,9.36%,MRAP2;PID1;MRAP;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.8712787234955146,1.4746301464423823,0.0,0.2612875578801153,1.0,2/13,1.03%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.8270910734725492,1.4735154539870678,0.06521739130434782,0.2640977843086059,1.0,3/8,8.87%,SULF1;MCAM;ITGA3
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8798807576908243,1.472906315408532,0.037037037037037035,0.2656104256180764,1.0,2/6,6.10%,SHANK3;LHX6
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.7252297553004243,1.472625388304467,0.015873015873015872,0.26548087903748807,1.0,5/29,8.97%,YWHAH;THY1;EFNB3;MAG;MCF2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.8308034668038689,-1.4724359431604992,0.044444444444444446,0.8830508136841798,1.0,2/8,9.50%,SAMD9;VPS11
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.8203629468223259,-1.4721586729115816,0.11904761904761904,0.873188300278611,1.0,1/9,1.75%,CEP72
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.7362294860684903,-1.4713374094176221,0.0625,0.8681358152191364,1.0,4/12,16.51%,HUS1;RAD9B;CLSPN;DNA2
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.9493345339258736,1.470986288290525,0.0,0.27066641518255624,1.0,2/7,0.47%,CACNA1H;SERPINA10
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.6095655195874481,-1.4706716307125813,0.10344827586206896,0.8633090554787746,1.0,5/70,5.41%,NUP62CL;RITA1;RBM8A;U2AF1;RAE1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5588661380565807,1.4702328750857392,0.0,0.27233822979460437,1.0,91/354,14.81%,SLITRK1;MOBP;MET;L1CAM;HAPLN2;IL1RAPL2;FLRT3;CHST8;MOG;CHRM3;GRIK1;PROX1;RAPGEF5;TAGLN3;CHRM1;SH3GL2;ZIC4;NLGN1;WDR62;MBP;NUMBL;CNTN4;IGF2BP2;SH3GL3;APBA2;NRGN;NELL1;UGT8;RELN;ACHE;EFNB3;WNT8B;FGF12;SCN2A;VLDLR;SRRM4;GFRA2;SHANK3;NINJ2;ZIC1;NRSN1;NEUROD2;DVL1;NRG1;LDB2;EIF2B2;KIRREL3;DPYSL2;ZBTB16;NPTX1;GLIS2;THOC6;MYT1L;ROBO2;VCAN;KCNQ2;ARHGAP26;KALRN;GSS;NEURL1;TRAK1;KLK6;SDK2;YAP1;DNER;DCX;HDAC4;PCDHB15;GFRAL;LY6H;STAT3;ST8SIA4;GDA;TEAD1;FGF13;NPAS2;DPYSL5;CRMP1;PCDHA1;PCDHB2;OPHN1;FN1;DPYSL4;RPS6KA6;JARID2;HAP1;RAPGEFL1;FGF2;DCTN1;ALDH3A2;LPAR1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6681243142900912,1.4696804604945148,0.02564102564102564,0.2730139001809262,1.0,16/61,12.92%,SLITRK1;FLRT3;NLGN1;GABRB2;GRID2;ACHE;SHANK3;GABRA1;DVL1;KIRREL3;GABRG2;SDK2;DNER;FGF13;LRRC4;PCDHB2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6666280507467037,1.4684423532173805,0.0,0.27658937029263464,1.0,14/63,10.74%,CDH22;CDH6;CDH9;CDH19;PKP2;CDH8;TJP3;CDH7;CDH18;GJC1;SMAD3;SDK2;FSCN1;TGFB2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7323413915846358,1.4679739996347196,0.045454545454545456,0.2774023133848715,1.0,13/42,10.62%,SLITRK1;IL1RAPL2;TLR2;IL1RAPL1;NLGN1;CLSTN2;GRID2;APP;SNCA;ROBO2;PTPRD;SRPX2;DLG5
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6137092932174255,1.467403698001514,0.0,0.27848257664353065,1.0,47/144,12.51%,SLITRK1;CA10;PCDH8;TAGLN3;STMN2;SH3GL2;VSTM2B;CNTN2;SNCB;GAP43;CAMKV;PLPPR5;SYT4;NEFL;OPCML;SYT16;ZDHHC22;OLFM3;NELL1;C11ORF87;STMN4;FGF12;RTN2;ATP2B3;MTUS2;GRIP1;CDK5R2;GALNTL6;ST8SIA3;HPCA;TCEAL5;SULT4A1;NYAP1;KCNQ2;CELF3;KIF5A;KCNC1;SRRM3;DNER;RBPMS;LY6H;NACAD;CRMP1;NEFM;FXYD7;PIANP;BBC3
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.8818547981221498,-1.4673866416378871,0.043478260869565216,0.8746371746706663,1.0,1/5,2.25%,VAMP8
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.6635210873590803,1.4673319674048706,0.015384615384615385,0.277846146868538,1.0,15/71,12.49%,EPHA7;GRIN2B;EPHA2;EPHA5;EFNB3;EFNA1;PAK3;FYN;DNM1;GRIN1;ARPC3;KALRN;ARHGEF7;SIPA1L1;EPHA4
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.87885403529273,1.4669949767582573,0.04918032786885246,0.27798837274283084,1.0,1/9,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.6936566797181767,1.4668504307691852,0.014492753623188406,0.2777437752041399,1.0,10/53,6.32%,CDH22;CDH6;CDH9;CDH19;PKP2;CNTNAP1;CDH8;CDH7;CDH18;GJC1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7204009925898742,-1.465735069751634,0.024390243902439025,0.8780536562618088,1.0,9/30,13.43%,LSM7;LSM3;EXOSC8;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.7022968031871825,1.4654245753705393,0.0,0.2828462536457606,1.0,5/54,9.33%,NR4A3;THBS1;PRKCB;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7202635576946745,1.4651838230707077,0.0,0.28285528701015916,1.0,11/47,10.62%,IL1RAPL1;S100A10;NLGN1;CLSTN2;GRID2;EPHA2;CNTNAP2;THY1;PTPRD;SRPX2;DLG5
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8750147560596556,1.464919923663574,0.015873015873015872,0.2825586672323354,1.0,4/14,7.32%,IGF1;APP;MFSD2A;GHR
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.7364827765827406,1.4647199078913886,0.04918032786885246,0.2822640249196971,1.0,9/24,10.74%,TGFBR2;PROX1;SLIT2;SOX4;SLIT3;APLNR;ROBO2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7963659393971506,1.4644175362041412,0.03125,0.2826164100424945,1.0,3/14,4.43%,RECQL4;BLM;RPA1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.6189955206642135,1.4640992568970534,0.0,0.28326901851810665,1.0,34/118,11.54%,COL4A1;PRRX1;PCDH18;SOCS3;DCN;COL11A2;PDGFRA;NPNT;COL4A2;ACTA2;CALD1;SULF1;ITGA2;NOD1;THY1;PODN;FOXO1;ANGPTL2;CD44;OSMR;POSTN;OLFML1;COL12A1;FAS;IGFBP7;FAP;C1R;EMP1;BGN;SRPX2;MMP14;ALPL;SPARC;THBS2
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.9550131162040807,1.463771459386535,0.0,0.2835403712331716,1.0,1/5,0.60%,COL4A1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6918454916559406,1.4636286027733052,0.046153846153846156,0.28290823916594304,1.0,1/41,0.01%,LEF1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.8646852252799473,1.4628234084616225,0.03389830508474576,0.2847517959583832,1.0,2/7,1.52%,SLC24A2;PLK2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.6530178637009535,1.4622996160963773,0.06578947368421052,0.2853515699644928,1.0,19/81,10.89%,RASGRP2;THBS1;NLGN1;SYT1;TRPC3;SYT4;DMTN;SYT5;KCNMB4;CLIC4;HPCA;ITPR3;NEUROD2;RYR2;ITPKB;SYT13;ANXA11;HOMER1;CPNE2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.8003095890147143,-1.4621951882784054,0.058823529411764705,0.8942028686967126,1.0,1/11,0.38%,RAB7B
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.6109633084308098,-1.462155852706052,0.0,0.8840810426959901,1.0,23/60,19.46%,RTRAF;TRPT1;ADAT2;TRMT61A;KARS1;TRMT10C;POP5;TRMT10A;THUMPD1;FTSJ1;C2ORF49;QTRT2;CPSF1;URM1;CLP1;TRMT10B;ADAT1;TRNT1;DTWD2;DTWD1;LCMT2;RPP40;TRDMT1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.9105522411800386,1.4615677293562785,0.014705882352941176,0.2872123615564965,1.0,1/10,0.18%,NR4A3
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7809654321669516,1.461170282389382,0.04477611940298507,0.28780025207685833,1.0,9/29,5.67%,CDH22;CDH6;CDH9;CDH19;CDH23;NLGN1;CDH8;CDH7;CDH18
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.8461628169128066,1.4609962951191862,0.0,0.287349377028205,1.0,3/12,9.13%,WAS;FHOD1;SLC9A1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.6112217029501905,1.4606989371378627,0.0,0.2877856581682111,1.0,28/124,11.54%,LEF1;COL4A1;PRRX1;PCDH18;DCN;PDGFRA;COL4A2;ACTA2;CALD1;SULF1;ITGA8;THY1;PODN;ANGPTL2;POSTN;COL12A1;TNS1;PAWR;LDB2;FAP;C1R;PML;BGN;SRPX2;YAP1;ACTN1;SPARC;THBS2
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.8417252009995283,1.4596807449709202,0.015384615384615385,0.29031246832795765,1.0,6/14,8.65%,SCN1B;CACNA1G;KCNJ2;SCN3B;TRPM4;CACNA1C
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.8290730726216815,1.4596086667330357,0.018518518518518517,0.28989448410220287,1.0,4/14,8.86%,PAK3;SHANK3;DOCK10;SHANK1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.5551367369804008,1.4594638036124852,0.0,0.2895886422151059,1.0,83/337,19.87%,TGFBR2;VRK2;MAP3K6;PLK2;EPHA7;FAM20C;PTK6;PIM3;PRKCB;PRKCG;TEC;APP;PIM1;NUAK2;NEK10;PAK3;PRKG2;MYLK3;PRKAR1B;NUAK1;FYN;CDK9;PAK4;STK25;GRK2;MAP3K11;AATK;DGKG;SIK2;LIMK2;CDK6;IKBKE;MAK;PRKCE;PRKCH;HIPK3;TGFB2;SYK;STAT3;MINK1;HUNK;CDKL5;PGK1;MAP3K21;GAS6;PRKCD;TYK2;PDK1;PXK;HIPK1;PICK1;PDK4;HK1;CCL2;ALK;PAK1;CAMK2B;GRK5;BMX;PIK3CD;RARA;HIPK2;NEK6;MAP3K5;PINK1;DCLK1;CDK2;FAM20A;STK3;MAPK9;STK24;CDK19;CDC25B;CILK1;PDK3;CDK20;CDK18;STK11;PRKCA;LIPE;COQ8B;RPS6KA4;DGKI
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.7036663613332074,1.4591509208387907,0.06060606060606061,0.2901577313858474,1.0,9/51,10.14%,ECM2;NPNT;S100A10;DMTN;NEDD9;SKAP1;PLEKHA2;CDK6;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.9569667227348867,1.4589243640290757,0.04081632653061224,0.2903606191063155,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.7536059970417691,1.458912691267178,0.03225806451612903,0.28944175638762465,1.0,4/29,1.93%,GGT5;CSPG4;DCN;OGN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8967866167488077,1.458457664422995,0.07142857142857142,0.29029416366912625,1.0,1/8,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.8435126772146555,-1.4580695022911632,0.09090909090909091,0.906765389364335,1.0,1/7,1.47%,ERCC8
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9489552755019098,1.457946609081749,0.017241379310344827,0.29128487691551724,1.0,1/5,1.60%,CD24
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.9504382551152695,-1.4575288155964807,0.0,0.899824861650983,1.0,3/8,2.27%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.7615562595635219,1.4572669827935592,0.03333333333333333,0.29262742041896733,1.0,6/19,4.13%,ANK3;RIMS2;CLSTN2;SYT1;GRIK2;RIMS3
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6393508882601601,1.4571421471519272,0.02666666666666667,0.29235542067169024,1.0,29/87,15.42%,IL13RA1;TLR2;P2RY6;SLC15A3;FAM20C;SLC39A14;ITGA2;SIGLEC1;DYSF;IL1R1;EGFL7;NRP2;TNS1;ITPR3;SERPINF1;CHI3L1;PID1;SLC7A7;RNASE1;ARHGEF10L;MMP14;RIN2;TNFAIP6;CCL2;SERPING1;RASSF4;KCTD12;SPP1;KCNMA1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.9169619643701913,-1.4567701839528426,0.047619047619047616,0.895921027174113,1.0,2/5,7.16%,HEY2;HEYL
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.9269291804432536,1.4567238099623105,0.03773584905660377,0.2928678994670385,1.0,1/7,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.944699404912751,1.4565834891873202,0.01639344262295082,0.2925968423298437,1.0,1/6,1.84%,THBS1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.9352704058023207,1.4565810672778423,0.0,0.2917263305203069,1.0,3/6,5.92%,CCBE1;PROX1;APLNR
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.8336074976353456,1.4562877105484524,0.01639344262295082,0.29177773459874873,1.0,7/20,7.59%,RIMS2;DOC2B;SYT1;SYT4;RIMS3;SYT5;SYT13
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7715102104864612,1.4562509654298563,0.07692307692307693,0.2909853864416707,1.0,7/18,19.15%,NDST4;UGDH;HS6ST1;HS3ST3B1;NDST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7763069477516434,1.4559475913577773,0.01818181818181818,0.2911788894382708,1.0,3/21,4.52%,IGF1;EGF;TGFA
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.8890874814578421,-1.4558797224930524,0.027777777777777776,0.8820571677693732,1.0,2/5,1.07%,EYS;REEP6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.8890874814578421,-1.4558797224930524,0.027777777777777776,0.8820571677693732,1.0,2/5,1.07%,EYS;REEP6
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8980856051766314,1.45483094975362,0.0,0.2947592462434477,1.0,1/9,1.88%,BLM
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.9401184877455956,1.454806862800581,0.02127659574468085,0.29424362904863255,1.0,1/8,0.01%,LEF1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.7284306695052543,-1.4546473875901849,0.022222222222222223,0.8829125808425172,1.0,13/25,19.44%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;APOO;DMAC2L;ATP5MC3;SAMM50;ATP5F1B;LETM1;ATP5F1A;AFG3L2;ATP5MC2
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.8377836942158455,1.4544391936799324,0.03125,0.29466847533808815,1.0,3/14,4.27%,KIF14;STMN2;STMN4
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.7184198424269753,1.454227677440472,0.029850746268656716,0.29464080782565927,1.0,1/35,0.01%,LEF1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7947738643947648,1.4541297382330176,0.015873015873015872,0.2943372584770647,1.0,3/25,7.40%,TGFBR2;APLNR;TBX20
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.9263047933844938,1.4540804934104539,0.03508771929824561,0.293519504854239,1.0,3/8,2.85%,TGFBR2;HLA-DRA;CD55
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9303690712311307,1.4540726105581627,0.018867924528301886,0.29267236378215256,1.0,1/5,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8399755470672632,1.453304710849227,0.05970149253731343,0.2951815221453698,1.0,4/15,3.62%,HPN;KLF2;EGF;APP
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.8821239624457743,1.4529126424592385,0.05660377358490566,0.29590280658351703,1.0,1/8,4.52%,SUV39H1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8565838647353415,-1.4528337523281187,0.05405405405405406,0.8891581157999308,1.0,4/14,7.09%,H1-2;H1-4;M1AP;NOC2L
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6887738852440825,1.452770307809326,0.04411764705882353,0.2956680036744583,1.0,10/47,13.70%,SP100;EGF;ZSWIM4;NRG1;ARHGAP18;NRG2;CDK6;YTHDF1;ACTN1;PDPN
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.9118809958394406,1.4524036122436883,0.018867924528301886,0.29587518731691614,1.0,2/7,1.74%,LEF1;TESC
prerank,MSigDB_Hallmark_2020__Glycolysis,0.5828316603612411,1.452363799633097,0.012048192771084338,0.2951687744528049,1.0,33/168,15.06%,CACNA1H;MET;IL13RA1;DCN;PKP2;P4HA2;IRS2;NSDHL;TGFA;TPST1;VLDLR;CD44;AGRN;CHPF2;GPR87;CHST6;ALDOB;VCAN;HK2;LDHA;GALK1;B4GALT7;HOMER1;AK3;PGK1;PYGL;ENO2;COL5A1;DPYSL4;PAM;PLOD2;CHST4;CHST2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.8007092518747061,-1.4523296761890674,0.06666666666666667,0.8827837761058485,1.0,2/11,7.20%,APOE;ZNF502
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.8154743888714431,1.452205205685665,0.03636363636363636,0.2947697556192936,1.0,3/13,4.23%,ZFP36;ZC3H12D;RBM24
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.9022496435223417,1.4515961306507064,0.037037037037037035,0.2960191276748724,1.0,3/7,4.15%,PTPRO;PTPRB;DUSP10
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.6733832755852647,1.4514751093601699,0.01639344262295082,0.2957204380730131,1.0,10/58,11.07%,LEF1;TGFBR2;HPN;DAB2IP;EFNA1;ZNF750;CTNNB1;SMAD3;TGFB2;LDLRAD4
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.7123488984094597,-1.4514631564150597,0.10869565217391304,0.879823725030632,1.0,2/14,8.69%,TNFAIP3;IFNLR1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.9099036364162622,1.4512593114127974,0.0,0.2956906654360643,1.0,1/7,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.7122908970907547,1.4512044260172985,0.014705882352941176,0.2949950881002371,1.0,1/37,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.785438180051045,1.4510239286404474,0.07407407407407407,0.2950672034830414,1.0,5/18,7.52%,CHRM3;KCNMB4;TRPM4;OXTR;ECE1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.7272014979422929,-1.4506230579540575,0.07317073170731707,0.8759302561173391,1.0,3/17,6.45%,MID1IP1;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.755618525804425,1.450331712915893,0.01694915254237288,0.296860406452531,1.0,3/24,1.88%,RECQL4;ANXA1;BLM
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.8267503043431297,1.450200658293945,0.06666666666666667,0.2966296221250374,1.0,2/11,3.77%,BOK;DAB2IP
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.8585897907448032,-1.4499764235428714,0.043478260869565216,0.8719552156896279,1.0,2/9,1.97%,OTUD3;TNFAIP3
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.812827737292355,1.4498731321279719,0.06896551724137931,0.2970255542177017,1.0,3/10,8.05%,EGF;PTPRC;MGAT5
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.627393582620127,1.4496811936444647,0.04,0.2968612626390264,1.0,25/106,13.77%,TGFBR2;FLRT3;PKP2;FGF12;SOX4;TBX19;APLNR;NTRK3;ECE1;ALPK2;SYNPO2L;ZFPM2;CACNA1C;SH3PXD2B;PDLIM4;TCAP;TGFB2;GLI2;IFT122;HDAC9;SMYD4;CDKN1A;CDKN1B;FN1;MEF2D
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7426498114043639,1.4493246056659446,0.04477611940298507,0.29738516781678676,1.0,7/20,19.15%,SULF1;UGDH;HS3ST4;HS6ST1;HS3ST3B1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.9543832875178693,-1.4490604422218087,0.0,0.867250457156083,1.0,1/5,0.08%,SLC2A5
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.8475065507374671,1.4488903878638395,0.06976744186046512,0.2982976744912272,1.0,2/7,5.12%,SULF1;MCAM
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7251459832369335,1.4488183757081778,0.034482758620689655,0.2975454434629,1.0,9/29,10.74%,TGFBR2;PROX1;SLIT2;SOX4;SLIT3;APLNR;ROBO2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.7599406558610964,1.4484903387086978,0.0,0.2981278348887904,1.0,6/25,18.05%,LZTS1;SMCR8;PHF23;MTM1;PINK1;TSC2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.8548798530721373,1.4483137220236826,0.03333333333333333,0.29815688139600477,1.0,3/9,5.91%,GAS2L3;BAIAP2L1;BAIAP2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8344571740418499,1.4482825276700586,0.031746031746031744,0.2975082155364024,1.0,2/9,6.50%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.743162541612807,1.4476323110430174,0.05970149253731343,0.2989866431128104,1.0,4/26,3.90%,C3;IL15;PTPRC;SFTPD
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8091658791291282,1.447123476936048,0.05263157894736842,0.3000396866521515,1.0,5/13,10.74%,TGFBR2;SLIT3;APLNR;TBX20;TGFB2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5966167323335613,1.4470848517961132,0.0,0.29932721165143916,1.0,31/127,9.44%,COL4A1;PRRX1;PCDH18;DCN;PDGFRA;OGN;ABCA8;COL4A2;ACTA2;CALD1;SULF1;ITGA8;THY1;PODN;ANGPTL2;MYH11;NRP2;SLIT3;POSTN;COL12A1;FAS;SLC38A11;GJC1;TNS1;LDB2;RASL12;C1R;OBSCN;MAP3K7CL;NEXN;BGN
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8358425596105457,1.446556377140846,0.0,0.30069245804797945,1.0,4/14,6.92%,PDGFRA;RASGRP1;FLT1;NTRK3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.6248313866733002,1.4465537216605064,0.027777777777777776,0.2998548745993778,1.0,17/74,16.07%,GGT5;ANXA1;WNT8B;FOXO1;ERBIN;SNCA;FOXO3;CTNNB1;STAT3;ALPL;ASXL1;ABCA2;PPARG;SPP1;IL12A;RARG;RARA
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.8855350200435497,1.4458703468870786,0.01639344262295082,0.30187732635452275,1.0,1/9,0.62%,KLF2
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.88675753819761,1.4451954349184049,0.03773584905660377,0.30388857339080266,1.0,1/9,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.6902835670053578,1.4446830824443389,0.046153846153846156,0.3051945825631026,1.0,8/33,13.96%,MYO1F;SYT4;BICDL1;MYO1C;MYO1B;TRAK1;MYO15A;HAP1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.7394548167867416,1.4445046996712567,0.046153846153846156,0.3049516471542229,1.0,3/31,5.49%,GGT5;GSTT2;GGCT
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.6241609376559394,1.444448226474105,0.0,0.3042707570226105,1.0,16/108,4.12%,CDKN2A;HLA-DRA;TLR2;CTSS;IL15;FYB1;IL27RA;STAT4;PRKCB;PRKCG;WAS;ICAM1;PTPRC;IRF7;THY1;ACHE
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.8958464046241117,1.4437767440728455,0.0,0.30600307079420846,1.0,1/9,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.7460879340357369,1.4436324910147411,0.04225352112676056,0.30575991767493405,1.0,7/30,9.12%,FLRT3;SH3GL2;NRP2;SEMA5B;FLRT1;MAP1B;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.7780597165019638,-1.4432893515883503,0.057692307692307696,0.9011193788365645,1.0,2/10,9.10%,TAX1BP3;GOPC
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.9118687898154861,1.4431548337953433,0.05,0.30654509350735115,1.0,1/6,0.18%,NR4A3
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.7378007865537923,1.4423489300527297,0.03125,0.30875369306099215,1.0,5/22,11.18%,CHST8;IGF1;SULF1;B4GALT7;HS3ST4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.8191802842232927,1.4417008069827337,0.03508771929824561,0.31064079538535977,1.0,1/16,0.12%,ENPP2
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.8897013255419692,-1.4412181179081107,0.06521739130434782,0.907284148515017,1.0,1/6,3.51%,PHYH
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.948758461808543,-1.4412041313182076,0.0,0.8981838476136588,1.0,3/9,2.27%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.9162190182831127,1.4411121242456408,0.017543859649122806,0.3120237932496189,1.0,3/6,7.40%,CCBE1;PROX1;TBX20
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7776550716498022,1.4407188224068515,0.03508771929824561,0.3127528340234004,1.0,7/21,11.15%,MYRF;KIF14;TYMP;NKX6-2;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.601487323351889,1.440327125383915,0.043478260869565216,0.31332444006386234,1.0,18/95,12.56%,CDKN2A;RASGRP2;IGF1;RAPGEF5;PLK2;RASGRP1;PLD1;RIT2;SHTN1;SHC2;MRAS;ARHGAP18;PLD2;RASSF1;RIN2;USP50;RGL1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8769186721706247,-1.4398500968007313,0.06818181818181818,0.8993363364449948,1.0,2/6,4.68%,ATF5;RGCC
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.6286808285832118,1.4397832182113057,0.0,0.31514843063447706,1.0,16/106,6.55%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;PLEK;CNTN4;PLP1;CNTNAP2;BICDL1;APP;STMN4;CFAP126;LAMB1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.9571237795049347,1.4396053274871305,0.0,0.3149471035066809,1.0,1/5,0.50%,C3
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.7486874867309807,-1.4392775478425248,0.05405405405405406,0.8952111910378504,1.0,2/18,5.52%,FAM47E;MCM9
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7833749175114094,1.4389782894738692,0.04477611940298507,0.31614789087310025,1.0,4/19,6.64%,NR4A3;THY1;CD44;SKAP1
prerank,MSigDB_Hallmark_2020__UV Response Up,0.5854096284407366,1.4389133019134728,0.012345679012345678,0.315428577629815,1.0,21/137,12.91%,CCK;FOSB;CXCL2;CHRNA5;RASGRP1;NPTX2;ATF3;NR4A1;ICAM1;ABCB1;BTG3;NTRK3;CLTB;KCNH2;STK25;PTPRD;MMP14;CDKN1C;DGAT1;PRKCD;ENO2
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.7763814563308351,1.4388044826103048,0.0,0.3151069261598177,1.0,9/29,13.86%,CLIC1;PDGFRA;PLEK;MYH9;RAP2B;ACTN1;P2RY12;FN1;UBASH3B
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.8859586466426285,-1.4387473484114242,0.0,0.8906321741473154,1.0,3/6,9.04%,RFT1;NPC2;CPTP
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7815647628825175,1.438435764067871,0.08620689655172414,0.31575387837797597,1.0,9/15,15.57%,MYRF;PRDM8;CNTNAP1;PLP1;EIF2B2;TPPP;B4GALT5;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.9251100326516708,1.4384290475856694,0.03389830508474576,0.31409201586019714,1.0,2/5,5.34%,CNTNAP2;SHANK3
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.9251100326516708,1.4384290475856694,0.03389830508474576,0.31409201586019714,1.0,2/5,5.34%,CNTNAP2;SHANK3
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.8463167492347787,1.4378450855863594,0.016666666666666666,0.3153061152772659,1.0,1/10,0.56%,ST6GAL1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.6432353065319286,1.4375375616489117,0.014492753623188406,0.3153776852254506,1.0,25/74,22.35%,ENPP2;PROX1;EGF;THBS1;EPB41L4B;NRP2;MAPRE2;PRKCE;TGFB2;RIN2;SPARC;ARF6;FGF2;BCAR1;PIK3CD;WNT5A;ETS1;PRKCA;GLIPR2;HIF1A;RTN4;RAB11A;RHOB;ADAM9;PPM1F
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.6320459303099857,1.4372403686551252,0.014492753623188406,0.31586637854177146,1.0,4/79,6.88%,LEF1;CD24;WNT8B;DVL1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.8102127340425542,1.437074494114987,0.038461538461538464,0.31575765533824357,1.0,3/13,6.40%,ANXA1;ZFP36;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.7158454477252425,-1.4370039677205975,0.11904761904761904,0.8963702905514944,1.0,3/13,14.84%,EIF4EBP1;EIF3E;EIF2AK1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.7467820608306803,1.435547806656681,0.01694915254237288,0.3209300994168229,1.0,6/31,7.23%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINF1;SERPINE3
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.7367277756419897,1.435488366526633,0.03076923076923077,0.32018744263996163,1.0,8/31,11.84%,TLR2;IL15;PTPRC;SFTPD;DYSF;PLSCR1;SYK;GAS6
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.76094434127296,-1.4353013523783265,0.12195121951219512,0.9012467609972467,1.0,3/13,11.26%,SETDB1;SIRT6;ZNF304
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.8175965633280134,-1.4347628276777111,0.06521739130434782,0.8883485859808777,1.0,3/11,7.02%,BLOC1S4;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.8175965633280134,-1.4347628276777111,0.06521739130434782,0.8883485859808777,1.0,3/11,7.02%,BLOC1S4;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.9038149759067288,1.4346555635386744,0.0392156862745098,0.3223408970848084,1.0,3/5,7.76%,P2RY6;HRH1;SNCA
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6600858390501854,1.4344910913211903,0.07936507936507936,0.32203998627090497,1.0,19/56,21.81%,EGF;PTK6;PTPRR;ERBIN;TGFA;NRG1;REPS2;MVP;NRG2;IQGAP1;BCAR1;GAB1;PLCE1;SHC1;PRKCA;ADAM17;NCK2;DGKD;PTPN11
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.8118968605650828,1.4337920487353546,0.057692307692307696,0.3235316590571173,1.0,4/12,8.14%,ZFP36;YBX3;ELAVL4;MYD88
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8269704561563807,1.4335318279814075,0.02040816326530612,0.3238735294543515,1.0,4/8,15.16%,RASGRP1;PTPRC;BCL2;CD70
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.9708215392837187,1.4332097643205155,0.0,0.3244181286345825,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.7988093708532559,-1.4331451105549113,0.08333333333333333,0.8919963301226486,1.0,4/10,17.28%,METAP1D;NAA11;METAP2;METAP1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.7710111902920501,1.4329946731204224,0.07272727272727272,0.32402757962720335,1.0,4/14,6.34%,FLRT3;GAP43;RTN4RL1;APOD
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.7221154607946609,1.4329444945178345,0.028985507246376812,0.32343558126376437,1.0,11/36,13.86%,CLIC1;PDGFRA;PLEK;MYH9;CD99;MEGF11;RAP2B;ACTN1;P2RY12;FN1;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6843468953488895,1.4326547175070334,0.0847457627118644,0.32365827015035536,1.0,10/28,12.45%,RIMS2;CLSTN2;SYT1;GRIK2;RIMS3;RAMP3;ECE1;SNCA;HOMER1;KCTD13
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.8560911078508238,1.4326064634031483,0.017241379310344827,0.3229834584265502,1.0,4/13,4.53%,NR4A3;C3;PRKCB;RTN2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6528481165988225,1.4323796900063106,0.041666666666666664,0.32311963761999896,1.0,4/53,9.12%,LEF1;WNT8B;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7467433382229487,1.43211009083301,0.03225806451612903,0.3232839003637311,1.0,3/22,4.52%,EGF;PTK6;TGFA
prerank,MSigDB_Hallmark_2020__Coagulation,0.6240406075529824,1.4320243741450904,0.014285714285714285,0.32304557538037815,1.0,16/85,11.44%,HPN;C3;ANXA1;MAFF;THBS1;SERPINE1;PLEK;ITGA2;FYN;CFH;C1R;MMP14;CRIP2;TF;GDA;SPARC
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.619214305973953,1.431994983316625,0.0,0.32232181349608746,1.0,26/98,9.81%,COL4A1;PRRX1;PCDH18;DCN;PDGFRA;COL4A2;CALD1;SULF1;SLIT2;TCEAL7;THY1;ANGPTL2;SLIT3;POSTN;ZIC1;LAMB1;PTPN21;RASL12;NNAT;BOC;MAP1B;GUCY1A2;ADGRL2;SCARA3;BGN;PKDCC
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.8256712314231338,1.431894006554898,0.08928571428571429,0.32194431625670206,1.0,3/14,9.66%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.9634650342889911,1.4318596573322606,0.0196078431372549,0.32128387566565614,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.8004129470496925,-1.4316020937356622,0.09375,0.8938426592133296,1.0,1/10,0.38%,RAB7B
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.9079097710391654,-1.4314408415284015,0.047619047619047616,0.8868542266431813,1.0,1/9,0.08%,SLC2A5
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.676602470309592,1.4313314092361273,0.04477611940298507,0.3225587205844249,1.0,11/37,13.71%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;SLC25A45;SLC38A11;SLC7A7;SLC25A29;SLC7A1;PDPN;SLC7A14
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.8435856328193889,1.43094143769067,0.03225806451612903,0.3230053421844048,1.0,2/10,0.60%,TGFBR2;COL4A1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.592181568147123,1.4307471439313673,0.014492753623188406,0.3232518550265971,1.0,28/100,9.49%,COL4A1;PRRX1;PCDH18;DCN;PDGFRA;COL4A2;ACTA2;CALD1;SULF1;RELN;THY1;PODN;ANGPTL2;SLIT3;POSTN;COL12A1;IGFBP7;SYP;COLEC11;LDB2;PTPN21;RASL12;FAP;MEG3;C1R;GFAP;BGN;SRPX2
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8647293116247039,1.4303450971046772,0.0,0.32380736485807254,1.0,6/11,7.88%,GRIN3A;GRIN2A;GRIN2B;GLRA2;GRIN1;ADCY7
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.7351715906654483,1.430290667276377,0.0967741935483871,0.32320673266617145,1.0,8/27,7.13%,IGF1;GRIN2A;ICAM1;APP;GRM5;FYN;RAMP3;GRIN1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5662621819931407,1.4302024139055378,0.0,0.32263711470580175,1.0,29/172,15.41%,CDKN2A;HPN;RASGRP2;KIF14;TP53TG5;PSRC1;RPS6KA1;LTBP4;SLIT2;TSPYL2;SLIT3;BCL6;MFSD2A;FAM107A;BAP1;PAK4;PML;SMAD3;MMP14;TGFB2;CDKN1A;CDKN1B;FBP1;TRIM32;BCL2;TMC8;PPP1R9B;BCAR1;SIPA1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.7341788673832597,1.4300899202415902,0.06557377049180328,0.32221025869437325,1.0,9/38,7.37%,TLR2;CTSS;TYMP;SP100;PLEK;CSF2RA;PTPRC;CIITA;BIRC3
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.7714902838816072,1.4299170708899638,0.06756756756756757,0.32206474495804877,1.0,8/20,13.45%,COL4A2;COL8A1;DUSP1;COL12A1;LAMB1;TBX20;MMP14;FN1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7526151418726068,-1.4297835208613427,0.13953488372093023,0.8902026050660484,1.0,3/9,10.21%,PGP;COQ3;GK
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.617166632835128,1.4295792597419439,0.025974025974025976,0.32247708874480185,1.0,31/94,16.28%,C1QL1;FLRT3;NPNT;SLC7A2;SHC2;DAB2IP;EFNB3;PRR36;EPB41L4B;PRIMA1;ABCC8;CKMT1B;CTNNB1;PCLO;ATP1B1;ASS1;C2CD4C;CACNG4;YAP1;TEAD1;EPB41L1;INPP5J;ENAH;CD276;BCAR1;COBL;CAMSAP3;SLC44A3;SEZ6L2;RGS16;TOX3
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7752930941913841,1.4295770091437041,0.04838709677419355,0.3216924729571016,1.0,7/18,17.12%,IL1RAPL1;RELN;PTPRD;CDKL5;CAMK2B;SS18L1;CUX2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.6850552680228232,-1.4289062484647617,0.0625,0.8874487367192031,1.0,3/21,7.30%,SELENOS;PGP;MST1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7170465481040692,1.4284930668527145,0.046875,0.32421060242586097,1.0,10/36,11.55%,SLC32A1;SYT1;GAD2;CPLX2;DVL1;SNCA;PCLO;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8774689793480588,1.428311478562006,0.03773584905660377,0.32419992973181516,1.0,3/8,8.25%,HRH1;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.8906239104774313,1.4277021877777156,0.02040816326530612,0.32570666133030185,1.0,2/8,2.00%,ANXA1;DOC2B
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.9638146229482283,1.4276811660783812,0.0,0.3250043912633575,1.0,4/5,3.47%,ANK3;CNTN2;CNTNAP1;CNTNAP2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.6220403376158987,1.427652030792005,0.014285714285714285,0.3243604086863958,1.0,31/123,15.35%,VRK2;IGF1;EGF;EPHA7;CD24;RASGRP1;RIT2;DUSP1;PTPRC;EPHA2;DAB2IP;FLT1;NEK10;PAK3;TRIM5;FAS;NTRK3;PAK4;PDGFA;WDR54;SYK;GFRAL;MINK1;HLA-DRB1;FN1;PAK1;FGF2;GPR37;LPAR1;IQGAP1;CD4
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.7056208061286846,1.4272798962085644,0.08064516129032258,0.3253081205468987,1.0,7/24,13.98%,PAK3;SHANK3;FYN;DOCK10;SHANK1;ITGA3;PICK1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.6381522414146332,1.4270390484428093,0.013888888888888888,0.32540424679243907,1.0,21/67,23.26%,MET;PROX1;EGF;THBS1;NRP2;RIN2;SPARC;FGF2;BCAR1;PIK3CD;WNT5A;ETS1;MAP2K3;PRKCA;ADAM17;HIF1A;FGFR1;RHOB;HSPB1;AKT3;SCARB1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.8514579787156065,1.426824411820076,0.05714285714285714,0.3253091010870551,1.0,5/9,14.48%,RELN;DAB2IP;NEUROD2;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5286084625411128,-1.4267032508899282,0.0,0.8941425917865328,1.0,34/161,13.55%,RPS24;RPL35A;RPL34;RPL39;RPL37;EXOSC8;NBDY;RPL13;RPL18;RBM8A;RPS28;RPL12;RPL31;RPL23;RPL41;RPL6;EXOSC4;RPS26;RPL29;RPL30;RPL22;RPS13;RPL14;RPSA;EXOSC5;RPL15;RPS2;RPL23A;PYM1;RPL11;EIF3E;CNOT7;RPS21;RPS23
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.8796821582159617,1.4266690247807987,0.06153846153846154,0.32491527320325847,1.0,3/8,7.13%,GRIN3A;APP;GRIN1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.6073445660290401,1.4266087993272507,0.0,0.324441927676277,1.0,17/120,10.63%,MTMR7;PTPRO;DUSP1;PTPRC;PTPRB;PTPRR;DUSP10;DUSP8;DUSP16;PDP1;SBF1;PTPN21;DUSP22;PTPRD;SSH2;PTPN9;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.6538907375745493,1.4262023112854598,0.0,0.3252428913909512,1.0,22/86,16.95%,ANK3;YWHAH;EPHA2;FYN;RAMP3;STAC2;MYO1C;NECAB2;ITGA3;YWHAG;PTPN9;PRKCE;PRKCH;SORBS1;BBC3;ARF6;STX4;CEMIP;BCL2;MTCL1;TP53;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.8105035339973764,1.4261186623947244,0.04918032786885246,0.32474400814533333,1.0,3/12,4.52%,IGF1;EGF;TGFA
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.8474331087992077,1.4259715019185817,0.05660377358490566,0.324355228385303,1.0,3/9,7.20%,SYT1;KCNMB4;RYR2
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.8204584479918925,-1.4257980349025183,0.11428571428571428,0.8922306494313368,1.0,2/6,11.71%,MIS12;CENPA
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6078378507902882,-1.425193385516532,0.12121212121212122,0.8882326597477388,1.0,16/49,15.46%,PAK1IP1;RPL35A;NSA2;RPF1;NOC2L;RPL6;SNU13;RPL14;RRP15;MDN1;RPL23A;NIP7;RPL11;MAK16;LAS1L;RPF2
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.9630125431029946,1.425055069365668,0.0,0.3269781866927074,1.0,2/5,2.39%,IL15;PTK6
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.8311006299854228,-1.4250375337479482,0.15,0.881796817134331,1.0,3/6,12.99%,SLC25A19;SLC25A33;ABCC11
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.6125532712663592,1.4246157234775194,0.01282051282051282,0.3279265425510944,1.0,30/124,11.41%,SLITRK1;CCK;ANK3;FLRT3;NLGN1;SLITRK5;CNTN4;SHTN1;CNTNAP1;CNTNAP2;APP;PLPPR4;DAB2IP;PAK3;SHANK3;NYAP2;BAIAP2;DOCK10;FLRT1;DVL1;PARD3;MAP1B;NYAP1;DCC;SHANK1;CTNNB1;PACSIN1;MINK1;SLITRK4;TRIO
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.9142904300052314,1.4244520362230977,0.04918032786885246,0.3269812634099401,1.0,1/5,0.18%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.9142904300052314,1.4244520362230977,0.04918032786885246,0.3269812634099401,1.0,1/5,0.18%,NR4A3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.5932394453753755,1.424451446434039,0.0273972602739726,0.3262190693227375,1.0,42/147,9.60%,GGT5;APOLD1;TGFBR2;COL4A1;DCN;PROX1;PDGFRA;S100A10;ABCA8;CD55;CASZ1;ICAM1;PTPRB;FLT1;PODN;ACKR1;PCDH12;ANGPTL2;EGFL7;SHROOM4;MCAM;NRP2;POSTN;CLIC4;APLNR;RAMP3;MFSD2A;IGFBP7;TNS1;CFH;PLAC8;SEMA3D;LDB2;RASL12;ECE1;C1R;CYP1B1;EMP1;BGN;ADGRF5;RNASE1;SPNS2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7066349676814536,1.424012770068361,0.016666666666666666,0.32702756019202933,1.0,7/25,14.81%,P2RY6;PDGFRA;FLT1;NTRK3;P2RY12;FGF2;LPAR1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6400920436508487,-1.4231239564657423,0.05405405405405406,0.8875678536652691,1.0,14/33,18.77%,TFB2M;MRPS21;MRPS7;MRPS16;MRPL47;FASTKD2;GATC;SLC25A33;NOA1;MRPS34;MRPS18B;MRPS12;TEFM;PTCD3
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8537016483857819,1.4228539566889649,0.04918032786885246,0.33064130621283944,1.0,2/8,9.12%,MET;CTNNB1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.6941890339102386,1.4223261634322903,0.058823529411764705,0.33214966289997105,1.0,6/32,8.54%,MET;SEMA3C;NRP2;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.9114123226348337,1.4222174545526323,0.031746031746031744,0.331619972571438,1.0,4/8,7.14%,CACNA1H;TRPM4;ABCC8;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8959164696175989,1.422108000691982,0.03278688524590164,0.33127694140328123,1.0,1/7,0.15%,CDKN2A
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7416803352239258,1.421757819249606,0.06349206349206349,0.33211702475365795,1.0,7/20,17.53%,THBS1;DMTN;GNA12;ARHGEF7;PRKCE;FGF2;RFFL
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.7474010533454091,1.4210187953891913,0.058823529411764705,0.33478698604614837,1.0,12/20,16.15%,RFTN1;PRKCB;PTPRC;TEC;NFATC2;LAT2;SYK;BCL2;BCAR1;BMX;PIK3CD;SH2B2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.8628553387307015,-1.4209919627190455,0.0,0.8959706010640311,1.0,2/6,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.6930170624913405,-1.4206779018293714,0.07692307692307693,0.8906903727068564,1.0,3/18,9.99%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.8842164012383956,1.4201962856071817,0.017857142857142856,0.337104956984799,1.0,1/6,0.37%,HPN
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.7331570622822705,1.419767832708734,0.07692307692307693,0.33800421001078246,1.0,13/26,9.52%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;SCN1A;KCNQ1;FGF12;KCND3;KCNH2;ATP1A1;CACNA1C;ATP1B1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7981987253319233,1.419671764297282,0.038461538461538464,0.3377285945646071,1.0,5/18,1.82%,GRIN2A;SLC24A2;PLK2;GRIN2B;GRIN2D
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.7091414731082205,1.4192319371866409,0.057971014492753624,0.33880404884357795,1.0,11/37,13.72%,ADAMTS4;CTSS;TIMP2;TLL1;CD44;CAPN1;SH3PXD2B;SCUBE3;MMP14;MMP16;WASHC1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7367867149470512,-1.4189538972121918,0.05714285714285714,0.8944712009528684,1.0,3/13,3.00%,APOBEC3G;TEX15;SMYD5
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.5351785442794247,1.4186630502606385,0.0,0.3401854156523347,1.0,78/408,16.22%,TGFBR2;VRK2;TLR2;SBK1;MAP3K6;PDGFRA;PLK2;FAM20C;PTK6;PIM3;PRKCB;PRKCG;CAMKV;RPS6KA1;TEC;RELN;APP;PIM1;DAB2IP;FLT1;NUAK2;NEK10;INCENP;PAK3;STK32B;PRKG2;MYLK3;PRKAR1B;NUAK1;FYN;CDK9;PAK4;STK25;GRK2;MAP3K11;AATK;SIK2;LIMK2;CDK6;IKBKE;PKDCC;MAK;PRKCE;PRKCH;HIPK3;TGFB2;SYK;STK32A;MINK1;HUNK;CDKL5;MAP3K21;GAS6;EPHA4;PRKCD;TYK2;PDK1;PXK;CDC7;HIPK1;RPS6KA6;PICK1;PDK4;CCL2;ALK;PAK1;MAPKAPK5;CAMK2B;GRK5;BMX;STK32C;PIK3CD;RPS6KB2;RARA;HIPK2;CAMK1D;NEK6;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8991494748856597,1.4186449886552839,0.061224489795918366,0.33957080875515017,1.0,3/6,8.71%,IGF1;ALOX12;BAG3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.885982835229419,1.4182765933295347,0.04411764705882353,0.3396361085505473,1.0,3/7,10.05%,CACNG3;CACNG8;CACNG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.885982835229419,1.4182765933295347,0.04411764705882353,0.3396361085505473,1.0,3/7,10.05%,CACNG3;CACNG8;CACNG4
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.8492588251998296,-1.4180919448641582,0.07692307692307693,0.8929287065614026,1.0,3/8,13.30%,HEY2;HEYL;HEY1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.701364680258121,1.4178639588513433,0.1076923076923077,0.34054119439698427,1.0,7/33,9.08%,SGPP2;PLPPR5;PLPPR4;PLPPR1;ALOX12;DGKG;PLPP4
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.9377362725656347,1.417798770118016,0.017543859649122806,0.34021299883430234,1.0,1/5,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.9249675691150752,-1.4174928620946012,0.0,0.8890293269650814,1.0,2/6,3.61%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.815822963585155,1.417376585073338,0.07575757575757576,0.3408827808493707,1.0,7/11,14.48%,APP;NETO1;SHANK3;SYP;NPTN;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.8211206890234112,1.4173322007640121,0.08196721311475409,0.34030034315762264,1.0,2/8,3.55%,GAP43;RTN4RL1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7702582106639428,1.4172816353496633,0.07936507936507936,0.33974593754434435,1.0,3/14,8.14%,RFTN1;IL15;MYD88
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.675426971525614,1.4169516665440105,0.015384615384615385,0.3401584805299686,1.0,17/38,22.80%,IRAK2;NOD1;MAP3K11;SH2D3A;TNFRSF19;MINK1;GPS1;MAP3K5;TAB1;IKBKG;MAPK9;SH2D3C;GPS2;ARHGEF6;RPS27A;ADORA2B;TAB2
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.8146897894935982,1.4168292853967643,0.0,0.3400120463567028,1.0,3/18,2.96%,RIMS2;SYT1;SYT4
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.9435903883917144,1.416723716695183,0.034482758620689655,0.3394619582514793,1.0,2/6,1.71%,ANXA1;AMH
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.8128073697133322,1.4167213518725963,0.07547169811320754,0.3387125941052288,1.0,5/11,15.11%,CD24;PTPRO;BASP1;PODXL;IQGAP1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.7814308000096887,1.4163309884167885,0.057692307692307696,0.3400546077999427,1.0,3/13,11.16%,NMNAT2;AK5;AK3
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8066182664212738,1.4158941975424204,0.03571428571428571,0.3409137796121748,1.0,2/14,0.79%,MET;GPNMB
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.8259845689354502,1.4157585151614438,0.020833333333333332,0.34046672819678303,1.0,5/9,13.84%,NPTX2;DLGAP3;NPTX1;DLGAP1;DLGAP2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7603647298553928,-1.4155655246485104,0.05128205128205128,0.8952846326048306,1.0,5/16,15.30%,MRPS7;RPS28;RPS27L;RPSA;LOC102724159
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.9035836769815309,1.4152319367795285,0.10294117647058823,0.34139621536903064,1.0,1/5,1.48%,EGF
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.7637634059314986,-1.415078650150284,0.058823529411764705,0.8908598174538419,1.0,4/15,6.86%,ADAMTS9;CTSL;ADAMTS12;FBXO27
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.8964301249411697,1.4148270938281602,0.09090909090909091,0.3423216436453295,1.0,1/5,5.88%,FAS
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.9455447359385976,-1.4147689221295636,0.0425531914893617,0.8850620026135027,1.0,1/5,0.38%,RAB7B
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.5999307083171864,1.414451406541423,0.0,0.3432430395544115,1.0,33/135,11.84%,RIMS2;IGF1;EGF;THBS1;SERPINE1;PLEK;SYT1;SYT4;APP;MYH9;RIMS3;SYT5;ABCC4;SYNGR2;CPLX2;RAB11FIP5;SYT13;SNCA;TMED10;PDGFA;SYNGR3;PCLO;CPLX1;SYTL4;RAB11FIP1;DNAJC5;TGFB2;TF;ACTN1;CYRIB;SPARC;RAB27B;GAS6
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7220784704402535,1.414365141273728,0.04285714285714286,0.34274515311732495,1.0,8/29,16.17%,CDKN2A;GPNMB;FAM107A;CDK6;CDKN1A;CCL2;GFI1B;KLF4
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.7958162166914825,1.413876927303267,0.05,0.34363685742306715,1.0,2/14,6.89%,IGF1;NRG1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5809878955382134,1.4133237774969478,0.0,0.34496969612854705,1.0,32/128,10.16%,GRIN3A;CA10;GRIN2A;RGS7BP;GRIN2B;CNTN2;GAP43;OPCML;OPALIN;PLP1;PLPPR4;C11ORF87;SCN1A;STMN4;SCN2A;GRM5;SYNPR;SEPTIN4;ST8SIA3;LRRTM2;FAM107A;GRIA1;KCND3;TCEAL5;NTRK3;RFX4;GRIA3;GFAP;VSTM2A;ADCY2;ALDH1L1;NRXN3
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.8240376085411736,1.413243638529135,0.03225806451612903,0.3444713064576314,1.0,3/15,3.48%,RFTN1;S100A10;FA2H
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.4555464758147328,-1.4130698104355734,0.0625,0.8885183261042274,1.0,55/254,18.24%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;SF3B4;LSM3;DHX16;SCNM1;SF3A1;IK;POLR2K;ZCRB1;RBM8A;U2AF1;CRNKL1;LSM2;PPWD1;SF3B6;GEMIN4;BUD31;TFIP11;LSM5;METTL3;DDX46;SNU13;PQBP1;FRG1;POLR2C;CPSF1;SYF2;PPIH;PPIL3;SNRNP25;LSM4;GPATCH1;PNN;CLP1;GTF2F1;PPIL1;RBM22;ESS2;PRPF8;WDR77;SUGP1;SRSF2;GTF2F2;PRPF3;RBMX;RNPC3;CPSF3;POLR2D;CWF19L1;DNAJC8;SRSF9
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.6699109624529244,-1.4128349377367082,0.07142857142857142,0.8823374591063089,1.0,1/21,0.08%,SLC2A5
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.8396975866774585,-1.4127653230879345,0.06382978723404255,0.8757640769755981,1.0,1/7,1.85%,AGER
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.953052016915202,1.412609476063899,0.0,0.3464612165542535,1.0,1/5,0.92%,BOK
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.6336333950963,1.412144706983625,0.014705882352941176,0.34787763211166933,1.0,16/74,7.83%,CDKN2A;ANLN;ST6GAL1;BOK;CD24;PSCA;LIPH;ICAM1;ITGA2;PLEKHG6;BAIAP2L1;INCENP;IL1R1;NRP2;PGR;POF1B
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5779404183225273,1.4120305188442523,0.0,0.3474497399012215,1.0,54/186,17.85%,CARNS1;SCN9A;IMPDH1;PDE1C;TESC;CLSTN2;SRCIN1;CNTN4;ARHGAP39;CEP170B;EFNB3;FGF12;PRR36;ATP9A;DUSP8;EPB41L4B;CFAP126;CDK5R2;HPCA;FLRT1;NRG1;LARP6;SYBU;NYAP1;MORN5;MAPK8IP1;CLGN;WDR54;PCLO;SRRM3;C2CD4C;DNER;KLHL5;EML2;EPB41L1;VSTM2L;CAP2;MEIS3;MACROD1;CCDC184;STOM;FAM131C;CYB561;SEZ6L2;RARG;CERS5;PFN2;TTC9;NRSN2;CALB2;CTXN1;SCAMP5;LRRC45;IFT140
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.884013120684033,-1.411531217489291,0.04081632653061224,0.8640233273800291,1.0,1/8,0.92%,AKR7A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.884013120684033,-1.411531217489291,0.04081632653061224,0.8640233273800291,1.0,1/8,0.92%,AKR7A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.884013120684033,-1.411531217489291,0.04081632653061224,0.8640233273800291,1.0,1/8,0.92%,AKR7A2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.8429516439779623,1.411426343905537,0.07352941176470588,0.3490780877845118,1.0,3/13,3.14%,SPOCK3;SP100;WAS
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.8583300157079546,1.411312801570763,0.015151515151515152,0.3487226740191419,1.0,2/9,8.23%,ENPP2;CYP1B1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.6168794954220386,1.4113101950686426,0.012987012987012988,0.3479791288719795,1.0,31/114,12.44%,SLITRK1;PCDH8;TAGLN3;ZNF536;STMN2;CNTN2;GAP43;CAMKV;PLPPR5;OPCML;ZDHHC22;PLP1;EFNB3;SEMA5B;CDK5R2;ZIC1;MGAT5;GFAP;SULT4A1;NYAP1;KCNQ2;CELF3;SRRM3;CACNG4;DNER;DCX;LY6H;NACAD;DPYSL5;CRMP1;MEIS3
prerank,MSigDB_Hallmark_2020__Apical Junction,0.5680079501829828,1.4111965082345495,0.0,0.34767616796223133,1.0,44/157,19.48%,CDH6;YWHAH;AMH;FYB1;ZYX;SLIT2;ICAM1;CERCAM;PTPRC;CDH8;ITGA2;THY1;MYH9;BAIAP2;CD99;KCNH2;HADH;VCAN;ITGA3;NEXN;FSCN1;ITGA9;SYK;COL9A1;ACTN1;INPPL1;CLDN18;STX4;CD276;CTNNA1;CDH4;LAMA3;TNFRSF11B;MAPK11;IKBKG;CALB2;THBS3;VAV2;VASP;PCDH1;SLC30A3;SHC1;CRAT;AMIGO2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.7367352334945617,1.4109935488899596,0.0967741935483871,0.3478352345492119,1.0,8/23,10.59%,SCN1B;SCN3B;KCNQ1;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.577340221559711,1.4109004020758518,0.014084507042253521,0.34758225853743224,1.0,30/134,16.15%,HLA-DRA;MOG;RFTN1;FYB1;PRKCB;WAS;PTPRC;TEC;THY1;PAK3;NFATC2;LAT2;FYN;SKAP1;EIF2B2;NFKBID;SYK;PAG1;CD276;HLA-DRB1;PAK1;BCL2;STOML2;BCAR1;CD4;BMX;INPP5D;EIF2B5;PIK3CD;SH2B2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.8579578512563276,-1.4108434662003686,0.06521739130434782,0.8621917151491663,1.0,1/7,1.13%,ID2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.5842320168318018,1.4107658645490153,0.031746031746031744,0.34733035219166447,1.0,20/84,15.87%,GPNMB;ANXA1;MOG;IL15;IGF2BP2;PTPRC;IRF7;SFTPD;ACKR1;BCL6;NLRP12;NPTN;HDAC9;CD276;HLA-DRB1;PER1;TRIM32;LURAP1;IFIH1;PIK3CD
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.8690004887233891,-1.4106115618877628,0.061224489795918366,0.8567898440550447,1.0,2/8,7.20%,APOE;ZNF502
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.9369739100848103,1.4105424253005705,0.0,0.3473927573959694,1.0,2/8,1.34%,MET;PROX1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.703856268358936,1.410445909692397,0.07042253521126761,0.347142310658271,1.0,8/32,16.17%,CDKN2A;GPNMB;FAM107A;CDK6;CDKN1A;CCL2;GFI1B;KLF4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.6536615572648168,1.4103935643288739,0.04918032786885246,0.3466529681537256,1.0,20/70,16.33%,MET;PROX1;STMN2;PSRC1;PLEK;CDC42EP3;APP;BAIAP2L1;MYLK3;BAIAP2;CDC42EP1;SYNPO2L;PRKCE;FCHSD1;MAPT;ARF6;PAK1;DCTN1;BIN1;PFN2
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.9338136298702185,1.410249094115573,0.0,0.34645301143367196,1.0,2/5,4.83%,RELN;VLDLR
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6389488700347531,-1.4097616346227158,0.09523809523809523,0.8556847268149945,1.0,9/23,11.39%,MT1E;MT1A;SLC30A8;SLC39A10;MT1G;MT1F;SLC30A5;SLC39A8;MT2A
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.613966129770516,1.4094125505390522,0.04,0.34890617083230113,1.0,26/97,9.35%,L1CAM;RGS7BP;ZNF536;STMN2;CNTN2;ADCY5;SHC2;PLP1;RCAN2;PLPPR4;THY1;ACKR1;IGSF21;PRIMA1;APLNR;CCDC3;RAMP3;APOD;FAM107A;TCEAL5;PHYHIP;RASL12;MAOB;GFAP;TMEM132C;PTPRD
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8370508423274412,1.4093474780815725,0.06557377049180328,0.3484162107230366,1.0,4/9,8.65%,SCN3B;KCNQ1;GJC1;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.8975640693469294,1.4086666253254834,0.041666666666666664,0.35054572557972913,1.0,2/5,8.51%,CCBE1;MYO1C
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.780363597222181,-1.4077625175502615,0.11627906976744186,0.8625559588752584,1.0,2/8,15.29%,UBE2M;DCUN1D2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.6156658934190168,-1.4077142039799642,0.08695652173913043,0.8567533071747011,1.0,15/51,16.24%,SLC25A5;COX18;TIMM8B;TIMM13;SLC25A4;AIP;BCAP31;ABCB10;BAK1;TIMM23;BAD;TSPO;TIMM10;SLC25A24;OXA1L
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.9225570652801887,1.407403110437537,0.06896551724137931,0.3552546323405336,1.0,2/6,3.14%,SHTN1;WAS
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7871893240442641,1.4066882827855849,0.06666666666666667,0.35693459335361366,1.0,4/15,8.56%,IGF1;PIM1;TBX20;ZFPM2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.7683008389549895,1.406686651383406,0.0410958904109589,0.35619559833631836,1.0,8/22,10.35%,SLC32A1;NLGN1;CPLX2;SNCA;PCLO;CPLX1;PLD2;DNAJC5
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8499136128245999,1.406586446113818,0.07142857142857142,0.355837228186019,1.0,1/10,0.93%,TLR2
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.6446086514176852,1.4064987056775282,0.031746031746031744,0.35538613768294164,1.0,15/72,8.65%,DOC2B;ADCY5;KCNC2;IRS2;EPHA5;BMP8A;SOX4;ABCC8;GIPR;GLP1R;ITPR3;NNAT;CACNA1E;HADH;CACNA1C
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.8605474477438235,1.40640105366489,0.08928571428571429,0.35496040460549316,1.0,3/10,2.21%,HPN;THBS1;SERPINE1
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.8502427619452533,-1.4063801099824282,0.024390243902439025,0.8597370219721231,1.0,2/6,13.10%,RAE1;LDB1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8306961258488738,-1.4063603898709673,0.0625,0.8412150721486195,1.0,3/5,12.53%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8306961258488738,-1.4063603898709673,0.0625,0.8412150721486195,1.0,3/5,12.53%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8306961258488738,-1.4063603898709673,0.0625,0.8412150721486195,1.0,3/5,12.53%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.6724574159268782,1.4059620236865369,0.08196721311475409,0.3562719292837226,1.0,12/34,17.11%,EPHA7;GRIN2B;FYN;SNCA;FOXO3;CTNNB1;TGFB2;MAPT;FOS;ZNF746;MAP3K5;WNT5A
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6983329155350431,1.404675438609334,0.029411764705882353,0.36108879438831004,1.0,2/33,3.34%,TGFBR2;EPHA2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.8028896211931539,1.4045788721880195,0.058823529411764705,0.36084086655692027,1.0,5/13,14.15%,SP100;APOD;BARD1;CABP1;RANGAP1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.7482662878397164,1.404534563351341,0.017241379310344827,0.36026762130873513,1.0,9/21,15.57%,MYRF;RELN;SOX4;STAT3;TPPP;PICK1;SOX10;SLC8A3;EIF2B5
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.6518802068701077,1.4039196360075097,0.04285714285714286,0.36167396131044954,1.0,22/58,22.80%,ZFP36;IRAK2;NOD1;MAP3K11;SH2D3A;TNFRSF19;MINK1;TNIP2;GPS1;MAP3K5;TAB1;MAPK11;IKBKG;SKP1;MAPK9;SH2D3C;GPS2;MAP2K3;ARHGEF6;RPS27A;ADORA2B;TAB2
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.8306275024743164,-1.4035803038795287,0.1,0.8544536942307411,1.0,2/9,6.39%,FBXO5;FBXO43
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.908089357478435,1.4033711135257994,0.08,0.3633531583328755,1.0,1/5,5.53%,NUAK1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.8158245910882452,1.40320700891439,0.0,0.36319531865316684,1.0,5/13,10.74%,ANXA1;RELN;GCM2;CDK6;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.9086765434225299,1.4031553446251817,0.045454545454545456,0.36257570796611044,1.0,2/5,4.23%,ELAVL4;RBM24
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6922333274551272,1.4029327276603005,0.045454545454545456,0.3626277407720006,1.0,7/43,5.67%,CDH22;CDH6;CDH9;CDH19;CDH8;CDH7;CDH18
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8727186421764426,1.4024066903616874,0.05660377358490566,0.3639000092843618,1.0,5/7,9.78%,GRIN2A;GRIN2B;GRIN2D;GRIN1;PDLIM4
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6391484144356416,1.4021518349055853,0.07692307692307693,0.3640870537606074,1.0,7/59,13.53%,TGFBR2;SBK1;GALNTL6;GALNT16;HIPK3;PRKCD;HIPK1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7813520304223183,1.4020579003941458,0.14754098360655737,0.3636541075924999,1.0,3/13,10.74%,TGFBR2;TBX20;TGFB2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6305403417600445,1.4013218775073755,0.04918032786885246,0.3656033353496031,1.0,19/65,16.67%,A4GALT;SGPP2;ABCA8;VAPB;FA2H;ST8SIA3;ST8SIA1;CERS3;SPNS2;HACD1;CYP4F22;ST6GALNAC5;ALDH3A2;ELOVL7;SGMS1;LARGE1;CERS5;HACD4;ELOVL5
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.6024477470593341,1.4012130054635652,0.02857142857142857,0.3652147745143877,1.0,21/80,8.06%,COL4A1;PRRX1;PCDH18;DCN;PDGFRA;COL4A2;ACTA2;CALD1;SULF1;THY1;PODN;ANGPTL2;SLIT3;POSTN;COL12A1;TNS1;LDB2;RASL12;FAP;C1R;GFAP
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8149090387816522,1.4007975816402454,0.056338028169014086,0.3662868023099827,1.0,7/14,14.10%,NLGN1;RELN;CACNG3;SHANK3;CACNG8;CACNG4;CCL2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.867765017125711,1.4006772801267544,0.07142857142857142,0.36633071694060365,1.0,1/9,0.37%,HPN
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.8871508190411637,1.4005482469828479,0.01639344262295082,0.3658522002197358,1.0,2/10,3.14%,SPOCK3;WAS
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.6790714089834493,1.4004485287504886,0.05970149253731343,0.36535292061313834,1.0,7/42,11.38%,IL1RAPL1;S100A10;DMTN;NEDD9;PTPRD;ARHGEF7;CDKL5
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.9184437986348131,1.400221751839407,0.016666666666666666,0.36551150806960536,1.0,1/8,0.56%,ST6GAL1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8930050831050712,1.3998911445303428,0.07547169811320754,0.3661434846761234,1.0,3/6,8.25%,HRH1;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.696724561634547,1.398837241595155,0.07462686567164178,0.3703548675446756,1.0,8/27,9.61%,ANXA1;TYMP;TSPYL2;IGFBP7;RYR2;GRK2;YWHAG;SCG5
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8378943558819776,-1.3986761086390793,0.15,0.8823507059578936,1.0,2/5,3.59%,PDCD7;AKR1C3
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.9181148289631405,1.3984243345181848,0.06382978723404255,0.37128958839765885,1.0,1/5,2.58%,ZFP36
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8570150655818861,1.3984163389101216,0.06,0.370582578455521,1.0,1/8,0.03%,APOLD1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.7239251387689482,1.3983202251735207,0.08955223880597014,0.37028145384901956,1.0,6/22,8.20%,SYT1;SYT4;SYT5;SYT13;SNCA;GRK2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.5522505537870055,1.3980768494740619,0.023255813953488372,0.37047323699574924,1.0,28/231,12.76%,LEF1;TEAD2;BOK;CTSC;BLM;WAS;DMTN;ADD2;TGFA;WASF1;FAS;GRIA1;REPS2;PARD3;TNFRSF1A;PML;TMED10;SHANK1;CTNNB1;SLC9A1;SH3PXD2B;YAP1;TCAP;PEX14;TEAD1;TLE3;ANKRD28;RSPH4A
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8891978692333625,1.397314066382322,0.10344827586206896,0.3726942691034313,1.0,3/7,9.66%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.6614002347923108,1.396948174534977,0.06153846153846154,0.37317003564293916,1.0,10/47,12.75%,EPHA2;RAMP3;STAC2;ITGA3;PTPN9;PRKCE;PRKCH;SORBS1;ARF6;STX4
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.5850995482790229,1.3967199484410653,0.0,0.3733550796238438,1.0,46/155,14.38%,ECM2;COL4A1;ADAMTS4;DCN;COL11A2;NPNT;ADAMTSL2;THBS1;SERPINE1;COL4A2;COL8A1;ITGA8;ICAM1;ITGA2;APP;ADAMTS10;CD44;POSTN;AGRN;COL27A1;ADAMTS19;COL23A1;LAMB1;PDGFA;VCAN;LAMA5;ITGA3;BGN;ITGA11;LOXL1;MMP14;ITGA9;ADAM12;ADAM19;COL9A1;COL4A4;SPARC;MMP16;MMP17;ITGB8;COL4A5;FN1;COL5A1;ITGAL;LAMA2;FGF2
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7533877981887909,1.3966009142804978,0.06451612903225806,0.3732067391276538,1.0,8/18,15.57%,MYRF;PRDM8;EIF2B2;TPPP;SOX13;SOX10;SLC8A3;EIF2B5
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.8709272297276154,1.3962706877794369,0.06666666666666667,0.37308851512903174,1.0,2/6,7.63%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.8709272297276154,1.3962706877794369,0.06666666666666667,0.37308851512903174,1.0,2/6,7.63%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6495650159416293,1.3961869991739821,0.1044776119402985,0.37256671056439106,1.0,6/32,8.73%,GPNMB;EPHA7;NEK10;NLRP12;PDGFA;MVP
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7872505771758209,1.396059269114881,0.07692307692307693,0.37242103236308394,1.0,2/14,3.19%,CHRM3;KCNB2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.8203631400770088,1.396037617814257,0.07142857142857142,0.37179269597661235,1.0,2/9,9.32%,SP100;MX1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.7218457359306553,1.3960005860196945,0.1206896551724138,0.37118869394834114,1.0,4/16,16.39%,MET;ITGA3;KCTD13;STMN1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.8116997216331423,1.3959373588269803,0.1,0.37003129614011326,1.0,2/10,9.24%,SYCE1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.8116997216331423,1.3959373588269803,0.1,0.37003129614011326,1.0,2/10,9.24%,SYCE1;STAG3
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6716494005789241,1.3954999134220853,0.015151515151515152,0.3710252806365215,1.0,11/41,13.45%,KIF14;TMEFF2;ATRNL1;SRCIN1;ITGA8;EFNA1;LAMB1;LAMA5;PXN;RADIL;FN1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.8446671206478317,1.394947563102846,0.1,0.3724288290570192,1.0,1/6,2.66%,P4HA2
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.752227015819709,1.39485290804482,0.04838709677419355,0.37215506808350624,1.0,6/22,14.10%,IL15;STAT4;PTK6;GHR;STAT3;CCL2
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6964873236694518,1.3946398493443608,0.03278688524590164,0.37212074606310735,1.0,8/38,10.85%,PROX1;SULF1;ITGA8;SOX4;ZBTB16;ROBO2;TGFB2;GLI2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6605832084525576,-1.394618760444131,0.10526315789473684,0.9042072281614765,1.0,4/30,5.66%,H1-2;KPNA2;H1-4;SIRT6
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.6337583435400571,1.3946153977639018,0.014925373134328358,0.3714808669674356,1.0,20/89,14.22%,TGFBR2;IGF1;KIF14;ADCY5;PAK3;PRKAR1B;NRG1;NTRK3;GHR;CHI3L1;PAK4;ADCY7;ADCY2;TGFB2;MINK1;GAS6;PRR5;PRKCD;TNFRSF10B;PAK1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.6303033142892883,-1.394517589309657,0.0967741935483871,0.8983293319830058,1.0,7/25,18.47%,TRIB3;FBXO5;ARRDC4;RPS2;FEM1A;DCUN1D2;PLK1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.5840196371192125,1.3944150725231184,0.0,0.3716854478799308,1.0,46/155,14.38%,ECM2;COL4A1;ADAMTS4;DCN;COL11A2;NPNT;ADAMTSL2;THBS1;SERPINE1;COL4A2;COL8A1;ITGA8;ICAM1;ITGA2;APP;ADAMTS10;CD44;POSTN;AGRN;COL27A1;ADAMTS19;COL23A1;LAMB1;PDGFA;VCAN;LAMA5;ITGA3;BGN;ITGA11;LOXL1;MMP14;ITGA9;ADAM12;ADAM19;COL9A1;COL4A4;SPARC;MMP16;MMP17;ITGB8;COL4A5;FN1;COL5A1;ITGAL;LAMA2;FGF2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.7726582099159908,1.394353717616315,0.01639344262295082,0.37119965510750563,1.0,11/22,15.57%,MYRF;TLR2;PRDM8;APP;SOX4;EIF2B2;CDK6;TPPP;PICK1;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.6315433688076402,1.3941535102318925,0.03225806451612903,0.37121040984182724,1.0,15/58,16.40%,PROX1;PLEK;CDC42EP3;BAIAP2L1;MYLK3;BAIAP2;CDC42EP1;NTRK3;SYNPO2L;PRKCE;FCHSD1;ARF6;BIN1;PFN2;P2RX7
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.8131898973286364,1.3939784362802006,0.10526315789473684,0.37132846933137176,1.0,4/13,8.24%,IGF1;SERPINE1;SLIT2;PDGFA
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.6339561791729256,1.393652858406103,0.0,0.3721746635824597,1.0,8/63,8.47%,BOK;ANXA1;CHRM1;IL15;DOC2B;SFTPD;SNCA;SYNGR3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.900447242678339,1.393414823003096,0.04918032786885246,0.37229047518301606,1.0,1/7,0.12%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.7634497075992751,-1.393360409196588,0.08695652173913043,0.8986938933061193,1.0,2/13,5.01%,IK;FBXO5
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.6058427671122552,1.3928092560358494,0.03076923076923077,0.37394295665639504,1.0,26/82,19.67%,BOK;MLLT11;CD24;EPHA2;DAB2IP;SCN2A;HIC1;ZNF385B;PML;PRODH;CYP1B1;BCL2L1;IKBKE;BBC3;CDKN1A;PRKCD;PDK1;TNFRSF10B;BCL2;HIPK2;MAP3K5;TP53;STK24;BRCA1;STK11;ITPR1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7586409274096203,1.3928053080365044,0.015384615384615385,0.3732453018865137,1.0,2/22,1.74%,LEF1;TESC
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6187942945096305,-1.392715446678698,0.08333333333333333,0.8961019804788917,1.0,8/30,13.21%,NDUFS5;NDUFA12;NDUFB4;NDUFB1;NDUFV3;NDUFA8;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.8340886853896425,1.3926482974789285,0.03225806451612903,0.3732095887793383,1.0,1/9,1.88%,BLM
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.7546794639430956,1.3922591590585516,0.12121212121212122,0.37376843739335114,1.0,2/17,3.13%,THBS1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.8147937211034382,1.3922013791583563,0.017857142857142856,0.3732021307694243,1.0,3/17,2.96%,RIMS2;SYT1;SYT4
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.6223082112994731,1.3917883392951453,0.07246376811594203,0.3741184900023681,1.0,13/62,16.79%,VRK2;SOCS3;CD24;PTPRC;IRAK2;BIRC3;TNFRSF1A;SYK;GAS6;HIPK1;FADD;ELF1;IKBKG
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8756152263598795,1.391660394436483,0.0967741935483871,0.37397586751453743,1.0,2/6,7.84%,SLIT2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.8569936070695894,-1.3914922479599179,0.09523809523809523,0.8979690485013485,1.0,3/6,6.53%,TNFAIP3;GREM1;IL33
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.623512398848576,-1.3913219893272064,0.15151515151515152,0.8927712600981702,1.0,9/31,15.25%,SLC25A5;SLC25A4;BAK1;APOO;MICOS10;BAD;SAMM50;TIMM50;TMEM11
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.6595115868480902,1.3912739483270127,0.07042253521126761,0.37484527193030437,1.0,12/41,13.24%,TGFBR2;TEAD2;MFSD2A;PDGFA;KITLG;PKDCC;PBX3;TGFB2;GLI2;IFT122;TEAD1;RNF112
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.8538787906681081,1.3912361256075338,0.04225352112676056,0.3743652903585996,1.0,5/8,14.48%,RELN;DAB2IP;NEUROD2;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.7751255892846676,-1.3909216158291333,0.09302325581395349,0.8894314635310396,1.0,1/10,3.10%,GALT
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.7765238654082047,1.3907455058653235,0.07017543859649122,0.3758816417075607,1.0,5/12,14.42%,IRF7;AHR;SKAP1;ADCY7;FADD
prerank,MSigDB_Hallmark_2020__Complement,0.5743137426188826,1.3905587143152616,0.0410958904109589,0.3759464001678783,1.0,25/145,9.19%,C3;CTSC;MAFF;CTSS;RASGRP1;SERPINE1;COL4A2;PLEK;TIMP2;CD55;WAS;CP;PIM1;IRF7;PLSCR1;GNG2;FYN;DOCK10;CFH;PDP1;C1R;ZFPM2;DGKG;PCLO;CASP10
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.7093003116121422,1.3904053146098352,0.12698412698412698,0.37578081737679525,1.0,3/21,7.46%,EGF;APP;CHI3L1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.6907240910824417,1.390160531504768,0.09375,0.3760543264511983,1.0,19/37,23.50%,NPY1R;CHRM3;CHRM1;ADCY5;ADCY7;ADCY2;P2RY12;HTR1E;GPR37;LPAR1;PDE2A;GRM7;FLNA;GNAI1;ADCY3;ADCY8;HTR1F;HRH3;ADCY9
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.7473866814639165,1.3897537292443818,0.05454545454545454,0.3770354722568656,1.0,5/23,8.65%,CACNA1H;CACNA1G;CACNA1E;MCUB;CACNA1C
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.7270757963259674,1.3888925444999347,0.04411764705882353,0.3794693405722798,1.0,3/23,4.27%,KIF14;STMN2;STMN4
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6443719521627996,1.388768039418365,0.06060606060606061,0.37925702384494414,1.0,16/61,11.54%,KLF2;DCN;THBS1;SERPINE1;COL4A2;SULF1;ISM1;DAB2IP;SERPINF1;PML;CTNNB1;CD160;TGFB2;PGK1;SPARC;THBS2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.7591113200184096,-1.3886465294955346,0.15384615384615385,0.8977800061761968,1.0,3/7,14.90%,CCDC22;PSMD10;NFKBIB
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.903756790214975,1.3885653855974072,0.05,0.37879331583350645,1.0,3/5,9.50%,CD24;PTPRO;BASP1
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.903756790214975,1.3885653855974072,0.05,0.37879331583350645,1.0,3/5,9.50%,CD24;PTPRO;BASP1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.8307022822972472,-1.3879349076516998,0.07692307692307693,0.8956960939663771,1.0,3/8,13.99%,KDM1B;RIOX1;RIOX2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.8358617376991049,1.3878505909991463,0.03389830508474576,0.38161947572243055,1.0,4/10,13.70%,ENPP2;CD44;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.8903925309051288,-1.3875774170277324,0.09523809523809523,0.8918369235647973,1.0,2/6,7.24%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5789482589883628,1.3874188025085632,0.01282051282051282,0.38282734771959304,1.0,31/145,12.49%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTN4;SHTN1;CNTNAP1;PLP1;CNTNAP2;BICDL1;APP;DAB2IP;STMN4;PAK3;SHANK3;NYAP2;DOCK10;LAMB1;NYAP1;FRY;SHANK1;MICALL1;PACSIN1;GPRIN1;MINK1;TRIO;MAPT;EPHA4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.8043828709334887,1.3866675246973585,0.05357142857142857,0.3851833094745493,1.0,4/13,5.14%,WAS;DMTN;EPHA2;CD44
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.8697367624345479,1.3865210734470472,0.03571428571428571,0.38506571859381256,1.0,4/5,11.22%,PLD1;RAP1GAP;FSCN1;PODXL
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.8480045666997563,1.386420840758808,0.07352941176470588,0.38470248471050483,1.0,4/13,9.52%,ANK3;TESC;SLC9A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.6361297671319252,1.385762280216879,0.03571428571428571,0.3866125770979083,1.0,10/47,12.75%,EPHA2;RAMP3;STAC2;ITGA3;PTPN9;PRKCE;PRKCH;SORBS1;ARF6;STX4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.9368919170607416,1.3855191920809207,0.05172413793103448,0.38619041040992413,1.0,1/5,2.75%,STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.9368919170607416,1.3855191920809207,0.05172413793103448,0.38619041040992413,1.0,1/5,2.75%,STPG4
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5510322237102553,-1.3850162895204796,0.03125,0.9049675849573321,1.0,9/59,6.89%,DAO;SOD3;OSGIN1;C6;APOE;SERPINF2;PPIC;HSD11B1;ADH6
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.9568261701421162,1.3849272987216337,0.03508771929824561,0.3877415292210309,1.0,1/5,0.18%,NR4A3
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.868790067712203,-1.384690244552268,0.09375,0.9010473587644446,1.0,5/9,11.10%,CHAMP1;IK;KNL1;SPDL1;MIS12
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.7042103526072105,1.3844425466431,0.109375,0.38922615902649593,1.0,6/30,13.52%,C3;SERPINE1;MKLN1;TF;ARF6;B2M
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.7108023034934473,-1.3843550686105541,0.18181818181818182,0.8976834316127036,1.0,3/13,10.71%,SMPD3;SNF8;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.611459061322887,1.3843351402892812,0.016129032258064516,0.38885940642714406,1.0,24/78,18.40%,PTK6;SRCIN1;PTPRO;PTPRC;CAMK2N2;PTPRB;DAB2IP;THY1;DUSP10;DVL1;SMCR8;SNCA;MVP;YWHAG;CDKN1C;GADD45A;CDKN1A;CDKN1B;UBASH3B;SLC8A3;TAB1;SLC8A1;TSC2;WWTR1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.9291348095863421,1.3840068079348111,0.09433962264150944,0.3896280067795095,1.0,3/6,3.41%,ACSL5;THBS1;IRS2
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5850656712619268,-1.3839502469701555,0.027777777777777776,0.8944133692946927,1.0,19/55,19.46%,BUD23;TFB2M;TRMT61A;TRMT10C;TRMT10A;METTL8;FTSJ1;METTL2A;METTL3;MTERF4;TRMT61B;TRMT5;VIRMA;MEPCE;TFB1M;LCMT2;FBL;TGS1;TRDMT1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8765442047566332,1.3838892557011664,0.016666666666666666,0.3886951756825645,1.0,3/7,5.42%,SLIT2;NRP2;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8765442047566332,1.3838892557011664,0.016666666666666666,0.3886951756825645,1.0,3/7,5.42%,SLIT2;NRP2;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.8540575562586228,1.3834396536003177,0.09523809523809523,0.38986287477686415,1.0,2/8,2.44%,STMN2;PLEK
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8499271437871698,1.3834264627415362,0.058823529411764705,0.389216713123558,1.0,6/11,13.19%,ITM2A;NECAB1;SOAT1;NECAB2;ABCA2;BACE2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.8343688118552627,-1.3832834917546721,0.11363636363636363,0.893129797287543,1.0,1/6,1.85%,AGER
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6850596400059954,1.3831218655199553,0.06779661016949153,0.3896166178524637,1.0,11/32,17.70%,STMN2;STMN4;FAM107A;MAPRE2;TRIM36;TPPP;MAPT;PHLDB2;CAMSAP3;STMN1;SKA2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5946152558167331,1.3826328819378384,0.04054054054054054,0.3907765545968462,1.0,18/78,17.12%,SCN1B;STMN2;PTK6;RIT2;PLPPR5;RELN;DAB2IP;VLDLR;NTRK3;NPTN;ZNF804A;PACSIN1;ALK;CAMK2B;COBL;CAMK1D;WNT5A;CUX2
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.9351255219865602,1.3823488266410706,0.015873015873015872,0.3913923562704331,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.759190098964896,1.382271277791567,0.13559322033898305,0.3909876517837584,1.0,1/16,0.01%,LEF1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.851981064137855,1.381634620421405,0.047619047619047616,0.39277697429955155,1.0,3/9,9.13%,CTSS;RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6528009290376667,1.3814322742002194,0.07575757575757576,0.39306770233147503,1.0,12/48,12.49%,PDGFRA;IL15;PTK6;TEC;RELN;FLT1;FYN;GHR;AATK;PKDCC;SYK;EPHA4
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7505041241924938,-1.3814158069737654,0.12903225806451613,0.9001844214297254,1.0,5/16,13.90%,RTRAF;TRPT1;C2ORF49;CPSF1;CLP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.8345589037608916,-1.3812022777268897,0.06060606060606061,0.8961734158994955,1.0,1/8,1.85%,AGER
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.6407043099158101,1.3809708926343325,0.056338028169014086,0.3943108684168078,1.0,11/65,13.51%,IGF1;KIF14;EGF;TGFA;PLSCR1;NUDT16;CDC14A;CENPV;PRKCE;CDC7;CCNB1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5308523846083069,-1.380545712897789,0.05555555555555555,0.8949030759772614,1.0,19/71,14.09%,FTL;MT1E;MT1A;SLC30A8;FTH1;SLC39A10;MT1G;MT1F;CCDC22;SLC31A2;ATP6V1G1;SLC46A1;SLC30A5;HFE;SLC39A8;MT2A;ISCU;COX19;MT3
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7944507874888886,1.3795790411814224,0.07692307692307693,0.39987244897959184,1.0,3/15,7.83%,SIX3;ACTA2;POF1B
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.8560114652704756,1.3795299259667229,0.03389830508474576,0.39870617200447916,1.0,1/9,2.58%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.8560114652704756,1.3795299259667229,0.03389830508474576,0.39870617200447916,1.0,1/9,2.58%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.8212977846458258,1.379452389907986,0.08196721311475409,0.3983331811125741,1.0,3/12,2.89%,IGF1;SULF1;DUSP1
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.8723265489328803,1.3794395611488701,0.15254237288135594,0.39766609205522385,1.0,1/6,0.95%,ANXA1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.8748237786861945,1.3794131935841083,0.05084745762711865,0.39706027453257775,1.0,2/7,3.77%,TLR2;DAB2IP
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.8889350900281464,1.3792951115778582,0.06779661016949153,0.39688828045964547,1.0,1/5,2.65%,PCSK2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.6807081763067748,1.3787506031294263,0.06756756756756757,0.3981861981823488,1.0,4/36,1.48%,LEF1;IGF1;SP100;EGF
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6594046934626003,1.3784684297709282,0.09090909090909091,0.39858003008909193,1.0,9/33,7.08%,ANK3;CTSS;KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.9034274154625219,1.3784341502846245,0.03225806451612903,0.39807441251739295,1.0,2/6,4.23%,ELAVL4;RBM24
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7672031482569528,1.3780918537493971,0.06779661016949153,0.39891537627121654,1.0,2/16,4.00%,S100A10;THY1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5540747838197528,1.3778750225459737,0.04285714285714286,0.39915029353297715,1.0,38/113,19.10%,MET;COL4A1;CSPG4;COL4A2;EPHA2;DAB2IP;ARHGEF17;NFATC2;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;BOC;SCARA3;KITLG;LIMCH1;SH3PXD2B;SRPX2;YAP1;TEAD1;EPB41L1;CAP2;ENAH;CD276;PARD3B;TRIM32;BCAR1;NOTCH3;FSTL1;PALLD;RBFOX2;FZD7;NTN4;MESP1;WWTR1;BARX2;SCRIB
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.6975775459233109,1.3774387084189634,0.029411764705882353,0.3997534747311599,1.0,4/42,9.01%,ANLN;ANK3;INCENP;TRIM36
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.8357043801422803,1.3773821020405768,0.05,0.39930747279476325,1.0,1/8,1.88%,BLM
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.570472662881631,1.377280854469039,0.02702702702702703,0.39899849238178875,1.0,23/119,15.87%,HLA-DRA;MOG;RFTN1;FYB1;WAS;PTPRC;TEC;THY1;PAK3;FYN;SKAP1;EIF2B2;NFKBID;PAG1;CD276;HLA-DRB1;PAK1;STOML2;BCAR1;CD4;INPP5D;EIF2B5;PIK3CD
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.858414618362829,1.3766746411599498,0.017543859649122806,0.40095167223821004,1.0,3/7,4.95%,DRAXIN;MDGA2;SOX4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.7706809626089438,1.376374313507667,0.06779661016949153,0.40145126941148535,1.0,4/18,8.23%,C3;CCBE1;SULF1;CYP1B1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.7665750710157919,1.376118981362684,0.1,0.40212252688206,1.0,6/13,13.08%,SHTN1;PTPRC;ITGA2;ITGA11;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7119169687810238,1.3760646683778692,0.10294117647058823,0.4016378345447076,1.0,4/26,10.85%,NPY;PKDCC;TGFB2;GLI2
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.7335046120524795,1.3759599585648008,0.1076923076923077,0.40125075065092136,1.0,2/16,4.91%,NR4A3;FABP3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7497908406195606,1.3757911211119336,0.03278688524590164,0.4013057293549962,1.0,2/14,11.16%,IMPDH1;AK3
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.7933899531058358,1.3756692564580115,0.0967741935483871,0.40122660311375385,1.0,1/11,1.87%,RASGRP1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.8522120218392217,1.3756572655784474,0.05084745762711865,0.40057475516180685,1.0,3/11,8.86%,NR4A3;WNT8B;UGDH
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.901352152264556,1.3755739732625323,0.1016949152542373,0.4002110985515056,1.0,1/5,0.54%,MET
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.8546002107916005,1.3755316432106868,0.09090909090909091,0.399772510610909,1.0,3/8,5.63%,CNTN2;CNTNAP2;AGRN
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6578941518451054,1.3755313253032817,0.09375,0.3991073317247012,1.0,14/39,17.12%,IL1RAPL1;NLGN1;CLSTN2;NUMBL;GRID2;SERPINF1;PTPRD;SRPX2;DLG5;TRIM32;NAP1L1;RGS14;CLSTN3;CUX2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.6364276745889139,-1.375375092391586,0.06896551724137931,0.9211074667546344,1.0,7/43,9.17%,H1-2;PADI4;H2BC21;H1-4;M1AP;NOC2L;H2BC18
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.62600727507913,1.3746399940828198,0.09230769230769231,0.40180251959451857,1.0,16/50,14.75%,ANXA1;RIMS2;SYT1;SEPTIN5;KCNMB4;RAB15;RAB3C;SEPTIN4;CPLX2;RHBDF1;CPLX1;SCG5;LGI3;STX4;HAP1;RHBDF2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.5262601596594927,1.374374944763244,0.0,0.4020264155967245,1.0,26/275,9.71%,LEF1;HPN;MET;ANXA1;IGF1;KIF14;PLK2;THBS1;PIM3;RPS6KA1;PIM1;PRAME;NUAK2;FOXO1;CD44;FAS;BIRC3;NAA38;THOC6;SNCA;SCX;MYD88;BAG3;CTNNB1;BCL2L1;DHCR24
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.8535694358529672,1.3742432588546605,0.078125,0.4019848328209554,1.0,3/7,7.76%,ANK3;THBS1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.8298842165403397,-1.3740222486048936,0.12,0.9244784537573657,1.0,1/7,5.01%,FBXO5
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.8107519037553361,-1.3738306996199803,0.1388888888888889,0.9200802350541953,1.0,1/10,0.15%,DAO
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6754239599861112,1.3737773968858449,0.06666666666666667,0.4029817082224954,1.0,6/36,2.21%,TLCD2;ANK3;RFTN1;IL1RAPL1;S100A10;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.7030020944505908,1.3735102191281743,0.043478260869565216,0.40346641365251956,1.0,4/29,10.41%,ENPP2;CLRN1;ARHGEF7;FSCN1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7787368015629016,1.373308613574063,0.06451612903225806,0.40336621500644276,1.0,5/16,13.78%,THY1;APLNR;RAMP3;SNCA;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6538788884210459,1.373150515511546,0.078125,0.4030784918847039,1.0,9/42,16.60%,SKOR1;VWC2;VWC2L;SMAD1;PPARG;SMAD9;FSTL1;HIPK2;SMURF1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.541266979568098,1.3731194935755517,0.013888888888888888,0.4026416771758514,1.0,31/136,20.19%,RASGRP2;S100A10;RASGRP1;DAB2IP;EPHA5;THY1;RGS6;AGRN;RAP1GAP;DOCK10;MAPRE2;ARHGEF7;SIPA1L1;CDKL5;FGD5;USP6NL;EPHA4;PLXNA4;CCL2;CPEB2;PLXNA1;PLXNA2;RGS16;TBC1D10B;PKP4;VAV2;NGEF;VAV1;RAP1A;DOCK9;SEMA4D
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.7529439103396864,-1.3731088450001665,0.14285714285714285,0.9188844868659,1.0,3/15,3.21%,CSTB;CST3;CTSH
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.8196009281897917,1.372935255257179,0.03773584905660377,0.40276800913077193,1.0,1/7,2.58%,ZFP36
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.6735698744375842,1.372506138624985,0.018518518518518517,0.4037164271110059,1.0,14/43,15.17%,HLA-DRA;SP100;ICAM1;IRF7;TRIM5;CD44;CIITA;TRIM22;PML;PRKCD;HLA-DRB1;B2M;CAMK2B;HLA-E
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8198327009612603,-1.37249851382797,0.12244897959183673,0.9175137827022225,1.0,2/6,15.24%,NBDY;CNOT1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5691192723462419,1.3723470782817917,0.038461538461538464,0.40378460220744056,1.0,25/114,11.97%,SCN9A;KCNJ2;KCNV1;SCN3B;KCNB2;SCN1A;KCNF1;SCN2A;KCNK1;KCNMB4;TRPM4;ABCC8;PIEZO2;SLC5A4;KCND3;GRIN1;ABCC9;KCNC1;ATP1B1;SLC4A11;SCN3A;SLC25A29;SLC7A1;KCNAB3;FGF13
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.7499290471716954,1.3723357074902247,0.08823529411764706,0.4031817963042447,1.0,5/17,7.76%,SYT1;SYT4;SYT5;SYT13;SNCA
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6687996068311484,1.372126353125745,0.03076923076923077,0.403287823739951,1.0,8/62,9.01%,ANLN;ANK3;SEPTIN5;INCENP;SEPTIN4;SEPTIN8;SEPTIN9;TRIM36
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6690701622521026,1.371901173129728,0.07575757575757576,0.40374636658097174,1.0,7/41,6.89%,SIX3;MET;ANXA1;PROX1;LSR;GCM2;NRG1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.8297117646940795,1.3718524840223068,0.034482758620689655,0.40320218281557535,1.0,5/13,11.15%,MYRF;RIMS2;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.7040230292557369,-1.3713652963519372,0.11627906976744186,0.918468569896987,1.0,2/11,11.26%,SETDB1;ZNF304
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.910637098106734,1.3713571864702563,0.05454545454545454,0.40465899317541826,1.0,2/5,7.40%,FLRT3;TBX20
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.6177761011591886,1.3707401042258707,0.047619047619047616,0.4065176805449188,1.0,12/52,13.66%,HPN;THBS1;SULF1;DAB2IP;DUSP10;CDK6;NLRC3;CDKN1C;TGFB2;SPARC;B2M;KLF9
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8163638936276726,-1.3706824213452073,0.13333333333333333,0.9173979948596251,1.0,2/10,6.17%,RPP25L;POP5
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.644446429290025,1.3706780728424963,0.04411764705882353,0.4060454634172123,1.0,15/53,12.90%,DCN;THBS1;COL4A2;SULF1;ISM1;DAB2IP;SERPINF1;PML;CTNNB1;CD160;TGFB2;PGK1;SPARC;THBS2;PPARG
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.8187825480158124,-1.3703933496996443,0.15217391304347827,0.9132680063528131,1.0,1/8,0.09%,NGF
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.7227822239899208,-1.3699509344135143,0.07894736842105263,0.9100666361019406,1.0,3/23,11.10%,SGO2;CHAMP1;MIS12
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.8679015504620454,1.3697771808174455,0.057692307692307696,0.40918544611652186,1.0,2/7,3.77%,DCN;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.8622408221970805,1.3697073952361325,0.08333333333333333,0.4089495519046396,1.0,3/10,9.12%,NLGN1;SHANK1;PCLO
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.905440745791288,1.3691309826900213,0.02,0.4104955869368434,1.0,1/5,2.71%,TIMP2
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.8960785011389831,1.368973195021556,0.05454545454545454,0.4106066761547255,1.0,1/5,0.23%,SLC6A15
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8650494561136215,1.368902772390575,0.03571428571428571,0.41020490486263855,1.0,3/6,11.95%,GHR;STAT3;PXN
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.917357582826747,1.3686763194861213,0.034482758620689655,0.4103526525754604,1.0,3/5,6.32%,SCN3B;KCNQ1;GJC1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.9114771863732609,1.3686259047824072,0.05263157894736842,0.40922587422353646,1.0,3/6,3.17%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.9114771863732609,1.3686259047824072,0.05263157894736842,0.40922587422353646,1.0,3/6,3.17%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7891261217171002,-1.3686239603249795,0.11428571428571428,0.9124688949076637,1.0,4/7,17.49%,TRMT10C;TRMT10A;TRMT10B;TRNT1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.8785427975880525,1.3686114120257205,0.04918032786885246,0.4087015506896554,1.0,3/7,4.61%,GRIN3A;NLGN1;EFNA1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6491244177430591,1.3686040247369924,0.07575757575757576,0.4080517866980979,1.0,11/33,15.05%,SP100;THBS1;SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1;STX4;TNFRSF10B;FADD;TMC8
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.7897102438667186,-1.3681959450882166,0.14,0.9094473107054287,1.0,1/8,0.57%,SPRY1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.751414866956246,1.3681894298206447,0.1724137931034483,0.40909012051286275,1.0,3/13,3.10%,ANXA1;RIMS2;LTBP4
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.780429744881384,1.3681838426149673,0.10204081632653061,0.40845990087314266,1.0,3/8,15.19%,IRF7;CLPB;IFIH1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6206777881555505,1.3681142887248685,0.056338028169014086,0.40819311635410077,1.0,13/62,8.65%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;GIPR;GNG2;FYN;RXFP1;RAMP3;GLP1R;ADCY7;ADCY2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5794292138141889,1.3677690735013042,0.05714285714285714,0.4087571752001669,1.0,24/92,9.49%,COL4A1;PRRX1;DCN;PDGFRA;ABCA8;COL4A2;ACTA2;CALD1;ASPN;PODN;ANGPTL2;MYH11;POSTN;COL12A1;TNS1;PTPN21;RASL12;MATN2;C1R;TPM4;CYP1B1;BGN;ADGRF5;RNASE1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.7203440926774182,1.367187948961243,0.11538461538461539,0.41029226620108916,1.0,3/18,5.88%,APP;SCN2A;FAS
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.9072291169460893,1.3671220001352307,0.07272727272727272,0.409879963202415,1.0,2/6,4.91%,HTR2C;FABP3
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.6512267847831686,1.366970884735753,0.07042253521126761,0.40975629078799986,1.0,11/55,7.59%,RASGRP2;NLGN1;SYT1;SYT4;DMTN;SYT5;CLIC4;HPCA;NEUROD2;ITPKB;SYT13
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.7052910569967377,1.3668995770353818,0.06060606060606061,0.4094716350049562,1.0,4/32,1.84%,NR4A3;IGF1;P2RY6;THBS1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7578694965758097,-1.3666954231732016,0.12121212121212122,0.9129613228056169,1.0,5/15,13.90%,RTRAF;TRPT1;C2ORF49;CPSF1;CLP1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7656511604843091,1.3666675724734867,0.04477611940298507,0.4096175215102405,1.0,1/22,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.9001132381321459,-1.3665821646293026,0.04,0.9030643148744784,1.0,1/5,1.82%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.9001132381321459,-1.3665821646293026,0.04,0.9030643148744784,1.0,1/5,1.82%,SELENOS
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.7127873507552214,1.3663983475857735,0.11290322580645161,0.41031704743700015,1.0,5/34,7.63%,EGF;DMTN;APP;CHI3L1;PARD3
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.6436246807191607,1.3663131142870255,0.04,0.41005069593294025,1.0,11/57,9.77%,ALS2CL;CHRM3;CD24;FA2H;TJP3;KCNQ1;EFNA1;LGR5;FAAH;AATK;ARHGEF10L
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7945010513662989,1.365941767435968,0.15625,0.4106226353991344,1.0,2/11,3.41%,IGF1;IRS2
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.6762351856901264,1.3658818661711096,0.0547945205479452,0.41024989440589893,1.0,13/33,13.08%,L1CAM;THY1;MYH9;ACHE;RTN1;VLDLR;NRP2;DPYSL2;PML;CDK6;CRMP1;TLE3;OPHN1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.5483763815658419,-1.3658563986342702,0.13636363636363635,0.9023109547254704,1.0,7/91,5.85%,NUP62CL;FIP1L1;AAAS;RBM8A;U2AF1;RAE1;NUP50
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.8443101591532884,1.3657683801384592,0.11267605633802817,0.4100559415316075,1.0,3/5,14.10%,TGFB2;P2RY12;CCL2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.8913653340343355,1.365399994716918,0.04477611940298507,0.41087350262186256,1.0,2/6,2.85%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8207382556112812,-1.3653938462415391,0.14583333333333334,0.9001451357108721,1.0,7/8,17.64%,CEL;APOE;SCARF1;CYP46A1;ADH4;MT3;SNX17
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.7386446712298949,1.3653779147900893,0.12962962962962962,0.4103250284150804,1.0,2/10,12.97%,TNFRSF1A;S1PR3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.8494492361939442,1.3653564715318238,0.09615384615384616,0.4098136130381936,1.0,4/9,11.84%,ANXA1;NLRP12;TMED10;GAS6
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6665421919508612,1.3652238861232107,0.07692307692307693,0.40963918662559357,1.0,8/31,11.54%,IGF1;SOCS3;IL15;PTK6;GHR;TNFRSF1A;STAT3;PARP9
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.551516818179274,1.3649575137857826,0.011764705882352941,0.4097825632286039,1.0,27/189,14.14%,GGT5;HPN;CTSC;CTSS;FOLH1;MMEL1;PRSS48;PRSS57;PCSK2;FAP;ECE1;TRHDE;CAPN8;CELA2B;CAPN1;ENPEP;CNDP1;MMP14;TBL1X;ADAM19;MMP16;MMP17;TMPRSS3;BACE2;TMPRSS5;FBXL2;ATG4B
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.7757908210861844,-1.3642931045727955,0.1388888888888889,0.9020664367328316,1.0,3/6,11.11%,ZC3H8;IDO1;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.6856662246734326,1.36417025292174,0.10294117647058823,0.41228371791885915,1.0,6/31,3.25%,ANXA1;IGF1;CD24;IL15;IL27RA;PTPRC
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.7990589175399665,1.3637414398732908,0.0,0.4132133060122179,1.0,5/16,6.79%,DUSP1;DUSP10;DUSP8;DUSP16;PDP1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.8259611256600999,1.3637040454646145,0.1044776119402985,0.41268383728884545,1.0,3/7,13.08%,SHTN1;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7947205948741846,1.363368950509103,0.11666666666666667,0.41348733643971514,1.0,4/13,12.83%,NPY;LHX6;MAPT;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.8217923184769574,1.36335994344723,0.047619047619047616,0.4128541245921811,1.0,1/13,1.03%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.6665689506153537,1.3632569773729097,0.046875,0.41274677246816227,1.0,5/36,6.43%,PTP4A3;TLR2;APP;NOD1;NLRP12
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.7487264814827974,1.3631170547311606,0.05172413793103448,0.4125525609013964,1.0,9/17,8.65%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;SCN1A;FGF12;ATP1A1;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.6770535389418062,1.3630052102449826,0.1206896551724138,0.4123241197118175,1.0,12/29,18.54%,CDKN2A;IL15;CGAS;HOMER1;TGFB2;PRKCD;B2M;IFIH1;IER5;WNT5A;HMGA1;BCLAF1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),0.8761643425912755,1.3629466089006297,0.05263157894736842,0.41188776154839635,1.0,2/6,2.93%,PLEK;RPS6KA1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5785507666166614,-1.3626875861735164,0.06666666666666667,0.9071270852803892,1.0,5/59,3.81%,H1-2;PADI4;H2BC21;H1-4;BRDT
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7915586981405762,1.3623683813790846,0.14754098360655737,0.41351832516371795,1.0,4/15,10.01%,KLF2;NOS1AP;ASS1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.871253150097583,1.3619519294413949,0.11666666666666667,0.41484930289031186,1.0,2/7,2.21%,NR4A3;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.8418006764252777,1.361879821135914,0.09523809523809523,0.4145322395545543,1.0,2/6,4.68%,NLGN1;BAIAP3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.735315100880035,1.3618143096804822,0.06666666666666667,0.41418157723388394,1.0,3/24,2.19%,MET;STMN2;PSRC1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.847089187585977,1.3615908286332798,0.016666666666666666,0.4145048437814466,1.0,2/12,1.84%,MET;THBS1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.7686426390383547,-1.3614447349442957,0.13043478260869565,0.904748800144503,1.0,1/8,6.82%,SCPEP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.7686426390383547,-1.3614447349442957,0.13043478260869565,0.904748800144503,1.0,1/8,6.82%,SCPEP1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5960003207589628,1.3613969715484682,0.05063291139240506,0.4145859565990129,1.0,12/71,11.93%,ANLN;NLGN1;PLPPR5;CDC42EP3;AGRN;CDC42EP1;PLEKHM1;EPS8L2;CLRN1;NEURL1;FSCN1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.7763170780770928,1.3612384706790117,0.06779661016949153,0.4146840261970226,1.0,4/17,8.23%,C3;CCBE1;SULF1;CYP1B1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7972063861433337,1.3604704211376555,0.06451612903225806,0.4174783119351366,1.0,6/14,8.87%,ITGA8;ITGA2;TBX19;TBX20;SCX;ITGA3
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7371784108980927,1.360434098788432,0.078125,0.41697151371142954,1.0,4/15,10.85%,SIX3;WNT8B;TBX20;GLI2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.911988394033121,1.360306574817877,0.10909090909090909,0.4168429571805794,1.0,2/5,5.42%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.8230030796431371,1.3602729363445503,0.07547169811320754,0.4163728236378617,1.0,3/8,5.41%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.590803628992549,1.3601841915159656,0.029411764705882353,0.41590409557658714,1.0,15/74,8.65%,HTR2C;PDGFRA;CD24;CD55;TRPC3;ADCY5;TRPM4;GLP1R;ITPR3;GRIN1;RYR2;JPH4;CCKBR;NPTN;CACNA1C
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.6926074186657383,1.3601829448263059,0.07352941176470588,0.41528334319512955,1.0,14/37,17.11%,IGF1;PDGFRA;DAB2IP;PDGFA;CTNNB1;CDK6;NLRC3;B4GALT7;GAS6;CDKN1A;FN1;TRIM32;TP53;WNT5A
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8982145222078048,1.3595348832932335,0.06779661016949153,0.41714960209651003,1.0,2/5,5.92%,CNTNAP2;APLNR
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5958586446852525,1.3593370383510597,0.07246376811594203,0.417327670856671,1.0,23/69,17.31%,HTR2C;SLC24A2;KCNJ2;CLDN16;VAPB;ATP2B3;GCM2;RYR2;NPTN;ATP1A1;SLC9A1;ATP1B1;ATP1B3;LETM2;TMPRSS3;TPCN2;STOML2;SLC8A3;KCNMA1;SLC8A2;ATP13A1;SLC8A1;SLC24A1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.6721961610152948,1.3591636897029704,0.06666666666666667,0.4176070368375993,1.0,6/33,3.83%,IL13RA1;CTSS;CD24;P2RY13;PTPRC;IRF7
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.6305733152608545,1.3591535900406477,0.03076923076923077,0.4170043877144715,1.0,15/63,10.85%,COL4A1;PCDH18;DCN;PDGFRA;COL4A2;ACTA2;CALD1;ITGA8;POSTN;COL12A1;IGFBP7;GLT8D2;BGN;LOXL1;GLI2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7119799174119065,1.359109766277485,0.08771929824561403,0.41657273203836725,1.0,9/26,9.44%,CSPG4;DCN;CHSY3;PXYLP1;CHST15;CHPF2;VCAN;UGDH;BGN
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.9297973651504852,1.3590540295984828,0.0,0.4161423534500621,1.0,1/7,1.34%,PROX1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8688104228755462,1.3587920467512482,0.08928571428571429,0.4163543364798606,1.0,3/6,7.76%,ANXA1;DOC2B;SNCA
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.5928735496405438,1.3586349792090293,0.05555555555555555,0.416346697344316,1.0,6/87,4.45%,GGT5;CXCL2;SERPINE1;ZFP36;DAB2IP;ERBIN
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.7283677674825064,-1.3585131984678318,0.16666666666666666,0.9194227724988312,1.0,4/13,13.88%,UQCRFS1;ETFB;ETFDH;SLC25A22
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.6213100752633092,1.3584774571569749,0.016129032258064516,0.4162045118987204,1.0,20/72,19.77%,PDGFRA;DMTN;EPHA5;PAK3;BAIAP2;FAM107A;RHOD;PDGFA;ARHGAP18;FSCN1;PRKCD;PAK1;ARHGAP17;IQGAP1;RHOBTB2;BST1;NEB;RHOQ;TRPM2;RHOBTB1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8730717875493925,1.3581653761516832,0.0967741935483871,0.416768191953961,1.0,1/8,1.07%,SOCS3
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.6374102377510222,1.3575884096229092,0.07692307692307693,0.41853777897697064,1.0,8/60,11.55%,SLC6A15;SLC32A1;SYT1;GAD2;DVL1;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8374166863814407,1.3575531702329757,0.13725490196078433,0.418074811193493,1.0,3/7,7.76%,CHRM3;PIM1;SNCA
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8391868883732383,-1.3574338323416348,0.06666666666666667,0.9196810696592274,1.0,2/5,6.10%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6780272845694347,1.3570991174850489,0.057971014492753624,0.41931890311164344,1.0,16/46,18.19%,IGF1;PDGFRA;DYSF;MYH9;EPB41L4B;NRG1;PDGFA;SYTL4;SMAD3;TGFB2;PAK1;FGF2;FZD7;PLEC;WNT5A;MYOF
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.7712228204488515,1.3570828489777154,0.13114754098360656,0.41873926005987044,1.0,7/11,15.00%,MYRF;CNTNAP1;PLP1;TENM4;ABCA2;B4GALT5;SOX10
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.7765186460544345,1.3570100712840965,0.08771929824561403,0.418561479715383,1.0,8/19,10.59%,SCN1B;SCN3B;KCNQ1;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.7435120805349946,1.3570028015702562,0.09375,0.4180012801582883,1.0,5/16,6.40%,ANXA1;ZFP36;SLIT2;SLIT3;FAM107A
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.9138021607593048,1.356734234406469,0.1111111111111111,0.41806444161772427,1.0,1/5,0.93%,TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.9138021607593048,1.356734234406469,0.1111111111111111,0.41806444161772427,1.0,1/5,0.93%,TLR2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5518667803547723,1.3567188747682173,0.04225352112676056,0.41749082567299456,1.0,30/120,17.76%,BOK;SLC7A2;ZDHHC9;SLC39A14;CEP170B;DAB2IP;ARHGEF17;EPB41L4B;PTPN21;RHBDF1;ADGRL2;SCARA3;MYO1B;GPT2;ASS1;DHCR24;PKDCC;FKBP5;YAP1;TEAD1;EPB41L1;KCTD3;CAP2;CD276;BCAR1;SMARCA1;RBFOX2;NR2F6;GYG2;RORA
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8767726744718587,-1.3565231287731665,0.06818181818181818,0.9202353597274463,1.0,1/5,0.57%,SPRY1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.7624872775403193,-1.3564935043733786,0.09090909090909091,0.9152640372024711,1.0,2/9,11.10%,CHAMP1;MIS12
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7261808387068382,1.3560866569470915,0.09090909090909091,0.41917007207524487,1.0,3/21,3.62%,IGF1;EGF;APP
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.8306561287351876,1.3559003588758798,0.05555555555555555,0.41937337857676205,1.0,4/10,12.77%,IL27RA;MX1;STAT3;TYK2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7944689115901933,1.3557440689108504,0.16129032258064516,0.41946056180089586,1.0,2/12,3.41%,IGF1;IRS2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.6255815712905459,1.3556022829813905,0.03125,0.4195969372574975,1.0,16/58,18.02%,TBC1D24;PLD1;GAP43;WAS;DMTN;EPHA2;PPP1R16B;FSCN1;PODXL;CDKL5;USP6NL;ARF6;TBC1D1;TBC1D10B;IFT140;TBC1D10A
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8842988520351356,1.3555981870126232,0.09375,0.41900878825258675,1.0,2/6,7.74%,NOS1AP;LRRC55
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.6267953005899167,1.3554861354020467,0.07462686567164178,0.4188496119413391,1.0,14/54,12.77%,IL13RA1;TLR2;SOCS3;CSF2RA;PIM1;IL1R1;CD44;OSMR;FAS;TNFRSF1A;MYD88;STAT3;IL4R;TYK2
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.8133989283608188,1.3553984519840656,0.14545454545454545,0.4185760213451435,1.0,2/5,12.49%,OPALIN;EPHA4
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.7181462118890112,-1.355270558953764,0.11627906976744186,0.9171031816698657,1.0,7/20,15.22%,COX18;TIMM8B;TIMM13;BAD;SAMM50;TIMM10;BCL2L11
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.6505457371561286,1.3552602162428011,0.08823529411764706,0.4186145630449769,1.0,12/52,16.86%,ENPP2;LPCAT4;ACHE;MFSD2A;PLAAT4;PLAAT3;DBI;PLB1;CHKB;SLC44A3;PNPLA8;ABCA3
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.7330301939415337,1.3551740339331786,0.1044776119402985,0.4183748195630904,1.0,7/21,16.95%,SP100;BAG3;GAS6;BARD1;RANGAP1;TP53;YWHAE
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.6794908621474752,1.3548300017794626,0.11290322580645161,0.41896909240064056,1.0,6/21,19.43%,PLEK;RARG;RAP1GAP2;VAV2;VAV1;CAV3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.558040300038483,-1.3543687849008477,0.09375,0.9178724264567777,1.0,9/49,13.30%,HEY2;NRARP;ASCL1;HEYL;MAML3;POFUT1;NCSTN;HES5;HEY1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.8981350788295184,1.3540331829301486,0.037037037037037035,0.4212096306197916,1.0,3/7,3.41%,THBS1;PRKCB;IRS2
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.778573875053989,1.353965427320596,0.13793103448275862,0.4209183316162538,1.0,2/11,4.91%,LIPH;FABP3
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.728392463092921,1.3537920280237188,0.10606060606060606,0.42113223198784466,1.0,4/15,10.64%,MYO1F;MYO1C;MYO1B;MYO15A
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.7297507719408257,1.3537692135834967,0.15,0.42056567554931135,1.0,7/24,7.13%,IGF1;GRIN2A;ICAM1;APP;GRM5;FYN;GRIN1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6565130267701028,1.3536333709678452,0.046153846153846156,0.4205685602863579,1.0,10/32,21.81%,PRKCB;PID1;SIK2;PIP4K2A;SORBS1;PRKCD;TSC2;PTPRE;GRB10;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.6016953320915648,1.3527161438288515,0.014925373134328358,0.4233093633738796,1.0,7/86,5.28%,TGFBR2;SKOR1;ADAMTSL2;VWC2;VWC2L;ASPN;PMEPA1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.8875098123213785,1.352567066518637,0.11538461538461539,0.42301715326873207,1.0,1/7,0.18%,NR4A3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.5887113257943702,-1.352483586636677,0.03333333333333333,0.9250658352676583,1.0,4/34,8.13%,TPX2;AAAS;KIF4A;ABRAXAS1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.6707374328249973,1.3524396853845726,0.09259259259259259,0.4230004034092015,1.0,5/33,8.14%,ZFP36;YBX3;ELAVL4;RBM24;MYD88
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.8369549230470693,1.3517368889639205,0.020833333333333332,0.42503247775390923,1.0,2/8,3.62%,C3;APP
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.684849168130588,1.3516926522130166,0.09230769230769231,0.4245457615581297,1.0,2/22,2.36%,SLC6A15;SLC43A1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.7152899996532093,1.3515701989798719,0.11594202898550725,0.4244304095495744,1.0,5/24,7.40%,TGFBR2;PROX1;PKP2;SOX4;TBX20
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8533525200791686,1.3514622116869126,0.12727272727272726,0.42423506185152515,1.0,4/7,13.08%,PROX1;GRID2;AGTPBP1;OPHN1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.62143269310721,1.3511610243201364,0.05194805194805195,0.4248583779395975,1.0,6/60,6.78%,CDKN2A;GPNMB;ANXA1;KIF14;FAM107A;LSM11
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.7148666742127902,1.3510215483132841,0.1724137931034483,0.42487122461609117,1.0,4/21,12.70%,S100A10;THY1;MAPRE2;ARF6
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7330428059910761,1.3510189688594858,0.07407407407407407,0.42427616687853364,1.0,6/18,10.26%,IGF1;PROX1;RBM24;MYLK3;NRG1;MMP14
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.6806146100576517,-1.3506532904538107,0.10256410256410256,0.9310601863899491,1.0,4/12,22.14%,SETDB1;ZNF304;TRIM28;TET1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.5655810252719067,1.3504005813324886,0.0,0.42596707920803645,1.0,38/170,15.59%,GPNMB;IGF1;HTR2C;P2RY6;PDGFRA;EGF;NPNT;CD24;RASGRP1;RIT2;ICAM1;PTPRC;APP;DAB2IP;FLT1;NEK10;TRIM5;CD44;RAMP3;NTRK3;CHI3L1;DIRAS2;STK25;PDGFA;NECAB2;TGFB2;GFRAL;DIRAS1;GAS6;TPD52L1;HLA-DRB1;CCL2;FGF2;GPR37;LPAR1;IQGAP1;CD4;GPR183
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.7433340280885655,1.350086414290027,0.1044776119402985,0.4265366385010569,1.0,3/15,3.62%,TLR2;DMTN;APP
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6680552840735358,-1.3500107100661627,0.1282051282051282,0.9305440979591142,1.0,9/21,11.39%,MT1E;MT1A;SLC30A8;SLC39A10;MT1G;MT1F;SLC30A5;SLC39A8;MT2A
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.5975657782532932,1.349843025351271,0.05405405405405406,0.42677008732904986,1.0,5/108,9.23%,LEF1;GNG2;DVL1;CTNNB1;DAAM1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7484351092417691,1.3498404210876154,0.08064516129032258,0.4261916074411953,1.0,2/19,0.53%,NR4A3;MRAP2
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.9050385410527085,1.3492182019535803,0.0967741935483871,0.4277751369376279,1.0,1/6,0.12%,ENPP2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.8074553814750611,-1.3486266823143018,0.13043478260869565,0.933445033860255,1.0,2/6,11.11%,IDO1;PRELID1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5451710398036691,1.3478446929588317,0.03896103896103896,0.4326696834639836,1.0,53/155,22.66%,TMEM204;SP100;CD24;PTK6;SULF1;CD55;IRAK2;APP;TSPYL2;TRIM5;PLSCR1;RGS6;ZIC1;FYN;NLRP12;IGFBP7;GRK2;ITGA3;SIK2;YWHAG;LRIT3;HOMER1;ZDHHC7;PXN;USP20;UBASH3B;NCLN;GRK5;RGS4;SLC8A3;ELF1;RGS16;BST1;SLC8A2;RGS14;RORA;TSC2;MAPK8IP2;WWTR1;CBFB;PLCE1;FRRS1L;CAV3;TSPAN15;LFNG;NCK2;AMFR;CDC42SE2;YJEFN3;UGCG;RIC8B;GRK3;GLI1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5544724534912816,-1.3478401243755467,0.10714285714285714,0.9327173617200896,1.0,9/50,19.16%,ATF5;PSMD10;PSMD12;PSMB5;PSMD2;CUL1;PSME3;PSMB4;PSMB6
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.7814018251593537,1.3475876158141442,0.06349206349206349,0.43298837823763797,1.0,5/15,7.93%,P2RY6;TRPC3;ABCC9;RYR2;VGF
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.6648617378605699,1.3475675382345802,0.04838709677419355,0.4325310449584241,1.0,13/41,19.29%,TLR2;EGF;DYSF;PLSCR1;NRG1;SNCA;PXK;SCAMP5;LRSAM1;MTMR2;CTTNBP2NL;NDFIP2;MCTP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8271197345779041,1.3471543661183476,0.1,0.4333861618563384,1.0,1/12,0.18%,NR4A3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8946545021147656,1.3468788089742807,0.08620689655172414,0.43412848741621113,1.0,2/6,1.80%,CHRM3;CHRM1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.769204515185497,1.3468528950929373,0.05084745762711865,0.4335927048285996,1.0,4/12,20.54%,RBM24;BOC;AKIRIN1;BTG1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.7432754680557178,1.3466844486482141,0.10144927536231885,0.43384500482728056,1.0,4/14,6.64%,KIF14;PLEK;FBLIM1;SKAP1
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.8747546308020462,1.346666368755478,0.10344827586206896,0.43335821760598614,1.0,1/6,2.71%,SULF1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6859370691398279,1.3462411055068797,0.12903225806451613,0.434378903252811,1.0,8/35,3.87%,CXCL2;GPNMB;TLR2;CTSS;TYMP;PLEK;MYO1F;SIGLEC1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7073989082184851,1.3459782148077029,0.07246376811594203,0.4348797647702452,1.0,5/23,8.01%,SLIT2;NRP2;SEMA5B;SLIT3;MAP1B
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5606257459001529,1.3459031949988793,0.039473684210526314,0.43461260356485953,1.0,55/164,15.55%,ENPP2;CDH9;PAPSS2;A4GALT;DCN;PDE1C;PDGFRA;ABCA8;PLEK;GRIK2;CD55;DUSP1;SLA;GPR34;ACHE;PODN;IL1R1;SHROOM4;STK32B;POSTN;APLNR;ESYT3;RAMP3;IGFBP7;TNS1;CFH;LDB2;RASL12;C1R;PID1;MAOB;CSRNP1;ADGRF5;RNASE1;ITGA9;GNAZ;HS3ST3A1;RIN2;SPARC;RAB27B;VWA5A;RGL1;ENAH;STARD13;ENO2;ST6GALNAC3;PDK4;LAMA2;CCL2;OPTN;SERPING1;LPAR1;KCTD12;SMARCA1;COBL
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.6977612383613389,1.3453477880014124,0.11864406779661017,0.436189867268704,1.0,5/22,16.84%,ZFP36;WTIP;STAT3;PUM1;TP53
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6536984288038407,1.3451131238027572,0.06349206349206349,0.4366393925400773,1.0,15/40,19.43%,CACNA1H;IGF1;MRAS;ITGA11;FHL3;CHODL;MEF2D;LAMA2;SMTN;LARGE1;NEB;SGCG;FHL1;CHD2;CAV3
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8526390360656166,1.3450950876834518,0.07936507936507936,0.4361216138861991,1.0,3/8,12.01%,NLGN1;SHANK3;LRRC4
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.8025404889355248,1.3449478811527036,0.03225806451612903,0.4354943101784551,1.0,4/12,5.67%,MET;FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.8025404889355248,1.3449478811527036,0.03225806451612903,0.4354943101784551,1.0,4/12,5.67%,MET;FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.6557729359682452,1.3449028584241824,0.14035087719298245,0.4350577897549716,1.0,4/28,6.92%,PDGFRA;BAIAP2L1;BAIAP2;NTRK3
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.7334459447714654,1.3448647957249071,0.08771929824561403,0.4345914592706307,1.0,3/15,4.85%,C3;APP;SRRM4
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5849365982326952,-1.3448492936927532,0.09090909090909091,0.9448897894910558,1.0,9/23,24.91%,SELENOS;TMED9;DERL2;AUP1;RANGRF;PREB;SURF4;VCP;DERL1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.8432490621410884,1.3445759899165386,0.05263157894736842,0.434869256154505,1.0,1/9,6.79%,PDP1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.6012039533234067,1.3444582200879491,0.12857142857142856,0.4345744520584093,1.0,8/56,14.63%,HPN;RFTN1;RPS6KA1;MFSD2A;MMP14;TGFB2;TRIM32;BCL2
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6214759406194759,1.3443722256841184,0.10526315789473684,0.43429587922723467,1.0,3/35,3.24%,IGF1;NPNT;NELL1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.9034146661745899,1.3443358859502101,0.05357142857142857,0.4337868532623495,1.0,3/5,6.12%,SLIT2;SLIT3;PADI2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7932424878510352,-1.344306419896165,0.1951219512195122,0.9434625011581896,1.0,2/8,3.59%,CES2;AKR1C3
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.8663219935713034,-1.3441726649045902,0.07317073170731707,0.939353564182466,1.0,2/6,5.24%,LEPR;GREM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.6746020126559846,1.3440179687965166,0.06944444444444445,0.4345106309091715,1.0,7/32,10.90%,TLR2;SERPINE1;NOD1;CHI3L1;MYD88;SYK;STAT3
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.7391374847862773,-1.3438386589160733,0.0975609756097561,0.9358077006012187,1.0,5/15,14.08%,HSD17B8;SLC25A1;PPCS;GCDH;ACSS1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.5068229369476025,1.343721120098634,0.012658227848101266,0.4349403889268771,1.0,69/413,14.97%,LEF1;TGFBR2;HPN;MYRF;IL13RA1;TLR2;IGF1;KIF14;PROX1;PDGFRA;EGF;THBS1;IL15;PTK6;ZFP36;RPS6KA1;TRPC3;IRS2;COLEC12;SFTPD;FLT1;PRAME;TGFA;TRPM4;SOX4;EPB41L4B;OSMR;RAMP3;MFSD2A;NRG1;NTRK3;GRIN1;RYR2;PARD3;CCKBR;RHOD;SCX;PRODH;PDGFA;KITLG;TENM4;CAPN1;GAB2;LMNA;MMP14;NAMPT;HDAC4;TGFB2;TPPP;NOXA1;GAS6;MAPT;MEIS3;EPHA4;PRKCD;STX4;MLXIPL;S1PR3;CDC7;CDKN1B;FN1;PDPN;PAK1;TRIM32;FGF2;BCL2;NAP1L1;CCND1;GRK5
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.8322955818233746,1.3437202083048625,0.125,0.4337727637217043,1.0,2/8,9.13%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.8322955818233746,1.3437202083048625,0.125,0.4337727637217043,1.0,2/8,9.13%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7646414784248121,1.3436124816497617,0.10606060606060606,0.4334821957128813,1.0,4/16,14.75%,EGF;RHBDF1;WDR54;RHBDF2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.7515938498030355,1.343453567087504,0.11666666666666667,0.4333300144331919,1.0,2/14,7.76%,NOS1AP;SNCA
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.92110898647883,1.3434383334125066,0.03636363636363636,0.432796504498854,1.0,3/5,7.84%,GAP43;APP;ROBO2
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.8789215865764952,1.3431393825453835,0.09836065573770492,0.4332403574513441,1.0,3/6,10.90%,AGTPBP1;DCX;STAT3
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.811932451214832,1.3430744777079437,0.11666666666666667,0.43276930456800394,1.0,2/12,11.54%,SOCS3;PARP9
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.90196641807937,1.3427866735035083,0.1,0.4334249296695198,1.0,1/5,0.54%,MET
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6058494927509828,1.3426190923519958,0.05714285714285714,0.4333953420005186,1.0,13/61,8.65%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;GIPR;GNG2;FYN;RXFP1;RAMP3;GLP1R;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6456962240578045,-1.3423151059025165,0.15151515151515152,0.9403443751928404,1.0,8/22,11.39%,MT1E;MT1A;SLC30A8;ZNF658;MT1G;MT1F;SLC30A5;MT2A
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5711241625649612,1.3421392778847152,0.02702702702702703,0.4347612918315021,1.0,15/83,12.90%,NR4A3;NR4A1;ADCY5;SLC39A14;IRS2;FOXO1;RAB15;PRKAR1B;ADCY7;ADCY2;SORBS1;HDAC9;NR4A2;PRKCD;PPARG
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.7510165715583057,1.3419992727136285,0.15151515151515152,0.4347754540255306,1.0,2/15,9.12%,SIX3;CTNNB1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.6360438470178306,1.3418075601544621,0.09375,0.4350467521785694,1.0,6/38,8.14%,TLR2;CTSS;IRAK2;SFTPD;NOD1;MYD88
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.7311187902948717,1.3416627946838258,0.16666666666666666,0.43493963658485885,1.0,2/18,3.25%,ANXA1;PTPRC
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.8687432493674178,-1.3414860149809114,0.09302325581395349,0.9406736497396718,1.0,1/5,4.09%,SF3A1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7841341896954986,1.3414395080400336,0.13793103448275862,0.4351194737788987,1.0,6/14,17.69%,ABO;B3GALT2;ST6GALNAC5;FUT2;B3GALT5;B3GALT4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.45318705849936636,-1.3414393748704103,0.058823529411764705,0.9360319949979584,1.0,52/231,18.24%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;SF3B4;LSM3;DHX16;SF3A1;IK;POLR2K;ZCRB1;RBM8A;U2AF1;CRNKL1;LSM2;PPWD1;SF3B6;BUD31;TFIP11;LSM5;METTL3;DDX46;SNU13;PQBP1;FRG1;POLR2C;CPSF1;SYF2;PPIH;PPIL3;SNRNP25;LSM4;GPATCH1;PNN;CLP1;GTF2F1;PPIL1;RBM22;ESS2;PRPF8;SUGP1;SRSF2;GTF2F2;PRPF3;RBMX;RNPC3;CPSF3;POLR2D;CWF19L1;DNAJC8;SRSF9
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6381390482472088,1.341338839368463,0.06153846153846154,0.4350577488093773,1.0,9/38,8.23%,TGFBR2;COL4A1;CCBE1;PROX1;FLT1;EGFL7;APLNR;TBX20;CYP1B1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5583439055288459,1.34119076819581,0.03614457831325301,0.43501123461428093,1.0,18/112,10.32%,NR4A3;P2RY6;HRH1;BLM;GABRB2;DMTN;ADCY5;KCNQ1;AHR;GNG2;RAMP3;CYP1B1;GABRG2;ATP1A1;TFPI;ADCY2;CTNNB1;HCN1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6679096079217586,1.341147775051939,0.11290322580645161,0.43404807543552265,1.0,4/21,10.93%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6679096079217586,1.341147775051939,0.11290322580645161,0.43404807543552265,1.0,4/21,10.93%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.620829032032765,1.3408346354047813,0.09722222222222222,0.43472253571907876,1.0,20/59,19.70%,CACNA1H;KCNQ1;ATP2B3;ITPR3;ABCC9;RYR2;ATP1A1;TMEM65;ATP1B1;TGFB2;ATP1B3;FXYD7;SLC8A3;SLC8A2;SLC8A1;CALM3;ATP2B4;CAV3;ITPR1;PDE4D
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.6368705278554486,1.340360436770356,0.04477611940298507,0.43576945901137604,1.0,11/56,8.50%,CACNA1H;NR4A3;CTSS;LMO2;SLIT2;SLIT3;RAMP3;GHR;ROBO2;ATP1A1;TFPI
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.6181802234432582,1.340260554902049,0.02857142857142857,0.43558777087665695,1.0,9/66,8.14%,TLR2;RFTN1;CTSS;IRAK2;COLEC12;SFTPD;BIRC3;SCARA3;MYD88
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5540075273011476,1.3400101803414766,0.05333333333333334,0.4360634822212134,1.0,34/109,14.09%,COL4A1;PRRX1;CSPG4;PCDH18;DCN;PDGFRA;COL4A2;CALD1;SULF1;THY1;PODN;ANGPTL2;NRP2;SLIT3;POSTN;COL12A1;IGFBP7;FAP;C1R;BOC;EMP1;CTNNB1;BGN;PBX3;MMP14;COL9A1;SPARC;THBS2;CHODL;FN1;COL5A1;CRTAC1;CHAD;LAMA2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.6060713916236836,1.339616049346331,0.11475409836065574,0.43731330325961176,1.0,13/57,16.60%,SKOR1;VWC2;SULF1;VWC2L;TBX20;ITGA3;SMAD1;PPARG;ELAPOR2;SMAD9;FSTL1;HIPK2;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.6961564571130736,1.3392981505353365,0.04477611940298507,0.43823225955907275,1.0,9/25,16.39%,STMN2;SLIT2;SNCA;SSH2;EML2;CYRIB;PRKCD;PFN2;STMN1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.8395118838472804,1.3381909381928474,0.09375,0.4417959997707801,1.0,3/7,8.87%,ITGA8;ITGA2;ITGA3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7645877312727508,1.3381573513191318,0.1,0.4413848694802382,1.0,7/11,18.45%,PRODH;STK25;CYP1B1;PRKCD;PDK1;MAP3K5;STK24
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6878059854204268,1.338012443856249,0.11475409836065574,0.4412566369685546,1.0,7/25,12.49%,IL1RAPL1;SRCIN1;SHANK3;HOMER1;SIPA1L1;CDKL5;EPHA4
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8582260781299883,1.3377284602402348,0.06557377049180328,0.4417064797501944,1.0,1/7,0.69%,NDST4
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.576492878306072,1.3375280657639432,0.08823529411764706,0.44199241515889726,1.0,17/67,17.11%,GPNMB;KIF14;GRIN2B;SNCB;GRID2;FYN;SNCA;DCC;DHCR24;INPP5A;MAPT;CD200;FOS;ZNF746;MAP3K5;IKBKG;WNT5A
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6374886469851428,1.3374991259663052,0.14705882352941177,0.4415979338122409,1.0,8/37,11.54%,IGF1;SOCS3;IL15;PTK6;GHR;TNFRSF1A;STAT3;PARP9
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.79909512046179,1.3372060090332702,0.15789473684210525,0.4421341310407905,1.0,2/10,3.13%,SH3GL2;SLIT2
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.7110638897268527,-1.3370519891648631,0.09090909090909091,0.9583458313825536,1.0,7/13,14.09%,MT1E;MT1A;MT1G;MT1F;HSF1;MT2A;MT3
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.844594974624755,-1.3364361572415353,0.24390243902439024,0.9569790967699929,1.0,1/5,4.18%,SRI
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.6281738844294802,1.336143607669899,0.078125,0.44599960943001266,1.0,15/56,16.31%,DMTN;EPHA5;PAK3;BAIAP2;FAM107A;RHOD;PDGFA;ARHGAP18;FSCN1;PRKCD;PAK1;ARHGAP17;IQGAP1;RHOBTB2;BST1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6368893523358661,1.3359209121211686,0.09375,0.44638156780731286,1.0,4/45,4.15%,ENPP2;DAB2IP;PTPRR;DUSP10
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.8094178855798917,1.3357102360303152,0.08333333333333333,0.4467625430227668,1.0,3/9,6.89%,EGF;KCNQ1;NRG1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6718558029001578,1.3356345724206313,0.12698412698412698,0.44651127190408485,1.0,7/22,21.54%,PRKCB;PID1;PIP4K2A;PRKCD;TSC2;PTPRE;GRB10
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.8466287404023133,1.3354354948090978,0.08333333333333333,0.44699373497630196,1.0,3/8,10.51%,BOK;ZFP36;YAP1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6718628422697508,-1.334710455817854,0.0975609756097561,0.9623049965537661,1.0,7/16,14.09%,MT1E;MT1A;MT1G;MT1F;HSF1;MT2A;MT3
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7964200486937787,-1.334348918808636,0.1282051282051282,0.9551902658707511,1.0,3/8,10.43%,UQCRFS1;SLC25A33;LYRM7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7964200486937787,-1.334348918808636,0.1282051282051282,0.9551902658707511,1.0,3/8,10.43%,UQCRFS1;SLC25A33;LYRM7
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.8989400755590993,-1.3341644498671266,0.0625,0.9511884292660854,1.0,2/6,7.30%,PGP;MST1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.58204133823287,1.3339245721069684,0.07575757575757576,0.4523803607452181,1.0,14/81,8.65%,CACNA1H;GRIN3A;CACNA1G;SLC24A2;CDH23;TRPC3;CACNG3;TRPM4;FYN;RAMP3;RYR2;CACNA1E;CACNG8;CACNA1C
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7208946005802573,1.3325405044146676,0.125,0.45697810786168963,1.0,4/17,10.64%,MYO1F;MYO1C;MYO1B;MYO15A
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.8426598213405679,1.3323075826975406,0.14545454545454545,0.45735770214583643,1.0,2/7,13.86%,IRF7;UBASH3B
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.6076072304880619,1.3323040293583555,0.09230769230769231,0.45677359269226575,1.0,5/47,5.36%,ANXA1;RIMS2;STEAP3;RAB15;RAB3C
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.8604651742154001,1.3320311103541498,0.08163265306122448,0.4573272987886506,1.0,1/8,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7367588086781092,1.332000185360547,0.11475409836065574,0.4568465642614628,1.0,4/13,17.19%,GHR;STAT3;PXN;STAT6
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7835991550284336,1.3315047734100132,0.14545454545454545,0.45834329698183374,1.0,2/8,14.01%,SLC9A1;PDK4
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.8318377999085225,1.3311781201114048,0.08,0.45887838509800494,1.0,3/7,6.34%,GAP43;RTN4RL1;APOD
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.7464439482202645,1.331154471972354,0.10714285714285714,0.45835402942072045,1.0,6/17,14.10%,EGF;FYN;PLPP4;CTNNB1;GRM6;CCL2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.6240506910492862,1.331016331340606,0.08571428571428572,0.45832318535083305,1.0,11/52,12.74%,ENPP2;PLPPR5;LPCAT4;PLPPR4;PLPPR1;PLAAT4;PLAAT3;AGPAT4;PIP4K2A;ABCA2;PLB1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7639665057930476,-1.3307221114623478,0.14583333333333334,0.965231079391636,1.0,3/9,6.45%,MID1IP1;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.6665439912397937,1.3305775844016698,0.09375,0.459232165329496,1.0,3/33,2.21%,C3;EGF;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.6308838509756572,1.3305522609373834,0.04411764705882353,0.4587237904545501,1.0,11/52,12.70%,TLR2;IGF1;DOC2B;IRS2;ACHE;SOX4;NNAT;TMED10;SYTL4;TGFB2;ARF6
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.8170569582253834,-1.3303350651715093,0.30612244897959184,0.9633404846731579,1.0,1/5,4.51%,APOE
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6344372917171492,-1.3300823404002309,0.10256410256410256,0.9597720915905027,1.0,5/19,16.23%,SGO2;BRDT;BCL2L11;ZSCAN21;FOXJ2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.6818300936416236,-1.3298044791611192,0.23255813953488372,0.9566509675232157,1.0,5/14,7.17%,MT1E;MT1A;ZNF658;MT1G;MT1F
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.7373802863829179,1.3295272355458132,0.10714285714285714,0.462168086514582,1.0,3/15,10.74%,THBS1;YAP1;TGFB2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.7648092850065277,-1.3292127807338048,0.21739130434782608,0.9554265040969079,1.0,3/6,16.07%,MOCS2;MOCOS;NFS1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),-0.8688955681239688,-1.3291442383220433,0.11627906976744186,0.9512789149478434,1.0,1/5,0.15%,DAO
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.7986837954689532,1.3290994544859103,0.17307692307692307,0.4632416144038298,1.0,3/10,7.08%,KCNJ2;KCNQ1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.681833729748197,-1.3290764281792236,0.15,0.9470600970333497,1.0,4/14,14.78%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.7461363510566993,1.3289595369681046,0.13636363636363635,0.463190424121747,1.0,5/18,13.34%,CDKN2A;PLEK;CDKN1C;CDKN1A;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.6874565900707155,1.3285001398181358,0.13114754098360656,0.46444673247471474,1.0,9/24,17.96%,HLA-DRA;CD55;CYRIB;HLA-DRB1;B2M;FADD;HLA-E;IL12A;ZBTB1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7929804910061186,-1.3281090326807066,0.16666666666666666,0.9492841032696,1.0,3/11,7.52%,UQCRFS1;UQCRB;UQCRHL
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.7139259979865146,1.327871890783766,0.1694915254237288,0.46641731692789257,1.0,5/14,9.44%,TMEM204;SULF1;SLIT2;ITGA3;LRIT3
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.7899317535736861,1.3278536345984802,0.1320754716981132,0.4659324152691953,1.0,4/10,15.84%,IL27RA;STAT4;STAT3;IL12A
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.8008016278221681,1.3278441885668535,0.14285714285714285,0.4653914781367131,1.0,4/8,12.01%,NLGN1;GRID2;SHANK3;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.7019172425629658,1.3277338261667226,0.19672131147540983,0.46518067494015397,1.0,5/22,15.87%,ANK3;FYN;MYO1C;CEMIP;MTCL1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.6742651531871439,1.327469912245894,0.10144927536231885,0.46558430587349486,1.0,10/29,13.08%,TBC1D24;NLGN1;SYT1;SNCB;SYT5;SNCA;SYNJ2;PLD2;PACSIN1;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.6111711576719504,1.3273678286336836,0.057971014492753624,0.46550212006682534,1.0,10/84,6.55%,NR4A3;HPN;IGF1;PROX1;EGF;NR4A1;TGFA;EGFL7;NRP2;LAMB1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.6460494873948563,1.3273004741629721,0.09090909090909091,0.46514955438792827,1.0,6/33,7.23%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINF1;SERPINE3
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5672437485470765,1.3272393661985922,0.09090909090909091,0.4648263139731118,1.0,26/89,11.54%,COL4A1;PRRX1;TLR2;PCDH18;DCN;PDGFRA;COL4A2;ACTA2;SULF1;ICAM1;THY1;PODN;ANGPTL2;POSTN;IGFBP7;TNS1;CFH;LDB2;FAP;C1R;B4GALNT1;BGN;SRPX2;MMP14;SPARC;THBS2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.7409053445483313,-1.326913888883957,0.1276595744680851,0.9518166306354527,1.0,3/11,13.00%,PYHIN1;AIM2;HTRA2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.5999560186086952,1.3266115258907336,0.06779661016949153,0.4666205538199862,1.0,23/69,11.54%,COL4A1;DCN;PDGFRA;COL4A2;ACTA2;CALD1;SULF1;FBLIM1;ASPN;PODN;ANGPTL2;MYH11;SLIT3;POSTN;COL12A1;TNS1;RASL12;MATN2;C1R;BGN;SRPX2;RBPMS;THBS2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7630350194317155,1.325824050599177,0.14545454545454545,0.4692048769958992,1.0,7/12,15.84%,HLA-DRA;CD55;SYK;HLA-DRB1;HSPH1;HLA-E;IL12A
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.891179373998862,1.3256008621232298,0.08928571428571429,0.4694162922348247,1.0,2/6,1.78%,RFTN1;S100A10
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.8584236733011983,1.3253040279614217,0.05172413793103448,0.46979702036559123,1.0,4/8,10.19%,THBS1;DMTN;ARHGEF7;PRKCE
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.6450054850480816,1.325088587763044,0.13513513513513514,0.4699789083402265,1.0,9/33,13.36%,GPNMB;ANXA1;IL15;PTPRC;SFTPD;DLG5;SLC7A1;CD276;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6767691727670115,1.3250786768945484,0.12857142857142856,0.4694403245024121,1.0,13/31,21.17%,FOXO3;SMAD3;TGFB2;STAT3;TEAD1;PPARG;FOS;FGF2;KLF4;TP53;ETS1;NFATC3;HIF1A
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6263885089175272,-1.3248652629927304,0.10810810810810811,0.9555043189471126,1.0,11/30,21.00%,GTF2H5;POLR2K;GTF2H2;POLR2C;ERCC2;GTF2F1;GTF2F2;POLR2D;ERCC3;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6263885089175272,-1.3248652629927304,0.10810810810810811,0.9555043189471126,1.0,11/30,21.00%,GTF2H5;POLR2K;GTF2H2;POLR2C;ERCC2;GTF2F1;GTF2F2;POLR2D;ERCC3;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8612410465377928,1.3248268179366052,0.08620689655172414,0.4698901161178545,1.0,1/7,0.95%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5599140016769649,1.3246432102573387,0.014705882352941176,0.46994446708839444,1.0,27/126,19.13%,TGFBR2;ANXA1;STMN2;NR4A1;ZFP36;DAB2IP;FLT1;CD44;NTRK3;VSTM2A;DUSP22;CTNNB1;SMAD3;MAPT;CCL2;SMAD9;IQGAP1;BCAR1;KLF4;WNT5A;PDE2A;SYAP1;LRP2;MAP2K3;MAP2K5;SHC1;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.770096765731299,1.3245961785070735,0.1774193548387097,0.469647036164627,1.0,5/11,18.83%,CCDC3;APOD;ASXL3;ALK;NCOR1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6741730582802381,1.3244211778491053,0.16417910447761194,0.46972964966125685,1.0,2/19,2.19%,PROX1;PSRC1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.7440251969392755,-1.324061108528944,0.22580645161290322,0.9556251909219022,1.0,1/11,3.57%,AAAS
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7533283781593663,1.324042031658733,0.12307692307692308,0.4704715341430605,1.0,3/20,9.46%,CDKN2A;SUV39H1;CENPV
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.6373638094801768,1.323997824589532,0.11764705882352941,0.4701184947706044,1.0,11/34,21.69%,PAK3;SHANK3;DOCK10;DVL1;SHANK1;MINK1;KLF7;PHACTR1;MAPK8IP2;CTNNA2;FARP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6489085032250591,1.3238119332412457,0.0821917808219178,0.47032619950687804,1.0,11/45,14.42%,TLR2;ANXA1;SERPINE1;PTPRC;NOD1;CHI3L1;MYD88;SYK;STAT3;MAPKBP1;FADD
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.8614035458675905,1.3235768065577607,0.10714285714285714,0.47061727481551907,1.0,3/6,6.12%,SLIT2;SLIT3;PADI2
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8911598945368298,1.323334672812176,0.061224489795918366,0.4709355639445534,1.0,2/5,4.24%,THBS1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.5964094865568351,1.3231259784329332,0.04838709677419355,0.47123913011130736,1.0,22/86,15.35%,MET;PDGFRA;EPHA7;PTPRC;EPHA2;RELN;EPHA5;FLT1;AGAP2;NTRK3;MMD;VAC14;GAS6;MAPT;EEF1A2;EPHA4;CDKN1A;HLA-DRB1;ALK;MRE11;IQGAP1;CD4
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.8633926623465816,1.3230411523486425,0.06,0.4709430220953048,1.0,1/7,2.26%,NMNAT2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.6334116452409438,-1.3228884053346572,0.1,0.9578295205772787,1.0,2/26,7.07%,CDC26;ANAPC13
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.6731096369664274,1.3228408957207265,0.09523809523809523,0.4712041044934442,1.0,10/42,3.87%,HLA-DRA;TLR2;CTSS;TYMP;SLC15A3;P2RY13;PLEK;MYO1F;IRF7;SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7473542479947493,1.3225816118348765,0.14545454545454545,0.4716590788929171,1.0,7/18,8.26%,MRAP2;MET;PLEK;ADA;SNCA;GRK2;MRAP
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.676798389080565,-1.3223909270944696,0.10869565217391304,0.956686394872608,1.0,9/15,19.44%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.5614698316510872,1.3222418854049138,0.05970149253731343,0.4722100930811473,1.0,21/97,15.84%,KIF14;EPHA7;TESC;DUSP1;EPHA2;EFNA1;ARHGDIG;EPB41L4B;NUAK1;RHOD;PPP1CB;MINK1;PODXL;EPHA4;STX4;PLXNA4;FUT2;PLXNA1;SIPA1;PLXNA2;IL12A
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5274142485060992,1.3219636810794144,0.012345679012345678,0.47266274231388883,1.0,35/215,14.24%,NR4A3;CXCL2;TLR2;P2RY6;PDGFRA;TESC;SERPINE1;PTK6;ZFP36;SLIT2;DMTN;KCNC2;DAB2IP;KCNQ1;WNT8B;FOXO1;GLRA2;AHR;GNG2;RAMP3;PID1;MYD88;NEURL1;HCN1;SHMT1;GUCY1B1;P2RY12;PXN;MAPT;PRKCD;AGAP3;PDK4;TNIP2;CCL2;FOS
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6624050023803965,1.321736991708087,0.03076923076923077,0.47289278579625843,1.0,7/32,12.83%,ANLN;PTP4A3;FAT2;FAP;CYP1B1;PXN;STARD13
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.9505847656099468,1.3214331431350557,0.0,0.47338499506818615,1.0,4/5,4.89%,ANK3;DCN;MLLT11;TRPM4
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.809062490731216,1.321269513156785,0.14583333333333334,0.4733926361499385,1.0,1/9,1.52%,PLK2
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.8592816446414391,-1.3212180287085817,0.07142857142857142,0.9595421042905043,1.0,1/6,6.92%,BCAP31
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.8157446600627118,1.3211484193588876,0.14754098360655737,0.4732485235016092,1.0,3/7,3.40%,MYRF;CNTNAP1;PLP1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.577365869125845,1.3210148966181632,0.07246376811594203,0.47325631077082003,1.0,26/83,14.09%,COL4A1;PRRX1;CSPG4;PCDH18;DCN;PDGFRA;COL4A2;ACTA2;CALD1;SULF1;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP;C1R;BGN;SRPX2;MMP14;SPARC;THBS2;FN1;COL5A1;TNFAIP6;LAMA2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.9155030148273178,1.3207902105083487,0.06896551724137931,0.47356681856792215,1.0,1/5,0.50%,C3
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.8279376254623453,1.3207651705210643,0.11475409836065574,0.47310689727337074,1.0,3/6,12.73%,IL15;SYK;PRKCD
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7781442335800026,1.320516748924561,0.1,0.47282108806823253,1.0,7/10,19.68%,SLC24A2;SLC8A3;SLC8A2;SLC8A1;SLC24A1;ATP2B4;TRPM2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7781442335800026,1.320516748924561,0.1,0.47282108806823253,1.0,7/10,19.68%,SLC24A2;SLC8A3;SLC8A2;SLC8A1;SLC24A1;ATP2B4;TRPM2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.8230902597493359,1.3203963404082426,0.125,0.47276086677610046,1.0,3/6,12.77%,STAT4;STAT3;TYK2
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.8371929060097848,1.3201060853576003,0.11666666666666667,0.4733026426911068,1.0,1/6,0.45%,SIX3
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.8878684531530148,1.3199624319990202,0.1,0.4733103000200378,1.0,2/5,8.78%,IL15;TMBIM1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6943919236746379,1.319630531986449,0.09523809523809523,0.4741503323599117,1.0,4/23,6.33%,MBP;TJP3;LSR;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.7997410571937305,1.3195998904185202,0.11290322580645161,0.47367992706466866,1.0,3/12,5.21%,TLR2;DYSF;PLSCR1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.771140839412501,1.3194445595032784,0.20967741935483872,0.4737279471196879,1.0,2/9,1.32%,DCN;MLLT11
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.5599402023671647,1.3193593474319631,0.043478260869565216,0.4735311058158972,1.0,13/127,8.08%,ST18;NPNT;ZFP36;YBX3;DAB2IP;ERBIN;MAP3K14;TNFRSF14;BIRC3;CHI3L1;PID1;TNFRSF1A;FOXO3
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7046572484342866,1.3193353527833838,0.1206896551724138,0.47304953395059496,1.0,2/18,3.41%,IGF1;IRS2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.851096969980448,1.3191663261000135,0.11666666666666667,0.47304387255852526,1.0,2/6,5.26%,ANXA1;ABCC4
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.74258566599102,1.3190525400115156,0.125,0.4729027379093851,1.0,2/14,3.00%,SCN1B;SCN3B
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.7678212060007414,-1.3187251028975544,0.21951219512195122,0.9687519788347178,1.0,2/8,11.37%,MEOX2;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7238847712656139,1.318420184545573,0.13846153846153847,0.47458884085381786,1.0,12/23,21.17%,FOXO3;SMAD3;TGFB2;STAT3;TEAD1;PPARG;FOS;FGF2;KLF4;TP53;ETS1;HIF1A
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.521029524610571,-1.318354171564163,0.06451612903225806,0.9663396767175949,1.0,5/58,11.10%,TPX2;SGO2;AAAS;ABRAXAS1;MIS12
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7034530315673461,-1.3182748560363067,0.14705882352941177,0.9623335901461538,1.0,5/15,14.97%,TRPT1;KARS1;POP5;YARS2;ADAT1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7853443846915076,1.3181966002653653,0.057692307692307696,0.47490577632051745,1.0,2/8,11.16%,AK5;AK3
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.8249935342831256,-1.3180848398311444,0.06818181818181818,0.9588882371697686,1.0,4/6,17.28%,METAP1D;METAP2;FKBP7;METAP1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.8273190848873543,1.3180727933258023,0.1111111111111111,0.47477644194092206,1.0,1/8,0.15%,CDKN2A
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7703185421058194,1.3180699914444673,0.13114754098360656,0.4736566861816275,1.0,6/16,9.35%,SLITRK1;IL1RAPL2;IL1RAPL1;APP;SNCA;PTPRD
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7703185421058194,1.3180699914444673,0.13114754098360656,0.4736566861816275,1.0,6/16,9.35%,SLITRK1;IL1RAPL2;IL1RAPL1;APP;SNCA;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8273773594521955,1.3178605899887335,0.05357142857142857,0.4736638092481713,1.0,2/9,2.85%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.717134659410184,1.3178397122773529,0.15254237288135594,0.47314686898264213,1.0,11/26,8.65%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNE4;KCNQ1;TRPM4;KCND3;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.7986618245725845,1.3176774806370632,0.11538461538461539,0.47295325486155265,1.0,2/11,3.13%,SERPINE1;SLIT2
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.5515349599425394,1.317345913610959,0.02702702702702703,0.47385935026147025,1.0,15/72,15.77%,BOK;BLM;KCNC2;SNCA;UGDH;SLC9A1;KCNC1;HOMER1;POLQ;RNF112;HLA-DRB1;STOML2;GLRA3;GSDMD;ATL3
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.7318571226952534,1.3170912336025313,0.15,0.4743750160031999,1.0,7/23,17.11%,IGF1;NRG1;NTRK3;GAS6;PRR5;PINK1;WNT5A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5738826834726999,1.317007415996712,0.015151515151515152,0.47416726975973716,1.0,15/62,21.19%,DAB2IP;EPHA5;RAP1GAP;SIPA1L1;FGD5;EPHA4;PLXNA4;PLXNA1;PLXNA2;TBC1D10B;VAV2;NGEF;VAV1;TDG;CAMK2A
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.8666947622956154,1.3168907585480492,0.16393442622950818,0.4740268020329227,1.0,3/6,11.82%,ST6GAL1;ST8SIA3;ST6GALNAC2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.6508414660584529,1.3168720456545417,0.0821917808219178,0.4729738644685493,1.0,7/38,15.17%,SP100;IRF7;SAMHD1;MYD88;MX1;TYK2;HLA-E
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.6508414660584529,1.3168720456545417,0.0821917808219178,0.4729738644685493,1.0,7/38,15.17%,SP100;IRF7;SAMHD1;MYD88;MX1;TYK2;HLA-E
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.8204536310692052,-1.3165048943195283,0.16326530612244897,0.9583275380969587,1.0,6/7,17.64%,CEL;APOE;SCARF1;CYP46A1;MT3;SNX17
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.8204536310692052,-1.3165048943195283,0.16326530612244897,0.9583275380969587,1.0,6/7,17.64%,CEL;APOE;SCARF1;CYP46A1;MT3;SNX17
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7638805771038198,1.316046991783484,0.14035087719298245,0.47541776878283876,1.0,6/15,17.69%,ABO;B3GALT2;ST6GALNAC5;FUT2;B3GALT5;B3GALT4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5761395166707233,1.3158797410887957,0.0641025641025641,0.47574187014405134,1.0,21/76,21.40%,CTSS;TESC;MMEL1;PCSK2;NNAT;ECE1;MMP14;ADAM19;MMP16;TSPAN14;PHEX;SRGN;PCSK5;AEBP1;TSPAN15;MMS19;CPD;F3;ADAM17;PCSK7;PCSK6
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5816288628452454,-1.3158550198412218,0.10526315789473684,0.9579819492231759,1.0,12/35,20.61%,KARS1;VARS1;AIMP1;GATC;EPRS1;NARS1;WARS2;AIMP2;YARS2;RARS1;LARS1;QRSL1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.886630189579557,-1.3156612494656341,0.09523809523809523,0.9544454691462293,1.0,3/5,10.83%,SLC25A5;FZD9;HSPA1A
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.9263395158625156,1.3155281081471846,0.057692307692307696,0.4765831707882948,1.0,2/5,4.37%,TYMP;FGF12
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7466835635012666,1.3154680768365599,0.16363636363636364,0.47629495637040975,1.0,1/15,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6803039665652151,1.3150560107218823,0.0847457627118644,0.4774516641850387,1.0,6/23,8.74%,ANK3;PPFIBP1;UNC13C;AGRN;DVL1;DOK7
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.8087628736461971,-1.3147216618338822,0.23809523809523808,0.955829702180616,1.0,1/6,2.58%,DNMT3B
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6784653334826511,1.3145105498272316,0.14754098360655737,0.47876450747888466,1.0,4/26,7.08%,CHRM3;KCNJ2;KCNQ1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.7257357372992814,1.3145100386205963,0.03225806451612903,0.4782103818915248,1.0,4/19,7.20%,HTR2C;PTPRC;ITPR3;RYR2
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.809100236287265,-1.3142457923617719,0.1282051282051282,0.9510377617651802,1.0,2/5,8.34%,AR;NCOA4
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.809100236287265,-1.3142457923617719,0.1282051282051282,0.9510377617651802,1.0,2/5,8.34%,AR;NCOA4
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6499919092513069,-1.3138843125414221,0.13513513513513514,0.9486394360139349,1.0,2/20,4.11%,HEY2;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.8849514065676233,1.3135517997226447,0.10416666666666667,0.48156594473724634,1.0,3/6,2.29%,NR4A3;SGPP2;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6142466055763356,1.3134615585232114,0.1232876712328767,0.481339584750525,1.0,14/39,23.12%,ANXA1;THBS1;SRPX2;HDAC9;FGF2;ETS1;MAP2K3;PRKCA;HDAC7;ADAM17;HIF1A;FGFR1;HSPB1;AKT3
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.653474337651659,-1.3132353797894438,0.10810810810810811,0.9478410283747664,1.0,2/20,4.71%,CFAP53;FOXJ1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6830927427160013,1.3131006776759284,0.12121212121212122,0.48207542113402757,1.0,4/17,13.04%,WNT8B;DVL1;CTNNB1;FRAT2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.8926239287247495,1.312685680647004,0.14035087719298245,0.4829674633486667,1.0,2/5,3.17%,ANK3;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.8237646263615032,1.3126334039076468,0.10909090909090909,0.48263512561574634,1.0,4/9,13.52%,CDKN2A;CGAS;LMNA;B2M
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5718044884479905,1.3125358314755442,0.12987012987012986,0.4824085774210576,1.0,19/82,14.09%,COL4A1;PRRX1;PLD1;SULF1;ANGPTL2;FABP3;LAMB1;RASL12;ITGA3;ARHGAP26;TCAP;ADAM12;TRIO;IL4R;PXN;CHODL;WASHC1;MEF2D;LAMA2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.7229331409766114,1.3124605263965938,0.08333333333333333,0.4821825494288825,1.0,7/23,16.37%,COL4A2;COL8A1;COL12A1;LAMB1;MMP14;FN1;LAMA3
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7661440055372418,-1.3118990460847595,0.14893617021276595,0.9509299242240384,1.0,2/10,12.23%,POMP;PSMD10
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.776170959675389,-1.3117404206200003,0.18,0.9477303896905552,1.0,5/9,15.63%,SLC25A5;SLC25A4;CR1;CD47;SLC25A24
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6589321034307416,1.3117236396504475,0.06896551724137931,0.4843801850928252,1.0,8/23,17.70%,STMN2;STMN4;MAP1B;MAPRE2;MAPT;CAMSAP3;STMN1;SKA2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.8213969208839943,1.3116679740755033,0.2,0.4840477518606924,1.0,1/8,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.7664271894604404,-1.3116379123172868,0.09090909090909091,0.9442930029181849,1.0,2/10,3.12%,PYGM;PPP1R3C
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.8375934342949409,1.3114501920405648,0.14516129032258066,0.48451323403506,1.0,2/7,3.34%,PROX1;EPHA2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.7271899126232483,1.3114337960820834,0.17857142857142858,0.4840378236728448,1.0,8/13,19.47%,ST8SIA3;B4GALNT1;ST8SIA4;B4GALT5;ST6GALNAC5;ST6GALNAC3;B3GALT4;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.743551121604415,1.3114311229521742,0.19047619047619047,0.483485269079611,1.0,3/9,17.12%,RELN;CAMK2B;CUX2
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.5471052116183016,1.3111704916028681,0.0410958904109589,0.4840930578019856,1.0,22/158,8.66%,GPNMB;HTR2C;P2RY6;PDGFRA;NPNT;EPHA7;RASGRP1;PSCA;ICAM1;PTPRC;EPHA2;APP;DAB2IP;PTPRR;DUSP10;NEK10;CD44;RAMP3;NTRK3;CHI3L1;PDGFA;NECAB2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6474806397236429,1.3110003395391798,0.1016949152542373,0.48412708478993977,1.0,10/38,16.39%,MET;STMN2;PSRC1;SNCA;EML2;MAPT;PAK1;DCTN1;CAMSAP3;STMN1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.8124899068492506,1.310832381499344,0.1206896551724138,0.4841220530321325,1.0,3/7,5.41%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8179726643275302,1.3106961667230652,0.08620689655172414,0.4841819277547378,1.0,5/9,15.55%,DAB2IP;VLDLR;PACSIN1;ALK;COBL
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5990475091846891,-1.3106451835782316,0.13157894736842105,0.9466639816990752,1.0,11/39,18.94%,PARS2;KARS1;VARS1;AIMP1;EPRS1;NARS1;WARS2;AIMP2;YARS2;RARS1;LARS1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7034707165495391,1.310609277588113,0.12962962962962962,0.4838527382492736,1.0,3/19,6.92%,PDGFRA;FLT1;NTRK3
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7355917781370812,1.3102397477318959,0.04918032786885246,0.48478040427715274,1.0,9/15,23.70%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY8;ADCY9;PRKAR2B
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5585960131533922,1.3101843008697898,0.07246376811594203,0.4844512826114264,1.0,19/80,13.70%,COL4A1;PCDH18;COL4A2;CALD1;SLIT2;FBLIM1;EPHA2;NRP2;PTPN21;ADGRL2;PDLIM4;CNN3;LOXL1;YAP1;P3H2;GLI2;ENAH;CD276;PDPN
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.5750510945948697,-1.3101417114399891,0.20833333333333334,0.9452004402752279,1.0,8/35,20.90%,AAAS;RAE1;NUP50;NUP54;NOL6;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6440929924646043,1.3101171301522434,0.15517241379310345,0.4841358258452261,1.0,13/37,21.81%,EGF;ERBIN;TGFA;REPS2;IQGAP1;BCAR1;GAB1;PLCE1;SHC1;ADAM17;NCK2;DGKD;PTPN11
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7685388153160814,1.3099548484905577,0.16393442622950818,0.4841824410488758,1.0,5/9,19.02%,TYMS;MTHFD2;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7888617611734365,-1.3095038223935378,0.2222222222222222,0.9442731885306309,1.0,7/9,17.78%,ALDH1A1;ADH6;ADH5;ADH4;SULT1C4;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.6765175717613526,1.3093377859984066,0.12727272727272726,0.4860208160049723,1.0,8/23,15.59%,PDGFRA;THBS1;ZSWIM4;YTHDF1;CYRIB;P2RY12;STX4;GPR183
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7614808893240895,-1.3093343422592816,0.18181818181818182,0.9413974755962936,1.0,4/10,23.01%,HUS1;CLSPN;CHEK2;RAD17
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.7509750543635091,1.3093252177844588,0.08333333333333333,0.4855115079638713,1.0,4/18,9.14%,GGT5;ECE1;TRHDE;ENPEP
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.7864441791574676,1.3093150212316922,0.20689655172413793,0.4849904849320415,1.0,3/6,19.89%,PODXL;IQGAP1;MYO1E
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6049031202891328,1.3092719242711366,0.17391304347826086,0.48457341495854606,1.0,9/41,12.49%,PDGFRA;TEC;RELN;FLT1;TPST1;FYN;PKDCC;SYK;EPHA4
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5378754020778495,1.3092378253484083,0.04938271604938271,0.4842214481077408,1.0,41/209,13.89%,TLCD2;SYCE1;ANK3;TEAD2;PKP2;NLGN1;CALD1;WAS;DMTN;FBLIM1;ADD2;BAIAP2L1;WASF1;NEDD9;FAS;BAIAP2;FAM107A;PAWR;DVL1;REPS2;PARD3;RHOD;PML;STK25;PDGFA;SHANK1;MYO1B;PCLO;STAG3;YTHDF1;FSCN1;YAP1;TCAP;DCX;PEX14;GAS6;TEAD1;RSPH4A;OPHN1;DNAJB13;CFAP74
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.43186977620403494,-1.309193372069137,0.041666666666666664,0.9379615083940208,1.0,57/274,17.92%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;SF3B4;LSM3;DHX16;SF3A1;GTF2H5;IK;POLR2K;ZCRB1;RBM8A;U2AF1;CRNKL1;PRPF18;LSM2;PPWD1;GTF2H2;SF3B6;BUD31;TFIP11;LSM5;METTL3;KIN;DDX46;SNU13;PQBP1;FRG1;POLR2C;CPSF1;SYF2;ERCC2;PPIH;PPIL3;SNRNP25;LSM4;GPATCH1;PNN;CLP1;GTF2F1;PPIL1;RBM22;ESS2;PRPF8;SUGP1;SRSF2;GTF2F2;PRPF3;RBMX;RNPC3;CPSF3;POLR2D;ERCC3;CWF19L1;DNAJC8
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.8294389047001556,1.3090505644316883,0.18518518518518517,0.484331747178689,1.0,2/6,10.26%,RBM24;MMP14
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8589834748816366,1.309018010522377,0.09375,0.4839040139987187,1.0,1/7,1.03%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6993542258589586,-1.3089196254810318,0.125,0.9356859114327026,1.0,2/13,7.74%,TRMT10C;FASTKD2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7501883042163151,-1.308866684136261,0.14285714285714285,0.9320769950134775,1.0,4/11,20.23%,COX7C;COX7B;COX5B;AFG1L
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.7551369522565742,1.308780920599994,0.1206896551724138,0.48432138306334455,1.0,3/10,2.25%,IGF1;CD24;IL27RA
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.789307671426273,1.308739747543061,0.1044776119402985,0.48393294564850137,1.0,2/9,13.19%,ITM2A;BACE2
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.8412165420962964,1.308724514343738,0.1016949152542373,0.48348156883207427,1.0,2/5,10.76%,MMP14;SYK
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.8137563055950803,-1.3085680678667098,0.10204081632653061,0.9295240636388548,1.0,2/5,9.07%,ABCB11;GPLD1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.6509883883113455,-1.308473499237304,0.17647058823529413,0.9265132641294588,1.0,4/12,16.03%,CCDC22;PSMD10;NFKBIB;NFKBIE
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.5469851645518096,1.3084090441267,0.05194805194805195,0.48433141812533237,1.0,29/141,15.55%,ENPP2;DCN;NLGN1;RPS6KA1;RELN;DAB2IP;VLDLR;TRPM4;GRIP1;SHANK3;NEUROD2;DVL1;ZBTB16;SCX;SHANK1;BASP1;TLE6;LMNA;NEURL1;ARHGEF7;DLG5;PACSIN1;PHLDB2;B4GALT5;ELAPOR2;ALK;CAMK2B;SPIRE1;COBL
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5733710610045301,-1.308338369315952,0.11764705882352941,0.9234318457260127,1.0,13/41,18.96%,MRPS7;RPS28;RPS27L;RPL6;RPSA;MDN1;RPL23A;RPL11;MTERF3;LOC102724159;RPF2;DHX29;RPL10
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7706557427357223,1.3082940650866102,0.15873015873015872,0.4843007934830281,1.0,2/9,5.88%,ST18;FAS
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.6816538416902661,1.308044661029781,0.12307692307692308,0.4846518025654104,1.0,4/20,7.20%,HTR2C;PTPRC;ITPR3;RYR2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.653039777560624,1.3078125607171025,0.10344827586206896,0.4849766213542847,1.0,5/24,10.41%,NLGN1;PLPPR5;AGRN;NEURL1;FSCN1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.7861979908680697,1.3077464294305585,0.13432835820895522,0.4846281172391599,1.0,3/13,3.13%,SERPINE1;DUSP1;SLIT2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7549645983484607,1.3076238083483591,0.09230769230769231,0.48464800526150964,1.0,4/19,12.90%,SOCS3;NLRC5;PARP9;PPARG
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7709667066347643,1.3075848369840013,0.17543859649122806,0.48419933862036196,1.0,4/12,7.20%,SCN3B;KCNQ1;TRPM4;RYR2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7397174217432334,-1.307123071335532,0.2,0.9263928681180157,1.0,1/7,1.84%,CFAP53
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.7146118481775805,1.3069857433103602,0.06666666666666667,0.48599043694337474,1.0,11/30,10.59%,SCN1B;SCN3B;KCNQ1;STAC2;KCNH2;RYR2;DTNA;GRK2;PVALEF;ATP1B1;TCAP
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.6556355285668203,1.3064653100652213,0.1076923076923077,0.4874743462563952,1.0,6/34,11.21%,S100A10;THY1;SKAP1;PLEKHA2;CDK6;RIN2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.6798603319822263,1.306141602599753,0.15151515151515152,0.48813464548229846,1.0,3/22,8.23%,ENPP2;FAAH;CYP1B1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.8024273375935806,1.306030935116948,0.16666666666666666,0.4880875206927253,1.0,2/6,11.66%,SCX;INPPL1
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.839745352123128,1.3057890389682256,0.19148936170212766,0.48854420556528844,1.0,3/6,9.87%,VAPB;GRAMD2A;TLE6
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.7136529702969848,-1.3056788329268902,0.07317073170731707,0.9306228639342857,1.0,1/13,0.15%,DAO
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.6675762619366183,1.3056652575649672,0.11290322580645161,0.4884086820912989,1.0,7/29,9.38%,RIMS2;SEPTIN5;RIMS3;BAIAP3;KCNMB4;CPLX2;CPLX1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8042453716798091,1.3055102319794267,0.21666666666666667,0.48841167110717953,1.0,2/7,8.23%,SERPINE1;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.540310487923352,1.3054812912182825,0.05333333333333334,0.4880255685391426,1.0,24/128,13.86%,SH3GL2;SLIT2;DMTN;PTPRC;CAMK2N2;DAB2IP;THY1;PMEPA1;NLRP12;DVL1;SMCR8;NTRK3;PID1;PARD3;SNCA;MVP;YWHAG;NIBAN1;LDLRAD4;INPP5J;TERF2IP;PRKCD;MLXIPL;UBASH3B
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.8425829226774111,1.3054066923327527,0.09523809523809523,0.4872934743668369,1.0,4/8,9.13%,KCNQ1;RYR2;SNCA;SLC9A1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.8425829226774111,1.3054066923327527,0.09523809523809523,0.4872934743668369,1.0,4/8,9.13%,KCNQ1;RYR2;SNCA;SLC9A1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.742054325946234,1.3053809122988687,0.06349206349206349,0.48682229601511784,1.0,9/14,23.70%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY8;ADCY9;PRKAR2B
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.7178422698615069,1.3046188421649931,0.12903225806451613,0.48902633573395476,1.0,4/23,4.21%,MET;ANXA1;PROX1;LSR
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7506626046392663,1.30437322271163,0.171875,0.4895404144264366,1.0,5/12,18.92%,FOXO1;PID1;FOXO3;PDK4;PDK3
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.7986099584238602,1.3042447312985432,0.1864406779661017,0.48961695858604043,1.0,2/10,9.93%,GGCT;GSS
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.7806089488686072,-1.3041102204100197,0.14583333333333334,0.9328795788759954,1.0,1/6,0.98%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.7806089488686072,-1.3041102204100197,0.14583333333333334,0.9328795788759954,1.0,1/6,0.98%,GMFG
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.6546815028262138,1.3040871070690156,0.16417910447761194,0.4895189613299283,1.0,9/30,12.38%,RIMS2;HTR2C;EPHA5;AHR;GLP1R;ADCY2;NUDT4;GUCY1B1;CAP2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.8270458488886869,1.3040416459328783,0.14754098360655737,0.4891225755401834,1.0,2/6,5.99%,APP;TNFRSF14
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8604098222584748,1.3038301159345707,0.11864406779661017,0.4892987501994642,1.0,1/5,2.41%,MBP
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.5947059768787,1.303803987112953,0.07462686567164178,0.48887863606951387,1.0,17/73,13.71%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;ABCC4;SLC25A45;MFSD2A;SLCO1A2;SLC7A7;SLC25A29;SLC27A3;SLC7A1;SLC51A;SLC27A5;SLC26A8;PDPN;SLC7A14
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6895156947894754,-1.3037441679863964,0.125,0.9311432759608197,1.0,2/13,5.00%,AR;ESR2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.6174140758976838,1.3036449384781732,0.15873015873015872,0.48894308199861775,1.0,21/53,21.56%,MET;PSRC1;CDC42EP3;BAIAP2L1;BAIAP2;CDC42EP1;PRKCE;FCHSD1;TPPP;MAPT;ARF6;PAK1;DCTN1;BIN1;PFN2;PINK1;VASP;CAV3;CDK5RAP2;NCK2;CRACD
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.8117808761961762,1.3036216717817644,0.15714285714285714,0.4884623260652112,1.0,1/8,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.7927176614669119,1.3031850991718772,0.08620689655172414,0.48897489033442254,1.0,4/11,19.08%,IL15;STAT3;CD4;SHC1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.7927176614669119,1.3031850991718772,0.08620689655172414,0.48897489033442254,1.0,4/11,19.08%,IL15;STAT3;CD4;SHC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.7298714228826358,1.3030806682692526,0.1016949152542373,0.4888784347499866,1.0,8/23,15.84%,HLA-DRA;RASGRP1;CD160;CYRIB;HLA-DRB1;FADD;HLA-E;IL12A
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7422025544297263,1.3026576046498675,0.16363636363636364,0.48995394250990026,1.0,3/12,6.40%,ANXA1;ZFP36;FAM107A
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8315336989525752,1.3024736828256895,0.16326530612244897,0.4900784161167088,1.0,2/7,10.74%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.6526069999890618,1.3023909326908898,0.1016949152542373,0.48984569871613814,1.0,6/29,14.67%,WTIP;CD44;MFSD2A;SPARC;PDPN;MYO9A
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5319880662601265,-1.3019817383776302,0.09375,0.9377999518825513,1.0,16/63,21.00%,KPNA2;POLR2K;NT5E;METTL3;POLR2C;DNASE2;DNASE1L1;GTF2F1;GTF2F2;DNA2;RBMX;LSM1;POLR2D;DDX24;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6735202889855506,-1.3017766830090636,0.17073170731707318,0.9314357446296012,1.0,5/17,21.82%,GSTT2B;AKR1A1;GSTM3;GSTP1;ESD
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6735202889855506,-1.3017766830090636,0.17073170731707318,0.9314357446296012,1.0,5/17,21.82%,GSTT2B;AKR1A1;GSTM3;GSTP1;ESD
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.7218561285813736,1.3017280441366221,0.16393442622950818,0.49175271358748074,1.0,4/18,8.54%,SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7657112658369868,1.3013911304335615,0.22448979591836735,0.4925380369921097,1.0,2/10,8.86%,CARNS1;UGDH
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.707269494534472,-1.3011896004621692,0.13043478260869565,0.9309899559193324,1.0,3/11,14.25%,ADCY10;SPAG17;SPEF2
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.8414355519388388,1.3010196197476251,0.1,0.49291490682515987,1.0,3/6,5.41%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.8414355519388388,1.3010196197476251,0.1,0.49291490682515987,1.0,3/6,5.41%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7126129996457797,-1.3009604785861582,0.12,0.9281348095024811,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.8202570951041963,-1.3009061144551803,0.13725490196078433,0.9248153836028672,1.0,5/7,17.84%,MGME1;PRIMPOL;POLG2;DNA2;TEFM
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.739675208391379,-1.3008179871825294,0.2619047619047619,0.9216735086924849,1.0,3/13,7.16%,SPRY1;HEY2;HEYL
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5869110100789676,1.3006618169058117,0.08333333333333333,0.4937209428688535,1.0,11/58,10.76%,NR4A3;ELMO1;WAS;BAIAP2;FYN;ARPC3;MYO1C;PLPP4;PLD2;PRKCE;SYK
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7887622179171734,1.3006266018242367,0.15517241379310345,0.49329016265464243,1.0,3/13,8.07%,C3;MFSD2A;LDLR
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6147184507272393,1.3004998746486371,0.06944444444444445,0.49328784771867695,1.0,9/48,12.39%,CCK;RELN;MAP1B;DNER;DCX;CDKL5;FGF13;ASTN2;NR4A2
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),0.8664744590571314,1.3003322186564792,0.13793103448275862,0.4928931698194598,1.0,1/5,0.95%,ANXA1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),0.8664744590571314,1.3003322186564792,0.13793103448275862,0.4928931698194598,1.0,1/5,0.95%,ANXA1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.7484600045057084,1.3003005331262445,0.18867924528301888,0.4924894620461923,1.0,3/13,2.41%,HPN;CTSS;LMO2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.7394156043130568,1.3002762854486563,0.08196721311475409,0.49205012363607525,1.0,9/16,23.70%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY8;ADCY9;PRKAR2B
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8328275182814675,-1.3001292913864206,0.13333333333333333,0.9219368865946355,1.0,1/6,0.92%,DCXR
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.5793913285629025,1.2997631140915502,0.078125,0.4935922615198757,1.0,19/61,16.68%,C1QL1;ARHGAP39;EFNB3;CDK5R2;VGF;B4GALNT1;SRRM3;C2CD4C;GLI2;TEAD1;IGDCC4;MEIS3;ENAH;FAM131C;BCAR1;SEZ6L2;RBFOX2;PFN2;FZD7
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.7628243413154305,1.2992893503159253,0.2033898305084746,0.4948883687631269,1.0,2/13,1.88%,ANXA1;BLM
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7953559445080468,1.2992339620127082,0.16666666666666666,0.4946055048440463,1.0,3/6,19.23%,SNCA;CTTNBP2NL;NDFIP2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.6795791125843827,1.2987110930939474,0.09259259259259259,0.4958614529766304,1.0,6/18,19.13%,ACSL5;CTNNB1;IL4R;FBP1;CDH17;RAP1A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8714573275342139,1.2986764337343726,0.09803921568627451,0.49548136492707207,1.0,1/5,1.15%,CHRM3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.8448850220120695,1.2985397278847115,0.12244897959183673,0.4954042381180806,1.0,2/6,10.82%,DENND3;DENND4A
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.9110824545677118,1.2984738889238214,0.037037037037037035,0.49456301055441076,1.0,1/5,0.85%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.9110824545677118,1.2984738889238214,0.037037037037037035,0.49456301055441076,1.0,1/5,0.85%,PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7507088762611904,1.2984397715945715,0.16393442622950818,0.4941497518414263,1.0,7/20,13.45%,IGF1;PDGFRA;PDGFA;CDK6;GAS6;CDKN1A;FN1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.8129763930157187,1.2983947674348941,0.20754716981132076,0.49379754071186993,1.0,2/7,11.98%,TPPP;MAPT
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7003797329490664,1.2983886831602884,0.13559322033898305,0.4932777538269101,1.0,8/26,10.62%,IL1RAPL1;NLGN1;CLSTN2;GRID2;AGRN;PTPRD;SRPX2;DLG5
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.5613439242725051,1.2981802026162452,0.05333333333333334,0.49344363114929957,1.0,30/107,11.44%,CDH6;C3;COL4A1;IGF1;DCN;PDGFRA;THBS1;COL4A2;CLDN16;CALD1;NRGN;KCNT1;ANGPTL2;SHROOM4;POSTN;APLNR;IGFBP7;TNS1;ENC1;LDB2;RASL12;C1R;MAOB;BGN;ADGRF5;RNASE1;ARHGEF10L;CDKN1C;RIN2;PXDC1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.8412268625628444,-1.2980460849517146,0.16666666666666666,0.9306170958962602,1.0,1/5,4.82%,ADAMTS12
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.8261254118056139,1.2979846722721398,0.1896551724137931,0.49348918595788727,1.0,1/5,4.09%,PTPRR
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.7437341067675384,1.2978216082861873,0.15151515151515152,0.493570599605857,1.0,4/16,10.20%,EGF;APP;TGFA;ZFYVE28
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.5958697909619111,-1.29711480902677,0.1956521739130435,0.9318920482564554,1.0,2/24,5.13%,NGF;BLOC1S2
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.7760835249199458,-1.2968331311756265,0.17073170731707318,0.9297857720259212,1.0,3/6,19.51%,PLA2G4C;CHPT1;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.6767879320851361,1.296603461364963,0.0847457627118644,0.49736324051382386,1.0,4/29,10.14%,S100A10;DMTN;NEDD9;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.735138843610759,1.2965478641305916,0.11320754716981132,0.4970457564645328,1.0,2/12,10.51%,PTPRC;YAP1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.7278797465153001,1.296353877219853,0.12121212121212122,0.4971231943683074,1.0,7/17,16.32%,CD22;PLEK;RIT2;NEUROD2;MAPT;BST1;SLC8A2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.5387578281265167,1.2963084366178441,0.06666666666666667,0.4967946899286241,1.0,49/165,13.66%,FOSB;FOSL2;COL4A1;KLF2;PRRX1;PCDH18;IGF1;DCN;PDGFRA;COL4A2;NR4A1;ACTA2;COL8A1;SULF1;CD55;ASPN;THY1;PODN;IL1R1;CTHRC1;ADAMTS10;ANGPTL2;CD44;SLIT3;POSTN;COL12A1;IGFBP7;TNS1;LAMB1;FAP;TBX20;C1R;CYP1B1;BGN;SRPX2;MMP14;STAT3;COL4A4;SPARC;PIP4K2A;THBS2;FLI1;NR4A2;PRKCD;KLF6;FN1;COL5A1;ITGAL;KLF9
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5864154984441465,1.2962512069223753,0.078125,0.49644302677618546,1.0,12/39,21.19%,EGF;PLPP4;CTNNB1;GRAMD2A;HOMER1;ORAI1;CAMK2B;BCL2;CD4;CACNB2;CAV3;CAMK2A
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.7635034424689344,1.2961912942796454,0.1111111111111111,0.49613973634293645,1.0,4/12,16.65%,SMCR8;PHF23;MTM1;PINK1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.6588787599922012,-1.2961208425477704,0.1111111111111111,0.9294194869405283,1.0,5/19,6.88%,MID1IP1;ABCD2;NPC2;ABCD1;ARV1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7787833931771181,1.2959484040341747,0.13333333333333333,0.49658661552987754,1.0,1/11,0.54%,MET
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.6272244446920747,-1.2956194020394536,0.0851063829787234,0.9287007290929871,1.0,4/22,7.74%,RAB7B;TNFAIP3;NR1D1;LY96
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7266868647201592,1.2955685845114222,0.10909090909090909,0.49768624213965584,1.0,5/10,20.03%,ZFP36;WTIP;STAT3;PUM1;XPO5
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5662646760635865,1.295463811884802,0.06060606060606061,0.4976200589963501,1.0,23/82,18.69%,PROX1;EGF;CD24;RASGRP1;PSRC1;DAB2IP;FLT1;NEK10;INCENP;SNCA;DIRAS2;PDGFA;DIRAS1;TPD52L1;CEMIP;FGF2;CCND1;SLC8A2;WNT5A;CALM3;SYAP1;ATP2B4;TELO2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.8284682301403603,1.2953558034854067,0.1568627450980392,0.4975184322214122,1.0,1/5,2.71%,TIMP2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.572486720632932,1.2949775606883467,0.05405405405405406,0.49840040509902117,1.0,19/86,13.45%,TGFBR2;FLRT3;PKP2;FGF12;SOX4;APLNR;NTRK3;ECE1;ZFPM2;CACNA1C;SH3PXD2B;PDLIM4;TGFB2;GLI2;HDAC9;SMYD4;CDKN1A;CDKN1B;FN1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.7372760658762672,-1.2949731971510783,0.1794871794871795,0.928282394209586,1.0,4/12,16.82%,HEY2;HEYL;HEY1;BMP2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.7687726685788441,-1.294526440795819,0.20512820512820512,0.9266332182841561,1.0,1/7,0.15%,DAO
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8369904233326442,1.294071676585508,0.11320754716981132,0.5009375592752513,1.0,3/8,7.20%,SIX3;DAB2IP;RYR2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.7960804502138306,-1.29398936276579,0.23255813953488372,0.9261673437052765,1.0,1/6,0.57%,SPRY1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.7666845876156859,1.293904960466413,0.1568627450980392,0.5009155785406779,1.0,2/16,3.25%,HLA-DRA;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6540198396452934,1.2937405185136392,0.07692307692307693,0.5010235675763355,1.0,3/31,6.88%,ANXA1;DOC2B;SMCR8
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.80212940552479,1.2936461139277722,0.06451612903225806,0.5007773605236095,1.0,5/11,14.42%,RFTN1;COLEC12;SCARA3;TNIP2;FADD
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5998484818046013,1.2936327701176005,0.10606060606060606,0.5002723493443793,1.0,7/52,9.80%,TLR2;IRAK2;DAB2IP;MAP3K14;BIRC3;TNFRSF1A;NLRC3
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.6025861931987228,1.2932436914699608,0.13559322033898305,0.5012402257976656,1.0,16/62,15.17%,HLA-DRA;TLR2;SP100;ICAM1;IRF7;TRIM5;CD44;CIITA;TRIM22;PML;PRKCD;HLA-DRB1;B2M;CCL2;CAMK2B;HLA-E
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.6053389538756919,1.2930404810919642,0.16216216216216217,0.5014885873676114,1.0,3/45,1.84%,NR4A3;TESC;THBS1
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.9014798819174382,1.2929786013536662,0.04,0.5006103784131487,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.9014798819174382,1.2929786013536662,0.04,0.5006103784131487,1.0,1/5,0.11%,CACNA1H
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.6759779267196147,1.2929146182140177,0.15625,0.5003661122551657,1.0,5/24,6.83%,THBS1;ELMO1;XKR4;MYH9;XKR6
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.553865449938737,1.292631724668344,0.09210526315789473,0.5006846377577878,1.0,24/103,15.81%,NPNT;CEP170B;DAB2IP;ARHGEF17;EPB41L4B;AGRN;RAP1GAP;PTPN21;RHBDF1;ATP1A1;LAMA5;CTNNB1;ATP1B1;ASS1;ARHGEF10L;CMTM4;EPB41L1;INPP5J;CTNNA1;GPRC5C;BCAR1;COBL;CAMSAP3;SLC44A3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7466636097464775,1.2923662460355003,0.18032786885245902,0.5011312367802243,1.0,4/16,10.01%,KLF2;NOS1AP;ASS1;SMAD3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6992940248509583,1.2918588286599095,0.12307692307692308,0.502395250082515,1.0,3/23,10.15%,IL1RAPL1;ZNF804A;HOMER1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7904986049762328,1.291792419748321,0.07547169811320754,0.5022319071228026,1.0,5/9,15.84%,THBS1;APLNR;PPP1R16B;FGF2;IL12A
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7084977004033794,1.2916947705713662,0.11320754716981132,0.5021155639560598,1.0,8/20,9.44%,CSPG4;DCN;CHSY3;CHST15;CHPF2;VCAN;UGDH;BGN
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.8002745949115564,-1.2915708331219447,0.1282051282051282,0.9348028228529541,1.0,2/8,7.23%,RAB7B;PTPN22
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.6743239052895619,1.2914505003633867,0.18461538461538463,0.5025122615155517,1.0,8/20,18.00%,CXCL2;ANXA1;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C;ADGRE2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.637571251078435,1.2913459872510993,0.13114754098360656,0.5023725842776998,1.0,6/37,9.65%,PLD1;LIPH;LPCAT4;DGKG;AGPAT4;PLD2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.7301320848578146,-1.291337259424697,0.23684210526315788,0.9328281825220068,1.0,2/5,18.36%,BCAP31;MIA3
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.8236206903830566,1.2912879185582415,0.17647058823529413,0.5019889429559752,1.0,2/10,5.92%,PDGFRA;APLNR
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.7141603193671222,1.2911851369276537,0.19672131147540983,0.5016874155483804,1.0,7/17,17.43%,NDST4;B3GNT2;B3GALT2;B3GALNT1;NDST1;B3GALT5;HS2ST1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5783671955444062,1.2911079161589674,0.1038961038961039,0.5013981082451195,1.0,10/77,6.14%,C3;HLA-DRA;CTSS;KCNJ2;C1ORF87;PLD1;CP;IL1R1;ERICH3;CLMN
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.6910812007641064,1.2909121616043506,0.14492753623188406,0.5014920385394616,1.0,7/20,16.07%,ANXA1;THBS1;XKR4;XKR6;GAS6;RHOBTB2;RARA
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.5878455001781302,1.2908123880630653,0.0821917808219178,0.5013541043129334,1.0,14/68,12.06%,HPN;NPY1R;PROX1;ABCA8;COL12A1;FAM124A;MATN2;MAOB;ALDOB;ENPEP;GRAMD2A;KALRN;SORBS1;VSTM2L
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5433212755580261,1.2905654800630708,0.05263157894736842,0.5017950477570499,1.0,26/109,13.06%,RGS7BP;ZNF536;STMN2;NLGN1;CNTN2;GAP43;OPCML;SLIT2;PLP1;TCEAL7;RCAN2;PLPPR4;C11ORF87;EFNB3;SEMA5B;BOC;MAP1B;GFAP;GUCY1A2;PTPRD;ASXL3;LY6H;NACAD;CRMP1;FAM13C;RUNX1T1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.863223280794586,1.2903558177781846,0.11290322580645161,0.5019923333350459,1.0,3/5,11.98%,SH3GL2;WASF1;MAPT
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5520849606361441,-1.2903375881263504,0.13513513513513514,0.9350937649399066,1.0,12/42,12.94%,AKR1C3;TM7SF2;PMVK;DHRS11;ABCB11;HSD11B1;CYP46A1;OSBPL3;SRD5A1;CYP7B1;DHCR7;SC5D
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7805347178417353,1.2902863673112956,0.15384615384615385,0.5017388260340886,1.0,2/11,7.32%,IGF1;GHR
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.5495098115369108,1.2902574040471775,0.06666666666666667,0.5014050725913692,1.0,6/101,9.22%,GGT5;IGF1;FA2H;ALOX12;LDHA;ACOT4
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7568584377226981,-1.2902092669438863,0.24390243902439024,0.9324119420951567,1.0,3/7,14.47%,TRMT10C;TRMT10A;TRMT10B
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6116103547311347,1.2900675017514223,0.17857142857142858,0.5016136797095077,1.0,10/29,18.08%,ANK3;CLDN16;KCNH2;GRIN1;SNCA;LETM2;SLC12A5;SLC8A1;FAM20A;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7571303866550586,1.290067239064895,0.14285714285714285,0.5011080207581876,1.0,5/11,16.39%,STMN2;SNCA;ARHGEF7;EML2;STMN1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5642846920294995,1.2897985456993628,0.08450704225352113,0.5016270620047575,1.0,13/72,12.73%,THBS1;PLD1;SAMD4A;EFNA1;SOX4;EIF4A3;LARP6;TNFRSF1A;YTHDF1;NIBAN1;ABCA2;EPHA4;PRKCD
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5987490137082163,1.2895634053754832,0.13846153846153847,0.5019382304306197,1.0,10/38,12.73%,NLGN1;GAP43;PLPPR5;DMTN;AGRN;PPP1R16B;NEURL1;FSCN1;ARF6;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6960118392174259,1.2889135389622903,0.17647058823529413,0.503913217149266,1.0,6/20,13.96%,P2RY6;STAC2;RYR2;SLC9A1;ATP1B1;HAP1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.8414664248345866,1.2888453510785216,0.15789473684210525,0.5036710303253589,1.0,2/7,4.95%,CCBE1;SOX4
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6467847392161113,1.288771995243115,0.16923076923076924,0.5034407852281289,1.0,10/21,23.70%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;RAB11A;ADCY3;ADCY8;ADCY9;PRKAR2B
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.702417242508877,1.2886658858612239,0.09090909090909091,0.5029130801222441,1.0,8/20,19.92%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.702417242508877,1.2886658858612239,0.09090909090909091,0.5029130801222441,1.0,8/20,19.92%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.6742222243138096,1.2882283825195764,0.1111111111111111,0.5040434455245948,1.0,9/29,23.44%,DAB2IP;FAS;NR4A2;TPD52L1;BCL2;SGMS1;MAPK8IP2;ING5;DAPK2
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.7885697628318034,-1.2881757359115218,0.18421052631578946,0.9388562429846974,1.0,1/7,0.08%,SLC2A5
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.6375650739944391,1.2881741635450705,0.13114754098360656,0.5036654169140248,1.0,6/38,9.65%,PLD1;LIPH;LPCAT4;DGKG;AGPAT4;PLD2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.5787338358762892,1.2880061912508056,0.04918032786885246,0.5037326933367385,1.0,13/77,12.96%,CACNA1H;ACTA2;CALD1;DYSF;MYH11;OXTR;GJC1;DTNA;TPM4;TCAP;SORBS1;PXN;TPCN2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7005740893126914,1.287883218363433,0.14814814814814814,0.5037087366830404,1.0,4/18,5.42%,TGFBR2;EFNA1;SOX4;SLIT3
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6844021282309274,1.287639444267486,0.06153846153846154,0.5039351002743575,1.0,7/24,18.74%,MTMR7;MTMR11;SYNJ2;INPP5J;MTM1;MTMR2;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7806144946569076,-1.2869176161850688,0.1,0.9424194539454074,1.0,3/7,10.56%,NMB;VAMP8;HFE
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.8177777992299893,-1.2868236037605552,0.11627906976744186,0.9362285409839156,1.0,3/7,9.99%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.8177777992299893,-1.2868236037605552,0.11627906976744186,0.9362285409839156,1.0,3/7,9.99%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.6180216828986014,-1.2867221011618992,0.16129032258064516,0.933280321462166,1.0,5/31,13.41%,AR;RNF6;TRIM68;UFL1;RUNX1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.707996710911502,1.286371647744047,0.20967741935483872,0.5080591069753093,1.0,4/16,19.47%,PLK2;ZFYVE19;WEE2;PLK3
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6660319082634719,1.2858380834121275,0.16129032258064516,0.5092003221156638,1.0,4/22,13.96%,BICDL1;KIF5A;TRAK1;HAP1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.8219162091352266,1.2858323658966584,0.17647058823529413,0.5087173456842669,1.0,2/5,11.98%,TPPP;MAPT
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.570896119313637,1.285745678511537,0.057971014492753624,0.5084959377979099,1.0,23/78,15.67%,CSPG4;DCN;OGN;B3GNT2;CHSY3;PXYLP1;CHST15;AGRN;CHPF2;CHST6;VCAN;UGDH;BGN;OMD;B4GALT7;UST;HS3ST3A1;HS6ST1;HS3ST3B1;B4GALT5;CEMIP;CHST2;NDST1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.8850450778251667,1.285729265759415,0.12903225806451613,0.5080259364557399,1.0,1/5,0.93%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.7868455526872722,1.2853612786169906,0.15384615384615385,0.5088460283586422,1.0,3/8,13.72%,DAB2IP;PIP4K2A;WASHC1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.6378160678392968,1.2849046429768736,0.11864406779661017,0.5097548759875484,1.0,8/42,7.13%,IGF1;GRIN2A;ICAM1;APP;NOD1;GRM5;FYN;GRIN1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.6773826345153442,1.2844404459709873,0.1206896551724138,0.5111020851686988,1.0,4/24,9.33%,CDKN2A;NUAK1;CGAS;CDK6
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.7555425191023065,1.2844355726751002,0.1746031746031746,0.5105975421428659,1.0,4/11,11.93%,NLGN1;PLEKHM1;EPS8L2;P2RY12
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.7321029522854272,1.284389508395505,0.1791044776119403,0.5103080071201804,1.0,2/11,3.73%,GMPR;ADA
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8420372381787772,1.2841973211069178,0.17307692307692307,0.5103678774505773,1.0,2/6,4.95%,EFNA1;SOX4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.7064662437085666,1.2841227281117078,0.21311475409836064,0.5101353467329951,1.0,4/15,13.36%,GPNMB;SFTPD;DLG5;HLA-DRB1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.8063887775446076,-1.2840859721614277,0.14893617021276595,0.9397557365894728,1.0,2/5,16.71%,FLAD1;SLC52A1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.8063887775446076,-1.2840859721614277,0.14893617021276595,0.9397557365894728,1.0,2/5,16.71%,FLAD1;SLC52A1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.5843881122585617,1.2840591222990363,0.08955223880597014,0.5099706569480893,1.0,17/72,18.63%,SH3GL2;SLIT2;DAB2IP;NTRK3;PID1;PPP1R16B;NIBAN1;TPPP;MAPT;TERF2IP;DBI;MFHAS1;XRCC1;CDYL;TINF2;WWTR1;ATP2B4
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6829122284843521,1.283961997378033,0.140625,0.509997023502094,1.0,2/22,10.06%,NMNAT2;AK5
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.5473874521478926,1.2837063511350155,0.05194805194805195,0.5103483866944953,1.0,32/118,19.08%,ARHGAP4;ARHGAP39;SLIT2;RELN;ARHGEF17;ARHGDIG;ARHGEF3;RHOD;ARHGAP18;OBSCN;MCF2;ARHGAP26;KALRN;TRIP10;ARHGEF7;TRIO;CYRIB;PLEKHG2;STARD13;OPHN1;ARHGAP17;MYO9A;RHOT1;VAV2;CGNL1;MCF2L;RHOQ;RHOT2;NGEF;PLCE1;VAV1;ARHGAP22
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5783139486495735,1.2836902717767744,0.09090909090909091,0.5099152305968505,1.0,10/82,11.07%,TGFBR2;ADAMTSL2;THBS1;LTBP4;ASPN;PMEPA1;ITGA3;SMAD3;CDKN1C;LDLRAD4
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.45666149555428825,-1.282658749491468,0.0,0.9437141861450283,1.0,81/320,19.91%,MRPL10;RPS24;RPL35A;FIP1L1;RPL34;RPL39;RPL37;AAAS;MRPS21;MRPL52;RPL13;RPL18;POLR2K;RBM8A;U2AF1;MRPS7;RPS28;RAE1;RPL12;RPL31;M1AP;NUP50;RPL23;MRPL36;MRPL18;MRPS16;RPL41;FASTKD2;ASMT;RPL6;RPS26;RRAGC;TFIP11;RPL29;RNASEL;RPL30;RPL22;RPS13;RPL14;RPSA;RPL15;POLR2C;CPSF1;RPS2;RPL23A;TSPAN33;RPL11;IGF2BP3;EEF1A1;MRPS33;MRPS18B;NUP54;RPS21;RPS23;CLP1;DDX25;NFKBIB;YARS2;THAP1;MRPS12;NUFIP1;RBM39;MCM3AP;MLF1;SRSF2;MRPS5;CPSF3;POLR2D;TNIP1;NUP85;SRSF9;NOL9;UPF3B;RPS25;RPL10;MRPL3;RPL8;DNAJB11;RPL32;RPS12;NUP42
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7344582669191027,-1.2818302964003585,0.175,0.9438222345396713,1.0,2/9,8.40%,FICD;BAK1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.638412059194176,1.2817141901325013,0.07575757575757576,0.5166759126181079,1.0,3/33,4.43%,RECQL4;BLM;RPA1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.6856766709934526,1.2816894263975003,0.1746031746031746,0.5162262372038507,1.0,5/19,11.84%,THY1;RHOD;ARHGEF7;ACTN1;SORBS1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6170661886936563,1.2815952015397636,0.15151515151515152,0.5160565593918076,1.0,9/38,13.27%,PAPSS2;IMPDH1;ADCY5;GUCY1A1;ADCY7;ADCY2;AK5;GUCY1B1;ACOT7
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.55592346815659,1.2812430088156366,0.07142857142857142,0.516857596695514,1.0,16/95,20.06%,NR4A3;TEC;NFATC2;LAT2;GAB2;SYK;PAK1;FOS;TAB1;IKBKG;VAV2;SKP1;MAPK9;VAV1;SHC1;NFATC3
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.532652510608234,1.281152967460463,0.11538461538461539,0.516687634001649,1.0,19/103,14.07%,SLC6A15;SLC15A3;SLC7A2;SLC43A1;AMN;MYH9;SLC16A10;SLC35F3;SLC25A45;RAMP3;SLC7A7;SEC14L1;CHMP1A;SLC25A29;SLC7A1;PDPN;SLC7A14;PICK1;SLC29A4
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7692608074391108,1.2810262818553169,0.15789473684210525,0.5165402668059191,1.0,5/12,8.50%,THBS1;SERPINE1;DMTN;FAP;TFPI
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.5659130680584852,1.2809871406575812,0.11290322580645161,0.5162152465320977,1.0,8/77,7.76%,TGFBR2;HPN;EGF;THBS1;RAMP3;ECE1;PID1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8278688622641309,1.2809852126595904,0.10909090909090909,0.5157130916230198,1.0,4/9,7.76%,ANXA1;IL1RAPL1;ATP9A;SNCA
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.62600206041726,-1.28075219896538,0.17647058823529413,0.9459308285089899,1.0,7/31,11.52%,TRIM21;CTSH;PYHIN1;NR1D1;MUL1;ISOC2;RAD23A
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5634686685865574,1.280528911269374,0.08571428571428572,0.5169545559386101,1.0,8/78,6.81%,IGF1;TYMS;IGF2BP2;SAMD4A;RTN1;RTN2;EIF4A3;ENC1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6793805604462521,1.2800616293998694,0.23333333333333334,0.5181492541959198,1.0,2/16,2.19%,PROX1;PSRC1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.6080546763370162,1.2799810877815796,0.0967741935483871,0.5180344183283497,1.0,16/59,16.42%,C3;MRAP2;PLEK;SLC39A14;RGS6;RAMP3;SYP;MRAP;KLK6;ZDHHC7;USP20;GRK5;RGS4;PPP1R9B;RGS16;RGS14
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6648034566163756,1.279937490589583,0.13793103448275862,0.517731659687809,1.0,3/22,9.49%,ZC3H12D;NUDT16;RNASE1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7368773932280522,1.2798987623887306,0.1791044776119403,0.5173852605882976,1.0,1/9,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.8338092217601052,1.2798367167001838,0.16,0.5170947613315775,1.0,1/5,3.44%,ABCB1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),-0.8017208570274452,-1.2796305220148112,0.2553191489361702,0.9480520036329767,1.0,1/5,1.97%,TNFAIP3
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6644844723646122,1.2791265212705483,0.09259259259259259,0.5193650113111749,1.0,8/27,9.44%,CSPG4;DCN;CHSY3;CHST15;CHPF2;VCAN;UGDH;BGN
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.580709268831908,-1.2791042680975233,0.21739130434782608,0.9438342469109214,1.0,8/33,20.90%,AAAS;RAE1;NUP50;NUP54;NOL6;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.580709268831908,-1.2791042680975233,0.21739130434782608,0.9438342469109214,1.0,8/33,20.90%,AAAS;RAE1;NUP50;NUP54;NOL6;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.8405748541113932,-1.278956014989255,0.1346153846153846,0.9415285883880335,1.0,1/6,1.48%,CYP4F3
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5378561420569372,1.2788672678104958,0.0821917808219178,0.5197456649951959,1.0,22/99,16.72%,ENPP2;SGPP2;VAPB;UGT8;FA2H;ESYT3;CERS3;B4GALNT1;SPNS2;HACD1;B3GALNT1;ABCA2;SERINC1;ST6GALNAC3;TEX2;ALDH3A2;ELOVL7;SGMS1;CERS5;HACD4;ELOVL5;NEU4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.7062084107225476,-1.278834293237024,0.225,0.9385839029918688,1.0,5/9,23.13%,ETFB;GCDH;ETFDH;ACADS;ACADM
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.8086026071372846,1.2787283454838276,0.16326530612244897,0.5196629961362609,1.0,2/8,8.73%,NLRP12;MVP
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5914446420593776,1.278680845519788,0.13432835820895522,0.519327408392143,1.0,20/75,15.35%,MET;PDGFRA;EPHA7;EPHA2;IRS2;EPHA5;FLT1;TSPYL2;NTRK3;LDB2;NLRC5;CDKN1C;VAC14;MAPT;EPHA4;CDKN1B;HLA-DRB1;ALK;MRE11;CD4
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7747157189411339,-1.2786271898023127,0.22727272727272727,0.9364490131711629,1.0,2/7,14.36%,HUS1;CLSPN
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.7263190742274599,1.2785718022847627,0.14925373134328357,0.5191903371800545,1.0,2/14,3.62%,C3;APP
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.8489840493179539,1.2784436815098765,0.12727272727272726,0.5191743341879356,1.0,1/6,4.57%,ATP9A
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7494672820380858,1.278253183195925,0.18333333333333332,0.5188464690540021,1.0,2/11,10.90%,IRS2;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7494672820380858,1.278253183195925,0.18333333333333332,0.5188464690540021,1.0,2/11,10.90%,IRS2;STAT3
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.6368497140973572,1.277661309328025,0.16666666666666666,0.5203201301698689,1.0,7/41,2.92%,CXCL2;TLR2;CTSS;CD24;P2RY13;PLEK;MYO1F
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6715964583029264,1.2769635983078873,0.16393442622950818,0.5225130187913226,1.0,3/21,3.14%,MET;TMEFF2;WAS
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.8694779670368672,1.2768058757312541,0.09836065573770492,0.5225048424606379,1.0,2/5,5.16%,ABCB1;GRM5
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.8330867544782232,1.2766970483058786,0.1896551724137931,0.5223765700939276,1.0,4/7,13.86%,COL4A2;ITGA2;ITGA11;UBASH3B
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.6428635750183308,1.2757727793002536,0.14705882352941177,0.5249539285308467,1.0,7/25,10.90%,ANXA1;STAT4;ERBIN;FYN;RAMP3;EIF2B2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.8241982570575339,1.27574949676569,0.16393442622950818,0.5245402055291911,1.0,2/6,6.79%,CPLX2;NEUROD2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.660039388935623,1.275691380425715,0.19047619047619047,0.5242470394887817,1.0,7/19,20.88%,LTBP4;ITGA3;SMAD3;BCL9;DKK3;SMAD2;TGFBR3
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.5442465234651568,1.2755119135683612,0.1111111111111111,0.5245418247207074,1.0,21/100,12.12%,HAPLN2;PAPSS2;IGF1;ADAMTS4;COL11A2;SULF1;TLL1;SOX4;CD44;NOTUM;CHI3L1;ZBTB16;VCAN;SH3PXD2B;PKDCC;MMP14;TGFB2;GLI2;ALPL;MMP16;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.49815704642153846,1.2752249836017895,0.022988505747126436,0.525216404342992,1.0,82/385,19.08%,LEF1;KLF2;TEAD2;MYRF;IGF1;MLLT11;SP100;YWHAH;EGF;CREB5;TESC;BLM;PSRC1;ACTA2;RPS6KA1;CASZ1;IRF7;FOXO1;SOX4;NFATC2;NFIL3;AHR;ZIC1;CIITA;SKAP1;KCNH2;ZBTB16;GLIS2;SCX;PML;FOXO3;CTNNB1;SMAD3;RAI1;YAP1;TBL1X;CDKN1C;HDAC4;GLI2;STAT3;RGMB;PARP9;TEAD1;NPAS2;FLI1;MLXIPL;PPARG;KLF6;HLA-DRB1;BRD4;FOS;DEAF1;FGF2;SS18L1;SOX10;CD4;SMARCA1;SPP1;ELF1;RARA;HIPK2;KLF4;MAP3K5;FZD7;TP53;PRDM16;WNT5A;TAF15;RORA;CXXC1;TFEB;MESP1;RNF187;HMGA1;RLF;ZMIZ1;BRCA1;ARID1A;ETS1;RXRA;MAP2K3;SHC1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.8531592543761143,1.2749741455634307,0.13636363636363635,0.5255422785941479,1.0,1/5,2.82%,PRKCB
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.8320207923546377,-1.2749694419288413,0.075,0.9517088193783426,1.0,1/6,1.47%,ERCC8
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.7760224942200287,1.2749345557072453,0.12727272727272726,0.5251733479726848,1.0,3/8,6.08%,HLA-DRA;DUSP10;BCL6
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.6972997764192053,1.2747517397301302,0.13846153846153847,0.5255419901738084,1.0,4/20,9.12%,NLGN1;TJP3;SHANK1;PCLO
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7651140779951163,1.2744175172116778,0.2,0.526321325051593,1.0,3/9,12.70%,EPB41L4B;MAPRE2;ARF6
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.7933394323515949,-1.2740924981540969,0.1702127659574468,0.9530824089463458,1.0,2/6,4.71%,ZC3H8;FOXJ1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7047307633020915,1.2738136496026624,0.23076923076923078,0.5279320036553747,1.0,1/15,0.92%,BOK
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.6298829349480851,1.273772413139036,0.09090909090909091,0.5275189858872955,1.0,10/44,10.03%,ARHGAP4;SHTN1;CDC42EP3;WAS;ARHGDIG;ARHGEF3;CDC42EP1;EPS8L2;RHOD;GNA12
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.6380521470180144,1.2735834193902889,0.125,0.5275169738789666,1.0,8/43,14.08%,NR4A3;ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.7152363917813018,1.273460589870604,0.20754716981132076,0.5275473212734374,1.0,4/13,20.69%,APP;BAG3;CAMSAP3;APBA1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6768260650898804,-1.2732891994643776,0.18181818181818182,0.9539887100450726,1.0,9/14,19.44%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.7939508553217303,-1.2731723569840678,0.2682926829268293,0.9509713903261678,1.0,1/5,5.41%,RHCE
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6482379620300611,1.2730580087016354,0.15,0.5285473637732504,1.0,7/23,21.54%,PRKCB;PID1;PIP4K2A;PRKCD;TSC2;PTPRE;GRB10
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.7333379680046033,1.2730196572842254,0.09615384615384616,0.528135323112574,1.0,10/14,19.47%,A4GALT;ST8SIA3;ST8SIA1;B4GALNT1;ST8SIA4;ST6GALNAC5;ST6GALNAC3;LARGE1;B3GALT4;B4GALT6
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7850463885608262,1.272928417559561,0.15254237288135594,0.5279391531094407,1.0,3/10,18.15%,TTLL7;CFAP20;TTLL5
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8440001537562404,1.2728918888255165,0.15,0.5276144167900446,1.0,3/6,5.34%,SHISA7;NLGN1;SHANK3
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6331799685581722,1.2728601236063715,0.06896551724137931,0.5272795563586085,1.0,11/44,9.71%,MET;ANXA1;EPHA2;FA2H;LSR;ALOX12;CLIC4;PDGFA;ITGA3;CERS3;DHCR24
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.565148708052079,1.2724915275659339,0.11764705882352941,0.5281571864134182,1.0,21/83,16.78%,FOSL2;IL13RA1;TYMP;ZFP36;ICAM1;IL1R1;AHR;SYNGR2;TNFRSF1A;MVP;TMBIM1;ANXA11;IL4R;DTX2;RAB20;FBP1;RELB;RHBDF2;IFIH1;KLF4;JUNB
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6958609212361743,1.272426150766492,0.17543859649122806,0.5279295888616576,1.0,4/17,9.36%,BOK;FAS;DCC;BCL2L1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5471722711216312,1.2722429696885336,0.1875,0.5280984784003688,1.0,23/92,16.40%,DMTN;EPHA5;PAK3;CLIC4;BAIAP2;FAM107A;RHOD;PDGFA;ARHGAP18;TRIM36;NEXN;FSCN1;TPPP;MAPT;PHLDB2;PRKCD;PAK1;ARHGAP17;IQGAP1;RHOBTB2;CAMSAP3;BST1;P2RX7
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.7746347110409743,-1.271813468393993,0.1794871794871795,0.9538573483216208,1.0,2/8,13.04%,ZC3H8;SNAPC5
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5243662385769524,1.2717931112366285,0.09876543209876543,0.5289194048489488,1.0,35/143,16.17%,GPNMB;DCN;SP100;THBS1;SERPINE1;COL4A2;SULF1;PRKCB;ISM1;EPHA2;DAB2IP;FLT1;APLNR;SERPINF1;CHI3L1;PAK4;PML;CYP1B1;HK2;PPP1R16B;CTNNB1;CD160;ADAM12;TGFB2;PGK1;SPARC;THBS2;ITGB8;PPARG;HIPK1;FGF2;GAB1;PIK3CD;HIPK2;KLF4
prerank,PanglaoDB_Augmented_2021__B Cells,0.5805873586254221,1.271560065023442,0.125,0.5292580014508282,1.0,22/71,16.31%,HLA-DRA;EBF1;CTSS;CD24;CD22;PLEK;CD55;NAPSB;WAS;PTPRC;CD37;BIRC3;ACAP1;FLI1;BCL11A;PXK;ITGAL;CD5;TMC8;CD70;CRELD2;BST1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.7753154524068906,-1.2713781307334646,0.15789473684210525,0.9524334026597093,1.0,3/6,14.10%,NDUFA12;NDUFV3;COA6
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.7169037021632816,-1.2711489951107842,0.225,0.9504350467892846,1.0,1/6,1.97%,TNFAIP3
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.8715558385626015,1.271138816885528,0.18867924528301888,0.5302897962929051,1.0,2/5,10.62%,CHRM1;PRKCH
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7467994374123683,-1.2704981616533728,0.225,0.9503557473513602,1.0,3/5,23.96%,RPAP2;SSU72;CTDP1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.7012733972287403,1.270157981255866,0.1,0.5329939686164771,1.0,1/18,0.12%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7664913305396946,1.2700173099571797,0.26785714285714285,0.532901640341909,1.0,3/8,12.70%,EPB41L4B;MAPRE2;ARF6
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.8513509803335517,1.2699122560567817,0.11764705882352941,0.5328307731225582,1.0,1/5,7.76%,SNCA
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.5032655077924972,1.2698322337108512,0.023809523809523808,0.5325154427690371,1.0,51/238,16.84%,CDKN2A;PROX1;THBS1;CCNB2;NR4A1;PTK6;PIM3;DUSP1;PTPRC;DAB2IP;UHRF2;TSPYL2;BAP1;FAP;GMNC;BIRC3;CDK9;PML;CDK6;CDC14A;DHCR24;SMAD3;RASSF1;CHMP1A;TGFB2;TTLL12;STAT3;SRA1;PES1;GADD45A;BARD1;CDKN1A;MLXIPL;RNF112;CDKN1B;CCNB1;CKS1B;TRIM32;CCND1;GRK5;PPP1R9B;IQGAP1;SIPA1;BIN1;IL12A;RARA;HIPK2;NEK6;PUM1;JUNB;TP53
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8761059691035724,1.2696438769829326,0.14,0.5324344419721626,1.0,4/5,9.97%,MLIP;TRPC3;FOXO1;LMNA
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6880457747023501,1.2690790996595551,0.17857142857142858,0.5336167532716447,1.0,4/24,10.01%,KLF2;NOS1AP;ASS1;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.830168514682422,1.2684995518305955,0.15384615384615385,0.5352634866721273,1.0,2/6,13.19%,ITM2A;BACE2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.565908051878693,1.268394321101442,0.12162162162162163,0.5352013523077077,1.0,12/52,13.52%,KCNJ2;GRIN2B;TRPM4;SAMHD1;GRIN1;SNCA;KCNC1;HOMER1;HCN1;SHMT1;HLA-DRB1;B2M
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8333458974625858,1.2683004537793765,0.18,0.534959383184519,1.0,2/5,11.16%,AK5;AK3
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.7790273792747675,1.267918330535772,0.20689655172413793,0.5361244021559829,1.0,2/10,10.76%,ANK3;SYK
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5852621669941247,1.2675864549586968,0.1509433962264151,0.5367272832791911,1.0,7/64,3.77%,SKOR1;THBS1;VWC2;SULF1;SLIT2;VWC2L;DAB2IP
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.8959349960071279,1.2675666240260854,0.09433962264150944,0.5362734559484319,1.0,1/5,4.34%,SLC28A3
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.6134559816961248,1.2674974619074937,0.15151515151515152,0.5360102981984224,1.0,4/32,3.90%,ANXA1;ZFP36;PTPRC;SFTPD
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5167662873584771,1.2674766128499666,0.05333333333333334,0.5355895790072305,1.0,40/151,18.74%,NPY1R;PAPSS2;RASGRP1;SLC7A2;TJP3;CD44;KLF10;PGR;HR;SYBU;RHOD;ANXA9;TTC39A;SEMA3B;GAB2;PLAAT3;ITPK1;FKBP5;AFF1;PODXL;MAPT;TMPRSS3;SYT12;TPD52L1;LRIG1;RAPGEFL1;FOS;BCL2;CCND1;TFAP2C;ELF1;RARA;KLF4;ELOVL5;CALB2;ABCA3;MED13L;MYOF;GFRA1;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.652542228213958,1.2674242422949873,0.2,0.5352538493655112,1.0,7/28,16.65%,IGF1;APP;PID1;MLXIPL;PFKFB3;P2RX7;PINK1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.6231014305380898,1.2673922578654249,0.14516129032258066,0.534855635646616,1.0,10/40,22.83%,ANXA1;STAT4;EIF2B2;STAT3;EIF2B5;STAT6;TGFBR3;GNAI1;SORT1;GHRHR
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6639626798511619,1.267095525291323,0.18461538461538463,0.5354668636029608,1.0,4/17,10.90%,ST18;SOCS3;YAP1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6390592607957335,-1.266986792829117,0.20512820512820512,0.9638064101507697,1.0,6/18,18.91%,RPS26;RPS13;SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7265400525896276,1.2668522095236103,0.19298245614035087,0.535929999789264,1.0,6/13,22.66%,PIM1;TBX20;ZFPM2;FGF2;TGFBR3;GLI1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.5324397833872677,1.2668201634225362,0.0684931506849315,0.5355742145388084,1.0,23/100,20.19%,RASGRP2;S100A10;RASGRP1;THY1;RGS6;AGRN;RAP1GAP;DOCK10;MAPRE2;ARHGEF7;CDKL5;USP6NL;CD200;CCL2;MTCL1;RGS16;PINK1;PKP4;RCN3;CALM3;RAP1A;DOCK9;SEMA4D
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.8875681286275017,1.2665177455967664,0.14285714285714285,0.5356497653029862,1.0,3/5,9.77%,KIF5A;KIF5C;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.8875681286275017,1.2665177455967664,0.14285714285714285,0.5356497653029862,1.0,3/5,9.77%,KIF5A;KIF5C;KIF17
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6452445662741163,1.266199500680363,0.2037037037037037,0.5364038972157912,1.0,9/31,12.73%,TGFBR2;THBS1;GRIN1;PID1;SYK;MAPT;GADD45A;CDKN1A;PRKCD
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6708792690437061,1.2661905439440504,0.11666666666666667,0.5359444833880991,1.0,4/27,4.07%,ANXA1;NR4A1;DAB2IP;FLT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.6064443566688569,1.2661776903585318,0.13793103448275862,0.5354859094394339,1.0,3/47,1.32%,BOK;DCN;MLLT11
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6774709340922225,1.2661421639612611,0.16393442622950818,0.5350803261639602,1.0,4/20,7.52%,CACNA1H;KCNQ1;KCNMB4;ECE1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.7870252340373318,1.2659764064450365,0.18181818181818182,0.5352069592086265,1.0,2/11,7.83%,MET;POF1B
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.7597145793809115,-1.2659702312983767,0.2,0.9659951116771957,1.0,2/7,11.35%,MTIF2;MTIF3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.581032447929634,1.2653099229439435,0.0967741935483871,0.5369471597560979,1.0,11/58,10.65%,CDKN2A;NR4A1;DUSP1;TSPYL2;BTG3;GMNC;CDK6;HECA;SMAD3;CHMP1A;CDKN1C
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5552898094051457,1.2652499887933912,0.06329113924050633,0.5365725601628265,1.0,16/103,7.88%,CACNA1H;ANK3;RASGRP2;NLGN1;SYT1;SYT4;DMTN;SYT5;GLRA2;CLIC4;HPCA;NEUROD2;ITPKB;SYT13;SNCA;ADCY7
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6979578898964547,1.2650832609109741,0.1935483870967742,0.5366351337896315,1.0,2/21,3.79%,ZFP36;SAMD4A
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6885974202869609,1.2649575353437457,0.2153846153846154,0.5364483966749449,1.0,7/16,22.62%,RELN;EPHA5;CD200;CAMK1D;RPS6KA4;CRTC3;ADCY8
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7939504886153883,1.2646540934868786,0.24074074074074073,0.5368221827011306,1.0,1/7,3.68%,LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7402465955715769,1.2644577565163533,0.16393442622950818,0.5370605536328558,1.0,4/13,8.44%,GHR;MGAT5;CYP1B1;OCIAD2
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.7953831060864107,-1.2644484181050553,0.20930232558139536,0.9673259769948473,1.0,4/5,20.33%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.7953831060864107,-1.2644484181050553,0.20930232558139536,0.9673259769948473,1.0,4/5,20.33%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.7921905531342026,1.2641995208339216,0.2,0.537547011533324,1.0,4/6,20.69%,APP;MAPT;DCTN1;APBA1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.7277838242485937,1.2641418713455952,0.16363636363636364,0.5372773603316079,1.0,8/19,21.20%,STAT4;GHR;STAT3;CCL2;STAT6;THPO;PIAS1;NMI
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.7991073661455101,1.2640152705450922,0.265625,0.5371322318779433,1.0,2/6,11.41%,PTPRD;TRIO
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.731273343979893,-1.2637143484417281,0.23529411764705882,0.967373266370461,1.0,3/10,9.99%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.6905481850065749,1.2635794100426863,0.15873015873015872,0.5382369181862066,1.0,4/16,7.19%,TYMS;GMPR;ADA;POLD1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6499945388851104,-1.263518059945341,0.1388888888888889,0.9652679954229166,1.0,9/18,27.43%,EIF2S3B;EIF3D;EIF3M;DHX29;EIF2B3;EIF5;EIF2S3;DENR;EIF2S2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.7229173297240966,1.2634146212930382,0.13114754098360656,0.5383388063246285,1.0,2/13,2.71%,PDGFRA;SULF1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7042043082333348,1.263178714399126,0.21428571428571427,0.5386363670739377,1.0,6/14,25.81%,CDKN1A;PPARG;CDKN1B;TGFB3;TAFA5;APLN
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6459090106862635,1.2631677614566488,0.15384615384615385,0.5381815683511915,1.0,5/24,8.86%,MET;TMEFF2;WAS;SHANK3;SHANK1
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.832532859975007,1.2629248704335547,0.2,0.5385301829344844,1.0,3/5,11.97%,RELN;LHX6;FGF13
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8364831731336446,1.2628675268059582,0.12727272727272726,0.5382407849562713,1.0,2/7,10.05%,PDGFRA;SLC4A11
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.4697659714061482,1.262819143062867,0.011764705882352941,0.537880009371053,1.0,129/669,19.26%,LEF1;NR4A3;MLIP;FOSL2;MET;KLF2;ST18;TLR2;IGF1;MAFF;DCN;PROX1;ATF3;SERPINE1;NR4A1;LMO2;RPS6KA1;CASZ1;WAS;APP;DAB2IP;IRF7;FOXO1;SOX4;PPARGC1B;PLSCR1;AHR;AGRN;SSBP4;KLF10;CIITA;SKAP1;PLAC8;ZNF750;DVL1;LDB2;GRIN1;PGR;FHOD1;RFX4;PID1;CDK9;TNFRSF1A;GLIS2;SCX;NLRC5;FOXO3;BEX1;ZFPM2;CTNNB1;SLC9A1;CSRNP1;CTBP2;NR1I3;SMAD3;ASXL3;NAMPT;YAP1;TBL1X;HDAC4;TGFB2;GLI2;SMAD1;STAT3;GLIS3;ASXL1;TEAD1;NPAS2;NR4A2;MEIS3;MLXIPL;PPARG;EIF5A;KLF6;PTPRN;MEF2D;KLF7;PER1;BRD4;TNIP2;FOS;FGF2;FADD;SS18L1;SMAD9;TFAP2C;ZNF746;MAML2;SMARCA1;NOTCH3;AKIRIN1;ELF1;RARG;IER5;ZNF513;RARA;HIPK2;KLF4;BCL9;TOX3;MRTFA;JUNB;IKBKG;TP53;WNT5A;STAT6;LAGE3;RORA;TFEB;MESP1;RGMA;DOT1L;ZBTB38;HMGA1;RHOQ;WWTR1;UBP1;RLF;ZMIZ1;BCLAF1;GPS2;BRCA1;ETS1;BARX2;RXRA;MAP2K5;METTL23;MAX;MLXIP
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.754743001621317,-1.262806994492268,0.16666666666666666,0.9664331396370989,1.0,5/7,23.96%,NT5E;AMPD3;PRTFDC1;PNP;NT5C1A
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.6551900501756,1.2626736690159788,0.14754098360655737,0.537807216113737,1.0,3/28,4.25%,TESC;PTK6;WNT8B
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.6124434067057475,1.2626664012873619,0.1875,0.5373346975425843,1.0,11/34,17.69%,ABO;B3GALT2;ST8SIA3;ST8SIA1;ST8SIA4;ST6GALNAC5;ST6GALNAC3;FUT2;NEU4;B3GALT5;B3GALT4
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.6266312618203088,-1.2625280447574707,0.23529411764705882,0.9644223108858924,1.0,4/12,17.29%,AKR1C3;CYP46A1;TSPO;STARD3NL
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.5428111940226485,1.2625159518417173,0.08,0.5374059332433273,1.0,15/90,10.76%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;GIPR;GNG2;FYN;RXFP1;RAMP3;GLP1R;ADCY7;ADCY2;NLRC3;SYK
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.8213472212171689,1.2623200754378812,0.19642857142857142,0.5377431342242533,1.0,2/6,13.76%,RAB11FIP5;PTPRN
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.7328677224221576,-1.262035824314981,0.16666666666666666,0.9641192078606191,1.0,2/11,6.88%,NPC2;ARV1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.7819274117010828,1.2619073535747383,0.21739130434782608,0.538652341613065,1.0,2/6,8.58%,FYN;DUSP22
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.5965444605023542,1.2616652372216166,0.17142857142857143,0.5390899848732067,1.0,10/47,10.70%,ANXA1;IRAK2;APP;DAB2IP;IL1R1;MYLK3;CHI3L1;SNCA;MYD88;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.7364251053456452,1.2616435827062922,0.171875,0.5386490520104048,1.0,3/14,9.66%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.8586081434528743,1.2614923737897918,0.08064516129032258,0.5382382263189242,1.0,3/6,13.72%,CDC42EP3;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.8586081434528743,1.2614923737897918,0.08064516129032258,0.5382382263189242,1.0,3/6,13.72%,CDC42EP3;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.7318785775253888,-1.2614848390138556,0.24390243902439024,0.9603311614034106,1.0,4/6,24.96%,GBA2;FUCA2;GBA3;FUCA1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.7318785775253888,-1.2614848390138556,0.24390243902439024,0.9603311614034106,1.0,4/6,24.96%,GBA2;FUCA2;GBA3;FUCA1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7243751825332185,-1.2613937983016454,0.21951219512195122,0.9575534600545982,1.0,1/10,2.35%,EIF2S3B
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.876133197992664,1.2613154928783377,0.14,0.5379915927453038,1.0,2/5,10.90%,STAT4;STAT3
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.876133197992664,1.2613154928783377,0.14,0.5379915927453038,1.0,2/5,10.90%,STAT4;STAT3
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6317364012316474,1.2611666593366684,0.16923076923076924,0.5379600586106339,1.0,5/29,12.63%,NR4A3;MYH9;PLEKHM1;SYTL4;KLC2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.7854325375233382,-1.2610504205768838,0.23529411764705882,0.9560354130571125,1.0,2/6,16.82%,AKR1C3;BMP2
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.46357054211476495,1.2610297011979832,0.0,0.5380402576978426,1.0,136/835,17.01%,TGFBR2;MTMR7;SERPINA10;C3;VRK2;ANXA1;CHGB;SOCS3;CHRM3;MAP3K6;PLK2;THBS1;FAM20C;PTK6;B3GNT2;PIM3;PTPRO;PRKCB;PRKCG;DUSP1;PTPRC;CP;PTPRB;TEC;APP;ASB16;PIM1;PTPRR;DUSP10;NUAK2;NEK10;PAK3;DUSP8;PRKG2;MYLK3;PRKAR1B;B3GALT2;NUAK1;FBXW12;ST8SIA3;FYN;DUSP16;IGFBP7;LAMB1;PDP1;NOTUM;SBF1;PTPN21;BAP1;ZBTB16;CDK9;PAK4;VGF;ST8SIA1;STK25;GRK2;SHISA5;VCAN;MAP3K11;AATK;SIK2;FBXO32;LIMK2;ITIH2;CDK6;PTPRD;ART3;SSH2;IKBKE;LOXL1;PTPN9;B4GALT7;MAK;PRKCE;UST;PRKCH;HIPK3;PPP1CB;TGFB2;SYK;KLHL5;MINK1;ST8SIA4;B3GALNT1;HUNK;TF;CDKL5;MAP3K21;PARP9;ST6GALNAC2;GAS6;PRKCD;TYK2;B4GALT5;PDK1;SPSB1;PXK;FBXL16;MACROD1;FN1;HIPK1;WSB2;FUT2;FBXL2;LCMT1;PICK1;PDK4;CCL2;ATG4B;PAK1;CAMK2B;MSRA;GRK5;PLOD2;CHST4;MTM1;GPS1;SPP1;BMX;GAN;PPM1D;PIK3CD;FSTL1;LARGE1;RARA;HIPK2;SERPIND1;NEK6;MAP3K5;HIF3A;TAB1;PINK1;B3GALT5;PHEX;DCLK1;PTPRS
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6946530749290997,1.2607676667271168,0.18181818181818182,0.5383536137498498,1.0,1/13,2.89%,DUSP1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.6232448518459082,-1.2605030493907883,0.15789473684210525,0.9549060786261611,1.0,8/28,20.75%,ZC3H8;POLR2K;SNAPC5;GTF3A;POLR3H;POLR3K;POLR2L;RO60
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7907954593044223,1.2603016024508038,0.11666666666666667,0.5395582455238168,1.0,3/9,14.45%,CLMN;SYNE3;DCTN1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4944879381194398,-1.2601562800330677,0.14285714285714285,0.953658249141161,1.0,12/94,6.89%,G0S2;RPP25L;AR;GOLT1A;C6;CEBPA;LEPR;FGL1;TM7SF2;APOM;HSD11B1;ADH6
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.7351281066951658,-1.2597720726401722,0.16,0.952267990040655,1.0,2/6,19.91%,BNIPL;PRUNE1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.5581893766221979,-1.259695053966509,0.21212121212121213,0.949586337262062,1.0,2/27,3.00%,DNMT3B;SMYD5
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4959659011431442,1.2594525490919628,0.08,0.5419757975800423,1.0,24/182,11.49%,LEF1;TGFBR2;IGF1;NPNT;VWC2;ZFP36;RPS6KA1;NELL1;PCP4;RBM24;TRPM4;NEUROD2;ZBTB16;BOC;KITLG;CTNNB1;PKDCC;SMAD3;MMD;YAP1;PRKCH;TGFB2;RIN2;WDFY2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.7079998423931531,-1.2593261695373394,0.25,0.9483178902597623,1.0,2/13,10.45%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.8213716727591485,1.2592520350731873,0.1864406779661017,0.5422443691152771,1.0,1/6,3.44%,ABCB1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6551985982215347,-1.2589929078963926,0.15,0.9466352062235666,1.0,3/20,8.41%,BUD23;TFB2M;THUMPD1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.6671558463836001,1.2585548873723533,0.19117647058823528,0.5441397803325411,1.0,3/31,8.50%,ABO;ALDOB;TFPI
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5387788462590867,1.2583883675047165,0.10606060606060606,0.5442241886254122,1.0,8/86,2.96%,HPN;L1CAM;RIMS2;IGF1;SYT1;SHTN1;RPS6KA1;SYT4
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.8401604472124552,1.2582262924854803,0.21875,0.5443790756094146,1.0,1/5,5.21%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6691325345441028,1.258157766621885,0.21428571428571427,0.544160700188829,1.0,2/23,2.14%,KLF2;ATF3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.6788144389548316,1.2580990637322815,0.17647058823529413,0.5440132131684087,1.0,6/17,15.84%,THY1;SH3KBP1;CYRIB;TNIP2;CCL2;IL12A
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.6998957964408987,1.2578579095563172,0.24242424242424243,0.5442785698624103,1.0,3/15,13.96%,NEFL;KIF5A;HAP1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.7219328753956624,-1.2574228109779184,0.24390243902439024,0.9506845049408466,1.0,2/12,10.45%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.6989984193039259,1.2573627185422613,0.20408163265306123,0.5455187130775472,1.0,4/12,20.74%,DMTN;BST1;FLNA;EMP2
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.8388350895478516,1.2572020410458167,0.11538461538461539,0.5456818257154434,1.0,4/5,14.94%,NLRP12;CIITA;NLRC5;HSPH1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.8026306631835163,1.2570155014911653,0.1935483870967742,0.5457643597522224,1.0,5/7,19.39%,PRKCH;GAS6;PRKCD;CCL2;PRKCA
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.6515816762353649,1.256894911460141,0.19298245614035087,0.5456060845383773,1.0,7/15,24.27%,EPHA2;GAB2;GPR183;SBNO2;SNX10;CSF1;ANXA2
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.6660474566193222,1.2567715474386127,0.21875,0.54548816253666,1.0,2/18,2.58%,MAFF;ZFP36
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.7953258400879467,1.2563247998152867,0.11864406779661017,0.5465115990089497,1.0,2/7,9.01%,SYT4;KIF5A
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.8041342461607598,1.2562250433765036,0.2391304347826087,0.5458850786423832,1.0,3/5,19.18%,TCP1;CCT4;WRAP53
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.8041342461607598,1.2562250433765036,0.2391304347826087,0.5458850786423832,1.0,3/5,19.18%,TCP1;CCT4;WRAP53
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.619398730989477,-1.2560844561785247,0.1935483870967742,0.9535722835890568,1.0,2/17,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.7064425352883912,1.255941431202677,0.1694915254237288,0.5462864854361859,1.0,5/12,15.17%,HLA-DRA;ABCB9;HLA-DRB1;B2M;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6894939340353806,1.255696370122732,0.1774193548387097,0.5466472905487785,1.0,9/23,23.04%,TRPC3;GRIN1;GRM6;ORAI1;CCL2;P2RX7;CACNB2;CAMK2A;CXCL12
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6804305949868533,1.2556846462743623,0.203125,0.5462201180781837,1.0,7/16,19.32%,PLEK;FHOD1;ARF6;FMNL3;RHOQ;FHOD3;FMNL1
prerank,PanglaoDB_Augmented_2021__Basophils,0.5856654696999471,1.255585916100712,0.05555555555555555,0.5461720845816264,1.0,18/69,13.59%,L1CAM;TLR2;CTSS;P2RY13;PLEK;MYO1F;TEC;SIGLEC1;CD44;NFIL3;IGFBP7;LAMA5;GRM6;IL4R;JAZF1;ST6GALNAC5;SLC26A8;ITGAL
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.7783475232330829,-1.2554191776152328,0.1590909090909091,0.953586986288707,1.0,3/6,21.22%,NUP54;PLK1;INTS13
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.7636154967759888,1.2554159025677887,0.17543859649122806,0.5463430142206799,1.0,4/6,21.32%,GRIP1;GRIP2;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5305605157589525,1.255011870369201,0.08695652173913043,0.5473188193136308,1.0,22/138,11.84%,KLF2;IGF1;EGF;THBS1;PLD1;IRS2;SAMD4A;NOS1AP;FABP3;SOX4;EIF4A3;MFSD2A;LARP6;SNCA;LDLR;ASS1;YTHDF1;SMAD3;GLI2;NIBAN1;DUOXA1;SORBS1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.5005361102543732,1.2549155216968473,0.06329113924050633,0.5472401604394265,1.0,38/238,14.48%,MET;IGF1;PDGFRA;EGF;GRIN2B;RASGRP1;MBP;ZFP36;RIT2;RASGEF1A;CSF2RA;ZDHHC9;NEFL;SHC2;IRS2;DAB2IP;TGFA;PRKG2;GFRA2;SHANK3;FYN;NRG1;GRIN1;MRAS;PDGFA;KITLG;NRG2;BCL2L1;PPP1CB;MINK1;FGF13;RGL1;DLG3;TNIP2;CCL2;PAK1;FGF2;CAMK2B
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.7503760814068725,-1.2548686879606799,0.22727272727272727,0.9530373778852096,1.0,1/7,9.95%,KMT2A
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5524987657876242,-1.25484767292174,0.17142857142857143,0.9501192511209016,1.0,10/48,14.91%,GRPEL2;TIMM8B;TIMM13;AIP;BCAP31;TIMM23;SAMM50;TSPO;TIMM10;TIMM50
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.6330991983172974,-1.2548181967709564,0.2,0.9473414174290964,1.0,5/19,7.17%,PRSS3;CEL;AKR1C3;CFTR;CPA1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.7854914909222616,-1.2547698953866782,0.13157894736842105,0.9444352557084793,1.0,4/7,20.79%,MGME1;PRIMPOL;DNA2;PARP1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.7997672881973208,1.2547056603860367,0.1864406779661017,0.5473898703387111,1.0,2/9,9.93%,GGCT;GSS
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.6493418353319489,1.2546558835952661,0.15625,0.5470336797691406,1.0,9/37,14.42%,HLA-DRA;IL15;PTPRC;PLSCR1;SKAP1;TGFB2;STX4;HLA-DRB1;FADD
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.6883244472717471,1.2544782249435436,0.1746031746031746,0.547163497218445,1.0,4/22,7.40%,TGFBR2;EGFL7;APLNR;TBX20
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.7272389299183393,1.2541776584469977,0.25862068965517243,0.5477186752072887,1.0,1/13,1.52%,PLK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.7683799984514061,1.2535926615882975,0.1956521739130435,0.5491727698007413,1.0,1/7,7.69%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6625194729417595,1.2534922025479767,0.21428571428571427,0.5490929154271926,1.0,2/20,4.24%,C3;NOS1AP
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8569942971508846,1.25329018609536,0.16666666666666666,0.5492994776624438,1.0,3/5,9.14%,OXTR;ECE1;ENPEP
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.5673159416497203,1.2529530287471302,0.19402985074626866,0.5501073352986854,1.0,10/41,16.33%,S100A10;PLEK;FHOD1;LIMCH1;SYNPO2L;ARHGEF10L;PXN;PAK1;LPAR1;PFN2
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6800093142359549,-1.2525681653381242,0.17073170731707318,0.9522541479804832,1.0,4/13,18.91%,SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.6913557711076718,1.2522089108099137,0.140625,0.5521554835248833,1.0,4/16,10.59%,PROX1;PKP2;TBX20;TCAP
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.7530029592274053,-1.252161048838377,0.21739130434782608,0.9511618904777159,1.0,1/6,9.95%,KMT2A
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6979086782050585,1.2521435531047296,0.19642857142857142,0.5519354871805394,1.0,5/17,16.33%,NLGN1;PLEKHM1;EPS8L2;P2RY12;PFN2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7417848064857497,1.2519883254040836,0.22807017543859648,0.5518634347728283,1.0,3/10,7.84%,NPNT;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6411384910770848,1.251918554236027,0.2033898305084746,0.5516735560059277,1.0,6/33,7.76%,TIMP2;PRKCG;NELL1;DAB2IP;AGAP2;SNCA
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7294215889898489,1.251877487532825,0.22580645161290322,0.5513072303398384,1.0,7/12,23.60%,TJP3;LSR;TJP2;CGNL1;SCRIB;ARHGEF18;TJP1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6884263951330523,1.2514392360075703,0.23076923076923078,0.5522563835252612,1.0,4/15,15.37%,SYNGR2;SYP;STX4;STX1B
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7771761672140983,1.251252326219422,0.21666666666666667,0.5523999885647384,1.0,3/7,21.84%,CTNNB1;STARD13;RHOB
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.6606252911795649,1.2512360182389384,0.22950819672131148,0.5519458230991587,1.0,4/25,7.37%,CD55;TRIM5;SAMHD1;BIRC3
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.5279952169729263,1.251197436578219,0.16901408450704225,0.5516098809970108,1.0,32/147,15.19%,SOCS3;IL15;STAT4;ICAM1;PIM1;IRF7;NOD1;MARCHF1;PLSCR1;FAS;MTHFD2;CIITA;CFH;SAMHD1;C1R;PML;NLRC5;MYD88;MVP;MX1;NAMPT;STAT3;ST8SIA4;IL4R;CDKN1A;HLA-DRB1;B2M;TNFAIP6;CCL2;HLA-DMA;SERPING1;IFIH1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5473632384787726,1.2511525344699068,0.0821917808219178,0.551284292843539,1.0,21/101,16.02%,ARHGAP4;CNTNAP1;DMTN;THY1;WTIP;SH3KBP1;NEDD9;DPYSL2;PAK4;RHOD;PCLO;PLD2;PACSIN1;FGD5;FMNL3;SYNE3;CCL2;SIPA1;BIN1;RHOBTB2;PALLD
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.7689723942233547,1.2510555439564426,0.2459016393442623,0.5510960464917775,1.0,1/6,1.60%,CD24
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.7675389890790432,-1.250941106220839,0.2857142857142857,0.9537595582675426,1.0,1/7,1.13%,ID2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7758215726485637,1.2509226837839464,0.24242424242424243,0.5510252658040306,1.0,2/7,5.88%,ST18;FAS
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.8077993557523677,1.2504666483197369,0.16666666666666666,0.5520275078531037,1.0,1/8,1.07%,SOCS3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.6688815122201042,1.250229524105193,0.15625,0.5523556117573724,1.0,7/23,14.08%,ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7568422889140413,1.2500823748432779,0.25806451612903225,0.5524105195937864,1.0,5/10,19.39%,CCNB2;PRKCB;CCNB1;NEK6;PRKCA
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.7953090922951046,-1.2497523357043325,0.21052631578947367,0.9561251101989893,1.0,2/8,5.46%,APOE;APOM
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.7036101943702134,1.2497085033032889,0.2545454545454545,0.5531074300046395,1.0,3/10,13.86%,PTK6;NLRP12;UBASH3B
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6888604586881807,1.2493131666969233,0.19047619047619047,0.5534390671545291,1.0,6/19,16.95%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6888604586881807,1.2493131666969233,0.19047619047619047,0.5534390671545291,1.0,6/19,16.95%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.717372688995296,1.2488878865422643,0.18032786885245902,0.5546961554213512,1.0,3/13,7.16%,ANXA1;RIMS2;RAB11FIP5
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6424043079039018,1.2488183868656315,0.13432835820895522,0.5544385811066371,1.0,3/23,8.14%,TLR2;IRAK2;MYD88
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7634532074931871,-1.2487840762829185,0.22916666666666666,0.9579018478083121,1.0,2/10,1.71%,BUD23;RIOK2
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.7847085515655912,-1.2487763693887133,0.18181818181818182,0.9549453606237186,1.0,1/7,3.59%,AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.8337770200800367,1.248525077197704,0.1896551724137931,0.5549951912601031,1.0,2/5,14.22%,YAP1;PAK1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.6865414755923466,1.248423496134127,0.16417910447761194,0.5548636304833837,1.0,6/20,11.98%,KIF14;STMN2;STMN4;TPPP;FGF13;MAPT
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6135756396757526,1.248039282124705,0.16666666666666666,0.5558251228553032,1.0,4/29,7.33%,SCN9A;CDH23;ASIC3;CLRN1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7382310668964449,-1.247824037434799,0.28888888888888886,0.9561917136556737,1.0,7/12,22.72%,GUCA1B;PPEF1;NMT2;METAP2;METAP1;FNTB;CALM1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6411024812393566,1.247801378668815,0.19718309859154928,0.5562921812973866,1.0,3/27,8.05%,ST6GAL1;TUSC3;MGAT5
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.8205454850123258,1.2477619181153135,0.2037037037037037,0.5559860729221907,1.0,1/5,3.67%,YBX3
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7813166677346307,1.247557740049922,0.14285714285714285,0.5563075080663915,1.0,3/10,9.36%,BOK;FAP;BCL2L1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4696960273620178,-1.2473833686809446,0.09523809523809523,0.9552259979620974,1.0,23/120,19.25%,EIF2S3B;MRPS7;CRNKL1;PRPF18;RPS28;RPS27L;GEMIN4;RPL6;RPSA;MDN1;RPL23A;RPL11;LSM4;CLP1;KHDC4;WDR77;LOC102724159;RPF2;POLR2D;DHX29;SRSF9;RPL10;TGS1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.7309796406582839,1.247353096790919,0.23529411764705882,0.5566284007040196,1.0,2/12,6.09%,ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.7138769808965375,1.2472671613392032,0.23728813559322035,0.5564864981291273,1.0,6/15,18.74%,SERPINE1;RTN4RL1;EPHA4;FGF2;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.511348236059318,-1.247010422819412,0.125,0.9539353550823245,1.0,21/62,25.37%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;POLR2C;SUPT16H;ERCC2;GTF2F1;CCNT1;GTF2F2;POLR2D;ERCC3;POLR2L;POLR2G;POLR2E;CTDP1;EAF1;CTR9;GTF2H3;LEO1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.7070312401296679,1.2468562794316247,0.18333333333333332,0.557586095889307,1.0,4/14,13.68%,TLR2;ROBO2;B2M;ELAPOR2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.8172843775539551,1.2467634022441814,0.18518518518518517,0.5574820823896354,1.0,4/8,11.61%,IGF1;NECAB1;NECAB2;ABCA2
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.623047038142579,1.2467291522803718,0.1320754716981132,0.5571284879840878,1.0,12/33,19.47%,FA2H;ST8SIA3;CERS3;B4GALNT1;CYP4F22;ST8SIA4;ST6GALNAC5;ST6GALNAC3;SGMS1;CERS5;B3GALT4;B4GALT6
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.7909899606690907,-1.2466905348577566,0.28888888888888886,0.952393433710963,1.0,2/5,11.14%,C17ORF75;WDR11
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8165246606800776,1.2465088102915927,0.16,0.5576201050403585,1.0,4/7,11.15%,MYRF;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7498018367553869,-1.2461791224286256,0.20454545454545456,0.9518003787419758,1.0,1/8,6.92%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5629140063654405,1.2461067802959398,0.08955223880597014,0.5584849012335027,1.0,15/103,8.66%,GPNMB;HTR2C;P2RY6;PDGFRA;NPNT;RASGRP1;ICAM1;PTPRC;APP;CD44;RAMP3;NTRK3;CHI3L1;PDGFA;NECAB2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.7847243437172473,-1.2461050848064121,0.1282051282051282,0.9463995001736388,1.0,2/6,14.67%,ASIP;CDH3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.7847243437172473,-1.2461050848064121,0.1282051282051282,0.9463995001736388,1.0,2/6,14.67%,ASIP;CDH3
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.5927901861579844,1.2460803250762216,0.16901408450704225,0.5580738645437907,1.0,6/35,13.52%,KCNJ2;TRPM4;SAMHD1;HCN1;SHMT1;B2M
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.5745025867197803,1.245867535700997,0.14285714285714285,0.5584198461051155,1.0,8/43,12.56%,TGFBR2;THBS1;PID1;SNCA;CYP1B1;NOXA1;GADD45A;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.7004437475711884,1.2457556315253284,0.3125,0.5583252227718022,1.0,4/16,16.48%,HELB;CGAS;POLQ;RADX
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.7062531724955379,1.2457412716721539,0.20634920634920634,0.5579057938316143,1.0,2/18,2.89%,CXCL2;DUSP1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7536494110219265,1.2455273239914404,0.23636363636363636,0.5582892471633623,1.0,3/10,13.52%,TLR2;PGK1;B2M
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.7651829334964867,-1.2451893663315745,0.3142857142857143,0.9481340921246803,1.0,1/5,0.90%,DSCAM
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5590422891095725,-1.2447779224717377,0.1724137931034483,0.9473056946045268,1.0,2/33,1.99%,PTCD2;RBM23
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7237038531722851,1.244356675715883,0.18518518518518517,0.5620116878306557,1.0,5/9,19.10%,RAMP3;ECE1;SNCA;INPP5F;SCRIB
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.4867470701871912,-1.244214289013184,0.07142857142857142,0.9471531933947872,1.0,28/97,21.27%,ERCC8;RFC3;COPS8;HUS1;POLD3;GTF2H5;POLR2K;CETN2;GTF2H2;COPS7A;BRIP1;GTF2H2C;POLR2C;ERCC2;RAD23A;ERCC6;PNKP;HMGN1;XPA;POLR2D;ERCC3;ATXN3;UBB;PPIE;POLR2L;PARP1;POLR2G;COPS3
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.8511537314407389,1.2439307761084384,0.12962962962962962,0.5631251785945789,1.0,3/5,14.43%,HLA-DRA;HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.7475480008441008,1.2438964645644874,0.1746031746031746,0.5627412491300673,1.0,4/12,12.83%,SCX;TENM4;TLE6;B4GALT5
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.8682719706432873,1.2437360959573494,0.11320754716981132,0.5629290359404696,1.0,1/5,5.34%,SHANK3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.6268503208728408,1.2437154190927837,0.12307692307692308,0.5625459091417224,1.0,9/33,11.27%,CACNA1H;SLC7A2;TRPM4;ABCC8;ABCC9;ATP1B1;SFXN3;SLC25A29;SLC7A1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6439715522235409,1.2435528729488903,0.1774193548387097,0.5626005165648329,1.0,10/33,13.08%,NLGN1;SYT1;SNCB;SYT5;DNM1;SNCA;SYNJ2;MX1;PACSIN1;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.8082101232074049,1.2429653095284028,0.21153846153846154,0.5641076464701722,1.0,5/7,18.74%,RTN4RL1;THY1;EPHA4;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.45416694643329086,1.2429609093006404,0.03571428571428571,0.563639118524599,1.0,61/545,12.22%,LEF1;HPN;BOK;ANXA1;IGF1;KIF14;MLLT11;PLK2;THBS1;PIM3;GRID2;STEAP3;RPS6KA1;SLIT2;PIM1;DAB2IP;PRAME;NUAK2;FOXO1;KLF11;ARHGEF17;SOX4;CD44;SEPTIN4;FAS;ARHGEF3;BCL6;TFPT;PAWR;BIRC3;NAA38;THOC6;SNCA;SCX;ALPK2;FOXO3;MYD88;CYP1B1;MAP3K11;OBSCN;BAG3;MCF2;CTNNB1;CASP10;BCL2L1;PNMA2;DHCR24;KALRN;NEURL1;ARHGEF7;HIPK3;TP53I3;NDRG1;ACTN1;TRIO;PLEKHG2;SRA1;PXT1;GAS6;GADD45A;BARD1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7338005434618949,1.2429448301962118,0.23636363636363636,0.5631808466651176,1.0,7/12,18.70%,PROX1;PDGFRA;MYLK3;TCAP;NEBL;NEB;FHOD3
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.7958884884286183,1.242919213014952,0.18867924528301888,0.562789628900715,1.0,5/11,8.25%,GABRB2;GABRG3;GABRA1;GABRA5;GABRG2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.5364703945884557,1.2429175445690683,0.08450704225352113,0.562323357460035,1.0,19/103,11.84%,TLR2;IGF1;EGF;THBS1;PLD1;IRS2;SAMD4A;SOX4;EIF4A3;NLRP12;CIITA;LARP6;NLRC5;YTHDF1;NAMPT;TGFB2;GLI2;NIBAN1;SORBS1
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.7944933481870163,1.2428718151235167,0.22033898305084745,0.5620185914136615,1.0,2/7,4.00%,ICAM1;THY1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7486991704171264,1.2427454739324326,0.1346153846153846,0.5620544246515505,1.0,1/7,2.58%,ZFP36
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7064231623571499,-1.2426501051880197,0.27906976744186046,0.9516380006946077,1.0,3/11,6.19%,HEY2;TMEM100;ASB4
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6687752771924715,1.2425049993811175,0.1791044776119403,0.5623450591997368,1.0,6/18,16.07%,GPNMB;SFTPD;TNFRSF14;DLG5;HLA-DRB1;PRKAR1A
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7357088428853196,-1.242482344525597,0.2,0.9495646789455218,1.0,1/7,2.25%,VAMP8
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7712168850934478,1.2424489221709898,0.24074074074074073,0.5615584525985342,1.0,2/6,12.70%,MAPRE2;ARF6
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7712168850934478,1.2424489221709898,0.24074074074074073,0.5615584525985342,1.0,2/6,12.70%,MAPRE2;ARF6
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.5809725624319461,-1.2422015622631202,0.2,0.948076905848579,1.0,9/29,17.51%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;TTF1;POLR1B;ERCC3
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7422144519174475,1.2421031007774403,0.21311475409836064,0.5621124233777126,1.0,6/12,19.39%,CCNB2;PRKCB;CCNB1;DCTN1;NEK6;PRKCA
prerank,MSigDB_Hallmark_2020__Myogenesis,0.5097683745880988,1.2420945083026318,0.08450704225352113,0.5616870310284705,1.0,35/141,16.03%,CACNA1H;PTP4A3;IGF1;COL4A2;APP;MYH9;ACHE;MYH11;FABP3;AGRN;APLNR;SYNGR2;APOD;IGFBP7;KCNH2;MRAS;DTNA;MYO1C;PKIA;CNN3;TCAP;ADAM12;SPARC;SORBS1;CDKN1A;TPD52L1;MEF2D;PICK1;LAMA2;FGF2;CAMK2B;SMTN;BIN1;RIT1;LARGE1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.7283068981720378,1.2420875543116479,0.23809523809523808,0.5612341376102161,1.0,2/12,1.39%,RIMBP2;TBC1D24
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.6742926354913201,-1.241776148799752,0.16666666666666666,0.947169484226393,1.0,8/15,20.33%,GDE1;PLA2G4C;ENPP6;LYPLA2;PRDX6;GPCPD1;PLA2G4A;GDPD1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.6461518129203419,1.2415821193670658,0.2542372881355932,0.5624538903630478,1.0,3/20,6.89%,LIPH;FABP3;FAAH
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.7848503471950575,1.2414172997785744,0.21052631578947367,0.5626205201704029,1.0,3/7,18.05%,DAB2IP;NLRC3;TSC2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.8407679272106379,-1.240426599598563,0.09090909090909091,0.9468933928815141,1.0,2/5,13.30%,HEY2;HEY1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.8407679272106379,-1.240426599598563,0.09090909090909091,0.9468933928815141,1.0,2/5,13.30%,HEY2;HEY1
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.8033910448997383,1.240229995595986,0.234375,0.5664252612634526,1.0,3/6,8.66%,SHANK3;FYN;NECAB2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.7478898916091774,1.2399912584547537,0.17543859649122806,0.5667195340235371,1.0,4/10,11.61%,CNTNAP1;TENM4;TPPP;ABCA2
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.7815316529497901,1.2399282173276038,0.24074074074074073,0.566451609884861,1.0,1/6,2.71%,TIMP2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7319499853704311,1.2398817202537886,0.15517241379310345,0.5661186449217223,1.0,6/12,9.52%,PKP2;GJC1;RYR2;ATP1A1;CACNA1C;ATP1B1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5113702435945788,1.2395394006601423,0.1388888888888889,0.5668517356907969,1.0,10/85,9.13%,SLC32A1;SLC24A2;SLC15A3;PIEZO2;SLC9A9;GRIN1;LASP1;SLC20A2;SLC17A5;SLC9A1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.7941721169317846,-1.239390884231158,0.2916666666666667,0.9487393809919967,1.0,2/7,7.40%,PIK3C2G;PIK3C2A
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.706305997879361,1.2393086107994915,0.2,0.5671446972771548,1.0,3/17,10.19%,ANXA1;DMTN;PRKCE
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.5089998307505229,1.239099979689049,0.15789473684210525,0.5673158730912776,1.0,14/86,15.77%,KCNJ2;BLM;KCNC2;TRPM4;SAMHD1;STEAP4;HCN1;SHMT1;POLQ;RNF112;B2M;GLRA3;GSDMD;ATL3
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.5252152231291995,1.2390952474982564,0.0958904109589041,0.5668900528776504,1.0,24/82,17.20%,PDGFRA;CD24;CDH23;CD55;TRPC3;ADCY5;ATP2B3;TRPM4;GLP1R;ITPR3;RYR2;CCKBR;HCRTR2;NPTN;CACNA1C;SMAD3;CCR10;S1PR3;LPAR1;SLC8A2;CALB2;YWHAE;WNT5A;SLC8A1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6810367593820328,1.238836376749699,0.2909090909090909,0.567294059433215,1.0,5/15,17.11%,GRIP1;MFSD2A;DVL1;MYO9A;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6562063269808038,1.2386526119562111,0.21153846153846154,0.56702119203142,1.0,7/19,21.17%,IGF1;APP;MLXIPL;PFKFB3;P2RX7;ARNT;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6562063269808038,1.2386526119562111,0.21153846153846154,0.56702119203142,1.0,7/19,21.17%,IGF1;APP;MLXIPL;PFKFB3;P2RX7;ARNT;HIF1A
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5705737951365312,1.2384722020069412,0.11940298507462686,0.567266118739742,1.0,11/56,10.20%,EGF;SH3GL2;PTK6;DAB2IP;TGFA;SH3KBP1;RHBDF1;MVP;WDR54;ARHGEF7;ZFYVE28
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7707391544648028,-1.2384519378311598,0.2,0.95066495198009,1.0,6/9,19.44%,ATP5MC1;ATP5PB;ATP5PD;ATP5MC3;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.8166363976026164,1.2383239383823266,0.23636363636363636,0.5672227875482673,1.0,1/5,5.21%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6818743339207262,1.2382110647108102,0.1746031746031746,0.5671609702533676,1.0,7/17,22.35%,DMTN;INPP5J;GADD45A;MLXIPL;PDE4D;NCK2;PPM1F
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5573181995342691,1.2381468063186933,0.15714285714285714,0.5668304024121656,1.0,6/51,7.18%,CTSC;CTSS;DAB2IP;VLDLR;DENND3;FAP
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7719430786581687,1.2378015824954665,0.21818181818181817,0.5676119549907672,1.0,3/6,17.11%,LHX6;ROBO2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.6831189303494377,1.237040749600065,0.18461538461538463,0.5695677141590968,1.0,4/21,10.19%,KIF14;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.7838803315995626,1.236749428339705,0.2830188679245283,0.5700220975946738,1.0,1/5,12.53%,IFFO1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7843256098830473,1.2366385306514642,0.21052631578947367,0.5694513408146334,1.0,1/7,0.93%,TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7843256098830473,1.2366385306514642,0.21052631578947367,0.5694513408146334,1.0,1/7,0.93%,TLR2
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6946347727933609,1.2366302062030743,0.26666666666666666,0.5690467187033913,1.0,4/14,8.20%,CHRM3;CHRM1;AGRN;GRK2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6809791949835281,1.2363290302645578,0.21875,0.5694724006685608,1.0,5/23,11.03%,ANK3;CTSS;ABCB1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.568177839463927,-1.2359715695616484,0.13636363636363635,0.9583916892115997,1.0,6/22,16.07%,ISCU;CIAO3;NFU1;CIAO2B;ISCA2;NFS1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.7987630488725406,1.2359454902026459,0.18333333333333332,0.5703026760703802,1.0,3/6,15.17%,ANXA1;STOML2;HLA-E
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.7773408084885179,1.2358627961599593,0.2830188679245283,0.570027194910766,1.0,1/7,1.88%,BLM
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5737996091376816,1.2358444132739919,0.11475409836065574,0.5696050201253289,1.0,15/62,16.39%,MET;TMEFF2;S100A10;WAS;FHOD1;LIMCH1;SYNPO2L;SLC9A1;ARHGEF10L;PXN;PHLDB2;PAK1;LPAR1;PFN2;STMN1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7630108534232468,1.2356020036978426,0.2545454545454545,0.5699921283650916,1.0,1/6,5.25%,NFATC2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4793078319257814,1.2355655473601692,0.0684931506849315,0.569680836015595,1.0,38/311,10.74%,LEF1;TGFBR2;NR4A3;IL13RA1;IGF1;KIF14;PROX1;PDGFRA;EGF;THBS1;IL15;PTPRC;IRS2;PIM1;FLT1;PRAME;TGFA;TRPM4;SOX4;OSMR;LAMB1;NRG1;NTRK3;TBX20;PID1;CCKBR;SCX;PDGFA;KITLG;ZFPM2;CAPN1;GAB2;CDK6;NAMPT;YAP1;PRKCH;HDAC4;TGFB2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5937080110722505,-1.235528790480184,0.1794871794871795,0.9578070574084097,1.0,7/24,16.93%,PYGM;PPP1R3C;NR1D1;AGL;PGM2;PHKG1;GAA
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.7577122792073772,1.235492568416444,0.2708333333333333,0.5694617829136437,1.0,1/7,1.56%,NPNT
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6793212402522159,1.235439794565343,0.21666666666666667,0.5691972486455258,1.0,8/14,24.27%,RAMP3;ECE1;SNCA;OPTN;INPP5F;SCRIB;AP1AR;ANXA2
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8140505360847721,1.2350685982225302,0.1724137931034483,0.5700047655617889,1.0,5/6,17.72%,DPYSL2;DPYSL5;CRMP1;DPYSL4;DPYD
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6341388323662867,-1.234952445046374,0.3076923076923077,0.9578529604056637,1.0,3/13,16.71%,LSM2;PRPF8;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),0.7958200344203352,1.234793554511785,0.23809523809523808,0.5705730398835661,1.0,4/5,19.32%,FLT1;PPARG;CCL2;COL4A3
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.7612674316618826,-1.2347657396199505,0.30612244897959184,0.9559555988829522,1.0,2/5,7.84%,BCL10;FAM3A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6295224655858378,-1.2346688166549966,0.1794871794871795,0.9538242145707446,1.0,5/15,7.23%,SELENOS;CD200R1;TNFAIP3;FOXJ1;PTPN22
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.666523748034573,1.2342637985945084,0.18461538461538463,0.5718171000437873,1.0,11/26,23.50%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;CDK2;TINF2;TELO2;WRAP53;ACD;PIF1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7490412329671353,1.2338678201825835,0.22916666666666666,0.5726936808165695,1.0,3/8,12.57%,HECW2;PRKCE;HECW1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.5839669707572861,1.2337166138669458,0.17391304347826086,0.5727654273668908,1.0,11/54,16.39%,MET;RIT2;ARHGEF3;EPS8L2;SYNPO2L;ITGA3;KCTD13;STARD13;OPHN1;LPAR1;STMN1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6599783666314575,1.233586373524584,0.21739130434782608,0.5725907484020079,1.0,6/21,12.38%,RIMS2;EPHA5;AHR;GLP1R;ADCY2;CAP2
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.8174676457282208,1.2333008984871507,0.17543859649122806,0.5731273451994455,1.0,2/6,8.07%,MGAT3;LDLR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.6167497681588867,-1.2327507798778776,0.25,0.9589216953395335,1.0,12/23,27.30%,SUPT16H;LDB1;ERCC6;CCNT1;HMGN1;HTATSF1;TSFM;WDR43;THOC1;EAF1;CCAR2;CCNK
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.7636250397583544,1.232486835682725,0.2571428571428571,0.575430053009005,1.0,3/11,14.09%,IRAK2;MYD88;TNIP2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6403323107494667,-1.2321638676538622,0.2558139534883721,0.9583439207079424,1.0,4/16,9.51%,BUD23;RIOK2;METTL18;RIOK1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5733082366325049,-1.2321424794909503,0.16129032258064516,0.9557161856500762,1.0,6/20,9.31%,GDF9;FSHR;MCM9;M1AP;DMC1;METTL3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5370615606812923,1.2317887200005513,0.08571428571428572,0.5773468567665352,1.0,20/120,13.45%,LEF1;GPNMB;ANXA1;THBS1;ZFP36;PTPRC;SFTPD;APOD;NLRP12;ADCY7;NLRC5;NPTN;IKBKE;NLRC3;GAS6;HDAC9;MAPKBP1;CD200;HLA-DRB1;FN1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.7832253444170896,1.231785126748921,0.18032786885245902,0.5768962792753591,1.0,3/9,16.24%,PLSCR1;CD200;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.709166458851493,1.2317095178077617,0.25757575757575757,0.5765554547588656,1.0,2/13,3.94%,PIM3;BMP8A
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7601587376742464,1.2315551954512494,0.2727272727272727,0.5765601784993772,1.0,3/10,7.63%,CHRM1;GAP43;PARD3
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7802189755088083,1.2313885201219394,0.14893617021276595,0.5767191171135663,1.0,2/6,10.87%,CHRM3;LY6H
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.633420231040691,1.2310698363757402,0.16923076923076924,0.577367297494932,1.0,6/29,10.41%,SLIT2;WAS;DMTN;EPHA2;CLRN1;FSCN1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.7798251070100684,1.2308080043509944,0.19672131147540983,0.5778695295762548,1.0,1/12,1.07%,SOCS3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7253204544692181,1.230778700900835,0.1724137931034483,0.577493082841761,1.0,5/13,10.76%,PDGFRA;PLEK;TEC;PDGFA;SYK
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6755726542215398,1.2301343630290484,0.20689655172413793,0.5792333347693758,1.0,5/13,29.14%,SMCR8;PHF23;RUBCN;CALCOCO2;UVRAG
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.7973273589879111,1.2300822119554968,0.1875,0.5789015848129858,1.0,4/7,19.39%,PLEKHM1;SYK;SPP1;PRKCA
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.8084921646499785,-1.2298743746159733,0.2926829268292683,0.9633404846731579,1.0,2/5,15.89%,TMEM126A;ERBB3
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.7818584370828693,-1.2298516936759054,0.3125,0.9606695798595206,1.0,3/5,14.67%,SELENON;RYR1;MYORG
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.6863118606852671,-1.2297882956096524,0.2558139534883721,0.9583202740002766,1.0,1/9,8.90%,GAS1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.607520630700518,1.2297463913849702,0.1935483870967742,0.5793739293060147,1.0,13/37,18.66%,SLIT2;PTPRC;SLIT3;PADI2;CCDC3;SAMHD1;NLRC5;TTLL12;GAS6;PPARG;TRAIP;RFFL;GPS2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.6067580542251763,1.229701917274202,0.22727272727272727,0.5790696576189174,1.0,11/53,16.22%,ECM2;NPNT;EPB41L4B;RHOD;TGFB2;SYK;P2RY12;EPHA4;STX4;IL12A;RNASE10
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.714142219415883,1.2295952644933161,0.2153846153846154,0.5789371440790293,1.0,4/13,7.20%,DMTN;PTPRC;GRM5;RYR2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6375287832290748,1.2293386909072936,0.1780821917808219,0.5793272753674917,1.0,4/23,5.34%,EGF;RELN;TGFA;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.8294540243252645,1.2293370947443585,0.14,0.5788887535237813,1.0,1/5,5.27%,OSMR
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.8499163559491469,1.2292724352724955,0.2127659574468085,0.5785858222008814,1.0,1/5,0.95%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7460383961318903,1.2290517054570878,0.18518518518518517,0.5788225427533658,1.0,1/10,3.77%,DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.6790735774339162,1.2287257129509248,0.22535211267605634,0.5794270378347204,1.0,7/21,16.44%,SLIT2;TMSB10;SSH2;CYRIB;PRKCD;PFN2;PFN4
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.801475215149537,1.2284125533330064,0.23728813559322035,0.5800036667937568,1.0,4/6,19.39%,PRKCH;PRKCD;CCL2;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),0.8249504972022168,1.2282580894028061,0.18518518518518517,0.5800056246065737,1.0,2/5,8.57%,APLNR;PPP1R16B
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7472743801439566,1.228244787430919,0.23809523809523808,0.5795955085396253,1.0,1/11,0.80%,SCN9A
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5191985248799363,1.2282338121090886,0.1527777777777778,0.5791591821659257,1.0,31/105,16.52%,FLRT3;HTR2C;SLC4A10;ADCY5;SHC2;CEP170B;DAB2IP;EFNB3;ATP9A;ARHGEF17;EPB41L4B;PTPN21;ADGRL2;ATP1B1;ARHGEF10L;CHMP1A;CMTM4;TEAD1;EPB41L1;PRICKLE2;PARD3B;SLC29A4;SLC13A4;BCAR1;SMARCA1;COBL;NOTCH3;SLC44A3;PDZRN3;TOX3;DIP2C
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.5191067959704463,1.228062454467045,0.09210526315789473,0.579233348932529,1.0,33/138,17.11%,CCK;SIX3;MET;IL1RAPL1;HES7;RELN;WNT8B;ANOS1;LHX6;NEUROD2;MYT1L;MAP1B;CTNNB1;CDK6;PTPRD;YAP1;DNER;DCX;TGFB2;CDKL5;FGF13;MAPT;ASTN2;NR4A2;OPHN1;RNF112;SMARCA1;TAFA1;POMGNT2;KIAA0319;FZD7;OLIG2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.7887328278876587,1.227736706965949,0.25862068965517243,0.5798257475314761,1.0,1/5,2.58%,ZFP36
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.5605807349698821,1.227683067296674,0.13924050632911392,0.5795331453061116,1.0,13/64,17.97%,SIX3;ANXA1;PROX1;BASP1;CNN3;OVOL3;ZDHHC7;PGK1;PPARG;FSTL1;FZD7;TAGLN2;MESP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.6886380583104033,1.2275384559344027,0.17391304347826086,0.5796157691542847,1.0,6/19,11.97%,PKP2;NOS1AP;TRPM4;RYR2;CACNA1C;FGF13
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.6150859439588987,1.2274194747127476,0.15,0.5796625995917676,1.0,6/28,11.93%,PTPRO;DMTN;WASF1;RHOD;ARHGEF7;P2RY12
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.6721579473179169,1.2272558147460677,0.16176470588235295,0.5797271752670227,1.0,8/21,19.92%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.6802219839880062,-1.2272353354663041,0.24,0.9672914641829432,1.0,2/10,9.10%,MAL;GOPC
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.4977470884344049,1.2271962866076784,0.1095890410958904,0.5794711709314195,1.0,31/129,11.54%,ECM2;C3;TLR2;DCN;PDGFRA;ABCA8;ACTA2;ASPN;PODN;IL1R1;ANGPTL2;POSTN;OLFML1;IGFBP7;TNS1;CFH;FAP;SERPINF1;STEAP4;ZBTB16;C1R;MAOB;CYP1B1;MYO1C;BGN;ADGRF5;SRPX2;TRIP10;ADAM12;PXDC1;THBS2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6511679031314814,1.2267963017739334,0.25,0.58029189313667,1.0,8/23,13.08%,NLGN1;SYT1;SNCB;SYT5;SNCA;SYNJ2;PACSIN1;OPHN1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5976288716461112,1.2267606049917699,0.14754098360655737,0.5799025225544207,1.0,10/41,16.84%,BOK;EPHA2;HIC1;PML;BCL2L1;IKBKE;HIPK1;BCL2;HIPK2;TP53
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.7280418850440707,1.2267341067467203,0.19298245614035087,0.5795137575251763,1.0,7/10,25.09%,FYN;ITGA3;PICK1;MTMR2;IGF1R;SUPV3L1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.7314073124217795,-1.2266911476697817,0.21621621621621623,0.9670263848480013,1.0,4/8,14.78%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7531785096448538,1.2266208704139647,0.24528301886792453,0.5784928539238222,1.0,6/8,22.43%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7531785096448538,1.2266208704139647,0.24528301886792453,0.5784928539238222,1.0,6/8,22.43%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7531785096448538,1.2266208704139647,0.24528301886792453,0.5784928539238222,1.0,6/8,22.43%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7597156945810373,1.226490164998724,0.1864406779661017,0.5785048125240146,1.0,2/13,3.77%,SHTN1;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.8169589331342355,1.226353768926827,0.2653061224489796,0.57849021147994,1.0,2/6,18.00%,HOOK1;HOOK2
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7322712869193568,-1.226346110394794,0.2641509433962264,0.9657209075195308,1.0,3/9,9.99%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.728809701349937,1.2258930850350418,0.21153846153846154,0.579633698168348,1.0,1/7,8.19%,STK25
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6443926190048872,1.225887381581028,0.21428571428571427,0.5791942456004293,1.0,4/17,14.38%,PIM1;TBX20;ZFPM2;FGF2
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.7372104579312423,1.225850534299897,0.2807017543859649,0.5788613905899521,1.0,3/7,12.65%,SAMHD1;POLQ;PMS2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7192361889325356,1.2257826533120062,0.2833333333333333,0.5785731482043925,1.0,4/10,20.37%,TEC;AATK;BMX;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6999323251946187,1.2255746564105252,0.20634920634920634,0.578840563796678,1.0,1/13,2.58%,ZFP36
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.49430626533378086,-1.2254000966877558,0.10526315789473684,0.966890294574888,1.0,19/70,22.60%,SELENOS;SEL1L2;TMUB2;FBXO27;UBXN8;FOXRED2;DERL2;AUP1;USP19;RNF103-CHMP3;ERLIN2;RNF5;ERLIN1;UBE4A;DNAJB9;RHBDD2;TMUB1;DNAJC10;YOD1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.48332003775530535,1.2252736789748153,0.06578947368421052,0.57936294428985,1.0,24/222,11.84%,LEF1;TGFBR2;EGF;IL15;NLGN1;SERPINE1;ACHE;TRPM4;PPARGC1B;OXTR;PLAAT4;PLAC8;GHR;ZBTB16;SCX;HADH;CTNNB1;TLE6;SMAD3;PRKCH;TGFB2;SYK;IL4R;GAS6
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7306965157025104,1.2251707462123944,0.234375,0.5792509682605664,1.0,3/11,11.03%,ANK3;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6686693915254961,-1.225109882510894,0.1951219512195122,0.9657004141609002,1.0,1/8,1.45%,HEY2
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.675570680812859,1.2249992958860465,0.2631578947368421,0.579279845501221,1.0,5/15,10.87%,CHRM3;CHRM1;AGRN;GRK2;LY6H
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6026968482297445,1.224770654729401,0.15873015873015872,0.5796161809882217,1.0,9/37,6.40%,HLA-DRA;MGAT3;APP;SHROOM4;GRM5;TUSC3;PTCHD1;MFSD2A;FAM107A
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6675663255002395,1.224730656951089,0.23333333333333334,0.5793462458429495,1.0,2/14,1.48%,IGF1;EGF
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.6878766100672435,-1.224500889444404,0.2647058823529412,0.9658301629847303,1.0,1/9,1.82%,SELENOS
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.7632693464609815,1.2244537941428244,0.2558139534883721,0.5797872812246336,1.0,3/6,17.05%,PRKCD;RNF112;XRCC1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7202357692458027,1.2238719883942533,0.18181818181818182,0.5812532104571416,1.0,8/13,17.11%,CD55;ICAM1;CFH;TGFB2;NOXA1;CD59;FZD7;WNT5A
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.6144530685907859,-1.2238117139021374,0.25,0.966302627874693,1.0,7/20,24.61%,TRMT10C;FASTKD2;MTG2;TSFM;ALKBH1;MALSU1;RPUSD4
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.7253112537142414,-1.2237426383845575,0.1935483870967742,0.963946969491008,1.0,4/9,20.26%,PPP1R3C;PPP1R3G;PPP1R3E;RUBCNL
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.8089270933591376,-1.2234906036670612,0.28888888888888886,0.9624581744233611,1.0,2/5,14.10%,COX18;COA6
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6373400110294998,1.2234758307097002,0.288135593220339,0.5819899075807767,1.0,3/27,3.17%,ANXA1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.7357034130666793,1.2232967155909855,0.22807017543859648,0.582139083049116,1.0,1/11,4.57%,ATP9A
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.6977854695412301,1.2228741613182585,0.22950819672131148,0.5830751185140209,1.0,2/10,15.57%,EIF2B2;EIF2B5
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6192171278369991,1.222760314885477,0.1791044776119403,0.5830309832137617,1.0,5/35,11.22%,EPHA7;ADA;PTPRR;MINK1;PODXL
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.6851837534445032,1.2227084301382496,0.2222222222222222,0.5827686140254016,1.0,4/10,26.84%,HR;KDM3A;PHF8;KDM4C
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6067420831173532,1.2225798338359335,0.18309859154929578,0.5828643864567546,1.0,12/34,24.05%,SLC39A14;FOXO1;SOX4;HK2;GAS6;HK1;PDK3;IGF1R;HIF1A;ADCY8;KCNB1;FOXK1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5793294426315458,1.222575583505652,0.16666666666666666,0.5824543267048012,1.0,4/56,5.28%,TGFBR2;ADAMTSL2;ASPN;PMEPA1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.4488353658008666,-1.2219648532064191,0.15789473684210525,0.9661929977094906,1.0,28/134,14.64%,ERCC8;RFC3;AAAS;BRF2;POLD3;GTF2H5;POLR2K;BCAM;RAE1;CETN2;MPC2;BCAP31;ZNF707;ELOA;MRPL40;APRT;TAF13;POLR2C;GTF2A2;ERCC2;NUDT9;SNAPC5;TMED2;NT5C;PRIM1;CLP1;GTF2F1;EIF1B
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.7633921325439943,1.2218463344581196,0.2765957446808511,0.5842664711642259,1.0,1/6,1.56%,NPNT
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.7440418724319854,1.2218037625716562,0.2545454545454545,0.5839691384677905,1.0,1/6,4.92%,ASIC3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.632403034264609,1.2217265009510891,0.19672131147540983,0.5837940419139942,1.0,8/28,9.87%,PTPRO;DUSP1;PTPRB;DUSP10;DUSP8;DUSP16;DUSP22;PTPN9
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.8006984321180467,-1.2216393829268826,0.23255813953488372,0.9648972727867215,1.0,1/5,4.42%,ORMDL1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.8458439114531323,1.221234953831723,0.13559322033898305,0.584862193971751,1.0,2/5,12.01%,NLGN1;LRRC4
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.8055557831788157,1.2209693074024552,0.2,0.5851470199378217,1.0,4/6,18.74%,RTN4RL1;EPHA4;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6319621951552195,-1.2208715267934442,0.25,0.9658315783006549,1.0,5/16,8.40%,SLC25A5;THEM4;MUL1;SLC25A4;BAK1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6639549563325637,1.2208200257979596,0.2222222222222222,0.5850582172188933,1.0,11/27,23.50%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;CDK2;TINF2;TELO2;WRAP53;ACD;PIF1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5408750517164986,1.2208175212787087,0.15625,0.5846139816705114,1.0,7/49,14.63%,MET;LZTS1;SMCR8;SNCA;STAT3;WASHC1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4565089337800699,1.2207585595665962,0.047058823529411764,0.5843870652930956,1.0,54/429,13.34%,LEF1;CDKN2A;SIX3;PROX1;MAEL;ZNF93;TYMS;IGF2BP2;TCEAL7;DAB2IP;SAMD4A;PRAME;FOXO1;CIC;SUV39H1;TSPYL2;ZNF282;NFIL3;AHR;EIF4A3;NKX6-2;GZF1;BCL6;MSX2;KLF10;CIITA;ENC1;NRG1;BAP1;GMNC;TBX20;ZBTB16;GLIS2;PML;HMBOX1;ZFPM2;CTNNB1;CTBP2;BASP1;SHMT1;CHMP1A;CDKN1C;HDAC4;PEX14;GAS6;DBI;HDAC9;PRICKLE1;CDKN1A;MLXIPL;PPARG;L3MBTL3;RUNX1T1;CDKN1B
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.7958889470985178,1.2205293303918172,0.23529411764705882,0.5846887061799498,1.0,1/6,1.05%,HTR2C
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5933250512214175,1.2204949752157908,0.18840579710144928,0.5843495922617783,1.0,5/36,10.24%,KLF2;LTBP4;APP;LDLR;CNDP1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5321255021881979,-1.2204360753491634,0.15,0.9651984219627879,1.0,7/25,6.40%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.6633441977029104,1.220384937891456,0.16923076923076924,0.5843395444193947,1.0,4/25,10.19%,KIF14;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6274960381669006,1.2203822979176724,0.16666666666666666,0.583897532661135,1.0,9/43,11.93%,HTR2C;P2RY6;HRH1;CHRM1;GRM5;CCKBR;GNA14;HOMER1;P2RY12
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.44520156570744934,-1.2199556604399813,0.17647058823529413,0.9644213283007764,1.0,33/162,18.67%,RP9;PDCD7;SF3B4;LSM3;DHX16;SCNM1;SF3A1;ZCRB1;RBM8A;U2AF1;PRPF18;M1AP;FASTKD2;RRAGC;TFIP11;RNASEL;LSM5;METTL3;KIN;YJU2;SNRNP25;LSM4;CLP1;PRPF8;NUFIP1;RBM39;SRSF2;PRPF3;RNPC3;LSM1;SRSF9;NOL9;TARDBP
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5529750704086321,-1.2199524929456669,0.30434782608695654,0.9618006181695243,1.0,8/37,20.90%,AAAS;RAE1;NUP50;NUP54;NOL6;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.6428685378288533,1.2197388505447333,0.1896551724137931,0.5854331580162866,1.0,4/18,16.84%,MLLT11;BBC3;PINK1;TP53
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.5067680654756417,-1.2197335071424764,0.15789473684210525,0.9602411761271897,1.0,11/40,16.41%,AKR1C3;ALDH1A1;HSPG2;APOE;APOM;SDC3;CYP4V2;ADH4;RDH10;RDH11;NAPEPLD
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.8039012950309666,1.219683712741932,0.21052631578947367,0.5851290124630956,1.0,2/7,4.18%,SH3GL2;TJP3
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5682148088388913,-1.2192251588232037,0.18604651162790697,0.9599641287325126,1.0,6/21,16.07%,ISCU;CIAO3;NFU1;CIAO2B;ISCA2;NFS1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5704941121190097,1.2190054345032078,0.16666666666666666,0.5867475906846489,1.0,12/59,14.43%,ZYX;MYH9;EPB41L4B;MYLK3;EPB41L4A;SYNPO2L;OBSCN;TCAP;SORBS1;EPB41L1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.5879322391967962,1.2189250310801023,0.1791044776119403,0.586606569481064,1.0,6/31,16.84%,IGF1;MLLT11;BCL2L1;BBC3;PINK1;TP53
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.5392747893477972,-1.2188915403494605,0.25,0.9589179246839915,1.0,5/27,7.91%,MID1IP1;ABCD2;APOE;ABCD1;LCN12
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6667454487592075,1.2188149811953235,0.19672131147540983,0.5865432240823416,1.0,8/24,17.41%,APP;POSTN;PDGFA;VCAN;SPP1;SLCO2A1;FSTL1;VAV2
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5887049696723234,-1.2187265668195935,0.175,0.9570256772869961,1.0,3/24,5.63%,TNFAIP3;TRIM21;MUL1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.6545493620851774,-1.2187156460091602,0.21212121212121213,0.9544806415036287,1.0,3/13,10.35%,CBFA2T3;ABCD1;SLC25A33
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.7147839047939694,1.2187109040671786,0.30357142857142855,0.5864283707948396,1.0,1/12,1.50%,SGPP2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5576106636100793,1.2185945418166049,0.1746031746031746,0.5863222844256403,1.0,15/43,15.57%,MYRF;MBP;CNTNAP1;PLP1;SCN2A;BCAS1;PLLP;EIF2B2;PARD3;KLK6;TPPP;B4GALT5;SOX10;SLC8A3;EIF2B5
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7637730449188084,1.2182307014776692,0.23214285714285715,0.5872640466055934,1.0,1/7,7.40%,TBX20
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.8389355372941348,1.2179538170377016,0.09090909090909091,0.5873254880246846,1.0,2/5,9.58%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.8389355372941348,1.2179538170377016,0.09090909090909091,0.5873254880246846,1.0,2/5,9.58%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5911509503948026,1.217755854260568,0.18840579710144928,0.5875018004906536,1.0,14/39,19.67%,ATP2B3;ITPR3;ABCC9;RYR2;ATP1A1;TMEM65;ATP1B1;ATP1B3;FXYD7;SLC8A3;SLC8A2;SLC8A1;ATP2B4;ITPR1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.7181817256867064,1.2172770295018873,0.27692307692307694,0.5887223961445555,1.0,2/11,2.21%,THBS1;SERPINE1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.7349007568291639,1.2172237716438308,0.23529411764705882,0.5884781809718161,1.0,2/6,4.45%,SLC15A3;ERBIN
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5424889002254601,1.2172148567837076,0.11764705882352941,0.5880633504348225,1.0,17/61,10.51%,COL4A1;COL4A2;ACTA2;FBLIM1;EPHA2;MYH11;OSMR;POSTN;COL12A1;RHBDF1;RHOD;EMP1;MYO1C;ITGA3;SRPX2;MMP14;YAP1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4748003607060138,1.2167042370033305,0.06329113924050633,0.5894772683053523,1.0,45/309,10.99%,NR4A3;HPN;MET;FLRT3;IGF1;PDGFRA;EPHA7;GRIN2B;COL4A2;PTK6;ELMO1;SULF1;SLA;SHC2;EPHA2;SLC39A14;IRS2;EPHA5;FLT1;EFNB3;FOXO1;EFNA1;PAK3;NRP2;GFRA2;NEDD9;BAIAP2;ANOS1;FYN;DNM1;FLRT1;NRG1;NTRK3;GRIN1;GHR;ARPC3;PDGFA;MVP;KALRN;ARHGEF7;NAMPT;SYK;GFRAL;STAT3;SIPA1L1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6715837928831287,1.2165727065880405,0.2222222222222222,0.5894464432444172,1.0,2/14,5.97%,HPN;ZIC1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7433826092350002,1.2163296547290663,0.30357142857142855,0.5893337899757326,1.0,4/7,17.38%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7433826092350002,1.2163296547290663,0.30357142857142855,0.5893337899757326,1.0,4/7,17.38%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.6921399882897048,-1.216268559543638,0.27906976744186046,0.962073257635068,1.0,5/8,28.94%,GBA2;FUCA2;GBA3;FUCA1;GUSB
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.6654944529580004,1.216251074725204,0.19230769230769232,0.5891498317695493,1.0,3/22,8.57%,MET;ICAM1;PPP1R16B
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.7505820586778996,1.2162219346910774,0.3018867924528302,0.5887959312082416,1.0,3/8,15.65%,SLCO1A2;SLCO3A1;SLCO2A1
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.7495104533351009,-1.2161680220074822,0.35135135135135137,0.9598786407924073,1.0,1/5,3.87%,SDSL
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.7867855885063025,1.2160122149302477,0.22807017543859648,0.5890293673727235,1.0,1/7,12.04%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8185124568645232,1.2158307470496355,0.23529411764705882,0.5892454598407562,1.0,4/5,17.75%,THBS1;CGAS;PDE10A;PDE2A
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6052224833129783,1.2155314043926484,0.26153846153846155,0.5896820188806474,1.0,4/29,10.74%,KREMEN2;NOTUM;ZBTB16;TGFB2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7165556598357928,1.2152991861569393,0.32727272727272727,0.5899227619780295,1.0,3/8,11.80%,SOAT1;MFSD2A;DGAT1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.5587770993581885,1.2147732982169346,0.22666666666666666,0.591155217972362,1.0,15/54,11.93%,CXCL2;C3;TYMP;SIGLEC1;SFTPD;IL1R1;SOAT1;STEAP4;NRN1;GRK2;CAPN8;ADGRF5;RNASE1;DUOXA1;CLDN18
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.7071565818601994,-1.2144269339194627,0.27906976744186046,0.964107737306303,1.0,2/8,12.20%,CHAMP1;KIF20B
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7731983369933,-1.2143844344431578,0.2631578947368421,0.9615914161468219,1.0,1/6,2.55%,RNF6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.7149929560627384,1.2142211679443586,0.2631578947368421,0.592606141928191,1.0,2/13,4.23%,YBX3;RBM24
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7226649278597714,-1.2140544047942428,0.2,0.9605193959097911,1.0,2/7,5.24%,TNFAIP3;GREM1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7010670664643603,1.2140182313169519,0.26666666666666666,0.5926155821313737,1.0,2/13,3.39%,TRPC3;SLC39A14
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7622959143366456,1.2139622812379085,0.2777777777777778,0.5923881174010812,1.0,1/8,0.72%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.6351745774729146,1.2138708462516232,0.21311475409836064,0.5923047095937357,1.0,7/26,16.95%,BOK;YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.6285342271642191,1.213651743550369,0.25,0.5925424444445961,1.0,2/26,4.00%,ANK3;AMN
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.8057927088020577,1.213459400984758,0.29411764705882354,0.5927376197175193,1.0,1/5,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6048379443887981,1.2133249854195485,0.208955223880597,0.5929072005044053,1.0,7/29,15.00%,SEMA3C;SEMA5B;SEMA3D;SEMA3B;RADIL;FN1;SOX10
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.7735595069637436,1.213142857503944,0.2903225806451613,0.5930681018157024,1.0,3/6,20.88%,GNG2;TNFSF4;TGFBR3
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6214236329138619,1.2131125201337989,0.20588235294117646,0.5927402343822417,1.0,11/27,24.19%,THY1;RHOD;ARHGEF7;ACTN1;SORBS1;FN1;LAMA3;PLEC;BCR;ITGB4;DST
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.8011274086841939,1.2130382308009566,0.2,0.592589601893295,1.0,4/5,17.46%,FSCN1;SPIRE1;FMN2;SPIRE2
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.7837759877767765,1.2130165919217935,0.27419354838709675,0.5922289274814776,1.0,2/6,15.67%,PADI2;SPTY2D1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6418095869205042,1.2129487248507649,0.2318840579710145,0.5919948492922984,1.0,3/26,8.05%,ST6GAL1;TUSC3;MGAT5
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.7582072622461486,1.2127725183002052,0.22950819672131148,0.5921222371721673,1.0,3/5,21.32%,LIMK2;IKBKG;RAB11A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.49255494323443233,-1.2125049266561394,0.1875,0.964631771143943,1.0,27/66,26.32%,FIP1L1;GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;CPSF1;ERCC2;CLP1;LSM10;TTF1;POLR1B;CPSF3;MTERF1;ERCC3;POLR3K;MTERF2;POLR2L;SSU72;CSTF2T;POLR2E;UBTF;GTF2H3;CSTF2;CPSF7;SLBP;SNRPB
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.8485040835521305,1.212448893844116,0.1956521739130435,0.5927109984950638,1.0,1/5,6.89%,NRG1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6778260553723896,-1.2124393350565612,0.23809523809523808,0.9623779575916522,1.0,4/12,19.72%,CLU;USP19;EIF2AK3;NR1H2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7335468770903207,1.2124315873259255,0.3225806451612903,0.5923261366511591,1.0,1/10,0.37%,HPN
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.4547003942285356,1.2123312443253633,0.07228915662650602,0.592176471068056,1.0,62/523,10.90%,LEF1;TGFBR2;CDKN2A;NR4A3;SIX3;ST18;GPNMB;IL13RA1;BOK;IGF1;KIF14;PROX1;PDGFRA;EGF;TESC;CHRM1;THBS1;IL15;STAT4;IRS2;APP;DAB2IP;FLT1;PODN;PRAME;TGFA;KLF11;TRPM4;FABP3;SOX4;BTG3;OSMR;NUAK1;BCL6;CLMN;KLF10;IGFBP7;NRG1;NTRK3;BAP1;CCKBR;SCX;PML;CYP1B1;PDGFA;KITLG;DUSP22;ZBTB7C;CAPN1;CTNNB1;CTBP2;GAB2;CDK6;LMNA;NEURL1;NAMPT;YAP1;DLG5;P3H2;HDAC4;TGFB2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.655341952128291,1.2122023509042819,0.21311475409836064,0.5922447373436422,1.0,9/18,24.13%,THBS1;P2RY12;CFAP20;STX4;TRIM32;CAVIN1;PPM1F;CCDC25;RARRES2
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.5585268302895996,-1.2120616957056916,0.1935483870967742,0.961434004283262,1.0,6/21,6.40%,CD247;CD96;PYHIN1;CD6;IL5;P2RY10
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7108192593308087,1.2120212205593583,0.22950819672131148,0.5924300474707606,1.0,8/13,22.57%,TRPM4;SLC9A9;SLC9A1;SLC9C2;SLC8A1;SLC9A5;SLC9A2;SLC9A6
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6252796135424575,1.2119630299431712,0.20833333333333334,0.5922137441593515,1.0,8/31,18.61%,CLDN16;LSR;PARD3;POF1B;CLDN18;CLDN20;PATJ;MICALL2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.5327407622088375,1.2119018272194022,0.12345679012345678,0.5919559814239304,1.0,5/83,8.14%,ST18;IRAK2;NOD1;IL1R1;MYD88
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7367791978360357,1.2118616109348634,0.18333333333333332,0.5916401520441559,1.0,5/10,17.72%,DPYSL2;DPYSL5;CRMP1;DPYSL4;DPYD
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5254523513422037,1.2118067388582134,0.16176470588235295,0.5913748418943715,1.0,23/98,17.31%,HTR2C;SLC24A2;CDH23;VAPB;TRPC3;ATP2B3;GCM2;RYR2;HCRTR2;MCUB;PML;NPTN;ATP1B1;TPCN2;BCL2;STOML2;SLC8A3;SLC8A2;ATP13A1;CALB2;YWHAE;SLC8A1;SLC24A1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.49320852960662415,-1.211777592788906,0.16666666666666666,0.9575634815851373,1.0,12/50,21.00%,AAAS;POLR2K;RAE1;NUP50;POLR2C;NUP54;POLR2D;NUP85;NUP42;POLR2L;POM121C;POLR2G
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.49320852960662415,-1.211777592788906,0.16666666666666666,0.9575634815851373,1.0,12/50,21.00%,AAAS;POLR2K;RAE1;NUP50;POLR2C;NUP54;POLR2D;NUP85;NUP42;POLR2L;POM121C;POLR2G
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5782258783626537,1.211749703342974,0.2,0.5911099190586743,1.0,18/60,17.58%,HTR2C;SLC24A2;VAPB;ATP2B3;GCM2;GRIN1;RYR2;SNCA;NPTN;ATP1B1;TPCN2;STOML2;SLC8A3;SLC8A2;ATP13A1;SLC8A1;SLC24A1;FAM20A
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.8312800985082407,1.2116776219130325,0.19298245614035087,0.590862044291081,1.0,1/5,6.66%,PLEKHM1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.6486592919201981,-1.2116413348682773,0.23809523809523808,0.9555527848158611,1.0,4/15,4.37%,DCLRE1B;RFC3;GINS3;POLD3
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6051279678304373,1.2111877442082828,0.2459016393442623,0.5918549154412026,1.0,10/25,17.01%,THY1;EFNB3;TRIM46;MAG;DCC;MCF2;FGF13;DIP2B;KIAA0319;PTPRS
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5859528021706083,1.211116354189841,0.17647058823529413,0.5915985404735387,1.0,4/35,9.88%,ZFP36;ZC3H12D;RBM24;YTHDF1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.8133930875002139,1.211069651687701,0.1836734693877551,0.5913342260750786,1.0,1/6,0.23%,SLC6A15
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.6726413473812367,1.2110479818391764,0.22388059701492538,0.5910038436082555,1.0,9/19,25.54%,APP;WDR54;ABCA2;ARF6;MTMR2;ANKRD13A;RIN3;PSEN1;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5143286299510685,1.211020619152523,0.12121212121212122,0.5906656408195461,1.0,17/107,9.35%,SLITRK1;SCN1B;IL1RAPL1;STMN2;PTK6;RIT2;PLPPR5;SLIT2;RELN;DAB2IP;GRIP1;DVL1;NTRK3;ROBO2;NPTN;ZNF804A;PTPRD
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.7451610663428678,-1.210991887181231,0.3269230769230769,0.9559811226817663,1.0,1/5,9.76%,MTRES1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.705134676772709,1.2108994426483706,0.25925925925925924,0.5906762982888285,1.0,2/9,3.77%,DCN;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5311711744808156,1.2107186191774042,0.1267605633802817,0.590910729297296,1.0,20/75,16.68%,RASGRP1;APP;DAB2IP;RELL1;STK25;MAP3K11;DUSP22;MAPK8IP1;UNC5CL;SH3RF3;TNFRSF19;TGFB2;MINK1;GADD45A;TPD52L1;ANKRD6;HIPK2;MAP3K5;MFHAS1;FZD7
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.6271880781432861,1.2106843224039345,0.2222222222222222,0.5905567648457716,1.0,3/28,9.97%,KLF2;GLRA2;NEURL1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.7344138753396355,1.2106251105972132,0.25757575757575757,0.5903191839585917,1.0,1/11,1.30%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.658587765555579,-1.210507506365514,0.27450980392156865,0.9529175743179079,1.0,3/8,13.40%,RFC3;DSCC1;POLG2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.658587765555579,-1.210507506365514,0.27450980392156865,0.9529175743179079,1.0,3/8,13.40%,RFC3;DSCC1;POLG2
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.6527197291471128,1.2104435288537208,0.2982456140350877,0.5905285528655071,1.0,2/15,10.85%,EGF;GLI2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.566820304812212,1.2099619684266063,0.21875,0.5916632418746841,1.0,4/45,4.43%,RECQL4;ANXA1;BLM;RPA1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6183056970805838,-1.2099448320425659,0.12,0.952552760104591,1.0,3/15,13.69%,SELENOS;DERL2;AUP1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.7551885307808,1.2099064219966489,0.3018867924528302,0.5914336348078094,1.0,3/6,11.62%,CLDN16;SLC4A11;LETM2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.7752521509943778,1.20985903024283,0.21875,0.5911548442489095,1.0,1/8,0.64%,ANK3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4716926491126457,1.2098325664486673,0.05063291139240506,0.590802236961109,1.0,32/345,10.63%,LEF1;HPN;ANXA1;IGF1;KIF14;PLK2;THBS1;PIM3;PRKCG;RPS6KA1;PIM1;PRAME;NUAK2;FOXO1;AGAP2;CD44;ALOX12;FAS;BIRC3;NAA38;MAG;THOC6;SNCA;SCX;MYD88;BAG3;CTNNB1;BCL2L1;DHCR24;YAP1;PRKCH;HIPK3
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6430978021676099,-1.2097460979489505,0.30612244897959184,0.9509780808344052,1.0,3/12,10.18%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5165218749949659,1.2093555829976164,0.2028985507246377,0.5918263254636662,1.0,26/100,15.63%,ENPP2;SPOCK3;KIF14;EGF;SRCIN1;WAS;MGAT3;TMSB10;DOCK10;NRG1;LDB2;ARHGAP18;NRG2;CDK6;NEXN;LMNA;MINK1;CYRIB;CFAP20;PLXNA4;TRIM32;FGF2;PLXNA1;ROBO4;PLXNA2;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.8133164933941853,1.2093250960523265,0.23809523809523808,0.5915231506924176,1.0,1/5,1.03%,IGF1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6838254479108912,1.209157625540547,0.2786885245901639,0.5916812236943048,1.0,2/11,4.68%,NLGN1;BAIAP3
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.6181091996600541,-1.2089552578783291,0.21951219512195122,0.951749489536716,1.0,8/20,25.28%,PPP1R35;ZCCHC9;BMP2;PPP1R26;PPP6R1;PTPA;GPATCH2;SH3RF2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.8169105812307078,1.2086093827698785,0.19230769230769232,0.5929984898428948,1.0,1/5,11.98%,MAPT
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.726241512148257,1.2083827174608246,0.21311475409836064,0.5933524802427912,1.0,1/8,4.12%,ACHE
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7021662684984665,1.2080235692594423,0.2727272727272727,0.5943053660792158,1.0,8/12,25.91%,HRH1;NFATC2;INPP5A;PLCE1;NFATC3;PPP3CC;PPP3CB;NFATC4
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.7127693824949041,-1.2080028018921083,0.34146341463414637,0.9536829689755032,1.0,3/7,16.20%,ALDH1A1;GNPDA2;NAGK
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.6761920649266763,1.2074980234384864,0.18518518518518517,0.5957738054234303,1.0,1/16,1.03%,IGF1
prerank,PanglaoDB_Augmented_2021__Microglia,0.5504358288512128,1.2073188434580335,0.18840579710144928,0.5959528572938084,1.0,11/59,3.87%,HLA-DRA;P2RY6;CTSS;P2RY13;PLEK;SLA;MYO1F;GPR34;PTPRC;COLEC12;SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.7619137128048046,1.2072184817210876,0.2830188679245283,0.5959022385160333,1.0,2/9,1.84%,KLF2;THBS1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6400419527886145,-1.2072072358264088,0.20408163265306123,0.9545815297316177,1.0,5/12,19.32%,MOCS2;MOCOS;NFS1;NOXRED1;LIAS
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6482242717742215,1.2069571481418542,0.32727272727272727,0.5963675032451196,1.0,1/13,0.18%,NR4A3
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6525647926759864,1.2068003170037944,0.21875,0.596553926658776,1.0,1/20,1.40%,PDGFRA
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.48853727530005825,1.2067277061073372,0.08536585365853659,0.5962822409769442,1.0,17/163,11.01%,THBS1;PLD1;TYMS;IGF2BP2;RPS6KA1;APP;SAMD4A;SOX4;GRM5;EIF4A3;ENC1;LARP6;EIF2B2;FOXO3;YTHDF1;SHMT1;NIBAN1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.7332151168684249,-1.2066756789929018,0.34146341463414637,0.954158135684662,1.0,1/8,1.38%,MID1IP1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.6816582940927783,-1.2064352383743273,0.3,0.952717040174163,1.0,5/13,20.26%,TPRKB;DMC1;RAD54B;RAD51;MSH3
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.6459023550102041,1.2063864052787825,0.265625,0.5970321821567336,1.0,5/25,7.52%,C3;HLA-DRA;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.60509188736693,-1.2063211023395815,0.2,0.9508332955470283,1.0,5/30,5.63%,REEP6;LEPR;SLC30A8;DISP3;MUL1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.7723104653947083,1.206274871486859,0.2807017543859649,0.5970136290547439,1.0,1/5,5.26%,ABCC4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.6501866504659305,1.2062398231953413,0.24193548387096775,0.5966932477925927,1.0,5/24,3.77%,DCN;SP100;THBS1;SLIT2;DAB2IP
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.7376752343607824,1.2060945823715574,0.35384615384615387,0.5967646396205902,1.0,3/7,11.22%,PLD1;FSCN1;PODXL
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.6831859394498587,1.2060869304414772,0.2807017543859649,0.5963634270271008,1.0,2/17,5.18%,SGPP2;PRKG2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7161882699449034,1.2059378796002316,0.25757575757575757,0.5965407824325413,1.0,6/10,18.70%,FHOD1;ACTN1;SPIRE1;COBL;SPIRE2;FHOD3
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5840526722786282,1.2057057136345024,0.2,0.5969863399093646,1.0,11/42,15.57%,GABRB2;GABRG3;GLRA2;GABRD;GABRA1;GABRA5;GABRG2;ANO9;ANO7;SLC12A5;GLRA3
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.7605141068827684,1.2056407020250657,0.2549019607843137,0.5967484102300964,1.0,3/7,8.06%,PKP2;NEFL;GFAP
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.5026335873307889,1.2055955075527367,0.17647058823529413,0.5964783253217817,1.0,34/96,16.40%,MET;A4GALT;NPNT;ICAM1;FBLIM1;EPHA2;CEP170B;DAB2IP;OSMR;COL12A1;PTPN21;RHBDF1;OLFML2A;RHOD;SCARA3;SEMA3B;LAMA5;ITGA3;GRAMD2A;YAP1;COL4A4;PXDC1;TEAD1;EPB41L1;CLDN18;RADIL;PDPN;SMARCA1;SLCO2A1;NOTCH3;SLC44A3;PALLD;LAMA3;P2RX7
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.6935444158028544,-1.205516402091959,0.2916666666666667,0.9515738683982853,1.0,3/10,14.25%,ADCY10;SPAG17;SPEF2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.7131802559046575,1.205422906482231,0.34,0.5965252125214597,1.0,3/10,10.93%,MX1;CLPB;ZDHHC1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.7277517103723014,-1.2051896534280229,0.24242424242424243,0.9502864224204175,1.0,5/7,25.82%,BCAP31;SLC25A23;FIS1;MCU;MICU1
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7515618369795707,1.2050202808545694,0.265625,0.597391333058067,1.0,3/7,13.03%,CLDN16;CLDN18;CLDN20
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.539054483231396,1.2046161392424075,0.13432835820895522,0.5982481180595978,1.0,17/56,16.68%,RASGRP1;APP;DAB2IP;MAP3K11;DUSP22;MAPK8IP1;UNC5CL;SH3RF3;TNFRSF19;MINK1;GADD45A;TPD52L1;ANKRD6;HIPK2;MAP3K5;MFHAS1;FZD7
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.47195333640711845,-1.204349607873226,0.13333333333333333,0.9511799710710507,1.0,19/69,23.09%,ZC3H8;POLR2K;TAF13;POLR2C;GTF2A2;TAF11;SNAPC5;GTF2F1;CCNT1;GTF2F2;POLR2D;NABP2;POLR2L;POLR2G;POU2F2;INTS13;INTS3;RPAP2;POLR2E
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.7825434622480478,-1.20416426834198,0.2391304347826087,0.9497837652153314,1.0,1/5,7.94%,S1PR1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5431338126087794,1.2040627767342655,0.21621621621621623,0.5994196023633456,1.0,12/76,14.45%,HLA-DRA;CTSS;SH3GL2;MARCHF1;AP1S1;KIF5A;ACTR1A;KLC2;HLA-DRB1;KLC1;HLA-DMA;DCTN1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.46005882264895,-1.2038056351212552,0.25925925925925924,0.9488774985195757,1.0,7/79,6.45%,NUP62CL;ABCD2;PXMP2;NXT2;APOE;NUP50;ABCD1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.6707536054268672,1.2036672780960824,0.22413793103448276,0.6001523159566197,1.0,3/15,16.56%,BIRC3;SEC14L1;PUM1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.760100012061041,-1.2034630408258815,0.2727272727272727,0.9476674294595708,1.0,4/7,17.32%,PIH1D2;ZNHIT3;NUFIP1;RUVBL1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7911802053939518,1.2032407346752254,0.23636363636363636,0.601021503024578,1.0,2/7,7.18%,BOK;FAP
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7333682104729308,1.2032229645795265,0.3,0.6006446506990806,1.0,3/11,11.61%,IGF1;SOAT1;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7644843701248354,1.203133415054916,0.27450980392156865,0.600454112974141,1.0,4/5,22.90%,SHANK3;KCNMA1;P2RX7;ANO6
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5296218287953427,-1.2031132750635851,0.13333333333333333,0.9467132694276817,1.0,13/48,19.37%,ABCD2;MCAT;ABCD1;ACOXL;ETFB;GCDH;ETFDH;ECHS1;CPT2;EHHADH;MTLN;DECR1;ACADS
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.546132472959365,1.2031015856606493,0.2153846153846154,0.6001104812889965,1.0,17/70,12.75%,MRAP2;EPHA2;RAMP3;STAC2;PID1;MRAP;TMBIM1;ITGA3;BCL2L1;PTPN9;PRKCE;MMP14;PRKCH;ZDHHC7;SORBS1;ARF6;STX4
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7850258729797677,1.2030145597974604,0.2777777777777778,0.5998721936189744,1.0,3/6,19.43%,SNCA;ATP2B4;CAV3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4727060778542773,-1.2027954833526213,0.13793103448275862,0.9456487975831822,1.0,19/68,23.09%,ZC3H8;POLR2K;TAF13;POLR2C;GTF2A2;TAF11;SNAPC5;GTF2F1;CCNT1;GTF2F2;POLR2D;NABP2;POLR2L;POLR2G;POU2F2;INTS13;INTS3;RPAP2;POLR2E
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5418744149354776,1.2027338643433783,0.18309859154929578,0.600287131306148,1.0,22/84,14.97%,CNR1;NPY1R;ADGRE5;ADCY5;GPR12;LGR5;GIPR;RXFP1;RAMP3;GLP1R;ADCY7;ADGRL2;ADCY2;GNA14;GNA12;GNAZ;P2RY12;HTR1E;S1PR3;GPR37;LPAR1;GRK5
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6277774123130213,1.2025827070966162,0.2033898305084746,0.600411515482775,1.0,2/27,2.19%,MET;PSRC1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.6134166424140005,1.2025450144448917,0.25806451612903225,0.6001091274646349,1.0,12/32,17.94%,CDC42EP3;BAIAP2L1;BAIAP2;CDC42EP1;PRKCE;FCHSD1;ARF6;SPIRE1;BIN1;PFN2;SPIRE2;VASP
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.7617549132563007,1.2019684852024999,0.24074074074074073,0.6013836579215164,1.0,5/8,19.92%,HK2;PFKL;FBP1;HK1;PFKP
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5962862721363634,1.201967660566861,0.25,0.6009604463395871,1.0,7/24,25.26%,RBM24;BOC;SRA1;AKIRIN1;BTG1;FLOT2;ANKRD2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6899628261415188,1.2018564844351733,0.25,0.6008751746963648,1.0,2/11,9.69%,KLF2;ASS1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.4921505363412169,-1.2017813607182701,0.21739130434782608,0.9471334936737988,1.0,12/52,21.20%,AAAS;RAE1;NUP50;ABCD1;SLC25A33;NUP54;JMJD8;NUP85;FIS1;NUP42;POM121C;SPHK2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.7862706459359492,1.2016315764900085,0.2033898305084746,0.6010147613265587,1.0,5/7,17.72%,DPYSL2;DPYSL5;CRMP1;DPYSL4;DPYD
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.7064848727465334,-1.2015975717191099,0.28205128205128205,0.9455771653776398,1.0,2/7,7.24%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7078279661656683,-1.201370800482753,0.2391304347826087,0.94425689771617,1.0,3/5,26.80%,MUS81;SLX4;FBH1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5502920727949302,1.2013531599103076,0.18840579710144928,0.6015952923798285,1.0,20/84,10.59%,RIMBP2;ANK3;NPNT;ADCY5;SHC2;KCNQ1;LGR5;PRIMA1;APLNR;RAI2;ZNF704;RASL12;SYT13;MAOB;TMEM132C;ZBTB7C;TNFRSF19;KALRN;ASXL3;ITGA9
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.55393044775509,1.2013306070432659,0.208955223880597,0.6012532713174529,1.0,9/37,15.14%,PLK2;BTG3;BCL6;CTNNB1;HECA;SMAD3;CDKN1C;CDKN1B;WEE2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6307665829798559,-1.2010276927786152,0.21428571428571427,0.9431899367537309,1.0,6/14,18.42%,NIFK;DDX18;RPL7L1;ZNHIT3;RPF2;NOL9
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.601660115964273,1.2009826477169931,0.1694915254237288,0.6018168019304728,1.0,6/38,13.52%,C3;NLGN1;SERPINE1;SNCA;TF;B2M
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.46089508035483684,1.2009795897915643,0.09090909090909091,0.6014030701336396,1.0,81/391,17.23%,MET;PTP4A3;BOK;TLR2;IGF1;DCN;PDGFRA;EGF;PLK2;THBS1;NLGN1;RIT2;PRKCB;PTPRC;IRS2;RELN;APP;TRAF3IP2;DAB2IP;NOD1;FLT1;NOS1AP;TGFA;TRIM5;MAP3K14;SEPTIN4;FYN;RAMP3;NLRP12;NEUROD2;SMCR8;NRG1;NTRK3;BIRC3;TRIM22;CHI3L1;TNFRSF1A;MYD88;PDGFA;SHISA5;KITLG;CGAS;NRG2;UNC5CL;CASP10;GAB2;BCL2L1;IKBKE;TNFRSF19;DLG5;TGFB2;GFRAL;GAS6;P2RY12;TERF2IP;APOL3;BBC3;HLA-DRB1;FN1;TNFRSF10B;BRD4;TNIP2;TRIM32;LURAP1;FGF2;FADD;BCL2;GPR37;LPAR1;IQGAP1;CD4;GAB1;PIK3CD;NEK6;MFHAS1;PUM1;PINK1;IKBKG;TP53;WNT5A;THPO
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.5968693573751053,1.2009344990118727,0.20689655172413793,0.601133886631543,1.0,3/25,8.58%,ZFP36;DAB2IP;DUSP22
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6293828277589971,1.2009211079928928,0.31666666666666665,0.6007531824696226,1.0,9/31,15.50%,IGF1;RTN1;RTN2;EFNA1;TMED10;ABCA2;EPHA4;HAP1;BIN1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7340063578179279,-1.200900407543189,0.16216216216216217,0.9414274432142313,1.0,3/7,19.69%,PPP1R3C;PPP1R3G;PPP1R3E
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.7081941711092534,-1.2006805819507835,0.3,0.9400703260047786,1.0,5/14,14.08%,PMVK;NUDT7;TDO2;PPCS;ACSS1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6672752046643671,1.200558194171613,0.25396825396825395,0.6014832152163729,1.0,3/16,9.33%,ZFP36;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.7133067335145645,1.2004722744989789,0.23333333333333334,0.6013103180452456,1.0,3/14,12.22%,CD24;SRPX2;BARD1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6490864893614542,1.2003537374238584,0.2033898305084746,0.6013051568232671,1.0,6/17,17.58%,ANK3;GRIN1;SNCA;TMC8;SLC8A1;FAM20A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.5532366052617449,-1.200340643533894,0.22580645161290322,0.9392475489830474,1.0,6/31,11.20%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.6844150331956084,1.2002308638655377,0.16981132075471697,0.6012282695522997,1.0,1/8,0.64%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.651319514768182,1.2001729398649548,0.19298245614035087,0.6009284750252353,1.0,3/14,6.92%,BAIAP2L1;BAIAP2;NTRK3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.5615396304637718,-1.2000089100373208,0.16666666666666666,0.9385415834809978,1.0,9/33,17.51%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;TTF1;POLR1B;ERCC3
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7705704144483887,-1.1994479189076583,0.30952380952380953,0.9385517599072509,1.0,2/5,20.34%,METTL3;AKNA
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.722638043000215,1.1991779026645952,0.2857142857142857,0.6037809624615442,1.0,4/11,9.44%,CSPG4;DCN;VCAN;BGN
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.7915327795812389,-1.1988963554798404,0.20512820512820512,0.9385057563259365,1.0,2/7,8.73%,IGSF1;FSTL3
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.6080267034943212,1.1984940361964127,0.22413793103448276,0.6056829855601384,1.0,4/25,9.37%,SULF1;PTPRC;NOTUM;SH3PXD2B
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6563046892681001,1.19839730797223,0.3114754098360656,0.6054681468256402,1.0,4/16,15.40%,PTP4A3;TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6339884484147871,1.1983935282089322,0.1774193548387097,0.6050709259888688,1.0,5/24,10.90%,ST18;SOCS3;PID1;YAP1;STAT3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5471390683997909,1.198066479649783,0.18181818181818182,0.6056584611597463,1.0,19/73,13.59%,ECM2;L1CAM;NPNT;ZYX;ITGA8;ITGA2;SIGLEC1;THY1;CD44;RHOD;ITGA3;ITGA11;ARHGEF7;MKLN1;ACTN1;SORBS1;ITGB8;FN1;ITGAL
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.48363656232701435,-1.197889862161962,0.14814814814814814,0.9403638099340922,1.0,13/69,19.94%,CDC26;FBXO5;PSMD10;PSMD12;PSMB5;ANAPC15;PSMD2;PSME3;PLK1;PSMB4;PSMB6;UBB;SKP2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.6484846627483732,1.1975331097090496,0.24242424242424243,0.6067528037695292,1.0,4/17,18.73%,BLM;BARD1;MRE11;BRCA1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.707539902118098,-1.1975198933013578,0.35555555555555557,0.9395688587708437,1.0,3/8,13.48%,GINS3;MCM6;MCM4
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.6290457657781675,1.1975117534060997,0.21311475409836064,0.6064427056335979,1.0,2/27,3.83%,TLR2;IRF7
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.7643884560465269,-1.1969790976659178,0.3333333333333333,0.9371379792807859,1.0,1/5,5.24%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7643884560465269,-1.1969790976659178,0.3333333333333333,0.9371379792807859,1.0,1/5,5.24%,SNF8
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.6948527604655268,-1.196179206742677,0.3023255813953488,0.9382420672405544,1.0,3/7,13.41%,TWSG1;TARM1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.6837882156517839,1.1959468373625308,0.2962962962962963,0.6108537245535272,1.0,4/12,14.34%,PTK6;NLRP12;UBASH3B;OPTN
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.7694836720814282,1.195894055021622,0.2542372881355932,0.6105887050333856,1.0,2/6,14.42%,SKAP1;FADD
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.8013412226788887,1.195702256713604,0.25,0.6107353541331971,1.0,1/6,2.21%,NLGN1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7169694141547627,1.1954386311834466,0.2413793103448276,0.611134733747184,1.0,4/10,20.62%,NUAK1;LMNA;NEK6;NEK4
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5575775603565964,1.1951484241708321,0.19736842105263158,0.6117863195381794,1.0,12/59,17.31%,SIX3;CDH23;SLC4A10;CLRN1;TYR;RP2;EML2;CABP1;MYO9A;RGS16;PCDH15;SLC24A1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.44891589459780457,1.1948575875444356,0.05813953488372093,0.6123817520005447,1.0,51/362,15.28%,LEF1;CDKN2A;SIX3;PROX1;MAEL;ZNF93;TCEAL7;DAB2IP;PRAME;FOXO1;CIC;SUV39H1;ZNF282;NFIL3;AHR;NKX6-2;GZF1;BCL6;MSX2;KLF10;CIITA;NRG1;BAP1;TBX20;ZBTB16;GLIS2;PML;HMBOX1;ZFPM2;CTNNB1;CTBP2;BASP1;CHMP1A;CDKN1C;HDAC4;PEX14;GAS6;HDAC9;PRICKLE1;MLXIPL;PPARG;L3MBTL3;RUNX1T1;CDKN1B;PER1;JARID2;DEAF1;SOX13;SPINDOC;ZNF746;SET
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5632846092861594,1.194624395331507,0.20634920634920634,0.6122853280127584,1.0,8/26,22.41%,IRF7;BIRC3;IKBKE;FADD;IKBKG;RPS27A;TBK1;TLR3
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5632846092861594,1.194624395331507,0.20634920634920634,0.6122853280127584,1.0,8/26,22.41%,IRF7;BIRC3;IKBKE;FADD;IKBKG;RPS27A;TBK1;TLR3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.796790560061149,1.194410976754484,0.21153846153846154,0.6124932155299613,1.0,2/5,13.36%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.7390807935584033,1.1943881908543423,0.2982456140350877,0.6121340694288349,1.0,4/8,17.38%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6580267599393436,-1.1943563505062962,0.16279069767441862,0.9426789441515029,1.0,2/10,7.64%,COPS8;COPS7A
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5731289468001262,1.1941315640896775,0.19444444444444445,0.6125384264224746,1.0,16/52,16.02%,L1CAM;CNTN2;CNTN4;IGSF21;EMB;FAT2;KIRREL3;ROBO2;NPTN;NEXN;SDK2;VSTM2L;CDH4;HMCN1;ROBO4;PALLD
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7839906605092877,-1.1940871129640314,0.2682926829268293,0.9415015779637035,1.0,2/5,15.67%,RPL23;MCM3AP
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.7152090791255523,-1.1939388111002698,0.2682926829268293,0.9397791638653261,1.0,5/8,25.58%,CTH;TXN2;MPST;TST;BLMH
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.7969056467949147,1.1938166968292152,0.28888888888888886,0.6128321777011246,1.0,1/5,3.34%,EPHA2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.7433602501039149,1.1937872473996336,0.2,0.6124813947389128,1.0,2/6,6.08%,IRS2;BCL6
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5481832623312253,1.1936483375659828,0.2236842105263158,0.6124529376926819,1.0,14/62,5.99%,HLA-DRA;TLR2;CTSS;TYMP;P2RY13;PLEK;MYO1F;ICAM1;PTPRC;IRF7;DYSF;CD44;PLSCR1;TNFRSF14
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.7681465130088122,-1.1936312029686549,0.3137254901960784,0.9389438508867662,1.0,2/5,8.35%,GREM1;EFNB2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.839846923043837,1.1935734690934807,0.24,0.6122990084407514,1.0,3/6,13.80%,TRPM4;PLAAT3;KLF7
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.7996853372794236,1.193566187327663,0.27586206896551724,0.6118944401821776,1.0,4/5,19.92%,ALDOB;PFKL;FBP1;PFKP
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6626762880730724,-1.1924680726056585,0.21428571428571427,0.9414920525483599,1.0,4/11,19.04%,UTP20;RPS21;NOL9;RPP40
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7021415274327227,1.192467802181503,0.23076923076923078,0.6148354148099121,1.0,5/11,19.10%,ZDHHC7;OPHN1;MYO9A;CAMSAP3;SCRIB
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.6535648807555428,-1.192420259284244,0.17777777777777778,0.9395267001161078,1.0,3/10,10.77%,M1AP;NOC2L;SUPT16H
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.49072145895560226,1.1923989896725076,0.1643835616438356,0.6146253708326165,1.0,31/136,18.36%,IGF1;PROX1;IGF2BP2;NELL1;PTPRC;APP;YBX3;TRIM5;TRIM61;AHR;APLNR;TRIM22;ALPK2;LDLR;CDK6;TRIM17;ATP1B1;MKLN1;NFKBID;AFF1;PRDM1;STX1B;ZNF513;SLC8A2;NOVA2;SLC8A1;CDK2;TFEB;KDM6A;RNF187;MTMR2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6490314568004193,1.1923461315171495,0.2857142857142857,0.6144390834796379,1.0,5/14,19.01%,CD55;STAT3;HLA-DRB1;CD70;BACH2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.8142618990808188,1.1921053007341758,0.2708333333333333,0.6148237366521327,1.0,2/5,13.96%,SEPTIN9;HAP1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.718817677078786,1.1920777779690472,0.2222222222222222,0.6145047599937133,1.0,3/10,17.19%,GHR;STAT3;STAT6
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7664585959934511,-1.1917911405504302,0.2978723404255319,0.9398978864050498,1.0,2/5,7.23%,TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.7525027966161542,-1.191645932687208,0.2608695652173913,0.938090617333679,1.0,1/6,2.95%,TRIM21
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.7345844333665811,-1.1914416745649967,0.3111111111111111,0.9366718458502545,1.0,1/6,2.38%,TPP1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.5927381239449867,-1.1913995525815593,0.2727272727272727,0.9345736327769008,1.0,3/19,13.34%,ATF5;VPS4B;CEP131
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.6619622172047323,-1.191325428226887,0.3333333333333333,0.9326112885538578,1.0,2/6,6.16%,FOXJ1;ASCL1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5100587262746968,1.1910803330834547,0.18840579710144928,0.6172465330757627,1.0,18/78,15.87%,IGF1;DCN;PDGFRA;EGF;IRS2;DAB2IP;FLT1;NTRK3;PDGFA;PPP1R16B;NLRC3;TGFB2;PIP4K2A;FN1;FBXL2;FGF2;GAB1;PIK3CD
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7340764065097914,1.1910304471067703,0.16071428571428573,0.6169887499827046,1.0,2/6,10.85%,ACHE;GLI2
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.7462614773582703,-1.1907551088712804,0.21052631578947367,0.9327067125141073,1.0,3/12,9.29%,ALG3;ALG9;ALG11
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6399866224780134,1.1905132583189395,0.26153846153846155,0.6181736277895349,1.0,9/18,23.70%,PRKAR1B;APLNR;CGAS;PRKAR1A;PDE2A;PDE4D;GNAI1;UBE2B;PRKAR2B
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5864176909641984,1.190509668834577,0.23943661971830985,0.617751954100729,1.0,11/35,19.77%,NLGN1;PLEK;FHOD1;RHOD;ARF6;FMNL3;RHOBTB2;RHOQ;FHOD3;FMNL1;RHOBTB1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.6486176824069877,1.1904371354097902,0.265625,0.6175722100034097,1.0,3/17,4.53%,IGF1;RTN1;RTN2
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6769167997255437,1.1902225661557237,0.20634920634920634,0.6177739470728603,1.0,2/19,9.13%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.7327789280564895,-1.1901116997084464,0.23076923076923078,0.9329451243927028,1.0,2/6,10.29%,BHLHE41;DACH1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.7276456430040668,1.1900935697494075,0.25,0.6177266083320171,1.0,2/9,7.63%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.5214656837046897,-1.1900769455858171,0.16129032258064516,0.9308928532263903,1.0,14/52,19.46%,APOBEC3G;ADAT2;TRMT61A;THUMPD1;FTSJ1;METTL3;QTRT2;URM1;MEPCE;DTWD2;TFB1M;DTWD1;LCMT2;TRDMT1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6938741898393851,-1.1899998937196596,0.3,0.9291177517914799,1.0,4/9,26.12%,VPS35;FIS1;DNM1L;CCAR2
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6944421769339049,-1.1899144349925719,0.3333333333333333,0.9273686354555576,1.0,4/8,23.96%,AMPD3;ADSS2;PNP;NT5C1A
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6653208357372897,-1.1898029557347936,0.24444444444444444,0.9256986169427058,1.0,2/10,9.07%,APOE;GPLD1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5108595106588313,1.1897069470177004,0.2463768115942029,0.6184796179217699,1.0,26/93,13.84%,RIMS2;GRIK1;NPTX2;NLGN1;CLSTN2;SYT1;GRIK2;GRID2;DLGAP3;RELN;APP;RIMS3;BAIAP3;KCNMB4;GRM5;CPLX2;NPTX1;CPLX1;HOMER1;GRM6;LRRC4;KCTD13;PXK;OPHN1;DLGAP1;DLGAP2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.7811544098891119,1.1896222893677515,0.3888888888888889,0.6183852770324128,1.0,1/5,7.64%,CDK9
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.4990791628766428,1.189280840222853,0.06944444444444445,0.6189505954833973,1.0,23/109,13.65%,GGT5;IGF1;PLK2;ADCY5;MYH9;PRKAR1B;GIPR;GNG2;FYN;RXFP1;RAMP3;GLP1R;NLRP12;TNFRSF1A;ADCY7;ADCY2;NLRC3;SYK;PRKCD;PPARG;CD200;HLA-DRB1;TNFAIP6
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.6283069013708775,-1.1891525231645905,0.23684210526315788,0.9257022430756703,1.0,3/17,10.93%,HSD17B8;SLC25A1;GCDH
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6645994580111282,1.189089527377343,0.20634920634920634,0.6190266492423125,1.0,4/14,16.34%,LPCAT4;PLAAT4;PLAAT3;PNPLA8
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.7883573851774438,1.1889095242275398,0.21052631578947367,0.619102599807525,1.0,1/8,1.34%,PROX1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6574522851178691,1.1888260606908443,0.3064516129032258,0.6189771187624213,1.0,3/18,17.75%,APLNR;ROBO2;PDE2A
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.7992911473522427,-1.188817796825172,0.29545454545454547,0.9251576896088967,1.0,6/7,17.78%,ALDH1A1;ADH6;ADH5;ADH4;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7961986170280076,1.188584415847209,0.2692307692307692,0.6192387158708158,1.0,2/7,13.59%,ICAM1;ITGAL
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7365047309218119,1.1885771036626966,0.2413793103448276,0.6188271944165021,1.0,6/9,25.25%,INCENP;PRKCD;CDK2;RPS6KA4;CCNA2;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.5769425259725299,1.1882871351611795,0.22857142857142856,0.6194208297032835,1.0,7/53,12.04%,PTP4A3;TLR2;APP;NOD1;NLRP12;NLRC3;TERF2IP
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5283859689844689,1.1882695260496625,0.1875,0.6190483539341107,1.0,24/60,21.04%,CHRM3;DMTN;PTPRC;RCAN2;TRPM4;GRM5;LAT2;RYR2;CACNA1C;SLC9A1;NUDT4;ATP1B1;CCR10;P2RY12;TPCN2;PPP1R9B;P2RX7;SLC8A1;PLCE1;MCTP1;TRPM2;SAMD14;PTPRJ;ACKR4
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6327823402170425,1.1882592088143122,0.2857142857142857,0.6186532297649312,1.0,3/19,4.53%,IGF1;RTN1;RTN2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.7736275174285886,1.1881383819537708,0.2903225806451613,0.6186905132985933,1.0,2/6,14.42%,TNFRSF1A;FADD
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6440159206417017,-1.1881323288244172,0.325,0.9253036726272396,1.0,3/13,5.76%,SGO2;TERB1;RNF212
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7801305542918608,1.1878964538559502,0.3090909090909091,0.6190051925377297,1.0,4/5,21.57%,SHANK3;FRMPD4;CAMK2B;CTNNA2
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.6956073115650947,1.1876768065197791,0.3064516129032258,0.6184084344835822,1.0,1/9,1.88%,BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.6956073115650947,1.1876768065197791,0.3064516129032258,0.6184084344835822,1.0,1/9,1.88%,BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.6956073115650947,1.1876768065197791,0.3064516129032258,0.6184084344835822,1.0,1/9,1.88%,BLM
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6635771435323478,-1.1872080133568428,0.20454545454545456,0.9224259364591119,1.0,3/12,23.14%,IK;PLK1;MAD2L2
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6635771435323478,-1.1872080133568428,0.20454545454545456,0.9224259364591119,1.0,3/12,23.14%,IK;PLK1;MAD2L2
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6635771435323478,-1.1872080133568428,0.20454545454545456,0.9224259364591119,1.0,3/12,23.14%,IK;PLK1;MAD2L2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5099042943671553,1.1870220290987503,0.140625,0.6201674411773332,1.0,27/85,20.88%,RASGRP1;APP;DAB2IP;DUSP10;MAP3K11;DUSP22;MAPK8IP1;UNC5CL;SH3RF3;TNFRSF19;MINK1;GADD45A;TPD52L1;ANKRD6;PER1;HIPK2;MAP3K5;MFHAS1;PINK1;FZD7;MAPK8IP2;GPS2;TRAF5;NCOR1;MAPK8IP3;IGF1R;TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.6626216549662648,-1.1869878746762637,0.275,0.9212306149617813,1.0,2/9,5.24%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.48635130870698107,1.1869770778664306,0.16666666666666666,0.6198502336594217,1.0,42/210,17.76%,C3;TLR2;ANXA1;RFTN1;CCBE1;IL15;RASGRP1;SERPINE1;MBP;SULF1;PTPRC;APP;IRF7;NOD1;IL1R1;TNFRSF14;CHI3L1;MYD88;TMED10;CYP1B1;CGAS;CTNNB1;SYK;STAT3;CYRIB;CD276;CD200;LURAP1;FADD;MRE11;STOML2;HLA-E;IFIH1;CD4;IL12A;PIK3CD;RARA;MAPK11;WNT5A;STAT6;SCAMP5;RORA
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.7408626781157355,-1.1869439990381394,0.3111111111111111,0.9193255194447335,1.0,3/7,12.27%,CYP4F3;HSD17B6;ADH4
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.623998384267033,1.186601909516517,0.22033898305084745,0.6207615737698368,1.0,3/16,4.29%,BLM;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5650231045875002,1.1863151506271519,0.26865671641791045,0.6212267948100774,1.0,13/48,14.38%,EGF;CD24;RASGRP1;DAB2IP;FLT1;NEK10;DIRAS2;PDGFA;MAP3K11;DIRAS1;TPD52L1;PAK1;FGF2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.4982263442477006,1.1860969395168446,0.21794871794871795,0.6216070713882881,1.0,27/101,14.59%,COL4A1;IGF1;DCN;PDGFRA;ABCA8;COL4A2;CALD1;COL21A1;ANGPTL2;POSTN;COL12A1;MLANA;PTPN21;RASL12;MATN2;C1R;MAOB;BGN;ADGRF5;ASS1;YAP1;THBS2;GAS6;PRICKLE2;PARD3B;LAMA2;SERPING1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.6615830492971085,-1.1859179237872908,0.3,0.9210316120354853,1.0,6/15,15.78%,TRMT61A;TRMT10C;METTL8;METTL3;TRMT61B;VIRMA
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5821777080398997,1.185817822505244,0.21739130434782608,0.622009818811832,1.0,7/39,9.50%,YWHAH;MBP;PLP1;PADI2;MAOB;SYNGR3;BASP1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.7152308483434576,-1.185687021925113,0.30952380952380953,0.9196043751845419,1.0,2/7,12.20%,CHAMP1;KIF20B
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.8151377705366619,1.1856497187763826,0.23636363636363636,0.6216126369295786,1.0,1/6,10.90%,STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.8151377705366619,1.1856497187763826,0.23636363636363636,0.6216126369295786,1.0,1/6,10.90%,STAT3
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.5588171682541071,1.1855343056010843,0.2542372881355932,0.6215482310688997,1.0,12/39,16.17%,CD24;PLEK;NAPSB;CD37;CCR10;PDK1;ABCB9;ITGAL;PRDM1;MAN1A1;TMEM156;KLF4
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.4835924375772136,-1.1853991280692604,0.25,0.918460752134399,1.0,8/40,20.90%,AAAS;RAE1;NUP50;NUP54;JMJD8;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.6292343362072879,-1.1853723348415561,0.25,0.9165961881050169,1.0,6/17,14.00%,ALAS1;HMBS;ABCB10;SLC25A38;FECH;TSPO
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.7138179716206863,-1.1852794760656629,0.3018867924528302,0.9150504211062064,1.0,2/7,21.48%,CTH;MYOCD
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5570257034576306,1.1851592177109012,0.2,0.6222631728017769,1.0,15/61,13.45%,FYB1;PLEK;ZYX;TEC;ITGA2;THY1;MYH9;ERBIN;NEDD9;LAMA5;ITGA11;SYK;ADAM11;ITGB8;FN1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.7072314275167446,-1.1850585715450028,0.3269230769230769,0.9138557412695714,1.0,2/7,8.30%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.7209444244781207,-1.1848607828226347,0.3,0.9125461682085733,1.0,5/8,26.56%,MTRES1;MTG2;TSFM;ALKBH1;METTL4
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.5139972759771486,1.1848449539810677,0.18055555555555555,0.6228779074855173,1.0,19/86,15.84%,IGF1;KCNC2;ACHE;ABCC8;GIPR;GLP1R;ITPR3;SERGEF;RHBDF1;CACNA1E;HADH;TMED10;CACNA1C;SYTL4;TGFB2;ARF6;PICK1;RHBDF2;IL12A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.49361540553805067,-1.1847614770124881,0.10714285714285714,0.9108140583268387,1.0,20/69,21.27%,ERCC8;RFC3;COPS8;POLD3;GTF2H5;POLR2K;GTF2H2;COPS7A;POLR2C;ERCC2;ERCC6;HMGN1;XPA;POLR2D;ERCC3;UBB;PPIE;POLR2L;POLR2G;COPS3
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.7637809754522435,1.184650897099071,0.25,0.6229882665463906,1.0,4/5,23.12%,SLC43A1;GRM7;SLC43A2;HRH3
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.824977931689806,1.1843227141559989,0.2631578947368421,0.6234415815719528,1.0,2/5,11.82%,ST8SIA3;ST6GALNAC2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.4372548838536401,1.1838137137563103,0.08602150537634409,0.6245800406111244,1.0,164/886,19.26%,LEF1;NR4A3;MLIP;FOSL2;MET;KLF2;ST18;TEAD2;MYRF;TLR2;IGF1;MAFF;DCN;MLLT11;SP100;PROX1;YWHAH;EGF;CREB5;TESC;BLM;ATF3;PSRC1;SERPINE1;NR4A1;ACTA2;LMO2;RPS6KA1;CASZ1;WAS;APP;DAB2IP;IRF7;FOXO1;SOX4;PPARGC1B;PLSCR1;NFATC2;NFIL3;AHR;AGRN;ZIC1;PADI2;SSBP4;KLF10;CIITA;SKAP1;PLAC8;ZNF750;DVL1;LDB2;KCNH2;GRIN1;PGR;FHOD1;RFX4;ZBTB16;PID1;CDK9;TNFRSF1A;GLIS2;SCX;PML;NLRC5;FOXO3;BEX1;ZFPM2;CTNNB1;SLC9A1;CSRNP1;CTBP2;NR1I3;SMAD3;ASXL3;RAI1;NAMPT;YAP1;TBL1X;CDKN1C;HDAC4;GLI2;SMAD1;STAT3;RGMB;GLIS3;PARP9;ASXL1;TEAD1;NPAS2;FLI1;NR4A2;MEIS3;MLXIPL;PPARG;EIF5A;KLF6;HLA-DRB1;PTPRN;MEF2D;KLF7;PER1;BRD4;TNIP2;FOS;DEAF1;FGF2;FADD;SS18L1;TFAP2C;UTP15;SOX10;ZNF746;MAML2;CD4;SMARCA1;SPP1;AKIRIN1;ELF1;RARG;IER5;ZNF513;RARA;HIPK2;KLF4;BCL9;MAP3K5;TOX3;MRTFA;FZD7;JUNB;IKBKG;TP53;PRDM16;WNT5A;STAT6;LAGE3;TAF15;RORA;CXXC1;TFEB;MESP1;RGMA;DOT1L;RNF187;ZBTB38;HMGA1;RHOQ;WWTR1;UBP1;RLF;ZMIZ1;BCLAF1;GPS2;BRCA1;ARID1A;ETS1;BARX2;RXRA;MAP2K3;MAP2K5;SHC1;METTL23;MAX;MLXIP
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7385795140304118,1.1837057796856179,0.29310344827586204,0.6245139141047671,1.0,3/7,18.54%,RPS6KA1;RGS14;BCLAF1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6276987332921905,1.183569504006315,0.26865671641791045,0.6245163592197676,1.0,5/17,9.35%,IL1RAPL1;NLGN1;DVL1;PCLO;PTPRD
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6476610852940363,1.1834337888377007,0.2698412698412698,0.6245035926530577,1.0,4/16,16.31%,THBS1;AKIRIN1;CAMK1D;BST1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5913377446349619,1.1833927732177059,0.18032786885245902,0.6242400710059095,1.0,4/34,1.93%,NR4A3;IGF1;THBS1;OGN
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6244629365097085,-1.18326706096887,0.2972972972972973,0.9146286722708452,1.0,2/13,8.34%,AR;NCOA4
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6679090766281827,1.1829148457674017,0.23636363636363636,0.62529067925321,1.0,8/21,14.48%,GRIN3A;NLGN1;SHANK3;SHANK1;NEURL1;DLG5;ARF6;CAMK2B
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.7121333211753059,-1.1827257478205866,0.38095238095238093,0.9146395411638994,1.0,2/6,7.85%,ACMSD;ASMT
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6651233997304584,1.1827168919047275,0.3064516129032258,0.6254899171778301,1.0,3/12,19.05%,WTIP;DLG5;MAP2K3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5739688964673574,1.182672284658783,0.26229508196721313,0.6252262655442388,1.0,2/32,4.00%,ANK3;AMN
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.744159960544963,1.1825079087730703,0.21818181818181817,0.6253646499287553,1.0,3/10,3.17%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.7913419730134098,1.1823819049599094,0.3157894736842105,0.6253968153751674,1.0,1/5,6.33%,MFSD2A
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5478650448270346,1.182206262975389,0.28,0.6255954548320469,1.0,15/53,17.28%,PSCA;PTK6;TJP3;SYNGR2;CAPN1;ANO9;SH2D3A;ANXA11;IL4R;DTX2;PRKCD;RHBDF2;PRRG4;RPS6KB2;ABHD11
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.589598536488928,-1.1820191809946972,0.24489795918367346,0.9151950198039241,1.0,6/16,14.28%,NSA2;RPF1;EXOSC4;RRP15;MAK16;LAS1L
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5590717561609658,1.1817684936615147,0.19696969696969696,0.6265275319859359,1.0,4/40,3.13%,CCBE1;THBS1;NR4A1;SLIT2
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.7179642621664294,-1.1812861247173971,0.38095238095238093,0.9157650399226542,1.0,2/5,21.90%,FAM3A;PLA2G5
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.6949945936477142,1.1809104523643625,0.2833333333333333,0.6287660685466078,1.0,1/10,1.30%,TYMP
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.48654114448384794,-1.1809041531381692,0.13333333333333333,0.9153666436917739,1.0,21/64,25.37%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;POLR2C;SUPT16H;ERCC2;GTF2F1;CCNT1;GTF2F2;POLR2D;ERCC3;POLR2L;POLR2G;POLR2E;CTDP1;EAF1;CTR9;GTF2H3;LEO1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.795190443438575,1.1808287583156678,0.2978723404255319,0.6285239581444853,1.0,1/5,0.19%,IPCEF1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7022367680925878,1.1804106702258974,0.30357142857142855,0.6294824473120052,1.0,6/15,15.84%,HLA-DRA;CYRIB;HLA-DRB1;FADD;HLA-E;IL12A
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.4935295125454978,1.180384116646566,0.047619047619047616,0.6291647441513255,1.0,23/100,17.01%,CDKN2A;TP53TG5;PSRC1;SLIT2;TSPYL2;SLIT3;BCL6;TRIM46;MAG;PML;DCC;SMAD3;TGFB2;FGF13;DIP2B;CDKN1A;CDKN1B;FBP1;PPP1R9B;SIPA1;KIAA0319;TP53;PTPRS
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.6505801540328205,1.1800796075885718,0.21875,0.6296692072889379,1.0,7/17,25.53%,IRF7;NLRC3;IFIH1;PTPRS;TBK1;TLR3;DHX9
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),0.7500814180119393,1.1798841989872741,0.2807017543859649,0.629736033525796,1.0,1/5,6.32%,GJC1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.7006386471999957,1.17973930075004,0.3559322033898305,0.6298103006824797,1.0,3/10,10.85%,RELN;SOX4;GLI2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.46726048658746866,1.1797139811405566,0.14634146341463414,0.6294555983913817,1.0,23/202,10.34%,TLCD2;ANK3;A4GALT;EGF;SH3GL2;VAPB;SYT1;CNTN2;DYSF;SUN3;TGFA;SH3KBP1;SYNGR2;DNM1;SYP;REPS2;CLTB;ARPC3;SYNJ2;LDLR;MX1;TRIP10;CHMP1A
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.7826983625236643,1.1796064548883067,0.33962264150943394,0.6293570128556911,1.0,2/7,10.66%,SLC25A45;SLC25A29
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7348105854554858,1.1794900687237653,0.3050847457627119,0.6292735853639283,1.0,2/7,18.00%,SYK;ADGRE2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.780032321964473,1.1793696418016963,0.27419354838709675,0.6293479612514045,1.0,1/5,7.64%,CDK9
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.4807942893863851,1.179303832792883,0.18181818181818182,0.6291445807116761,1.0,36/153,18.74%,MTMR7;PLD1;LIPH;LPCAT4;ACHE;PLSCR1;MFSD2A;SBF1;SYNJ2;DGKG;PLEKHA2;AGPAT4;PLD2;PIP4K2A;VAC14;INPPL1;PITPNM2;INPP5J;PLEKHA4;PITPNM3;INPP4A;PLEKHA8;CHKB;IMPA1;FGF2;CDS2;MTM1;BMX;INPP5D;SLC44A3;PIK3CD;CPNE7;PIP5K1C;MTMR2;PITPNM1;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6677904753989993,1.1788832863246175,0.3620689655172414,0.6298938861850543,1.0,2/17,4.89%,KREMEN2;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6871031684588333,1.178827596549496,0.31746031746031744,0.6296379532445382,1.0,1/12,1.84%,THBS1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.566901211894993,1.1787822875268876,0.24285714285714285,0.6293748664273217,1.0,5/38,7.19%,RECQL4;SP100;BLM;RPA1;POLD1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.64069485786713,1.1786959834816615,0.26,0.6292693014046484,1.0,5/13,20.93%,SLC43A1;KCNH2;BIN1;CAV3;SLC43A2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.745211232286894,1.1785677882066337,0.29508196721311475,0.6292910298354697,1.0,2/8,3.13%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.7836648409800914,1.1785360614778226,0.2727272727272727,0.6289763628408412,1.0,3/6,17.75%,SEPTIN9;HAP1;MAP4
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.7388406356176969,-1.1785047397707675,0.2653061224489796,0.9224944152572603,1.0,2/5,19.91%,BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.738331190125132,1.1783079603533506,0.35294117647058826,0.6293269314986595,1.0,3/8,16.07%,ANXA1;NFKBID;RARA
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.5235767278644309,1.1780732355572137,0.2,0.6296247865406204,1.0,13/47,12.96%,CHRM3;HRH1;RCAN2;TRPM4;GUCY1A1;LAT2;RYR2;NUDT4;CCR10;INPP5A;GUCY1B1;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7251400307352603,1.1780621900840764,0.3142857142857143,0.6292359163884373,1.0,3/11,12.90%,LDLR;SYK;PPARG
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.6570670799335744,-1.1780070401504747,0.358974358974359,0.9223698880846194,1.0,4/14,7.23%,RAB7B;TNFAIP3;NR1D1;PTPN22
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7576376750213456,1.1774106056493694,0.33962264150943394,0.6308232098266016,1.0,5/8,17.11%,GABRB2;GABRA1;GABRG2;FGF13;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6700957785861981,1.177209825521156,0.23728813559322035,0.6310002988613573,1.0,2/17,2.62%,SIX3;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6794890013042225,1.177187546645654,0.23076923076923078,0.630663411625134,1.0,3/15,8.44%,GHR;CYP1B1;OCIAD2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6157832380165686,1.1771721107848836,0.3103448275862069,0.6302897596561582,1.0,7/32,19.39%,BOK;ZNF385B;PML;HIPK1;HIPK2;TP53;STK11
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.7759265308213834,1.1769555181771225,0.2982456140350877,0.6304891577837621,1.0,1/6,7.16%,BAP1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.5571945018853265,1.176481151839198,0.1780821917808219,0.6315948848647682,1.0,5/44,7.19%,RECQL4;SP100;BLM;RPA1;POLD1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6836357094602161,-1.1762565935467808,0.3191489361702128,0.9268418972282694,1.0,3/10,14.68%,TIMM8B;TIMM13;TIMM10
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5742878978527496,-1.1762300236709717,0.20930232558139536,0.9248774191696708,1.0,8/20,20.79%,GTF2H5;CETN2;GTF2H2;ERCC2;XPA;ERCC3;UBB;PARP1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7093836348806712,-1.176037616602309,0.3111111111111111,0.9236422342781622,1.0,1/5,5.50%,SLC6A13
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.5872009225577592,-1.1756860339482262,0.25,0.9226632838480117,1.0,1/21,0.15%,DAO
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6850842354701902,1.1756452904871564,0.24615384615384617,0.6338650907612512,1.0,1/15,2.58%,ZFP36
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.578476916785179,1.1755048612671555,0.2361111111111111,0.6338465565736361,1.0,8/28,13.83%,RASGRP1;DUSP1;DAB2IP;DUSP10;RELL1;MINK1;GADD45A;PER1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6306075539352641,-1.1752934060792544,0.225,0.9204349284425266,1.0,3/11,13.89%,PPP1R3C;NR1D1;PGM2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6306075539352641,-1.1752934060792544,0.225,0.9204349284425266,1.0,3/11,13.89%,PPP1R3C;NR1D1;PGM2
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.6766357748912639,-1.1752654379584433,0.3488372093023256,0.9185552059739315,1.0,2/7,11.58%,PTPN22;SPSB4
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.8046224789558607,1.1752317725961852,0.32142857142857145,0.6344065394253933,1.0,2/5,2.21%,THBS1;SERPINE1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7107053592073136,-1.1750718684252712,0.3157894736842105,0.9173136766134771,1.0,4/8,6.40%,CD247;CD96;PYHIN1;P2RY10
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.4838552019095793,1.1750340748223702,0.12658227848101267,0.6347730896426339,1.0,29/132,15.87%,TGFBR2;MET;SERPINE1;DUSP1;ICA1;VLDLR;FYN;PTPN21;MAP1B;SYNJ2;LDLR;ADGRL2;TFPI;KALRN;SMAD3;PRKCE;RBPMS;SIPA1L1;PEX14;SLC7A1;MMP16;CAP2;PPARG;CDKN1B;LPAR1;GRK5;RGS4;KCNMA1;PIK3CD
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.6718175695908194,-1.1744611802894351,0.28888888888888886,0.9178645127959454,1.0,1/8,6.45%,ABCD1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6274277179366188,1.1743656451730096,0.30434782608695654,0.6363539054025966,1.0,2/19,7.80%,CD24;SCX
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6144173766114496,-1.174077796219671,0.25,0.917372777465389,1.0,2/16,3.61%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.7026118864644679,-1.1739778539278438,0.3333333333333333,0.9157627586049301,1.0,4/9,17.32%,PIH1D2;ZNHIT3;NUFIP1;RUVBL1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.5495200261167925,1.1736582982006796,0.23076923076923078,0.6380511066545046,1.0,6/37,17.01%,TLR2;IRF7;NLRC3;RELB;IFIH1;PTPRS
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.6686346140523328,1.173553649890324,0.26229508196721313,0.6379559477107691,1.0,3/11,15.16%,WASF1;PID1;MTM1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7965103922603982,-1.17347604822323,0.36585365853658536,0.9158530270574285,1.0,2/5,17.27%,IDH1;IDH3G
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.6915505204023442,1.173400619605999,0.18,0.6380383337419686,1.0,2/12,9.12%,MET;CTNNB1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7712477853707922,1.1733425891238678,0.3225806451612903,0.6378103258910595,1.0,6/6,22.90%,PLSCR1;PLSCR2;ANO7;P2RX7;PLSCR4;ANO6
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.7473209365162645,1.17315371826721,0.3018867924528302,0.6379739127342186,1.0,3/6,16.84%,CDKN1A;MAPKAPK5;TP53
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.7303572951338522,1.1728956187633306,0.2037037037037037,0.638454552887352,1.0,1/7,0.29%,MLIP
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.6770577665695405,-1.1728452759358485,0.2682926829268293,0.9158936935413964,1.0,2/5,24.81%,GBA2;GBA3
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.6095756069295437,-1.172839830337573,0.3225806451612903,0.9140187266490711,1.0,2/14,3.59%,AR;AKR1C3
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.8343982384196269,1.1727152427030456,0.26,0.6381244453132483,1.0,1/5,0.72%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.8343982384196269,1.1727152427030456,0.26,0.6381244453132483,1.0,1/5,0.72%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.5703491689980537,1.1725886832039045,0.2112676056338028,0.6380959443479735,1.0,13/30,24.98%,RASGRP1;IL1R1;CYRIB;CD276;FADD;IL12A;SCRIB;PDE4D;TNFSF4;ZFPM1;TLR3;IL12RB2;HLA-A
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.4922845717158531,1.1725416206136723,0.2,0.6378319846911702,1.0,30/90,16.05%,COL4A1;PRRX1;CSPG4;COL4A2;CALD1;ACHE;RBM24;ANGPTL2;POSTN;COL12A1;LAMB1;PTPN21;RHBDF1;ZBTB16;MYD88;CAPN1;BGN;SRPX2;PKDCC;YAP1;ADAM12;TEAD1;CAP2;FN1;COL5A1;CCL2;BCAR1;FSTL1;PALLD;PDZRN3
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.7028457325916826,1.1723097069326607,0.2653061224489796,0.6380464070237607,1.0,4/12,15.35%,IRF7;CDK6;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6699285329235927,1.172003120677194,0.27692307692307694,0.6387162385468282,1.0,6/15,22.45%,FOLH1;ASS1;NAT8L;MSRA;MTHFR;NAALAD2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.5856825483503942,1.1716440005289306,0.25396825396825395,0.6392897231084239,1.0,4/37,4.52%,IGF1;EGF;DUSP1;TGFA
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.7308602566508432,1.1714121505923576,0.24528301886792453,0.6396716223916074,1.0,3/10,14.38%,ITPKC;ITPKB;FGF2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.549142584504389,1.1713521527652575,0.22033898305084745,0.6394148339924082,1.0,12/53,16.67%,SGPP2;VAPB;FA2H;CERS3;SPNS2;HACD1;ALDH3A2;ELOVL7;SGMS1;CERS5;HACD4;ELOVL5
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6698219151565915,1.17110224868441,0.17647058823529413,0.6398694716382646,1.0,3/10,9.97%,MLIP;FOXO1;LMNA
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8090479180029101,1.1709343370435412,0.34545454545454546,0.6399498904286914,1.0,3/5,11.27%,SLC7A2;SLC25A29;SLC7A1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.572031346199187,1.1709018589646525,0.2608695652173913,0.6396275240464895,1.0,10/44,18.61%,YWHAH;BAP1;YWHAG;ARIH2;BBC3;BCL2;PINK1;TP53;YWHAE;MICALL2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.6029615311502058,1.1705282071606042,0.25396825396825395,0.6403226061613019,1.0,5/24,14.32%,CDKN2A;PML;CDKN1A;PRKCD;MAPKAPK5
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7915410916611281,-1.1703225168632854,0.325,0.9202711022281883,1.0,2/5,15.46%,NOL8;RPF2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.5978326664676463,1.170259933122162,0.2833333333333333,0.6407096893427553,1.0,6/21,9.36%,MRAP2;DMTN;PID1;MRAP;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.8232130572681238,1.1701053567988935,0.23809523809523808,0.6403431390537406,1.0,2/5,12.90%,SOAT1;PPARG
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.8232130572681238,1.1701053567988935,0.23809523809523808,0.6403431390537406,1.0,2/5,12.90%,SOAT1;PPARG
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.7619284934186471,1.1698682913327025,0.288135593220339,0.640692976598335,1.0,4/9,8.65%,PKP2;TRPM4;RYR2;CACNA1C
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.5500464479639501,-1.1696540102300839,0.21621621621621623,0.9213129383134578,1.0,8/31,16.51%,ATRIP;HUS1;BRIP1;ATR;RAD9B;ERCC6;CLSPN;DNA2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.7881329763713665,-1.1695946745805945,0.2926829268292683,0.9194872085709805,1.0,4/5,20.79%,MGME1;PRIMPOL;DNA2;PARP1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.7059160987274353,1.1694435416503592,0.2903225806451613,0.6416696032361379,1.0,3/11,6.83%,THBS1;XKR4;XKR6
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.6835658250572204,-1.1694161175612898,0.3076923076923077,0.9180749971305177,1.0,3/16,9.59%,ALG3;ALG9;DOLK
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),0.7608114949650318,1.1693778289971624,0.3090909090909091,0.6415297991054385,1.0,1/5,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.7290686359845032,1.1690539520237033,0.3114754098360656,0.6420821663739483,1.0,4/7,22.65%,TFPI;SERPING1;F3;F10
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.6968724249414702,1.168944283983538,0.36507936507936506,0.642022351951004,1.0,1/13,0.98%,IMPDH1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.5621380666544427,1.1688815063878166,0.25396825396825395,0.6418025668377142,1.0,7/34,12.10%,L1CAM;SHTN1;TRIM46;MAG;CDKL5;MAPT;DIP2B
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5029805736834609,1.1688756842580468,0.18421052631578946,0.6414303867437674,1.0,14/87,13.14%,P2RY6;HRH1;GABRB2;SLIT2;DMTN;KCNQ1;GLRA2;AHR;GABRG2;CTNNB1;NEURL1;HCN1;P2RY12;CTNNA1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8242762378123272,1.1687607438909442,0.2962962962962963,0.6413275074708245,1.0,2/5,11.98%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.7840170311806363,1.1685845560272614,0.3137254901960784,0.6414643714766977,1.0,2/5,15.42%,DOCK4;KCNMA1
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.7797405803517267,1.1684533321917814,0.2833333333333333,0.6413833704485841,1.0,1/5,1.85%,PKP2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5387461236258089,1.1683962344001222,0.23809523809523808,0.6411211781860702,1.0,22/55,20.04%,SLC24A2;KCNJ2;SLC39A14;TRPM4;SLC9A9;KCNH2;ABCC9;ATP1A1;SLC9A1;ATP1B1;ATP1B3;SLC9C2;SLC12A5;SLC8A3;SLC8A2;SLC8A1;SLC24A1;SLC9A5;ATP2B4;TRPM2;SLC9A2;KCNE2
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5022911632585983,-1.1681960618083462,0.24242424242424243,0.9207348701255104,1.0,8/47,7.81%,HSD17B8;MCAT;ACSM6;ELOVL4;ABCB11;ACMSD;CYP46A1;OSBPL3
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.5389377831825855,-1.1680086883338203,0.21739130434782608,0.9193582892739773,1.0,5/40,11.14%,BUD23;RIOK2;RIOK1;HSPA1A;ZPR1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7029015841509552,1.167984975839806,0.26,0.64188841570728,1.0,2/15,1.40%,NR4A3;PDGFRA
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6178489301302985,1.1677107080552418,0.2777777777777778,0.6422997944208386,1.0,4/17,15.63%,PARD3;OPHN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5553327290324133,1.1676014857571517,0.25,0.6421678034600393,1.0,5/35,10.93%,ZDHHC9;ZDHHC22;FOXO1;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.732503415591742,1.1673043783010142,0.3333333333333333,0.6425929509579672,1.0,2/7,9.32%,DNM1;MX1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6313844535330608,1.1671030234294528,0.3157894736842105,0.6427284076907215,1.0,8/21,17.12%,NLGN1;RELN;SHANK3;SHANK1;NEURL1;DLG5;CAMK2B;CUX2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5039367653405048,1.1661664829785594,0.16176470588235295,0.6450237416616309,1.0,15/78,16.03%,ST6GAL1;B3GNT2;GALNT12;GALNTL6;GALNT8;GALNT16;TRAK1;ST6GALNAC2;B4GALT5;POMGNT1;PLOD2;CHST4;TMTC1;POMGNT2;LARGE1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5916130710039664,1.1658473084385084,0.265625,0.6455256941062393,1.0,13/40,16.31%,ANXA1;IL15;PTPRC;IRS2;NFATC2;SLC7A1;CD276;BCL2;CD70;HLA-E;GPR183;IL12A;BST1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6924589792188782,1.1655402198024742,0.2982456140350877,0.6460991635272252,1.0,2/8,6.88%,GRIP1;DVL1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.7485678259671986,1.1652124725652289,0.2545454545454545,0.6466935405521924,1.0,3/7,20.59%,DOCK10;GPR183;LFNG
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.7958084943504258,1.1650885980848888,0.22916666666666666,0.6466962746511621,1.0,2/5,14.41%,SLC4A11;SLC12A5
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6425167485545514,1.1646242201133237,0.3220338983050847,0.6477144122549088,1.0,3/17,8.25%,PAPSS2;TPST1;SULT4A1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7411372063984215,1.1646191201844,0.26,0.6473062746290392,1.0,3/5,24.97%,NLGN4X;MTMR2;TMEM25
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.6239773297950857,1.1644434757375757,0.2647058823529412,0.647344579699592,1.0,4/19,8.50%,PDGFRA;SERPINE1;PDGFA;TFPI
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.6955056223845074,1.1644236557723417,0.3157894736842105,0.6466165099982047,1.0,1/9,1.30%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.6955056223845074,1.1644236557723417,0.3157894736842105,0.6466165099982047,1.0,1/9,1.30%,TYMP
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.6429324955923954,1.164371219435286,0.24074074074074073,0.6463536652760119,1.0,1/16,1.88%,BLM
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6030406363007489,1.1643041572591033,0.2727272727272727,0.6461557196996037,1.0,4/26,7.32%,IGF1;APP;MFSD2A;GHR
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.7524595043806327,1.1642141901666558,0.2727272727272727,0.6460799096314152,1.0,2/6,6.08%,IRS2;BCL6
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6016770458727005,-1.164159562909493,0.25806451612903225,0.9318288950189949,1.0,3/18,3.03%,SLC2A5;SELENOS;SLC30A8
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5142802629409698,1.1640023098653007,0.17647058823529413,0.6462836423526027,1.0,28/118,20.55%,RASGRP2;KIF14;CD22;RIT2;LTBP4;DAB2IP;FAM107A;BAP1;PAK4;GFAP;PACSIN1;SLITRK4;OPHN1;ANGPTL7;NCLN;TMC8;BCAR1;CAMSAP3;PINK1;WNT5A;ERMN;TSC2;TFRC;PLCE1;RAP1A;STK11;SEMA4D;SPOCK1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.7233802433193017,-1.163795310142131,0.3488372093023256,0.9311754731695322,1.0,3/8,13.30%,TRMT10C;TRMT61B;TRMT5
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.8146751492737998,1.163735935160856,0.3103448275862069,0.6467234270823103,1.0,4/5,15.94%,CD55;CFH;TGFB2;CD59
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.7669378528085291,1.1632683106001298,0.288135593220339,0.6477280120191912,1.0,2/5,21.27%,P2RY12;CSF1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5336410322730388,-1.1631293125666413,0.3142857142857143,0.9315850671822363,1.0,5/24,8.34%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6362162245924636,1.1630361338277164,0.2909090909090909,0.6479732412128554,1.0,4/17,12.17%,RBM24;MMP14;HDAC4;HDAC9
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),0.7723393540273356,1.1624917768374854,0.38461538461538464,0.6490829975726007,1.0,3/5,20.68%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.7312522724985399,-1.1621599333091783,0.35185185185185186,0.9334037604895035,1.0,2/5,20.17%,PDCL3;PDCD5
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.5813051685894746,1.1621337541943302,0.24324324324324326,0.6496985044424572,1.0,5/28,20.03%,ZFP36;WTIP;ZC3H7B;PUM1;XPO5
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7542675399062185,1.1620709172012789,0.3888888888888889,0.6491223104450475,1.0,1/5,5.21%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7542675399062185,1.1620709172012789,0.3888888888888889,0.6491223104450475,1.0,1/5,5.21%,PLSCR1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5481207773455088,1.1620458097079656,0.2191780821917808,0.6488097995534109,1.0,13/56,15.57%,GABRB2;GABRG3;GLRA2;GABRD;GABRA1;GABRA5;SLC20A2;GABRG2;ANO9;SLC37A2;ANO7;SLC12A5;GLRA3
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.702929824321133,1.1618867989730017,0.35714285714285715,0.6489323093857918,1.0,1/10,3.44%,ABCB1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.763986222973318,-1.161866300636759,0.32,0.9288091442941687,1.0,3/5,19.63%,APOE;ERLIN2;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.763986222973318,-1.161866300636759,0.32,0.9288091442941687,1.0,3/5,19.63%,APOE;ERLIN2;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.763986222973318,-1.161866300636759,0.32,0.9288091442941687,1.0,3/5,19.63%,APOE;ERLIN2;ERLIN1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.503822319631424,1.1618573354657789,0.20512820512820512,0.648577582693498,1.0,12/95,6.49%,TGFBR2;TLR2;MAFF;P2RY13;LMO2;PTPRC;ABCB1;SIGLEC1;THY1;DYSF;CD44;TNS1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.7355582140629868,1.161832604746826,0.3,0.6482944601955212,1.0,2/5,18.99%,LDLR;LRP2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7455256650938411,1.161644590129283,0.34545454545454546,0.648459732778187,1.0,3/6,18.99%,NLGN1;PHACTR1;LRP2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.5048944366367845,1.1611095519323655,0.20253164556962025,0.6496553668997495,1.0,23/124,19.47%,ANK3;YWHAH;ZIC1;FYN;BAP1;MYO1C;BAG3;YWHAG;SMAD3;ARIH2;GAS6;BBC3;PRKCD;CEMIP;BCL2;OAZ2;MTCL1;PINK1;TP53;YWHAE;MICALL2;FLNA;PLK3
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5208367458444957,1.1610013052944783,0.25757575757575757,0.6496491170195691,1.0,18/81,19.29%,PLK2;PRKCG;DAB2IP;FOXO1;AGAP2;HECW2;GFAP;BARD1;EEF1A2;HECW1;CDKN1B;TRIM32;OAZ2;FMN2;SMURF1;WNT5A;VIP;FLNA
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.7091976207579842,1.1608257849673167,0.3220338983050847,0.6497493527935233,1.0,3/9,13.01%,MFSD2A;DCX;CDHR1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.7143819676095071,1.1606657474859159,0.3269230769230769,0.6499062169844015,1.0,1/6,10.33%,SEC14L1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.7114325831204629,1.1604556393341323,0.3877551020408163,0.6500132584419911,1.0,5/8,7.08%,KCNT2;KCNE4;KCNQ1;KCND3;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.7474971194644201,1.1604332685083698,0.2711864406779661,0.6496879628761735,1.0,3/9,4.61%,NELL1;DAB2IP;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5782581748947022,1.1602720081271924,0.2537313432835821,0.6497312786180458,1.0,7/27,16.33%,SLIT2;SHANK3;SHANK1;SSH2;CYRIB;PRKCD;PFN2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6318934392763709,1.1600622933721878,0.2857142857142857,0.6499939132768012,1.0,5/18,17.91%,SP100;PML;BARD1;RANGAP1;SKP1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6773121536551862,-1.1597600010638933,0.3,0.9343232471916678,1.0,2/9,8.30%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6390014149299831,-1.1597500975404498,0.3333333333333333,0.9324364533785061,1.0,6/16,19.51%,CES2;AKR1C3;PTGIS;PTGR1;GSTP1;PLA2G4A
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5239330677430667,1.1596602450307454,0.2328767123287671,0.650687624052894,1.0,23/74,24.75%,HLA-DRA;CTSS;SH3GL2;AP1S1;KIF5A;ACTR1A;KLC2;HLA-DRB1;KLC1;HLA-DMA;DCTN1;KIF3C;DYNC1LI2;DNM2;DYNC1LI1;ACTR1B;RAB7A;DCTN3;DCTN6;CAPZB;KIF11;AP2A2;SEC23A
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7242847988163392,1.1594574449370016,0.3333333333333333,0.6508927996537608,1.0,3/7,18.38%,ZBTB16;PKDCC;LOXL2
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.6039523670912682,1.159290949760079,0.18333333333333332,0.6509211363260945,1.0,7/28,16.17%,KLF2;THBS1;PPP1R16B;SMAD1;FGF2;EPN1;KLF4
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.688464330953819,-1.1592231436308547,0.36,0.9320458534509525,1.0,4/8,18.71%,PRDX1;CAT;GPX1;PRDX3
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.742327663023059,1.159120998378189,0.2962962962962963,0.6510623826228079,1.0,2/5,12.32%,DGAT1;DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5077530370918314,1.1590230006552646,0.2727272727272727,0.6508930484884098,1.0,18/77,20.30%,DCN;PLK2;FOXO1;TRIM5;TRIM22;FOXO3;PLEKHF1;OPTN;RNF152;TRIM65;DHRSX;PINK1;IKBKG;TFEB;TSC2;STK11;PLK3;WAC
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.7245007021934748,-1.1589508962960624,0.36363636363636365,0.9310563632501853,1.0,3/6,5.56%,RAB7B;TNFAIP3;NR1D1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.684218235961692,-1.1588663100659915,0.3783783783783784,0.9294716494513465,1.0,6/8,28.97%,GLUD1;GLYATL1;SIRT4;GLUL;NIT2;CPS1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.6731735894118145,1.1588352709281553,0.3448275862068966,0.6505550069961752,1.0,4/9,21.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.6731735894118145,1.1588352709281553,0.3448275862068966,0.6505550069961752,1.0,4/9,21.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.8097202462093278,1.1585990099096999,0.24615384615384617,0.650865129872747,1.0,1/5,7.76%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7536704773086983,1.158458942351483,0.38181818181818183,0.6508652296617466,1.0,1/6,5.21%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.6677033093567775,-1.1583695639909177,0.3157894736842105,0.9293727573554569,1.0,4/12,11.66%,CBFA2T3;IFNLR1;PRELID1;NOA1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.5209582690374935,1.1582524001804493,0.2361111111111111,0.6512240103132738,1.0,17/84,10.93%,TLR2;PTPRC;IRF7;TRIM5;MAP3K14;PLSCR1;APOBEC3H;SAMHD1;ABCC9;NLRC5;MYD88;CGAS;MX1;BCL2L1;RNASE1;CLPB;ZDHHC1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7264873314934099,-1.1581999872681243,0.2777777777777778,0.9280020848669331,1.0,2/7,11.37%,SMYD5;SFRP2
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.5232235000589134,1.1579865002370404,0.20270270270270271,0.6516877788764557,1.0,15/77,9.49%,TLR2;PTPRC;IRF7;TRIM5;MAP3K14;PLSCR1;APOBEC3H;SAMHD1;ABCC9;NLRC5;MYD88;CGAS;MX1;BCL2L1;RNASE1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.750499059575194,1.1579460253156426,0.2830188679245283,0.6513923515325846,1.0,1/6,6.88%,SMCR8
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.5976721835798217,1.1578103567560614,0.2698412698412698,0.6514061670160421,1.0,5/28,10.59%,PDGFRA;MYLK3;SYNPO2L;OBSCN;TCAP
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5152268491277,1.1576166515490316,0.24358974358974358,0.6515953575395917,1.0,16/59,13.59%,HLA-DRA;CTSS;PLEK;NAPSB;SLA;MYO1F;WAS;PTPRC;IRF7;CD37;SERPINF1;ETV6;PACSIN1;CD83;BCL11A;ITGAL
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.558885696600001,1.1572641736824985,0.21153846153846154,0.652310168816771,1.0,5/36,15.84%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6970003433551637,1.156895500281334,0.3870967741935484,0.6531292091094026,1.0,1/11,0.98%,IMPDH1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.44654065591924913,1.1562400353056956,0.10714285714285714,0.6547735726427768,1.0,38/332,11.01%,LEF1;HPN;ANK3;TLR2;RIMS2;IGF1;EGF;AMH;TESC;THBS1;IL15;PLD1;ACTA2;APP;SAMD4A;ELAVL4;RBM24;NOS1AP;SOX4;EPB41L4B;PLSCR1;EIF4A3;RAMP3;NTRK3;LARP6;PID1;SCX;MYD88;VSTM2A;MYO1C;ZNF804A;YTHDF1;SMAD3;YAP1;SMAD1;STAT3;ADAM19;NIBAN1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6482167393511655,1.156128033528968,0.32786885245901637,0.6546942936651007,1.0,6/10,31.81%,PPARG;NFATC3;NFATC4;NFIB;PPARD;SRF
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.6517490794499792,-1.1560456294002346,0.275,0.933721665007398,1.0,4/13,17.44%,ENY2;DDX25;MCM3AP;DDX19A
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.6015762203747026,1.156036608792647,0.2786885245901639,0.6545661523867564,1.0,3/15,14.81%,P2RY6;P2RY12;LPAR1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.691156599743451,1.1558126794351133,0.2909090909090909,0.6547946538274325,1.0,5/15,10.36%,CSPG4;DCN;VCAN;BGN;UST
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.5649771960447777,-1.1557655027865978,0.21212121212121213,0.9326449433469175,1.0,5/33,8.78%,OTUD3;TRIB3;THEM4;MUL1;DAG1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6323655075786219,1.1557607269455954,0.25396825396825395,0.6545129237476855,1.0,4/18,14.98%,PLSCR1;GGCT;GSS;PLOD2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.48633240951813234,-1.1557422378575077,0.2608695652173913,0.9308700875232606,1.0,8/39,20.90%,AAAS;RAE1;NUP50;NUP54;JMJD8;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5476338308947495,1.1556875474305504,0.21428571428571427,0.6543851283090433,1.0,10/43,16.22%,GRIN2A;GRIN2B;NOD1;FYN;GRIN1;SYK;USP50;NLRP2;FADD;MAP3K5
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.739598403582359,1.1556040586662677,0.3389830508474576,0.654285397441125,1.0,2/6,18.00%,SYK;ADGRE2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.734618505738199,1.1555588037051154,0.3770491803278688,0.654081195598844,1.0,2/6,9.32%,DNM1;MX1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.737685878346366,-1.1555561842491806,0.40476190476190477,0.9295697672124585,1.0,2/7,12.44%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6584234912189999,1.1554510190648266,0.3103448275862069,0.6540166148430022,1.0,6/16,18.13%,RYR2;CACNA1C;SLC9A1;ATP1B1;SLC8A1;CALM3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5360978145012781,1.1552196597247142,0.2714285714285714,0.654286401464164,1.0,28/78,25.44%,HLA-DRA;CTSS;SH3GL2;AP1S1;KIF5A;MFSD6;ACTR1A;KLC2;HLA-DRB1;KLC1;HLA-DMA;DCTN1;HLA-E;KIF3C;DYNC1LI2;DNM2;DYNC1LI1;ACTR1B;RAB7A;DCTN3;DCTN6;HLA-F;CAPZB;KIF11;AP2A2;SEC23A;HLA-A;CLTC
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6648983777828188,1.1550420869861504,0.3275862068965517,0.6544792981526102,1.0,3/18,12.04%,CENPV;MAPT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.787475579781499,1.1550121095272812,0.2857142857142857,0.654198961170447,1.0,3/6,10.76%,TNFRSF14;MAPK8IP1;SYK
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.7224080730676585,1.1550076415061945,0.2641509433962264,0.6538216426204642,1.0,2/6,16.25%,CD200;LRFN5
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.6881977417170909,1.1549951100125873,0.2857142857142857,0.653465625299586,1.0,1/12,1.30%,TYMP
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.7041307521312838,1.1549610950942812,0.29508196721311475,0.6531725294287302,1.0,3/8,18.00%,GAB2;SYK;ADGRE2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.7055045237751426,1.154957559746657,0.36363636363636365,0.6527757052917746,1.0,3/11,13.72%,ARPC5L;ARPC3;WASHC1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.7119424897483926,1.1548399556937676,0.24561403508771928,0.6527330351126799,1.0,8/8,28.83%,CDK9;AKAP8;RPS6KA4;RPS6KA5;AKAP8L;MACROH2A1;MAPK3;FMR1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.785855591514034,1.154728432409132,0.29545454545454547,0.6526696251015521,1.0,2/5,3.83%,CDKN2A;IRF7
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.7837398395511563,1.1545237982856746,0.3684210526315789,0.6528625664248406,1.0,1/6,2.44%,PLEK
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5097126771835101,-1.1542581924766884,0.13333333333333333,0.9318662555367345,1.0,5/25,18.47%,TRIB3;ARRDC4;RPS2;DCUN1D2;PLK1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7656254315555724,1.1538997935735271,0.3392857142857143,0.6543151030123445,1.0,2/7,11.69%,GRIN1;DUOXA1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.585627069147814,-1.1538902338821855,0.2857142857142857,0.931050175598278,1.0,2/18,2.25%,AR;VAMP8
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.7839753595991127,1.1534843808032587,0.25806451612903225,0.6550118239676459,1.0,2/6,4.15%,DUSP1;DUSP10
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.6977612347651686,1.1533863020450126,0.3275862068965517,0.6548918780172892,1.0,6/11,27.14%,DUSP1;CXCL12;LRCH1;SH2B3;OXSR1;WNK1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.739296108702097,1.1533519137823915,0.3220338983050847,0.6545855186609829,1.0,5/7,20.37%,FYN;ITGA3;PICK1;MTMR2;IGF1R
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5533858063136651,1.1533357477924537,0.26153846153846155,0.6542450027626363,1.0,14/51,22.03%,FSD1;LIMK2;HOOK1;CLIP2;TPPP;MAPT;KATNAL1;DCTN1;CAMSAP3;HOOK2;PLK3;TUBGCP6;RAB11A;FIGN
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6480288804714713,1.1532210777685465,0.3088235294117647,0.6541326387983253,1.0,5/13,17.01%,SLITRK1;PTPRD;LRRC4;LRFN5;PTPRS
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8162465017895251,1.1529934228352139,0.3508771929824561,0.6542962928544896,1.0,1/5,1.82%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.6783545922736223,1.152744987452083,0.35384615384615387,0.6547147865137426,1.0,3/15,13.52%,CD55;IL1R1;B2M
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.4900159007252253,-1.1525699755214687,0.1951219512195122,0.934217173802615,1.0,12/37,11.94%,GMFG;CD247;CD96;PYHIN1;CD6;CD38;IL5;CXCR4;P2RY10;ARHGAP30;BIN2;TRAF3IP3
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.8091816071351694,1.1524594214203394,0.3392857142857143,0.6551603303081458,1.0,2/5,13.86%,COL4A2;UBASH3B
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.4682665968151153,1.1523332692018753,0.2191780821917808,0.6550752238722914,1.0,34/140,16.79%,C3;TLR2;SP100;PTK6;SLA;APP;COLEC12;IRF7;SFTPD;TRIM5;TRIM61;FYN;CIITA;COLEC11;TRIM22;SNCA;PML;NLRC5;MYD88;MX1;TRIM17;CLPB;SYK;ZDHHC1;PPARG;B2M;RELB;TRIM32;HLA-E;IFIH1;PIK3CD;MFHAS1;SERINC5;IKBKG
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7134907061611787,1.1522690102034925,0.3148148148148148,0.6548594916435045,1.0,2/9,10.68%,P4HA2;P3H2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.6781935918950978,-1.1522086587867888,0.2631578947368421,0.9335851122695634,1.0,4/12,20.09%,LSM3;LSM4;RC3H1;PATL1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.4834292328530721,1.1521813495740103,0.22857142857142856,0.654754039914446,1.0,29/110,18.74%,MTMR7;SOCS3;ITPKC;SBF1;ITPKB;SYNJ2;PLEKHA2;PIGA;PGAP4;PIP4K2A;VAC14;INPPL1;PITPNM2;INPP5J;PLEKHA4;PITPNM3;INPP4A;PLEKHA8;IMPA1;FGF2;MTM1;BMX;INPP5D;PIK3CD;PIP5K1C;MTMR2;PITPNM1;PIGB;INPP5F
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6917674343229571,1.1521567658233631,0.32727272727272727,0.6544356781613951,1.0,3/11,2.57%,IL1RAPL1;NLGN1;CNTN2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6612031030900285,1.1520648819921837,0.31343283582089554,0.6543031359967038,1.0,3/15,15.75%,THBS1;P2RY12;AKIRIN1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5196166710159776,1.151996731796779,0.24074074074074073,0.6541432975417069,1.0,10/60,13.53%,RFTN1;ZDHHC9;ZDHHC22;PARD3;MYO1C;MICALL1;ZDHHC7;ZDHHC1;NACAD;SYNE3
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.7630935358698435,-1.1519098353310089,0.3684210526315789,0.9324774357469836,1.0,1/6,1.45%,HEY2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.5464027720288549,1.151624284818811,0.208955223880597,0.6548136840396797,1.0,8/37,15.01%,ST6GAL1;B3GNT2;GALNT12;GALNT8;ST6GALNAC2;B4GALT5;POMGNT1;CHST4
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.700177852144295,1.151502391228391,0.3684210526315789,0.6547497102418012,1.0,3/7,17.01%,NLRC3;RELB;PTPRS
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6910543982231881,1.1513493594653812,0.3157894736842105,0.6547680317539344,1.0,3/9,22.17%,OR51M1;OR51I2;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.5778850096877197,1.151253890353991,0.26865671641791045,0.6546082978901021,1.0,14/37,20.94%,ANXA1;IL15;PTPRC;THY1;SLC7A1;CYRIB;CD276;CCL2;CD70;ZBTB1;ZMIZ1;TFRC;TNFSF4;NCK2
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.42134717753522066,1.1510196404313415,0.043010752688172046,0.6549277889616743,1.0,86/735,13.95%,LEF1;CDKN2A;NR4A3;SKOR1;MLIP;FOSB;SIX3;KLF2;SP100;PROX1;ZNF536;MAEL;ATF3;ZNF93;ZFP36;TCEAL7;DAB2IP;IRF7;PRAME;FOXO1;ZNF140;CIC;SUV39H1;HIC1;KLF11;EFNA1;ZNF282;NFIL3;AHR;NKX6-2;GZF1;BCL6;MSX2;KLF10;CIITA;CHD3;ZNF750;NRG1;LDB2;ZNF608;BAP1;TBX20;ZBTB16;GLIS2;MYT1L;SNCA;PML;FOXO3;HMBOX1;ZFPM2;DUSP22;NR6A1;CTNNB1;CTBP2;BASP1;TLE6;NR1I3;SMAD3;ETV6;CHMP1A;YAP1;TBL1X;CDKN1C;HDAC4;GLI2;STAT3;PEX14;GLIS3;PARP9;GAS6;HDAC9;GADD45A;PRICKLE1;NR4A2;BCL11A;MLXIPL;JAZF1;PPARG;L3MBTL3;RUNX1T1;CDKN1B;FBP1;KLF7;PER1;JARID2;PRDM1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.41248320831459306,-1.151018408382573,0.11764705882352941,0.9335445976623933,1.0,58/271,13.55%,MRPL10;RPS24;RPL35A;RFC3;RPL34;RPL39;RPL37;GAL3ST2;ATRIP;MRPS21;MRPL52;HUS1;RPL13;POLD3;APOE;RPL18;POLR2K;MRPS7;RPS28;MCM9;RPL12;RPL31;RPL23;ALAS1;MRPL36;MRPL18;MRPS16;RPL41;ASMT;BRIP1;RPL6;RPS26;MCM6;RRAGC;RPL29;RPL30;RPL22;RPS13;KIN;RPL14;EEFSEC;RPSA;RPL15;POLR2C;RPS2;ATR;GAL3ST4;RPL23A;RPL11;EEF1B2;RAD9B;IGF2BP3;EEF1A1;MRPS33;MRPS18B;RPS21;MCM4;RPS23
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.4754218621398014,-1.1507695547227934,0.3,0.9324874934219711,1.0,10/44,20.90%,AAAS;RAE1;NUP50;NOA1;NUP54;JMJD8;NUP85;NUP42;RUBCNL;POM121C
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7712690983173676,1.1503379178070583,0.2962962962962963,0.6564232463853207,1.0,1/5,12.40%,ATP8A2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.5130800387798233,1.1496200188940642,0.26666666666666666,0.6581219682737408,1.0,5/58,3.77%,CXCL2;TLR2;SERPINE1;ZFP36;DAB2IP
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.696310966666157,1.1495304715065406,0.3333333333333333,0.6581177249239475,1.0,2/11,9.34%,LPCAT4;PLAAT3
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.7426929576815766,-1.148799436257606,0.3181818181818182,0.937383401649354,1.0,1/6,9.07%,GPLD1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.6827594376997058,1.1487475808236263,0.2857142857142857,0.6599021538893118,1.0,4/8,26.95%,ZDHHC7;SLC2A3;SORT1;SLC27A1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5102648561993549,1.1485776124691953,0.23529411764705882,0.6599719040326057,1.0,13/59,16.68%,SERPINE1;PTPRO;DUSP1;DMTN;PTPRC;ARHGDIG;CYP1B1;PODXL;PLXNA4;PLXNA1;SIPA1;PLXNA2;FZD7
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6916692592072402,1.148505821979742,0.34545454545454546,0.6597960932786656,1.0,5/13,10.36%,CSPG4;DCN;VCAN;BGN;UST
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.6777836552018524,1.1484828595743763,0.3389830508474576,0.6594569382246781,1.0,2/9,10.62%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.5356846684072918,1.148219148190826,0.24615384615384617,0.6597583925493176,1.0,26/79,13.59%,C3;HLA-DRA;IL15;NPDC1;CD22;ICAM1;COLEC12;IRF7;SFTPD;PLSCR1;AHR;BCL6;CD99;SAMHD1;BIRC3;ADCY7;CD160;TGFB2;SYK;PILRA;PIANP;CD276;CD200;HLA-DRB1;B2M;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.600502535270024,1.1481705352588552,0.3387096774193548,0.659535376937689,1.0,6/20,24.54%,PTK6;HAP1;RTN4;DGKD;DOK1;CBL
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.49775989247093244,1.148035212743484,0.23728813559322035,0.6594826914198424,1.0,7/66,12.90%,IGF1;NPNT;NELL1;TRPM4;CDK6;YAP1;PPARG
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7008116040007171,1.1476202014422976,0.22033898305084745,0.6603886611387871,1.0,4/11,16.47%,PRKG2;FTCD;MTHFD1L;GCHFR
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.5976265152998489,-1.1476012842829033,0.2647058823529412,0.9399952768669999,1.0,5/12,24.72%,KMT2A;PRDM7;WDR82;TET3;CTR9
prerank,PanglaoDB_Augmented_2021__Platelets,0.49002143160418776,1.1475381097988673,0.21794871794871795,0.6601996410164463,1.0,13/91,6.06%,RASGRP2;CTSS;ADGRE5;THBS1;SERPINE1;P2RY13;PLEK;MYO1F;NRGN;ITGA2;ABCC4;ALOX12;TUBB1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.7418840002845984,1.1472014366865855,0.3389830508474576,0.6608732321171294,1.0,3/7,6.12%,DUSP1;SLIT2;PADI2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.6890895512141993,-1.1470659249284396,0.3695652173913043,0.9401228611258101,1.0,2/6,13.30%,DCHS1;HEY1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.727762381681484,-1.146783412587145,0.34210526315789475,0.9394116715709705,1.0,2/6,17.49%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5563396744650647,1.146773924228674,0.2711864406779661,0.6618378383784338,1.0,8/41,15.00%,SEMA3C;FAT2;SEMA5B;SEMA3D;SEMA3B;CENPV;RADIL;SOX10
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6674124882982205,1.1467571775443943,0.3,0.6614990820746436,1.0,1/14,1.05%,HTR2C
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.7229556189558461,1.14634172690929,0.2982456140350877,0.662285934753416,1.0,2/6,15.75%,FGF2;AKIRIN1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5141618010188874,1.14615684949352,0.2,0.6623808719244764,1.0,10/63,11.36%,TGFBR2;PLEK;PTPRC;FLT1;KIRREL3;ZBTB16;KITLG;ETV6;TGFB2;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.665630144104919,1.145886236545313,0.328125,0.6627939015286031,1.0,5/10,23.67%,GAS6;HLA-E;IL12A;ZBTB1;HLA-F
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.7436540728477927,1.1457182744922312,0.34545454545454546,0.6625230005892909,1.0,3/5,15.35%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.7436540728477927,1.1457182744922312,0.34545454545454546,0.6625230005892909,1.0,3/5,15.35%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.6469975780151165,-1.145663496546858,0.2857142857142857,0.9415934251192652,1.0,3/13,17.51%,HMGB3;MTERF1;ERCC3
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6009449033355548,1.145557811614031,0.3,0.6625229565743084,1.0,7/28,18.61%,CLDN16;PARD3;POF1B;CLDN18;CLDN20;PATJ;MICALL2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.6257397811850934,-1.145404431132138,0.3125,0.9405481502070877,1.0,2/15,3.57%,NXT2;AAAS
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6298352564172112,-1.1453095070910233,0.4090909090909091,0.9389766674451862,1.0,2/9,6.45%,FBLN5;ABCD1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.605855945203012,1.1452585731383627,0.2857142857142857,0.6628741364127865,1.0,5/25,5.54%,CD22;PTPRC;IRS2;NFATC2;AHR
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5232775487343505,1.145095576959862,0.2564102564102564,0.6629751396022652,1.0,2/80,0.79%,CDKN2A;GPNMB
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.7072974870066944,1.1448470631068492,0.3684210526315789,0.663366115438612,1.0,3/11,10.85%,SIX3;GCM2;GLI2
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6235721532927961,1.1445882226340789,0.3225806451612903,0.6638173107548719,1.0,2/18,3.44%,ABCA8;ABCB1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.5403767244731851,1.1445773157492578,0.2459016393442623,0.6634458932166969,1.0,9/35,16.33%,S100A10;FHOD1;LIMCH1;SYNPO2L;ARHGEF10L;PXN;PAK1;LPAR1;PFN2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6582632246130905,1.1445335738102942,0.3137254901960784,0.6631287888022673,1.0,4/13,14.38%,ANXA1;SRPX2;HDAC9;FGF2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.6243206942532784,1.1441030932711598,0.25757575757575757,0.6640571863683794,1.0,3/18,2.25%,IGF1;CD24;IL27RA
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6756418261473043,1.1440783284046412,0.3090909090909091,0.6637266425310866,1.0,3/9,13.08%,OXCT1;HMGCLL1;SLC27A5
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7397410278405243,1.1438001630426347,0.43333333333333335,0.6641225178199953,1.0,2/6,15.37%,UNC13C;STX1B
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.5589704104806297,1.1437788586272906,0.24242424242424243,0.6637856058817457,1.0,6/27,21.15%,ODAD1;ZMYND10;SPAG1;ODAD4;DNAH17;DNAAF4
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.725618501424427,-1.1436763707265103,0.3191489361702128,0.9431425644680168,1.0,3/8,17.28%,METAP1D;METAP2;METAP1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.7191447494024791,-1.1436748155469088,0.375,0.9413004891467902,1.0,1/6,5.74%,PDZD11
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5581730125293805,-1.1436342044155976,0.28205128205128205,0.9396614146868207,1.0,8/24,20.79%,GTF2H5;CETN2;GTF2H2;ERCC2;XPA;ERCC3;UBB;PARP1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.4843883869485296,1.1435106421739871,0.2077922077922078,0.6642346978131396,1.0,6/90,8.49%,CTSC;SH3GL2;ICA1;TMED10;ATP1A1;TPD52
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.6452962186562243,1.1432390945588617,0.3157894736842105,0.6647101046255764,1.0,10/20,25.18%,CD55;TNFRSF14;CD160;B2M;HLA-E;WNT5A;TNFSF4;HLA-F;HLA-A;SCIMP
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5431884959314168,1.142939942691291,0.29411764705882354,0.6652922604879055,1.0,13/42,17.59%,A4GALT;UGT8;ST8SIA3;ESYT3;ST8SIA1;B4GALNT1;B3GALNT1;ABCA2;ST6GALNAC5;ST6GALNAC3;LARGE1;NEU4;STS
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.7521610310023706,1.1429057296396092,0.33962264150943394,0.6649889668268462,1.0,1/5,1.17%,SQOR
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.5809285624949252,1.1426927926308255,0.25,0.6651013572209123,1.0,7/24,16.22%,DAB2IP;DUSP10;MAP3K11;MAPK8IP1;HIPK3;PAK1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7280510624573192,-1.1426087533312625,0.32558139534883723,0.941336135497146,1.0,1/6,4.84%,MCRS1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.5433245391570809,-1.1425364702190306,0.2682926829268293,0.9398233933542586,1.0,6/28,14.36%,ATRIP;HUS1;BRIP1;ATR;ERCC6;CLSPN
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.660240628890689,1.142528080695966,0.34615384615384615,0.6651265819392276,1.0,1/13,2.14%,ATF3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.7066768415225967,-1.1424154056871199,0.36363636363636365,0.9383614408907485,1.0,1/6,5.24%,GREM1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.668648759148601,1.1423150309831311,0.4,0.6649562692169926,1.0,4/14,14.43%,ZYX;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.668648759148601,1.1423150309831311,0.4,0.6649562692169926,1.0,4/14,14.43%,ZYX;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.6446734440394332,1.1420219814288588,0.2807017543859649,0.6649266192641888,1.0,1/8,7.43%,STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.6446734440394332,1.1420219814288588,0.2807017543859649,0.6649266192641888,1.0,1/8,7.43%,STEAP4
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.743402522973222,-1.1419750485845275,0.2777777777777778,0.938130755298391,1.0,3/5,24.12%,ENTR1;CCDC66;CCDC88A
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.44568150296130926,-1.1418006529219,0.21739130434782608,0.9369014794648951,1.0,18/93,18.69%,FIP1L1;AAAS;RBM8A;U2AF1;ENY2;RAE1;NUP50;CPSF1;NUP54;DDX25;MCM3AP;SRSF2;CPSF3;POLR2D;DDX19A;NUP85;SRSF9;UPF3B
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.6554228378062898,-1.1416196381621977,0.35714285714285715,0.9356918296078113,1.0,2/9,7.25%,WASHC5;ARFIP2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4640359862791811,1.1415459212201056,0.2222222222222222,0.6658663956655791,1.0,23/135,13.55%,HPN;SIX3;PKP2;CNTN4;DAB2IP;ABCA5;PRAME;FOXO1;EFNA1;TRPM4;ZNF750;ZBTB16;ZFPM2;CDK6;SMAD3;YAP1;LDLRAD4;TRIO;ASXL1;SRA1;PPARG;RUNX1T1;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.6224224101868198,1.1411432003686963,0.3333333333333333,0.6666916594932288,1.0,7/22,21.57%,NRG1;BOC;CTNNB1;CTNNA1;MAPK11;MESP1;CTNNA2
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6509832751481963,-1.1407941878031904,0.3548387096774194,0.9346509795433768,1.0,2/18,2.92%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6509832751481963,-1.1407941878031904,0.3548387096774194,0.9346509795433768,1.0,2/18,2.92%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.5205447063209035,1.1407047032736997,0.23809523809523808,0.6676226407277299,1.0,8/64,18.02%,TBC1D24;PLK2;CDKL5;USP6NL;TBC1D1;TBC1D10B;IFT140;TBC1D10A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4263757847120967,-1.1406497490693694,0.2,0.9333637731133948,1.0,12/68,15.83%,CEBPA;TRIB3;PYHIN1;CBFA2T3;CCDC22;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.42960506246424035,-1.1405665445077604,0.21212121212121213,0.9317416638550529,1.0,12/67,15.83%,CEBPA;TRIB3;CBFA2T3;SIRT6;BCAP31;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5978560914429726,-1.1405154572598881,0.24324324324324326,0.9300815054139702,1.0,3/13,16.23%,BRDT;ZSCAN21;FOXJ2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7024657349169305,1.1403026782881291,0.3709677419354839,0.6684392532715016,1.0,2/5,26.07%,PHF23;RUBCN
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7428005873250656,-1.1402851941821408,0.43478260869565216,0.9289575454493763,1.0,1/5,9.14%,ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.5626768702446595,1.1399879350664368,0.24615384615384617,0.6689019449983002,1.0,10/35,16.31%,PTPRC;IRS2;SH3KBP1;NFATC2;MMP14;SYK;TNIP2;BCL2;GPR183;BST1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7620491773653273,1.1399317177041552,0.39622641509433965,0.6686652277462836,1.0,4/6,17.97%,RBM24;NRG1;HDAC9;MESP1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5849720174823324,1.1394576066291664,0.32142857142857145,0.6696660629779616,1.0,2/26,1.84%,TLR2;THBS1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4824783038120337,1.1391666288604392,0.22535211267605634,0.6700673992708068,1.0,24/90,19.43%,PTPRC;CAMK2N2;RELN;THY1;AGAP2;TSPYL2;DVL1;SMCR8;SNCA;RAP2B;YWHAG;MMD;GAS6;CDKN1A;UBASH3B;IQGAP1;CD4;TAB1;TSC2;WWTR1;PLCE1;MAP2K3;RAP1A;CAV3
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6838342996764987,1.1391223257256191,0.27419354838709675,0.6697905514372815,1.0,4/11,11.58%,KLF2;PRAME;CTBP2;ASXL1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.7035906055782136,1.1388660682367557,0.3,0.6701183040281563,1.0,5/9,21.81%,PPARG;RARG;RARA;RXRA;ACTN4
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5352738843358702,-1.13886273603113,0.35294117647058826,0.932054101941123,1.0,5/24,8.34%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.5418630461619987,1.1386691169393397,0.265625,0.6702797616153016,1.0,8/43,13.86%,PTK6;PIM3;SLIT2;THY1;NLRP12;CDK6;KLF7;UBASH3B
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.6648621689607991,1.138409952017333,0.3728813559322034,0.6705736858933964,1.0,2/8,19.40%,ACOT4;CRAT
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.6696850098946749,-1.1384041098212758,0.3333333333333333,0.9318984135313785,1.0,1/9,1.41%,GALNT3
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.7039348223762266,-1.1381188891401963,0.3055555555555556,0.9312310865300352,1.0,2/5,14.45%,FASTKD2;MTERF3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.4975808356085248,1.137845105509019,0.2608695652173913,0.6719146290639223,1.0,4/69,6.84%,RECQL4;BLM;RPA1;SAMHD1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.4659863995697964,1.1377863081686643,0.17073170731707318,0.6717103878520436,1.0,26/185,14.14%,ANLN;ARHGAP4;RAPGEF5;CCNB2;LMNB1;MYH9;INCENP;WASF1;NEDD9;ARHGEF3;CDC42EP1;SEPTIN9;MAP3K11;CLIP2;SSH2;ARHGEF7;FSCN1;TRIO;PLEKHG2;PXN;ARF6;STAU1;OPHN1;DOCK4;KLC1;ATG4B
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6166467132109639,1.1375468822398924,0.22950819672131148,0.6720228351356324,1.0,7/22,10.61%,LMO2;PCSK2;FOXO1;PAK3;ABCC8;SYT13;DCX
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6497871697326902,1.1374579418355424,0.3283582089552239,0.6719114106481132,1.0,5/15,13.64%,TYMP;DPYSL2;DPYSL5;CRMP1;DPYSL4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5511715581674542,1.137270539547598,0.265625,0.6720117474461514,1.0,9/26,18.73%,SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1;TNFRSF10B;FADD;RFFL;BRCA1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5825015208733269,1.1372462418513407,0.3235294117647059,0.6716691195222511,1.0,7/25,12.49%,SHISA7;RELN;APP;SHANK3;FAM107A;YTHDF1;EPHA4
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.41639908828763944,1.1370110298969298,0.14444444444444443,0.6719082034008957,1.0,76/776,11.00%,LEF1;SKOR1;MYT1;ELAVL2;HPN;PTP4A3;ANK3;TEAD2;TLR2;MOG;RIMS2;IGF1;PROX1;EGF;ZNF536;AMH;TESC;SH3GL2;ACTA2;PRDM8;IGF2BP2;CASZ1;NELL1;PTPRC;APP;YBX3;SFTPD;NOS1AP;HIC1;WTIP;TRIM5;TRIM61;SRRM4;ZNF282;SOX4;EPB41L4B;PPARGC1B;PLSCR1;NFATC2;NFIL3;AHR;NKX6-2;GZF1;APLNR;BCL6;CCDC3;RAMP3;ZNF114;CHD3;DVL1;SMCR8;NTRK3;PGR;MBNL2;TRIM22;PID1;SCX;ALPK2;PML;MYD88;VSTM2A;FAM50A;ZNF804A;CDK6;TRIM17;ATP1B1;SMAD3;NFKBID;YAP1;HDAC4;TGFB2;DENND4A;SMAD1;STAT3;ADAM19;AFF1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6872062258696718,1.1365226945836158,0.2857142857142857,0.6728072148039269,1.0,3/9,19.05%,MBP;KLF4;MAP2K5
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.7479622355458132,-1.1365082753355193,0.3157894736842105,0.934875474142749,1.0,2/5,17.02%,PRIMPOL;DDX21
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.7128739903857899,-1.136152861401664,0.4222222222222222,0.9343800066781656,1.0,3/7,18.36%,SLC8B1;JAM2;MIA3
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.49824836389106575,1.1359901300190112,0.2112676056338028,0.6740219022982166,1.0,16/91,11.84%,IGF1;EGF;THBS1;SERPINE1;PLEK;APP;ABCC4;PDGFA;SYTL4;TGFB2;TF;ACTN1;CYRIB;SPARC;RAB27B;GAS6
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.588195362099825,1.1358960684709725,0.2916666666666667,0.6739888425993555,1.0,6/27,8.65%,ATP2B3;ITPR3;RYR2;JPH4;MCUB;CACNA1C
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4787743296722922,1.1358569374727172,0.20270270270270271,0.6737515121307683,1.0,24/134,16.65%,VRK2;PDGFRA;PTK6;PIM3;TEC;PIM1;FLT1;STK25;MAP3K11;AATK;SIK2;MAK;MINK1;CDKL5;MAP3K21;EPHA4;ALK;PAK1;MAPKAPK5;CAMK2B;GRK5;BMX;NEK6;PINK1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.6637354433442036,1.135713808287897,0.3076923076923077,0.6737911014030199,1.0,2/10,15.16%,CD55;CD70
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7432031428217368,1.1356767961505736,0.31666666666666665,0.6735080773939066,1.0,3/7,7.18%,THBS1;SERPINE1;FAP
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5856548363404536,-1.1355532526593755,0.3870967741935484,0.9346867879705166,1.0,7/22,15.78%,TRMT61A;TRMT10C;METTL8;METTL3;RPUSD2;TRMT61B;VIRMA
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.6521705946349539,-1.1354861247569947,0.3,0.9331622588229317,1.0,3/13,13.37%,UQCRFS1;ETFB;ETFDH
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6919130496695728,1.135389558028399,0.3090909090909091,0.6740872574149185,1.0,5/12,10.36%,CSPG4;DCN;VCAN;BGN;UST
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.6944413259161867,1.1353386431029546,0.3333333333333333,0.6738043887840471,1.0,3/8,15.63%,OPHN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5840327902004074,1.1350050214479763,0.2916666666666667,0.6746061679278726,1.0,4/22,10.33%,GMPR;ADA;PRPS2;SHMT1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7440659843372519,1.134977422750208,0.33962264150943394,0.6743167583532976,1.0,3/6,18.53%,PRR5;PINK1;SYAP1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.568889126183187,1.134871795201732,0.25806451612903225,0.674152399266245,1.0,8/33,10.20%,EGF;SH3GL2;DAB2IP;TGFA;SH3KBP1;MVP;ARHGEF7;ZFYVE28
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7685424841756325,1.1348667899308844,0.4,0.6737914192042873,1.0,2/5,6.84%,NUDT16;SAMHD1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5208627219798017,1.1348269779671818,0.2786885245901639,0.6735226454282173,1.0,11/47,20.41%,KHDRBS2;RBM24;SRRM4;MBNL2;CELF3;WTAP;KHDRBS3;RBFOX2;NOVA2;RBFOX3;RBM5
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.7358552383304643,1.134734858097919,0.39344262295081966,0.6734442112133558,1.0,4/7,22.90%,EMP1;P2RX7;EMP2;ANO6
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5993002857829417,1.1344460141369594,0.3076923076923077,0.6738308488710525,1.0,6/21,16.33%,SLIT2;RAP1GAP;LIMK2;YAP1;PRKCD;PFN2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.5638572668195554,-1.1342409932209465,0.2727272727272727,0.9355868532082486,1.0,4/31,9.13%,H1-2;H1-4;TTN;KMT5A
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5944758467920659,1.1341932122990057,0.3157894736842105,0.6742235886791985,1.0,12/25,24.16%,ICAM1;TJP3;RAP2B;PPP1R16B;ROBO4;TJP2;PDE2A;RAP1A;PDE4D;RAP1B;TJP1;PECAM1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6596634732386519,1.1341827057066993,0.38333333333333336,0.6738439769605103,1.0,2/10,7.25%,TSPYL2;GMNC
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6437688270602593,1.1341560327865319,0.43137254901960786,0.6735301777787035,1.0,3/13,10.62%,EPHA2;MYO1C;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6462424841588665,-1.134025935554297,0.41304347826086957,0.9344570560934605,1.0,4/10,21.73%,DDX11;NCL;PWP1;NOL11
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5774343142447551,-1.133939091677776,0.21739130434782608,0.9330137231510616,1.0,4/17,17.41%,SELENOS;DERL2;AUP1;HM13
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.7552414370649175,1.1339091818206328,0.34,0.6737655982409004,1.0,2/7,5.54%,PTPRC;AHR
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.5950243259941732,-1.133835251460948,0.2777777777777778,0.9316766924036659,1.0,4/10,10.89%,NT5E;AMPD3;ADSS2;NUDT2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.597913737578559,1.1336280488627413,0.3220338983050847,0.6742293106606769,1.0,1/18,0.15%,CDKN2A
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5278601474727229,1.1335556001182587,0.2608695652173913,0.6739354089916665,1.0,5/41,11.27%,SLC6A15;SLC16A14;SLC17A5;SLC25A29;SLC7A1
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.7207496930399869,-1.1335105329626984,0.3191489361702128,0.9294053448437076,1.0,3/5,20.02%,GINS3;MCM4;MCMDC2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.7207496930399869,-1.1335105329626984,0.3191489361702128,0.9294053448437076,1.0,3/5,20.02%,GINS3;MCM4;MCMDC2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6589784065243853,-1.133377775718886,0.35714285714285715,0.9263780890713936,1.0,3/8,10.18%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6589784065243853,-1.133377775718886,0.35714285714285715,0.9263780890713936,1.0,3/8,10.18%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6367102997501053,1.1333436379253068,0.3508771929824561,0.674241946137898,1.0,6/12,19.43%,RYR2;CTNNB1;SLC9A1;TCAP;SLC8A1;CAV3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6421564754205137,1.1333377542518672,0.3333333333333333,0.6738636239813406,1.0,5/12,7.08%,SCN1B;KCNE4;KCNQ1;NOS1AP;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.5838655450845553,-1.1332510436886918,0.27906976744186046,0.9250942476918326,1.0,2/13,4.71%,TMEM100;FOXJ1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.6594085884103787,1.1330746450085625,0.34615384615384615,0.6742284911112362,1.0,4/10,20.65%,SYK;HLA-E;RARA;TNFSF4
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6410281531418246,1.1329091965415685,0.3793103448275862,0.6743520091734635,1.0,4/11,17.94%,NLGN1;DVL1;WNT5A;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.711834379429034,1.1329016545165214,0.3559322033898305,0.6739937949866968,1.0,5/5,28.83%,CDK9;RPS6KA4;RPS6KA5;MAPK3;FMR1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7102024649078235,1.1323860087211954,0.38461538461538464,0.6749823761833083,1.0,1/7,2.96%,SYT4
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7137137954549636,1.1323599385153964,0.40384615384615385,0.6746957174135635,1.0,3/5,20.94%,PXN;MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6459055273831507,1.1321661691144516,0.36363636363636365,0.6749161419713487,1.0,5/10,19.94%,MYH11;ALPK2;TCAP;SLC8A1;CXADR
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.762220412237198,1.1320271033653362,0.32142857142857145,0.674889574540848,1.0,5/10,13.96%,NEFL;SYBU;TRAK1;MAPT;HAP1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.656576512857224,1.1318943477068526,0.36538461538461536,0.6749798483808876,1.0,2/9,8.31%,PLK2;RAP2B
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5600599019158312,-1.1318405562390252,0.3157894736842105,0.9276930658464053,1.0,3/12,7.23%,CD6;BCL10;PTPN22
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5378090607094808,1.131517354873735,0.25,0.6757121158094661,1.0,13/38,17.43%,B3GNT2;PXYLP1;B3GALT2;AGRN;UGDH;B4GALT7;HS3ST3A1;B3GALNT1;HS6ST1;HS3ST3B1;NDST1;B3GALT5;HS2ST1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.5045985048446536,1.1314365026093607,0.2647058823529412,0.6755295705469937,1.0,11/81,11.93%,ANXA1;PDGFRA;CD55;IL1R1;TRIM5;BCL6;SAMHD1;BIRC3;MYD88;CYRIB;P2RY12
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.621037130471336,1.1314073162613227,0.31666666666666665,0.6752241415984098,1.0,7/17,19.94%,CXCL2;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C;CXADR
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5363227588602275,1.1313118605449106,0.3225806451612903,0.6751197774010903,1.0,5/43,13.70%,S100A10;DMTN;NEDD9;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6020177994286576,1.131246564942594,0.2608695652173913,0.6749637624987277,1.0,7/29,9.35%,IL1RAPL1;NLGN1;GRID2;ICAM1;IGSF21;TENM4;PTPRD
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.561765873826731,1.1312445559148525,0.23809523809523808,0.6745880307690283,1.0,6/35,4.96%,MET;PROX1;PKP2;BAIAP2L1;EFNA1;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7215025174251031,1.131149230688991,0.28846153846153844,0.6745423779209258,1.0,1/8,0.18%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.7306276908998915,1.1311375917295678,0.36585365853658536,0.6738055782349768,1.0,3/6,21.73%,HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.7306276908998915,1.1311375917295678,0.36585365853658536,0.6738055782349768,1.0,3/6,21.73%,HLA-DRB1;CD4;LGALS1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6662910504307418,1.1310493800822032,0.32786885245901637,0.6736765579004537,1.0,5/9,20.09%,SP100;RPS6KA6;HIPK2;TP53;TFAP4
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.5059315123343047,-1.13099125075496,0.23333333333333334,0.9292576935721415,1.0,6/39,13.41%,SLC25A5;CEBPA;SNRK;SLC25A38;UFL1;RUNX1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6136942369360261,1.1307276801057173,0.32786885245901637,0.6741410093913508,1.0,2/15,4.96%,ZFP36;EPB41L4B
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.6063292084133163,-1.1304144843272035,0.3488372093023256,0.9294103085507145,1.0,4/10,15.22%,BLOC1S2;VDAC2;BAD;BCL2L11
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5662030002843488,1.130266330350096,0.2903225806451613,0.6750045612342146,1.0,7/28,13.53%,SIX3;C3;SH3PXD2B;PBX3;TGFB2;MEIS3;HIPK1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.6506097086473763,1.1300945987917401,0.2878787878787879,0.6749974794824011,1.0,2/15,4.31%,NMNAT2;PRPS2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5575726104068928,1.1300111052546193,0.28125,0.6748873930619923,1.0,7/34,15.00%,SEMA3C;SEMA5B;NRG1;SEMA3D;SEMA3B;RADIL;SOX10
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.7261634012293412,1.1299425132855965,0.3442622950819672,0.6747645613554665,1.0,2/8,16.57%,SUV39H1;H3-3A
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.7111199989465297,-1.1298308148024763,0.32,0.9293496846644773,1.0,4/7,25.49%,GTF2H2;MSH3;CHTOP;MSH2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.7221028158814503,1.129323973671219,0.36363636363636365,0.6760245416709266,1.0,3/6,11.33%,KCNK10;KCNK1;KCNK12
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.716763972170049,1.1292637050302474,0.30357142857142855,0.6757919421204859,1.0,3/10,15.35%,IL15;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6670104902846422,1.1292210566801653,0.3380281690140845,0.675533908986076,1.0,5/14,17.46%,ARPC5L;ARPC3;WASHC1;SPIRE1;SPIRE2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.7732074180307442,1.129025904163825,0.43859649122807015,0.6757448402132623,1.0,2/5,20.65%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7562405912734163,1.1289805341778436,0.3939393939393939,0.675525622997545,1.0,2/5,12.90%,CTBP2;PPARG
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.6770772928224077,-1.1289320399171336,0.38636363636363635,0.9309451392918207,1.0,1/8,1.82%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.561288778570099,1.1289160017098379,0.2857142857142857,0.675300238969128,1.0,8/35,10.20%,EGF;SH3GL2;DAB2IP;TGFA;SH3KBP1;MVP;ARHGEF7;ZFYVE28
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6707832385154874,1.1287570566425633,0.2903225806451613,0.6752930270590831,1.0,3/16,4.21%,MET;PROX1;LSR
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.719144822043102,-1.1286407750769811,0.38636363636363635,0.9303027345706694,1.0,3/5,26.00%,MRPL18;TST;NPM1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.5581221733434215,-1.1285455866327878,0.34375,0.9289576260263326,1.0,5/25,12.61%,ABCD2;PXMP2;ABCD1;PEX10;PEX11B
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6536193486268848,1.1284333638061101,0.3125,0.6758239098002858,1.0,9/17,19.05%,CD24;IRAK2;PARP9;IFIH1;ELF1;KLF4;WNT5A;CBFB;MAP2K5
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.6268589744465425,1.128289070991857,0.31666666666666665,0.6758164124378803,1.0,6/14,7.20%,PKP2;SCN3B;KCNE4;KCNQ1;KCNH2;RYR2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6797743095069029,1.1282890329853916,0.3620689655172414,0.6754378038034613,1.0,3/13,9.59%,NLGN1;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.6010618323243714,1.1279797016989526,0.2857142857142857,0.6758717882564725,1.0,5/20,20.65%,PTPRC;STX4;HLA-E;TFRC;TNFSF4
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.7778999569664484,1.127967613772081,0.3050847457627119,0.6755319210929808,1.0,1/5,12.70%,ARF6
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6833352044100124,1.1278617238732707,0.36666666666666664,0.6750384715679064,1.0,4/12,15.84%,RASGRP1;CD160;HLA-E;IL12A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6833352044100124,1.1278617238732707,0.36666666666666664,0.6750384715679064,1.0,4/12,15.84%,RASGRP1;CD160;HLA-E;IL12A
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.5370984385081276,1.1278262727702317,0.32786885245901637,0.6747315432633123,1.0,12/30,19.10%,DVL1;TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;VASP;TSC2;LRP2;MTHFR;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.7313121877385984,1.1275840043127379,0.3888888888888889,0.6750116581852726,1.0,2/5,22.87%,GPS2;TRIM44
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5239384462898286,1.1273215892811237,0.296875,0.6749530542919212,1.0,5/47,16.10%,CCNB2;LMNA;CCNB1;RANGAP1;IST1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5239384462898286,1.1273215892811237,0.296875,0.6749530542919212,1.0,5/47,16.10%,CCNB2;LMNA;CCNB1;RANGAP1;IST1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5773401532331742,1.1270334028584779,0.3114754098360656,0.6754745048897374,1.0,5/25,11.93%,PTPRO;DMTN;RHOD;ARHGEF7;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.4587889540339026,1.126982688144017,0.2537313432835821,0.6752254553365894,1.0,34/145,21.27%,RASGRP2;S100A10;RASGRP1;TBC1D9;EPHA2;THY1;RGS6;AGRN;RAP1GAP;DOCK10;NTRK3;MAPRE2;ARHGEF7;SIPA1L1;CDKL5;USP6NL;CCL2;RANGAP1;TBC1D1;SIPA1;RGS16;TBC1D10B;RAP1GAP2;PKP4;TBC1D10A;NGEF;ARHGAP22;SCRIB;RAP1A;DOCK9;SEMA4D;SNX13;SGSM1;BCR
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.7219740355915152,-1.1266247184409626,0.3953488372093023,0.9338668431240275,1.0,3/6,20.12%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.6578695823425514,-1.1265842942697393,0.3488372093023256,0.9322953506289267,1.0,1/10,5.96%,SLC5A10
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.7202265285230163,1.1261412435083678,0.3125,0.6772469979556932,1.0,4/7,26.44%,CXADR;CRACD;PIWIL4;MUC4
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.6174112431079066,-1.1261221157204204,0.33962264150943394,0.9321880783052418,1.0,3/10,6.10%,FBLN5;GUCA1B;ABCB11
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.5871857045648287,1.125642940647261,0.27450980392156865,0.6782620606162811,1.0,10/23,28.83%,RBM24;TAF15;VIP;AXIN2;NOCT;FUS;DHX34;TENT5D;MEIOC;FMR1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.6323333070866431,-1.1256275371236755,0.34210526315789475,0.9319412067854298,1.0,3/9,19.73%,MICA;CEBPG;TUBB
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.5980003662412765,-1.1255024523892152,0.2777777777777778,0.9306611911721432,1.0,3/20,6.45%,ABCD2;PXMP2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5419810113700407,1.125281357721474,0.2676056338028169,0.6786407590331164,1.0,5/43,3.62%,TLR2;THBS1;RASGRP1;PTPRC;APP
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.7033336246865162,-1.1252160231110029,0.4117647058823529,0.9249627992004549,1.0,1/5,4.03%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.7033336246865162,-1.1252160231110029,0.4117647058823529,0.9249627992004549,1.0,1/5,4.03%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.7033336246865162,-1.1252160231110029,0.4117647058823529,0.9249627992004549,1.0,1/5,4.03%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.7033336246865162,-1.1252160231110029,0.4117647058823529,0.9249627992004549,1.0,1/5,4.03%,EXOSC8
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6385428110536273,-1.1250130033897705,0.35555555555555557,0.9242745381021876,1.0,6/10,20.93%,SAT1;ASMT;SRM;MOXD1;SAT2;TPH1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6294522852451663,1.1250117932627612,0.3898305084745763,0.6790126876196663,1.0,4/11,8.65%,ADCY5;EPHA2;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6473840508687153,-1.1248142095780018,0.32653061224489793,0.9218152846367308,1.0,1/8,4.18%,SRI
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6473840508687153,-1.1248142095780018,0.32653061224489793,0.9218152846367308,1.0,1/8,4.18%,SRI
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6055566625114832,1.1248021434033013,0.328125,0.6792509517939875,1.0,3/13,15.16%,WASF1;PID1;MTM1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7399740736744012,1.1247333769861176,0.30357142857142855,0.6790513692442879,1.0,1/5,24.77%,ZDHHC3
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.5472125709564568,-1.1246537204747886,0.3684210526315789,0.9205577979306884,1.0,3/18,9.95%,CSKMT;SMYD2;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.7342621377698075,1.1245398202254155,0.40476190476190477,0.6792956857592728,1.0,1/5,6.03%,FYN
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.7692470241327636,1.1245151504465354,0.42105263157894735,0.6790012787577662,1.0,2/5,13.92%,PARD3;PARD3B
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.662058521766,1.1239404743331531,0.3050847457627119,0.6799417868031823,1.0,1/15,1.28%,CCBE1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5734893228134447,1.1237872214436115,0.25,0.6799700615929675,1.0,6/23,7.84%,SLIT2;EFNA1;SLIT3;TBX20;TNFRSF1A;ROBO2
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.45152951404978775,-1.1237276285489115,0.2571428571428571,0.9216559845680027,1.0,21/83,22.60%,SELENOS;SEL1L2;TMUB2;FBXO27;UBXN8;FOXRED2;DERL2;AUP1;USP19;RNF103-CHMP3;ERLIN2;RNF5;POMT2;ATXN3;ERLIN1;UBE4A;DNAJB9;RHBDD2;TMUB1;DNAJC10;YOD1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.6898844480388403,-1.1235252009939583,0.41509433962264153,0.9205130501074461,1.0,2/6,6.39%,FBXO5;FBXO43
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.6841523827828215,1.123438570733628,0.3333333333333333,0.68059910526211,1.0,1/7,9.36%,BCL2L1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6290646921122385,1.1234161719999531,0.3389830508474576,0.6802856665090566,1.0,1/10,5.34%,SHANK3
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.7335710898355087,1.1234085276183086,0.36666666666666664,0.6799283539631712,1.0,1/5,0.37%,HPN
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6593993014107679,-1.1233921897638608,0.34210526315789475,0.9194015704857246,1.0,5/9,15.83%,ID2;ASCL1;POU3F2;EPOP;PAX6
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.540752625183726,1.1230365128846218,0.2835820895522388,0.6805879461209094,1.0,8/56,7.76%,TLR2;IL15;SERPINE1;APP;PLSCR1;NLRP12;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.6840136108375602,-1.1229912286905626,0.3333333333333333,0.9189368297551863,1.0,2/5,10.21%,COQ3;GK
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.7366204445641268,1.1229892853959145,0.3469387755102041,0.6803002739903965,1.0,1/5,3.67%,YBX3
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6060671598891963,1.1229770202163147,0.25806451612903225,0.6799435452822563,1.0,9/17,19.10%,ERBIN;CLIC4;PARD3;FSCN1;DLG3;PARD3B;MTCL1;PATJ;SCRIB
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.638133950243831,1.122563479048791,0.328125,0.6807344057165103,1.0,2/14,11.42%,SHTN1;CYRIB
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5364779437691772,1.122225767639962,0.3382352941176471,0.6812157037759754,1.0,12/58,8.65%,CNR1;ADGRE5;ADCY5;GPR12;LGR5;GNG2;RXFP1;RAMP3;GLP1R;ADCY7;ADGRL2;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6444197776572651,1.1219381611616142,0.328125,0.6816901748652264,1.0,2/15,7.63%,DMTN;PARD3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6325856560418299,1.121651100396055,0.34375,0.6821767088269405,1.0,6/17,17.80%,AGTPBP1;STAT3;IFT122;COL5A1;RARG;C12ORF57
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.6672915092546468,-1.12142031490042,0.39473684210526316,0.9224466164768228,1.0,2/8,5.24%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.6149356250717057,1.1214168227702683,0.3333333333333333,0.6825306298190719,1.0,3/14,6.08%,DUSP10;NFATC2;BCL6
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.7809319347840128,1.121310107356479,0.4,0.6820687645943397,1.0,1/5,4.00%,THY1
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.7809319347840128,1.121310107356479,0.4,0.6820687645943397,1.0,1/5,4.00%,THY1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.7206510946523692,-1.1211903817006574,0.40425531914893614,0.9198107654577024,1.0,2/8,15.11%,ABHD17A;LYPLA2
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.7206510946523692,-1.1211903817006574,0.40425531914893614,0.9198107654577024,1.0,2/8,15.11%,ABHD17A;LYPLA2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5916137019294855,1.1208097811456115,0.38181818181818183,0.6830877367867456,1.0,8/23,12.49%,GRIN2B;MBP;EFNA1;FYN;GRIN1;STAT3;USP50;EPHA4
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.6458531423355484,1.1206389569600583,0.3673469387755102,0.6831768056461266,1.0,3/8,12.32%,FAAH;DGAT1;DGAT2L6
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.6979289442008384,1.1202541703405944,0.4067796610169492,0.6838177231123357,1.0,2/10,9.69%,KLF2;ASS1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.4511386136073542,1.1201770729046798,0.20253164556962025,0.6836680838584763,1.0,16/170,10.14%,TLCD2;GOLGA8O;ANK3;ALS2CL;A4GALT;VAPB;ATP8B4;DYSF;SUN3;SYNGR2;DNM1;SYP;TMED10;HOOK1;PLEKHF1;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5982724037105605,1.1201412270891333,0.29508196721311475,0.6833870387865527,1.0,8/21,13.80%,PIM3;ADCY5;EPHA5;BAIAP3;TRPM4;STX4;HLA-DRB1;KLF7
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.485649169288832,-1.120041330368765,0.3,0.9217794902003317,1.0,14/54,24.02%,MCM6;PSMD10;PSMD12;MCM4;PSMB5;PSMD2;PSME3;PSMB4;PSMB6;UBB;ORC6;ORC2;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7657299849094151,1.1199448803606729,0.4067796610169492,0.6835383662539696,1.0,1/6,9.90%,JADE2
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.801122064508414,1.119938163913528,0.3877551020408163,0.6831763414262682,1.0,3/5,10.59%,PROX1;MYH11;TCAP
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.571584916787899,1.119569547778607,0.3384615384615385,0.6839656228274587,1.0,8/26,24.65%,SHTN1;DAB2IP;PHACTR1;CAMK2B;CAMK2A;CTNNA2;SRGAP2;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.7109491205262152,1.1195460572680223,0.4074074074074074,0.6836600241320654,1.0,3/7,12.73%,SYK;MAPT;PRKCD
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6350366258616924,1.1193803797185973,0.36507936507936506,0.6834245103187203,1.0,1/13,2.58%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6350366258616924,1.1193803797185973,0.36507936507936506,0.6834245103187203,1.0,1/13,2.58%,ZFP36
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6790659662776732,1.1191019844923318,0.3333333333333333,0.68390610857285,1.0,5/8,30.37%,IKBKG;TSC2;STK11;DAPK2;MAP3K7
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.48998620624104644,-1.1189815502231122,0.275,0.9236464101006415,1.0,10/38,13.44%,PYHIN1;RPL23;PDCL3;CCDC22;HFE;RAD23A;ARAF;RPL11;UFL1;CLU
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6510075624074112,-1.1189472346526856,0.4,0.9220964805741164,1.0,2/5,18.54%,BDP1;POLR3H
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5472747481966547,1.1188562966230544,0.2777777777777778,0.6842624235099413,1.0,9/35,19.47%,A4GALT;ST8SIA3;ST8SIA1;PIGA;PGAP4;ST6GALNAC5;LARGE1;PIGB;B4GALT6
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6222166300558432,-1.118773514974193,0.3541666666666667,0.9211328710702564,1.0,2/14,9.91%,SCNM1;PQBP1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.7063135778111403,1.1185836203316804,0.37735849056603776,0.684580942706328,1.0,1/8,0.09%,TGFBR2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.614377362835023,-1.1184972310372718,0.2972972972972973,0.9205367399808181,1.0,1/6,5.41%,RHCE
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4637304073329429,1.1184193290046762,0.2375,0.6846685652476012,1.0,34/138,19.55%,PLK2;PRKCB;TRAF3IP2;NOD1;TRIM5;MAP3K14;BIRC3;TRIM22;TNFRSF1A;MYD88;SHISA5;UNC5CL;CASP10;IKBKE;TNFRSF19;TERF2IP;APOL3;HLA-DRB1;TNFRSF10B;BRD4;TNIP2;TRIM32;LURAP1;FADD;LPAR1;CD4;NEK6;PINK1;IKBKG;TFRC;TRAF5;NDFIP2;FLNA;LITAF
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.771539783300291,1.1183846142876754,0.4230769230769231,0.684382432654714,1.0,1/5,6.92%,NTRK3
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.5656564078108463,1.1183631077802532,0.3448275862068966,0.6840530420619573,1.0,3/20,13.68%,SULF1;TBX20;ELAPOR2
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.7172745269385716,1.11807098255458,0.36538461538461536,0.6845887120096477,1.0,3/6,20.74%,DMTN;FLNA;EMP2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.6611318112382643,1.1180141422195955,0.3333333333333333,0.6843901350187795,1.0,5/16,18.33%,APOD;CABP1;CTNNA1;MFHAS1;OTUD7B
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.4740603451671035,-1.1178909074405978,0.25,0.9209792790641722,1.0,7/63,6.45%,ABCD2;CEL;MCAT;PHYH;NUDT7;ABHD1;ABCD1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.5238150246126378,1.117721867600344,0.3333333333333333,0.6848753258284678,1.0,5/40,12.16%,HELB;WAS;CGAS;TERF2IP;POLQ
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.5483654245216281,1.1176380518063087,0.3484848484848485,0.6846954411289055,1.0,6/27,16.84%,ZFP36;IRS2;CDKN1C;MAPT;CDKN1B;TP53
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.6409116811341529,1.117630907034419,0.4117647058823529,0.6843357387455196,1.0,3/18,12.50%,TTLL7;AGTPBP1;CFAP20
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7101904736313372,1.117620548134718,0.3559322033898305,0.684013651012793,1.0,1/8,1.03%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6409567146230888,-1.1175505203079596,0.32432432432432434,0.920492999270234,1.0,2/9,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.4943668395171612,1.117495657957956,0.24,0.6839895423855167,1.0,8/81,10.33%,TYMS;IGF2BP2;SAMD4A;RBM24;EIF4A3;ENC1;YTHDF1;SHMT1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.49240745312959466,1.11721114358716,0.2676056338028169,0.6842815195626771,1.0,14/96,11.85%,TEAD2;WAS;DMTN;ADD2;WASF1;FAS;REPS2;PARD3;PML;SHANK1;YAP1;TCAP;PEX14;TEAD1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.7750478222960695,1.1167106516880365,0.40625,0.6853288342904233,1.0,1/7,9.81%,PKDCC
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5842572659209033,1.1164620385619026,0.3333333333333333,0.6856197690576873,1.0,2/17,5.31%,ELMO1;WASF1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.4484495403984835,-1.1161764648785384,0.2692307692307692,0.9235501009061599,1.0,7/75,8.66%,DIRAS3;DNMT3B;SMYD5;POLR2K;POLR1F;KDM1B;TAF1D
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.6939707864134906,1.1161670236209928,0.40384615384615385,0.686071255208782,1.0,4/7,24.98%,B2M;HLA-E;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.6360668023130364,-1.1161544542506627,0.42105263157894735,0.9221102011837775,1.0,4/9,24.83%,MICA;CEBPG;TUBB;KLRD1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7237026237729909,1.1160680265857459,0.4107142857142857,0.6860275463407866,1.0,4/6,19.15%,HS6ST1;HS3ST3B1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5699309377581405,1.1159701768224597,0.3157894736842105,0.6859035385310668,1.0,5/26,11.84%,IGF1;IRS2;RTN2;PID1;SORBS1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.5958317843707542,1.115845957461042,0.3384615384615385,0.6858661447859828,1.0,7/16,27.48%,NOS1AP;FYN;UBASH3B;CAV3;PRNP;DIAPH1;CBARP
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.5103389088509419,-1.1155985876934682,0.2727272727272727,0.9223464192136702,1.0,2/28,1.48%,DAO;CYP4F3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7141390622685918,1.1149356350895934,0.39655172413793105,0.6879957948585483,1.0,2/8,16.65%,FYN;PINK1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.5508156437087267,-1.1148700214469138,0.34285714285714286,0.9229021251297861,1.0,4/23,9.13%,CSKMT;SMYD2;METTL18;KMT5A
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7479512712232115,1.1146447459818911,0.3870967741935484,0.6885373347434007,1.0,3/6,23.35%,UHRF2;HELLS;UHRF1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.693846128266616,1.1145725572154492,0.40350877192982454,0.6883690696701226,1.0,3/10,17.10%,TYMP;MACROD1;NME4
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.6771713680470176,-1.114512502012184,0.3783783783783784,0.9226831818095088,1.0,2/9,17.59%,PDZD11;SLC5A6
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5864458292212685,1.1143862742794375,0.3448275862068966,0.6884228831358228,1.0,4/24,7.76%,KCNJ2;PRKCB;PIM1;SNCA
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6479332517289611,1.1143250558696858,0.3728813559322034,0.688248700831641,1.0,4/9,27.17%,HDAC4;HDAC9;RCOR1;HDAC3
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6128500248305648,1.1141495048546866,0.3,0.6884318214815709,1.0,9/21,11.03%,KCNT2;KCNE4;KCNQ1;KCND3;KCNH2;ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.6002362058676822,1.1138785376899458,0.3793103448275862,0.6888239753780429,1.0,5/18,19.85%,RBM24;YTHDF1;PUM1;ZC3H18;FTO
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6641809165719357,1.1137190110572204,0.3125,0.6888774279608294,1.0,5/14,21.85%,ITPKC;ITPKB;FGF2;ACER3;ISYNA1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6605855718250985,1.1136127182606679,0.3492063492063492,0.688326762284343,1.0,1/9,4.83%,VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6605855718250985,1.1136127182606679,0.3492063492063492,0.688326762284343,1.0,1/9,4.83%,VLDLR
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5904979191258382,1.1135407465993594,0.2857142857142857,0.6881102092918441,1.0,4/24,12.49%,CTSC;EFNA1;RHBDF1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5489328768237383,-1.1134564878671387,0.38235294117647056,0.9245797004016298,1.0,2/22,2.58%,FAM47E;DNMT3B
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.662119241550669,1.1133184753875836,0.37254901960784315,0.688311225885454,1.0,1/8,5.45%,OXTR
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7512221843138607,1.113050648795548,0.3902439024390244,0.6885488306283173,1.0,4/7,22.43%,MYO1C;GAB1;PIK3CD;HSPB1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.6946687202662036,1.1128965164948894,0.3898305084745763,0.6885409515689989,1.0,3/8,9.12%,SOX4;NRP2;CTNNB1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6489517444137375,1.112651077787535,0.3333333333333333,0.6887720506986547,1.0,5/10,20.09%,SP100;RPS6KA6;HIPK2;TP53;TFAP4
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6708272303074361,-1.1125948965713588,0.3953488372093023,0.9257925645748105,1.0,2/7,20.09%,LSM1;PATL1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7065207771888753,1.1125486190921101,0.4264705882352941,0.6886354533836846,1.0,2/8,11.53%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.764563266363612,1.1122641047905708,0.38461538461538464,0.6890437591626224,1.0,2/5,5.16%,ABCB1;GRM5
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6668345439414678,1.1119723481924875,0.3584905660377358,0.689402686883524,1.0,3/8,17.11%,ARHGAP39;PICK1;WNT5A
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.6732308600203537,1.111930873274574,0.3137254901960784,0.6891436851781743,1.0,4/13,15.17%,CD22;PTPRC;STX4;HLA-E
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7685808712765857,1.1112639152004367,0.32727272727272727,0.6905777178322209,1.0,4/6,19.43%,KCNJ2;SLC8A3;C12ORF57;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.5171422170811998,-1.1108429836688103,0.3103448275862069,0.9299039871726468,1.0,4/35,5.56%,ID1;LAMA4;ALDH1A1;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.6873963837176887,1.1107427099961371,0.3870967741935484,0.6916681817029103,1.0,5/11,24.51%,NECAB2;WDR54;MTMR2;ANKRD13A;RIN3
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6558461635274596,1.1106703924431318,0.3559322033898305,0.6915304745284456,1.0,1/15,0.39%,CXCL2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6575052910690282,1.110586519217212,0.40350877192982454,0.6913563070159746,1.0,2/8,5.81%,DMTN;NEDD9
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.6751529192686783,1.1105364408509781,0.36923076923076925,0.6911030516620632,1.0,2/10,4.31%,ADA;PRPS2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6115963285490951,1.1101629191694877,0.4107142857142857,0.6918069395221715,1.0,3/18,11.54%,NMNAT2;NAMPT;PARP9
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.5124420951502318,-1.11011259628977,0.34375,0.9304155308323903,1.0,5/29,8.14%,ID2;GOLT1A;CFTR;KRT8;B3GNT3
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.43653376127115034,-1.110110972329239,0.2,0.9288250769335313,1.0,4/93,4.16%,NGF;FGF6;TRIB3;THEM4
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.7028640037646272,1.1099562712045261,0.38181818181818183,0.6919679347133081,1.0,1/7,1.26%,RFTN1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5502226665153891,1.1098297274591562,0.34328358208955223,0.6918913171237883,1.0,8/31,18.54%,BOK;SEPTIN4;BCL2L1;BBC3;EIF5A;BCL2;TP53;BCLAF1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5223371434425745,1.1098112038274266,0.38028169014084506,0.6915652965472419,1.0,4/35,10.19%,RTN4RL1;APP;THY1;CD160
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.6972764257971726,1.108826926589593,0.4067796610169492,0.6939095117359069,1.0,1/6,1.03%,IGF1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.6980933470329423,1.10882426898685,0.36666666666666664,0.69355845003916,1.0,3/7,13.80%,MAFF;ELAPOR2;KLF7
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5988916947424991,-1.1085370305180826,0.3333333333333333,0.932013589588812,1.0,3/12,13.30%,HEY2;HEYL;HEY1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.595462629312397,1.1085348563062607,0.3620689655172414,0.6940400752779288,1.0,5/17,14.63%,BOK;GGCT;BCL2L1;BBC3;BCL2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.6345099717749386,1.10819246640095,0.3870967741935484,0.6945819089313797,1.0,1/6,3.77%,DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.5983569547863009,1.1081596862984064,0.3076923076923077,0.69429780663646,1.0,7/23,27.37%,RFX4;GLIS2;IFT122;KIF7;GPR161;SUFU;PTCH1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.4855791967363606,-1.1081109251373913,0.2702702702702703,0.9319265402545371,1.0,9/38,12.94%,AKR1C3;TM7SF2;PMVK;ABCB11;CYP46A1;OSBPL3;CYP7B1;DHCR7;SC5D
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.6689749147018005,-1.1079978602634386,0.38235294117647056,0.9306438906828325,1.0,3/7,20.59%,SDSL;ALDH18A1;SDS
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6737244439409884,1.1078971207559203,0.3620689655172414,0.694602369453589,1.0,3/8,12.57%,HECW2;PRKCE;HECW1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.650605338233917,-1.1077086062923585,0.3488372093023256,0.9301789996251905,1.0,2/11,8.73%,IGSF1;FSTL3
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.7261092495654851,-1.1076986122662962,0.36363636363636365,0.9286024250495545,1.0,2/5,9.00%,CTSH;MICA
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.519989406952287,1.107607226852075,0.3611111111111111,0.6950460437435965,1.0,14/64,10.64%,SLC24A2;XKR4;SCN3B;SV2B;GABRG3;SRRM4;PMEPA1;CDH7;UNC13C;AIPL1;MYT1L;GRM6;HCN1;MYO15A
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6555515275866642,1.107572390639604,0.359375,0.6947682065414736,1.0,3/11,17.80%,GLI2;EPHA4;C12ORF57
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6413413169700004,-1.1073644405332936,0.32432432432432434,0.9281033364580303,1.0,2/10,5.09%,APOBEC3G;SETDB1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.4639562033772485,-1.1068537646599912,0.27586206896551724,0.9282063684093564,1.0,13/52,14.00%,CYP3A43;AKR1C3;DHRS11;ABCB11;HSD11B1;ARV1;CYP46A1;GBA2;CYP4V2;SRD5A1;CYP7B1;CYP2C8;TSPO
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.6539790711592315,1.1066590561971628,0.37681159420289856,0.6970159964801936,1.0,1/13,1.30%,TYMP
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.62587832710007,1.106611866422207,0.3492063492063492,0.6967797790007066,1.0,3/20,3.34%,GPNMB;SP100;EPHA2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5615329851856681,1.1064549828361807,0.373134328358209,0.6967676446596671,1.0,3/28,10.92%,BOK;ZNF385B;NDRG1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5457267176408211,1.106409190498569,0.30434782608695654,0.6965257624151883,1.0,6/29,7.21%,DOC2B;IRS2;BAIAP3;TRPM4;SOX4;NNAT
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.47095241598840865,1.1062768034818298,0.3037974683544304,0.6965379478607442,1.0,15/104,13.45%,CDKN2A;EGF;CD24;THBS1;APP;GRM5;LDB2;PML;NLRC5;SRPX2;CDKN1C;BARD1;CDKN1A;CDKN1B;FN1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7082410688582006,1.1060471464004644,0.4117647058823529,0.6966890390543947,1.0,4/6,27.45%,CHADL;AEBP1;COLGALT1;EMILIN1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.577463803946014,1.1059248240072403,0.3235294117647059,0.6966407578371467,1.0,8/26,26.35%,SIGLEC1;CLTB;PIP5K1C;INPP5F;AP2A2;FCHO2;CLTC;FCHSD2
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.7240902549121803,1.1056832560317502,0.375,0.6966046520899785,1.0,2/7,19.08%,SYK;SHC1
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.7240902549121803,1.1056832560317502,0.375,0.6966046520899785,1.0,2/7,19.08%,SYK;SHC1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.6065737495977348,-1.105633902253144,0.35,0.9305764313420055,1.0,2/11,17.33%,HES5;ZFP36L2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.636902706261861,1.1053480372153892,0.43137254901960786,0.6971230478376201,1.0,4/10,19.43%,KCNH2;BIN1;VIP;CAV3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.5510287191744501,-1.1052305547460632,0.34210526315789475,0.9304798183267473,1.0,1/16,9.30%,ATP6V0D2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.5634534898598306,-1.105137332462782,0.375,0.929201703106032,1.0,5/27,12.61%,ABCD2;PXMP2;ABCD1;PEX10;PEX11B
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),-0.6481474582081463,-1.1050444610323948,0.45,0.9279278768625675,1.0,3/5,16.46%,ABCB11;SLC46A1;SLC19A1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.5084321560393964,1.1049857549942876,0.32786885245901637,0.6978216171316692,1.0,4/44,3.25%,LEF1;SP100;SLA;PTPRC
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6720844927611546,1.1049843316803278,0.39344262295081966,0.6974537617720847,1.0,1/11,4.00%,THY1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6250311913508545,1.1049459013342204,0.38461538461538464,0.6972126649981473,1.0,5/14,7.08%,SCN1B;KCNE4;KCNQ1;NOS1AP;KCNH2
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.7061868903891269,1.1049234816961524,0.43103448275862066,0.6969297206721305,1.0,1/7,5.27%,OSMR
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.610360249717834,1.104503852136771,0.26785714285714285,0.6977050683409335,1.0,6/20,16.67%,ACSL5;HACD1;DGAT1;ACOT7;ELOVL7;ELOVL5
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.44988374491467203,1.1044539252495342,0.26582278481012656,0.6974702280170761,1.0,35/142,16.86%,NPY1R;PAPSS2;CHST8;ZFP36;PCP4;TJP3;LSR;GINS2;BTG3;CD44;PGR;HR;ANXA9;SEMA3B;UGDH;PLAAT3;ITPK1;ASS1;FKBP5;DLG5;AFF1;ST6GALNAC2;MAPT;TMPRSS3;TPD52L1;RAPGEFL1;FOS;BCL2;ALDH3A2;CCND1;TFAP2C;LARGE1;KLF4;ELOVL5;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5206931010369688,1.1043647755568635,0.2923076923076923,0.6973917648776213,1.0,5/41,4.15%,PSCA;PTPRC;DAB2IP;PTPRR;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.5262949699861413,1.1041362099962952,0.3230769230769231,0.6975894694771861,1.0,8/53,7.76%,TLR2;IL15;SERPINE1;APP;OSMR;NLRP12;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7268785336223573,1.1038281174570954,0.4489795918367347,0.6980449105727216,1.0,2/8,5.88%,FOXO1;FAS
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.6702071927413028,1.1037174071843834,0.4,0.6979362915632487,1.0,2/6,23.93%,MAPT;KIF13A
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.7213359575919174,1.1035604799804442,0.41818181818181815,0.6979656118919482,1.0,1/6,5.21%,PLSCR1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.46652374951036585,-1.1034888528133358,0.23333333333333334,0.9311626913630583,1.0,15/49,19.59%,ABCD2;MCAT;PHYH;ABCD1;CYP4V2;ADH5;ADIPOR1;ADH4;ECHS1;CPT2;EHHADH;MTLN;DECR1;ACADS;PEX13
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6950803667465157,1.1034106480262345,0.38181818181818183,0.6978691269110009,1.0,2/7,15.03%,RBM24;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5763494003398675,1.1033093864076473,0.3275862068965517,0.6978326043244231,1.0,1/20,0.15%,CDKN2A
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.6615250607373935,1.1032793422654912,0.4,0.6975508174127248,1.0,6/8,28.76%,NEIL2;OGG1;TDG;NEIL1;NTHL1;UNG
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5445742096223504,1.1031074217348193,0.3088235294117647,0.6976639961617008,1.0,5/38,8.23%,GGT5;AWAT1;ALOX12;FAAH;CYP1B1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7045027282091791,-1.1030136762955574,0.38095238095238093,0.931117432047472,1.0,4/6,26.77%,UTP20;RPS21;RPP40;NOP14
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.7825270038018424,1.10273369265493,0.37037037037037035,0.6976147412663378,1.0,2/5,17.53%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.7825270038018424,1.10273369265493,0.37037037037037035,0.6976147412663378,1.0,2/5,17.53%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.7825270038018424,1.10273369265493,0.37037037037037035,0.6976147412663378,1.0,2/5,17.53%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6190499141134305,1.1024448971178993,0.4032258064516129,0.6980498875518977,1.0,5/15,12.21%,NLGN1;CNTN4;NINJ2;NRXN3;ASTN2
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5920125762295746,1.102354237433354,0.3448275862068966,0.6978642979685723,1.0,7/26,7.76%,ANXA1;IL1RAPL1;SYT4;SERGEF;RHBDF1;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.5356099263075228,-1.1022954436515322,0.3023255813953488,0.9316141399813875,1.0,2/23,1.97%,OTUD3;TNFAIP3
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.608649475453512,1.1019419496477438,0.36923076923076925,0.6984836548564599,1.0,8/19,25.54%,ABCA5;PRKCH;PPARG;MAPK9;ABCG1;CSF1;MSR1;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.436551227036817,1.1018237499700894,0.25925925925925924,0.6984112350389154,1.0,29/254,10.95%,LEF1;HPN;KLF2;ANK3;TLR2;RIMS2;IGF1;EGF;AMH;TESC;ACTA2;APP;NOS1AP;EPB41L4B;PLSCR1;RAMP3;NTRK3;ECE1;PID1;SNCA;SCX;MYD88;VSTM2A;ZNF804A;SMAD3;YAP1;SMAD1;STAT3;ADAM19
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.6713172393093658,1.1012873814923085,0.3469387755102041,0.6995060541672155,1.0,2/8,5.54%,CD22;AHR
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.5003807245895863,1.101273097157021,0.2727272727272727,0.6991772491192371,1.0,5/50,16.10%,CCNB2;LMNA;CCNB1;RANGAP1;IST1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.6349547807308324,-1.1012622087295587,0.3611111111111111,0.9333069283862887,1.0,2/11,5.09%,APOBEC3G;SETDB1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.5318870499244255,-1.1010199723364265,0.35294117647058826,0.9324225926730504,1.0,3/21,7.94%,HEY2;FBXO5;S1PR1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.6183410298542669,-1.1010133664650559,0.4090909090909091,0.9308993901273841,1.0,5/13,26.58%,SNF8;TMEM50B;TMEM50A;VTA1;VPS28
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4883157110872441,1.1008942664215455,0.2753623188405797,0.6998005805639722,1.0,16/89,22.67%,ST18;MAP3K14;TNFRSF14;BIRC3;TNFRSF1A;FOXO3;EIF5A;CD70;TNFRSF11B;TP53;TRAF5;TNFSF4;ADAM17;ACTN4;TNFRSF8;CDIP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6255119928550028,1.1008539089918545,0.34545454545454546,0.6991852880915537,1.0,5/12,23.10%,DMTN;ACTN4;SPRY4;GBP1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6255119928550028,1.1008539089918545,0.34545454545454546,0.6991852880915537,1.0,5/12,23.10%,DMTN;ACTN4;SPRY4;GBP1;AP1AR
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6790256621051938,1.1008216160636446,0.3492063492063492,0.6989226675431134,1.0,3/9,10.19%,IRS2;SNCA;PRKCE
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.7331141996941821,-1.1001843667501865,0.32608695652173914,0.9316622757430485,1.0,3/6,20.12%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.6323602991066323,-1.1000155334725217,0.35555555555555557,0.9306059450604549,1.0,3/9,3.05%,WFDC10B;H2BC21;RPL39
prerank,PanglaoDB_Augmented_2021__T Cells,0.4947683177791676,1.0998446973592444,0.27419354838709675,0.7010823487637361,1.0,4/55,4.00%,LEF1;MAFF;PTPRC;THY1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5286600317147523,-1.0997322855607004,0.3548387096774194,0.9300001420052147,1.0,2/23,3.58%,NGF;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.7202755925170459,1.099559925158736,0.375,0.7014894740996666,1.0,3/7,14.10%,RAMP3;GRM6;CCL2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6310786368832221,1.0995317975316363,0.3114754098360656,0.7011964153562055,1.0,3/13,5.42%,RASGRP1;PTPRC;NFIL3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5134997095806936,1.099408589140756,0.3114754098360656,0.7011703804169543,1.0,8/53,8.24%,IGF1;DCN;PDGFRA;EGF;IRS2;FLT1;NTRK3;PDGFA
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.7384133085760097,1.0992609335693846,0.39655172413793105,0.7011917647166422,1.0,3/5,25.67%,PINK1;HIF1A;PRKN
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.561659830111469,1.0992532905190104,0.35,0.7008578693690686,1.0,9/37,14.42%,MAP3K14;PIEZO2;FAS;TNFRSF1A;MYD88;SLC9A1;GADD45A;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.7018681444015035,1.099140280282111,0.3709677419354839,0.7003981350420296,1.0,2/7,13.13%,APOD;CABP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.7018681444015035,1.099140280282111,0.3709677419354839,0.7003981350420296,1.0,2/7,13.13%,APOD;CABP1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.7485475418923977,1.0991300830637794,0.4090909090909091,0.7000533454191032,1.0,1/5,0.85%,FLRT3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5247732696047561,1.0991225411705665,0.33783783783783783,0.6997030038310432,1.0,5/45,3.62%,TLR2;THBS1;RASGRP1;PTPRC;APP
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.7570476195950278,1.0990404065267922,0.4107142857142857,0.6995656279543362,1.0,2/5,20.01%,BRCA1;CDK5RAP2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.5602685195371878,1.0988083719227557,0.36666666666666664,0.6998297707574828,1.0,3/22,7.52%,KLF2;KCNMB4;ECE1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6277565033101775,1.098281907937756,0.39215686274509803,0.7003867206809822,1.0,3/8,11.07%,B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6277565033101775,1.098281907937756,0.39215686274509803,0.7003867206809822,1.0,3/8,11.07%,B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.45749506395973166,1.0982664909385373,0.35365853658536583,0.7000665782528424,1.0,15/129,8.65%,CXCL2;TESC;SERPINE1;PTK6;ZFP36;ADCY5;DAB2IP;WNT8B;AHR;RAMP3;PID1;MYD88;ATP1A1;TFPI;ADCY2
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.7566220207487886,1.0980651407898077,0.4482758620689655,0.7003240273740082,1.0,3/5,22.41%,IFIH1;SERINC5;TLR3
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7572170044242571,1.0980171364533975,0.49019607843137253,0.7001161076300454,1.0,2/5,14.07%,SNCA;SLC29A4
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.6589214864549214,-1.0978967958898138,0.42857142857142855,0.9338465663556774,1.0,3/8,12.54%,SCPEP1;ADH6;CYP2C8
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.47257413612316707,1.0978390046935285,0.2876712328767123,0.70016142927558,1.0,6/95,6.89%,GGT5;ACSL5;LIPH;FA2H;ALOX12;FAAH
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.49688530221991434,1.0972827327593873,0.3114754098360656,0.7011771224205329,1.0,23/65,19.58%,ADGRE5;IL27RA;LMO2;PRSS57;LMNB1;PIM1;CD44;GAB3;TUBB1;ADCY7;BCL11A;GRSF1;MFSD2B;TMC8;SIPA1;GFI1B;ELF1;VASP;ADGRE2;FAM117A;TFRC;ETS1;RELT
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.7121968718726549,1.097236015963939,0.3728813559322034,0.700939693168046,1.0,2/7,16.65%,PID1;PINK1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.47854716437623845,1.096973184304886,0.30303030303030304,0.7013370375093076,1.0,7/73,5.75%,CDKN2A;PROX1;BLM;CCNB2;PSRC1;CDK5R2;CCNI2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5583784116250078,1.096939462043658,0.40789473684210525,0.7010586644257,1.0,6/36,13.51%,SLC39A14;CHST15;ALDOB;PGK1;ENO2;FBP1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.6312656853743646,1.0968512550539662,0.3870967741935484,0.7009801313693528,1.0,5/15,19.29%,TMEFF2;CD44;PDPN;MRTFA;FLNA
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7308371686384495,1.0968055162197787,0.3333333333333333,0.7008019532655849,1.0,1/7,0.18%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6308964274304711,1.0962773977222329,0.35384615384615387,0.7017848731445693,1.0,3/13,9.81%,ZBTB16;SCX;PKDCC
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.607298732517722,1.0962760018401834,0.36507936507936506,0.7014306590115291,1.0,2/16,3.77%,NELL1;DAB2IP
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.5368059586924351,1.0961937993322668,0.3442622950819672,0.7012700955694112,1.0,12/41,10.95%,FOSL2;MAFF;S100A10;SERPINE1;CD55;PLEKHG6;IL1R1;SMAGP;MLANA;GPR87;SH2D3A;ADAM19
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6166098147664176,1.0960568016175691,0.3870967741935484,0.7013028850467791,1.0,5/15,19.41%,EFNA1;ABCA2;EPHA4;SLC2A13;ABCG1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7098451101870231,-1.0958971903013204,0.4358974358974359,0.9389406230460153,1.0,2/5,19.24%,OAT;ARG1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.46404414830699303,1.0956344691039421,0.26153846153846155,0.7019617185307747,1.0,5/84,6.84%,RECQL4;BLM;RPA1;GINS2;SAMHD1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.49375729733784207,-1.0956171598142352,0.25806451612903225,0.9382859725251621,1.0,13/36,28.44%,LSM2;GEMIN4;LSM4;PRPF8;WDR77;PRPF3;TGS1;SART3;SNRPD1;SNRPB;SNUPN;COIL;PRMT7
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.7707191195653013,1.0951668778385144,0.4098360655737705,0.7027836268293208,1.0,3/5,20.68%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5932840570280897,1.0951054527043422,0.3442622950819672,0.7025993188501266,1.0,4/17,10.62%,PRKCB;PTPRC;TESPA1;PRKCH
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5910126397766369,1.0950813856588835,0.3684210526315789,0.7023100395740874,1.0,3/16,10.85%,OXTR;NRG1;GLI2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5711135635032711,1.0947528821481263,0.3442622950819672,0.7028210301722446,1.0,7/26,23.72%,ACHE;MFSD2A;CHKB;SLC44A3;SLC44A1;SLC44A5;LPIN3
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.6374486121710141,1.0947064073129464,0.4444444444444444,0.7025961319148943,1.0,2/10,7.43%,STEAP3;STEAP4
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5233753397232142,1.094543474330412,0.3333333333333333,0.7027856250129201,1.0,4/37,7.76%,TLR2;SP100;CIITA;SNCA
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5696278864958607,-1.0945061436488581,0.35714285714285715,0.9404757082792138,1.0,7/19,15.75%,ALAS1;HMBS;ABCB10;SLC25A38;FECH;TSPO;SUCLA2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4963978283823621,1.094418210388289,0.36619718309859156,0.7027941858243051,1.0,20/61,23.99%,KIF14;PLK2;FSD1;BCL2L1;CDC14A;CENPV;PRKCE;ZFYVE19;PKP4;CALM3;CDC25B;PLK3;PRPF40A;RAB11A;DCDC1;RAB11FIP4;CSPP1;CUL3;KIF13A;PIN1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6725745232235075,1.0943229076693928,0.3968253968253968,0.7027328101786409,1.0,1/10,1.30%,TYMP
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.4546252215717748,-1.0942021576115077,0.30303030303030304,0.939884026391579,1.0,13/50,12.79%,AKR1C3;ALDH1A1;HSPG2;APOE;RETSAT;APOM;SCPEP1;ADH6;SDC3;CYP4V2;ADH4;CYP2C8;RDH10
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6817208378429284,1.0941626749911921,0.3709677419354839,0.7027705108841916,1.0,2/10,10.74%,RBM24;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5273548533791644,-1.0940396452777517,0.2631578947368421,0.9389781057338973,1.0,1/20,0.22%,G0S2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.4886971219782358,1.0939628851790875,0.33783783783783783,0.7029711715175577,1.0,27/72,22.49%,THBS1;SERPINE1;PRKCB;FLT1;APLNR;CHI3L1;PAK4;CYP1B1;HK2;ADAM12;ITGB8;HIPK1;FGF2;GAB1;PIK3CD;HIPK2;WNT5A;BRCA1;ETS1;PRKCA;F3;BTG1;HIF1A;ANGPTL4;RHOB;HSPB1;VEGFD
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.46350346442513735,-1.0938670314550292,0.25925925925925924,0.9379110029685896,1.0,11/46,24.02%,PPM1K;PSMD10;PSMD12;PSMB5;NQO1;PSMD2;PSME3;PSMB4;PSMB6;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6581077559494365,1.093849581994776,0.43333333333333335,0.7029214363186295,1.0,4/14,7.93%,TYMS;TRPC3;ABCC9;VGF
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.6458390399823453,-1.0937630558902973,0.35,0.9366835069151059,1.0,3/13,9.99%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.6636640240152664,1.0937553854655626,0.4107142857142857,0.7027903355802437,1.0,2/7,0.64%,TLCD2;ANK3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.5917861600674655,1.0936795205907728,0.32142857142857145,0.7026128684187948,1.0,3/15,3.90%,ZFP36;PTPRC;SFTPD
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.7133935451648238,1.0933796156115547,0.34146341463414637,0.7029874867507447,1.0,1/5,9.95%,CLPB
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7408530750473628,1.0933309187155817,0.3870967741935484,0.70276945379784,1.0,4/5,21.81%,PPARG;RXRA;PDK3;ACTN4
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5515490759604306,1.0933212609988445,0.3188405797101449,0.7024471772293943,1.0,8/35,18.61%,CLDN16;PARD3;POF1B;CLDN18;CLDN20;CTNNA1;PATJ;MICALL2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5206937056113875,1.0932350178064378,0.28846153846153844,0.7022702448708893,1.0,5/38,15.84%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.6277918541039432,1.0929898863646326,0.3389830508474576,0.7024761423107507,1.0,1/11,3.76%,PGD
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6684797474160465,1.0929069907805553,0.3387096774193548,0.7023457330990909,1.0,1/9,5.97%,ZIC1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.7088985624620369,-1.0927763337238452,0.36538461538461536,0.9382161741873999,1.0,5/5,29.13%,MUL1;OAS3;MAVS;SIRPA;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.6909575255584018,1.0924377200294804,0.3888888888888889,0.7032406135668314,1.0,2/11,3.41%,NR4A3;IRS2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5249454885790296,1.0920427041291503,0.3225806451612903,0.7038972414229333,1.0,12/41,15.54%,ITPKC;PLCH2;ITPKB;NUDT4;ITPK1;INPPL1;INPP5A;INPP5J;INPP4A;IMPA1;FGF2;INPP5D
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5465381647224631,1.09138840175117,0.3230769230769231,0.7052012339514908,1.0,8/33,21.94%,SMCR8;PIP4K2A;PHF23;MTM1;PINK1;LRSAM1;MTMR3;ELAPOR1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5775286407102365,1.0913270424776123,0.3709677419354839,0.7050523599102904,1.0,6/28,14.32%,APP;GRM5;FOXO3;TMED10;PRKCD;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5893389691769426,1.0910029811788067,0.3870967741935484,0.705579911226615,1.0,2/23,6.78%,ANXA1;LSM11
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.6008056368570311,1.0906585297728817,0.39344262295081966,0.7060029392227964,1.0,7/19,19.94%,CXCL2;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C;CXADR
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.49107942350983164,1.0905922455090507,0.30666666666666664,0.7057614971690889,1.0,28/108,16.73%,SERPINA10;EGF;CLDN16;SNCB;GRID2;EPHA5;ARHGDIG;RYR2;ZBTB16;PRODH;KCNQ2;DCC;NR6A1;STAG3;MX1;MFSD6;MYO15A;TGFB2;BARD1;NR4A2;ARPP21;GPRC5C;SOX10;CHST2;CAMK1D;CLSTN3;COPZ2;PNMT
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6427473501938602,1.0904939787147354,0.35185185185185186,0.7056184122945366,1.0,4/8,19.47%,SNCA;GFAP;EEF1A2;PLK3
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.7179886319721533,-1.090236672308279,0.4634146341463415,0.9442923018798292,1.0,4/5,28.17%,DMC1;RAD51;FANCM;RAD54L
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.6207189659406,1.0898839311362682,0.36065573770491804,0.7067156883580566,1.0,5/14,25.53%,IRF7;IFIH1;TBK1;TLR3;DHX9
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6980317629169847,1.089421244351893,0.44642857142857145,0.7074659244301106,1.0,4/8,24.38%,NOS1AP;BIN1;CACNB2;SESTD1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.44081642855784353,1.089392805960323,0.24691358024691357,0.7072069436273913,1.0,44/178,19.55%,PLK2;PRKCB;TRAF3IP2;DAB2IP;NOD1;CARD19;TRIM5;MAP3K14;NLRP12;BIRC3;TRIM22;TNFRSF1A;MYD88;SHISA5;UNC5CL;CASP10;IKBKE;TNFRSF19;NLRC3;TERF2IP;APOL3;MAPKBP1;HLA-DRB1;TNFRSF10B;PER1;BRD4;TNIP2;TRIM32;LURAP1;OPTN;FADD;LPAR1;CD4;NEK6;PINK1;IKBKG;WNT5A;RORA;OTUD7B;TFRC;TRAF5;NDFIP2;FLNA;LITAF
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.5860440824600323,-1.089153278496897,0.34375,0.9462592382329109,1.0,2/10,6.45%,ABCB11;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6427185247032245,1.0891469077856035,0.4107142857142857,0.7074608392443433,1.0,4/12,21.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.49411045711778434,1.0891004745182646,0.3188405797101449,0.7072136357110245,1.0,5/63,8.21%,CTSC;VAPB;TGFA;GRIA1;TMED10
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.6735072775043122,1.0888928603179602,0.359375,0.7073809633677448,1.0,1/9,1.30%,TYMP
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.5256790777180047,1.0885547585467705,0.36923076923076925,0.7080542123716149,1.0,7/42,11.98%,EGF;TRIM46;DVL1;RAB11FIP5;CTNNB1;ABCA2;MAPT
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.5885809444155399,-1.0885370952994726,0.37142857142857144,0.9467544865902898,1.0,2/17,2.30%,CYP4F3;CEL
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.7534767512746969,1.0885057324139724,0.43859649122807015,0.7077955871884589,1.0,4/5,20.45%,TPST1;UST;CHST4;TPST2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6744178583346258,-1.088477359353219,0.4,0.9453975741868647,1.0,4/7,25.95%,SLC30A5;DNAJC30;SPHK2;ANTKMT
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.5285507705207045,1.088186741375454,0.37142857142857144,0.7082323956673509,1.0,4/27,7.21%,DOC2B;IRS2;SOX4;NNAT
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.5813700505099678,1.0881352811762703,0.3442622950819672,0.7080141373831476,1.0,5/15,21.15%,ODAD1;ZMYND10;ODAD4;DNAH17;DNAAF4
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.6253595422502708,1.0881222115241502,0.46153846153846156,0.7077157459967715,1.0,2/11,10.62%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5672855876920362,-1.087915701419559,0.36,0.9454931401604317,1.0,2/14,6.18%,ID2;CXCR4
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.42235304381716055,1.0878953201500807,0.2948717948717949,0.7079167366825581,1.0,47/270,14.31%,CDKN2A;HPN;ST18;GPNMB;PROX1;TESC;OGN;NELL1;APP;DAB2IP;DUSP10;PODN;KLF11;FABP3;SOX4;BTG3;CLMN;KLF10;APOD;IGFBP7;BAP1;FAP;PML;CYP1B1;ZBTB7C;CTNNB1;CTBP2;CDK6;NLRC3;LMNA;NEURL1;B4GALT7;DLG5;CDKN1C;P3H2;TGFB2;ATP8A2;CDKN1A;PPARG;CD200;CDKN1B;B2M;PDPN;DLG3;PAK1;CGREF1;TRIM32
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.5591849268994598,1.087820193393958,0.3548387096774194,0.7077448351536928,1.0,11/25,18.66%,FOXO1;ZFPM2;SMAD3;YAP1;TRIO;ASXL1;RUNX1T1;WNT5A;RORA;WWTR1;GPS2
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6933476290933173,1.087633037538759,0.48214285714285715,0.7078596472201766,1.0,1/7,3.14%,WAS
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6125312011526676,1.0876286766606962,0.3333333333333333,0.7075218362554465,1.0,1/16,0.93%,TLR2
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.7314552776526322,1.0874345183274157,0.39344262295081966,0.7076881706905571,1.0,2/5,13.51%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.4212512075907319,1.0866728815267643,0.20987654320987653,0.709473723418517,1.0,48/273,15.35%,ENPP2;C3;CSPG4;GPNMB;IGF1;EGF;IL15;RASGRP1;PTPRC;TEC;RELN;APP;BMP8A;NEK10;AGAP2;EFNA1;CD44;FAS;APLNR;TNFRSF14;RAMP3;NTRK3;GHR;CHI3L1;CDK9;SNCA;NPTN;PDGFA;LIMCH1;LIMK2;SH2D3A;MMD;RBPMS;TGFB2;NIBAN1;WDFY2;GAS6;TERF2IP;CDKN1A;HLA-DRB1;CEMIP;PAK1;FGF2;SLCO3A1;CCND1;MRE11;IQGAP1;CD4
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.5464982760611912,1.0865642748847706,0.33962264150943394,0.7093643853985412,1.0,6/17,22.80%,KCNH2;SLC9A1;PDK4;SLC12A5;SLC12A7;SLC12A4
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.7079036483343938,1.086538824749448,0.4032258064516129,0.7090493635314479,1.0,2/6,11.25%,CACNA1C;ORAI1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.49819497743726354,1.0862459540619744,0.3472222222222222,0.7093860096076128,1.0,11/71,13.08%,EGF;CLDN16;ZNF750;EPB41L4A;ZBTB7C;ADGRF5;ALDH1L1;PDZD2;CFAP61;ITGB8;OPHN1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.662709174380385,1.0861853343220764,0.37254901960784315,0.7091226888256046,1.0,4/9,12.90%,MYH9;PIR;PDE1B;PPARG
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6790372043911824,1.085968445846761,0.4,0.7092934323904846,1.0,6/11,24.20%,DUSP1;CCNB1;LCMT1;CDK5RAP2;DYNC1LI1;USP44
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6839709228620405,1.0856250278157247,0.38333333333333336,0.7098804746795808,1.0,2/8,16.65%,PID1;PINK1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4815128017380751,1.0855188372225724,0.3055555555555556,0.7098168787962273,1.0,17/84,12.12%,ABO;COBLL1;EGF;PLD1;CLDN16;CLMN;LPP;TRHDE;EPB41L4A;ZBTB7C;ADGRF5;ATP1B1;ALDH1L1;PDZD2;GDA;CDKL5;ITGB8
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.4738386029369145,1.084814104194341,0.3888888888888889,0.7113947635577899,1.0,19/78,13.70%,NR4A3;HLA-DRA;ANXA1;CTSS;CD22;PLEK;SLA;MYO1F;PTPRC;PLAC8;VCAN;ASS1;ETV6;ADAM19;CD83;HLA-DRB1;RELB;ITGAL;PDPN
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.5037233908365992,1.0845727856735006,0.3142857142857143,0.7117121428708465,1.0,15/64,20.09%,SP100;PLK2;SOX4;PML;NDRG1;GADD45A;CDKN1A;CDKN1B;CCNB1;RPS6KA6;HIPK2;TP53;PLK3;PRMT1;TFAP4
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5186807554782118,-1.0844824129757062,0.3611111111111111,0.954449900590009,1.0,5/17,24.62%,SELENON;RYR1;MYORG;ZBTB18;CAV2
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.7405935204113694,1.0842646315530773,0.5,0.7121089173141458,1.0,1/5,7.52%,C1R
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.47281215313062935,1.0842343636616676,0.3333333333333333,0.7118223948512058,1.0,28/122,11.44%,C3;BOK;AMH;FAM20C;CD55;SHC2;DAB2IP;ARHGEF17;SEMA5B;FAS;CDC42EP1;PADI2;TNS1;PTPN21;RASL12;MATN2;RHBDF1;C1R;MAOB;SCX;KITLG;SEMA3B;LAMA5;BGN;ARHGEF10L;YAP1;TF;PXDC1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.5541443479171944,1.0840833750498968,0.36507936507936506,0.7117466142086623,1.0,2/26,10.34%,PLK2;CHMP1A
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.6670988463346059,-1.0839811981995402,0.425531914893617,0.9545679118645787,1.0,4/9,21.62%,PPCS;PDHA1;ACSS1;MLYCD
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.7065844629237594,1.0836180142218415,0.39655172413793105,0.7121919261116589,1.0,2/7,9.32%,DNM1;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.7065844629237594,1.0836180142218415,0.39655172413793105,0.7121919261116589,1.0,2/7,9.32%,DNM1;MX1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6748303497076392,1.0834593415806815,0.4339622641509434,0.7123886920367141,1.0,3/8,12.73%,SYK;MAPT;PRKCD
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5890699344704668,1.083367451075119,0.35185185185185186,0.7123184572953803,1.0,7/17,19.94%,MYH11;NRG1;ALPK2;TCAP;SLC8A1;MESP1;CXADR
prerank,MSigDB_Hallmark_2020__Androgen Response,0.4694583886483287,1.0831320186963524,0.3333333333333333,0.7126568119602283,1.0,25/92,23.18%,ABCC4;PMEPA1;GUCY1A1;PTPN21;STEAP4;TPD52;CDK6;DHCR24;FKBP5;MAK;NDRG1;ACTN1;DBI;B2M;CCND1;ELOVL5;ZMIZ1;ADAMTS1;PIAS1;MAP7;INPP4B;HMGCS1;MAF;UBE2I;PLPP1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.7241200847913326,1.0830519600345543,0.46296296296296297,0.7125411453056688,1.0,2/5,11.98%,BAG3;MAPT
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.5452703193025619,-1.0830218909133364,0.3076923076923077,0.9561515001941072,1.0,5/18,18.47%,FBXO5;RPL23;RPL11;BAG2;PLK1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5024549624417645,-1.0828779183725155,0.25,0.9549640423166639,1.0,1/30,0.51%,TAX1BP3
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.51340750929387,1.0828034616630424,0.34285714285714286,0.7127543520747212,1.0,10/40,13.66%,BLM;ADCY5;GLRA2;AHR;GNG2;ADCY7;ADCY2;CTNNB1;CTNNA1;KLF9
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.6690858916167906,1.0827870924917176,0.46153846153846156,0.7124404613717804,1.0,4/7,21.32%,GRIP1;GRIP2;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6172184851634686,1.082430069281899,0.4,0.7130725413838946,1.0,6/16,19.47%,IGF1;EPHA2;GAS6;CCL2;TSC2;PLK3
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.5113719513411819,1.0823074783363604,0.37681159420289856,0.713019156069047,1.0,14/55,12.73%,CDC42EP3;SLIT2;BAIAP2L1;PAK3;BAIAP2;CDC42EP1;ARHGAP18;SSH2;PRKCE;FCHSD1;CYRIB;PLEKHG2;ARF6;PRKCD
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.6569643522495929,-1.082233601591528,0.4186046511627907,0.9553159495786984,1.0,4/7,9.99%,APOBEC3G;CDADC1;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7324789339908371,1.0821493696206341,0.5094339622641509,0.7131694764368197,1.0,2/6,13.35%,BLM;ZFYVE19
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6291662695189444,1.0819660486299036,0.43548387096774194,0.713240488868638,1.0,2/10,6.89%,PTPRC;NRG1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.4441335184812689,-1.0818104536723947,0.3333333333333333,0.9548507246798885,1.0,4/46,5.52%,DCLRE1B;FANCF;ATRIP;MCM9
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.58263196077222,1.0816256961572617,0.3880597014925373,0.7137861506396405,1.0,4/23,7.52%,C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6233935557655017,1.0810746355896153,0.40298507462686567,0.7149130814734285,1.0,6/16,21.42%,NLRP12;NLRC3;IFI35;HDAC7;NMI;TSPAN6
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5473613741347316,-1.0809217968755251,0.4,0.9558929514119013,1.0,5/17,14.50%,SRPRB;SRPRA;SPCS1;ZFAND2B;SPCS2
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.6734748777944188,1.0805918034486552,0.42592592592592593,0.7157283771646619,1.0,1/9,7.39%,AIPL1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.45879885609391213,-1.0804597299855827,0.2727272727272727,0.9557363974863587,1.0,3/54,4.65%,FGF6;GALNT3;POLR2K
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5961817266776037,1.0802666642640313,0.42857142857142855,0.7163002161914143,1.0,3/13,12.50%,CTU2;GTPBP3;TRMT9B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.6958397595569648,1.0801959550067657,0.375,0.7161608175949146,1.0,3/8,12.75%,GAB2;SYK;STX4
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6315375638469087,1.0800728114971792,0.38181818181818183,0.7160722938986311,1.0,2/14,4.77%,CD55;TRIM5
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.5983029927209573,1.0798237966866178,0.4262295081967213,0.7163670168432733,1.0,7/16,15.84%,HLA-DRA;PTPRC;CYRIB;HLA-DRB1;FADD;HLA-E;IL12A
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.6673641981046846,-1.079813757268857,0.43902439024390244,0.9563063174194433,1.0,1/6,4.17%,RHOH
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.6606162166982888,-1.0795278409892668,0.3888888888888889,0.9556090595477024,1.0,3/6,18.17%,ATP1A2;NLGN3;MTG2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.595028682370361,1.0795044800448301,0.3492063492063492,0.7167121363878936,1.0,7/21,20.84%,TMEFF2;CD44;COL5A1;PDPN;MRTFA;FLNA;ADAM17
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6039415209981644,1.079265447976663,0.40350877192982454,0.7168655249389353,1.0,5/19,16.34%,LPCAT4;PLAAT3;DBI;PLB1;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6814081668954786,1.0790913648919698,0.4603174603174603,0.7169737514210618,1.0,1/8,6.33%,MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),-0.6185518605832458,-1.0790477334791702,0.34210526315789475,0.9555150297556448,1.0,1/7,1.81%,RGS2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.6679008030310634,1.0788603583238756,0.4426229508196721,0.7171887196935259,1.0,2/12,13.44%,APLNR;AKAP8
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.538511939788,1.0785390881864714,0.3333333333333333,0.7176564137616006,1.0,7/30,7.08%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.4869742371168425,1.078392475689823,0.40789473684210525,0.7176011676043256,1.0,12/75,11.89%,MYRF;CTSS;MMEL1;PCSK2;C1RL;ECE1;C1R;ATP23;KLK6;MMP14;ADAM19;MMP16
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6483340609745152,1.0780986292058583,0.39215686274509803,0.7177041148648238,1.0,7/9,31.62%,NFATC2;NFATC3;PPP3CC;PPP3CB;NFATC4;PPP3CA;ADGRB2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6483340609745152,1.0780986292058583,0.39215686274509803,0.7177041148648238,1.0,7/9,31.62%,NFATC2;NFATC3;PPP3CC;PPP3CB;NFATC4;PPP3CA;ADGRB2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.5280797420575569,1.0779299812561776,0.4603174603174603,0.7177667322253324,1.0,5/42,10.85%,EGF;BLM;TSPYL2;GMNC;GLI2
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.6634931273424639,1.0778737684315363,0.3620689655172414,0.7175937926862835,1.0,2/8,8.07%,PTPRC;LDLR
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7365222485639953,1.077764248684447,0.3333333333333333,0.7175331085133128,1.0,2/6,20.59%,DOCK10;LFNG
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.5318171084830239,1.0777035541783755,0.3333333333333333,0.717366054717589,1.0,12/27,19.94%,IGF1;DYSF;MYH11;ALPK2;TCAP;NEBL;BIN1;NEB;SLC8A1;MYOF;CAV3;CXADR
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7094153131095486,1.0776078082476774,0.4528301886792453,0.7172663501580341,1.0,4/7,25.89%,SNCA;ABCG1;BMP6;PTH1R
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7196522010162597,1.0775171933837862,0.45454545454545453,0.717149955165148,1.0,3/5,18.89%,PML;HIPK2;ETS1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.5283821805934695,-1.0771839644155574,0.3333333333333333,0.959168624476136,1.0,3/17,6.88%,APOE;ABCB11;ARV1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.6554074836738976,1.0766337600156242,0.47058823529411764,0.7192038763307225,1.0,3/12,9.80%,DYSF;MYH9;SYTL4
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.5118116437359466,1.0765718905347192,0.4090909090909091,0.7190139695423249,1.0,3/46,9.14%,ENPP2;TRHDE;ENPEP
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5643554604152308,1.0764358171061479,0.4090909090909091,0.7191092279857763,1.0,6/20,15.06%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5661197036922254,-1.0758623884596237,0.4117647058823529,0.961685792681106,1.0,3/14,10.83%,SELENOS;CREB3L1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.6714016081448202,1.0757710803148093,0.42857142857142855,0.7204275299901788,1.0,4/7,20.25%,TRPM4;OXTR;SMTNL1;ADRA1D
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5177425168527757,-1.0757185346481921,0.3170731707317073,0.9604961435812244,1.0,3/21,12.62%,TPP1;USE1;BECN1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.7116061927271815,1.0756928001821884,0.42105263157894735,0.720259633064002,1.0,3/5,20.50%,NTRK3;ANGPT2;F3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.7231003479367977,1.0753531570840744,0.45,0.7207949351133426,1.0,2/5,24.32%,SCARB1;MSR1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.6660909254553763,1.0753063117960688,0.45454545454545453,0.7205489459014415,1.0,4/8,31.14%,PDPN;EMP2;GSN;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.5974287953442552,1.075252847319008,0.375,0.7202920484039009,1.0,4/9,13.05%,PDGFRA;LDLR;PDGFA;CD200
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.5256972428249901,1.0749123882337923,0.3548387096774194,0.720809836841029,1.0,7/31,10.51%,KIF14;TYMP;HES7;NKX6-2;TENM4;CTNNB1;YAP1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.7127243177222897,1.0748000869144896,0.5555555555555556,0.7207145567065746,1.0,3/6,24.93%,KLF4;DLEC1;RBMS3
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.676400609174884,-1.0742794472728943,0.5,0.9635761235508004,1.0,2/8,6.19%,TMEM100;ASB4
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.49819541434337383,-1.0741772944842558,0.38461538461538464,0.9623629064306793,1.0,4/31,11.33%,REEP6;AAAS;GAS1;DNAJC30
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.733056159415614,1.0740958686051678,0.47368421052631576,0.7220609755357067,1.0,1/5,8.71%,BAG3
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.7343712875396896,1.0736699062265584,0.4444444444444444,0.7226828490856921,1.0,1/5,4.24%,NOS1AP
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6664577160780906,-1.0736155497013335,0.4074074074074074,0.9622348446758662,1.0,1/5,12.12%,PDHA1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5361901986554646,1.0732960186638771,0.4126984126984127,0.7232373895873361,1.0,9/28,17.01%,SEMA3C;SEMA5B;TRIM46;SEMA3D;MAG;SEMA3B;DIP2B;KIAA0319;PTPRS
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5298126211422758,-1.073200510242967,0.3888888888888889,0.9617675221376352,1.0,7/17,11.94%,CD247;CD96;PYHIN1;CD6;P2RY10;BIN2;TRAF3IP3
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6203130213799666,1.0731476034312009,0.417910447761194,0.7232911774916783,1.0,5/12,18.83%,FABP3;PPARG;PDK4;ADIPOR2;NCOR1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.5679645380189442,1.0726652078889696,0.3684210526315789,0.7242170822717778,1.0,1/17,1.48%,EGF
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4464138620449932,1.072424631772825,0.3333333333333333,0.7244646797075921,1.0,23/128,11.15%,MTMR7;SGPP2;PTPRO;DUSP1;PLPPR5;PTPRC;PTPRB;PLPPR4;PLPPR1;PTPRR;DUSP10;DUSP8;PXYLP1;DUSP16;PDP1;SBF1;PTPN21;PLPP4;PTPRD;SSH2;PTPN9;PPP1CB;ALPL
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.6353423351642666,1.0720932216635384,0.4,0.7250505754932343,1.0,7/12,30.41%,APLNR;AKAP8;AKAP8L;DYRK1A;CTBP1;BRMS1;NNMT
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.5003202037838782,1.072006225934522,0.42424242424242425,0.7249647001951677,1.0,8/46,7.08%,KCNJ2;KCNQ1;NOS1AP;KCNIP4;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.5686658615738415,-1.071821046720242,0.40384615384615385,0.9644749568547462,1.0,2/14,7.76%,NEU1;ASAH2B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.6331821762530588,1.0717592103463462,0.3939393939393939,0.7251893964068904,1.0,5/12,19.05%,ANXA1;MAPKBP1;KLF4;OTUD7B;MAP2K5
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.44884610457780605,-1.0716472313047076,0.3548387096774194,0.9634614131565846,1.0,7/75,5.56%,ID2;MID1IP1;DISP3;TM7SF2;PMVK;NPC2;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.653299748289564,1.0716399797921587,0.40350877192982454,0.7251589544946447,1.0,3/9,19.41%,ABCA5;PPARG;ABCG1
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.720217024241453,1.071477417850613,0.36538461538461536,0.7251950107482663,1.0,3/5,26.99%,CDKN1A;STK11;MME
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5192373165118019,-1.0712895176934414,0.4166666666666667,0.9630064386327674,1.0,2/24,3.58%,H1-2;H1-4
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7335884274241626,-1.071150673418701,0.4444444444444444,0.9619139624774786,1.0,3/5,24.84%,ZFAND2B;SEC61A1;SRP54
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.7204598180793226,-1.070870254559344,0.4473684210526316,0.9612100525452761,1.0,3/6,23.57%,CTH;MPST;TST
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5714135038259311,-1.0708404721378635,0.4634146341463415,0.9597752572076549,1.0,1/21,1.69%,CSKMT
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6058423044106002,-1.0705459454443307,0.4146341463414634,0.9593168334974298,1.0,3/9,10.18%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.5151634447782548,1.0704665328745098,0.3387096774193548,0.7272960974310406,1.0,11/40,15.54%,ITPKC;PLCH2;ITPKB;NUDT4;ITPK1;INPPL1;INPP5A;INPP5J;INPP4A;IMPA1;INPP5D
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.49449807868121315,1.0703979416728144,0.3611111111111111,0.7270710000682046,1.0,7/68,3.62%,TLR2;IGF1;THBS1;RASGRP1;ZFP36;PTPRC;APP
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.7173538381093536,1.0703581720108823,0.4,0.72679634166134,1.0,3/5,17.11%,NLRC5;FADD;WNT5A
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.6482489312917735,1.0702791390999775,0.453125,0.7266325157200139,1.0,4/11,19.02%,CDK9;AKAP8;HPF1;MTHFR
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.523360004978032,-1.0702597872528306,0.41379310344827586,0.9588119098291527,1.0,7/31,13.30%,TRMT61A;TRMT10C;TRMT10A;FTSJ1;METTL2A;TRMT61B;TRMT5
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.6323216399317084,-1.0700537758128945,0.45454545454545453,0.9564810360658801,1.0,4/7,27.06%,EEFSEC;SECISBP2;DIO2;SEPSECS
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.6323216399317084,-1.0700537758128945,0.45454545454545453,0.9564810360658801,1.0,4/7,27.06%,EEFSEC;SECISBP2;DIO2;SEPSECS
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.6356112220130298,1.0699212259911746,0.4423076923076923,0.7271871833792262,1.0,1/8,10.06%,AK5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.5198447163003518,1.0698594364848322,0.3492063492063492,0.7270067579343297,1.0,7/25,15.84%,THBS1;SULF1;FLT1;SPARC;PPARG;CCL2;IL12A
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.6632933776872442,1.0697392463781208,0.4339622641509434,0.7269534740995962,1.0,1/6,7.40%,TBX20
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5885263013510008,1.0694502119763414,0.4166666666666667,0.7273195828659393,1.0,5/14,11.79%,ADCY5;GUCY1A1;ADCY7;ADCY2;GUCY1B1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.6410065939512455,-1.0693760119800004,0.4583333333333333,0.9567698691174178,1.0,3/6,25.49%,RNF168;RNF8;MSH2
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7386874890656309,1.0692926908964704,0.4166666666666667,0.7273985590076063,1.0,1/5,1.85%,PKP2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5649539986782374,1.0691154226188995,0.390625,0.7274333603543509,1.0,8/23,12.38%,ADCY5;LGR5;GIPR;RXFP1;GLP1R;ADCY7;ADCY2;CAP2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.4370490235195713,-1.0691130259353867,0.37142857142857144,0.9561291036894516,1.0,9/39,7.94%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;CXCR4;P2RY10;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.5155867440021954,-1.0689879204655628,0.4375,0.9550385582420995,1.0,3/18,3.00%,APOBEC3G;TEX15;SMYD5
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.4118376926530324,1.0688719019513833,0.2911392405063291,0.7276554566090492,1.0,23/339,8.01%,SKOR1;MYT1;ELAVL2;PTP4A3;TEAD2;ZNF536;PRDM8;CASZ1;HIC1;WTIP;ZNF282;SOX4;PPARGC1B;NFATC2;NFIL3;AHR;NKX6-2;GZF1;ZNF114;CHD3;DVL1;TRIM22;PML
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.6778302452489054,1.0688611292401036,0.46153846153846156,0.7273321452217002,1.0,1/7,1.53%,TEKT2
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.6781383329329373,1.0688246822122422,0.4745762711864407,0.7270917107213472,1.0,2/6,17.96%,FADD;ZBTB1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6729929666504865,1.0687403708045944,0.38,0.7269670435397992,1.0,4/7,28.18%,YAP1;TRERF1;UBR5;NEDD4
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.6988152575111234,1.0687244405862795,0.49056603773584906,0.7266335324853981,1.0,5/6,29.35%,SMAD3;SMAD1;SMAD2;EID2;TGFB1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6200084239497075,1.068696528695782,0.3793103448275862,0.726349810060811,1.0,1/12,1.20%,GRIN2A
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.49792959737922965,-1.0685454339258293,0.3870967741935484,0.9546516895478374,1.0,5/27,15.68%,CSKMT;SMYD5;KMT2A;PRDM7;WDR82
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.39825683967229475,-1.0685250999744387,0.2608695652173913,0.9532941654393571,1.0,37/185,19.63%,KPNA2;RPL34;LSM7;SNRPB2;CCT7;SF3A1;RPL18;DDX18;KARS1;U2AF1;LSM2;NOP56;EIF2S1;RPL6;MCM6;RPL22;RPL14;EIF1AX;RPS2;VBP1;EPRS1;EIF3D;EEF1B2;MRPS18B;MCM4;AIMP2;SRM;SRSF2;EIF3J;DDX21;CUL1;TARDBP;PRDX3;NOP16;FBL;HDGF;CYC1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.4548594418367218,-1.0683378757133293,0.30303030303030304,0.9524851439838649,1.0,6/45,12.47%,FTL;FTH1;ATP6V1G1;SLC46A1;HFE;ISCU
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6860269490203743,1.0681530911464874,0.45454545454545453,0.7274013443520818,1.0,4/7,21.54%,PRKCB;ARNT;HIF1A;GRB10
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.6603196880976729,-1.0680617979221565,0.43902439024390244,0.9517967514944591,1.0,1/6,4.25%,PKD1L1
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6430863228872151,1.06781386786811,0.43103448275862066,0.7279741401859076,1.0,2/7,22.57%,GPS2;UBR5
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7198815924153723,1.0677927153606737,0.4444444444444444,0.7276627401641681,1.0,1/7,11.98%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5089173622662126,1.0677420549238497,0.36666666666666664,0.7274503844754422,1.0,16/56,19.43%,PTPRC;IRS2;CAMK2N2;THY1;DVL1;SMCR8;SNCA;YWHAG;CDKN1C;MAPT;CDKN1B;UBASH3B;TAB1;TSC2;WWTR1;CAV3
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.6071889495130831,-1.067681291262508,0.375,0.9514643844824695,1.0,6/15,16.93%,PYGM;MGAM;AGL;PGM2;PHKG1;GAA
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.7010002833006717,1.0669038754320765,0.44642857142857145,0.7294205505320176,1.0,1/6,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6686131611890139,1.0657960203956829,0.39285714285714285,0.7317889081437263,1.0,1/7,7.37%,BIRC3
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6359959464798217,1.0657882407806047,0.4426229508196721,0.7314434082011392,1.0,3/10,9.35%,IL1RAPL1;NLGN1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6772091461870349,1.0657633591961235,0.47540983606557374,0.7307862378160858,1.0,2/7,24.94%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6772091461870349,1.0657633591961235,0.47540983606557374,0.7307862378160858,1.0,2/7,24.94%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.5772905375230529,1.0652064065659008,0.36923076923076925,0.7317162432178855,1.0,3/22,4.29%,TLR2;APP;ACKR1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.4971956493048955,-1.0650844823274663,0.35294117647058826,0.9577413115483049,1.0,5/27,8.34%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.6800929790177972,1.0646127091619038,0.4696969696969697,0.7328257844781001,1.0,1/8,1.88%,BLM
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.5506828130104842,1.064388579438932,0.3448275862068966,0.7330598886385854,1.0,5/22,13.36%,GPNMB;SFTPD;DLG5;PAG1;HLA-DRB1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5699041274727343,1.0643484487001655,0.3880597014925373,0.7328021679713459,1.0,3/19,5.34%,SHISA7;NLGN1;SHANK3
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.4331972507347159,-1.06413212756572,0.35714285714285715,0.9591886619606628,1.0,16/61,19.46%,ADAT2;TRMT61A;TRMT10A;TPRKB;THUMPD1;FTSJ1;METTL2A;QTRT2;URM1;TRMT61B;TRMT5;OSGEP;DTWD2;DTWD1;LCMT2;TRDMT1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.6737317916974195,1.063939884641349,0.5102040816326531,0.7336093198528538,1.0,2/5,21.50%,MTHFR;SUPV3L1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.5518275321252292,1.0634850019957585,0.3787878787878788,0.7343502162933887,1.0,3/27,3.62%,TLR2;MBP;APP
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.42666837667635743,1.0633997099234542,0.27631578947368424,0.7342231544144654,1.0,33/207,14.86%,C3;GPNMB;EPHA7;SH3GL2;RASGRP1;ATF3;SLIT2;APP;DAB2IP;EFNA1;TSPYL2;GRM5;FAS;FYN;NTRK3;PID1;PML;NPTN;PDGFA;LIMCH1;LIMK2;NIBAN1;WDFY2;GAS6;TERF2IP;HLA-DRB1;AKAP8;FN1;BRD4;PAK1;FGF2;SLCO3A1;CCND1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.5923807403289022,-1.063308808465428,0.3695652173913043,0.9604437145276101,1.0,1/13,3.79%,NIFK
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6027403049995868,1.0632490798242817,0.4307692307692308,0.7342761233435565,1.0,2/14,7.80%,ZBTB16;SCX
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.5986574575267911,1.0632196825324922,0.5254237288135594,0.7340184372033357,1.0,2/12,12.10%,TERF2IP;DIP2B
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4988874552447076,1.063166858607623,0.4090909090909091,0.733777336640525,1.0,9/61,9.80%,CDKN2A;IRAK2;TCEAL7;DAB2IP;ERBIN;NLRP12;NLRC5;CYP1B1;NLRC3
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.4460768166236891,1.0627075091819396,0.3333333333333333,0.7346198234195486,1.0,7/111,8.14%,ST18;IRAK2;DAB2IP;NOD1;IL1R1;MYLK3;MYD88
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4532469314875254,1.062702095306698,0.36619718309859156,0.7342807206240647,1.0,20/119,16.40%,IGF1;DCN;PLK2;IRS2;APP;FOXO1;TRIM5;TRIM22;SNCA;FOXO3;PLEKHF1;PRKCD;MLXIPL;GRSF1;OPTN;RNF152;TRIM65;PFKFB3;DHRSX;P2RX7
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.5714163559631615,1.0624810583079944,0.36923076923076925,0.7344314348343154,1.0,2/20,6.77%,TEKT2;DNAH3
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6019425121060977,-1.0624703216489007,0.425,0.9614135379180523,1.0,1/8,3.77%,NEU1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6198270870272714,1.0623926476957928,0.43859649122807015,0.7343210663386192,1.0,2/10,10.15%,MYRF;KLK6
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5672459163447141,1.0623288791352212,0.4074074074074074,0.73418363461635,1.0,5/13,16.03%,MGAT3;CHST6;CHST4;CHST2;LARGE1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.4765728862302627,1.0621102971800802,0.3484848484848485,0.7344536634039022,1.0,11/66,11.20%,HPN;OTOS;COL11A2;CDH23;KCNQ1;EPS8L2;LHFPL3;CLRN1;CDC14A;TBL1X;EML2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.7312449968923772,1.0618257516608423,0.46938775510204084,0.7347505779241883,1.0,1/5,10.05%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6915710674775403,1.0613833190577924,0.43636363636363634,0.7355355416974013,1.0,5/6,30.82%,ATP10A;DNM2;ASAP1;SH3GLB1;PLEKHM2
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6785335964282585,1.061259431469955,0.4909090909090909,0.735533377519181,1.0,4/7,28.83%,RAP1A;RAP1B;PRKN;FMR1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.5638959849308476,-1.0609778963131775,0.4642857142857143,0.9643473792001618,1.0,1/9,0.90%,DSCAM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.625089890571592,1.0607718932593204,0.38181818181818183,0.7365123717980604,1.0,3/12,20.65%,SYK;STAT3;TNFSF4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.6817306687881252,-1.0605462233665555,0.4489795918367347,0.9639172092588675,1.0,5/7,28.40%,MCM6;MCM4;MCMDC2;ORC3;MCM3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.5114660206460456,1.0605137779478964,0.3918918918918919,0.7367698190216571,1.0,6/38,15.05%,KIF14;PMEPA1;NLRC3;LDLRAD4;LCMT1;TMC8
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.39116085322330346,-1.0601621680599584,0.2777777777777778,0.9635350297409061,1.0,23/139,12.43%,PAK1IP1;SETD9;TPX2;RFC3;RPL37;ATRIP;HUS1;RPL23;SMYD2;CHD4;NOC2L;BRIP1;KMT5A;BRPF1;TAF13;SUPT16H;TTC5;TAF11;MAP2K6;ATR;RPL11;RAD9B;PIP4P1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6606102904554453,1.0597925696485744,0.39655172413793105,0.7381913789020518,1.0,3/8,24.55%,CD200;FADD;HMOX1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.6201660630454744,1.0597773455621091,0.48333333333333334,0.7378848295389682,1.0,4/15,16.40%,TRPC3;ABCC9;P2RY12;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.578099007632805,1.059683277757226,0.4696969696969697,0.7377949898929403,1.0,4/15,16.22%,DAB2IP;MAP3K11;PAK1;MAP3K5
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.6960830324262185,1.0596729884296219,0.4,0.7374781026662376,1.0,3/6,17.75%,GUCY1A1;GUCY1B1;PDE2A
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6447306389465224,1.0593766681155223,0.42857142857142855,0.7378912391187259,1.0,1/10,4.91%,PXYLP1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.614718825114706,1.05931288755159,0.45,0.7377258846758512,1.0,1/16,0.03%,GGT5
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.5974717402211275,1.0592820202464013,0.45,0.7374364808563091,1.0,9/15,28.76%,TERF2IP;NEIL2;OGG1;TINF2;TDG;NEIL1;ACD;NTHL1;UNG
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.542537973385314,1.0592716449557333,0.4107142857142857,0.7371203620879917,1.0,9/28,19.10%,ERBIN;PARD3;OPHN1;DLG3;PARD3B;MYO9A;CAMSAP3;MTCL1;SCRIB
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.7060605403544029,1.0591427162353277,0.5272727272727272,0.7371174605387605,1.0,2/5,13.96%,NLGN1;HAP1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.752679719601642,1.059117076824107,0.5,0.7368071835011814,1.0,4/6,20.21%,TBX19;SCX;MESP1;SMAD2
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.43128347501198483,-1.0590863881808374,0.41935483870967744,0.9651819901850309,1.0,11/61,11.32%,PRSS3;DHFR2;CD320;ALDH1L2;FLAD1;PDZD11;SLC25A19;AOX1;SLC46A1;MMACHC;MMAB
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5522205118575187,-1.0588675426463123,0.40540540540540543,0.9643684678428892,1.0,3/17,4.37%,RFC3;GINS3;POLD3
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.513496387330864,1.0588296946037423,0.4393939393939394,0.7371979065459549,1.0,12/48,18.66%,PLK2;DAB2IP;FOXO1;HECW2;BARD1;HECW1;CDKN1B;TRIM32;OAZ2;SMURF1;WNT5A;VIP
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.635173993316624,1.0586861130405363,0.47540983606557374,0.7372003600382516,1.0,2/9,12.39%,CTNNB1;NR4A2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4621843861967978,1.058587950997503,0.34285714285714286,0.7370843418098162,1.0,26/107,17.11%,MET;IL1RAPL1;EPHA5;WNT8B;SOX4;ANOS1;LHX6;NEUROD2;MYT1L;TENM4;UGDH;CTNNB1;PTPRD;PBX3;TGFB2;GLI2;HS6ST1;NR4A2;ATP8A2;OPHN1;RNF112;ALK;SMARCA1;FZD7;OLIG2;WNT5A
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4068905063618885,1.0583761966612448,0.3373493975903614,0.7371891127794415,1.0,27/375,8.24%,SKOR1;MYT1;ELAVL2;PTP4A3;TEAD2;ZNF536;PRDM8;CASZ1;APP;HIC1;WTIP;ZNF282;SOX4;PPARGC1B;GRM5;NFATC2;NFIL3;AHR;NKX6-2;GZF1;ZNF114;CHD3;DVL1;TRIM22;PML;FOXO3;PDGFA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5602872949055845,1.0581638216313212,0.36486486486486486,0.7373960031495381,1.0,12/31,24.13%,THBS1;SERPINE1;GAS6;AKIRIN1;IL12A;ADAM17;CSF1;VEGFD;ANO6;CXCL12;IL6R;RARRES2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6397745133190706,1.0581455590437907,0.45901639344262296,0.7371026035616594,1.0,5/10,18.66%,CCDC3;GAS6;TRAIP;RFFL;GPS2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5067740797510444,-1.0581289041215791,0.4166666666666667,0.9650098978406788,1.0,7/35,14.61%,ID2;SLC25A5;ALAS1;ABCB10;SLC25A38;UFL1;CEBPG
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5905016194920635,1.0581244475285891,0.46551724137931033,0.736814854951204,1.0,1/15,3.33%,CORO7
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6178878704068033,1.0578302826960384,0.3559322033898305,0.7368952829250733,1.0,5/19,20.84%,THBS1;CDKN1C;HIPK2;STK11;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6178878704068033,1.0578302826960384,0.3559322033898305,0.7368952829250733,1.0,5/19,20.84%,THBS1;CDKN1C;HIPK2;STK11;ADAM17
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.6935147484284447,1.0570702572144484,0.4444444444444444,0.7383094586072624,1.0,3/6,24.77%,TNFRSF10B;FADD;ZDHHC3
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.7134784131209304,1.056998846552694,0.46808510638297873,0.7381128843100232,1.0,4/5,24.65%,YBX3;RCSD1;TLR3;ARHGEF2
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.5014771899240564,1.056647757159486,0.453125,0.7385814098258955,1.0,12/64,13.60%,CHST8;IGF1;B3GNT2;B3GALT2;ST8SIA3;ST8SIA1;B4GALT7;ST8SIA4;B3GALNT1;ST6GALNAC2;B4GALT5;FUT2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.600537717385973,1.056351315017156,0.3728813559322034,0.7390548553215041,1.0,2/9,7.20%,P2RY6;RYR2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.48268893151443926,1.0559373893667416,0.3389830508474576,0.7396617864199481,1.0,14/57,10.14%,RASGRP2;CTSS;CD22;PLEK;NAPSB;MYO1F;WAS;PTPRC;LINC00926;CD37;BIRC3;ACAP1;STAG3;ADAM28
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5745861690630315,1.055729997110663,0.4583333333333333,0.7398933209822179,1.0,2/18,1.34%,SIX3;PROX1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6380562472106404,1.0557211390969823,0.41818181818181815,0.7395680130114661,1.0,5/10,30.89%,FGD5;PPP1R9B;SRGAP2;DNM3;SPEF1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.7009231581945781,1.0555241047719188,0.4642857142857143,0.7396281854253057,1.0,2/8,9.69%,SKAP1;ASS1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.5003361299459861,1.055236747095823,0.373134328358209,0.7399182292589485,1.0,6/54,8.14%,ANXA1;IL1R1;BCL6;SAMHD1;BIRC3;MYD88
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.5856165712016739,-1.0551314523965247,0.3953488372093023,0.9718219836168405,1.0,3/8,12.47%,IFNLR1;PRELID1;ISCU
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5745060063308342,1.0550772857513961,0.44642857142857145,0.7400102494060691,1.0,7/18,23.60%,APLNR;MYO1C;PRKCH;CBFB;RAP1A;RAP1B;TJP1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5205642482497668,1.0547201943464362,0.4067796610169492,0.7405883195971592,1.0,3/34,5.36%,STEAP3;RAB15;RAB3C
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.6297745267387397,1.0545588060542086,0.5,0.7406639214580806,1.0,2/9,14.07%,RAB40B;SLC29A4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.47966378902461143,1.0545504462605964,0.4067796610169492,0.7399880395060171,1.0,14/57,17.41%,ELMO1;WAS;BAIAP2;FYN;ARPC3;MYO1C;PLPP4;PLD2;PRKCE;SYK;PRKCD;PAK1;WIPF3;VAV2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.47966378902461143,1.0545504462605964,0.4067796610169492,0.7399880395060171,1.0,14/57,17.41%,ELMO1;WAS;BAIAP2;FYN;ARPC3;MYO1C;PLPP4;PLD2;PRKCE;SYK;PRKCD;PAK1;WIPF3;VAV2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6271453681973141,1.0539533567041248,0.49295774647887325,0.7409809505474311,1.0,2/8,12.90%,ADAM19;PPARG
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.5118587431569444,1.0539331266211351,0.4788732394366197,0.7406831497075328,1.0,7/36,11.84%,THBS1;SLC39A14;IRS2;SOX4;EIF2B2;PFKL;GAS6
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5479304471498623,-1.0538312687791647,0.35714285714285715,0.9745008964487091,1.0,1/19,1.60%,TPX2
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.5403840800388522,-1.0534829340100136,0.3333333333333333,0.9739674915247991,1.0,2/15,8.30%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.5462018386743421,-1.0530185964555434,0.38095238095238093,0.9738977039603605,1.0,2/15,13.00%,MAPK7;HTRA2
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.48581680295686386,1.0526749447185044,0.32894736842105265,0.7434700784508984,1.0,20/55,24.91%,CDKN2A;PLK2;MAP3K11;CDK6;CDKN1A;CDC7;CDKN1B;CCND1;CDK2;MAX;PLK3;BCAT1;CDKN2D;CAMK2A;CCNA2;ACVR1B;RCC1;CUL3;ACVR1;PHF8
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.6331363638713128,-1.0522138409955464,0.45454545454545453,0.9748545909529731,1.0,1/8,3.77%,NEU1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.6817948351968333,1.0521940630061652,0.4583333333333333,0.7443055605507256,1.0,2/5,21.44%,STX1B;NAPA
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5760069195097683,1.052007745180424,0.4098360655737705,0.7444111170775912,1.0,7/18,28.18%,SNCA;PXK;VIP;CAV3;HRH3;WNK1;NEDD4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5392736307533273,1.0518428332005954,0.46875,0.7444740171834744,1.0,9/28,24.51%,EGF;WDR54;MKLN1;PICK1;MTMR2;ANKRD13A;AHI1;ARRB1;RIN3
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.7084290548477004,1.05150179345706,0.46875,0.744861213098764,1.0,1/5,14.09%,TNIP2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.512027663399175,1.0514856605810534,0.423728813559322,0.7445783825362209,1.0,4/29,10.93%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.48046846706381896,1.0513691068277236,0.40298507462686567,0.7444339358737758,1.0,26/78,22.41%,TLR2;THBS1;IL15;SERPINE1;APP;PLSCR1;NLRP12;TNFRSF1A;SNCA;P2RY12;STX4;OPTN;PUM1;WNT5A;PDE2A;LRSAM1;ETS1;IFI35;PRKCA;TNFSF4;NMI;ABCC1;BMP6;SLC15A4;PPM1F;TLR3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.5825214162949834,-1.0512721034953547,0.4186046511627907,0.9766147556391508,1.0,2/9,15.29%,RPL11;DCUN1D2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5948884843518326,1.0510893439061504,0.423728813559322,0.7447462722370763,1.0,4/14,26.88%,OR51M1;OR51I2;ADCY3;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6516824223416829,1.0503511705277229,0.4426229508196721,0.7460773393970173,1.0,3/7,29.07%,PHF23;RUBCN;HDAC6
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.4812628749715279,1.0502291449213923,0.4098360655737705,0.7460438014516951,1.0,7/52,10.76%,TRIM5;TRIM46;DVL1;TRIM22;TRIM17;MMD;ZDHHC7
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.7188855730552377,1.0500254077433704,0.5,0.746206486164832,1.0,1/5,12.90%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.4629960546389602,1.0498750570525714,0.4090909090909091,0.7461623193904721,1.0,21/64,17.12%,SLITRK1;IL1RAPL1;NUMBL;SLIT2;SHANK3;SERPINF1;ROBO2;NPTN;CTNNB1;PTPRD;NEURL1;CDKL5;CHODL;PLXNA4;TRIM32;SS18L1;NAP1L1;PLXNA1;PLXNA2;RGS14;CUX2
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6147644948901975,1.049869655885115,0.423728813559322,0.7458427207447657,1.0,2/14,9.36%,IGF1;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.4331563408959103,1.0498474019870467,0.3287671232876712,0.7455551890273799,1.0,37/158,19.70%,THBS1;CD22;PLEK;DUSP1;SLIT2;EPHA2;DAB2IP;CARD19;WTIP;APLNR;NLRP12;TNFAIP8L1;DGKG;BCL2L1;NLRC3;DLG5;CYRIB;MAPKBP1;PER1;MAPKAPK5;BCL2;P2RX7;PINK1;PDE10A;RFFL;PDE2A;RORA;CGNL1;TSC2;OTUD7B;ATP2B4;MAP2K3;IFI35;CAV3;HDAC7;ITPR1;PDE4D
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4981028344642813,1.049811128198591,0.4393939393939394,0.74533143552947,1.0,7/41,10.74%,RASGRP1;DAB2IP;FOXO1;FAS;STK25;MAPK8IP1;TGFB2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.6344531753701065,-1.0498047905773322,0.5384615384615384,0.9790251249173112,1.0,2/11,13.44%,APOE;CLU
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5571979647519838,1.0497239851358209,0.4098360655737705,0.7452189833709923,1.0,5/20,7.84%,SLIT2;EFNA1;SLIT3;TBX20;ROBO2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.6391731965168606,-1.049613679300382,0.358974358974359,0.9766932499243045,1.0,1/8,5.74%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.6391731965168606,-1.049613679300382,0.358974358974359,0.9766932499243045,1.0,1/8,5.74%,PDZD11
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.4711533869678795,-1.0495288710483797,0.4,0.9754752548900746,1.0,18/50,19.02%,IMP4;TFB2M;DDX18;NDUFAF4;NOP56;EXOSC5;NIP7;UTP20;MCM4;RABEPK;LAS1L;AIMP2;SRM;SLC19A1;DCTPP1;TMEM97;PLK1;NOP16
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.5799733499928414,-1.0493136992325611,0.42857142857142855,0.9747181018583699,1.0,3/11,19.63%,TRIB3;ERLIN2;ERLIN1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5088025828792467,1.0492556900323224,0.4482758620689655,0.7460055518785913,1.0,10/53,19.29%,CD22;RIT2;SNCA;PACSIN1;OPHN1;SCAMP5;TSC2;LRSAM1;MTMR2;MCTP1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.6498029764629336,1.0492140857694705,0.42857142857142855,0.745766044708351,1.0,1/9,11.61%,ABCA2
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6657455387012159,1.0492087423563428,0.4915254237288136,0.7454369506005064,1.0,4/6,33.38%,DDB1;ARPP19;NNMT;SIRT1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.660584238404144,1.0487258095748389,0.48214285714285715,0.7463384964266148,1.0,4/5,33.86%,PDE4D;CHGA;CAMK2D;PLN
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.46874143054343786,1.048658704239193,0.36,0.746167781048891,1.0,16/83,17.11%,KLF2;PLK2;RASGRP1;APP;DAB2IP;FOXO1;HECW2;ABCA2;BARD1;HECW1;CDKN1B;TRIM32;OAZ2;KLF4;SMURF1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5569293857956481,1.048311222405266,0.4166666666666667,0.7465458787552778,1.0,10/28,17.01%,DUSP10;TRIM46;MAG;DCC;FGF13;DIP2B;CDKN1A;CDKN1B;KIAA0319;PTPRS
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.44233647834905204,1.048221320676166,0.3283582089552239,0.7464121369432848,1.0,43/142,21.89%,SCN9A;MAFF;ABCB1;PIM1;CD44;PLSCR1;NFIL3;AHR;SYNGR2;EMP1;MYO1C;HK2;BCL2L1;PRKCH;CDKN1C;NDRG1;ADAM19;CD83;IL4R;GUCY1B1;KLF6;LRIG1;IKZF2;BCL2;SPP1;RGS16;HIPK2;SLC2A3;GABARAPL1;PLEC;RORA;ENO3;CTSZ;APLP1;MYO1E;IGF1R;GLIPR2;RRAGD;SMPDL3A;CSF1;CDC42SE2;RHOB;TNFRSF8
prerank,MSigDB_Hallmark_2020__Hypoxia,0.43495749598117234,1.0482207715497427,0.3924050632911392,0.7460676920254522,1.0,47/162,16.16%,FOSL2;MAFF;DCN;ATF3;SERPINE1;ZFP36;P4HA2;DUSP1;IRS2;CP;PIM1;MYH9;EFNA1;VLDLR;NFIL3;PLAC8;ALDOB;DTNA;FOXO3;TPD52;HK2;LDHA;KIF5A;BGN;GALK1;CDKN1C;NDRG1;PFKL;PGK1;CDKN1A;PDK1;ENO2;KLF6;CDKN1B;FBP1;COL5A1;DPYSL4;KLF7;HK1;PAM;FOS;BCL2;CHST2;NDST1;LARGE1;PFKFB3;SLC2A3
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.7256798599293403,1.048110572465157,0.44642857142857145,0.7459606353193639,1.0,2/5,15.37%,BAIAP3;STX1B
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5390528834297375,1.0479983278234206,0.359375,0.7458536773285416,1.0,6/24,15.06%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5508654021628471,1.0476761746008876,0.38028169014084506,0.7462152584596472,1.0,4/22,6.86%,HPN;DAB2IP;EFNA1;ZNF750
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5076405680877366,1.0475770358308174,0.375,0.7461188036233806,1.0,15/35,23.74%,WAS;ZNF750;EMP1;CERS3;OVOL3;HLA-DRB1;ALDH3A2;LAMA3;STS;SVEP1;RBP2;POU2F3;UGCG;GLI1;FLOT2
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.6295552817554904,-1.0471339078830075,0.45454545454545453,0.9796702240874391,1.0,3/8,19.56%,RORB;SOX8;RPGRIP1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6106114180608373,1.0465480581156987,0.43548387096774194,0.7481942106248212,1.0,3/13,10.23%,GRM5;HOMER1;GRM6
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.5567008666393913,-1.0462837807192145,0.4222222222222222,0.9805161284004122,1.0,1/11,0.81%,AR
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4066737609571539,1.0460982514099642,0.39436619718309857,0.7488695820892347,1.0,56/246,20.89%,BOK;MLLT11;EPHA7;SLIT2;DAB2IP;FOXO1;KLF11;ARHGEF17;SOX4;SEPTIN4;FAS;ARHGEF3;BCL6;TFPT;PAWR;FAP;SNCA;FOXO3;CYP1B1;MAP3K11;OBSCN;MCF2;CTNNB1;PNMA2;KALRN;NEURL1;ARHGEF7;TGFB2;TRIO;PLEKHG2;PXT1;GADD45A;BARD1;TPD52L1;TNFRSF10B;FADD;KCNMA1;BIN1;RARG;MAP3K5;TP53;VAV2;STK3;MCF2L;NGEF;BCLAF1;VAV1;SCRIB;RNF122;TFAP4;RBM5;ARHGEF6;BTG1;DNM2;RPS27A;ING5
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.6676201417812246,1.0460905641180323,0.43548387096774194,0.7485251158601228,1.0,2/8,12.17%,HDAC4;HDAC9
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5722556496566917,1.045870904721106,0.4126984126984127,0.7486903402672666,1.0,4/16,16.67%,ACSL5;HACD1;ELOVL7;ELOVL5
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7310826208919883,1.0456949318144948,0.4642857142857143,0.748739937807911,1.0,1/6,12.73%,PRKCD
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.7225946896012188,1.045606885986971,0.41304347826086957,0.7485219206882873,1.0,1/5,15.77%,ATL3
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7316753847498374,1.0454222820925738,0.5087719298245614,0.7487078951566561,1.0,3/5,14.10%,TLR2;NAMPT;CCL2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.5082461035689966,-1.0448203681361232,0.425,0.9830779900552251,1.0,8/21,14.44%,UCP3;ATP12A;SLC36A1;SLC46A1;DMAC2L;ATP1A2;ATP6V1F;ATP5F1B
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.53206120652512,1.0446871431815308,0.4117647058823529,0.7501150004373186,1.0,12/32,22.67%,ZFP36;FOXO3;CDK6;STAT3;MAPK11;ETS1;PRMT1;ARNT;HIF1A;ZFPM1;MAFB;ACVR1B
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.6744044083884635,-1.0445661112015958,0.5238095238095238,0.9823368378134373,1.0,1/6,4.16%,THEM4
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.6000495284435711,1.044376836773453,0.42105263157894735,0.7504886859028869,1.0,4/15,13.59%,ICAM1;CERCAM;SYK;ITGAL
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6177333082753445,-1.044211988834291,0.4358974358974359,0.9819836613830686,1.0,6/14,16.93%,PYGM;MGAM;AGL;PGM2;PHKG1;GAA
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.676136041768777,-1.044155775888728,0.5116279069767442,0.98063444581026,1.0,2/5,11.81%,ADAMTS12;TSPAN12
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.6763333436631651,1.0441261085681555,0.47540983606557374,0.7508934496793978,1.0,5/6,27.63%,PCLO;CAST;ERC2;RAB3A;ERC1
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7124818527995982,1.043930197003228,0.47619047619047616,0.7509785421789287,1.0,4/6,26.40%,FSTL1;MESP1;PECAM1;KDM6B
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.7266067669073801,1.0437159768591195,0.48,0.7511525012787537,1.0,2/7,9.69%,KLF2;ASS1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4851642493936615,-1.0435605775301535,0.41379310344827586,0.9807939174017906,1.0,4/24,13.44%,SELENOS;CREB3L1;HSPA1A;CLU
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7383321441270466,1.0435003863552654,0.543859649122807,0.7513367603499611,1.0,1/5,7.32%,GHR
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.40103132987685547,1.043351033835804,0.3888888888888889,0.7513901696663039,1.0,82/373,19.47%,VRK2;ARHGAP4;CD24;BLM;NLGN1;RIT2;ARHGAP39;DAB2IP;RPA1;MOB3B;ARHGEF17;PAK3;ARHGDIG;PRKAR1B;NUAK1;ARHGEF3;NLRP12;CHD3;NTRK3;BIRC3;PAK4;RHOD;PML;PPP1R16B;ARHGAP18;OBSCN;MCF2;WDR54;ARHGAP26;KALRN;GNA12;TRIP10;ARHGEF7;TAF4B;MINK1;TRIO;PIP4K2A;PLEKHG2;MAPT;BARD1;PRR5;STARD13;OPHN1;HIPK1;FBXL2;PRDM1;PAK1;MAPKAPK5;OPTN;ARHGAP17;MYO9A;MRE11;SGMS1;PRKAR1A;HIPK2;BST1;TTI1;MAPK11;IKBKG;TP53;RHOT1;WNT5A;CDK2;VAV2;RCN3;RFFL;TAF15;STK3;PDE2A;PIP5K1C;MCF2L;RHOQ;RHOT2;NGEF;TELO2;BRCA1;TRAF5;VAV1;RFC4;ARHGAP22;STK11;PLK3
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6112360325001025,1.0432087766175422,0.4423076923076923,0.7513912815914632,1.0,7/11,9.52%,KCNJ2;KCNE4;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5897801564732982,1.0428901502404906,0.47761194029850745,0.7518833040762928,1.0,6/12,30.58%,BMP8A;MIDN;KCNB1;PRKN;IRS1;CHGA
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.4059569967913925,-1.0428125704345153,0.3076923076923077,0.9814387051493565,1.0,6/67,11.17%,NUP62CL;NXT2;NUP50;GEMIN4;RANBP6;RANBP17
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5310385245396935,1.0425114023768571,0.42028985507246375,0.7524166374285018,1.0,4/33,8.81%,SLC25A21;ABCB1;SLC38A11;SLC7A7
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.7150293417677838,1.0423702417287355,0.5,0.7524120612168921,1.0,3/5,26.40%,KDM6A;PHF8;KDM6B
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.6062909876470453,1.0419974274633161,0.46153846153846156,0.7529133742079405,1.0,2/11,1.86%,ANXA1;IL15
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.552198433911091,1.0416780094310054,0.423728813559322,0.7532161382787417,1.0,5/24,17.48%,TYMS;NUDT13;AK5;NME4;DUT
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.5987913380923214,1.041475007027808,0.4032258064516129,0.7533310462680088,1.0,4/17,17.80%,CYP1B1;CACNA1C;IFT122;C12ORF57
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.6382977121781053,1.0414206136943347,0.49056603773584906,0.7531021099097873,1.0,3/6,30.99%,MTCL1;MAP2;FBXW11
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5542211250733746,1.0413080685830611,0.42105263157894735,0.7530191446785035,1.0,8/17,22.35%,KCNQ1;KCNH2;GAS6;FBP1;TP53;TFRC;KCNE2;PPM1F
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.4429200544250214,1.0412700431272386,0.375,0.7527593384374615,1.0,13/100,6.92%,MET;PDGFRA;EPHA7;PTK6;SLA;SHC2;EPHA2;EPHA5;FLT1;GFRA2;NEDD9;FYN;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.39077811333940266,1.041002959485339,0.3333333333333333,0.7529886684579548,1.0,58/418,13.72%,CDKN2A;ST18;GPNMB;TLR2;SP100;PROX1;TESC;BLM;TP53TG5;PSRC1;NR4A1;DUSP1;SLIT2;APP;DAB2IP;DYSF;MYH9;PODN;PRAME;KLF11;TSPYL2;ARHGDIG;FABP3;SOX4;BTG3;PLSCR1;SLIT3;BCL6;CLMN;APOBEC3H;KLF10;IGFBP7;BAP1;GMNC;PML;CYP1B1;ZBTB7C;CTNNB1;CTBP2;CDK6;LMNA;NEURL1;SMAD3;CHMP1A;DLG5;P3H2;TGFB2;PODXL;ACTN1;NPAS2;ATP8A2;CDKN1A;CD200;PLXNA4;CDKN1B;FBP1;PDPN;DLG3
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5644162148369603,-1.0409204048219114,0.45,0.9851161384720658,1.0,5/10,18.22%,SLC6A13;SLC46A1;SLC19A1;SLC5A6;SLC1A4
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.6111911715415763,-1.0407389106995817,0.46511627906976744,0.9841757396171538,1.0,1/8,1.13%,ID2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5687352504084239,1.0405162954546907,0.47368421052631576,0.7538832223768052,1.0,3/16,7.13%,GRIN2B;KCNC2;GRIN1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5496240701293885,1.0397003643656682,0.375,0.7554732702101186,1.0,9/21,18.68%,PROX1;CHI3L1;ITGA3;HECA;GLI2;PDPN;FGF2;ABCA3;PCSK5
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.6472808906399452,1.0396333819765078,0.4745762711864407,0.755306311900283,1.0,2/8,5.42%,PTPRC;NFIL3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6275118126734431,1.0395663921758715,0.4444444444444444,0.7547912268458676,1.0,2/10,14.63%,CD44;BCL2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6275118126734431,1.0395663921758715,0.4444444444444444,0.7547912268458676,1.0,2/10,14.63%,CD44;BCL2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5520112482078581,1.039471014216114,0.36363636363636365,0.7546870483963805,1.0,2/20,4.07%,ELMO1;MYH9
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.665768381177626,1.0389336650800431,0.4126984126984127,0.7556302403429398,1.0,2/6,14.10%,MSMP;CCL2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5357234727391499,1.0388979411431722,0.3728813559322034,0.7553858568532831,1.0,7/25,18.40%,TEAD2;YAP1;TEAD1;TJP2;YWHAE;STK3;WWTR1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.6059716216915275,1.0388424606712932,0.46774193548387094,0.7551779538452253,1.0,3/10,17.97%,HES7;BMX;MESP1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5805347161073577,-1.0386675622860073,0.3870967741935484,0.9888507971131869,1.0,2/20,2.92%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5255272195330746,-1.0385187312529536,0.3611111111111111,0.9878178510174912,1.0,5/18,14.35%,PPIC;PPWD1;PPIH;PPIL3;PPIL1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.7202034584747465,1.0382593012265848,0.509090909090909,0.7561403505198487,1.0,1/5,7.32%,GHR
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6147873296122149,1.0381839708197127,0.42857142857142855,0.7560357967955875,1.0,5/9,21.32%,GRIP1;GRIP2;STX1B;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5183984298596394,1.0381651939549643,0.3968253968253968,0.755708907659153,1.0,6/30,16.95%,THBS1;BAG3;CLPB;MAPT;IER5;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6649398368340959,1.038037176092512,0.44642857142857145,0.7556511779733501,1.0,1/6,12.75%,STX4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.6923542890564027,1.0377248111444746,0.46938775510204084,0.7560276219521292,1.0,3/5,17.11%,DVL1;MAPT;WNT5A
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.41505342026951264,-1.0377166581733186,0.30434782608695654,0.9889075918294634,1.0,15/88,18.69%,FIP1L1;AAAS;RBM8A;U2AF1;RAE1;NUP50;CPSF1;NUP54;DDX25;MCM3AP;SRSF2;CPSF3;NUP85;SRSF9;UPF3B
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5996139257049583,1.0376001727388031,0.39285714285714285,0.7559956292108427,1.0,1/12,3.25%,PTPRC
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6259135643673824,-1.0374033303181938,0.43902439024390244,0.988448707954223,1.0,2/8,10.86%,GTF2A2;TAF11
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.649803397885055,1.037232939428606,0.5,0.7566607297087787,1.0,2/11,3.30%,HTR2C;KCNC2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.6057384399198747,1.0370700799064037,0.46875,0.7566955741747985,1.0,1/9,10.11%,B4GALT7
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.46590496336269704,1.0369993253618537,0.4117647058823529,0.7565034010643467,1.0,5/53,6.33%,MET;TIMP2;NELL1;DAB2IP;MFSD2A
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.48247039733111047,1.0369094191454988,0.359375,0.7563268708115785,1.0,7/64,5.13%,PROX1;EGF;THBS1;NR4A1;SULF1;EGFL7;NRP2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.6741105942545398,-1.0368287342982478,0.46511627906976744,0.9885838418251062,1.0,4/6,28.96%,TTN;MYOM1;RDX;EZR
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.46441965238450406,1.0367893970933104,0.4090909090909091,0.7562896610969153,1.0,13/46,17.11%,GRIN2B;FYN;RAMP3;SNCA;PRODH;MAPT;CDKN1B;FOS;ZNF746;HEBP2;RARG;MAP3K5;WNT5A
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.44023822843453503,1.0366637552020626,0.45,0.7562370295671331,1.0,29/98,20.03%,ABCA6;ABCA8;ABCA5;AMN;MYH9;SLC35F3;ABCA10;RAMP3;MFSD2A;SLCO1A2;SPNS2;CHMP1A;ABCA9;ABCA2;PLEKHA8;ABCB9;PICK1;SLC29A4;MFSD2B;SLCO2A1;ABCA3;NME4;RCN3;SCAMP5;MFSD12;LRP2;ABCG1;RAMP1;TXNIP
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.7242178056034465,1.0366221550228336,0.4727272727272727,0.7556738123888562,1.0,1/5,10.33%,SHMT1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.7242178056034465,1.0366221550228336,0.4727272727272727,0.7556738123888562,1.0,1/5,10.33%,SHMT1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.5199728835096156,-1.0365642130827788,0.3695652173913043,0.9879480854589692,1.0,3/27,14.09%,MID1IP1;NCSTN;MT3
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5513358277292607,1.0365206781134155,0.43661971830985913,0.7555803707331739,1.0,4/22,9.02%,ANXA1;EPHA2;CLIC4;CERS3
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.37982347088258944,-1.036358366622216,0.3103448275862069,0.9871023034665753,1.0,40/142,13.55%,MRPL10;RPS24;RPL35A;RPL34;RPL39;RPL37;MRPS21;MRPL52;RPL13;RPL18;MRPS7;RPS28;RHCE;RPL12;RPL31;RPL23;MRPL36;MRPL18;MRPS16;RPL41;PCSK1;ASMT;RPL6;RPS26;RPL29;RPL30;RPL22;RPS13;RPL14;RPSA;RPL15;RPS2;RPL23A;RPL11;IGF2BP3;EEF1A1;MRPS33;MRPS18B;RPS21;RPS23
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4160090951032635,1.03608544732712,0.410958904109589,0.7562326780290825,1.0,37/194,16.68%,C3;MET;GPNMB;IGF1;PDGFRA;EGF;EPHA7;THBS1;RASGRP1;EPHA2;APP;EPHA5;FLT1;EFNA1;FAS;NTRK3;NPTN;LIMCH1;LIMK2;NIBAN1;WDFY2;VAC14;GAS6;EPHA4;MLXIPL;HLA-DRB1;ALK;PAK1;FGF2;SLCO3A1;CCND1;MRE11;CD4;PFKFB3;P2RX7;PINK1;FZD7
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.678957932536413,1.0355822910640282,0.4423076923076923,0.757018043430074,1.0,2/6,19.02%,PLOD2;MTHFR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.5930463797034369,-1.03555271663712,0.45714285714285713,0.9879402655775242,1.0,2/8,7.24%,BLOC1S2;VDAC2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4591208481482726,1.0354479269659442,0.3880597014925373,0.75700119152323,1.0,26/95,18.74%,MTMR7;PLEK;MTMR11;SBF1;SYNJ2;PLEKHA2;PLAAT3;PIP4K2A;VAC14;INPPL1;PITPNM2;INPP5J;PLEKHA4;PITPNM3;INPP4A;PLEKHA8;IMPA1;FGF2;MTM1;BMX;INPP5D;PIK3CD;PIP5K1C;MTMR2;PITPNM1;INPP5F
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.62466691635335,1.0354451390054775,0.46875,0.7566659488687004,1.0,3/12,23.66%,CDK9;HPF1;MLLT3
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.49425737011305115,1.0353342460222072,0.4492753623188406,0.756582537832118,1.0,11/46,16.90%,NR4A3;NR4A1;FOXO1;STEAP4;PID1;CTBP2;NR4A2;PPARG;TRIM32;KLF4;PRDM16
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5782036041425624,-1.0352487782683646,0.4318181818181818,0.9874193640980858,1.0,1/10,4.51%,APOE
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.6582696225374605,1.0350658187297535,0.4782608695652174,0.7569096789294217,1.0,1/5,14.38%,FGF2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.6737884371130287,1.0348237789760737,0.5,0.7572519122141318,1.0,1/5,3.25%,PTPRC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5899337510643352,1.0347980943760469,0.4696969696969697,0.7570043070027656,1.0,5/19,11.97%,PKP2;TRPM4;RYR2;CACNA1C;FGF13
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6843495228848226,1.0345997599987558,0.49122807017543857,0.7570848637441981,1.0,1/6,4.29%,FOXO1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.49534364476842047,1.0341476827091134,0.463768115942029,0.7577441072719563,1.0,3/41,9.88%,ZFP36;RBM24;YTHDF1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.42082027982638026,-1.034001967449016,0.4,0.989753298303038,1.0,4/56,8.13%,ERCC8;DCLRE1B;SMARCAL1;ABRAXAS1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5097230545070026,-1.0339957676835028,0.42105263157894735,0.9883554523372976,1.0,9/18,23.54%,FASTKD2;RPL6;MDN1;RPL23A;RPL11;RPF2;RPL10;RSL24D1;RPLP0
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.6520651182303419,1.03396443288173,0.4827586206896552,0.7577730655408443,1.0,4/6,30.03%,ATG9A;ULK1;ATG7;ULK2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.6005815833533179,-1.0337251811215633,0.4666666666666667,0.9880908203560981,1.0,1/8,4.51%,APOE
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.664962312938637,1.0329720824247508,0.5510204081632653,0.7598028121039089,1.0,1/8,0.18%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.4384434642467706,1.0327225883487812,0.3561643835616438,0.7600507623459976,1.0,12/89,16.17%,THBS1;PLD1;SAMD4A;SOX4;EIF4A3;LARP6;YTHDF1;NIBAN1;TRIM32;FADD;IST1;KLF4
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.4881475601619318,-1.032471012088093,0.3684210526315789,0.9903363932312796,1.0,6/23,17.60%,GAL3ST2;ALG11;GK;GAL3ST4;ST8SIA6;TNIP1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.7066809257684843,1.032461819793663,0.43137254901960786,0.7600298565598179,1.0,1/5,3.39%,SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.7066809257684843,1.032461819793663,0.43137254901960786,0.7600298565598179,1.0,1/5,3.39%,SLC39A14
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5335697261772006,1.0324251556397916,0.3870967741935484,0.7597461387377179,1.0,5/25,12.39%,SLC4A10;SLC9A9;SLC9A1;SLC4A9;SLC9C2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.6479588417680527,1.032359751674246,0.5294117647058824,0.7595596835283956,1.0,3/7,19.43%,KCNH2;BIN1;CAV3
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.5888932120722309,1.0322550991979615,0.4461538461538462,0.7594499467409503,1.0,1/15,6.28%,RAMP3
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.6115351306608522,-1.0321986506664793,0.42105263157894735,0.989561891448486,1.0,4/7,23.57%,PM20D1;MPST;CYP2D6;TST
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6659783764711439,1.0320173446024345,0.5272727272727272,0.7596973901335127,1.0,2/8,7.76%,APOD;SNCA
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5620930557009075,1.0320051794264433,0.5,0.7593786350983628,1.0,8/16,17.69%,ST8SIA3;B4GALNT1;ST8SIA4;ABCA2;ST6GALNAC5;ST6GALNAC3;NEU4;B3GALT4
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.6837115931692103,-1.0312170914211207,0.45652173913043476,0.9909832351602244,1.0,1/5,1.97%,TNFAIP3
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.678478462291507,-1.0311961505113119,0.4772727272727273,0.9896376236864146,1.0,1/5,3.77%,NEU1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.6046550201337147,1.031190571638313,0.41509433962264153,0.760849078539443,1.0,1/8,11.86%,LRMDA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.471648160679355,1.031090599822949,0.4782608695652174,0.760744056774294,1.0,7/57,8.57%,PROX1;EGF;NR4A1;EGFL7;NRP2;APLNR;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.45793902638608686,1.0309614546652883,0.463768115942029,0.7606085761934666,1.0,26/119,16.65%,MET;PDGFRA;EPHA7;EPHA2;EPHA5;FLT1;PLAAT4;NTRK3;TCP1;HMBOX1;CTNNB1;CCT4;VAC14;DBI;EPHA4;CHTF18;CD200;SERINC1;HLA-DRB1;ALK;MAPKAPK5;MRE11;CD4;KLF4;SERINC5;PINK1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.549782174153281,1.0308372304304902,0.4666666666666667,0.7605546532805327,1.0,4/18,16.92%,PGD;HK2;HK1;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.6897700016514577,-1.030761221257546,0.4782608695652174,0.9895489209655454,1.0,1/5,4.51%,APOE
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.4960880893587034,1.0307492126878257,0.4189189189189189,0.7604906033253391,1.0,11/54,10.90%,TLCD2;ANK3;A4GALT;FA2H;DYSF;MYH9;PLSCR1;MICALL1;PLSCR2;SYTL4;PACSIN1
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.641901134007501,-1.03059031249675,0.48717948717948717,0.9886043171911914,1.0,2/5,9.80%,VEGFC;VEGFB
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.6275348245528399,-1.0305576837630186,0.4375,0.9873226098348926,1.0,1/6,6.53%,IL33
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.47356854622586547,1.0300437066812584,0.4927536231884058,0.7617843788535457,1.0,16/54,24.99%,FOXO1;MAP1LC3A;KLF10;MFSD2A;FAM107A;PDK4;TFEB;STK24;RRAGD;ELAPOR1;WDR45;KCNB1;CDKN2B;ULK1;EIF4G1;ATG7
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6371698378647475,1.0299420691726038,0.49122807017543857,0.7617198386332596,1.0,1/7,4.59%,PDIA2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.5768514342771777,1.0297254777737395,0.5,0.7618433436135389,1.0,4/16,10.95%,TMCC2;ACHE;KLK6;ADAM19
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.6766598690874965,1.0293671586410493,0.43859649122807015,0.7624085675413249,1.0,1/5,3.39%,SLC39A14
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.5203998670035139,1.0293247647022128,0.4262295081967213,0.7621610915118799,1.0,4/26,8.51%,ANK3;DMTN;FYN;MYO1C
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.6917108653484217,1.0290180196538745,0.49230769230769234,0.7622652625180049,1.0,1/6,2.85%,CD55
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.6917108653484217,1.0290180196538745,0.49230769230769234,0.7622652625180049,1.0,1/6,2.85%,CD55
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5512228274264032,-1.0287413822899067,0.4883720930232558,0.9910246115523899,1.0,1/12,2.58%,DNMT3B
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6117216320374791,1.028176133246819,0.48484848484848486,0.7638837465337058,1.0,6/11,32.02%,RBPMS;KIAA0319;BMP6;TGFB3;TGFB1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4866948630199148,1.0280136441608023,0.390625,0.7638742148405742,1.0,9/31,20.01%,SMCR8;LIMK2;YAP1;PHF23;MTM1;PINK1;BRCA1;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.48781271253090797,1.0279614797684338,0.4393939393939394,0.7636519624794642,1.0,4/38,6.88%,PROX1;SULF1;PTPRR;DVL1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.6980936174060004,1.027881775663034,0.4074074074074074,0.7634552208204685,1.0,2/5,20.73%,ABCG1;LDLRAP1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.577570528659173,-1.0275520258187671,0.4418604651162791,0.993153187235315,1.0,3/12,21.83%,PJVK;PIK3R4;ACBD5
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.6152385068789754,1.0274681353453363,0.4423076923076923,0.7640582110549299,1.0,4/10,20.80%,MFSD2A;ABCA3;MTMR2;MTMR3
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5394034927582233,-1.0267452891740043,0.475,0.994304376577193,1.0,6/12,28.25%,BCAP31;DERL2;YOD1;SVIP;OS9;ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4489981046259764,-1.0264798146718372,0.3157894736842105,0.9937520879601517,1.0,1/38,0.09%,NGF
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6419370434879078,1.0263961004165896,0.4576271186440678,0.7660466276181263,1.0,5/10,27.56%,CACNA1C;ORAI1;AKAP5;CACNA1D;MAPK3
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.5352291930068654,1.0261833042877946,0.4262295081967213,0.7661979519093081,1.0,8/24,16.86%,PROX1;CHI3L1;ITGA3;BASP1;GLI2;PDPN;FGF2;ABCA3
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5883582368285641,-1.026096183765477,0.5128205128205128,0.9934407934828784,1.0,7/12,20.55%,TFB2M;SLC25A33;MTERF1;TFB1M;TEFM;MTERF2;FASTKD1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5240910069104844,-1.0260925048130123,0.4772727272727273,0.9920544173037056,1.0,3/18,7.03%,KPNA2;TRIM21;TRIM68
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5371261584247122,1.0260647159539713,0.48333333333333334,0.7661874215368769,1.0,5/20,16.41%,LPCAT4;PLSCR1;PLAAT3;SERINC1;SERINC5
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6625982545904314,-1.0252062161420628,0.48717948717948717,0.9932766534478319,1.0,1/7,3.61%,DISP3
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.4473054734575175,-1.0247315834408848,0.36585365853658536,0.9933358197574265,1.0,6/32,9.31%,TNFAIP3;TRIM21;MUL1;FAM3A;CR1;METTL3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3713604649331277,1.0245767082868866,0.3229166666666667,0.7693644210776502,1.0,257/1616,19.05%,LEF1;CDKN2A;NR4A3;SKOR1;MYT1;MLIP;FOSB;FOSL2;SIX3;MET;KLF2;PRRX1;ST18;TEAD2;ZFP92;TLR2;IGF1;MAFF;EBF1;DCN;SP100;PROX1;ZNF536;CREB5;ATF3;ZIC4;SERPINE1;NR4A1;STAT4;ZNF93;LMO2;ZFP36;PRKCB;RPS6KA1;CASZ1;HES7;WAS;ZSCAN1;APP;DAB2IP;IRF7;FOXO1;ZNF140;CIC;SUV39H1;TGFA;HIC1;KLF11;EFNA1;ZNF282;SOX4;GCM2;PPARGC1B;PLSCR1;NFATC2;NFIL3;AHR;NKX6-2;TBX19;AGRN;GZF1;ZIC1;BCL6;LHX6;SSBP4;MSX2;KLF10;ERFL;MAMLD1;CIITA;CHD3;SKAP1;PLAC8;ZNF704;NEUROD2;ZNF750;DVL1;CCNQ;LDB2;ZNF608;GRIN1;PGR;FHOD1;TBX20;RFX4;ZBTB16;PID1;DBX2;CDK9;TNFRSF1A;GLIS2;HR;MYT1L;SNCA;SCX;NLRC5;FOXO3;HMBOX1;BEX1;HIVEP2;ZFPM2;DUSP22;ZBTB7C;PCGF3;NR6A1;CTNNB1;SLC9A1;CSRNP1;ZNF787;CTBP2;ZNF654;PBX3;TLE6;NR1I3;SMAD3;ETV6;ZNF597;ASXL3;TRAK1;RAI1;OVOL3;NAMPT;YAP1;TBL1X;HDAC4;GLI2;SMAD1;STAT3;GLIS3;PARP9;ASXL1;ABCA2;SRA1;ZNF467;TEAD1;NPAS2;HDAC9;GADD45A;FLI1;NR4A2;ZNF850;MEIS3;CDKN1A;BCL11A;MLXIPL;JAZF1;PPARG;EIF5A;MED12L;KLF6;SRCAP;ZNF552;CCNB1;FBP1;RELB;KLF9;ZNF667;PTPRN;MEF2D;KLF7;PER1;ZNF182;ZBTB26;PRDM1;IKZF2;BRD4;TNIP2;FOS;DEAF1;FGF2;FADD;SS18L1;SOX13;SMAD9;CCND1;TFAP2C;SOX10;ZNF746;MAML2;SMARCA1;GFI1B;DUXB;ZBTB46;AKIRIN1;ZNF571;PPM1D;ELF1;PHF6;RARG;IER5;ZNF513;RARA;PRKAR1A;ETV3;HIPK2;KLF4;BCL9;PROX2;TOX3;HIF3A;ZNF524;MRTFA;OLIG2;JUNB;IKBKG;BACH1;KLF3;TP53;PRDM16;NR2F6;ZKSCAN2;WNT5A;CUX2;PKNOX2;STAT6;LAGE3;MED13L;ZNF473;ZNF668;CBX7;PDE2A;RORA;SP140L;ZBTB1;TFEB;MESP1;RGMA;DOT1L;ZBTB38;HMGA1;MNT;ZEB1;HDX;CHD5;OTUD7B;RHOQ;LOXL2;WWTR1;UBP1;RLF;ZMIZ1;ZIK1;ZSCAN31;BCLAF1;ATP2B4;CBFB;GPS2;BRCA1;NCOR1;ARID1A;ETS1;BARX2;RXRA;DMRTA1;MTA1;BACH2;MAP2K5
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.508009552329509,-1.0245017639014329,0.4117647058823529,0.9925614808154479,1.0,6/17,17.29%,HSD17B8;HSD17B6;SRD5A1;DHCR7;TSPO;STARD3NL
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6624510795932461,1.0243209970556129,0.49056603773584906,0.7695494230561057,1.0,3/8,16.07%,PRKAR1B;PKIA;PRKAR1A
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.6493832772319585,1.024318684512691,0.5294117647058824,0.768879698767054,1.0,3/7,19.38%,ENPEP;AOPEP;CTSZ
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.6493832772319585,1.024318684512691,0.5294117647058824,0.768879698767054,1.0,3/7,19.38%,ENPEP;AOPEP;CTSZ
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.6291698655397179,1.0239126677389712,0.5,0.7694277381501613,1.0,4/9,16.25%,PTPRC;LDLR;CD200;LRFN5
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.65005685228908,1.0238391128204904,0.49122807017543857,0.7692847601483868,1.0,2/7,10.30%,FOLH1;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.6797653911591398,1.023687346291566,0.5370370370370371,0.7689437869762603,1.0,5/6,24.20%,DUSP1;CCNB1;LCMT1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.6797653911591398,1.023687346291566,0.5370370370370371,0.7689437869762603,1.0,5/6,24.20%,DUSP1;CCNB1;LCMT1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5305759100199614,-1.0234054628621683,0.40540540540540543,0.9943182522499293,1.0,2/13,5.70%,HEY2;ZNF593
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.44420436303560523,-1.023155279716705,0.46153846153846156,0.9934475729093096,1.0,10/28,23.12%,SF3B4;HSPA1A;ZPR1;RBM22;NCL;PRDX6;RBMX;CIRBP;SNW1;HABP4
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.5431206862678013,-1.0230867138697723,0.45652173913043476,0.9922128937577952,1.0,1/13,1.09%,FAM47E
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6018631369275336,1.0229569703831365,0.4,0.7703264307565774,1.0,4/14,16.86%,LPCAT4;CDS2;PNPLA8;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.6181270135065856,-1.0229166679623185,0.4666666666666667,0.9913260473656315,1.0,1/9,5.63%,MUL1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.6519084888649007,1.0228261281794537,0.47058823529411764,0.7703493486307644,1.0,1/7,10.06%,AK5
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4718754140083785,1.0225410468810332,0.45588235294117646,0.7706237110477632,1.0,11/57,16.07%,PROX1;PSRC1;PTK6;APP;NUDT16;TGFB2;CDKN1B;CCNB1;TRIM32;CCND1;RARA
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5898900258845342,1.0224548517427956,0.48484848484848486,0.7704755571512982,1.0,3/12,6.88%,PROX1;SOX4;DVL1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4717170198087574,1.0220124038902647,0.453125,0.7711415624362701,1.0,11/50,21.32%,ANXA1;LSM11;CDC7;CCNB1;BRD4;CCND1;CDC25B;ADAMTS1;CDC27;ADAM17;RAB11A
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.5095938945658613,1.0219926461790139,0.4262295081967213,0.7708325860091199,1.0,5/21,18.79%,ZFP36;PLAAT4;PRKCH;CBFB;CTSK
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.6379822200409964,-1.0216995440686025,0.40425531914893614,0.9935261515004359,1.0,1/5,11.26%,ZNF304
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.4485638412889126,-1.0216988153781912,0.35714285714285715,0.9921462540677964,1.0,10/43,24.02%,PSMD10;PSMD12;PSMB5;NQO1;PSMD2;PSME3;PSMB4;PSMB6;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.6497287070426335,-1.021485935656504,0.5208333333333334,0.9912846252055195,1.0,3/6,24.52%,AQP6;CA2;AQP1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.46783144921089503,1.021479713068164,0.4745762711864407,0.771799075967296,1.0,15/40,20.94%,RASGRP1;PTPRC;ADA;SOX4;CD44;NLRC3;KIF13B;CD276;CD4;PIK3CD;SCRIB;CXADR;LFNG;TNFSF4;NCK2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.6037890046729535,-1.0209267179912844,0.5121951219512195,0.9912280836210081,1.0,3/6,25.16%,PLA2G4A;PLA2G5;HADHA
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.5664055979374701,1.020748431625695,0.5384615384615384,0.7731962857915257,1.0,5/17,23.41%,RBPMS;KIAA0319;WWTR1;BMP6;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.4509012536252095,1.020735053722738,0.4864864864864865,0.7729018621924275,1.0,29/84,22.49%,THBS1;SERPINE1;PRKCB;FLT1;APLNR;CHI3L1;PAK4;CYP1B1;HK2;ADAM12;SMAD1;ITGB8;HIPK1;FGF2;GAB1;PIK3CD;HIPK2;KLF4;WNT5A;BRCA1;ETS1;PRKCA;F3;BTG1;HIF1A;ANGPTL4;RHOB;HSPB1;VEGFD
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.5565773580551538,1.0206651644426148,0.45614035087719296,0.7726628493279837,1.0,5/16,10.59%,PDGFRA;MYH11;MYLK3;ALPK2;TCAP
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.5653951831794142,1.0206122557368953,0.4642857142857143,0.7724340694961979,1.0,6/16,20.65%,PTPRC;TNFRSF14;STX4;HLA-E;WNT5A;TNFSF4
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.6088691798538385,1.0203211762313136,0.515625,0.7728016139511442,1.0,2/11,13.44%,APLNR;AKAP8
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.49510156964674157,1.0202313859377692,0.5147058823529411,0.7726530898145062,1.0,18/46,25.09%,RASGRP1;IL1R1;CYRIB;GAS6;CD276;HLA-DRB1;FADD;IL12A;RARA;SCRIB;PDE4D;TNFSF4;ZFPM1;TLR3;PDCD1LG2;IL12RB2;HLA-A;PRNP
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.6714286140278634,-1.0202110741558639,0.5227272727272727,0.991919849352591,1.0,1/5,10.03%,AMPD3
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5537157983444426,1.019929761555287,0.4492753623188406,0.7730802767869658,1.0,7/25,18.91%,ABCA8;ABCA5;ABCA2;PPARG;ABCA3;GPS2;RXRA
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6109571045993131,1.0198735212602423,0.5535714285714286,0.7729067464068717,1.0,5/12,24.08%,LAMA5;ZDHHC7;LAMA3;SCRIB;AHI1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5761119967718564,1.0193458600196657,0.4603174603174603,0.7737285010980575,1.0,1/18,0.98%,IMPDH1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.6996313961622099,1.0191159510806123,0.4897959183673469,0.7736111581920837,1.0,2/6,18.08%,SLC16A10;SLC7A8
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.6996313961622099,1.0191159510806123,0.4897959183673469,0.7736111581920837,1.0,2/6,18.08%,SLC16A10;SLC7A8
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.51872744568518,1.019112683481396,0.45161290322580644,0.7732778876934643,1.0,10/33,20.40%,ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1;NEU4;ENO3;MAN2C1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5684416498451067,1.0188140753471648,0.47692307692307695,0.7736487701527869,1.0,2/14,3.13%,NR4A1;SLIT2
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6233973005076622,1.018811676716799,0.45098039215686275,0.7733107846699765,1.0,5/11,20.19%,MFSD2A;MYO9A;ERMN;FAM110C;SEMA4D
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.5715529619758826,-1.018700416684374,0.5128205128205128,0.9948724029955284,1.0,2/9,7.30%,CD200R1;MST1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.5604506193050254,1.018454519695956,0.4098360655737705,0.7737960428841648,1.0,1/16,1.84%,THBS1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4647157613820516,1.0181788803557852,0.38571428571428573,0.7740964180573847,1.0,18/70,21.19%,CDKN2A;PLK2;TYMS;KLF11;CDK6;CDKN1A;CDC7;CDKN1B;BRD4;CCND1;BACH1;CDK2;CDK18;MAX;PLK3;BCAT1;CDKN2D;CAMK2A
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6000346448462158,1.018030909786653,0.49056603773584906,0.7741324207496414,1.0,2/12,2.41%,CTSS;LMO2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.5461346864225612,1.0178949521360525,0.39344262295081966,0.7741484678741779,1.0,7/18,15.42%,KCNJ2;KCNH2;ATP1A1;ATP1B1;ATP1B3;SLC12A5;KCNMA1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.6494952746385905,-1.017777897172239,0.46511627906976744,0.9959196188957389,1.0,1/5,10.71%,VPS4B
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.4922337482267365,1.0174150405984121,0.42857142857142855,0.7749561413430105,1.0,7/44,7.32%,L1CAM;RIMS2;SYT1;SHTN1;SYT4;AGRN;GHR
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6017773057115916,1.0172922508435107,0.5087719298245614,0.7749519087611242,1.0,8/10,39.79%,SORBS1;PTPN11;IRS1;ECHDC3;SIRT1;PRKCZ;ZBTB7B;GKAP1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.6402288306524306,1.017096588623612,0.5370370370370371,0.7750969158572203,1.0,2/9,13.86%,RYR2;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4829804935543967,1.0170752977727249,0.46551724137931033,0.7748042283669233,1.0,12/31,24.72%,NELL1;ZBTB16;PKDCC;TGFB2;P2RX7;WNT5A;SLC8A1;PTPN11;BMP6;ANO6;TGFB3;ACVR1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.47902563374461166,-1.0168029830529024,0.425531914893617,0.9973790544126809,1.0,5/32,11.71%,FAM47E;TPP1;MCM9;ATR;CENPA
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.6537827298542741,-1.0167946190310295,0.4418604651162791,0.9960071437463637,1.0,1/5,15.42%,TRIB1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.6321577266100543,1.016792928145914,0.6,0.7751380412613144,1.0,4/8,21.87%,TERF2IP;OGG1;TINF2;ACD
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5788195955478472,1.0166064992009345,0.41818181818181815,0.775267874047999,1.0,4/10,27.81%,STX4;STX1B;SNAP25;STX3
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5946594519538491,-1.0165433873631167,0.4807692307692308,0.9940802065713572,1.0,2/8,5.75%,EXOSC8;ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5946594519538491,-1.0165433873631167,0.4807692307692308,0.9940802065713572,1.0,2/8,5.75%,EXOSC8;ERI2
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.6079851617434571,1.0165166527165561,0.5087719298245614,0.775124470444556,1.0,4/6,20.91%,FAP;YAP1;PAK1;PTPRJ
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6000115459070139,1.0165150483647931,0.4339622641509434,0.7747876062679178,1.0,1/10,2.65%,IGF2BP2
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.4666436432118517,1.0164459863270674,0.4444444444444444,0.7745750739438382,1.0,13/45,15.87%,RASGRP1;CD22;PRKCB;PTPRC;LAT2;TPD52;HDAC4;HDAC9;KLF6;BCL2;CD70;GPR183;PIK3CD
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.6059619125640499,1.0160803145951605,0.39655172413793105,0.7750024904505134,1.0,2/10,19.47%,STK25;PLK3
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.6792656143151841,1.0159815872910631,0.5483870967741935,0.7748743227765668,1.0,2/6,16.44%,TMSB10;PFN4
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.6949021717221359,1.0158982731016664,0.5370370370370371,0.7747512214207101,1.0,4/6,16.60%,ALOX12;NOXA1;TAFA4;NOX4
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.49000447865783553,1.0156456415843031,0.45588235294117646,0.7749551222507928,1.0,6/32,13.51%,MET;DAB2IP;ITGA3;TGFB2;KCTD13;FBP1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.6379295370237652,1.0153729917697272,0.5,0.7752578625933717,1.0,3/7,17.11%,CTNNB1;NR4A2;WNT5A
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.565015656853223,-1.0153385375389195,0.4594594594594595,0.9961692879454422,1.0,2/9,19.59%,TPRKB;RAD51
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.343725146780411,-1.0151428500474424,0.6,0.9952610880904024,1.0,48/335,14.21%,ACP3;SLC2A5;FTL;GMFG;EPX;CSTB;CST3;VAMP8;PRSS3;CHRNB4;CTSH;NEU1;FTH1;NPC2;CREG1;MGAM;FLG2;RAP2C;CKAP4;AGL;DDOST;CAP1;CR1;ABCA13;JUP;APRT;AMPD3;NCSTN;APEH;AGPAT2;HSPA1A;BIN2;FUCA2;CD47;TARM1;DSC1;PSMD12;STK11IP;FRK;DEGS1;DNASE1L1;EEF1A1;IDH1;AGA;NRAS;PGM2;NFAM1;MAGT1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.45256663416293375,1.015003621242046,0.421875,0.7757533386835433,1.0,16/50,15.62%,SLITRK1;SLIT2;THY1;EFNB3;PAK3;MAG;ROBO2;MCF2;SIPA1L1;EPHA4;CHODL;KIF13B;PLXNA4;PAK1;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5947971003258309,1.014994954940745,0.5147058823529411,0.7754272623375128,1.0,2/13,1.86%,GPNMB;IL15
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.44384819870252523,-1.0149501338813978,0.4117647058823529,0.9944820471982063,1.0,4/39,2.25%,TRIM29;GALNT3;CEBPA;VAMP8
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5123243461311734,-1.014677126052313,0.4594594594594595,0.9938738048916034,1.0,8/18,31.90%,ACVR1C;DNASE2;DEDD2;KPNB1;CASP3;ENDOG;EXOG;HMGB1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.6193445152451206,1.01460742729906,0.484375,0.7760310125665432,1.0,3/8,24.27%,THPO;SH2B3;ANXA2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.624410922374055,1.014592882494663,0.4603174603174603,0.7757001560175527,1.0,1/8,13.51%,CCNB1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.5975955733325793,1.014458268829989,0.5818181818181818,0.7756462316799236,1.0,2/10,4.45%,NOD1;ERBIN
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.5919874174671064,1.013679975657472,0.47540983606557374,0.7771033732180449,1.0,4/18,15.60%,SERPINE1;TNFRSF14;OPTN;GSDMD
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.45936813829086387,1.0136703133599134,0.4507042253521127,0.7768020972118773,1.0,7/62,9.36%,IGF1;THBS1;SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.406150858137724,-1.0133090925182062,0.34615384615384615,0.9962570860597226,1.0,8/67,11.17%,NUP62CL;KPNA2;NXT2;NUP50;RPL23;RGPD8;RANBP6;RANBP17
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.4752632971006481,-1.0131113565148002,0.4857142857142857,0.9953537093357112,1.0,15/42,22.70%,GRPEL2;TIMM8B;TIMM13;AIP;BCAP31;TIMM23;TSPO;TIMM10;TIMM50;FIS1;TIMM17A;RALA;TOMM34;DNAJC19;GDAP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4155410108077379,-1.0126926542194992,0.41379310344827586,0.9950407364684143,1.0,10/54,13.44%,SELENOS;TPT1;NOC2L;CREB3L1;MAPK7;HSPA1A;SFRP2;NDUFS3;HTRA2;CLU
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.584347558013263,1.0126574052090598,0.5079365079365079,0.7788051218785872,1.0,4/13,16.95%,BAG3;GAS6;TP53;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.48664129391565103,1.01248511539215,0.45588235294117646,0.7789077604177597,1.0,7/55,15.09%,IGF1;ACHE;TMED10;SYTL4;TGFB2;ARF6;OAZ2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.615212105320374,-1.012349729423525,0.5,0.9944140675943409,1.0,4/7,22.06%,PEX11B;PEX11A;FIS1;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.4138038061793068,-1.0123062847283235,0.42857142857142855,0.9932027413390403,1.0,6/78,6.18%,G0S2;KSR2;LEPR;DISP3;SIRT6;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5014368950941294,1.012281208478737,0.47619047619047616,0.7789708747878022,1.0,9/37,11.03%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6402476386812241,-1.012050053781358,0.5370370370370371,0.9925279732530896,1.0,1/5,0.59%,KCNE1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6274521002579135,-1.0118829197690735,0.5294117647058824,0.9916252974295319,1.0,2/10,9.62%,ID2;HSF1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.34254007952754084,-1.0115424546830338,0.631578947368421,0.9911734725446496,1.0,48/338,14.21%,ACP3;SLC2A5;FTL;GMFG;EPX;CSTB;CST3;VAMP8;PRSS3;CHRNB4;CTSH;NEU1;FTH1;NPC2;CREG1;MGAM;FLG2;RAP2C;CKAP4;AGL;DDOST;CAP1;CR1;ABCA13;JUP;APRT;AMPD3;NCSTN;APEH;AGPAT2;HSPA1A;BIN2;FUCA2;CD47;TARM1;DSC1;PSMD12;STK11IP;FRK;DEGS1;DNASE1L1;EEF1A1;IDH1;AGA;NRAS;PGM2;NFAM1;MAGT1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.42657854019496355,-1.0113776623817938,0.34375,0.9902021559417372,1.0,6/44,8.25%,TRIM29;AR;KRT8;IL20RA;B3GNT3;ATP2C2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.514005736492794,1.0113539311575985,0.47619047619047616,0.7807240054751983,1.0,6/29,14.38%,MET;THBS1;NTRK3;P2RY12;STX4;FGF2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3415019251423885,-1.011123087263499,0.6,0.9895142586465795,1.0,48/337,14.21%,ACP3;SLC2A5;FTL;GMFG;EPX;CSTB;CST3;VAMP8;PRSS3;CHRNB4;CTSH;NEU1;FTH1;NPC2;CREG1;MGAM;FLG2;RAP2C;CKAP4;AGL;DDOST;CAP1;CR1;ABCA13;JUP;APRT;AMPD3;NCSTN;APEH;AGPAT2;HSPA1A;BIN2;FUCA2;CD47;TARM1;DSC1;PSMD12;STK11IP;FRK;DEGS1;DNASE1L1;EEF1A1;IDH1;AGA;NRAS;PGM2;NFAM1;MAGT1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4205584642148676,1.0109995836919388,0.4230769230769231,0.7810571679512878,1.0,32/129,26.56%,KREMEN2;DRAXIN;PTPRO;DAB2IP;NOTUM;DVL1;TLE6;TLE3;PRICKLE1;HECW1;ANKRD6;SOX13;WNT5A;STK3;MESP1;WWTR1;DKK3;STK11;FRMD8;AMFR;AXIN2;TLE2;GLI1;PSMB3;MLLT3;CUL3;RBMS3;PRKN;UBAC2;TMEM131L;TLE4;FRZB
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.6561332041320012,1.0107663386938714,0.48936170212765956,0.7812029664690877,1.0,4/8,26.99%,CDKN1A;IL12A;STK11;MME
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.5193970482146031,1.010560173714342,0.43103448275862066,0.7814224536214014,1.0,9/31,12.12%,COL11A2;SULF1;CD44;CHI3L1;ZBTB16;SCX;SH3PXD2B;NAMPT;ITGB8
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5443010615237203,1.010412877915977,0.46551724137931033,0.7814007289567778,1.0,3/11,17.75%,LIMK2;YAP1;MAP4
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6968499760397622,1.010411627722985,0.576271186440678,0.7807331816546849,1.0,1/5,21.25%,DYNC1LI1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6968499760397622,1.010411627722985,0.576271186440678,0.7807331816546849,1.0,1/5,21.25%,DYNC1LI1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4826805333864654,-1.0103037978741103,0.42105263157894735,0.9905627053296218,1.0,4/24,5.01%,ID2;CCNE1;CDK15;FBXO5
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.6210941795150478,-1.0100086444746015,0.5128205128205128,0.9898657985245467,1.0,1/5,10.63%,ACVR1C
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3650607706290249,1.0099774238852612,0.46875,0.7813651420007878,1.0,165/1648,14.02%,LEF1;CDKN2A;NR4A3;SKOR1;MYT1;ELAVL2;FOSB;FOSL2;SIX3;PTP4A3;KLF2;PRRX1;ST18;TEAD2;MYRF;ZFP92;IGF1;MAFF;EBF1;MLLT11;SP100;PROX1;YWHAH;EGF;ZNF536;CREB5;TESC;BLM;MAEL;ATF3;PSRC1;ZIC4;NR4A1;ACTA2;STAT4;ZNF93;TYMS;PRDM8;PRKCB;RPS6KA1;CASZ1;HES7;ZSCAN1;TCEAL7;DAB2IP;IRF7;PRAME;FOXO1;ZNF140;CIC;SUV39H1;TGFA;HIC1;KLF11;WTIP;ZNF282;SOX4;GCM2;PPARGC1B;NFATC2;NFIL3;AHR;NKX6-2;TBX19;GZF1;ZIC1;BCL6;LHX6;MSX2;ZNF114;KLF10;ERFL;MAMLD1;CIITA;CHD3;SKAP1;ZNF704;NEUROD2;DVL1;NRG1;CCNQ;ZNF608;KCNH2;BAP1;PGR;TBX20;RFX4;TRIM22;ZBTB16;DBX2;GLIS2;HR;MYT1L;SCX;PML;FOXO3;HMBOX1;HIVEP2;ZFPM2;ZBTB7C;PCGF3;NR6A1;CTNNB1;CSRNP1;ZNF787;CTBP2;BASP1;ZNF654;PBX3;SMAD3;ETV6;ZNF597;TRAK1;RAI1;OVOL3;CHMP1A;YAP1;TBL1X;CDKN1C;HDAC4;DENND4A;GLI2;SMAD1;STAT3;RGMB;PEX14;GLIS3;PARP9;ABCA2;SRA1;ZNF467;GAS6;TEAD1;NPAS2;TERF2IP;HDAC9;PRICKLE1;FLI1;NR4A2;ZNF850;MEIS3;CDKN1A;BCL11A;MLXIPL;PPARG;L3MBTL3;RUNX1T1;MED12L;KLF6;SRCAP;ZNF552;CDKN1B;HLA-DRB1;RELB;KLF9;ZNF667;MEF2D;KLF7;PER1;ZNF182;ZBTB26;JARID2;PRDM1;IKZF2;BRD4
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.46455389189014373,-1.0098930903971834,0.40540540540540543,0.9888807262651327,1.0,7/25,12.82%,APOBEC3G;TNFAIP3;MUL1;PTPN22;IFNLR1;PQBP1;AIM2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.561778127238542,-1.0095125578637394,0.48717948717948717,0.9886224053455931,1.0,4/10,17.33%,METTL3;PRELID1;IKZF3;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.4901042828556005,-1.0094741174223791,0.47619047619047616,0.98740402418993,1.0,2/22,3.17%,MID1IP1;TRIB3
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.5131257443703469,1.008950170405223,0.4461538461538462,0.7834205671601545,1.0,6/24,15.35%,GPNMB;THY1;PAG1;CYRIB;CCL2;CD4
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.6189799900340854,1.0088968517915458,0.5,0.7831820669409147,1.0,3/9,15.94%,CD55;SERPING1;CD59
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5259363541243967,1.0088820141456283,0.42105263157894735,0.7828652731455784,1.0,6/21,18.99%,NUMBL;SERPINF1;TRIM32;NAP1L1;RGS14;LRP2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.6455116444454352,1.008117186680543,0.5,0.7842161277213917,1.0,2/6,13.05%,THBS1;CD200
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.6069808931059464,-1.0079757267648641,0.5217391304347826,0.989995818689642,1.0,1/9,2.58%,DNMT3B
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.5590671886471332,-1.0079726391049146,0.4772727272727273,0.9886861273715105,1.0,2/8,14.63%,VAX2;AMER2
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.6985518670103811,1.007697859190647,0.5660377358490566,0.7848256293296427,1.0,1/5,7.77%,MAOB
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6669559673276623,1.0076233068860099,0.5254237288135594,0.7846898322522075,1.0,2/8,12.90%,PRKCB;PPARG
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.41597853962727127,1.0076070957789012,0.4025974025974026,0.7844072194623669,1.0,6/133,5.10%,TLR2;EGF;SULF1;TRPM4;SOX4;LGR5
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5964026363378844,1.0073638508875924,0.5423728813559322,0.7846339954946111,1.0,1/14,0.98%,IMPDH1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.6458781187185877,-1.0067594149936394,0.5333333333333333,0.9909914989622519,1.0,3/6,26.44%,ZNHIT3;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6598411019402941,1.00665741380133,0.4807692307692308,0.7858392856733111,1.0,3/7,23.05%,LAMB1;NTN4;LAMB4
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.6785917885592417,1.0063390983138651,0.5614035087719298,0.7862804778113801,1.0,2/6,18.79%,DIO1;CTSK
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5647043316555118,-1.0060404179696496,0.4594594594594595,0.9915130422964539,1.0,2/9,1.82%,AR;SELENOS
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.6050054585673657,-1.0059869167856708,0.48936170212765956,0.9903399607280302,1.0,1/6,2.54%,SFXN2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5840252575308345,1.0058811861632615,0.49056603773584906,0.7869559811448678,1.0,4/13,18.13%,RYR2;CACNA1C;SLC8A1;CALM3
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.6780879358763277,1.0058291489955038,0.5909090909090909,0.7866876651023977,1.0,1/5,18.53%,SYAP1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.4699767427698929,1.0058290875010116,0.42857142857142855,0.7863511862037226,1.0,7/37,19.18%,WAS;PML;TERF2IP;SPIRE1;FMN2;SPIRE2;WRAP53
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7026757525515865,1.0050820703994774,0.5471698113207547,0.7877777874724066,1.0,2/5,22.16%,BIRC3;SLC15A4
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6628978920235524,1.0049389471033672,0.5423728813559322,0.7876851800386462,1.0,1/5,2.42%,TYMS
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6718842480034555,1.0046015775079997,0.5272727272727272,0.7881293318010876,1.0,3/6,10.15%,GRIN2B;FYN;HOMER1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.6386812801381594,1.0041731484294298,0.4642857142857143,0.7888559602124375,1.0,2/6,17.53%,SLC29A4;SLC29A1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.6100934256368062,1.003901010873299,0.4745762711864407,0.7888553027562947,1.0,3/9,8.65%,ADCY5;AHR;ADCY2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.6100934256368062,1.003901010873299,0.4745762711864407,0.7888553027562947,1.0,3/9,8.65%,ADCY5;AHR;ADCY2
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),0.716203508015553,1.003876034523589,0.5714285714285714,0.7882752935592048,1.0,2/5,10.58%,CHI3L1;CHI3L2
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),0.716203508015553,1.003876034523589,0.5714285714285714,0.7882752935592048,1.0,2/5,10.58%,CHI3L1;CHI3L2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.550375497124936,1.0031355570669744,0.49122807017543857,0.7897254109120779,1.0,3/16,8.83%,RFTN1;COLEC12;CGAS
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.707958488677054,1.002446893011247,0.6379310344827587,0.7908483806496956,1.0,4/5,24.73%,DCC;FGF13;PTPRS;ULK1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5671175402943143,1.0024002972043435,0.43636363636363634,0.7906478503811283,1.0,3/17,10.19%,CD22;THY1;CD160
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6050628252248271,1.0023932165418343,0.5517241379310345,0.790335705610433,1.0,2/13,4.89%,CD55;TRPM4
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4538057527604867,1.002241591252768,0.4507042253521127,0.7903104576634976,1.0,15/60,21.54%,SLC39A14;IRS2;FOXO1;BAIAP2;NAMPT;SORBS1;PDK4;BCAR1;GAB1;SH2B2;RHOQ;SHC1;IGF1R;ATP6V1B2;GRB10
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.44934022684830455,1.0021405125628897,0.4266666666666667,0.7902172459010868,1.0,2/76,2.14%,KLF2;ATF3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4901908508409913,1.0019891575455804,0.4931506849315068,0.7902066318424437,1.0,9/38,18.54%,BOK;SEPTIN4;BCL2L1;BBC3;BCL2;SGMS1;PINK1;TP53;BCLAF1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.6767742042993744,1.0016431692384395,0.509090909090909,0.7906666674989726,1.0,2/6,8.07%,PTPRC;LDLR
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.6525093734133817,-1.0012107357341151,0.5490196078431373,1.0,1.0,3/6,11.99%,CFTR;AQP4;AQP6
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5643402706039982,-1.0011458377154787,0.4594594594594595,1.0,1.0,1/9,3.73%,CEP19
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6066343559510415,1.0011367410811989,0.5238095238095238,0.7914706557695139,1.0,5/11,27.35%,PIP4K2A;LRSAM1;ELAPOR1;ANXA2;SH3GLB1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.5945050145527477,1.0006662965670419,0.5076923076923077,0.7921818524417186,1.0,1/17,4.38%,SUN3
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.6237789776206032,-1.0005002020577605,0.5,1.0,1.0,2/5,17.49%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.6257810605694949,1.000296720457674,0.5344827586206896,0.7927083056045368,1.0,3/8,21.32%,LIMK2;TPPP;RAB11A
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.498195363891495,1.0002845349512823,0.45614035087719296,0.7924011897697157,1.0,6/30,14.63%,BOK;GGCT;HK2;BCL2L1;BBC3;BCL2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.5730034744163106,1.000212292236984,0.55,0.792239584773027,1.0,2/12,1.85%,PROX1;PKP2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5610499454602386,0.9999848735916116,0.4915254237288136,0.792436249382632,1.0,4/12,30.29%,AK3;RHOQ;GNAI3;ENTPD7
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.38875908207701887,0.9992226756585595,0.5517241379310345,0.7938856807791033,1.0,51/302,20.30%,RECQL4;BOK;HELB;BLM;EPHA2;IRF7;RBM24;FOXO1;RPA1;SUV39H1;HIC1;NFATC2;BCL6;HROB;SAMHD1;POLD1;PML;CGAS;BCL2L1;IKBKE;YAP1;POLQ;GADD45A;BARD1;CDKN1A;MACROD1;PAK1;BCL2;CCND1;MRE11;POLE3;FANCL;TRAIP;FMN2;HPF1;SPATA18;IKBKG;BACH1;TP53;OGG1;ZBTB1;DOT1L;ZBTB38;DDB2;BRCA1;RFC4;STK11;PLK3;RAD18;MMS19;WAC
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.6811864389911642,0.9990901609140311,0.5263157894736842,0.7938735540581612,1.0,3/5,29.35%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5443193248476264,0.9989792204910813,0.45901639344262296,0.7937889353083152,1.0,6/15,29.84%,TGFB2;PCSK5;IQCE;ZNF141;PTCH1;FBXW4
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6322903029226654,0.9989446673715923,0.5384615384615384,0.7935642763426761,1.0,1/9,4.57%,ATP9A
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6943636343516073,0.9985336035945095,0.559322033898305,0.7941994403263545,1.0,1/5,8.14%,MYD88
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5090024636987563,0.9981435019948418,0.4838709677419355,0.7946747646029323,1.0,1/27,1.12%,HELB
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.628079531886637,0.9980491074106811,0.41935483870967744,0.7945513478140743,1.0,3/9,4.24%,ANK3;KCNE4;NOS1AP
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.6016555900920536,0.9979413600368301,0.5,0.7944714447854456,1.0,4/6,32.38%,TGFB2;TGFB3;TGFB1;MSN
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6388408866186792,0.9973696520165197,0.5094339622641509,0.7954040705261055,1.0,6/7,33.87%,ITPK1;IMPA1;ISYNA1;PPIP5K1;IMPA2;IPPK
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5785318844831742,0.9972080017418653,0.48214285714285715,0.7954347169590308,1.0,4/12,15.62%,NRP2;PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.551348873954107,0.9970503361399388,0.5,0.7954605203633962,1.0,3/16,8.12%,LDB2;NLRC5;HMBOX1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.4985195183020687,0.9965848975533587,0.5087719298245614,0.7960689347555256,1.0,3/31,4.29%,DUSP1;DUSP10;FOXO1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.5354821621926171,-0.9964834136848706,0.48936170212765956,1.0,1.0,3/12,21.50%,TMED9;SURF4;SNX2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.39411177382610757,0.9964532392531286,0.46987951807228917,0.7960655704432026,1.0,47/206,25.68%,EGF;KREMEN2;DRAXIN;PTPRO;DAB2IP;TRPM4;SOX4;LGR5;NOTUM;DVL1;CTNNB1;TLE6;TBL1X;PLEKHA4;TLE3;PRICKLE1;HECW1;ANKRD6;SOX13;FZD7;WNT5A;STK3;WWTR1;LGR6;DKK3;STK11;FRMD8;TBL1XR1;AMFR;AXIN2;TLE2;UBR5;GLI1;LYPD6;UBE2B;PSMB3;MLLT3;CUL3;PIN1;RNF220;DAPK3;PSEN1;RBMS3;LRRK1;CSNK1G2;PRKN;UBAC2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5150268005439771,-0.9961206423619374,0.5833333333333334,1.0,1.0,1/12,3.58%,PYHIN1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.6345192440050815,0.9958869901438477,0.5,0.7971206487827357,1.0,3/7,11.80%,PLAAT4;PLAAT3;PLAAT5
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.467271180190613,-0.9958038263444845,0.4782608695652174,1.0,1.0,2/28,2.25%,AR;VAMP8
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5199274100996283,0.9957108637289844,0.5,0.7972514982785736,1.0,9/24,19.44%,ANXA1;THBS1;SRPX2;HDAC9;STARD13;FGF2;KLF4;MAP2K5;HDAC7
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.6754023684954368,0.9956718476213826,0.5283018867924528,0.7969832532834616,1.0,1/5,3.25%,PTPRC
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5710396783065464,0.9953049601458112,0.5,0.7974167666207063,1.0,2/13,7.20%,BLM;RYR2
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.4640441989421234,-0.9950947779436807,0.38461538461538464,1.0,1.0,2/19,6.88%,APOE;ARV1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5958532415772272,0.9949102475237533,0.5178571428571429,0.7978835363365343,1.0,8/15,17.20%,KCNJ2;ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3;KCNMA1;SLC8A1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4936685683651328,0.9946741699697536,0.4406779661016949,0.7977073389818374,1.0,11/27,19.10%,TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;VASP;TSC2;LRP2;MTHFR;SCRIB
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.4936685683651328,0.9946741699697536,0.4406779661016949,0.7977073389818374,1.0,11/27,19.10%,TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;VASP;TSC2;LRP2;MTHFR;SCRIB
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.6729470668193369,0.9945814593185246,0.5806451612903226,0.7976073589422078,1.0,3/5,27.69%,ADAM9;PRKN;D2HGDH
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.5762965500962038,0.9945222014949764,0.5283018867924528,0.7974547185976811,1.0,3/8,17.72%,SHMT1;GDA;DPYD
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5772083008111285,0.994003768945726,0.4915254237288136,0.7982943407565231,1.0,5/13,28.98%,CHKB;ETNK2;LPIN3;SLC27A1;ETNK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.4450082722239887,-0.9938991412284566,0.35714285714285715,1.0,1.0,3/26,2.95%,CSTB;CST3;TRIM21
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5678920466317953,0.9933879439808233,0.527027027027027,0.7994302949129946,1.0,1/16,0.99%,CTSC
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.43056450279444136,0.9933057946311722,0.5466666666666666,0.7992914489368583,1.0,16/108,11.84%,CDKN2A;SP100;PROX1;IRAK2;TCEAL7;PIM1;DAB2IP;ERBIN;NLRP12;GLIS2;NLRC5;CYP1B1;NLRC3;HDAC4;PEX14;GAS6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.48658539529777817,0.9928745205125197,0.45714285714285713,0.799961704343166,1.0,7/36,20.27%,WAS;PARP9;SPIRE1;FMN2;SPIRE2;WRAP53;MMS19
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.48708627467455906,-0.9926410422357025,0.5365853658536586,1.0,1.0,2/12,19.50%,BCAP31;ATXN3
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.44755487903760927,0.9925416627115515,0.44776119402985076,0.8004878515189346,1.0,12/90,8.76%,SIX3;TEKT2;C1ORF87;NME9;EFNB3;ANGPTL2;CFAP126;ERICH3;TMEM212;ZMYND10;GFAP;MORN5
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5964061270071311,0.992409149845588,0.46875,0.8004396119123388,1.0,2/10,1.84%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5125129233170679,0.9920315876013633,0.5901639344262295,0.8009698994505725,1.0,12/34,27.76%,NUAK2;NUAK1;FOXO3;SIK2;PICK1;TP53;MTMR3;SESN1;HSPA5;CPEB4;SH3GLB1;BRSK1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.41453613500103237,-0.9920145560382937,0.36363636363636365,1.0,1.0,6/42,12.47%,FTL;FTH1;ATP6V1G1;SLC46A1;HFE;ISCU
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.40093945151799293,0.9920128082749465,0.4268292682926829,0.8007016699486652,1.0,23/202,14.63%,MET;BOK;DCN;PLK2;DEPP1;FOXO1;TRIM5;SMCR8;TRIM22;GFAP;FOXO3;CAPN1;PLEKHF1;STAT3;PIP4K2A;MAPT;EEF1A2;TPCN2;WASHC1;FBXL2;OPTN;RNF152;BCL2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5667348330353089,0.9919576310469911,0.5,0.8005196487112056,1.0,3/10,22.35%,MAPT;NDFIP2;PPM1F
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6788892612701681,0.9916265438803429,0.6101694915254238,0.8008868915812557,1.0,3/6,27.95%,PHF19;MACROH2A1;OGT
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.5452547031078387,0.9914854636139452,0.49122807017543857,0.8009006335960612,1.0,9/15,37.14%,ATG9A;WDR45;ULK1;ATG7;ATG5;ULK2;ATG13;RB1CC1;WDR45B
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5164776034959488,0.9914794145833238,0.4782608695652174,0.8005851722250511,1.0,5/24,16.65%,DCN;CYRIB;MAPT;SPIRE1;PINK1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5588827372666046,0.991416823210629,0.5245901639344263,0.8003701212956195,1.0,7/17,22.50%,KIF5A;LIMK2;KIF5C;IKBKG;DNM2;RAB11A;SYNJ1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.4977288636312907,0.9913959132478031,0.4482758620689655,0.8000932799821378,1.0,4/27,10.19%,IGF1;NYAP2;NYAP1;CD160
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.39482809584375883,0.9912844042477967,0.4567901234567901,0.7999882069979041,1.0,18/163,10.33%,C3;TMCC2;LMO2;P4HA2;DMTN;ADD2;ACKR1;RAP1GAP;TNS1;SNCA;FOXO3;TYR;NUDT4;DAAM1;AGPAT4;FTCD;ALDH1L1;SEC14L1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.632683491830315,0.9912248518913163,0.5344827586206896,0.7998022516836154,1.0,2/9,12.90%,PRKCB;PPARG
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.43195982131989874,-0.991179583559799,0.5142857142857142,1.0,1.0,6/50,6.86%,TPP1;ADAMTS9;APOE;NR1D1;USE1;FBXO27
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5163477786700237,0.9909998025542094,0.5151515151515151,0.7999735229217809,1.0,8/23,23.72%,PLAAT4;PLAAT3;PLAAT5;CHKB;PNPLA8;ETNK2;PLAAT1;LPIN3
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5660159328569642,0.9905702916924319,0.5245901639344263,0.8005063331491478,1.0,5/12,19.18%,PML;USP50;HIPK2;ETS1;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.6882149129610252,0.9905679489086198,0.603448275862069,0.80017292776258,1.0,3/6,25.67%,HK2;PINK1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.6029155897765203,-0.9904708613846616,0.5151515151515151,1.0,1.0,2/8,9.63%,SCPEP1;GPR37L1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.4847201536782891,0.9901784637682002,0.4266666666666667,0.8007337413795392,1.0,8/40,16.56%,APP;GRM5;FOXO3;PARP9;ZC3H7B;PER1;MAPKAPK5;PUM1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.372058379347328,0.9901499121302654,0.5057471264367817,0.8005003324504754,1.0,67/531,15.14%,NR4A3;SKOR1;MLIP;FOSB;KLF2;SP100;PROX1;ZNF536;ATF3;ZFP36;DAB2IP;IRF7;ZNF140;SUV39H1;HIC1;KLF11;EFNA1;ZNF282;NFIL3;GZF1;BCL6;MSX2;KLF10;CIITA;CHD3;ZNF750;LDB2;ZNF608;TBX20;ZBTB16;GLIS2;MYT1L;SNCA;FOXO3;HMBOX1;ZFPM2;DUSP22;BAG3;NR6A1;CTBP2;TLE6;NR1I3;SMAD3;ETV6;YAP1;TBL1X;HDAC4;GLI2;STAT3;GLIS3;PARP9;HDAC9;GADD45A;NR4A2;BCL11A;JAZF1;PPARG;FBP1;KLF7;PER1;PRDM1;DEAF1;SOX13;CCND1;TFAP2C;SOX10;ZNF746
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.6107441479258999,-0.9900068027225346,0.5106382978723404,1.0,1.0,3/7,25.49%,RNF168;RNF8;MSH2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.39148183532963693,0.9897742983688149,0.5294117647058824,0.8010415391026594,1.0,52/226,20.89%,BOK;MLLT11;SLIT2;DAB2IP;FOXO1;KLF11;ARHGEF17;SOX4;SEPTIN4;FAS;ARHGEF3;BCL6;TFPT;PAWR;SNCA;FOXO3;CYP1B1;MAP3K11;OBSCN;MCF2;CTNNB1;PNMA2;KALRN;NEURL1;ARHGEF7;SYK;TRIO;PLEKHG2;PXT1;GADD45A;BARD1;TNFRSF10B;FADD;KCNMA1;BIN1;RARG;MAP3K5;TP53;VAV2;STK3;MCF2L;NGEF;BCLAF1;VAV1;SCRIB;RNF122;TFAP4;RBM5;ARHGEF6;DNM2;RPS27A;ING5
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.5650233935536423,0.9897306738213654,0.5538461538461539,0.8007986981421759,1.0,4/10,18.06%,FYN;RAMP3;NOX4;SGCG
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.5766459750516462,0.9896745620759619,0.5076923076923077,0.8005703003510479,1.0,4/14,6.64%,MBP;THY1;CD44;SKAP1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.49260533812134205,-0.98961282950416,0.5416666666666666,1.0,1.0,4/18,10.45%,SFXN2;SLC6A13;SLC36A1;SLC25A38
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5205826332590324,-0.9895182264697009,0.4888888888888889,1.0,1.0,6/17,19.19%,CTSH;NCSTN;PRELID1;MAPK12;PSME3;CLDN4
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5710866218853241,0.9893522805079731,0.5373134328358209,0.8008071150754286,1.0,1/12,3.14%,WAS
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5459882239465581,0.9892644561497469,0.47692307692307695,0.8006785098355828,1.0,4/20,11.98%,L1CAM;SHTN1;CDKL5;MAPT
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.3968240822990219,0.9891419259676031,0.5,0.8005452701759074,1.0,23/179,16.67%,CTSC;MLLT11;ARPC5L;SLA;RPA1;VLDLR;NFIL3;MTHFD2;LDLR;HK2;LDHA;DHCR24;NAMPT;NIBAN1;PFKL;PGK1;CDKN1A;PDK1;PLOD2;RIT1;ADIPOR2;SLC2A3;ELOVL5
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.4647110188836589,0.9888911374820767,0.4166666666666667,0.8007723220497914,1.0,1/31,0.34%,ANLN
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5602013225123271,0.9883206384866566,0.5283018867924528,0.8018329428982741,1.0,6/13,9.52%,KCNJ2;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.5330789075106159,-0.9882777561700405,0.45,1.0,1.0,6/13,24.27%,TRIB3;ERLIN2;ERLIN1;APPL2;SIRT4;APOC1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.6501813979222377,-0.9881542018607822,0.5384615384615384,1.0,1.0,3/6,23.95%,PON1;PON3;EPHX2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.4077320314926661,0.987969448684768,0.5068493150684932,0.8022392137944672,1.0,30/98,17.71%,COL4A1;COBLL1;DCN;COL4A2;SULF1;OSMR;POSTN;COL12A1;FRAS1;PTPN21;MATN2;C1R;RHOD;SCARA3;BGN;ADGRF5;SRPX2;YAP1;PXDC1;IL17RE;PRICKLE2;FN1;PARD3B;SLCO2A1;FSTL1;PALLD;LAMA3;CALB2;FAM114A1;NTN4
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.5114401384354895,0.9877910460752969,0.46774193548387094,0.8022901481260096,1.0,1/23,0.52%,TMEM204
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5241337961843474,-0.9877770699570502,0.46153846153846156,1.0,1.0,3/15,12.20%,FBXO5;FBXO43;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6088008775021589,0.9876549838025924,0.6129032258064516,0.8023126520367735,1.0,4/9,27.35%,PIP4K2A;LRSAM1;ELAPOR1;SH3GLB1
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.5635316169426543,-0.9876540267113003,0.5128205128205128,1.0,1.0,1/8,2.40%,LEPR
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.5836324097996971,0.9875074567324295,0.4915254237288136,0.8023162196662869,1.0,4/11,22.54%,PRKCB;GFI1B;CBFB;MAFB
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.471857623856713,0.9867699816962214,0.5223880597014925,0.8036340164377255,1.0,20/62,19.11%,CTAGE14P;GCM2;MYLK3;PTCHD1;RYR2;DTNA;SYNPO2L;GALNT16;ADCY2;ART3;COL9A1;SORBS1;FGF13;MAPT;HIF3A;WIPF3;SPTB;RGMA;CACNB2;LDB3
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.3914641742354928,0.9865991945835293,0.5256410256410257,0.8036984658886634,1.0,17/178,12.90%,ENPP2;C3;COL4A1;SQOR;PIM3;BCL6;HADH;MRAP;YWHAG;OMD;ATP1B3;PFKL;PEX14;DGAT1;SORBS1;GADD45A;PPARG
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.5733700633747355,0.9863193280152761,0.5263157894736842,0.8038856741589498,1.0,5/12,10.74%,SCN3B;KCNQ1;TRPM4;RYR2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.3869175462445716,0.986166470234026,0.4418604651162791,0.8038649776578772,1.0,26/257,12.17%,GPNMB;IGF1;SH3GL2;TYMS;ZFP36;IGF2BP2;APP;SAMD4A;ZC3H12D;EIF4A3;APLNR;NUDT16;CCDC3;NLRP12;ENC1;SMCR8;PGR;NPTN;CENPV;SHMT1;YAP1;TGFB2;PARP9;MAPT;ITGB8;HDAC9
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.5259151455469105,0.9860748410092741,0.484375,0.803754625108814,1.0,5/23,3.25%,CTSS;PLEK;MYO1F;ICAM1;PTPRC
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4162020959388992,0.9854147372259358,0.49333333333333335,0.8047954801187621,1.0,13/90,15.49%,RECQL4;HELB;BLM;RPA1;RBMS1;POLD1;BARD1;CDC7;DONSON;NAP1L1;MRE11;SET;POLE3
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5450751030912413,0.9853328706824148,0.4482758620689655,0.8046659715380057,1.0,5/13,19.43%,HECW2;PRKCE;HECW1;YWHAE;CAV3
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.5579543426808029,0.9849518483082272,0.47540983606557374,0.8051682185284377,1.0,2/16,11.42%,SHTN1;CYRIB
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.42223057727060076,-0.9848834101758837,0.4473684210526316,1.0,1.0,8/58,8.27%,SELENOS;TNFAIP3;TRIM21;APOE;NR1D1;MUL1;METRNL;MAPK7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.48786656787211335,-0.9847409984389774,0.42105263157894735,1.0,1.0,3/23,7.64%,COPS8;CETN2;COPS7A
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.6145198744087372,-0.9843550439889553,0.5625,1.0,1.0,1/7,15.58%,GNGT1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.48989964571101857,0.9842288613448695,0.49206349206349204,0.8063815406885431,1.0,6/26,14.38%,PDGFRA;DAB2IP;FLT1;P2RY12;WASHC1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5713339828034485,0.9841618212139969,0.5833333333333334,0.806209149103468,1.0,4/15,14.38%,SERPINE1;TFPI;PHLDB2;FGF2
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.5815193825915655,-0.9840734889254852,0.48148148148148145,1.0,1.0,4/9,26.12%,WDR76;RFWD3;THOC1;CCAR2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.4231240243154846,0.9840729288552372,0.5384615384615384,0.8060557315062611,1.0,27/118,26.57%,APP;TRAM1L1;RPA1;DVL1;OBSCN;MICALL1;LMNA;IFT122;ARF6;OPTN;ALDH3A2;YWHAE;IFT140;SNX10;DDRGK1;RAB11A;GBP1;SIX4;BICD1;MTCH2;HMOX1;ARFRP1;PRNP;DHX9;UBAC2;GABARAPL2;TUB
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4185144869115307,-0.9840717916024339,0.47368421052631576,1.0,1.0,9/46,6.40%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;CXCR4;HSD11B1;P2RY10
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.41259103253775026,0.9837086236290268,0.46875,0.8064718696177394,1.0,34/134,16.02%,TAMALIN;COL4A1;SQOR;DCN;COL4A2;CALD1;SULF1;ANGPTL2;POSTN;COL12A1;FAS;IGFBP7;PTPN21;C1R;SCARA3;CYP1B1;BGN;ADGRF5;SRPX2;ITGA9;COL4A4;PXDC1;FGD5;BACE2;FN1;COL5A1;TRIM47;TMTC1;BMX;ROBO4;SLCO2A1;FSTL1;ENPP4;PALLD
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5064939985623819,0.983520340987871,0.4642857142857143,0.8065489705457811,1.0,3/18,8.24%,GPNMB;NEK10;PDGFA
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.5181168549243704,0.9834733650794315,0.5423728813559322,0.806343878854299,1.0,1/18,4.64%,WTIP
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.5954062328471583,0.983406045122024,0.5357142857142857,0.8061389559625628,1.0,2/9,10.15%,GRAMD2A;HOMER1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.4636945128975491,-0.9833669786605421,0.4634146341463415,1.0,1.0,5/28,9.78%,ABCD2;ELOVL4;ABCD1;ACOT2;ELOVL2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.4536558323853274,0.9831452645846309,0.49295774647887325,0.8064885991473466,1.0,6/63,9.59%,TGFBR2;RFTN1;ZFP36;EIF4A3;THOC6;KIF5C
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.6105097677092385,0.9831130829885644,0.53125,0.8062462144557316,1.0,1/9,2.44%,PLEK
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.4629806955434325,0.9831061337589849,0.5079365079365079,0.8059383071087493,1.0,9/41,18.91%,TESC;PTK6;WNT8B;ASXL1;RARG;RARA;FZD7;WNT5A;RXRA
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.48819279704823654,0.9828277113936906,0.5373134328358209,0.8061796744425723,1.0,7/28,22.49%,DYSF;DNM1;MX1;MYOF;DNM2;NAPA;GCA
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4580694690080707,0.9827923466825217,0.5714285714285714,0.8059095718502112,1.0,10/57,12.70%,IGF1;ACHE;BAIAP3;SNCA;GRK2;TMED10;SYTL4;TGFB2;RAB27B;ARF6
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.6461476401979227,0.9827057158529,0.5555555555555556,0.8057756615865935,1.0,2/8,9.13%,RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.6100384385250514,0.9825657122115906,0.5094339622641509,0.8057168486828931,1.0,3/10,12.41%,SCX;TENM4;PHLDB2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.48083123548423373,0.9822151385295932,0.5294117647058824,0.8061968353396912,1.0,8/35,19.02%,FOLH1;GPT2;ASS1;KYAT1;NAT8L;NOX4;GPT;MTHFR
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.46026111484143845,0.9821565375928993,0.5147058823529411,0.80533702881522,1.0,4/56,8.21%,CTSC;TGFA;GRIA1;TMED10
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.46026111484143845,0.9821565375928993,0.5147058823529411,0.80533702881522,1.0,4/56,8.21%,CTSC;TGFA;GRIA1;TMED10
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.46026111484143845,0.9821565375928993,0.5147058823529411,0.80533702881522,1.0,4/56,8.21%,CTSC;TGFA;GRIA1;TMED10
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.6218979559085436,-0.9818403640113368,0.5897435897435898,1.0,1.0,1/7,2.70%,CXCL13
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.6218979559085436,-0.9818403640113368,0.5897435897435898,1.0,1.0,1/7,2.70%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6128416725875057,0.9817170990769096,0.5833333333333334,0.8060221780840644,1.0,1/11,2.14%,ATF3
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.6057727578792002,0.9815988353242854,0.5714285714285714,0.8059166566590501,1.0,2/9,15.13%,CDC7;STOML2
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6558740536884293,-0.9813256750363398,0.5777777777777777,1.0,1.0,2/6,27.50%,GSTM3;GSTM4
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.42462993773799307,0.9812967180009841,0.4927536231884058,0.8063065906329282,1.0,15/95,20.06%,TEC;NFATC2;LAT2;GAB2;SYK;PAK1;FOS;TAB1;IKBKG;VAV2;SKP1;MAPK9;VAV1;SHC1;NFATC3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.4668397270341549,0.9812784068858844,0.43478260869565216,0.8060235267015832,1.0,16/50,18.92%,THBS1;SNCB;TRPC3;PLSCR1;ITPR3;SNCA;ANXA11;HOMER1;NDRG1;MAPT;PAM;BCL2;KCNMA1;CALM3;LOXL2;SLC30A3
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5646640684488462,-0.9809238944753041,0.5,1.0,1.0,5/14,16.93%,PYGM;AGL;PGM2;PHKG1;GAA
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.6383237418166234,0.9809012178684879,0.5961538461538461,0.8065998770188744,1.0,2/7,5.99%,TRPM4;TNFRSF14
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.38672122958268923,0.9808744914585567,0.4868421052631579,0.8063075894609574,1.0,27/189,12.73%,DCN;EGF;THBS1;PTK6;PLEK;SULF1;PRKCB;PTPRC;DAB2IP;PRAME;HIC1;EGFL7;APOD;NLRP12;NOTUM;PID1;GLIS2;SNCA;DCC;TMBIM1;NEURL1;MMP14;PIP4K2A;ASXL1;IFT122;NR4A2;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6306203795864489,-0.9808203331802768,0.5517241379310345,1.0,1.0,2/9,9.62%,ID2;HSF1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5310400118561216,0.9801310036878248,0.5161290322580645,0.8077511650301299,1.0,4/32,16.62%,ABCA8;AGPAT4;SGMS1;CPNE7
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.6392116951094439,-0.9798094240914486,0.5681818181818182,1.0,1.0,2/6,9.99%,EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.43161424565132783,0.9795399927215385,0.5555555555555556,0.8087038677633157,1.0,9/84,11.01%,THBS1;PLD1;YBX3;SAMD4A;SOX4;EIF4A3;LARP6;YTHDF1;NIBAN1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5329175618080221,0.9794402668823221,0.5074626865671642,0.8085742440203619,1.0,2/14,10.74%,STK25;TGFB2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5023998937953336,-0.9793433290269672,0.4318181818181818,1.0,1.0,2/14,17.21%,EXOSC4;LSM1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.47874395578488377,-0.9792845267358872,0.4,1.0,1.0,5/23,13.37%,ABCD2;ABCD1;PEX10;PEX11B;PEX11A
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.46495541378762184,0.9791741472264143,0.49295774647887325,0.8087196628684341,1.0,12/47,22.74%,PLK2;SOX4;PML;GADD45A;CDKN1A;CDKN1B;CCNB1;TP53;PLK3;PRMT1;ARID3A;CARM1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5673524528812623,0.9791481041039051,0.5172413793103449,0.8084177907249709,1.0,3/16,6.33%,SLC15A3;VLDLR;MFSD2A
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.5286575495682282,-0.9791360986834136,0.45,1.0,1.0,2/13,6.10%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.4614521735082552,0.9790719716571523,0.4927536231884058,0.8082511929606033,1.0,13/52,17.76%,SCN2A;SUV39H1;LMNA;NDRG1;PGK1;PICK1;CPEB2;SLC8A3;HIPK2;FMN2;PINK1;TP53;RORA
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5927526208114877,0.979035284347071,0.48148148148148145,0.8079916459861866,1.0,4/9,23.34%,APLNR;PDE2A;PDE4D;UBE2B
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.5315293608369718,-0.9789390867539458,0.5405405405405406,1.0,1.0,3/10,14.18%,PGP;DGKB;PLA2G15
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.5053855605841293,-0.9788720467510419,0.47058823529411764,1.0,1.0,1/19,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.682053786048952,-0.9784309875373389,0.5789473684210527,1.0,1.0,1/5,5.05%,PDCD2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.46630023218208483,0.9783580618583471,0.546875,0.8091791923947154,1.0,17/40,29.07%,TBL1X;HDAC4;MORF4L2;HDAC9;MTA1;FLNA;HDAC7;TBL1XR1;MORF4L1;RCOR1;TRERF1;MTA3;MIDEAS;HDAC5;HDAC3;BRMS1;HDAC6
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.3485546023004784,-0.9781244920483885,0.4230769230769231,1.0,1.0,39/155,19.41%,PTCD2;ATAD3C;TFB2M;MSTO1;TIMM8B;HAX1;MUL1;TIMM13;SLC25A4;ALAS1;CHCHD10;AIP;BCAP31;MGME1;RAB5IF;MTFR1L;TIMM23;SLC25A33;POLG2;SAMM50;TSPO;YME1L1;ATP5F1B;TIMM10;TIMM50;TMEM11;ESRRA;TRAK2;MTFR1;OXA1L;AFG3L2;CHCHD2;MTERF1;TFB1M;MIEF1;FIS1;PRDX3;TMEM70;TIMM17A
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.6100747880498317,0.9780548003997893,0.5087719298245614,0.8094914854121547,1.0,3/8,17.97%,NRG1;TGFB2;MESP1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.49048771304339445,-0.9778853168343222,0.41935483870967744,1.0,1.0,6/19,23.90%,NCOA4;CLU;ZFYVE16;GCC2;AP4M1;GNPTAB
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4728577722853965,0.9778561044447686,0.5555555555555556,0.8095664473321755,1.0,2/39,2.19%,KIF14;PSRC1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6320451805329913,0.9775830516847348,0.5423728813559322,0.8098783286974698,1.0,3/5,30.89%,PLEKHA4;MLLT3;SPEF1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5992292616477256,0.9775139289893489,0.5161290322580645,0.8096976091214165,1.0,2/9,16.47%,PRKG2;GCHFR
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.6391908992867684,0.9774459284729119,0.6153846153846154,0.8094752503943501,1.0,1/6,19.62%,RAMP1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5538313026551298,0.9773362299066716,0.4918032786885246,0.809396943711488,1.0,1/11,4.59%,PDIA2
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.6183876535650067,0.9768589840959935,0.6,0.810265082314839,1.0,2/10,10.74%,RPUSD1;GAR1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.663886403362848,0.9766785923529849,0.5892857142857143,0.810325635809374,1.0,4/5,30.03%,ULK1;ATG7;ATG5;ULK2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.43887839928767963,0.9765394891658072,0.547945205479452,0.810321245108746,1.0,29/88,22.11%,ABCA6;ABCA8;ABCA5;FABP3;ABCC4;ABCA10;MFSD2A;SLCO1A2;LDLR;SPNS2;ABCA9;SLC27A3;ABCA2;SLC51A;SLC27A5;PLEKHA8;SLCO3A1;MFSD2B;SLCO2A1;ABCA3;NME4;PITPNM1;RXRA;ABCG1;ABCC3;TNFAIP8L3;PITPNA;GLTP;UGCG
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7011400861794592,0.9765282313842245,0.5454545454545454,0.8100017813402228,1.0,1/5,11.61%,ABCA2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4797908151804125,0.9764048029680626,0.47368421052631576,0.8099512095193094,1.0,6/34,13.86%,THY1;APLNR;JPH4;SNCA;CEMIP;UBASH3B
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.44954331270232833,0.9763986327936847,0.4852941176470588,0.8096599330755625,1.0,9/56,18.02%,TBC1D24;LIMK2;YAP1;CDKL5;USP6NL;TBC1D1;TBC1D10B;IFT140;TBC1D10A
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5676211833717909,0.9763347526946515,0.5362318840579711,0.8094429382357373,1.0,5/16,16.84%,DAB2IP;NLRC3;B4GALT7;TRIM32;TP53
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.47576655837089754,0.9759407198547444,0.5454545454545454,0.8097997398491373,1.0,9/25,21.40%,LTBP4;ITGA3;SMAD3;FSTL1;BCL9;DKK3;SMAD2;TGFBR3;PCSK6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.509986720087566,0.9759019727580623,0.5,0.809541247208608,1.0,2/29,6.78%,ANXA1;LSM11
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6027956054462235,-0.9758619768888956,0.6176470588235294,1.0,1.0,1/5,4.62%,HAX1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.6277666177629118,-0.9758129787872905,0.6458333333333334,1.0,1.0,5/6,35.81%,MEPCE;METTL4;NOP10;NHP2;METTL16
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.48253609895788696,0.9756468039727492,0.547945205479452,0.8097960312077273,1.0,2/44,4.00%,ANK3;AMN
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.6416809564067127,0.9756427211708183,0.5873015873015873,0.8094730641756245,1.0,4/6,23.84%,WAS;NEB;CXCL12;ARHGAP35
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.42979817353971433,-0.9752269408553649,0.4878048780487805,1.0,1.0,3/46,4.65%,H1-2;H1-4;POLR2K
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.36448903680694245,-0.9746876243044686,0.5416666666666666,1.0,1.0,14/89,15.83%,CEBPA;TRIB3;CBFA2T3;HFE;HSPA1A;RAD23A;ARAF;RPL11;PSMD10;UFL1;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.5750669698099247,0.9746248734124918,0.5483870967741935,0.8112563901614831,1.0,2/14,12.70%,PLEK;ARF6
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.46000943655735826,0.9745919353174936,0.4852941176470588,0.8109977266722269,1.0,8/54,14.24%,ANXA1;PDGFRA;CYP1B1;PXN;MAPT;PRKCD;AGAP3;FOS
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6458277175167154,0.9743053773110978,0.6140350877192983,0.8113161170448541,1.0,4/5,35.43%,MTMR2;MTMR3;MTMR1;MTMR9
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6131410392126,-0.9742317259060386,0.5675675675675675,1.0,1.0,1/8,2.70%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.6106256731337945,0.9738441138875636,0.559322033898305,0.8119756044611466,1.0,2/8,11.54%,HMBOX1;PARP9
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.4995742157355833,0.9737012209257051,0.5873015873015873,0.8119751817210782,1.0,9/44,10.10%,CSPG4;DCN;OGN;CD44;AGRN;VCAN;SLC9A1;BGN;OMD
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.6172006829566556,-0.9735957803453917,0.5,1.0,1.0,3/6,18.79%,EDNRB;ARX;SOX8
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.5124713198522095,-0.9734473804496966,0.5263157894736842,1.0,1.0,3/14,16.18%,ABCD1;ACOXL;EHHADH
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5730789260766664,0.9732013987488323,0.5333333333333333,0.8127306635059461,1.0,5/10,20.43%,ARHGEF7;EML2;PAK1;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.6327011545139942,0.9718041725558061,0.5555555555555556,0.8150595702476555,1.0,3/6,24.98%,HLA-E;HLA-F;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.6327011545139942,0.9718041725558061,0.5555555555555556,0.8150595702476555,1.0,3/6,24.98%,HLA-E;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6252763071629701,0.9716599765407423,0.4576271186440678,0.8150625087542712,1.0,4/6,34.00%,POLE3;SIRT1;EZH1;BAHD1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.4662699207940866,0.9714607142977899,0.5454545454545454,0.8151436745358375,1.0,7/35,7.80%,COL11A2;SULF1;SLC39A14;CD44;CHI3L1;ZBTB16;SCX
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.6107907584620718,0.9714301921487813,0.559322033898305,0.81491198239339,1.0,2/6,9.12%,NRP2;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5962605958445564,0.9711761948665721,0.5319148936170213,0.8150851041941944,1.0,2/8,6.89%,EGF;NRG1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.5132990036391503,0.9709765773198585,0.5915492957746479,0.8151937400257857,1.0,5/33,13.51%,SLC39A14;ALDOB;PGK1;ENO2;FBP1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.5367643811570423,-0.9709303079517917,0.4523809523809524,1.0,1.0,1/8,1.45%,HEY2
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.40403808203105956,0.9708096485068097,0.5616438356164384,0.815192024312707,1.0,29/119,19.55%,TLR2;ANXA1;IL15;SERPINE1;APP;IL1R1;BCL6;NLRP12;BIRC3;TNFRSF1A;SNCA;MYD88;NLRC3;PRKCD;PPARG;CD200;TNFAIP6;BRD4;KLF4;MFHAS1;LRFN5;BST1;WNT5A;PDE2A;RORA;GPS2;ETS1;IFI35;SBNO2
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.592821807823869,-0.9706075778514875,0.6041666666666666,1.0,1.0,1/6,3.51%,PHYH
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.5369863576861793,0.9704538030626157,0.5079365079365079,0.8156082267603547,1.0,3/17,11.61%,ABCA8;ABCA5;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5144202669327065,-0.9704429631917028,0.5128205128205128,1.0,1.0,2/14,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4743119623873638,0.9703536739564292,0.5303030303030303,0.8154961703223179,1.0,6/34,11.34%,PLSCR1;RYR2;ALDOB;ATP1B1;ATP1B3;AHSA1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5615760959877134,-0.9701725744235709,0.5,1.0,1.0,1/8,0.38%,RAB7B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5184728340960276,0.9701671723380555,0.546875,0.8155356343872575,1.0,8/16,23.12%,FLT1;PPARG;CCL2;FGF2;COL4A3;ADAM17;FGFR1;AKT3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.5767599934270435,0.9696021538321642,0.6037735849056604,0.8164924585492904,1.0,5/11,17.20%,ACTA2;MYH11;TPCN2;SMTN;SLC8A1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5460593519845062,0.9692549381373937,0.6307692307692307,0.8168937152612596,1.0,8/11,32.55%,CYP1B1;MTARC2;GCHFR;CYB5B;GCH1;DDAH2;CYB5R3;ARG2
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.608594858328938,-0.9692196254685518,0.5510204081632653,1.0,1.0,1/5,3.45%,FBLN5
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5325353821394857,0.9688819058286622,0.5370370370370371,0.8173038164926008,1.0,2/26,3.77%,CTSC;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.5114282122322802,-0.9688029202949499,0.5897435897435898,1.0,1.0,1/18,1.25%,KPNA2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5864519215752368,-0.9684804726943388,0.5625,1.0,1.0,2/7,10.35%,MID1IP1;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.4863881868394073,0.9682376307196937,0.4857142857142857,0.8183778974013223,1.0,6/31,11.22%,ANK3;THY1;CD44;SKAP1;ADAM19;PODXL
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.5435387681962941,0.9681078919423511,0.5517241379310345,0.8182924776253079,1.0,3/14,11.84%,IGF1;NLRP12;GAS6
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.4156010044125299,0.9675034380154212,0.5694444444444444,0.8192783237235725,1.0,6/112,7.19%,RECQL4;HELB;BLM;RPA1;GINS2;POLD1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.5688525845484065,0.9673665329082201,0.5081967213114754,0.8188874114159319,1.0,4/8,18.92%,PDP1;PDK1;PDK4;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.5688525845484065,0.9673665329082201,0.5081967213114754,0.8188874114159319,1.0,4/8,18.92%,PDP1;PDK1;PDK4;PDK3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.574979266917979,0.9672915618658477,0.5932203389830508,0.8186876177283294,1.0,1/12,1.30%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5325785470637194,0.9672190851311563,0.5384615384615384,0.8185245474541607,1.0,7/18,18.67%,PTPRC;IRS2;NFATC2;BCL2;GPR183;BST1;TFRC
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5313989383439397,0.9670998397669959,0.5263157894736842,0.8184027251364694,1.0,1/18,1.50%,SGPP2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.48296964244807367,0.967012289548003,0.4918032786885246,0.8182398991778305,1.0,8/25,14.10%,THBS1;SERPINE1;ICAM1;PAK4;CD160;GAS6;TNIP2;CCL2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5709827143729427,0.9668114669763224,0.5645161290322581,0.8183100162936279,1.0,4/15,15.84%,RASGRP1;CD160;HLA-E;IL12A
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.6483645573559036,0.9666884855782185,0.5555555555555556,0.8182066782386259,1.0,2/5,24.15%,SLC25A29;SLC22A4
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.4909793969720059,-0.9666474153073723,0.425,1.0,1.0,3/12,8.71%,HEY2;HEYL;PEF1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.47129400504366054,0.9664628015962226,0.532258064516129,0.8182949978696412,1.0,16/41,29.07%,TBL1X;HDAC4;MORF4L2;HDAC9;PER1;MTA1;TBL1XR1;MORF4L1;RCOR1;TRERF1;MTA3;MIDEAS;HDAC5;HDAC3;BRMS1;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.4609935667683634,0.9663972996022104,0.5245901639344263,0.8181187964409636,1.0,7/50,9.32%,PROX1;ZFP36;TRIM5;PLSCR1;APOBEC3H;PML;MX1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.5179194644066044,0.9662749333081081,0.578125,0.8180521197813382,1.0,5/17,17.91%,PML;HK2;HK1;PINK1;SKP1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.43678934997449237,0.9659299718894825,0.47619047619047616,0.818431970079258,1.0,9/60,7.76%,FOSB;THBS1;TMCC2;CD55;MYO1F;CD44;GAB3;TUBB1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6017000471523124,0.9659069632038851,0.6,0.8181602900011536,1.0,7/9,39.79%,SORBS1;PTPN11;IRS1;SIRT1;PRKCZ;ZBTB7B;GKAP1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.6029323549466463,-0.965788014596506,0.5675675675675675,1.0,1.0,2/6,9.80%,VEGFC;VEGFB
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.5722953883610814,0.9657423979688574,0.5660377358490566,0.818184720991352,1.0,8/13,11.03%,KCNJ2;KCNE4;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.569712517542377,-0.9650407585669103,0.5853658536585366,1.0,1.0,1/6,5.13%,BLOC1S2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.41452704509677096,0.964502734210006,0.5277777777777778,0.8206071983220626,1.0,25/119,19.44%,NR4A3;TEAD2;NR4A1;PGR;CDK9;NR6A1;NR1I3;TAF4B;YAP1;TBL1X;TEAD1;HDAC9;NR4A2;PPARG;MAML2;NOTCH3;RARG;RARA;NR2F6;TAF15;RORA;WWTR1;NCOR1;RXRA;HDAC7
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4578414415604294,0.9643565597205233,0.4852941176470588,0.820635183974765,1.0,8/39,13.55%,SIX3;CACNA1C;SH3PXD2B;PBX3;TGFB2;MEIS3;HIPK1;COL5A1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.47355360017693426,-0.9637524068302459,0.5142857142857142,1.0,1.0,9/20,31.90%,DNASE2;DNASE1L1;MUS81;KPNB1;FBH1;CASP3;ENDOG;EXOG;HMGB1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.42015878526846817,-0.9636861927122264,0.53125,1.0,1.0,7/32,6.40%,DPEP2;GMFG;CD247;PYHIN1;CD6;C1ORF162;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.43447683609807963,0.9631763075921672,0.49295774647887325,0.8228456048967494,1.0,7/76,6.81%,TYMS;IGF2BP2;NELL1;DAB2IP;SAMD4A;EIF4A3;ENC1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.42512874868852063,0.9631620501733101,0.4722222222222222,0.8225408942060811,1.0,11/70,12.92%,RECQL4;TEAD2;KREMEN2;EPHA2;BAIAP2L1;AGRN;PAK4;LAMA5;TTLL12;PES1;EIF5A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6323795748376778,0.962737738781787,0.6206896551724138,0.8230587395862696,1.0,2/5,26.39%,PPARG;OSBPL8
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6542077587483144,0.9626712286348512,0.6607142857142857,0.8228995100796468,1.0,1/5,17.05%,XRCC1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.4157272793912356,-0.9626261443235067,0.4722222222222222,1.0,1.0,2/59,0.22%,NGF;G0S2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.5545810048894704,-0.9625216374649623,0.48717948717948717,1.0,1.0,1/7,1.45%,HEY2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.43971409134225076,0.9623207359929953,0.5416666666666666,0.8233214705665631,1.0,12/98,11.95%,TGFBR2;AMH;ZYX;BMP8A;PARD3;SCX;DUSP22;SMAD3;TGFB2;SMAD1;RGMB;PXN
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.5848685386300119,-0.9622313707754314,0.6666666666666666,1.0,1.0,3/8,22.80%,MAP2K6;MAPK12;CHEK2
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.5648366425362873,-0.9621075210089368,0.5238095238095238,1.0,1.0,1/6,12.37%,HES5
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.5648366425362873,-0.9621075210089368,0.5238095238095238,1.0,1.0,1/6,12.37%,HES5
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4169461478261801,-0.9618233874056321,0.4594594594594595,1.0,1.0,1/28,0.26%,FTL
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.5157010184558739,0.9614299028871739,0.47058823529411764,0.8249365251748282,1.0,4/25,7.52%,C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.6291871906679077,0.9610435405164517,0.5918367346938775,0.8254435246184842,1.0,3/5,30.56%,FLNA;MACROH2A1;NOP53
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.44243584833854843,-0.9608383632793649,0.5151515151515151,1.0,1.0,1/42,0.09%,NGF
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.48183344026925273,0.9604807938034827,0.55,0.826308319497321,1.0,9/29,26.61%,RBM24;TAF15;VIP;AXIN2;NOCT;FUS;PARN;TENT5D;MEIOC
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5153288423072285,0.9603710827241638,0.5,0.8262115693389185,1.0,3/19,4.44%,PDGFRA;FLT1;AGAP2
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.5960812425529763,0.9603683211666021,0.5081967213114754,0.8258974293207549,1.0,5/9,21.80%,ABCC4;SLCO3A1;SLCO2A1;ABCC3;ABCC1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.44137181422703686,-0.9602046182221602,0.6,1.0,1.0,4/32,7.16%,NGF;BEND6;ASCL1;HEYL
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.6231371122401548,-0.9598732791292207,0.6363636363636364,1.0,1.0,2/6,11.44%,CFTR;NOX1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.605999170041517,0.9597644013720382,0.6440677966101694,0.8267972455847847,1.0,3/9,8.86%,CDH23;CLRN1;SHANK1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.6065315868649147,-0.9595066875756465,0.5348837209302325,1.0,1.0,2/6,19.56%,RORB;RPGRIP1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6238133964277361,0.959281405103021,0.5416666666666666,0.8275831744810918,1.0,2/6,6.08%,IRS2;BCL6
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.5496053970338936,-0.959263737060061,0.5789473684210527,1.0,1.0,1/11,1.13%,ID2
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6142344960331998,-0.9591422582679613,0.6,1.0,1.0,1/6,4.51%,APOE
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.3739108412932795,-0.9587804555221916,0.5454545454545454,1.0,1.0,23/92,19.57%,UCP3;DHX16;CHD4;ABCB10;BRPF1;URB2;GANAB;EIF3D;NEMP1;NOL6;GART;USP19;PRPF8;CNOT1;DDX11;MCM3AP;SLC11A2;DDX21;RUVBL1;NUP85;RFWD3;HDGF;TAF5L
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.580296023966187,-0.9587689419606573,0.6,1.0,1.0,1/6,5.82%,MSRB1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.583879270965957,-0.9575774275901899,0.6086956521739131,1.0,1.0,6/9,20.28%,TFB2M;SLC25A33;MTERF1;TFB1M;TEFM;MTERF2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.49193710707401206,-0.9572672984700873,0.47368421052631576,1.0,1.0,3/18,10.35%,ABCD2;ABCD1;SLC25A33
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.4278300695342377,0.9571661118348187,0.5074626865671642,0.8314863224069101,1.0,11/63,11.20%,OTOS;COL11A2;CDH23;KCNQ1;PIEZO2;EPS8L2;LHFPL3;CLRN1;CDC14A;TBL1X;EML2
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.42427581073515336,0.9569411185094082,0.5428571428571428,0.8316319755165287,1.0,13/81,16.68%,IL15;GMPR;IRF7;TRIM5;PLSCR1;MX1;PARP9;IL4R;TMEM140;B2M;IFIH1;ELF1;CNP
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.4658332015539641,0.9567772213216661,0.515625,0.8316102145973864,1.0,12/49,19.47%,PDGFRA;FYN;APOD;STK25;PXN;MAPT;AGAP3;PTPRN;FOS;MAPK9;STK24;PLK3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5082133042952394,0.9563811711058836,0.5573770491803278,0.8319952526605513,1.0,6/27,13.76%,SLC39A14;SOX4;RAB11FIP5;GAS6;MLXIPL;PTPRN
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.4100472320379442,-0.9562833745499982,0.4642857142857143,1.0,1.0,5/68,6.18%,G0S2;KSR2;LEPR;SIRT6;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.523120542773359,-0.9558439138840202,0.49019607843137253,1.0,1.0,1/11,0.03%,ACP3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.528229456587157,0.9556887874001353,0.5573770491803278,0.8331299756710596,1.0,1/18,1.29%,DCN
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5501459554461086,-0.955557224413352,0.5384615384615384,1.0,1.0,3/9,13.45%,EXOSC8;ERI2;RPS21
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.49558483066664055,0.9553376122994279,0.5166666666666667,0.8336360463220993,1.0,7/22,15.11%,SERPINE1;ICAM1;PAK4;YAP1;GAS6;TNIP2;CAST
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5263364739889429,0.9552227556457271,0.5263157894736842,0.8335503255543321,1.0,2/15,8.54%,OPALIN;TENM4
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5068968532006236,0.9551256997295723,0.5272727272727272,0.8334782104859262,1.0,10/21,31.23%,LIMCH1;SLC9A1;CAMSAP3;DAPK3;EPHA3;VCL;CORO1C;CLASP1;PEAK1;MACF1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6548753007842874,0.9549820327582348,0.5952380952380952,0.8334828372040836,1.0,1/5,13.83%,PER1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.49461329205224386,0.954973307448623,0.578125,0.8331582966161031,1.0,1/28,1.12%,HELB
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.49435903959769556,0.9547269487145591,0.5416666666666666,0.8333027725938368,1.0,6/23,11.61%,THBS1;ATP1A1;TFPI;YAP1;TGFB2;ABCA2
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.6028755421331529,-0.9542576486240242,0.5454545454545454,1.0,1.0,3/7,18.22%,SLC36A1;SLC36A4;SLC1A4
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.3986086281705767,-0.9541749890798334,0.5714285714285714,1.0,1.0,9/57,7.23%,RAB7B;SELENOS;AGER;CD200R1;TNFAIP3;FOXJ1;IL33;BCL10;PTPN22
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.4893159641255826,0.9540023511366486,0.6229508196721312,0.8344248353926269,1.0,3/25,7.80%,SULF1;SLC39A14;SCX
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5186708254955456,0.9537331998226434,0.5,0.8346812919324682,1.0,5/15,16.03%,MGAT3;CHST6;CHST4;CHST2;LARGE1
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.6232016669037007,0.9534904169587075,0.6229508196721312,0.8348475066630588,1.0,1/6,0.95%,ANXA1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.5224518684950282,-0.9532354029152869,0.6190476190476191,1.0,1.0,3/13,16.34%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.5224518684950282,-0.9532354029152869,0.6190476190476191,1.0,1.0,3/13,16.34%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.6477516908437622,0.9532031598414269,0.625,0.8350945941563874,1.0,2/5,16.69%,TJP3;TJP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.5683529545516091,0.9531168111201194,0.5925925925925926,0.8348781481548436,1.0,1/11,1.03%,IGF1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.39927897767675896,0.9531030902875217,0.5,0.8345809326220842,1.0,17/111,11.44%,COLEC12;SFTPD;AMN;VLDLR;WASF1;RAMP3;DNM1;COLEC11;CLTB;SNCA;LDLR;GRK2;AP1S1;MICALL1;MX1;SYK;SPARC
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.6238555122142018,-0.9530347100148029,0.625,1.0,1.0,3/5,26.56%,JAM2;EIF2AK3;TNFRSF21
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5169739896688279,-0.9529076658361069,0.525,1.0,1.0,3/17,6.86%,ADAMTS9;BPGM;FBXO27
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.4700256736927079,0.9528809736316773,0.5151515151515151,0.8346884915629641,1.0,6/32,20.95%,PRKCG;OPHN1;UBXN1;WAC;MAP1A;DDRGK1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.5811269833229988,0.9524113342312985,0.5818181818181818,0.8353261548186962,1.0,5/10,18.74%,RTN4RL1;EPHA4;PTPRS;STK24;INPP5F
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.4844649246047456,0.9523907792858326,0.6031746031746031,0.8350425878205351,1.0,3/30,5.19%,NSDHL;ABCA5;SOAT1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.49527682003481155,0.9523622424014005,0.5230769230769231,0.8347861813180865,1.0,6/31,10.34%,ANXA1;EPHA2;CLIC4;CERS3;CTNNB1;OVOL3
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.5464826652270836,-0.9522184949108404,0.5,1.0,1.0,1/7,9.22%,CDHR2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5212134584788967,0.9520230433440564,0.5689655172413793,0.8351089064091882,1.0,6/20,14.15%,SP100;DMTN;APOD;BARD1;CABP1;RANGAP1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6082585601936273,0.9518240655434169,0.5769230769230769,0.8348791566380379,1.0,1/6,20.75%,CDC27
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6082585601936273,0.9518240655434169,0.5769230769230769,0.8348791566380379,1.0,1/6,20.75%,CDC27
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6242852391490921,0.9514608350543051,0.62,0.8353449067450697,1.0,1/7,4.29%,FOXO1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5862617957285211,0.9513657904143173,0.5925925925925926,0.8352098658626772,1.0,5/10,28.82%,SH3PXD2B;NAMPT;PGRMC2;ZNF516;ARID5B
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.5546316439499093,-0.9513154065637105,0.5384615384615384,1.0,1.0,1/8,2.55%,RNF6
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.671031358633938,0.9510602589792186,0.5925925925925926,0.8355049178255056,1.0,4/7,24.19%,LAMA3;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5066655732544141,0.951018878379814,0.532258064516129,0.8352400791238463,1.0,7/21,19.08%,IL1RAPL1;SLITRK4;CDKL5;EPHA4;CAMK2B;WNT5A;ARHGAP22
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.6164360976677686,-0.9509659659647828,0.5882352941176471,1.0,1.0,2/6,18.24%,WDR76;RFWD3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5861095071198643,0.9509507331232716,0.5409836065573771,0.8350336297401518,1.0,2/7,23.18%,STAU1;DDB1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5633972707107083,0.9508901171924374,0.5873015873015873,0.8348318158545446,1.0,3/10,11.79%,KCNC2;GUCY1A1;GUCY1B1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5964622494322279,-0.9506818519045112,0.5116279069767442,1.0,1.0,2/6,18.71%,TMX3;PRDX3
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5861052682205198,0.9505796218698485,0.5797101449275363,0.8351757459099732,1.0,3/7,28.27%,CCNB1;RAD18;SMC5
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3808389969016601,0.950442352170568,0.5232558139534884,0.8351394341934586,1.0,54/188,25.74%,CDKN2A;PLK2;CCNB2;ABCB1;CCNI2;HAUS7;YWHAG;CDK6;PPP1CB;ACTR1A;CDKN1A;CDC7;TPD52L1;CDKN1B;CCNB1;LCMT1;OPTN;DCTN1;CCND1;YWHAE;CDK2;SKP1;NEDD1;CDC25B;MAX;PLK3;BCAT1;CDK5RAP2;CKAP5;DNM2;CDKN2D;CDC27;PPP2R2D;CAMK2A;FBXL8;PPME1;CEP76;CCNA2;ACVR1B;TUBA4A;DCTN3;RCC1;PRKAR2B;CUL3;TUBB4A;CDKN2B;ARPP19;ACVR1;PHF8;CCNF;ODF2;CEP70;USP37;ENSA
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.511371738140893,-0.9502981565248633,0.47619047619047616,1.0,1.0,3/16,14.91%,GRPEL2;TIMM23;TIMM50
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5610239399986013,0.9502882869608266,0.5666666666666667,0.835179115668209,1.0,3/13,14.45%,CLMN;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.6045838244783841,0.9502108928227172,0.5517241379310345,0.835017761508945,1.0,2/5,33.46%,KIF13A;KIF3A
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5270804104279233,0.9500001915680714,0.6212121212121212,0.8351735501118508,1.0,8/12,32.55%,CYP1B1;MTARC2;GCHFR;CYB5B;GCH1;DDAH2;CYB5R3;ARG2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.6192136438248897,0.9497887951780171,0.5967741935483871,0.8353381435129172,1.0,2/6,17.53%,BCL2L1;RFFL
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.48872316512965014,0.9496104773048948,0.5074626865671642,0.8354267622420137,1.0,2/20,3.41%,IGF1;IRS2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5517578878444278,-0.9493954465837786,0.5333333333333333,1.0,1.0,4/9,21.48%,GREM1;EFNB2;BMP2;MYOCD
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4996724315408481,-0.94924742172208,0.6111111111111112,1.0,1.0,5/16,14.25%,CFAP53;ADCY10;AQP4;SPAG17;SPEF2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.47222132835841335,0.9492099972095582,0.5,0.8360148084922666,1.0,6/24,18.92%,SLC4A10;SLC4A9;SLC4A11;SLC12A5;FHL1;SLC30A3
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5959666486184001,0.9488870682195253,0.6481481481481481,0.8364017833741642,1.0,2/6,7.64%,LARP6;CDK9
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.636532783546238,0.9487340570881743,0.6078431372549019,0.8364141260714661,1.0,2/6,26.44%,CRACD;MUC4
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.619804189122536,0.9486808018503795,0.6,0.8358910835979737,1.0,3/6,19.05%,MBP;KLF4;MAP2K5
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.619804189122536,0.9486808018503795,0.6,0.8358910835979737,1.0,3/6,19.05%,MBP;KLF4;MAP2K5
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.46225686129086124,0.9486610490455457,0.5606060606060606,0.8355875826453817,1.0,5/31,13.08%,LIPH;FABP3;PLAAT3;DGAT1;SLC27A5
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.5385404118713119,-0.9486455637288067,0.5952380952380952,1.0,1.0,2/10,3.59%,MAGED2;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5926613525361241,0.9485365438482121,0.5925925925925926,0.8355112359281727,1.0,3/7,6.64%,THY1;CD44;SKAP1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.4716098618610049,0.9484397194798101,0.5373134328358209,0.835381577045559,1.0,2/38,6.26%,NR4A3;MTFR2
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6317932612247009,0.9482973311018313,0.6181818181818182,0.8352875863375506,1.0,3/5,29.46%,STOML2;TNFSF4;CDH26
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.5740575517748876,-0.948206062767441,0.5714285714285714,1.0,1.0,1/7,8.90%,GAS1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5758078149843937,0.9480777191446924,0.6428571428571429,0.8354958726237756,1.0,1/14,3.44%,ABCB1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.5508037268414723,0.9480407465888077,0.5833333333333334,0.8352464249772632,1.0,3/15,5.19%,ABCA8;ABCA5;SOAT1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.6039827769234958,0.9479419943304623,0.5892857142857143,0.8351303928559365,1.0,4/8,32.02%,TGFB2;SIX4;PTCH1;BMPR1A
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.6527911651811724,0.9478095787544212,0.5849056603773585,0.8351076697703972,1.0,1/5,9.69%,ASS1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5207623760063653,0.9478009686665956,0.5633802816901409,0.8348231655283127,1.0,2/14,14.63%,CD44;BCL2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.5829539501691596,0.9476606048778147,0.5384615384615384,0.8347340462314169,1.0,2/8,13.08%,HMGCLL1;SLC27A5
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5793942356952834,0.9476255757175657,0.5522388059701493,0.8344809446783734,1.0,5/10,28.47%,SNCA;PCSK5;PCSK6;FURIN;ANGPTL3
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6209208425611774,0.9476130422998612,0.5263157894736842,0.8341704222254709,1.0,2/8,7.57%,CHI3L1;PID1
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.5065407632811131,-0.9475575106962356,0.5,1.0,1.0,2/14,10.49%,NUDT7;PPCS
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.6020792521470263,0.9473423546106651,0.603448275862069,0.8344360904883694,1.0,4/7,29.35%,PPARG;NCOR1;NCOR2;TGFB1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.5653080761129279,0.9472177615427739,0.5833333333333334,0.8343561168323913,1.0,1/8,1.38%,YWHAH
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),-0.6225939037985179,-0.9469755921859526,0.6382978723404256,1.0,1.0,2/5,4.71%,TNFAIP3;FOXJ1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6212455721617951,0.946884401853835,0.5714285714285714,0.8347233269981602,1.0,2/6,16.09%,ALOX12;ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.5172879739037419,0.9464721607496916,0.6,0.8353336404616387,1.0,10/23,25.53%,PLSCR1;NLRC5;FADD;HLA-E;WNT5A;IFI35;NMI;SLC15A4;POLR3C;DHX9
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5764586379914913,0.9463084100478008,0.5606060606060606,0.8353286119429322,1.0,3/11,23.84%,B4GALT5;B4GALT6;ARHGAP35
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5876532322238874,0.9462660333175864,0.6170212765957447,0.8350980751534997,1.0,4/7,29.35%,STAT3;NCOR1;NCOR2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.43811423242088504,0.9461319854279651,0.5238095238095238,0.8350754613062125,1.0,7/72,4.29%,PSCA;DUSP1;PTPRC;DAB2IP;PTPRR;DUSP10;FOXO1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.48654273011927246,0.9459579971601396,0.5,0.8351014672013001,1.0,5/27,18.73%,BLM;CDKN1A;DONSON;MRE11;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.5146650415442704,-0.9458369963245197,0.6341463414634146,1.0,1.0,2/13,5.05%,CCNE1;PDCD2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.40946483714817067,0.9457196691846813,0.5303030303030303,0.8353173701133003,1.0,22/71,21.80%,SLC7A2;ABCB1;ABCC4;MFSD2A;ABCC9;SLC7A1;ABCA2;SLC29A4;SLCO3A1;SLC2A3;SLC8A2;SLC29A1;SLC2A13;SLC7A8;ATP2B4;TFRC;LRP2;SLC44A1;ABCC3;SLC38A1;SLC6A9;ABCC1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.5083790443669538,-0.9456811256810329,0.5454545454545454,1.0,1.0,3/11,14.49%,NLRP9;AIM2;NLRP1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4374358320777501,0.9454835588671466,0.5492957746478874,0.8354845414396154,1.0,16/56,22.74%,PLK2;SOX4;PML;GADD45A;CDKN1A;CDKN1B;CCNB1;CCND1;TP53;CDK2;PLK3;PRMT1;WAC;FBXO31;ARID3A;CARM1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.49210709647955886,0.9452755752574927,0.5076923076923077,0.8356383437836271,1.0,7/18,27.56%,SOX4;DIP2B;BRCA1;RPS6KA4;ARRB1;RPS6KA5;MAPK3
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.6158147314775645,0.9452465466050525,0.6037735849056604,0.8353817522710578,1.0,1/5,5.78%,CTU2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.4177325432081841,0.9451980819613273,0.6575342465753424,0.8351385884675903,1.0,4/103,9.03%,LZTS1;DCN;SMCR8;CAPN1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5429924662887483,0.9449148345932693,0.5409836065573771,0.8354069582643331,1.0,3/13,10.89%,CACNA1G;MSX2;SMAD1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.406490511178885,-0.9447688635423217,0.5882352941176471,1.0,1.0,1/59,0.09%,NGF
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.45818368685686534,0.9442269436452071,0.509090909090909,0.8366225085194248,1.0,4/40,3.13%,SLITRK1;L1CAM;SHTN1;SLIT2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.5905740082645493,0.9439005871174,0.6333333333333333,0.8368548610070888,1.0,2/8,11.27%,SLC7A7;SLC7A1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.4374418703259662,-0.9438164788938943,0.5172413793103449,1.0,1.0,4/41,5.56%,ID1;LAMA4;ALDH1A1;NR1D1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.5905559498258139,0.9438125633015192,0.5384615384615384,0.8366995654007945,1.0,2/8,14.08%,ITPK1;HK1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.5133384789723902,0.9438075976535029,0.6,0.8363859405415646,1.0,2/19,6.26%,IGF1;MSX2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.6083563732273852,0.9437158952539687,0.5862068965517241,0.8362441442015363,1.0,2/7,13.70%,FSCN1;PDPN
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.428403364044301,0.9436895599843514,0.5384615384615384,0.835979313904209,1.0,5/56,9.87%,PLK2;BLM;FSD1;BCL2L1;TLE6
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.6411270980719674,-0.943419884066398,0.6842105263157895,1.0,1.0,1/5,1.60%,ZNF358
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.6411270980719674,-0.943419884066398,0.6842105263157895,1.0,1.0,1/5,1.60%,ZNF358
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4702217744692732,-0.9432234347179952,0.5,1.0,1.0,4/14,21.73%,DDX11;NCL;PWP1;NOL11
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6127018792336589,0.9432228411274718,0.6166666666666667,0.8365060173534168,1.0,1/6,13.09%,CDC7
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.42148391067523966,0.9428424102912363,0.547945205479452,0.8369663967069569,1.0,7/61,3.58%,SIX3;YWHAH;NLGN1;VWC2;CNTN4;CASZ1;PCP4
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6009233896821649,0.9427815612059209,0.5892857142857143,0.8367850592048323,1.0,5/9,24.54%,APOD;SNCA;F3;PTPRJ;CBL
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6293066606821401,0.9424681902413093,0.6065573770491803,0.8371395883204079,1.0,4/7,29.07%,OPTN;PINK1;PRKN;HDAC6
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3889733165939979,-0.9421966511337403,0.5,1.0,1.0,9/79,15.41%,RAB7B;VPS29;STX16;ARL1;WASHC2C;TMED9;VTI1B;RNF126;VPS35
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5700128667512058,0.9414526627773038,0.5666666666666667,0.8386526778871851,1.0,6/10,35.60%,IFT122;C12ORF57;TENM3;NF1;TBX2;VEGFA
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6170818200750168,0.9413657401640789,0.6,0.8384445745626361,1.0,4/6,37.51%,HIF1A;PRKN;MCL1;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.46174509627599414,0.9410287998153661,0.6,0.8388287609716994,1.0,2/40,1.28%,CTSC;CCBE1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.4286039713367308,0.940676216854788,0.5205479452054794,0.8392258058109854,1.0,5/74,10.51%,PDGFRA;LMO2;RBM24;SLC4A11;YAP1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.48673952445985413,-0.9402232282336992,0.5277777777777778,1.0,1.0,3/17,12.35%,GMFG;ARFIP2;BRK1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.5998715003440025,0.9399755511820572,0.576271186440678,0.8403720015223279,1.0,3/6,21.17%,SMAD3;TGFB2;HIF1A
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.5982905989497732,-0.9399274961086606,0.5789473684210527,1.0,1.0,1/7,1.97%,TNFAIP3
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.5997035384879221,0.939881031671339,0.6,0.8402029878948668,1.0,1/6,3.83%,IRF7
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.4457111085675691,0.9397298747105826,0.5671641791044776,0.8402486954682793,1.0,8/41,14.58%,ZFP36;PIM1;TRPM4;ZBTB16;VSTM2A;WDFY2;PPARG;SOX13
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.6085388948717889,0.9396247645866266,0.6551724137931034,0.8400711031814124,1.0,3/6,32.45%,UBE2E1;HERC5;UBE2E2
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.44752443077838705,0.9396214557463266,0.5857142857142857,0.8397579889869746,1.0,4/37,12.04%,HELB;CDK9;PDGFA;TERF2IP
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.632037322670681,0.9394994192310732,0.6346153846153846,0.8396944547679519,1.0,2/5,21.95%,ST6GALNAC3;GAL3ST1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.5926582825286306,-0.9393378822469051,0.5952380952380952,1.0,1.0,3/6,27.47%,TKFC;DHX58;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4089494249705706,0.9388329774079383,0.647887323943662,0.8409165469869764,1.0,17/105,11.93%,MET;PDGFRA;EGF;THBS1;IRS2;TGFA;FYN;RAMP3;NRG1;CHI3L1;PDGFA;KITLG;NRG2;GAB2;GFRAL;GAS6;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.5931704871085232,0.9387947384261309,0.5862068965517241,0.8406734053697942,1.0,6/8,37.84%,RARA;TNFSF4;IL18;CD81;PRKCZ;CD74
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5654900790024711,0.9387688139742346,0.6290322580645161,0.8403954948392376,1.0,2/7,17.11%,CTNNB1;WNT5A
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.5491494853051605,0.9385267639260886,0.5573770491803278,0.8405545665671922,1.0,3/12,13.20%,ABCB1;ABCA2;PLEKHA8
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.5579216622455605,0.9384331167192137,0.5254237288135594,0.8404471890052871,1.0,1/11,2.43%,VAPB
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.552899968759446,0.9381870721838756,0.5588235294117647,0.8406715847990118,1.0,6/12,15.87%,MSMP;HSD3B7;GAS6;CCL2;GPR183;PIK3CD
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.5497560432900105,-0.9378597916628547,0.5,1.0,1.0,1/5,4.92%,RABL3
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.48258402366790953,-0.9372784748383725,0.5945945945945946,1.0,1.0,4/20,6.40%,CD247;CD96;S100B;P2RY10
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.621297230855032,0.9368506258481211,0.5862068965517241,0.8429811759787011,1.0,1/5,3.39%,SLC39A14
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.5887001122333428,0.9364678626958667,0.7090909090909091,0.8434312062396312,1.0,5/9,34.62%,SLC27A5;SLC27A1;ACSL1;CD36;RPS6KB1
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6430377788113172,-0.9364009847545499,0.6739130434782609,1.0,1.0,1/5,9.70%,PLEKHH2
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.5545534717572937,0.9362988527060191,0.5294117647058824,0.8435103472151697,1.0,1/7,11.97%,KYAT1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4593138486266365,0.936113175835442,0.5671641791044776,0.8434979161316506,1.0,16/42,24.23%,THBS1;EPHA2;GADD45A;PPARG;FGF2;ANGPT2;ATP2B4;ETS1;MAP2K3;PRKCA;ADAM17;HIF1A;FGFR1;HSPB1;AKT3;PRCP
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.40469900855592034,-0.9360356646045092,0.4878048780487805,1.0,1.0,6/44,7.23%,FLT3;SLC25A5;LEPR;RHOH;RABL3;PTPN22
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4124911335686036,0.9359083162668429,0.5142857142857142,0.8436161756269458,1.0,16/70,14.46%,IGF1;KIF14;RASGRP1;RASGEF1A;IRS2;DAB2IP;ERBIN;DENND3;EPS8L2;TGFB2;DENND4A;ARF6;STARD13;OPHN1;FBP1;ARHGAP17
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.6135369996551594,0.9355849803652855,0.6923076923076923,0.8439346462400773,1.0,3/7,27.61%,FN1;CXCL12;FERMT3
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.42830021623876974,0.9355418278767317,0.5373134328358209,0.8436696101180511,1.0,18/60,18.67%,GRIN3A;THY1;PRAME;NEUROD2;ALPK2;DCC;CDK6;GAS6;MAPT;BCL11A;RPS6KA6;ELAPOR2;KLF7;KIAA0319;PINK1;PTPRS;LOXL2;TFRC
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.6104604460976787,0.9353802975923798,0.639344262295082,0.843770264819491,1.0,1/7,13.09%,CDC7
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.4139118998806782,0.9349643904619458,0.5068493150684932,0.8443536264066458,1.0,4/60,3.77%,CXCL2;SERPINE1;ZFP36;DAB2IP
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.5368178869390607,0.9348176473895399,0.5074626865671642,0.8442496000518939,1.0,2/15,16.56%,ZC3H7B;PUM1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.5174152895120636,-0.9339477966862763,0.5555555555555556,1.0,1.0,2/16,13.88%,SLC6A13;SLC25A22
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5143759372324629,0.9338500336541935,0.5714285714285714,0.8459492807406106,1.0,1/9,12.10%,DIP2B
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5684345215746105,0.9336903756596633,0.5892857142857143,0.845622996699367,1.0,5/7,35.31%,ULK1;ATG7;ULK2;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5684345215746105,0.9336903756596633,0.5892857142857143,0.845622996699367,1.0,5/7,35.31%,ULK1;ATG7;ULK2;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6006015000160938,0.9331503560411742,0.5849056603773585,0.8463695086166106,1.0,3/6,20.65%,HLA-E;RARA;TNFSF4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.5772160203386348,0.9330055587331687,0.6382978723404256,0.84628227191268,1.0,6/10,9.52%,KCNJ2;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5105798657641996,0.9329677185249742,0.6376811594202898,0.846047614975755,1.0,6/23,18.91%,ABCA8;ABCA5;PPARG;ABCA3;GPS2;RXRA
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.4154407148598419,-0.9320330060965691,0.5277777777777778,1.0,1.0,9/38,13.26%,CSTB;CST3;FICD;PLXNB3;RRP1B;MAPK7;PPP1R35;ZCCHC9;TMED2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5484812981471667,0.9319783897883318,0.6440677966101694,0.8475476127289053,1.0,1/11,2.85%,CD55
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.5975879634942245,0.9318856921552708,0.5614035087719298,0.8473993446079374,1.0,1/5,6.50%,CIITA
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.5350963001392817,0.9316996228935407,0.6545454545454545,0.847424505034094,1.0,2/10,7.37%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.5899634139012603,-0.9316993449038297,0.627906976744186,1.0,1.0,1/7,14.74%,PJVK
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5643488549856686,0.9313461999471156,0.603448275862069,0.8477788220001473,1.0,3/9,8.65%,ADCY5;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5062104180264808,0.9313063997314408,0.6,0.8475310536724144,1.0,3/19,6.69%,NOS1AP;HPCA;STAC2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.4989721719170498,0.9312126235924482,0.6557377049180327,0.8474089844141359,1.0,7/19,35.16%,BIRC3;FLOT2;OGT;FLOT1;BIRC2;HSP90AA1;NUPR1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6196555692067794,0.9306547497946978,0.6739130434782609,0.8481652539028108,1.0,1/5,6.89%,FAAH
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.565408464471294,0.9302833492634167,0.6086956521739131,0.8486095724092295,1.0,2/12,22.83%,ABCA2;H6PD
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.5315001010488681,-0.9293049474083354,0.6097560975609756,1.0,1.0,2/9,14.67%,ASIP;CDH3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5412809206177784,0.9292164254112956,0.6,0.8503375037598108,1.0,2/9,7.37%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.658328325134343,0.9289161843336864,0.6507936507936508,0.8505429857476557,1.0,3/5,29.05%,GAS6;CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.38650007730735964,0.9283512039061549,0.609375,0.8511673320461749,1.0,13/99,13.51%,CDKN2A;TP53TG5;PSRC1;SLIT2;TSPYL2;SLIT3;BCL6;PML;SMAD3;TGFB2;CDKN1A;CDKN1B;FBP1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3346342679313003,-0.9280679806602363,0.5909090909090909,1.0,1.0,31/176,22.02%,CDC26;PCYOX1L;RNF6;FBXO45;ELOC;RNF114;PPP1R11;SPSB4;FEM1A;UBL7;PCYOX1;WDR91;ANAPC15;KLHL8;RNF126;RC3H1;RNF5;RNF167;RNF34;RNF168;FEM1C;PLK1;ATXN3;UBB;UBE4A;RNF8;UBE2A;NUB1;COPS3;FBXO8;FBXL14
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.5857236127556993,0.9280499828443016,0.5892857142857143,0.8514284809791167,1.0,3/9,8.07%,IGF1;PTPRC;LDLR
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4944208700389418,0.9279450196264836,0.5714285714285714,0.8513052617047767,1.0,6/23,16.10%,PRKCG;EFNA1;PML;EPHA4;OPHN1;HIPK2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.3982461232093827,-0.9278777261291186,0.5294117647058824,1.0,1.0,16/46,23.93%,ATRIP;HUS1;BRIP1;ATR;TRIAP1;ERCC6;CLSPN;HINFP;SESN2;USP10;CASP9;CHEK2;RAD17;E2F7;MAD2L2;PAXIP1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.6098600528508771,0.9275566059074637,0.6666666666666666,0.851751701710632,1.0,5/8,21.20%,DYSF;SYK;IFI35;SBNO2;NMI
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3950259874416073,0.9273377574926295,0.6714285714285714,0.8518268636669915,1.0,38/165,14.22%,EPHA7;PRKCG;PLPPR5;ITPKC;PTPRC;PLCH2;PTPRB;LPCAT4;PLPPR4;PLPPR1;DUSP10;DUSP8;PXYLP1;DUSP16;PLAAT4;ITPKB;ALDOB;HK2;NUDT4;LIMK2;PLAAT3;PTPRD;ITPK1;STAT3;PFKL;ALPL;PGK1;PIP4K2A;INPPL1;INPP5A;INPP5J;PLB1;INPP4A;FBP1;HK1;IMPA1;ALK;PAK1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.41951446223967165,0.9270132713294988,0.5616438356164384,0.8522382766042288,1.0,17/61,18.66%,ZFP36;FOXO1;TRPM4;ZBTB16;ZFPM2;SMAD3;YAP1;TRIO;WDFY2;ASXL1;PPARG;RUNX1T1;WNT5A;RORA;WWTR1;SYAP1;GPS2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.5667911165038388,-0.9269129862259843,0.5909090909090909,1.0,1.0,2/6,9.78%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.5667911165038388,-0.9269129862259843,0.5909090909090909,1.0,1.0,2/6,9.78%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.5667911165038388,-0.9269129862259843,0.5909090909090909,1.0,1.0,2/6,9.78%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.5667911165038388,-0.9269129862259843,0.5909090909090909,1.0,1.0,2/6,9.78%,ELOVL4;ELOVL2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.3981339505399616,-0.9267614612226783,0.5454545454545454,1.0,1.0,4/44,7.40%,NGF;PIK3C2G;PLCB4;PIK3C2A
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.4223273822744087,0.9267184863609532,0.5689655172413793,0.8524855986417852,1.0,8/54,5.78%,RASGRP2;CTSS;CD22;PLEK;NAPSB;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.4442451746219322,-0.926686189575152,0.5581395348837209,1.0,1.0,3/22,14.77%,SNF8;VPS4B;RNF126
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.6521840565167958,0.9263742789897167,0.7142857142857143,0.8528706024021284,1.0,2/6,8.50%,SERPINE1;TFPI
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.570126266958844,0.9262526227990326,0.5714285714285714,0.8527944924794351,1.0,4/11,29.14%,SMCR8;IGF1R;CALCOCO2;UVRAG
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.44515289395198215,0.9260061670911428,0.59375,0.8529466121820215,1.0,4/40,8.23%,ANXA1;FYN;STK25;CYP1B1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.36642945754607315,0.9254961649295924,0.691358024691358,0.8536193425215255,1.0,25/277,13.57%,SERPINA10;C3;CHGB;SOCS3;FAM20C;CP;APP;ASB16;FBXW12;IGFBP7;LAMB1;NOTUM;ZBTB16;VGF;SHISA5;VCAN;FBXO32;ITIH2;KLHL5;TF;GAS6;SPSB1;FBXL16;FN1;WSB2
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.6514709982114818,0.9253420680863856,0.5932203389830508,0.8536204706745154,1.0,2/5,19.69%,PLAAT3;LIPE
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.521405610626309,0.9250181717786131,0.5454545454545454,0.8538667135982557,1.0,1/15,2.44%,PLEK
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.621059522337216,0.9248893797863634,0.6842105263157895,0.8538247612447054,1.0,2/5,9.61%,ANXA1;SCG5
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.4017303654964553,0.9248099742495471,0.581081081081081,0.8536754145000605,1.0,7/86,10.69%,SIX3;PLK2;NUDT16;FSD1;CTNNB1;BCL2L1;IHO1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.4078921661096628,0.9242625152684042,0.5555555555555556,0.85434660574441,1.0,22/73,21.80%,SLC7A2;ABCB1;ABCC4;MFSD2A;ABCC9;SLC7A1;ABCA2;SLC29A4;SLCO3A1;SLC2A3;SLC8A2;SLC29A1;SLC2A13;SLC7A8;ATP2B4;TFRC;LRP2;SLC44A1;ABCC3;SLC38A1;SLC6A9;ABCC1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.4717099394926056,0.9241088519890419,0.6065573770491803,0.8543131079098872,1.0,5/29,17.34%,HELB;CGAS;POLQ;RADX;OGG1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.3942921742235554,-0.9240136537252226,0.46153846153846156,1.0,1.0,8/48,7.03%,TLCD1;CEBPA;TLCD3A;ORMDL1;APOE;ABCB11;ABCD1;ACOXL
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.5736921097689462,0.9239458889531149,0.6458333333333334,0.8543440181600737,1.0,2/6,22.90%,P2RX7;ANO6
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.5652367159632304,0.923703348784704,0.5645161290322581,0.8545293661195315,1.0,2/8,14.45%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5844822758998065,-0.9236926946558783,0.5882352941176471,1.0,1.0,2/7,6.18%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5844822758998065,-0.9236926946558783,0.5882352941176471,1.0,1.0,2/7,6.18%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.6023970982886844,-0.9235532475762008,0.6410256410256411,1.0,1.0,1/6,9.63%,GPR37L1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5824795081729888,0.9233559738458019,0.6956521739130435,0.8548689778066126,1.0,3/10,10.63%,DUSP10;MAPK8IP1;HIPK3
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3891077588992218,0.9230922592963043,0.5625,0.8550625642796339,1.0,7/84,9.12%,TLR2;SULF1;APP;HIC1;NOTUM;ITGA3;CTNNB1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.5325907398869684,-0.9229632347156935,0.627906976744186,1.0,1.0,2/8,10.18%,IDO1;TDO2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5423273543327307,0.9226091752390231,0.59375,0.855697437880441,1.0,8/11,25.54%,SMAD3;TGFB2;ITGB8;CD200;FN1;HIF1A;LTBP1;ITGAV
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.472450433230895,0.9223311160121738,0.578125,0.8558948525210652,1.0,6/24,16.09%,C3;ASXL3;SORBS1;MLXIPL;PDK4;ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5020351988661884,0.9221936760603279,0.6206896551724138,0.8558308843240073,1.0,6/23,4.45%,IGF1;RASGRP1;RASGEF1A;IRS2;RELN;ERBIN
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6156276951628711,0.9219456865855549,0.6885245901639344,0.855942482310691,1.0,4/6,19.43%,DYSF;BIN1;MYOF;CAV3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.5137543246309336,-0.921826083445129,0.5,1.0,1.0,3/9,10.01%,ZC3H8;FOXJ1;CLPTM1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.4876245192535553,0.9216705401740639,0.5555555555555556,0.8562080524991755,1.0,4/18,23.50%,TINF2;EXOSC10;ACD;PIF1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5202343277056154,-0.9214866217745092,0.5428571428571428,1.0,1.0,7/11,21.06%,RETSAT;ADH6;ADH4;RDH10;RDH11;CYP2D6;LRAT
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.6244784419235485,0.9211379712414672,0.6551724137931034,0.8569910285788243,1.0,1/6,2.60%,RIT2
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.6341722562776092,0.9211247842757406,0.6666666666666666,0.8563923134670491,1.0,1/6,7.75%,THOC6
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.6341722562776092,0.9211247842757406,0.6666666666666666,0.8563923134670491,1.0,1/6,7.75%,THOC6
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.4992081046261038,-0.9210731714760455,0.5813953488372093,1.0,1.0,4/14,20.63%,SEC24A;SEC31B;MIA3;SEC24C
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),-0.534631498363657,-0.9208603707462709,0.5777777777777777,1.0,1.0,2/9,17.52%,HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4591155527102355,0.9207954338824968,0.5666666666666667,0.8566615908818485,1.0,4/35,14.38%,ITPKC;ITPKB;AGPAT4;FGF2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5571256661393948,0.9206192375153202,0.6491228070175439,0.8566402166703977,1.0,2/9,4.95%,EFNA1;SOX4
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.5785848272627627,0.9203318956864402,0.5686274509803921,0.8568921211620452,1.0,2/7,26.99%,CCND1;MME
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.6051795211969501,0.9200466578615891,0.6666666666666666,0.8571481055187401,1.0,4/10,17.97%,RYR2;TBX20;IFT122;MESP1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5072940950387058,0.9200436852529272,0.6190476190476191,0.8568364487948626,1.0,3/15,15.96%,YTHDF1;EIF2B5;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.594194670149633,0.9199202096917772,0.6567164179104478,0.8567297422764453,1.0,2/6,24.36%,BRCA1;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.4189323738440839,0.9193512136700708,0.5362318840579711,0.8575013665344466,1.0,5/66,9.12%,TLR2;IRF7;MYD88;CGAS;CTNNB1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5580182318249163,0.9193338330342448,0.5689655172413793,0.8572027121585932,1.0,4/11,24.94%,FAM107A;KCNB1;ULK1;EIF4G1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4697222503096028,0.9191878161609398,0.5873015873015873,0.857176931744365,1.0,6/30,11.03%,KCNJ2;KCNH2;ABCC9;ATP1A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.5879790393161659,0.9191356514922994,0.5964912280701754,0.8569978614562547,1.0,2/8,16.77%,ALOX12;LTC4S
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.45541839578811955,0.9181379603512808,0.6153846153846154,0.8585642941718177,1.0,6/32,10.89%,CACNA1G;MSX2;NRG1;TBX20;TCAP;SMAD1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.510448993575477,0.9180464648148426,0.5555555555555556,0.8584018620690823,1.0,4/13,10.85%,PDGFRA;PKDCC;TGFB2;GLI2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.38171320685723703,0.9179076199206629,0.6891891891891891,0.858367165794909,1.0,19/140,11.93%,MET;PDGFRA;EGF;THBS1;EPHA2;IRS2;TGFA;FYN;RAMP3;NRG1;NTRK3;CHI3L1;PDGFA;KITLG;NRG2;GAB2;GFRAL;GAS6;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.5881874398732923,0.9177578931674613,0.660377358490566,0.8583920267740645,1.0,1/6,5.25%,NFATC2
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.3358185268169032,-0.9177021443075942,0.75,1.0,1.0,21/85,18.24%,SF3B4;LSM3;SF3A1;U2AF1;PRPF18;LSM2;NUDT16L1;LSM5;METTL3;KIN;HSF1;RNH1;HSPA1A;PRPF8;LSM10;SRSF2;PRPF3;CPSF3;ZFP36L2;NUDT12;SRSF9
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4232889304601576,0.9169178298824375,0.6060606060606061,0.8597430756829086,1.0,13/63,10.12%,GRIN3A;CDH23;TRPC3;CACNG3;TUSC3;FYN;RAMP3;RYR2;CACNA1E;CACNG8;CACNA1C;NIPAL2;NIPAL3
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.547024727195948,-0.9168915840167068,0.5405405405405406,1.0,1.0,4/9,13.44%,APOE;PFDN4;VBP1;CLU
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5634936876660721,0.9166837603975072,0.6290322580645161,0.8597929007748806,1.0,8/14,16.02%,CNTN2;CNTN4;EMB;NPTN;NEXN;VSTM2L;ROBO4;PALLD
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.52973816722298,0.9162623550544403,0.578125,0.8603821213249027,1.0,3/16,16.31%,SLIT2;CAMK1D;BST1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.45960067800541193,0.9159670533730503,0.5846153846153846,0.8606567056288431,1.0,6/21,24.27%,ENO2;MTM1;ENO3;MTMR3;ELAPOR1;ANXA2
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.47002121674328595,0.9159520814708764,0.5409836065573771,0.8603496108231649,1.0,8/23,17.51%,PROX1;CHI3L1;ITGA3;GLI2;PDPN;FGF2;ABCA3;RCN3
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.527264409837389,0.9158986734545157,0.6071428571428571,0.8601318422709969,1.0,1/14,1.48%,EGF
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5355229158732027,0.9157983930074027,0.55,0.8600287476100431,1.0,3/13,19.59%,FAP;ANGPTL7;AEBP1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.565321355304883,0.915592548439007,0.6,0.8600868349266697,1.0,5/9,34.43%,CSRP2;PTCH1;PGM5;NF1;SRPK3
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.5422114851459057,0.9153063699746251,0.5862068965517241,0.8603313530598986,1.0,1/10,2.44%,PLEK
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.5959160218941725,0.9152947386190253,0.5925925925925926,0.8600418943588177,1.0,1/5,14.07%,SLC29A4
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5485805069378743,-0.9151202399570764,0.6222222222222222,1.0,1.0,5/7,30.62%,CLU;ATXN3;DNAJB12;DNAJC18;DNAJB14
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.564260429899586,0.9149252450214915,0.6226415094339622,0.860464113668902,1.0,3/12,11.19%,GPNMB;ASS1;PAG1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.46498608059750984,0.9147794913877667,0.5689655172413793,0.8604584535307224,1.0,1/25,2.43%,VAPB
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5659586925936864,0.9132809144880178,0.6530612244897959,0.8630426364322414,1.0,4/7,37.13%,RAB7A;MAPK3;MAPK1;TRIM27
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.4710173251485501,0.9127588977728058,0.6212121212121212,0.8636409434347974,1.0,6/31,13.13%,ZIC1;APOD;BAG3;SMAD3;PRKCD;CABP1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.5845278467346279,0.912534673707174,0.6666666666666666,0.8636975428554443,1.0,1/7,5.67%,ALOX12
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.634744260660954,0.9124808515953249,0.6851851851851852,0.8634582058777552,1.0,2/5,17.45%,LSM11;ZNF473
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3593014923246897,-0.912449198458853,0.5,1.0,1.0,9/114,5.88%,NGF;AR;ID2;HEY2;SMYD5;PDCD2;GREM1;NR1D1;SERPINF2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.5060762943048599,-0.9121410453929374,0.5952380952380952,1.0,1.0,2/10,17.52%,HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5625687035724565,0.9118437558013438,0.6842105263157895,0.8644317646332335,1.0,3/9,25.17%,BRCA1;CDK5RAP2;CCNF
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.5765748559039063,0.9118340365858802,0.6730769230769231,0.8641331980188156,1.0,3/7,10.70%,RYR2;TCAP;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5737656923635184,0.9113639449147097,0.6551724137931034,0.864658215531523,1.0,2/9,12.22%,CDK9;BARD1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.49884250849964296,-0.9108024972307748,0.6410256410256411,1.0,1.0,3/12,15.16%,NRARP;SEMA5A;THAP1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.6084866726434379,-0.9105938821448235,0.717948717948718,1.0,1.0,1/6,2.30%,CEL
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.4713325615867394,0.9100279993772334,0.5573770491803278,0.8670146791091383,1.0,4/19,14.20%,CYP1B1;SERINC1;FUT2;TEX2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.5787399200411183,0.9099806993491556,0.6727272727272727,0.8667872165799838,1.0,3/10,22.55%,ATG9A;PACS2;WDR45
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4173360030620295,0.9096059885063918,0.5303030303030303,0.8672052299319322,1.0,7/42,16.34%,GRM5;CDK9;PML;PPP1R16B;ABCA2;FN1;HPF1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5571028457180873,0.9094940729886467,0.6785714285714286,0.8670959169612938,1.0,2/13,8.07%,MFSD2A;LDLR
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.4525159200249439,0.90914626406109,0.5483870967741935,0.8674545037018112,1.0,7/27,12.83%,PTP4A3;NR4A1;MYH9;FAP;CYP1B1;PXN;STARD13
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6003244221347708,0.9089444197820675,0.5961538461538461,0.8675179137094097,1.0,2/7,2.85%,HLA-DRA;CD55
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3948065349227091,0.9086743718754055,0.7435897435897436,0.867703409811263,1.0,24/137,10.12%,ST6GAL1;PRRX1;SCN1B;GPNMB;CTSS;CSF2RA;ABCB1;ITGA2;PCP4;RELN;PTPRR;PRKG2;GUCY1A1;LAT2;CD37;APOD;CFH;BIRC3;EMP1;TFPI;SEMA3B;KIF5C;SCG5;MMD
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.44033025865091807,-0.9083595636627382,0.5238095238095238,1.0,1.0,4/24,9.99%,EXOSC8;NUDT16L1;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.3936680409483418,0.9082397386254694,0.5833333333333334,0.8682760823119171,1.0,8/63,11.10%,ACSL5;AWAT1;GLYATL2;ALOX12;FAAH;CYP1B1;ACOT4;SLC27A3
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.562703810417658,-0.9080255106203987,0.5952380952380952,1.0,1.0,3/8,22.22%,MT3;OXA1L;SIRT4
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.5599866165669183,-0.9079145694465406,0.5714285714285714,1.0,1.0,2/5,14.18%,MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.41919435218310924,-0.907671743171688,0.6486486486486487,1.0,1.0,6/24,13.30%,HEY2;HES6;HEYL;BHLHE41;HES5;HEY1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.4505553449583745,0.9072644110692689,0.5806451612903226,0.8697573416476789,1.0,12/29,27.71%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;KLF4;WRAP53;ACD;PARM1;PARN;MAPK3;MAP2K7
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.5553631698782666,-0.9070123751160121,0.5405405405405406,1.0,1.0,1/6,3.89%,LRPPRC
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.48621052276332627,-0.9067261652656236,0.5853658536585366,1.0,1.0,3/14,16.34%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.5810267761480532,0.9064214490674711,0.6,0.8710103413066296,1.0,5/8,28.36%,CHI3L1;CHI3L2;CTBS;AMDHD2;CHIT1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.5910139203059387,0.9061434647511074,0.5862068965517241,0.8709450960481692,1.0,2/5,3.63%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5910139203059387,0.9061434647511074,0.5862068965517241,0.8709450960481692,1.0,2/5,3.63%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.580903955420211,0.9060058708735628,0.5964912280701754,0.8708725887071352,1.0,1/7,6.50%,CIITA
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.45656987691979123,0.9059985580572539,0.6071428571428571,0.8705648991134763,1.0,3/15,14.10%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.53777691667051,0.9059580065796546,0.6333333333333333,0.8703162230378613,1.0,1/9,11.54%,PARP9
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.6314455004013535,0.9059240751243736,0.6964285714285714,0.8700593346492925,1.0,1/6,4.31%,PRPS2
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.5574334050603142,0.9057237772233188,0.5849056603773585,0.8701047474296943,1.0,2/13,9.13%,RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4937145086437109,0.9056774252603319,0.6363636363636364,0.8698858755681289,1.0,1/22,1.64%,KREMEN2
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5723211388378465,0.9056425107673496,0.6140350877192983,0.8696378139300499,1.0,5/10,15.42%,KCNJ2;ATP1A1;ATP1B1;ATP1B3;KCNMA1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.5799576700953407,-0.9055676364806545,0.6956521739130435,1.0,1.0,2/5,29.81%,RC3H1;RC3H2
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.5547873175542433,0.9054676505033867,0.6190476190476191,0.8696120778329974,1.0,1/12,3.41%,IRS2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5362809188960159,-0.9052007584574628,0.6530612244897959,1.0,1.0,1/9,1.02%,MADCAM1
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.596770089245162,-0.9051112821641748,0.6226415094339622,1.0,1.0,2/5,17.23%,GTF2H2;ADM
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.4334790823050949,0.9050865916971248,0.6792452830188679,0.8699592571617693,1.0,5/24,15.35%,TRIM5;CIITA;TRIM22;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.44762557974795747,0.9050839336244486,0.5362318840579711,0.8696402401991137,1.0,3/42,3.45%,STEAP3;SLC39A14;CP
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.45617975285168166,0.9049613513198103,0.603448275862069,0.8695726637441168,1.0,6/33,17.24%,BLM;GADD45A;CDKN1A;RGR;TP53;RRH
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.5670938981011371,0.9049085974450213,0.6451612903225806,0.8693251713695096,1.0,3/8,30.74%,PHLDB2;RREB1;CLASP1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.380090881521166,-0.904878499492201,0.5,1.0,1.0,12/54,22.16%,CFTR;VIM;BECN1;UFL1;TEX264;AUP1;PJVK;DYNLL1;ATG14;UBB;ACBD5;UFC1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5198335761387083,-0.9045413116794274,0.575,1.0,1.0,3/9,26.80%,DNASE1L1;MUS81;FBH1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.4839634238178846,-0.9045072871451881,0.5833333333333334,1.0,1.0,4/15,11.32%,PRSS3;CD320;MMACHC;MMAB
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.4839634238178846,-0.9045072871451881,0.5833333333333334,1.0,1.0,4/15,11.32%,PRSS3;CD320;MMACHC;MMAB
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.4389814166785575,-0.9043732403403996,0.5714285714285714,1.0,1.0,3/28,4.92%,FLT3;SLC25A5;RABL3
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.3740031845451358,0.9042379200176941,0.6538461538461539,0.8703413406781574,1.0,22/147,13.80%,HPN;GPNMB;KREMEN2;IL15;PTPRO;DAB2IP;PTPRR;DUSP10;EFNA1;NLRP12;ZNF750;RAB11FIP5;ALPK2;NPTN;RAB11FIP1;LDLRAD4;GAS6;HDAC9;TLE3;RPS6KA6;ELAPOR2;KLF7
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.5644791544183411,0.9037533786833154,0.6557377049180327,0.8709218193112428,1.0,4/9,29.70%,CTNNB1;PIP5K1C;VCL;TBCD
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6153731904923571,0.9037299831931914,0.6615384615384615,0.8706406596960647,1.0,1/5,16.65%,PINK1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.5715973636110306,0.9037172821853509,0.5636363636363636,0.8703346311281367,1.0,1/6,8.45%,RPUSD1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4818587307307758,0.9036881834595151,0.5970149253731343,0.8700497143730772,1.0,5/26,20.21%,SMAD3;SMAD1;ZC3H7B;PUM1;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.5967501591786404,-0.903660182858357,0.6341463414634146,1.0,1.0,3/6,22.42%,STXBP4;CDH3;MDK
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5954587569078356,0.9030426458187405,0.7096774193548387,0.8709927680097003,1.0,1/8,5.31%,WASF1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.37190269157017813,-0.9026798083339079,0.6666666666666666,1.0,1.0,9/59,19.16%,VAMP8;PSMD10;PSMD12;PSMB5;PSMD2;TAP1;PSME3;PSMB4;PSMB6
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4361864236448014,0.9025915304159595,0.6818181818181818,0.8715302023814583,1.0,10/69,14.63%,TGFBR2;ZYX;PARD3;DUSP22;SMAD3;TGFB2;SMAD1;PXN;FOS;SMAD9
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.5057452788855328,0.9024396688848814,0.5483870967741935,0.8714955416914262,1.0,5/11,19.02%,TYMS;MTHFD2;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.589656447749427,0.9021225034375725,0.66,0.8718196540899381,1.0,3/7,34.00%,TP53;TGFB1;MAP2K1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5539959658292334,-0.9019566089622253,0.6744186046511628,1.0,1.0,2/6,14.09%,SLC6A13;MT3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.3979834028848914,0.9016585936675903,0.625,0.8723520279589414,1.0,2/67,1.88%,ANXA1;BLM
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.3858365494577392,-0.9015164242516078,0.6129032258064516,1.0,1.0,5/45,8.55%,TRIM29;KRT8;PPIC;TUFT1;TMEM54
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.6444277559024671,0.9014989497939664,0.75,0.8723087684005859,1.0,2/5,23.60%,THPO;SH2B3
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3993471446503963,0.9013268806683101,0.6521739130434783,0.8724488848891084,1.0,14/86,14.48%,RELN;DAB2IP;SHANK3;NEUROD2;NRG1;SNCA;FRMPD4;NEURL1;TGFB2;SYK;TPPP;ATP10A;DCTN1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.5619438463686751,-0.9011009417297023,0.6,1.0,1.0,2/6,14.20%,PLIN3;PLIN2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.418894102411475,0.9009783994169581,0.5362318840579711,0.8726971995873716,1.0,18/62,24.72%,THBS1;SULF1;BMP8A;TBX20;RBPMS;CDKN1C;TGFB2;ELAPOR2;HIPK2;KIAA0319;STK11;SMAD2;ADAM17;BMP6;ACVR1B;TGFB3;CDKN2B;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4922050243397962,-0.9004881228977504,0.6666666666666666,1.0,1.0,1/11,6.92%,BCAP31
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5520459117996592,0.9003902773176382,0.6307692307692307,0.8734949656333317,1.0,2/9,14.14%,MFSD2A;ALK
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.5353358335959435,0.9003171200931042,0.6507936507936508,0.8733098322242754,1.0,3/10,15.22%,ABCA8;ABCA2;SGMS1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5898671184787053,0.8997710625767605,0.6271186440677966,0.8738779471968477,1.0,4/6,40.56%,MTA1;SASH1;TAF1;RBX1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.5744237242611717,0.899764641959579,0.6226415094339622,0.8735680291737238,1.0,4/8,23.60%,PTPRC;KLF4;MAP2K5;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),0.6277806336652062,0.8991960677778705,0.6557377049180327,0.8744349994714752,1.0,4/5,28.47%,HDAC9;ANGPTL4;SORT1;ANGPTL3
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5141182888425417,0.8991753328569579,0.6,0.8741251042954299,1.0,2/9,21.42%,SEC14L1;TSPAN6
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.4467677091106451,0.8986991202391469,0.7258064516129032,0.8746422385236752,1.0,3/33,9.97%,GLRA2;FYN;NEURL1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.5059886394651752,0.8981684477208693,0.6229508196721312,0.8753002082713478,1.0,5/16,13.70%,DMTN;ALOX12;SYK;PRKCD;PDPN
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.3552304028578366,-0.8980962420807904,0.56,1.0,1.0,28/106,22.78%,PADI4;H2BC21;GTF2H5;CETN2;GTF2H2;MCM6;DMC1;H2BC18;ERCC2;PSMD10;PSMD12;MCM4;PSMB5;PSMD2;XPA;ERCC3;H2BC5;PSME3;PSMB4;PSMB6;RAD51;UBB;PARP1;SMARCA5;ORC6;ORC2;ANP32B;PSMA1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.5350119760569573,0.8979794520121045,0.6153846153846154,0.8753473890210683,1.0,3/7,21.80%,ABCC4;ABCC3;ABCC1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4123166285366025,0.897923495034841,0.6086956521739131,0.8751413693491622,1.0,5/61,10.11%,ST6GAL1;MGAT3;TUSC3;MGAT5;B4GALT7
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.47070695632258186,0.8974667564215084,0.5510204081632653,0.8757569532201319,1.0,2/14,3.25%,RASGRP1;PTPRC
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.45310099807930054,0.8972467298911133,0.7164179104477612,0.8758039167268613,1.0,6/32,15.91%,BLM;SAMHD1;CDK9;EME2;MRE11;TRAIP
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.36441042372545746,-0.8965643642708964,0.6,1.0,1.0,3/43,4.37%,RFC3;APEX2;POLD3
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.5636562477858917,0.8964894281983676,0.625,0.8768126590118344,1.0,1/5,15.11%,CAST
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.47606007493121677,0.8963826387866624,0.6166666666666667,0.876689291504546,1.0,3/24,7.08%,ANK3;KCNIP4;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.543928781718644,-0.8962558422353354,0.631578947368421,1.0,1.0,1/5,2.56%,XG
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.543928781718644,-0.8962558422353354,0.631578947368421,1.0,1.0,1/5,2.56%,XG
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5719158891807952,0.8960463770578626,0.6428571428571429,0.8770507138026261,1.0,2/10,8.07%,MFSD2A;LDLR
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.5639926473090233,-0.8960097925017495,0.5471698113207547,1.0,1.0,1/5,7.74%,LY96
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5882327766659653,0.8959330673783473,0.6792452830188679,0.8769604793276146,1.0,4/7,30.03%,ULK1;ATG7;ATG5;ULK2
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.4670073070361883,-0.8958524513634207,0.5294117647058824,1.0,1.0,5/11,24.91%,AUP1;RNF5;POMT2;VCP;DERL1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.4337597913565009,-0.8958012486720528,0.5526315789473685,1.0,1.0,6/24,16.00%,ABCB11;CYP46A1;OSBPL3;GBA2;CYP7B1;OSBPL6
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.568932148098966,0.8957104571016806,0.6935483870967742,0.877085576464463,1.0,4/8,27.76%,SHANK1;MAP1A;ADCY3;BRSK1
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.6015724838729546,0.895685392853186,0.6666666666666666,0.8768008977131336,1.0,2/5,15.57%,CDK6;EIF2B5
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.30586832784289136,-0.8956686283728639,0.8,1.0,1.0,52/291,20.82%,FBXO48;CDC26;ERCC8;SELENOS;SEL1L2;DMAC2;FBXO45;TMUB2;FBXO5;KCTD2;FBXO27;UBXN8;ZFAND2B;RAD23A;SPSB4;FEM1A;FOXRED2;PSMD10;PSMD12;DERL2;AUP1;FBXL22;PSMB5;USP19;ANAPC15;RNF103-CHMP3;ERLIN2;RNF126;FBXO9;DCAF11;PSMD2;RNF5;RNF34;FEM1C;TRIM3;DDIT3;CUL1;PSME3;PLK1;PSMB4;PSMB6;ATXN3;ERLIN1;GID8;UBB;SKP2;UBE4A;UBXN2A;DNAJB9;SHARPIN;UBE2A;KBTBD7
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.4978231069137432,0.8956617417820295,0.6206896551724138,0.8765371088555929,1.0,3/15,7.19%,TYMS;HROB;POLD1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.564816813726318,0.8954228666714174,0.6551724137931034,0.8766580881615983,1.0,4/6,36.23%,SND1;PARN;DIS3L2;LIN28B
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.5538181605572352,0.8947290749723122,0.6774193548387096,0.8776139956858375,1.0,2/9,11.25%,CACNA1C;ORAI1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.46684531072235014,0.8943568294118756,0.6271186440677966,0.8780650775180784,1.0,2/21,7.37%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5569326284962017,0.8942074722130273,0.603448275862069,0.8780160121411152,1.0,2/7,9.12%,NRP2;CTNNB1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5091503572469249,0.8941810987679882,0.6,0.8777563900795649,1.0,3/13,9.52%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.4425119024694067,0.8941135465319195,0.5692307692307692,0.8775464888630872,1.0,8/44,8.48%,IGF1;RASGRP1;RASGEF1A;IRS2;ERBIN;ARHGEF3;MAPRE2;SYNPO2L
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.4584121041741253,-0.8939593440249557,0.5531914893617021,1.0,1.0,8/20,19.32%,DHRS11;MOCS2;SRD5A1;MOCOS;NFS1;NOXRED1;PRLR;LIAS
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.538322778104934,0.8934277535644016,0.6666666666666666,0.8784797173491868,1.0,6/10,21.97%,SNCA;TF;B2M;BCL2;HIF1A;BMP6
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.5341455701258069,-0.8921966184699358,0.6744186046511628,1.0,1.0,4/9,19.51%,PLA2G4C;GNPAT;CHPT1;PLA2G4A
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.5030886348261335,0.8918553301285443,0.631578947368421,0.8809714402629225,1.0,3/20,10.69%,SYCE1;STAG3;IHO1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.5964147121618557,0.8916373983623307,0.72,0.881057482966527,1.0,1/5,21.00%,GNAI1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.5644432925790839,0.8915999398617694,0.6382978723404256,0.880817840796254,1.0,1/5,19.96%,PIGK
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.5350502595893508,0.8915555329215514,0.6666666666666666,0.8805907324888556,1.0,2/12,4.12%,CHRNA5;ACHE
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3679919791290223,0.8915378203067338,0.7105263157894737,0.8802896489615959,1.0,37/129,28.38%,NUAK2;FOXO1;MAP1LC3A;NUAK1;FAS;KLF10;MFSD2A;FOXO3;SIK2;CDKN1A;PICK1;PDK4;RNF152;MAP3K5;GABARAPL1;TP53;TFEB;STK24;ATP6V1B2;RRAGD;MTMR3;ELAPOR1;RHEB;WDR45;SESN1;HSPA5;ATG7;CPEB4;GABARAPL2;ATP6V1C1;ATP6V1C2;SH3GLB1;MAPK3;BRSK1;ATP6V1G2;ZFYVE1;ATG5
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5798326660196247,0.8910183799607534,0.7090909090909091,0.8808740126782761,1.0,2/6,12.20%,MYD88;USP50
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4550036242164048,-0.8910000892173454,0.65,1.0,1.0,3/13,15.51%,NFU1;CIAO2B;ISCA2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.5318504414930353,-0.890579208169047,0.6944444444444444,1.0,1.0,2/12,8.91%,FAM47E;SMARCD1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5714702287280347,0.8904284676207548,0.6666666666666666,0.8816225898675849,1.0,3/6,15.57%,CDK6;STAT3;EIF2B5
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.44765547558927216,0.8903207309173945,0.7333333333333333,0.8814736921917782,1.0,9/33,19.29%,PRKCG;AGAP2;HDAC4;ZDHHC7;FBP1;ALK;FMN2;NCOR1;FLNA
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3755968600826616,-0.8902926659441858,0.5384615384615384,1.0,1.0,1/57,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5270510455911492,0.8900008444021973,0.6610169491525424,0.8817279661128742,1.0,2/9,9.88%,ZSWIM4;YTHDF1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5279178546956222,-0.8898059568215412,0.6304347826086957,1.0,1.0,3/7,26.52%,ZCCHC17;NRDE2;PHAX
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.48250551240840783,0.8897604246173779,0.5272727272727272,0.881846380074692,1.0,2/10,12.34%,SRA1;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.4782989630512179,0.8895470609097873,0.6333333333333333,0.881944159107697,1.0,3/16,10.62%,WTIP;MOB3B;DLG5
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.5370599245320054,0.8895016108448135,0.59375,0.8817460584416994,1.0,5/8,40.96%,ARRB1;CTBP1;TAF7;IWS1;SMARCB1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4208726039873438,0.8894377258426515,0.6440677966101694,0.8815522072288414,1.0,13/44,21.51%,CCDC3;BIRC3;TNFRSF1A;SYK;GAS6;HIPK1;FADD;TRAIP;IKBKG;RFFL;GPS2;ADAM17;SPPL2B
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.510939660505933,0.8894234010640946,0.6078431372549019,0.8812640686550519,1.0,3/13,20.83%,AK5;AK3;SMPDL3A
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.5821342477149036,0.889135529754336,0.6379310344827587,0.8814439970780233,1.0,1/6,7.20%,RYR2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.4533467533217118,-0.8890257498101559,0.6410256410256411,1.0,1.0,1/12,2.13%,COX18
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.4606426522900704,0.8887718959577143,0.5961538461538461,0.8818863601006787,1.0,3/28,4.95%,ANXA1;PTPRC;SOX4
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.4673387318459157,-0.8885995454294042,0.5714285714285714,1.0,1.0,2/17,3.59%,TRIB3;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5456632365212366,-0.8882734761098133,0.5833333333333334,1.0,1.0,1/7,4.18%,SRI
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.39212915834866074,0.8882282619238854,0.6896551724137931,0.8824186293662939,1.0,6/55,10.93%,ZDHHC9;ZDHHC22;PIGA;PGAP4;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4306575302938809,-0.8873651485580516,0.5789473684210527,1.0,1.0,2/21,6.28%,KCNE1;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5752736107929726,0.8870172425322456,0.6615384615384615,0.8842869910728254,1.0,2/7,15.17%,PTPRC;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5180538851081666,0.8867461671248797,0.6833333333333333,0.884572128354059,1.0,4/12,12.73%,PDGFRA;ALOX12;PDGFA;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.5308059309038738,0.88666376653396,0.5714285714285714,0.8843982335715544,1.0,4/8,17.11%,SYK;NOXA1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.49761041582055326,0.886427475563131,0.6774193548387096,0.8844988422510357,1.0,7/15,34.07%,BASP1;LARGE1;SIX4;FXR1;IGSF8;MYH14;MYOZ2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5243615653380326,-0.8862200950742186,0.6842105263157895,1.0,1.0,2/8,17.96%,ZNF593;DDIT3
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.5101389498924833,0.8861713027571682,0.6440677966101694,0.8846648786108872,1.0,2/10,7.76%,RASGRP1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5649250568173578,0.8861314276212493,0.6721311475409836,0.8844256611800483,1.0,4/10,24.32%,PRKCH;MAPK9;CSF1;MSR1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.5776344268144342,-0.8858655954767477,0.6666666666666666,1.0,1.0,2/6,25.99%,DNAAF1;DNAH11
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.49938247865207963,0.8858605221058937,0.6206896551724138,0.8845384243473167,1.0,2/12,7.84%,APLNR;ROBO2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.5269064511663,0.8857344267799255,0.6545454545454545,0.8844384610647081,1.0,5/10,29.90%,CCDC91;SORT1;ANKFY1;AP1G1;GAK
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.49346361958679785,-0.8854336480664571,0.6388888888888888,1.0,1.0,2/13,15.69%,DSCC1;RAD21L1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.44857429326119347,-0.8853772767939432,0.5348837209302325,1.0,1.0,6/15,22.20%,SF3B4;NCL;PRDX6;RBMX;CIRBP;SNW1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.5234497560462454,0.8851303709660845,0.6349206349206349,0.8852256386088349,1.0,1/12,1.88%,BLM
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5825153580139455,-0.8846654016041302,0.6666666666666666,1.0,1.0,1/6,9.59%,DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5825153580139455,-0.8846654016041302,0.6666666666666666,1.0,1.0,1/6,9.59%,DOLK
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.4994772815115279,0.8845315508492751,0.6451612903225806,0.8859550430778342,1.0,2/10,12.49%,SLIT2;EPHA4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.4607782418101032,-0.8844814539619966,0.6458333333333334,1.0,1.0,2/14,11.50%,TPP1;ATR
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.4798076472401345,-0.8844517245745439,0.6571428571428571,1.0,1.0,3/14,8.34%,AR;ESR2;NCOA4
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4161530718063332,-0.8843073614830651,0.6363636363636364,1.0,1.0,6/25,13.44%,TPT1;FBXO5;YJU2;SFRP2;PSMD10;CLU
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.534615888189816,-0.8842091141588513,0.7027027027027027,1.0,1.0,4/11,22.52%,EXOSC4;EXOSC5;FBL;LARP7
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4037648164061261,-0.8840193021081431,0.6571428571428571,1.0,1.0,11/31,26.32%,FIP1L1;CPSF1;CLP1;LSM10;CPSF3;SSU72;CSTF2T;CSTF2;CPSF7;SLBP;SNRPB
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.4872208557781329,-0.8839036701375786,0.6842105263157895,1.0,1.0,4/10,26.17%,EMC6;EMC4;EMC8;EMC7
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.40793598306235035,0.8838076658230792,0.6470588235294118,0.8869371928679097,1.0,9/51,10.89%,THBS1;SERPINE1;PMEPA1;KLF10;CDK9;CTNNB1;SMAD3;CDKN1C;SMAD1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.5059849228903697,0.8836018999733658,0.6818181818181818,0.8869671866735357,1.0,3/11,22.13%,SHMT1;CRAT;CPT1C
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.533630778661092,0.8834793744613523,0.6774193548387096,0.8868951082190304,1.0,4/10,13.05%,APP;TNFRSF14;APOD;CD200
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5874063651066558,0.8833677458562921,0.6610169491525424,0.8861572410728382,1.0,2/5,28.27%,MACROH2A1;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5874063651066558,0.8833677458562921,0.6610169491525424,0.8861572410728382,1.0,2/5,28.27%,MACROH2A1;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5874063651066558,0.8833677458562921,0.6610169491525424,0.8861572410728382,1.0,2/5,28.27%,MACROH2A1;SMC5
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.39797125892680585,-0.8832952448602267,0.7,1.0,1.0,2/22,3.93%,ATP10B;RFT1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.4377012990093392,-0.8831374841388453,0.6857142857142857,1.0,1.0,2/15,4.51%,DISP3;APOE
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.40481423582452775,0.8829252045522021,0.6486486486486487,0.8866643757568203,1.0,4/64,4.04%,VAPB;SHTN1;APP;TRAM1L1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.5282714287375994,0.8827374517734645,0.6363636363636364,0.8867229259481845,1.0,2/8,27.10%,PINK1;DYRK1A
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5635958492251766,-0.8825076628387295,0.725,1.0,1.0,2/7,19.24%,ALDH18A1;ARG1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5332999056048624,0.8822289048590334,0.6507936507936508,0.8873028165333963,1.0,3/12,19.69%,PLAAT3;PEX7;LIPE
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.43052081127468855,-0.8816208412926038,0.6486486486486487,1.0,1.0,3/22,4.04%,RITA1;NRARP;BEND6
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.4918803062179457,0.88119558597662,0.7096774193548387,0.8890101949735563,1.0,6/19,19.86%,ABCC4;SLCO1A2;SLC51A;SLC27A5;RXRA;ABCC3
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5276079236909482,0.8810910236077074,0.6440677966101694,0.8888521156403971,1.0,2/11,10.90%,MICALL1;PACSIN1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.5583390743866925,-0.8810142267880273,0.6530612244897959,1.0,1.0,2/5,14.09%,SLC6A13;MT3
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5597723969438607,0.8809551979073372,0.6666666666666666,0.8888528377838305,1.0,3/11,14.58%,PIM1;VSTM2A;SOX13
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.515617778892423,0.8806483729781931,0.6333333333333333,0.8890813391705983,1.0,3/12,9.52%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.3537847455249539,-0.8806200478436254,0.5384615384615384,1.0,1.0,9/72,10.93%,DAO;SDSL;IDO1;PIPOX;ACMSD;HYKK;GLUD1;TDO2;GCDH
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.4906462750098896,-0.8803009018598743,0.625,1.0,1.0,7/11,24.40%,NT5E;NT5C;GPX1;NUDT15;PNP;NT5C1A;ITPA
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5670175050460999,0.8802915155461414,0.6333333333333333,0.8893584704368321,1.0,2/6,10.62%,PRKCB;PRKCH
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.5731704504808669,0.8801416417175092,0.6296296296296297,0.8892736549980359,1.0,3/7,26.22%,PRKCD;CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5316209765682203,0.8795777966959161,0.6610169491525424,0.8900949834017539,1.0,2/13,12.37%,GAR1;TRUB1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5023196250861123,0.8795385300368838,0.5636363636363636,0.8898759299469122,1.0,5/13,29.66%,ARF6;ARHGAP17;KBTBD6;OGT;RASGRF1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.5096563402885587,-0.8794074381163606,0.6222222222222222,1.0,1.0,2/12,12.44%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.5399222742797272,-0.8791686192798538,0.7111111111111111,1.0,1.0,1/7,8.96%,CTH
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5893230846845754,0.879161164848449,0.6610169491525424,0.8901929873285578,1.0,1/5,11.98%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.5840710982939469,-0.8788312161219363,0.7,1.0,1.0,1/6,1.82%,SELENOS
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4463467869635571,-0.8788151576969011,0.5625,1.0,1.0,1/17,0.09%,NGF
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4169075330991573,0.8787980333061887,0.6515151515151515,0.8905747605349468,1.0,12/35,15.59%,CTSS;PLEK;SLA;PTPRC;IL1R1;ITGB8;ITGAL;IKZF2;CD5;HLA-E;CD4;GPR183
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.6204967263933443,0.8786929609475533,0.7368421052631579,0.8897560756253189,1.0,1/5,14.76%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.6204967263933443,0.8786929609475533,0.7368421052631579,0.8897560756253189,1.0,1/5,14.76%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.6204967263933443,0.8786929609475533,0.7368421052631579,0.8897560756253189,1.0,1/5,14.76%,MAN1A1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.4757543094705124,-0.8786494612624871,0.5714285714285714,1.0,1.0,4/13,22.08%,STX16;TMED5;FHDC1;GCC2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3939946212470186,0.8785829185813866,0.6164383561643836,0.8896024578248765,1.0,22/70,25.94%,GPNMB;SOX4;FYN;SNCA;INPP5A;NPAS2;CD200;FGF2;PINK1;IKBKG;AMIGO2;PACRG;RAD18;CSF1;SRGAP2;HLA-F;MECOM;EIF4G1;PARP16;HTR2B;PRKN;CCN4
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5386887934227997,-0.8784087737875775,0.6666666666666666,1.0,1.0,4/7,14.84%,ABCB10;SLC25A37;LDB1;EIF2AK1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.42725989734906233,0.878384787732305,0.6333333333333333,0.8897163561910411,1.0,7/35,13.53%,SIX3;ECE1;SH3PXD2B;PBX3;TGFB2;MEIS3;HIPK1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5380240827679654,0.8782228685570178,0.6538461538461539,0.8896722164781768,1.0,3/9,21.27%,HLA-DRB1;CD4;CSF1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5802299427544997,0.8782222607893907,0.7454545454545455,0.8893568417116124,1.0,3/5,35.68%,CTBP1;SIRT1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4249862148251908,0.8780378276627635,0.6290322580645161,0.8893816650630098,1.0,8/33,18.46%,ROBO2;YAP1;TGFB2;STAT3;TSPAN14;MAML2;MESP1;ZMIZ1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.47835009680666885,0.8779858335107609,0.6774193548387096,0.8891920390262653,1.0,7/14,40.19%,RTN4;GBP1;SH3GLB1;CD81;KPTN;SH3BP4;ATP13A2
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.5082246208867233,-0.8777001772317192,0.5869565217391305,1.0,1.0,2/6,16.20%,GNPDA2;NAGK
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.514317876302653,0.8776350786294301,0.6885245901639344,0.8895202369331484,1.0,3/13,14.58%,PIM1;VSTM2A;SOX13
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.45166553432323314,-0.8776176392067566,0.5853658536585366,1.0,1.0,3/10,20.41%,CYP2C8;NUDT15;CYP2D6
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.46533349296309356,0.8771258133151553,0.660377358490566,0.8901271707783676,1.0,3/22,10.05%,SLC4A10;SLC4A9;SLC4A11
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5321171726300005,0.8767926810392439,0.7301587301587301,0.8904830966284144,1.0,3/9,12.20%,MYD88;NLRC3;USP50
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5478623599449175,0.8765715010149852,0.6166666666666667,0.8905438391092675,1.0,1/8,8.00%,ZMYND10
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5176919230887107,0.8765452162233602,0.6851851851851852,0.8902975951680833,1.0,2/12,7.13%,GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3818252714604789,-0.8765129153603433,0.6060606060606061,1.0,1.0,11/56,12.71%,HSD17B8;MCAT;ACSM6;ELOVL4;ABHD1;ABCD1;ASAH2B;ACSBG2;ELOVL2;CYP2C8;DEGS1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5479565452624129,0.8758131069163292,0.6296296296296297,0.8914524691666823,1.0,3/7,11.22%,ADA;SKAP1;PODXL
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.5320184996653183,0.8755001419043795,0.6,0.8916137016108765,1.0,2/6,17.46%,SPIRE1;SPIRE2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.4049217917215156,-0.8753068164586295,0.6,1.0,1.0,5/25,15.60%,APOE;ABCB11;ARV1;ADIPOR1;FMO5
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.4579358160213045,0.8747626322850518,0.7428571428571429,0.892690640292068,1.0,2/32,4.04%,APP;TRAM1L1
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.40431147734038636,-0.8745567108688164,0.7,1.0,1.0,10/36,12.34%,TRIM29;LEPR;ALDH1A1;SCEL;TMC5;B3GNT3;ATP2C2;EHF;TFCP2L1;TEKT1
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.5529173920886012,0.8743741068880925,0.6666666666666666,0.8930045766283055,1.0,2/5,21.97%,CDK6;BMP6
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.5084396437113223,0.8742618787936317,0.6530612244897959,0.8928990047509824,1.0,1/10,2.44%,PLEK
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.38030267942787105,-0.8742485269007497,0.7142857142857143,1.0,1.0,9/34,12.92%,RIOK2;RPS28;DDX52;RIOK1;SNU13;DCAF13;NGDN;SRFBP1;RRP36
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.5211568655824447,0.8737788323912509,0.676923076923077,0.8934584869452598,1.0,3/11,11.93%,PLEK;SKAP1;P2RY12
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.5118834954823455,-0.8737026896403486,0.6,1.0,1.0,2/9,13.99%,RIOX1;RIOX2
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.52980034484924,0.8736905126784724,0.71875,0.8933205993750415,1.0,7/12,28.47%,HDAC9;PCSK5;ANGPTL4;PCSK6;SORT1;FURIN;ANGPTL3
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4184711971879809,0.8736867599485548,0.7536231884057971,0.8930176882270066,1.0,10/43,19.15%,PXYLP1;AGRN;UGDH;B4GALT7;HS3ST3A1;HS6ST1;HS3ST3B1;NDST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.36409653548682874,-0.8736667813001047,0.625,1.0,1.0,2/42,5.28%,SF3A1;CRNKL1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.510056089755436,0.8735989153518962,0.5740740740740741,0.8928760273208732,1.0,1/10,5.14%,CD44
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.5812373189639995,-0.8733601019945368,0.673469387755102,1.0,1.0,2/5,24.52%,AQP4;AQP1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.40838754195187593,-0.8731570473320318,0.7317073170731707,1.0,1.0,2/27,5.08%,TPX2;TPPP3
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.5841625296092013,0.8730602559905718,0.7254901960784313,0.8935635130175593,1.0,2/6,26.95%,CDS2;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.4961578548926463,0.8728379544977701,0.6833333333333333,0.8936390060391797,1.0,1/16,0.93%,TLR2
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3968161885285222,0.8725968388157381,0.7142857142857143,0.8938793341508652,1.0,8/87,11.95%,TGFBR2;ZYX;PARD3;DUSP22;SMAD3;TGFB2;SMAD1;PXN
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.31187809165234304,-0.872204407852771,0.84,1.0,1.0,41/191,21.00%,TFB2M;BRF2;GTF2H5;POLR2K;ELOC;BTF3;GTF2H2;ELOA;RRAGC;HSF1;SLC25A33;TAF13;POLR2C;GTF2A2;SUPT16H;TAF11;ERCC2;ERCC6;GTF2F1;NFKBIB;CCNT1;THAP1;MLF1;TTF1;GTF2F2;RBMX;DDX21;MTERF1;POLR2D;ERCC3;TEFM;GTF3A;POLR3H;POLR3K;TAF5L;PWP1;POLR2L;RO60;PARP1;SMARCA5;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5548836738123085,0.8719639188697571,0.6885245901639344,0.8946260444705085,1.0,1/10,5.31%,WASF1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.5045607544167761,0.8717675727886972,0.6666666666666666,0.8946006130703293,1.0,3/13,5.54%,CD22;SH3KBP1;AHR
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.42170716767410515,-0.8716199963850594,0.5526315789473685,1.0,1.0,8/21,24.31%,DHX33;DDX11;NCL;EIF2AK3;PWP1;NOL11;WDR43;UBTF
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.4244047544920326,-0.8715679899721469,0.6551724137931034,1.0,1.0,14/51,17.30%,LSM7;LSM3;EXOSC8;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;CNOT1;RC3H1;CNOT9;LSM1;POLR2D
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5038905953888396,0.8711598507780594,0.6451612903225806,0.8954389450716397,1.0,6/15,18.66%,CD22;PRKCB;PRKCH;ELF1;CBFB;GPS2
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.5482603437060596,-0.8711424381391876,0.6304347826086957,1.0,1.0,1/5,10.32%,USF1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.3635756097312638,-0.8708717065646234,0.6857142857142857,1.0,1.0,11/53,14.09%,CEL;TM7SF2;PMVK;APOE;SCARF1;ARV1;CYP46A1;GBA2;PIP4P1;DHCR7;MT3
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5031645278421754,0.8707270563513083,0.6190476190476191,0.8959473748410026,1.0,3/10,18.88%,PADI2;ZMIZ1;ARID1A
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5051858108170744,-0.8706467382383112,0.6578947368421053,1.0,1.0,3/10,18.04%,SFRP2;BMP2;MEOX1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.5474715707627196,-0.8705618840421745,0.66,1.0,1.0,1/8,2.25%,VAMP8
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.5223446486473231,-0.8704280006247395,0.5581395348837209,1.0,1.0,1/6,14.30%,MPI
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.365549207720381,0.8703060205433013,0.8142857142857143,0.8964233304162232,1.0,5/73,3.68%,MET;IGF1;EGF;APP;ADD2
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5203889527216188,-0.8700207662992855,0.6956521739130435,1.0,1.0,3/10,20.09%,PNRC2;LSM1;PATL1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4683866001195627,-0.8699942513091257,0.7368421052631579,1.0,1.0,2/14,5.17%,ORMDL1;SMPD3
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.39858865783107855,-0.8698973566715259,0.6486486486486487,1.0,1.0,2/29,3.61%,TMEM17;DISP3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.5087132475379648,-0.8696989534595633,0.6,1.0,1.0,1/11,3.73%,CEP19
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5571472833324975,-0.8695784429163281,0.6304347826086957,1.0,1.0,1/5,13.44%,CLU
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.4124069020968191,0.8692149556025989,0.6923076923076923,0.8980065909019505,1.0,10/34,26.46%,PPP1R16B;PRKCD;PPP1R7;MFHAS1;CALM3;PIN1;ARPP19;ENSA;DLC1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5820735360819558,0.8691263107043885,0.746031746031746,0.8977994868137992,1.0,3/8,11.03%,LRRC55;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.5214573976766945,-0.8691176049179935,0.6304347826086957,1.0,1.0,1/5,10.83%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.5214573976766945,-0.8691176049179935,0.6304347826086957,1.0,1.0,1/5,10.83%,HSPA1A
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.42856940640090196,0.8690504294064523,0.7014925373134329,0.897604559267686,1.0,8/41,16.18%,ABCA8;FA2H;CERS3;ASS1;CYP4F22;PAM;SGMS1;CERS5
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5416184958674298,0.8683829251735894,0.7058823529411765,0.89842403551273,1.0,4/11,30.38%,FBXL2;PRKN;FMR1;NUCKS1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5346613370258408,0.8680036238213015,0.5769230769230769,0.8987059245001184,1.0,3/7,19.79%,MAPT;HEBP2;RNF122
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.5549771451269009,0.867588882522749,0.6842105263157895,0.8992119600261231,1.0,1/5,19.43%,CAV3
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.43279414774675623,-0.8674369881761714,0.6410256410256411,1.0,1.0,2/36,9.16%,CSKMT;ICMT
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.4721073086764948,0.8673263317476352,0.7230769230769231,0.8994132801988282,1.0,3/18,4.07%,PLEK;PTPRC;FLT1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.42896222312090393,-0.8673262020127355,0.6153846153846154,1.0,1.0,5/19,20.08%,ENY2;USP51;EPOP;BRCC3;ATXN7L3
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.44452547774749884,-0.8672690318192373,0.6,1.0,1.0,2/21,1.60%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.38915017326990486,0.8672587528795761,0.6911764705882353,0.8992301386421625,1.0,13/66,17.20%,CDKN2A;DUSP1;DAB2IP;PRKAR1B;PKIA;CDKN1C;GADD45A;PRKCD;CDKN1B;SLC8A3;PRKAR1A;RGS14;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.4969620128713829,0.8666805052714053,0.7096774193548387,0.8999715728445508,1.0,5/18,18.91%,ABCA8;PPARG;ABCA3;GPS2;RXRA
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5516060032653549,-0.8666577013981445,0.7083333333333334,1.0,1.0,2/5,16.10%,PTPN22;TIRAP
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.5056988376357112,-0.8662418773212617,0.5918367346938775,1.0,1.0,1/7,7.23%,PTPN22
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.4813313550912722,0.8659299443156744,0.6551724137931034,0.9010765363519813,1.0,8/18,23.63%,MYLK3;SYNPO2L;OBSCN;TCAP;FHOD3;CSRP2;SIX4;WDR1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.4644109579001593,-0.8658511983130074,0.6176470588235294,1.0,1.0,2/17,1.91%,MADCAM1;CD200R1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.44033663798396044,-0.8655312491284969,0.6060606060606061,1.0,1.0,11/19,30.62%,AUP1;RNF126;RNF5;POMT2;ATXN3;VCP;DERL1;DNAJB12;DNAJC18;UGGT1;DNAJB14
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.5099407715478043,-0.8654676850302687,0.7446808510638298,1.0,1.0,3/7,11.64%,SELENOS;TMEM106A;CD47
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4968595475528791,-0.8649539358473086,0.673469387755102,1.0,1.0,1/9,3.87%,SDSL
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3304491361355022,-0.8648154985137129,0.7619047619047619,1.0,1.0,8/91,12.01%,NUP62CL;NXT2;NUP50;CHCHD10;NOL8;RANBP6;RANBP17;RPL11
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.4856409383186509,-0.8647819938353214,0.6304347826086957,1.0,1.0,1/12,1.71%,RIOK2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.43011505890029533,0.8643748801059937,0.6833333333333333,0.9036883997446473,1.0,5/31,3.61%,GRIK1;NLGN1;GRIK2;GRID2;RELN
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.513621964757236,-0.8641046538649874,0.7435897435897436,1.0,1.0,3/12,16.28%,CNOT7;CNOT1;RC3H1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.5056206225172628,-0.8635721259092417,0.5909090909090909,1.0,1.0,3/8,17.21%,VPS11;CNOT1;CNOT9
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.45448398623242114,-0.8631469095745824,0.7352941176470589,1.0,1.0,5/15,26.17%,EMC6;EMC4;UBL4A;EMC8;EMC7
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.33932527349089614,0.8631457741851549,0.8072289156626506,0.90568678134251,1.0,35/278,18.91%,NR4A3;PRRX1;TEAD2;NR4A1;GCM2;LSM11;PGR;CDK9;PIR;NR6A1;NR1I3;TAF4B;YAP1;TBL1X;GLIS3;TEAD1;HDAC9;NR4A2;PPARG;DEAF1;MAML2;NOTCH3;RARG;RARA;NR2F6;TAF1C;ZNF473;TAF15;RORA;ZBTB1;MNT;WWTR1;CBFB;NCOR1;RXRA
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3374313716883014,-0.8630869991912151,0.8214285714285714,1.0,1.0,15/74,16.21%,ARF5;DNAJC28;TMEM115;KIF4A;USE1;KIF15;COPB2;COPE;TMED9;TMED2;ARCN1;ERGIC3;ARF4;KDELR1;RAB1B
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.39559667961043143,0.8629607550535211,0.6666666666666666,0.9056336442035042,1.0,13/67,19.47%,PLK2;DAB2IP;FOXO1;HECW2;BARD1;HECW1;CDKN1B;TRIM32;OAZ2;SMURF1;WNT5A;VIP;PLK3
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.5360274080303726,0.8629136083098571,0.6607142857142857,0.905380797334455,1.0,1/5,9.22%,ACOT4
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.4562309133412122,0.862675198947326,0.676923076923077,0.9054715718251232,1.0,11/27,30.99%,TNIP2;MAP3K5;MAPK11;IKBKG;SKP1;RPS27A;MAP3K8;MAPK3;MAP2K7;MAP3K7;FBXW11
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.4310596898216735,0.862574333546653,0.6865671641791045,0.9053427148650041,1.0,8/27,14.19%,ATP8B4;ABCB1;ATP9A;PLSCR1;MFSD2A;PLSCR2;ATP8A2;ATP10A
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.592499123527727,0.8624358939526383,0.6724137931034483,0.9052578462068643,1.0,2/5,22.67%,SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.4582600979241057,-0.8618663632462802,0.7272727272727273,1.0,1.0,5/13,13.41%,RGCC;SERPINF2;CREB3L1;VIM;RUNX1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.4586841108665117,0.8614743871016115,0.6349206349206349,0.9065892584163022,1.0,8/17,35.71%,USP6NL;CAMSAP3;MAPK3;PDCD10;MAP2K1;STX5;CAMSAP2;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.44856954878187205,0.8614037443736066,0.6428571428571429,0.9063604470874864,1.0,7/24,18.66%,OGN;APOD;CDKN1A;PPARG;CDKN1B;IL12A;VIP
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.3869993424858176,-0.8611933798063759,0.6190476190476191,1.0,1.0,3/30,11.87%,TNFAIP3;ABRAXAS1;USP27X
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.5603316649942138,-0.8608067375051875,0.6875,1.0,1.0,1/6,7.36%,RAB5IF
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.37688820763619335,0.8607638629509732,0.7808219178082192,0.9071204652627979,1.0,12/90,16.65%,FBLIM1;DAB2IP;SEPTIN8;NRG1;GFAP;SYK;TPPP;LCMT1;NCLN;TMC8;STX1B;PINK1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.34556007796246013,0.860693643481467,0.7368421052631579,0.9068836578977338,1.0,16/150,10.74%,PAPSS2;IGF1;GSTT2;SERPINE1;EPHA2;PGD;IL1R1;TPST1;FAS;RAP1GAP;TNFRSF1A;TYR;UGDH;ENPEP;GSS;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5036161437929252,0.8605276670114909,0.7121212121212122,0.9067904321920038,1.0,3/13,12.90%,IRS2;PRKCE;PPARG
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.48816309949718556,0.8601910359360464,0.6229508196721312,0.907035775635024,1.0,5/14,14.09%,SERPINE1;ICAM1;PAK4;GAS6;TNIP2
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.3455030772946536,0.8598096646059356,0.7236842105263158,0.9075118468327962,1.0,24/164,15.35%,C3;GPNMB;RASGRP1;APP;NOS1AP;EFNA1;FAS;NTRK3;NPTN;LIMCH1;PPP1R16B;LIMK2;NIBAN1;WDFY2;GAS6;TERF2IP;PRKCD;HLA-DRB1;PAK1;FGF2;SLCO3A1;CCND1;PPP1R7;CD4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.4866960615554624,0.8597743030046248,0.6382978723404256,0.9072394165050996,1.0,3/14,9.38%,KCNMB4;CPLX2;CPLX1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.36030038358635397,-0.8592446000946378,0.6666666666666666,1.0,1.0,3/61,0.68%,TRIM29;KCNE1;TMEM229A
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.5351500209127439,0.859241080372937,0.6595744680851063,0.9079498013078361,1.0,1/5,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.5376416521580762,-0.8592136694417744,0.6904761904761905,1.0,1.0,1/5,7.30%,MST1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.37882964499334953,0.8591199018592973,0.7301587301587301,0.9078364824077715,1.0,14/65,16.39%,STMN2;SLIT2;SHANK3;SNCA;LDLR;SHANK1;SSH2;EML2;CYRIB;FGF13;PRKCD;CAMSAP3;PFN2;STMN1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.3501092424709338,-0.8590963622196011,0.7391304347826086,1.0,1.0,5/62,7.03%,ERCC8;TRIM21;TRIM52;ASB4;TRIM68
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.4061968255187692,-0.8590130607644009,0.65625,1.0,1.0,4/33,6.54%,RFC3;POLD3;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3737232078173803,0.8587322335637625,0.6515151515151515,0.9082837837877538,1.0,24/76,25.94%,SNCB;SOX4;RAMP3;SNCA;PRODH;DCC;DHCR24;NPAS2;CDKN1B;FGF2;RILPL1;CTSZ;PACRG;RRAS2;RAD18;AXIN2;ACER3;TBK1;SRGAP2;EIF4G1;PARP16;HTR2B;PRKN;CCN4
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4949678212195604,-0.8581781014961893,0.6530612244897959,1.0,1.0,1/10,1.02%,MADCAM1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4567575984381863,0.857906315983882,0.603448275862069,0.9094262392285906,1.0,8/21,24.68%,HPCA;JPH4;YWHAE;CACNB2;CAV3;PDE4D;AHNAK;JPH2
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.5205296514275778,-0.8577668927883005,0.7027027027027027,1.0,1.0,3/7,33.82%,ACADS;MMAA;MMUT
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.4127819720406441,0.857109598216674,0.7051282051282052,0.9104924185163763,1.0,6/45,7.78%,CXCL2;C3;S100A10;EFNA1;EPS8L2;RHOD
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.4971672489732554,0.8570189481545438,0.6349206349206349,0.910314831957341,1.0,3/12,13.27%,GLYATL2;OLAH;ACOT7
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5824884855057272,-0.8569184413107822,0.6944444444444444,1.0,1.0,2/5,32.95%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5824884855057272,-0.8569184413107822,0.6944444444444444,1.0,1.0,2/5,32.95%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5133465493166189,-0.8564640752962174,0.6666666666666666,1.0,1.0,1/7,6.70%,PRDM4
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.5010147678610675,-0.8563607797306556,0.6458333333333334,1.0,1.0,5/8,28.25%,DERL2;YOD1;SVIP;OS9;ERLEC1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.5154884186435789,0.8562196096966925,0.6346153846153846,0.9111426612084486,1.0,5/9,28.38%,MAP1LC3A;GABARAPL1;ATG7;GABARAPL2;ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.5154884186435789,0.8562196096966925,0.6346153846153846,0.9111426612084486,1.0,5/9,28.38%,MAP1LC3A;GABARAPL1;ATG7;GABARAPL2;ATG5
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5333410069198266,0.8561264640866364,0.7142857142857143,0.9109967713287397,1.0,5/7,35.60%,NCAM1;NFIB;NRP1;EPHB2;VEGFA
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.5821069140925004,-0.8560425383339555,0.7741935483870968,1.0,1.0,1/6,1.45%,HEY2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.514304016038913,-0.8557313501256613,0.6818181818181818,1.0,1.0,3/8,30.76%,AGA;ENGASE;NGLY1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5187362377578937,-0.8555588504323208,0.6470588235294118,1.0,1.0,6/11,25.87%,CTH;SEPHS1;PHGDH;SRR;PSPH;SEPHS2
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.46782483606220937,-0.8550279982010038,0.5789473684210527,1.0,1.0,3/9,20.41%,CYP2C8;NUDT15;CYP2D6
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.502538364900717,0.8549395100577378,0.6515151515151515,0.9127268100783902,1.0,1/13,2.10%,MAEL
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.521843908557607,-0.8545169660586157,0.6444444444444445,1.0,1.0,1/6,1.71%,RIOK2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4226516889536728,0.8540434584471006,0.609375,0.9139363072710192,1.0,7/30,18.38%,BICDL1;TRAK1;PEX14;MAPT;HAP1;RHOT1;RHOT2
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.5205932643997918,0.8534129486229926,0.7659574468085106,0.9147684747828418,1.0,1/8,10.06%,AK5
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.5409552962841357,0.8532867859036818,0.6938775510204082,0.9146809548870687,1.0,2/5,15.35%,PAG1;CD4
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4350149394690344,0.8532608617628167,0.6491228070175439,0.9144350833705649,1.0,5/30,16.22%,ANXA1;CYP1B1;PRKCD;RNF112;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5362698786263485,0.85311575404496,0.6304347826086957,0.9143358629020554,1.0,3/6,19.79%,MAPT;HEBP2;RNF122
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.4822502825908698,0.8528376102155744,0.671875,0.9145176981917748,1.0,4/13,24.32%,PPARG;ABCG1;SCARB1;MSR1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.5340366275509741,0.8527167435913219,0.6865671641791045,0.9143868683028702,1.0,5/9,31.34%,THPO;ZFPM1;SH2B3;CDKN2B;UBA5
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3421614557305317,-0.8522338414611681,0.76,1.0,1.0,3/64,5.85%,NUP62CL;NXT2;NUP50
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.4919139625417248,0.8521026585313412,0.6290322580645161,0.9152527443273463,1.0,2/14,8.07%,ABCA8;LDLR
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.41764669076659855,-0.8518067434295279,0.6451612903225806,1.0,1.0,7/25,25.40%,SF3B4;PRPF8;PRPF3;LSM1;SRRM1;MPHOSPH10;SCAF11
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3366956443540732,-0.851497942474224,0.7083333333333334,1.0,1.0,4/75,2.68%,ATF5;TPX2;CEP72;SSNA1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3492424739951797,-0.8512861054267957,0.7741935483870968,1.0,1.0,3/85,5.15%,SLC2A5;CFTR;LDHC
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.47819920360238377,0.8510368985669158,0.6333333333333333,0.9166635975381068,1.0,6/14,25.15%,THY1;CD160;PTPRJ;GBP1;PRNP;DGKZ
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.45938816176563085,-0.8509467907633645,0.6976744186046512,1.0,1.0,5/12,13.41%,RGCC;SERPINF2;CREB3L1;VIM;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.4993223741008967,0.8508477446876985,0.6885245901639344,0.9167376693926255,1.0,9/19,31.33%,ARF6;SCAMP5;LRSAM1;MTMR2;MCTP1;RUBCN;EPHA3;ABCA7;PICALM
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.351982353943524,-0.850714917914848,0.7692307692307693,1.0,1.0,31/81,26.17%,ERCC8;GTF2H2;NOC2L;EIF2S1;BAK1;PRIMPOL;METTL3;USF1;ERCC2;ATR;MEN1;TRIAP1;ERCC6;SMPD1;XPA;ERCC3;CAT;GPX1;CIRBP;UBE2A;PARP1;CASP9;POLK;YY1;AQP1;MAP3K4;MSH2;SPRTN;NPM1;CCAR2;USP28
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5353792276045333,0.8506962170600646,0.7192982456140351,0.9166813162859744,1.0,2/7,31.13%,IDI1;MVD
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4992687940070243,0.8506804599036997,0.6923076923076923,0.9163880409923405,1.0,5/11,11.93%,SKAP1;TGFB2;SYK;PODXL;P2RY12
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.5191582593220659,-0.8505117821835049,0.7027027027027027,1.0,1.0,3/10,20.12%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.5204557976205734,0.8503613325369376,0.6984126984126984,0.916564778959914,1.0,4/8,14.70%,SFTPD;P2RY12;CCL2;TAFA4
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4499435483685081,0.8502403882707344,0.6071428571428571,0.9164769710249827,1.0,10/23,19.50%,NLGN1;THY1;AGRN;DVL1;ITGAL;DLG3;PICK1;SCRIB;FLNA;DNAJA3
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.3514375940994322,-0.8501217477635734,0.7931034482758621,1.0,1.0,7/63,9.31%,RITA1;ENHO;NRARP;BEND6;MAML3;POFUT1;METTL3
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.40342880121244196,0.8499552824274152,0.6825396825396826,0.9166101583147285,1.0,10/49,21.15%,PRKCG;DAB2IP;RHBDF1;GNA12;OPHN1;PINK1;OSBPL7;KCNE2;DDRGK1;DNAAF4
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.440215341020817,0.8497979267366501,0.6865671641791045,0.9165578904306121,1.0,11/21,32.59%,VLDLR;SMURF1;AP2A2;CLTC;SH3GLB1;NEDD4;KIF16B;UVRAG;TGFB1;MYLIP;SNX25
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.4722696487229255,0.8496552223086256,0.6779661016949152,0.9164898884851808,1.0,5/13,21.39%,RAI2;TGFB2;CAMSAP3;BRCA1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4017301971419093,0.8492014805903482,0.6349206349206349,0.9169579333966914,1.0,6/31,15.40%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.5086424740939279,-0.8491528076794842,0.6097560975609756,1.0,1.0,3/7,13.60%,APOE;PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.5673425803868785,-0.84879009864297,0.7631578947368421,1.0,1.0,1/7,2.30%,CEL
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.43015909620672527,-0.8485635016696577,0.7317073170731707,1.0,1.0,6/19,19.04%,EXOSC8;ERI2;UTP20;RPS21;NOL9;RPP40
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.48260553699758024,0.8484442789084135,0.711864406779661,0.9179220722782637,1.0,6/12,19.10%,FSCN1;OPHN1;MYO9A;CAMSAP3;PATJ;SCRIB
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.5182584675248294,0.8484288217935189,0.7241379310344828,0.9176252397151495,1.0,2/9,5.92%,TMEM204;APLNR
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.41591157773295717,-0.8482440463631453,0.6666666666666666,1.0,1.0,2/18,13.00%,HAX1;HTRA2
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.5031007835747283,-0.8481085692699508,0.6666666666666666,1.0,1.0,1/7,3.72%,ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5180963581465561,0.8475101152763727,0.639344262295082,0.9189861310023455,1.0,1/8,7.64%,CDK9
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.4443503953232215,-0.847439972092708,0.717391304347826,1.0,1.0,3/15,16.94%,LY96;BECN1;KLRG1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3452931400283454,-0.8473097991759577,0.8285714285714286,1.0,1.0,1/77,0.09%,NGF
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.48040440939802,0.8471980546448017,0.6666666666666666,0.9191574898315429,1.0,4/15,12.90%,FABP3;MFSD2A;SLC27A3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.49898174675946055,0.8466862101523994,0.7142857142857143,0.9197064318353495,1.0,3/17,12.90%,RAMP3;ZFYVE28;PPARG
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.5076917499732334,0.8456409832931732,0.7540983606557377,0.9212264549324098,1.0,3/9,6.80%,NUDT16;APOBEC3H;ADARB2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.41775237551782896,0.8455565512908059,0.7301587301587301,0.9210430144821342,1.0,5/37,12.20%,ALS2CL;DNM1;HOOK1;PLEKHF1;USP50
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.4516315130370054,0.8453790988380664,0.6727272727272727,0.9210129830019307,1.0,3/16,11.88%,MRAP2;PID1;PYGL
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.5417880868207595,0.8453392529046865,0.6444444444444445,0.920766878605057,1.0,3/5,38.26%,ANGPT1;SLC10A7;GLCE
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.38145445619365337,-0.8452267135123103,0.6666666666666666,1.0,1.0,5/28,12.94%,TM7SF2;PMVK;ARV1;DHCR7;SC5D
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.5321486008505574,0.8451560530762384,0.6491228070175439,0.9207958770824117,1.0,1/6,7.67%,TCP1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.4755068527008014,0.8447659125932008,0.6181818181818182,0.9211153998168671,1.0,3/11,15.19%,COLEC12;CGAS;IFIH1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.4510197279702928,0.8445310805954026,0.6379310344827587,0.9212463066124073,1.0,3/14,15.19%,COLEC12;CGAS;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.45494564164142554,0.8445042240744209,0.7230769230769231,0.9209533773305398,1.0,5/21,14.38%,PDGFRA;FLT1;P2RY12;EEF1A2;FGF2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.38957249600413535,-0.8444990096085507,0.6363636363636364,1.0,1.0,5/26,12.94%,TM7SF2;PMVK;ARV1;DHCR7;SC5D
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.4942154162910419,0.844495377167136,0.7241379310344828,0.920656727008396,1.0,3/11,21.76%,DGKG;WNT5A;DGKD
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.48275620911720085,-0.8443212645087752,0.6904761904761905,1.0,1.0,2/11,9.49%,FBXO5;ZKSCAN3
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.5427067949609541,0.8439811524043797,0.7142857142857143,0.9211993490035979,1.0,3/6,19.43%,CTNNB1;TCAP;CAV3
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3343678661743394,-0.8439408932635396,0.8571428571428571,1.0,1.0,4/88,3.87%,SLC2A5;G0S2;CES2;SDSL
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3944499126465087,-0.8435959694214982,0.6590909090909091,1.0,1.0,2/19,6.20%,SRI;SELENON
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.35850394253881734,-0.8435680582373376,0.6451612903225806,1.0,1.0,16/60,25.40%,FIP1L1;RBM8A;U2AF1;CPSF1;CLP1;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;CSTF2T;THOC1;SRRM1;CSTF2;THOC3;CPSF7
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.5740432561144687,0.8435333429501507,0.7966101694915254,0.9216279320311869,1.0,3/5,35.14%,BRCA1;SIRT1;AUTS2
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.4844443944123209,-0.8433485374972052,0.7380952380952381,1.0,1.0,1/11,4.37%,POLD3
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.4423350596006662,0.8431029095640498,0.6666666666666666,0.9221620121722853,1.0,8/29,15.84%,BMP8A;SERGEF;RAB11FIP5;RHBDF1;RAB11FIP1;CD200;RHBDF2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.5119844712976586,0.843070464498549,0.6458333333333334,0.9212491635479292,1.0,2/11,23.73%,CDC27;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5119844712976586,0.843070464498549,0.6458333333333334,0.9212491635479292,1.0,2/11,23.73%,CDC27;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5119844712976586,0.843070464498549,0.6458333333333334,0.9212491635479292,1.0,2/11,23.73%,CDC27;CUL3
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),-0.5844163117029054,-0.8429629578394613,0.7142857142857143,1.0,1.0,1/5,18.98%,SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.47458908802758226,0.842953520528023,0.6470588235294118,0.9211526772156311,1.0,3/11,14.10%,THBS1;CD160;CCL2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.373023163990102,0.8427423052340133,0.7361111111111112,0.9212166277376113,1.0,20/96,14.38%,CORO6;COL21A1;RBM24;VLDLR;FABP3;PDE1A;RASL12;RYR2;TBX20;SYNPO2L;ZFPM2;OBSCN;CTNNB1;NEXN;ART3;TCAP;SORBS1;CAP2;LAMA2;FGF2
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.5688208452895903,0.8424673515305569,0.7627118644067796,0.9214408503379152,1.0,1/5,13.79%,KLC1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.5598189955835122,0.8424645388847931,0.6724137931034483,0.9211294131981177,1.0,1/8,8.44%,OCIAD2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5738194796566354,0.842411695127308,0.7843137254901961,0.9209041534401086,1.0,3/5,42.27%,VPS13D;GOLPH3;VPS13C
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.40331798944965297,-0.8421797702467357,0.6666666666666666,1.0,1.0,5/20,16.24%,UQCRB;UQCRHL;MTFR1L;MTFR1;OXA1L
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.30345522091201316,-0.8420432438468551,0.8333333333333334,1.0,1.0,23/231,15.57%,AR;OTUD3;TNFAIP3;COPS8;CFTR;MCRS1;IL33;KDM1B;COPS7A;ABRAXAS1;RAD23A;USP27X;PSMD10;PSMD12;BECN1;USP51;FOXO4;PSMB5;USP19;TADA2B;CLSPN;PSMD2;USP9Y
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.41457966214001674,-0.8418985736140165,0.6578947368421053,1.0,1.0,7/23,19.78%,PPIC;PPWD1;PPIH;PPIL3;PPIL1;FKBP7;PPIE
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.48458896375867927,0.8413609257096182,0.6551724137931034,0.9222219696123504,1.0,2/12,13.19%,MGAT3;BACE2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.5430850101942557,0.8409570573162836,0.7090909090909091,0.9226290672815941,1.0,1/6,9.13%,SLC9A1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.36650394869248865,0.8409236858621929,0.7741935483870968,0.9223840086466006,1.0,16/76,19.10%,RASGRP1;TBC1D9;EPHA2;RAP1GAP;NTRK3;SIPA1L1;USP6NL;RANGAP1;TBC1D1;SIPA1;TBC1D10B;RAP1GAP2;TBC1D10A;NGEF;ARHGAP22;SCRIB
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.33851855465303204,0.8405772313261667,0.7926829268292683,0.922642491935027,1.0,15/153,16.79%,ANK3;CTSC;VAPB;CD55;TGFA;GRIA1;TMED10;ERGIC1;GAS6;ACTR1A;DCTN1;ATL3;CD59;COPZ2;SPTB
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.5065295389048416,0.8402386930447581,0.6896551724137931,0.9229671121793496,1.0,3/9,29.84%,TGFB2;PTCH1;FBXW4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.39163903473218326,-0.839890406092292,0.7241379310344828,1.0,1.0,4/35,6.54%,RFC3;POLD3;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.44378921600279986,-0.8394905614071868,0.6170212765957447,1.0,1.0,1/13,2.96%,FSHR
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4337993361582867,-0.8393201816810741,0.6595744680851063,1.0,1.0,1/17,4.18%,SRI
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.3864025842860308,-0.8390572373358721,0.6666666666666666,1.0,1.0,7/19,18.47%,BCAP31;SLC8B1;SLC25A23;LETM1;AFG3L2;MICU2;FIS1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.321170587129537,-0.8388413719452097,0.6296296296296297,1.0,1.0,4/82,3.75%,SOD3;SELENOS;PRDX1;BRF2
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.5106128466589832,0.8386613403147852,0.6612903225806451,0.9252685386302918,1.0,4/7,10.74%,SOX4;TBX20;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3756802023014513,0.838652539489117,0.7894736842105263,0.9249683398496663,1.0,15/75,16.65%,KIF14;EPHA7;GRID2;PRKCG;AGAP2;MAG;FOXO3;CTNNB1;TGFB2;VSTM2L;CCL2;BCL2;SET;TOX3;PINK1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.3100591168711474,-0.8386307657506697,0.8571428571428571,1.0,1.0,38/197,20.49%,TTC29;TMEM17;CATIP;CNGA4;UBXN10;CEP19;FOXJ1;TEKT5;CFAP221;CFAP52;INTU;TMEM237;EXOC7;WDR11;RAB8A;TEKT1;IQCB1;AVIL;CEP131;DNAH5;TMEM250;DYNC2I1;ARF4;SCLT1;BBS9;FAM149B1;DYNLL1;MKS1;CEP83;UNC119B;DNAAF1;CEP20;CFAP70;CCDC66;EXOC1;FAM161B;FHDC1;FUZ
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.47321343830611495,0.8385902887967501,0.696969696969697,0.9247696627755054,1.0,3/19,14.81%,ARHGEF3;SYNPO2L;LPAR1
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3626170857216483,0.8385589207359742,0.7714285714285715,0.9244932117576743,1.0,8/83,9.29%,SPATA12;MARCHF11;CREB5;MAEL;DNAH3;MORN5;NR6A1;HOOK1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.43754070316199406,-0.8383541338983654,0.7209302325581395,1.0,1.0,5/14,18.71%,PRDX1;NOX1;CAT;GPX1;PRDX3
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4307922262581956,0.8382463327639267,0.7719298245614035,0.9247387647063837,1.0,7/27,18.83%,DUSP10;MAPK8IP1;HIPK3;PER1;PINK1;GPS2;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.33574551944486364,0.8380940909361645,0.7848101265822784,0.924692188924825,1.0,29/147,23.73%,KREMEN2;DRAXIN;PTPRO;DAB2IP;HIC1;NOTUM;DVL1;ALPK2;TLE6;TLE3;PRICKLE1;HECW1;ANKRD6;SOX13;WNT5A;STK3;TSC2;WWTR1;DKK3;STK11;FRMD8;AMFR;AXIN2;GRB10;TLE2;GLI1;PSMB3;MLLT3;CUL3
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5126598207706861,0.8378544275930371,0.7413793103448276,0.9247546066462808,1.0,3/11,10.74%,PROX1;TBX20;TGFB2
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.40500774614695684,-0.8375762809350276,0.7575757575757576,1.0,1.0,3/23,2.41%,DAO;GOLT1A;FGL1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.36333631993030363,0.8375497213229223,0.7792207792207793,0.9249492474983357,1.0,11/92,12.20%,PLEK;DAB2IP;RPA1;SKAP1;NRG1;SNCA;MYD88;FSCN1;SYK;TPPP;USP50
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.3693725941332907,0.8374750709501664,0.7027027027027027,0.9247626493272543,1.0,12/67,15.03%,ATF3;NSDHL;PLSCR1;NFIL3;LDLR;SEMA3B;CTNNB1;NIBAN1;ABCA2;PPARG;ETHE1;CPEB2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5374063315745763,0.8374649219651565,0.746031746031746,0.9244634401584559,1.0,6/12,21.17%,NEFL;SYBU;MAPT;RHOT1;RHOT2;HIF1A
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.43138941593209035,-0.837243644944033,0.7083333333333334,1.0,1.0,1/17,3.79%,NIFK
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.41425789060278456,0.836852732388577,0.7230769230769231,0.9250971214633591,1.0,6/35,15.91%,BLM;POLD1;CDK9;EME2;DONSON;TRAIP
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.390088436381766,0.8367411972554295,0.7857142857142857,0.9249378575152349,1.0,9/70,8.24%,EGF;CD24;RASGRP1;DUSP1;DAB2IP;FLT1;NEK10;DIRAS2;PDGFA
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.5048695236387001,-0.8366486514590152,0.6976744186046512,1.0,1.0,1/5,3.72%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.5048695236387001,-0.8366486514590152,0.6976744186046512,1.0,1.0,1/5,3.72%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5384075739452279,-0.8364599990640842,0.7021276595744681,1.0,1.0,1/6,4.18%,SRI
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.4210385777217455,-0.8359403034739037,0.6052631578947368,1.0,1.0,2/24,1.60%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.48154388526457415,-0.8353452940365932,0.6046511627906976,1.0,1.0,3/7,17.51%,USH2A;ERCC2;ERCC3
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.3606071614134858,-0.8352812475178605,0.7567567567567568,1.0,1.0,6/27,19.61%,COPB2;COPE;VTI1B;COG6;RAB33B;COPG2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.356432542028087,0.834934493578821,0.7317073170731707,0.9275903938700373,1.0,35/122,25.74%,CCNB2;ABCB1;HAUS7;YWHAG;PPP1CB;ACTR1A;CDKN1A;TPD52L1;AKAP8;CCNB1;LCMT1;OPTN;DCTN1;YWHAE;CDK2;SKP1;NEDD1;CDC25B;PLK3;CDK5RAP2;CKAP5;DNM2;FBXL8;PPME1;CEP76;CCNA2;TUBA4A;DCTN3;PRKAR2B;TUBB4A;CDKN2B;ARPP19;ODF2;CEP70;ENSA
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.5759748816120149,0.8345497988296495,0.8333333333333334,0.9279816677227674,1.0,2/6,24.74%,SMURF1;FCHO2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.5104263990298694,0.8344184640877322,0.7090909090909091,0.9279069660778281,1.0,2/10,8.31%,TJP3;RAP2B
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4610446889100744,-0.8341722346796008,0.6956521739130435,1.0,1.0,6/14,10.83%,SLC25A5;MUL1;CHCHD10;FZD9;BAK1;HSPA1A
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3574496270769938,0.8339866880473618,0.7108433734939759,0.9283444217288871,1.0,35/121,25.74%,CCNB2;ABCB1;HAUS7;YWHAG;PPP1CB;ACTR1A;CDKN1A;TPD52L1;CCNB1;LCMT1;OPTN;DCTN1;BACH1;YWHAE;CDK2;SKP1;NEDD1;CDC25B;PLK3;CDK5RAP2;CKAP5;DNM2;FBXL8;PPME1;CEP76;CCNA2;TUBA4A;DCTN3;PRKAR2B;TUBB4A;CDKN2B;ARPP19;ODF2;CEP70;ENSA
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.42960599909588715,0.8339823811556928,0.7678571428571429,0.9280408292541229,1.0,10/33,26.13%,MAP1LC3A;ATG9A;GABARAPL1;PINK1;CTSK;WDR45;ULK1;ATG7;PRKN;GABARAPL2
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.5276252999714873,0.8337305401663908,0.7049180327868853,0.928179416466999,1.0,1/6,2.29%,NR4A1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.49494130822819893,-0.8334431882521446,0.6818181818181818,1.0,1.0,1/9,12.11%,DUSP6
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.4515914235758597,-0.8333707853243785,0.65,1.0,1.0,2/13,17.19%,ATL2;ZFYVE27
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.32817798449816604,-0.8331847231301035,0.6956521739130435,1.0,1.0,13/112,15.50%,ID2;TM7SF2;PMVK;APOE;NR1D1;ADIPOR1;PSMD10;PSMD12;DHCR7;SC5D;PSMB5;NQO1;PSMD2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.38410487434948254,0.8329288278720113,0.7246376811594203,0.9291317952217691,1.0,10/42,17.11%,IGF1;APP;NLRP12;MYD88;STAT3;USP50;NLRP2;GSDMD;P2RX7;WNT5A
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.5157540371771846,0.8327998706533004,0.7586206896551724,0.9290452071443933,1.0,3/7,29.81%,KIF11;NSFL1C;RANBP1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5232236605335081,0.8327906868528625,0.76,0.9287611539113148,1.0,5/10,34.00%,TP53;NCOR1;NCOR2;TGFB1;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.5083042078552145,-0.8324572372266053,0.7021276595744681,1.0,1.0,2/9,8.35%,GREM1;EFNB2
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.5476592157585711,-0.8323990295415394,0.7021276595744681,1.0,1.0,1/5,0.59%,KCNE1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.47034531469395213,-0.8323404201725609,0.6585365853658537,1.0,1.0,2/8,9.94%,GALNT3;EOGT
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.45408551596970825,-0.8321603953672023,0.7073170731707317,1.0,1.0,2/12,9.78%,ABCD1;ELOVL2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.4841400433090541,0.8320575904275423,0.7068965517241379,0.9296697781982701,1.0,4/11,33.38%,TERF2IP;TAOK1;GSK3B;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4971642800925524,0.8319083268895137,0.7,0.9296024478032066,1.0,5/10,17.90%,BAIAP3;TRPM4;STX4;HLA-DRB1;C2CD2L
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.35081819912568046,0.8317998382936593,0.8,0.9294732577249447,1.0,27/99,25.85%,INCENP;PADI2;TBL1X;HDAC4;MORF4L2;HDAC9;PRKCD;CDK2;MTA1;RPS6KA4;PRMT1;TBL1XR1;MORF4L1;RCOR1;TAF10;TRERF1;ATXN7;CCNA2;CARM1;MTA3;UBE2B;UHRF1;MIDEAS;NSD1;RPS6KA5;HDAC5;SUPT3H
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5473063545034047,0.8312496145481807,0.7457627118644068,0.9300016762191735,1.0,2/7,10.10%,OGN;OMD
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.4112112869695088,0.8306605675691285,0.7540983606557377,0.9306689295697301,1.0,7/35,10.74%,TBX19;RYR2;TBX20;ALPK2;SYNPO2L;TCAP;TGFB2
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.40438283741816083,0.8306452521664481,0.6666666666666666,0.9303694429984367,1.0,6/34,3.25%,CTSS;PLEK;SLA;MYO1F;WAS;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.37136787185374853,0.8305669283554659,0.7123287671232876,0.9302092575014747,1.0,7/69,11.15%,PLEK;DAB2IP;NRG1;SYNPO2L;SMAD3;SYK;TPPP
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.5413611495733629,0.8302258160744284,0.7457627118644068,0.930485647255775,1.0,3/7,28.24%,MSRA;MTHFR;SMS
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.47443235221754326,0.830018368031419,0.7183098591549296,0.9305301761410839,1.0,3/18,7.40%,PDGFRA;RYR2;TBX20
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.466992964625101,-0.8298699312163317,0.675,1.0,1.0,1/11,7.16%,HEYL
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.38907564659865845,0.8296032101913802,0.7916666666666666,0.9309336482613472,1.0,14/49,24.10%,DCN;SMCR8;BAG3;PIP4K2A;OPTN;PINK1;IKBKG;TSC2;LRSAM1;WAC;ELAPOR1;TBK1;SUPT5H;SESN1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.4814707192933681,0.8290898580478525,0.7586206896551724,0.9314757582391577,1.0,1/11,8.00%,ZMYND10
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.5696547850419743,0.828922139619104,0.7758620689655172,0.9314697624504774,1.0,3/6,38.52%,ACVR1B;VEGFA;SMURF2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3361143131003002,0.8287456869805112,0.881578947368421,0.9314522026537044,1.0,30/184,17.11%,TLR2;PRKCB;IRAK2;RELN;APP;EPHA5;NOD1;TRIM5;PPARGC1B;NEUROD2;TRIM22;MYD88;BEX1;CTNNB1;IKBKE;SMAD3;PRKCH;HDAC4;STAT3;TERF2IP;PPARG;CD200;ALK;TRIM32;SLCO3A1;HIPK2;CAMK1D;TAB1;IKBKG;WNT5A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3415615731045145,0.8287021310161525,0.7922077922077922,0.9311956622268021,1.0,26/147,18.91%,NR4A3;TEAD2;NR4A1;PGR;CDK9;NR6A1;NR1I3;TAF4B;YAP1;TBL1X;TEAD1;HDAC9;NR4A2;PPARG;MAML2;NOTCH3;RARG;RARA;POLR1E;NR2F6;TAF1C;TAF15;RORA;WWTR1;NCOR1;RXRA
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.4871560560653216,-0.8283633276690899,0.6666666666666666,1.0,1.0,3/6,26.23%,DPH2;DPH3;DPH5
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.4871560560653216,-0.8283633276690899,0.6666666666666666,1.0,1.0,3/6,26.23%,DPH2;DPH3;DPH5
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.42088006466751965,-0.8277800572367008,0.6842105263157895,1.0,1.0,2/16,5.88%,RGCC;SERPINF2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.407517237509973,0.827680226691544,0.7166666666666667,0.9326964530347878,1.0,6/29,15.40%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.487662573621911,0.8275591220844754,0.7090909090909091,0.9325629337619007,1.0,4/13,18.63%,PRKAR1B;PKIA;PRKAR1A;ATP2B4
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.40198172698046614,0.8265630573559473,0.7272727272727273,0.9339159204864641,1.0,14/40,27.71%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;KLF4;TP53;WRAP53;ACD;PIF1;PARM1;PARN;MAPK3;MAP2K7
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3834276243016731,0.8264077324029935,0.7638888888888888,0.9338590706197392,1.0,4/45,12.56%,BLM;YAP1;GADD45A;CDKN1A
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5363381810391887,0.8261280643478123,0.7014925373134329,0.933772414265928,1.0,4/7,35.71%,PRKN;MAPK3;GABPA;MAPK1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5363381810391887,0.8261280643478123,0.7014925373134329,0.933772414265928,1.0,4/7,35.71%,PRKN;MAPK3;GABPA;MAPK1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.35964405790187587,-0.8259198458914346,0.7352941176470589,1.0,1.0,3/40,5.82%,GMFG;EPOR;MSRB1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.3907029526040495,0.8258177852110969,0.7538461538461538,0.9339887100332546,1.0,4/49,9.32%,PROX1;VAPB;PLSCR1;MX1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.5169146679998438,0.8257117246652045,0.75,0.9338396480970356,1.0,1/7,16.56%,PUM1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.37908211772548706,0.8253841514214881,0.7142857142857143,0.9341134213517027,1.0,7/60,13.85%,BOK;DEPP1;SMCR8;PIP4K2A;MAPT;TPCN2;FBXL2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5604105900323378,-0.8250755573653721,0.75,1.0,1.0,1/7,3.58%,PYHIN1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.46542328858958937,0.8248793547974239,0.7450980392156863,0.9347481350945435,1.0,2/13,5.26%,PLSCR1;MYLK3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.4543541856694331,0.8247343750703797,0.7424242424242424,0.9346719369074459,1.0,4/27,6.40%,WAS;CORO7;WASF1;FAM107A
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.4796724300253199,0.8245557586425432,0.7272727272727273,0.9346418599743208,1.0,2/12,5.99%,APP;TNFRSF14
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.4215798239020322,0.8241668297174346,0.676923076923077,0.9349418608466125,1.0,5/24,8.75%,IL13RA1;CD24;ICAM1;GPR87;LAMA5
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.5039192663014258,0.8236479112712523,0.6909090909090909,0.9354603457920228,1.0,2/8,21.36%,CTNNB1;AXIN2
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.4734817800261393,-0.8232410379980483,0.6363636363636364,1.0,1.0,1/12,1.13%,ID2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4333728762908729,0.8229300713718932,0.7407407407407407,0.9362891419482846,1.0,7/29,24.18%,TNFAIP8L1;MAPKAPK5;RNF152;TSC2;STK11;SESN1;SPAAR
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.42525115942297004,0.822690583851219,0.6984126984126984,0.936362080911308,1.0,5/30,12.39%,SLC4A10;SLC9A9;SLC9A1;SLC4A9;SLC9C2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.49225196839367114,-0.8226136421762472,0.6585365853658537,1.0,1.0,2/6,9.35%,CPTP;TTPA
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.5354135763330485,0.8221190791376084,0.7924528301886793,0.9370980327736709,1.0,4/5,33.24%,CAV3;EMP2;FLOT1;PACSIN2
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.5264625522798616,0.821818846560169,0.711864406779661,0.9372894261461483,1.0,2/5,17.20%,SMAD3;SLC8A1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4716499370792102,0.8216939380457123,0.7017543859649122,0.9368907378520401,1.0,1/16,3.68%,ADD2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4716499370792102,0.8216939380457123,0.7017543859649122,0.9368907378520401,1.0,1/16,3.68%,ADD2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.5127186550986788,-0.8216365009655395,0.6956521739130435,1.0,1.0,1/6,9.50%,VPS11
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.4339765302347297,0.8213271832663327,0.7627118644067796,0.9369173039446881,1.0,2/13,21.32%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.4339765302347297,0.8213271832663327,0.7627118644067796,0.9369173039446881,1.0,2/13,21.32%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.4114349000741615,-0.8209832177642312,0.5806451612903226,1.0,1.0,2/19,9.95%,MCRS1;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.525210184744246,-0.8209311601834267,0.6666666666666666,1.0,1.0,1/5,7.23%,PTPN22
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.4543011303984823,-0.820556174633132,0.8888888888888888,1.0,1.0,3/13,6.45%,ABCD2;ABCB11;ABCD1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.5688482668854606,0.8205449132388515,0.7678571428571429,0.937919342885167,1.0,3/5,41.51%,NUCKS1;VAPA;YTHDC2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.33436331479609843,0.8201629088964917,0.8947368421052632,0.9382630266639491,1.0,19/146,19.01%,RECQL4;BLM;RPA1;SAMHD1;BAP1;ATP23;EME2;PARP9;POLQ;BARD1;IFFO1;MRE11;MEIOB;HPF1;XRCC1;ZSWIM7;BRCA1;UBXN1;MTA1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3795159305956077,0.8199132737802854,0.7205882352941176,0.9383427302589393,1.0,5/55,8.01%,IGF1;SP100;THBS1;FAS;PML
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.41133789356341444,0.819912845427676,0.7605633802816901,0.9380326194518434,1.0,10/41,15.81%,CD24;TJP3;EFNA1;EPS8L2;CCKBR;CAPN8;ALPL;GPRC5C;SPP1;SLC44A3
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4465885019207834,0.8197008552708126,0.75,0.938024488886126,1.0,4/22,8.54%,SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.43856962506160746,0.8188767436677638,0.6716417910447762,0.9390053894050434,1.0,4/25,11.93%,PLEK;PDGFA;KIF17;P2RY12
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5106109270462215,0.8188522706835566,0.74,0.9387259069054579,1.0,3/6,37.13%,MAPK3;MAPK1;TRIM27
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.5700740159800963,0.8178643150397247,0.7796610169491526,0.9397926091604177,1.0,3/5,18.73%,CTNNB1;CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.5700740159800963,0.8178643150397247,0.7796610169491526,0.9397926091604177,1.0,3/5,18.73%,CTNNB1;CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.41821210874132797,0.8178382164880136,0.75,0.9395283978925989,1.0,2/24,3.95%,IRAK2;NOD1
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.5246437882671311,-0.8175873284338675,0.7111111111111111,1.0,1.0,3/5,25.82%,SLC25A23;LETM1;MICU1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.4870298975789297,0.8173126326873408,0.6911764705882353,0.9399734431676824,1.0,1/9,2.21%,NLGN1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.4167031869941126,-0.8168523741835634,0.6666666666666666,1.0,1.0,4/18,10.93%,SDSL;PIPOX;HYKK;GCDH
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.5225550281447358,0.8165653855868599,0.6785714285714286,0.9408869428421432,1.0,2/5,33.23%,MOV10;AGO1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.547555810329346,0.8162362177729977,0.7377049180327869,0.9410797968318485,1.0,3/5,44.80%,ASH1L;SETD2;SETD5
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.43401324087398085,0.8162348321335914,0.75,0.9404524103006272,1.0,2/12,21.32%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.43401324087398085,0.8162348321335914,0.75,0.9404524103006272,1.0,2/12,21.32%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.5125681752446756,0.8158678629170505,0.74,0.9406870812769756,1.0,1/5,11.97%,KYAT1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.41028478724839246,0.815832706733749,0.7627118644067796,0.9404231881326606,1.0,11/37,26.13%,MAP1LC3A;ATG9A;GABARAPL1;PINK1;SPATA18;CTSK;WDR45;ULK1;ATG7;PRKN;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.4661253999753153,-0.815599733127283,0.6744186046511628,1.0,1.0,1/9,1.95%,ADAMTS18
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4565697672682897,0.8153035477545134,0.7894736842105263,0.9409733924728854,1.0,5/19,11.93%,PSCA;LIPH;KPNA7;CAPN8;CLDN18
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.431331256330485,0.8151761413981633,0.7580645161290323,0.9408996850368146,1.0,4/24,20.03%,DUSP16;XPO6;SMURF1;XPO5
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.42327700966878934,0.814753693299098,0.76,0.9412365175084355,1.0,7/22,26.46%,PPP1R16B;PRKCD;PPP1R7;CALM3;PIN1;DLC1;SPPL3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.48407911730987224,0.8147401318898235,0.6964285714285714,0.9409499952787077,1.0,4/11,24.18%,RNF152;STK11;SESN1;SPAAR
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.42511117206868143,0.8145411190198945,0.746031746031746,0.9409637303634351,1.0,4/22,18.28%,PML;TERF2IP;MRE11;TINF2
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.4831134241266646,-0.8142045940163306,0.7027027027027027,1.0,1.0,3/7,23.86%,VPS4B;CHMP3;VCP
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.39440310027912084,-0.8141814188157576,0.7073170731707317,1.0,1.0,3/28,10.25%,GRPEL2;PEX10;TIMM23
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5327939457270418,0.8141636666347362,0.7704918032786885,0.941273626253378,1.0,5/9,32.54%,ZFYVE28;CBL;ERRFI1;TSG101;SNX6
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.39564719425077727,-0.8141526231538593,0.5789473684210527,1.0,1.0,2/24,1.60%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.4428458749795805,-0.8139392744949222,0.7291666666666666,1.0,1.0,1/11,1.18%,NIPAL1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.481353503581257,-0.8139259710723703,0.7,1.0,1.0,2/12,9.95%,DNMT3B;KMT2A
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.5274503574724799,-0.813526082833959,0.7307692307692307,1.0,1.0,1/5,15.11%,LYPLA2
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.49377671613861235,0.8135258597652208,0.7213114754098361,0.9420843602570959,1.0,1/9,3.17%,DMTN
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.4723740834505197,-0.8134774897401567,0.7368421052631579,1.0,1.0,2/13,9.49%,FBXO5;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.37968727515598316,0.8134110118958666,0.7301587301587301,0.9419535127409886,1.0,10/48,14.86%,BLM;CCNB2;CDK5R2;CCNI2;CDKN1C;GADD45A;CDKN1A;CDKN1B;CCNB1;CCND1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.39144904504357353,0.8133386414143106,0.7543859649122807,0.9418037858013625,1.0,8/27,24.72%,NELL1;PKDCC;P2RX7;SLC8A1;BMP6;ANO6;TGFB3;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.40355175793763814,0.813313563618075,0.7183098591549296,0.9415252300127981,1.0,17/40,30.51%,ZIC1;BAG3;SMAD3;GAS6;PRKCD;TP53;YWHAE;FLNA;UBR5;PSEN1;DHX9;HDAC3;NEDD4;TGFB1;DMAP1;GSK3B;TCF7L2
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.4766951121124475,-0.8132984680928218,0.7272727272727273,1.0,1.0,2/7,9.00%,PTPN22;MICA
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.44385731859299915,-0.812902647628931,0.7317073170731707,1.0,1.0,2/12,6.45%,SELENON;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3480616981475997,0.8128584774524541,0.8157894736842105,0.9418533790259231,1.0,14/143,12.12%,IGF1;SH3GL2;APP;APLNR;CCDC3;SMCR8;PGR;LDLR;WDR54;YAP1;TGFB2;PARP9;MAPT;ITGB8
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.5010625656815376,-0.8125747736507931,0.7435897435897436,1.0,1.0,2/5,22.91%,PRPS1;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.4738406020188477,-0.8124606405603197,0.6818181818181818,1.0,1.0,1/6,1.85%,AGER
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5026870153757702,0.8123297857418795,0.7457627118644068,0.9422836265639022,1.0,5/10,24.72%,SMAD3;SMAD2;ACVR1B;HJV;ACVR1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.36552942381119374,-0.8122204402037467,0.6818181818181818,1.0,1.0,9/26,25.37%,SUPT16H;LDB1;RNF168;RNF8;LARP7;WDR43;RECQL5;EAF1;LEO1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.33658024838064393,0.8119212803639914,0.8,0.9425582710713989,1.0,20/112,17.69%,B3GNT2;MGAT3;B3GALT2;TUSC3;ST8SIA3;MGAT5;ST8SIA1;TRAK1;B4GALT7;ST8SIA4;B3GALNT1;ST6GALNAC2;B4GALT5;FUT2;POMGNT1;PLOD2;POMGNT2;LARGE1;B3GALT5;B3GALT4
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.39178639173569235,0.8115193099891327,0.7313432835820896,0.9428971120922993,1.0,9/30,9.07%,EPHA2;BAIAP2L1;EPS8L2;GPR87;HR;RHOD;KPNA7;ITGA3;PSORS1C1
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.33003167328296484,0.8115146011446718,0.8701298701298701,0.9425845840471909,1.0,17/170,8.31%,CDKN2A;PLK2;S100A10;ATF3;STEAP3;EPHA2;APP;ADA;TGFA;TSPYL2;FAS;BAIAP2;EPS8L2;ZBTB16;FOXO3;PDGFA;RAP2B
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.4776711341329188,0.811419130814611,0.7796610169491526,0.9424274263459916,1.0,2/11,11.54%,HMBOX1;PARP9
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5084099261658908,-0.8111917353831677,0.7058823529411765,1.0,1.0,4/6,35.70%,NPM1;ABCE1;RAN;TSC1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.35098280417792393,-0.811087427191298,0.7407407407407407,1.0,1.0,9/54,10.95%,SLC25A5;SFXN2;SLC3A2;SLC6A13;SLC25A4;SLC25A19;SLC25A1;SLC25A38;SLC39A8
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3020957383949792,-0.8110608648402837,0.9047619047619048,1.0,1.0,9/163,6.45%,CDC26;ID2;TPX2;RIOK2;CEP72;SSNA1;RGCC;FBXO5;CETN2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.44768058573888514,0.8109671999805365,0.7307692307692307,0.9427735404299468,1.0,5/14,18.83%,PID1;HDAC4;MLXIPL;FBP1;NCOR1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.5313703790803995,0.8108258597357176,0.7708333333333334,0.9427147552728223,1.0,2/6,12.96%,SIGLEC1;TPCN2
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.5642405487903637,0.810578765837033,0.7346938775510204,0.9427958953393801,1.0,2/5,36.06%,AAMP;PLAT
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.5145943339053536,0.8099470455627469,0.7384615384615385,0.9434174444735555,1.0,1/6,9.03%,CAPN1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.4586967936724037,-0.809867164638006,0.8292682926829268,1.0,1.0,3/12,9.78%,ELOVL4;ABCD1;ELOVL2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.393829422464104,0.8096927029926371,0.7777777777777778,0.9435171894590393,1.0,15/45,23.41%,AMH;BMP8A;SCX;SMAD3;TGFB2;SMAD1;RGMB;SMAD9;SMURF1;RGMA;SMAD2;TGFBR3;BMP6;HJV;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.44853836255845103,-0.809607772869839,0.6976744186046512,1.0,1.0,1/11,1.95%,ADAMTS18
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.3552612268219162,-0.8094406173841047,0.7777777777777778,1.0,1.0,9/42,13.86%,ERCC8;GTF2H2;PRIMPOL;DCT;USF1;ERCC2;FECH;MEN1;ERCC6
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3158656711514449,-0.8093355400637636,0.8275862068965517,1.0,1.0,4/81,4.53%,FTL;VAMP8;FTH1;BLOC1S4
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4644036924303586,-0.8089203222250789,0.7380952380952381,1.0,1.0,3/9,17.41%,SPCS1;SPCS2;HM13
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.36875584655813526,0.8088721290922682,0.7777777777777778,0.9444515766947745,1.0,9/73,9.52%,HTR2C;SLC24A2;VAPB;SLC39A14;ATP2B3;GCM2;RYR2;NPTN;ATP1B1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.43629027173993573,-0.808766327727725,0.7352941176470589,1.0,1.0,2/16,9.95%,DNMT3B;KMT2A
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.4360531926739231,-0.8083221260032416,0.775,1.0,1.0,6/13,31.90%,DNASE2;KPNB1;CASP3;ENDOG;EXOG;HMGB1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.44623757710399564,0.8081444932246971,0.7142857142857143,0.9452645233798802,1.0,1/12,0.39%,CXCL2
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.4221491994327476,0.8079361550316976,0.7014925373134329,0.9452578740845816,1.0,9/20,23.08%,CFAP20;PDPN;TRIM32;ETS1;STK11;CAVIN1;ADAM17;ACTN4;CCDC25
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.5253416732716991,0.80781363569956,0.746031746031746,0.9451380326727012,1.0,1/7,3.24%,NELL1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.5506406096459079,-0.8076774290486355,0.7272727272727273,1.0,1.0,1/5,4.51%,APOE
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.3791338702957706,0.807139632637424,0.7571428571428571,0.9458782797788199,1.0,7/46,12.17%,CD24;ABCA5;FABP3;SOAT1;LDLR;ABCA2;HDAC9
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.2978473335748457,-0.8069694524020796,0.9411764705882353,1.0,1.0,20/258,8.54%,KPNA2;ERCC8;DCLRE1B;FANCF;RFC3;APEX2;ATRIP;HUS1;POLD3;GTF2H5;CETN2;GTF2H2;MGME1;SMARCAL1;BRIP1;WDHD1;ABRAXAS1;PMS1;PRIMPOL;GTF2H2C
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.3978077625362704,-0.8068639580708092,0.6744186046511628,1.0,1.0,6/21,13.41%,RHOH;CR1;METTL3;CLPTM1;PRELID1;RUNX1
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.3610285333426773,0.806710885416943,0.8421052631578947,0.9463050678866823,1.0,22/67,16.37%,A4GALT;TYMP;EPHA2;ITGA2;EPS8L2;RHOD;EMP1;MYO1C;ITGA3;CAPN1;CTNNB1;FBXO32;SRPX2;ANXA11;LMNA;DUOXA1;BACE2;OPTN;BCL2;HEBP2;CD59;LAMA3
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.5008049455845126,-0.806689758260687,0.6842105263157895,1.0,1.0,1/6,2.25%,VAMP8
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.29519180608384066,-0.8065623683043276,0.9047619047619048,1.0,1.0,41/223,22.82%,AR;OTUD3;TNFAIP3;CFTR;MCRS1;ENY2;IL33;KDM1B;ABRAXAS1;RAD23A;USP27X;PSMD10;PSMD12;BECN1;USP51;FOXO4;PSMB5;USP19;TADA2B;CLSPN;PSMD2;USP9Y;RUVBL1;TNIP1;PSME3;PSMB4;BRCC3;PSMB6;ATXN3;UBB;SKP2;ATXN7L3;TADA3;NFRKB;USP10;SPATA2;DESI2;YOD1;USP40;PSMA1;MYSM1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.5087929325336844,-0.8065142749257632,0.7777777777777778,1.0,1.0,2/7,12.74%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4373849454322498,-0.8059909965483188,0.717948717948718,1.0,1.0,3/18,8.40%,SELENOK;BCAP31;BAK1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4606226674284322,0.8059505598353187,0.7719298245614035,0.9471273698057587,1.0,3/14,10.77%,SAMHD1;NLRC5;TTLL12
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.39682589029993626,0.8054623545652697,0.7571428571428571,0.9476137559932479,1.0,10/32,17.11%,APP;NLRP12;MYD88;TMED10;STAT3;USP50;NLRP2;GSDMD;P2RX7;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.43752251628393196,-0.8050624321975148,0.6511627906976745,1.0,1.0,2/11,13.90%,FSTL3;LRRC17
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3374971913556819,0.804959352295468,0.8055555555555556,0.9480583844041149,1.0,14/108,14.76%,NLGN1;ZDHHC9;ZDHHC22;CACNG3;PARD3;MYO1C;MICALL1;TRAK1;ZDHHC7;ZDHHC1;NACAD;KIF13B;HAP1;MAN1A1
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),0.5555716855249454,0.8049403099425703,0.7358490566037735,0.9477947581191294,1.0,1/5,18.45%,STK24
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.49556183330633935,-0.8047868943625154,0.8333333333333334,1.0,1.0,2/8,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.5184400133864967,-0.8047585316065292,0.7608695652173914,1.0,1.0,3/6,13.10%,ABCB10;SLC25A37;LDB1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.47015624297738456,-0.8044375263275656,0.725,1.0,1.0,3/13,10.77%,RPL23;SMARCD1;SUPT16H
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.43253223865240403,0.8043765849347738,0.7424242424242424,0.9483331465620625,1.0,3/14,13.83%,HDAC4;HDAC9;PER1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4654788502925552,-0.8043630601178782,0.7111111111111111,1.0,1.0,5/9,28.25%,DERL2;YOD1;SVIP;OS9;ERLEC1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.4058903605340278,0.804268509536328,0.7966101694915254,0.948193791416927,1.0,2/24,11.98%,FOXO1;MAPT
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.4752727879624411,0.8038182379184563,0.7619047619047619,0.9486301189039579,1.0,2/10,12.70%,MICALL1;ARF6
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.36430727178616984,0.8035837727981711,0.8448275862068966,0.9486750365947036,1.0,2/63,1.29%,CTSC;CTSS
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.36038509963445764,-0.8027390840167435,0.7045454545454546,1.0,1.0,3/25,6.45%,ABCD2;CD6;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3411017003892752,0.8026851845825452,0.8392857142857143,0.9498177147517631,1.0,15/85,14.42%,ST18;BOK;NOD1;FAS;NLRP12;SNCA;CASP10;SMAD3;SYK;MAPT;BBC3;PPARG;TNFRSF10B;NLRP2;FADD
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.33407819711437586,0.802519177347867,0.8636363636363636,0.9497757707867778,1.0,12/135,11.98%,ANLN;PSMG3;NRG1;CLTB;TESPA1;TCP1;SNCA;SPAG1;SMAD3;SMAD1;PXN;MAPT
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.41019827524836044,0.8024286675618669,0.8103448275862069,0.9495985994814468,1.0,11/29,32.13%,TLE6;PHLDB2;B4GALT5;RPS6KA6;TDG;CRB2;NIBAN2;NLRP5;BAG6;CLASP1;SEPTIN7
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.31949686182987563,-0.8023356461871171,0.7931034482758621,1.0,1.0,14/83,19.94%,FBXO48;DMAC2;FBXO27;PSMD10;PSMD12;FBXL22;PSMB5;FBXO9;PSMD2;CUL1;PSME3;PSMB4;PSMB6;SKP2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.360009199656868,0.802103783025444,0.8771929824561403,0.9497520591505859,1.0,19/95,18.69%,BLM;CCNB2;DAB2IP;THY1;INCENP;CDK5R2;CCNI2;SNCA;GADD45A;CDKN1A;CDKN1B;CCNB1;CCND1;SLC8A3;SLC8A2;SLC8A1;CALM3;SYAP1;TELO2
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5266738158707585,0.8020767517091891,0.7213114754098361,0.9494811468386837,1.0,1/5,4.63%,GLYATL2
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.4850215511145838,0.8019455403278054,0.7857142857142857,0.9493830679496205,1.0,3/10,21.36%,ATP23;STOML2;PMPCB
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.37825811012235866,-0.8018917568593444,0.7441860465116279,1.0,1.0,1/27,1.56%,TMEM17
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.3656719711600616,0.8017662078753042,0.7142857142857143,0.9493863614027759,1.0,13/47,27.71%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8;TINF2;EXOSC10;ACD;PIF1;PARN;MAPK3;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4263724017446521,0.8011130034341163,0.7014925373134329,0.9501323333213787,1.0,2/19,9.12%,PROX1;CTNNB1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.506800685541247,0.8010812220618225,0.8275862068965517,0.9498766506504728,1.0,3/9,28.53%,PNMT;PRKN;PAH
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.37984196194878384,0.8007737525290262,0.6901408450704225,0.9500672013827265,1.0,10/44,14.63%,BOK;DAB2IP;SEPTIN4;FAS;PML;BCL2L1;BBC3;TPD52L1;FADD;BCL2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.5266845643248578,-0.8007536346867379,0.7073170731707317,1.0,1.0,2/6,20.37%,NLGN3;CHRNA4
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.48678846052555924,0.8007130566714891,0.7796610169491526,0.9498716633781171,1.0,3/11,13.95%,FOLH1;AGTPBP1;LCMT1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.4740559656545206,-0.8006096813737719,0.6578947368421053,1.0,1.0,2/7,8.72%,GBP7;BATF2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5421374850185838,0.8001564283082037,0.746031746031746,0.9504217059304286,1.0,2/5,4.89%,WAS;TRPM4
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5690473284697232,0.7994047123266764,0.8113207547169812,0.9512185421722356,1.0,3/5,29.59%,CAMSAP3;TJP1;PLEKHA7
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.4798396048844327,0.7989969635065655,0.7017543859649122,0.9516442460215215,1.0,3/10,10.59%,STAC2;PVALEF;TCAP
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.3513602033848576,-0.7987632991903774,0.8378378378378378,1.0,1.0,5/28,8.98%,APOE;RGCC;SERPINF2;CREB3L1;VIM
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3738106124972515,0.7985602097356301,0.7777777777777778,0.9519985670278067,1.0,7/42,17.79%,NELL1;TRPM4;NOTUM;PKDCC;P2RX7;SLC8A1;SRGN
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.39356871878812966,0.7985555224314277,0.8507462686567164,0.95168674306219,1.0,4/31,15.57%,GLRA2;GRIN1;NEURL1;GLRA3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.4989655245531677,-0.7985504969652216,0.7111111111111111,1.0,1.0,3/7,27.88%,MSH3;MSH2;PRKDC
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.5199712725175,0.7985187284606645,0.7254901960784313,0.951420001605455,1.0,2/5,23.61%,AKIRIN1;SIX4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.43182933443411603,-0.7983056977349954,0.6842105263157895,1.0,1.0,3/14,13.44%,TPT1;SFRP2;CLU
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.5208038103108964,-0.7982609824747383,0.7045454545454546,1.0,1.0,2/6,4.51%,SELENOS;APOE
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.39279053510733647,-0.7980989863148328,0.7352941176470589,1.0,1.0,5/19,10.53%,TRIM29;SCEL;IL20RA;EHF;MGP
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.37499307960166883,-0.7980354750877432,0.7111111111111111,1.0,1.0,3/25,6.88%,TM7SF2;PMVK;ARV1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.530514682156764,0.7978249515099677,0.7407407407407407,0.9522787637053817,1.0,2/5,35.60%,HIF1A;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.39560994267683275,-0.7977861780585783,0.7692307692307693,1.0,1.0,10/23,26.69%,PPP1R35;PPP1R11;ZCCHC9;BOD1L1;PPP1R26;PTPA;GPATCH2;MASTL;SH3RF2;STYXL1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.39888006748198007,0.7976603081260164,0.7777777777777778,0.9522026110518512,1.0,3/38,6.09%,ZFP36;ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.39343251402094104,0.7973909094797875,0.7258064516129032,0.952257274813119,1.0,4/41,6.88%,ADCY5;EPHA5;TRIM46;DVL1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.4853459623537357,0.7973337129688438,0.7090909090909091,0.9520093705288245,1.0,3/7,20.43%,PAK1;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.40513107840526097,-0.7973106135048021,0.7631578947368421,1.0,1.0,6/20,22.20%,SF3B4;NCL;PRDX6;RBMX;CIRBP;SNW1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3760198597348339,-0.7973095854508161,0.75,1.0,1.0,10/23,30.76%,AUP1;YME1L1;RNF5;POMT2;ATXN3;VCP;DERL1;CLPP;UGGT1;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.4332375257841644,-0.797253134591981,0.8205128205128205,1.0,1.0,2/13,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.3771539423051925,-0.7971203990620852,0.71875,1.0,1.0,2/36,2.08%,CSTB;CST3
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.44198847985716117,0.7970618413911886,0.7368421052631579,0.9521163341602762,1.0,4/10,19.18%,TCP1;CCT4;CCT8;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.47093514015801086,-0.7970424463777789,0.7619047619047619,1.0,1.0,1/7,1.85%,AGER
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.41212413364780726,0.7969534193621425,0.7692307692307693,0.9519955438289567,1.0,8/23,22.67%,FOXO3;STAT3;MAPK11;ETS1;PRMT1;ARNT;HIF1A;ACVR1B
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.48511023752027643,0.796869922850367,0.7413793103448276,0.9518076689106958,1.0,3/10,20.21%,SMAD3;SMAD1;SMAD2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.5320686947356805,0.7967270232555107,0.7868852459016393,0.9517355494180292,1.0,4/5,45.31%,PSIP1;PRPF39;SFSWAP;SNRPC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.5290963265992047,0.7966152549295589,0.7627118644067796,0.9515888996223903,1.0,2/6,19.43%,FGF13;CAV3
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.5344008800965765,-0.7962871527185686,0.7045454545454546,1.0,1.0,1/5,9.07%,GPLD1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.5115214792437598,0.7962071099860809,0.7358490566037735,0.9518784809161701,1.0,3/7,19.68%,TRPM4;GPR183;TRPM2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.47531459604924636,0.7961555937429803,0.6507936507936508,0.9516200870854936,1.0,1/10,3.25%,PTPRC
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.41215383379498083,0.7960628309961996,0.7611940298507462,0.9514475418941513,1.0,4/32,8.07%,ABCA8;ABCA5;SOAT1;LDLR
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.3889707447723548,-0.7960275662444015,0.8064516129032258,1.0,1.0,3/17,10.71%,SMPD3;SNF8;VPS4B
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.3713357853229675,-0.7957980834253109,0.7894736842105263,1.0,1.0,5/28,15.62%,ATP6V1G1;ATP6V1E2;ATP6V0D2;ATP6V1F;GPR89A
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.5400705877938294,0.7956169101106024,0.7575757575757576,0.9517219899966851,1.0,1/6,9.69%,ASS1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.43709097062557656,-0.7955647493433153,0.7,1.0,1.0,5/14,9.00%,TNFAIP3;FGL1;FOXJ1;PTPN22;MICA
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5078590624724748,0.7954661579058495,0.7833333333333333,0.951623979924137,1.0,4/7,34.62%,SLC27A1;ACSL1;CD36;RPS6KB1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.5260649067279394,0.7954283176538254,0.8,0.9513771705378603,1.0,2/7,35.57%,RABEP1;RAB29
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.3893529631026701,-0.7949423157765123,0.6976744186046512,1.0,1.0,1/21,1.85%,AGER
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.557293908163288,0.7949385965539839,0.7843137254901961,0.9517443825567737,1.0,1/5,11.97%,FGF13
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.38664908697650824,0.7949127207620167,0.7878787878787878,0.9514456265167189,1.0,10/45,11.41%,SHTN1;CNTNAP1;CNTNAP2;DAB2IP;WASF1;NYAP2;NYAP1;PACSIN1;MINK1;TRIO
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.47549482522521913,0.7947834676556734,0.7321428571428571,0.9513032186803612,1.0,1/7,11.97%,KYAT1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.33073222300569016,-0.7947168636604143,0.8421052631578947,1.0,1.0,11/57,17.30%,KPNA2;POLR2K;POLR2C;PPIH;RAD23A;CNOT7;TMEM250;GTF2F1;CCNT1;GTF2F2;POLR2D
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.4512918487775099,0.7946494611699232,0.7540983606557377,0.9511794872042116,1.0,4/14,10.74%,SLIT2;TNFRSF1A;ROBO2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.43693609217321766,0.7946008600019875,0.711864406779661,0.9509257928094613,1.0,1/13,2.58%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5106019220982964,0.794583892977689,0.7543859649122807,0.9506276916031977,1.0,1/6,4.29%,FOXO1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.3967965152168192,0.794541266955223,0.671875,0.9503854808781285,1.0,1/25,1.06%,KIF14
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.3564931490061933,-0.7942564108937762,0.75,1.0,1.0,4/34,7.34%,TRIM29;CFTR;IL33;IL20RA
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.38178372365282465,0.7940221170697948,0.7846153846153846,0.950870960721777,1.0,9/41,19.41%,PID1;CYP1B1;CNDP1;MKLN1;ABCA2;PDK4;PINK1;PDK3;ABCG1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.5106375748698475,0.7939955915992677,0.8070175438596491,0.950628828343794,1.0,5/6,30.17%,CHDH;SLC44A1;SARDH;BHMT;DMGDH
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3941559816621668,0.79387294174818,0.8548387096774194,0.9505092665029299,1.0,9/41,19.86%,ABCC4;SLC16A14;SLCO1A2;SLC51A;SLC27A5;SLCO3A1;SLCO2A1;RXRA;ABCC3
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.4670233193762824,0.7936060776501281,0.7843137254901961,0.9505863215775536,1.0,1/9,1.03%,IGF1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4394688171060812,0.7935783981528003,0.7222222222222222,0.9503148606742484,1.0,4/12,19.18%,TCP1;CCT4;CCT8;WRAP53
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.42265707103026384,-0.793279495775101,0.7142857142857143,1.0,1.0,6/16,24.31%,POLR2K;DHX33;EIF2AK3;POLR2L;WDR43;UBTF
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.454909951155907,0.7931542139081652,0.7096774193548387,0.9506809876073854,1.0,4/13,10.74%,SLIT2;TBX20;ROBO2;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.392834789442975,-0.7926852196065319,0.7368421052631579,1.0,1.0,10/25,23.96%,POLR2K;POLR2C;GTF2F1;CCNT1;GTF2F2;POLR2D;POLR2L;POLR2G;POLR2E;CTDP1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.47099258408600464,0.7926539241809393,0.796875,0.9510802191453807,1.0,5/12,26.99%,IFT122;IFT140;CILK1;IFT43;DYNC2I2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.41324193675762616,0.7923783027432003,0.7183098591549296,0.9512458726296823,1.0,7/21,26.72%,CLRN1;FSCN1;AKIRIN1;PLCE1;ARPC2;CYFIP1;ACTR3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.37496041804918495,-0.7920418193778352,0.7837837837837838,1.0,1.0,8/26,20.79%,GTF2H5;CETN2;GTF2H2;ERCC2;XPA;ERCC3;UBB;PARP1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5261802733547221,0.7912022924992579,0.7222222222222222,0.952773857051304,1.0,2/6,16.09%,MCAM;ADIPOR2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.37439767085266695,-0.7909233167924296,0.8055555555555556,1.0,1.0,4/21,13.98%,ATP6V1G1;ATP6V1E2;ATP6V0D2;ATP6V1F
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.42379810002426854,-0.7905998256944331,0.6923076923076923,1.0,1.0,2/13,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.42729764262261016,0.7904701874403913,0.7413793103448276,0.9534644074927503,1.0,4/11,19.18%,TCP1;CCT4;CCT8;WRAP53
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.3741232929156575,0.7904303199169096,0.8235294117647058,0.9532221409212561,1.0,10/57,13.66%,TEKT2;C1ORF87;CFAP126;DNAH3;TMEM212;ZMYND10;MORN5;RSPH4A;DNAJB13;ECT2L
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.4478668140507181,0.7903739426473824,0.7777777777777778,0.9529985246646553,1.0,1/13,1.34%,PROX1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.37026264323404817,-0.7902829360759647,0.8387096774193549,1.0,1.0,4/23,13.51%,ACSM6;THEM4;ACOT2;ACOT6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.37026264323404817,-0.7902829360759647,0.8387096774193549,1.0,1.0,4/23,13.51%,ACSM6;THEM4;ACOT2;ACOT6
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.41915671459247944,0.7894532896767423,0.8360655737704918,0.9539360631433228,1.0,1/19,4.09%,PTPRR
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.40935401558154266,-0.7891365825902397,0.7906976744186046,1.0,1.0,2/17,5.63%,MSTO1;MUL1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.43508326732856506,-0.7889969924406646,0.7727272727272727,1.0,1.0,2/11,16.03%,GOPC;NFKBIE
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3695530065685606,0.7888843547512083,0.847457627118644,0.9544737957693369,1.0,6/52,10.05%,TLCD2;SLC4A10;IRS2;VGF;SLC4A9;SLC4A11
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.4157653580751144,0.7888055997868796,0.7903225806451613,0.9542684670679508,1.0,4/14,20.52%,CTNNB1;HDAC4;ZMIZ1;PIAS1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.465109248174832,0.7883024905221961,0.6491228070175439,0.9547872748852895,1.0,5/12,11.99%,ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.4912613587508826,0.7882730147505134,0.7636363636363637,0.9545265870699509,1.0,4/11,22.50%,KIF5A;KIF5C;DNM2;SYNJ1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4325477531887474,0.7877480140072042,0.796875,0.9551335723057611,1.0,1/19,0.92%,BOK
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.5019371965864882,-0.787609941829572,0.7291666666666666,1.0,1.0,1/5,1.91%,CD200R1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.4263911496729558,0.7875523030224711,0.7833333333333333,0.9551570953862605,1.0,3/17,11.84%,MYH11;LAMB1;GAS6
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.45337041167955583,-0.7875195584310696,0.7111111111111111,1.0,1.0,2/6,21.48%,FOXO4;MYOCD
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4568545138528895,0.787517777356456,0.7941176470588235,0.954896540724328,1.0,4/11,33.05%,BARD1;AHCYL1;PAPOLA;PAF1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.3820175561443201,0.7872553378118202,0.8,0.9549606924104989,1.0,8/32,6.82%,PLEK;SLA;MYO1F;WAS;PTPRC;CD37;BCL6;CD99
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.45030602352899823,0.7869672699598511,0.7538461538461538,0.9551280314680102,1.0,2/14,6.28%,PRKAR1B;RAMP3
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.5005817036733267,0.7868283080297359,0.7884615384615384,0.9550262171821443,1.0,2/7,11.07%,PMEPA1;LDLRAD4
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.35485232360246083,0.7868201058420301,0.8103448275862069,0.9547218285726822,1.0,7/54,14.18%,IGF2BP2;SRRM4;MBNL2;FAM50A;CLK1;GRSF1;HNRNPH1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.3223514966215018,0.7861704046648906,0.881578947368421,0.9554047273675653,1.0,10/90,11.26%,YWHAH;ACSL5;ABCB1;SEMA3C;ABCC8;DIO1;MVP;HSD3B7;DHCR24;PEX14
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.39082245024084,0.7861655550867447,0.819672131147541,0.9551004129898998,1.0,5/29,10.32%,DMTN;KCNQ1;AHR;VGF;HCN1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.4709328329509665,0.7860377394668595,0.7368421052631579,0.9549766540403295,1.0,6/11,33.38%,TGFB2;WNT5A;TGFB3;TGFB1;PLCG2;SIRT1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.4537978674677475,-0.7858587370971175,0.7317073170731707,1.0,1.0,2/8,7.94%,XG;S1PR1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.48505453278063376,0.7855240235997413,0.7857142857142857,0.955493228004324,1.0,3/11,24.98%,PARP9;PARP8;PARP16
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5029683488177888,0.7854944058620437,0.7868852459016393,0.9552406771797628,1.0,1/8,1.40%,PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3611786278946299,-0.7854448808126954,0.7307692307692307,1.0,1.0,1/30,0.38%,RAB7B
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.48926294913730367,0.7851598929477149,0.7627118644067796,0.9553486591404227,1.0,3/7,28.53%,KYAT1;THAP4;PAH
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.38915721213594756,0.7850168618653532,0.819672131147541,0.9552654163144415,1.0,7/39,26.58%,SUN3;CHMP1A;BIN1;IRAG2;ATXN7;SUN1;NUP35
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.4754030055852865,0.7848358948268308,0.8035714285714286,0.9552300004986584,1.0,3/12,16.84%,PXK;PAM16;TP53
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.47913730214505895,0.7845208503843044,0.7586206896551724,0.9554554400411717,1.0,3/11,10.59%,PROX1;TBX20;TCAP
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.5366997050804834,-0.7840854031481033,0.7560975609756098,1.0,1.0,1/5,4.42%,ORMDL1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.4571395864229211,-0.7840527341550624,0.6949152542372882,1.0,1.0,2/8,6.45%,APOE;ABCD1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.38475253458383507,0.7838236286025788,0.7910447761194029,0.9562205946045161,1.0,8/49,11.14%,AMH;BMP8A;SCX;VSTM2A;SMAD3;TGFB2;SMAD1;RGMB
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.44005513632042725,0.7828376742610893,0.75,0.9572459221566697,1.0,4/20,7.76%,EGF;THBS1;APP;SNCA
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4118466914184413,0.7826550763518296,0.8088235294117647,0.9572319363937523,1.0,2/22,3.95%,IRAK2;NOD1
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.39275945189785766,0.782003639311962,0.734375,0.9578416858399363,1.0,9/29,20.59%,DTX2;CCND1;MAML2;NOTCH3;FZD7;WNT5A;SKP1;PRKCA;LFNG
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.49890785894128187,-0.7816038205457109,0.7045454545454546,1.0,1.0,2/5,16.58%,BECN1;ATG14
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.4848774252837527,0.7812438188984326,0.7272727272727273,0.9585170640601728,1.0,2/7,11.03%,ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.321894011274668,0.7807051048001339,0.8783783783783784,0.9590306772782207,1.0,20/107,20.66%,SLC39A14;IRS2;FOXO1;RAB15;BAIAP2;NAMPT;ZDHHC7;SORBS1;HDAC9;PPARG;PDK4;CPEB2;BCAR1;GAB1;SH2B2;RHOQ;SYAP1;SHC1;IGF1R;ATP6V1B2
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3257330629919623,-0.7806889960279658,0.8148148148148148,1.0,1.0,12/55,24.02%,PSMD10;PSMD12;PSMB5;PSMD2;CUL1;PSME3;PSMB4;NABP2;PSMB6;INTS3;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.5289163919081148,0.7806510108758646,0.7704918032786885,0.9588072063100753,1.0,3/6,18.82%,CBLN2;DCTN1;ERC2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.45824682744130335,-0.7804983299496253,0.7567567567567568,1.0,1.0,2/8,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.39297504282958146,0.7802752489461666,0.7536231884057971,0.9590565694883904,1.0,4/36,9.32%,PROX1;PLSCR1;APOBEC3H;MX1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3750653976909944,0.7802694130561675,0.7936507936507936,0.958752645485299,1.0,3/32,7.55%,SOCS3;ITPKC;ITPKB
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.45043464363610547,0.7802540570766106,0.7735849056603774,0.9584708878865369,1.0,5/14,28.04%,NRG1;MESP1;SORT1;KDM6B;MYEF2
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.35052402423908574,-0.7802345782370363,0.8235294117647058,1.0,1.0,5/51,5.44%,RFC3;CCT7;RGCC;GREM1;DSCC1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.5023599556227029,0.7800861943877406,0.8035714285714286,0.9583723482069,1.0,3/7,11.98%,GRID2;SHANK3;MAPT
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.4585018731273102,0.7793936641651567,0.7307692307692307,0.9591851053916896,1.0,3/7,18.63%,ATP2B3;SLC8A2;ATP2B4
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.43985767725791525,0.7790281095055603,0.8135593220338984,0.9595217497850635,1.0,2/23,4.04%,APP;TRAM1L1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.4302937552952407,-0.7787246627831026,0.7804878048780488,1.0,1.0,3/10,6.53%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.4354255445164803,0.7786473256553101,0.8070175438596491,0.9598106346040445,1.0,4/21,14.38%,HMBOX1;PDGFA;CDKN1A;FGF2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4413843262727832,0.7784258248143718,0.8363636363636363,0.9598872830642203,1.0,7/23,21.35%,SLC7A2;SLC25A29;SLC7A1;SLC1A6;SLC7A8;SLC38A1;SLC6A9
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.5145962635667742,0.7783352818447471,0.7761194029850746,0.9597080402455537,1.0,1/5,8.04%,ALDOB
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.43924846591004924,0.7782699299015498,0.765625,0.9594814137492143,1.0,7/13,28.76%,NEIL2;OGG1;DUT;TDG;NEIL1;NTHL1;UNG
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.4811568683447096,-0.7781734255339114,0.7674418604651163,1.0,1.0,3/6,11.69%,TWSG1;HFE;TARM1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.43623049122677515,0.7778869534726711,0.7611940298507462,0.9597041960083836,1.0,1/11,2.21%,NLGN1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.508187276090905,0.7774844004933826,0.7794117647058824,0.9599998634953251,1.0,1/7,2.85%,CD55
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.47185208757170927,0.7772902155620615,0.7678571428571429,0.9599595220665988,1.0,3/9,27.56%,IL12A;CSF1;MAPK3
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.44113938214700127,0.7772734353072637,0.85,0.9593791562750024,1.0,7/11,29.11%,RAP2B;MINK1;RAP1A;RAP1B;MAP4K4;RAPGEF2;RAP2A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.44113938214700127,0.7772734353072637,0.85,0.9593791562750024,1.0,7/11,29.11%,RAP2B;MINK1;RAP1A;RAP1B;MAP4K4;RAPGEF2;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.5154656458427472,0.7771813467312633,0.7704918032786885,0.9591822426987601,1.0,3/6,43.87%,LIN28B;NFKB1;HRAS
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.4908418916003779,-0.7768295364113864,0.7916666666666666,1.0,1.0,2/6,16.82%,GREM1;BMP2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.4529646431827779,0.776587559342805,0.7575757575757576,0.9597109205266655,1.0,5/11,25.53%,GAS6;IFIH1;WNT5A;TRIM44;DHX9
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.319393592436185,-0.7763199368495923,0.8666666666666667,1.0,1.0,9/61,19.16%,VAMP8;PSMD10;PSMD12;PSMB5;PSMD2;TAP1;PSME3;PSMB4;PSMB6
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.47767205894141684,-0.7762897075638157,0.7441860465116279,1.0,1.0,5/7,31.55%,ME2;FH;MDH1B;MDH1;MDH2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.394906840719928,0.7762516785558464,0.8333333333333334,0.9598128669844234,1.0,3/33,6.03%,PROX1;PLEK;FYN
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3535954193476305,0.7761840571729629,0.8142857142857143,0.9595832144223354,1.0,9/46,17.59%,UGT8;ESYT3;B4GALNT1;B3GALNT1;ABCA2;ST6GALNAC3;FUT2;NEU4;STS
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.4877288308618476,0.7758490165180553,0.7307692307692307,0.9597033469299773,1.0,1/8,3.95%,NOD1
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.4434737633183975,-0.7757229020603909,0.8108108108108109,1.0,1.0,5/12,20.91%,HSD17B8;CYP2C8;UGT2B7;CYP2D6;HSD17B11
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.5093950531417861,0.7755639948957953,0.7833333333333333,0.9598561710173543,1.0,4/6,26.38%,GRK2;GRK5;TAC4;TAC1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.48127831821013906,0.7751423817380751,0.7142857142857143,0.9601872453330456,1.0,4/7,25.09%,PRKAR1A;SCRIB;PDCD1LG2;PRNP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.38334751150354335,-0.7748846552226785,0.85,1.0,1.0,2/23,4.37%,RFC3;POLD3
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.45991253374707974,0.7747415132462602,0.7692307692307693,0.9604562527095609,1.0,3/12,19.86%,IHO1;PUM1;RAD18
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3565904781631097,-0.7742303974209944,0.85,1.0,1.0,4/60,7.08%,NGF;PDCD2;MUL1;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.43833843120379723,0.7742238444117017,0.6481481481481481,0.9609687965036434,1.0,3/12,14.31%,TRIM5;PML;TRIM32
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.34957899752359256,-0.7741933570052473,0.7297297297297297,1.0,1.0,3/32,4.05%,AR;AKR1C3;CFTR
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3229991628021529,0.7740952036335287,0.92,0.9608992105481233,1.0,22/152,17.65%,IGF1;TESC;EFNA1;SOX4;DVL1;TCP1;BAG3;ATP1B1;TBL1X;CCT4;ATP1B3;EPHA4;CDKN1A;PRKCD;SYVN1;TNIP2;NCLN;CCT8;PFN2;PINK1;ZSWIM7;STK3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.39534524575535684,0.7740377852068788,0.821917808219178,0.9606806292170728,1.0,5/23,16.79%,IRAK2;NOD1;IFIH1;TAB1;IKBKG
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.3520389579729424,0.7737705292791067,0.8333333333333334,0.9607092960745126,1.0,9/59,11.86%,IGF1;PDGFRA;IRS2;PLCH2;NYAP2;NYAP1;GAB2;CD160;PITPNM2
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.5031611336601346,-0.7735620745321549,0.7804878048780488,1.0,1.0,3/5,23.97%,TPRKB;OSGEP;TP53RK
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.360267251844867,0.7733830106120885,0.7887323943661971,0.960915951968501,1.0,7/47,12.17%,CD24;ABCA5;FABP3;SOAT1;LDLR;ABCA2;HDAC9
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.42263601052439204,0.7732801056705289,0.7692307692307693,0.9607193636961688,1.0,2/21,5.14%,HIC1;CD44
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.40628011239484213,0.7732479910182629,0.7910447761194029,0.9604757040044156,1.0,7/23,22.42%,SYVN1;MAN1A1;MARCHF6;RPS27A;AMFR;MAN1C1;RNF185
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33782410563394893,0.7730892591642399,0.8472222222222222,0.9603810020378648,1.0,20/103,23.90%,PLK2;WDR62;INCENP;CENPP;ERCC6L;CENPH;CCNB1;RANGAP1;NEK6;STMN1;SKA2;MAP4;DYNC1LI2;CKAP5;DYNC1LI1;CENPU;RCC1;DCTN6;NUP160;KIF11
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.4690877877090142,-0.7730274629548197,0.6818181818181818,1.0,1.0,3/10,15.11%,APOE;ABHD17A;LYPLA2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.3557744054537251,0.7726795954526172,0.7192982456140351,0.960591127816958,1.0,6/35,17.01%,NLRC5;IKBKE;NLRC3;RELB;IFIH1;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.32862886938066327,-0.7725991178118544,0.8125,1.0,1.0,7/48,14.78%,TNFAIP3;TRIM21;PRR7;HSPA1A;RPL11;UFL1;BAG2
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5273658009903388,0.7724767746822171,0.8166666666666667,0.9606342766088702,1.0,1/5,1.40%,PDGFRA
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.5139275435814235,-0.772398336182369,0.75,1.0,1.0,2/5,10.45%,SLC36A1;SLC25A38
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.40322315183329116,0.7723559403411033,0.7719298245614035,0.9605069815574463,1.0,4/20,16.11%,TRIM5;PML;TRIM32;VPS37B
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.42986967251922426,0.7722523372607035,0.7090909090909091,0.9603616436468841,1.0,4/13,15.35%,ORAI1;CAMK2B;BCL2;CD4
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.41387334410716575,0.7722177418027399,0.8275862068965517,0.9601113141018637,1.0,8/26,25.15%,THY1;TESPA1;CD160;IKBKG;PTPRJ;GBP1;PRNP;DGKZ
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.4096692037176435,-0.7717604989071458,0.7380952380952381,1.0,1.0,2/16,8.17%,HEYL;MAML3
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.48028604474753295,0.7715466701702777,0.7627118644067796,0.9608174653723673,1.0,2/8,7.57%,PRKCB;PID1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.47292797621180144,-0.7710730552464534,0.7916666666666666,1.0,1.0,2/7,14.24%,INTU;COL5A2
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.5148088354515421,0.7706592229348914,0.7608695652173914,0.9619106461854682,1.0,3/7,18.28%,HPF1;XRCC1;TINF2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.4640947387599247,-0.7700977598134495,0.8076923076923077,1.0,1.0,1/7,0.59%,KCNE1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.3810246509363162,-0.7698450364455088,0.8205128205128205,1.0,1.0,4/15,18.06%,CEP131;CEP83;STIL;CEP192
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.49006183430263794,0.769712668239921,0.7966101694915254,0.9628981500827969,1.0,2/8,4.91%,TLCD2;FABP3
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.48807145950728476,0.7694029218923916,0.8035714285714286,0.9629658050949679,1.0,1/9,0.77%,MYRF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.36395081492443404,0.7693087503789117,0.8285714285714286,0.9628163467143636,1.0,6/38,10.90%,TLR2;MBP;APP;MYD88;SYK;STAT3
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.47743769606151354,0.7688799596224286,0.7391304347826086,0.9631805539041787,1.0,2/9,13.36%,NOD1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.44172722561562616,0.7685164657615313,0.7903225806451613,0.9633456751661367,1.0,5/14,18.46%,MMP14;SYK;GAS6;ZBTB1;ZMIZ1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.41385001553872447,-0.7685138167484479,0.7105263157894737,1.0,1.0,4/14,18.91%,SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.46156637557642627,0.7684409396598862,0.746031746031746,0.9631311791285008,1.0,5/11,25.12%,SLC29A4;SLC1A6;SLC29A1;SLC38A1;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.30870207588243026,-0.7674424160133996,0.90625,1.0,1.0,4/52,8.13%,ERCC8;RGCC;SIRT6;ABRAXAS1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.4483263755113862,0.7666397652712861,0.7758620689655172,0.9653955179838754,1.0,3/9,35.20%,RTN4;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.39636139348607813,-0.7665065956551484,0.8285714285714286,1.0,1.0,5/20,16.00%,ABCB11;CYP46A1;OSBPL3;CYP7B1;OSBPL6
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.4683312007313295,-0.7663421984380402,0.7727272727272727,1.0,1.0,2/5,13.54%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4464002153817614,0.7663376667468796,0.8225806451612904,0.9655272729970951,1.0,1/12,3.13%,SLIT2
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.31095582369843194,-0.7663207450884495,0.9375,1.0,1.0,2/54,2.55%,TNFAIP3;RNF6
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.34867044523899177,-0.7662856444726661,0.7,1.0,1.0,4/28,13.98%,ATP6V1G1;ATP6V1E2;ATP6V0D2;ATP6V1F
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3784537331495132,0.7662711471310477,0.8208955223880597,0.9652942357805261,1.0,9/29,17.11%,APP;NLRP12;MYD88;STAT3;USP50;NLRP2;GSDMD;P2RX7;WNT5A
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.3833963458878337,0.7657535622703836,0.8333333333333334,0.9656822380280975,1.0,6/31,8.63%,PSCA;LIPH;TJP3;POF1B;KPNA7;CAPN8
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.428820535157134,-0.7654965718181032,0.75,1.0,1.0,2/11,13.55%,PHYH;IDH1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.37222709980868346,0.7652839476157138,0.8266666666666667,0.9659689515602566,1.0,7/47,13.51%,SLC39A14;IRS2;APOD;ALDOB;PGK1;ENO2;FBP1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.387914497736914,-0.7652207352613498,0.7142857142857143,1.0,1.0,7/23,16.20%,NPC2;SLC25A19;MTTP;PRELID1;TRIAP1;PRELID2;PCTP
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3791249796587375,-0.7651084748960306,0.6976744186046512,1.0,1.0,2/19,12.74%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.4019636529666118,0.7650167622887355,0.796875,0.9660714985265955,1.0,5/25,11.39%,GRIN2A;C1RL;C1R;MMP14;PGK1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4337715236323119,0.7649718251935387,0.7627118644067796,0.9658133388687227,1.0,4/16,9.44%,THBS1;SULF1;NPTN;LRIT3
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.4056654369068064,-0.7645819984117757,0.78125,1.0,1.0,2/17,6.28%,PRDX1;ATP1B2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.41771590517308643,0.7643589498365406,0.8307692307692308,0.966388161929455,1.0,1/18,6.81%,ENC1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.33721408872418895,0.7642708431128861,0.8873239436619719,0.9662526061222587,1.0,2/80,4.30%,SIX3;NEK10
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.5301503918374545,0.7635985560719738,0.7966101694915254,0.9668701640160569,1.0,3/5,25.09%,IL12A;TNFSF4;PRNP
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.42991985745744615,-0.7635283992146016,0.8928571428571429,1.0,1.0,8/18,31.57%,CNOT1;TAF5L;WNT9B;TAF6L;WDR43;PTN;NODAL;NCOA3
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.46355714239055584,0.763421535242839,0.8275862068965517,0.9667453473110607,1.0,4/12,26.71%,SLC26A8;SLC13A4;SLC26A11;SLC26A6
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.3309410388505543,0.7631525657716154,0.8571428571428571,0.9668582577408293,1.0,10/57,23.99%,DVL1;PEX14;CDKN1A;PRKCD;B2M;TMC8;CTSZ;ZFPM1;TTBK2;PIN1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.5299451967984878,0.7626660980159776,0.8695652173913043,0.9671258797611015,1.0,1/6,4.52%,SUV39H1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.37945293743034036,-0.7626221621943998,0.8108108108108109,1.0,1.0,5/26,21.83%,CFTR;VIM;DYNLL1;UBB;ACBD5
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.34337940333737504,0.7622212675926002,0.8615384615384616,0.967418522402327,1.0,6/66,6.64%,FLRT3;NR4A1;ZFP36;CD44;ANOS1;FLRT1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.5208377535904714,0.7622130448482356,0.9107142857142857,0.9671174209867197,1.0,3/5,42.88%,NBN;WDR18;WRNIP1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.430512712552536,-0.7622058971425759,0.7058823529411765,1.0,1.0,2/8,11.71%,MIS12;CENPA
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.30398917695008154,-0.7620392651073801,0.9090909090909091,1.0,1.0,5/115,5.09%,FAM47E;PADI4;BRDT;CHRAC1;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4473472020866576,-0.7620224798697445,0.7777777777777778,1.0,1.0,1/9,4.68%,RGCC
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.3013303766367602,0.761551086170615,0.9523809523809523,0.9676867893262766,1.0,9/239,7.19%,RECQL4;HELB;SP100;BLM;TYMS;RPA1;UHRF2;SAMHD1;POLD1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.38470176379361676,0.7614411972198303,0.8333333333333334,0.9675295957010016,1.0,2/22,7.19%,RPA1;POLD1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.4076181327973666,-0.7611633648332832,0.7272727272727273,1.0,1.0,2/13,10.21%,MOGAT1;GK
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5059776879707722,0.7611556517152269,0.7358490566037735,0.9676168886336292,1.0,2/5,35.93%,HIP1;LRP1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.4646881939925449,-0.7610981640637912,0.7692307692307693,1.0,1.0,1/6,3.10%,GALT
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3173421765321209,-0.7609770074169265,1.0,1.0,1.0,8/74,10.34%,MEOX2;ZNF358;TPP1;FOXJ1;DAG1;CDHR2;EHF;NDRG4
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.3716847721978983,0.7607370280236587,0.7727272727272727,0.9678909525201123,1.0,7/53,6.50%,PROX1;PLEK;MYO1F;WAS;ACHE;ALOX12;SYP
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.3733243826219992,0.7603180427718856,0.835820895522388,0.9681397023114007,1.0,8/31,23.41%,MBP;ASS1;PODXL;KLF4;MAP2K5;BMP6;PPM1F;NOTCH4
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.34390262939928373,0.7599878522066381,0.8974358974358975,0.968316484779026,1.0,5/46,13.04%,WNT8B;MAP1LC3A;DVL1;CTNNB1;FRAT2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4958697777527325,0.7597585159474485,0.7857142857142857,0.9682993275644372,1.0,3/7,14.10%,TLR2;NAMPT;CCL2
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.4225755724742195,0.759413399521336,0.8115942028985508,0.9685441263182553,1.0,6/14,25.67%,PDK1;PDK4;RORA;PDK3;FOXK1;PRKN
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.40267362187266637,0.7591646805152278,0.8571428571428571,0.9685914773242004,1.0,4/18,14.76%,ST8SIA3;ST8SIA1;ST8SIA4;MAN1A1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5286342220928083,-0.7591414574053006,0.9024390243902439,1.0,1.0,2/8,16.58%,BECN1;ATG14
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.39836322440512906,-0.7589158988831014,0.7837837837837838,1.0,1.0,2/14,6.45%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.4231642727065379,-0.7588369114290119,0.7272727272727273,1.0,1.0,7/11,24.40%,NT5E;NT5C;GPX1;NUDT15;PNP;NT5C1A;ITPA
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.5147481499373328,0.7587350431642641,0.803921568627451,0.9688396166684682,1.0,2/5,21.81%,WNT5A;PTPN11
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.3575628588058568,0.7586373552355014,0.8289473684210527,0.9686968448971427,1.0,10/59,16.30%,C1ORF87;CYP4X1;DNAH3;ZBTB7C;MORN5;ATP1B1;FUT2;NEBL;KCNMA1;NWD1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3983014199020098,0.75735864401969,0.7903225806451613,0.9700020125028884,1.0,1/30,2.10%,MAEL
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.42766879687615544,-0.7573166848296639,0.7272727272727273,1.0,1.0,1/7,4.62%,HAX1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.4266969637273623,0.7572388991523359,0.8620689655172413,0.9698947923081636,1.0,8/18,26.46%,MYH9;ADAM19;BACE2;ADAM17;SPPL2B;ADAM9;PSEN1;SPPL3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.40371644630402836,0.7571641080622492,0.696969696969697,0.9696945193433866,1.0,2/21,8.23%,IGF1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3353751658911138,0.7571063471284212,0.918918918918919,0.9694800502765819,1.0,11/64,21.17%,IGF1;APP;HDAC4;MLXIPL;FBP1;PFKFB3;P2RX7;GCKR;NCOR1;ARNT;HIF1A
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.35992485846994,0.756883789019414,0.868421052631579,0.9695556384626572,1.0,9/57,16.00%,SIX3;SLC4A10;TYR;GRM6;RP2;EML2;CABP1;MYO9A;RGS16
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.46606855050530405,0.7567985472138319,0.8135593220338984,0.9693735508399814,1.0,2/10,12.49%,CNTN4;EPHA4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2647549791786933,-0.7566639730417546,1.0,1.0,1.0,49/273,20.49%,TMEM17;CEP72;CNGA4;SSNA1;UBXN10;DYNLRB2;CEP19;FOXJ1;CETN2;TEKT5;CFAP221;CFAP52;INTU;DYNLRB1;TMEM237;RSPH1;EXOC7;WDR11;RAB8A;HAUS1;BBS10;TEKT1;IQCB1;AVIL;CEP131;DNAH5;TMEM250;DYNC2I1;ARF4;SCLT1;BBS9;FAM149B1;DYNLL1;MKS1;CEP83;TBC1D32;UNC119B;CEP192;DNAAF1;CEP20;PLK1;CFAP70;IFT57;RPGRIP1;TUBB;CCDC66;EXOC1;FHDC1;FUZ
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.31431750100129546,0.7565381603972784,0.8888888888888888,0.9694240856681233,1.0,20/134,16.67%,SGPP2;VAPB;FA2H;ACHE;MFSD2A;CERS3;SPNS2;ASS1;HACD1;B4GALT5;CHKB;PAM;ALDH3A2;ELOVL7;SGMS1;SLC44A3;LARGE1;CERS5;HACD4;ELOVL5
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.31397954983363874,-0.7564663675122276,0.9047619047619048,1.0,1.0,6/92,5.85%,FIP1L1;AAAS;RBM8A;U2AF1;RAE1;NUP50
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4475805930336842,0.7564575304860458,0.7936507936507936,0.9692421532514712,1.0,1/15,2.71%,TIMP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.3368719404322942,-0.7552527257619396,0.9032258064516129,1.0,1.0,5/32,10.83%,TPX2;ANKRD53;RAE1;VPS4B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.4327518819528081,-0.7549454264064079,0.8372093023255814,1.0,1.0,1/8,1.85%,AGER
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.3824003278979702,0.754900256803935,0.8115942028985508,0.9709978834198715,1.0,8/32,18.67%,LIMK2;YAP1;PARP9;CTNNA1;MFHAS1;OTUD7B;WWTR1;TFRC
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.33063245666146485,0.7546630716267182,0.9090909090909091,0.9710049782382328,1.0,19/79,18.74%,SERPINE1;GRID2;RTN4RL1;NLRP12;TNFRSF1A;NLRC3;EPHA4;MAPKBP1;PRKCD;PPARG;TNFAIP6;FGF2;KLF4;MFHAS1;LRFN5;PTPRS;RORA;GPS2;INPP5F
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.3835035327400912,0.7546514193515906,0.85,0.970711972171705,1.0,5/39,12.20%,ALS2CL;DNM1;HOOK1;PLEKHF1;USP50
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.35905731907223876,0.7543158790282198,0.796875,0.9708477245023217,1.0,11/57,21.95%,SMCR8;TNFAIP8L1;GNA12;GAS6;MAPKAPK5;TTI1;RFFL;TSC2;TELO2;RRAGD;RHEB
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.47455048444992487,0.7541644548293949,0.7538461538461538,0.9707691713700971,1.0,2/7,11.61%,LDLR;ABCA2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2910471226187138,0.7541035850846349,0.9873417721518988,0.9705657443727268,1.0,43/293,21.44%,ANK3;YWHAH;TBC1D9;STEAP3;PRKCB;AMN;MYH9;VLDLR;RAB15;RAB3C;RAMP3;TMED10;SCG5;CHMP1A;TF;USP6NL;RAB20;ARF6;STX4;PPARG;PICK1;OPTN;TBC1D1;STX1B;TBC1D10B;COPZ2;RCN3;RAB3D;SCAMP5;TBC1D10A;LRSAM1;TFRC;GGA1;LRP2;ABCG1;RAMP1;TXNIP;DNM2;ATP6V1B2;SNX13;SGSM1;SAR1A;NAPA
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.42021796943156225,0.753938822860125,0.7192982456140351,0.9704730559624629,1.0,6/18,19.43%,RYR2;GRK2;SLC8A3;C12ORF57;CALM3;CAV3
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3270734070794128,0.7538790628593477,0.8918918918918919,0.9702591475115804,1.0,12/97,19.23%,PRKCG;SOX4;SEPTIN4;FAM107A;BIRC3;PRICKLE1;PHF23;WASHC1;PINK1;BRCA1;UBXN1;NDFIP2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4399044211295463,0.7538724528357506,0.7704918032786885,0.9699597914017889,1.0,2/12,8.25%,TPST1;SULT4A1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.39236133961529074,0.7537586306812641,0.8333333333333334,0.96982816641595,1.0,11/31,23.50%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;CDK2;TINF2;TELO2;WRAP53;ACD;PIF1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.4485579381503694,-0.7535179707524025,0.75,1.0,1.0,3/8,33.16%,ERCC3;HMGB1;TOP3B
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.3440608750467274,0.7531953951923059,0.8591549295774648,0.9701884085418734,1.0,9/48,10.90%,EPHA2;LSR;BAIAP2L1;NEDD9;PADI2;EPS8L2;RHOD;MMP14;STAT3
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.33731251611503993,-0.7529877046668473,0.9333333333333333,1.0,1.0,10/36,21.00%,POLR2K;RRAGC;POLR2C;NFKBIB;THAP1;MLF1;POLR2D;PWP1;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.45179652595772746,0.752343923389985,0.7894736842105263,0.9709509938252318,1.0,1/12,0.95%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.493987435932551,0.7522184503872495,0.7818181818181819,0.9708476743882952,1.0,2/6,30.44%,BICD1;GSK3B
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.4943314741359487,0.7517759445054448,0.8135593220338984,0.9712072618277003,1.0,1/5,8.75%,ATP23
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.36969041500182503,0.7517146187214996,0.8311688311688312,0.9710007096276715,1.0,10/45,18.96%,WAS;CORO7;WASF1;FAM107A;ENAH;SPIRE1;COBL;SPIRE2;MICALL2;DSTN
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.3153886963018885,0.7514597527696598,0.9466666666666667,0.9710042145140971,1.0,18/104,16.84%,VRK2;PDGFRA;MGAT3;FOXO1;SNCA;FOXO3;SLC4A11;PXN;MAPT;PRKCD;STX4;AGAP3;FOS;MSRA;CPEB2;NOX4;PINK1;TP53
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.3418326170334995,0.7513664818619787,0.90625,0.9707942972016002,1.0,7/56,14.17%,ACSL5;LIPH;CYP21A2;AGPAT4;OLAH;ACSM5;PAM
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.47539354538906153,0.7511913803702073,0.7818181818181819,0.9706840755972008,1.0,4/9,11.03%,ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.44624561284703057,0.7505689945935513,0.8307692307692308,0.9711889006038085,1.0,1/7,19.35%,WHRN
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.45599978268210717,-0.7503275117732173,0.8095238095238095,1.0,1.0,6/9,26.92%,CYP2C8;PLA2G4A;PLA2G5;LTA4H;FADS1;MGST2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.43832686613243277,-0.7500972978252393,0.775,1.0,1.0,1/8,4.49%,GTF2H5
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.3950191766589064,0.7500268302623534,0.8032786885245902,0.9715868010660799,1.0,2/20,5.32%,AMN;SLC35F3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.38188784128857556,-0.7499650755746161,0.7837837837837838,1.0,1.0,3/18,13.22%,PDZD11;TSPAN33;BAD
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.34160383576745623,-0.7498301532900725,0.8461538461538461,1.0,1.0,2/28,6.82%,MEOX2;SCPEP1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.3940872944974705,-0.7498019957433966,0.8205128205128205,1.0,1.0,4/17,12.24%,MGAT4D;WDR87;PRNT;SPATA33
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.439335995512004,-0.7496734589294402,0.85,1.0,1.0,3/8,13.60%,APOE;PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.34746659047217876,0.7495342005285995,0.9047619047619048,0.9719666911270537,1.0,10/61,11.84%,EPHA7;THBS1;RPS6KA1;NOD1;CD44;NLRP12;SNCA;DHCR24;SYK;GAS6
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.426757333559833,0.7485367056935797,0.7758620689655172,0.9730069183770441,1.0,5/22,11.98%,APP;DYSF;SNCA;SYK;MAPT
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3588925978621354,0.7485152694630374,0.7846153846153846,0.9727399641837329,1.0,6/39,19.71%,CHD3;SRCAP;SMARCA1;SPTY2D1;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.42257048939741226,0.7485049036379584,0.7777777777777778,0.972455429589284,1.0,4/19,16.84%,PML;HIPK1;HIPK2;TP53
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.43901138722816196,-0.7483356487184355,0.8461538461538461,1.0,1.0,4/10,20.91%,HSD17B6;SRD5A1;UGT2B7;HSD17B11
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4483033147712179,0.7480646158273144,0.8103448275862069,0.9727671627015448,1.0,2/10,22.29%,TP53;THRA
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.2949404287896905,-0.7476522649719527,0.9393939393939394,1.0,1.0,8/89,14.27%,PADI4;BRDT;CHRAC1;CHD4;SMARCD1;MPND;ERCC6;TADA2B
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.4938419888322948,0.7474595366078339,0.7666666666666667,0.9731886609992432,1.0,2/5,12.92%,GRM5;EIF5A
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.39655925171940265,0.7467067990226414,0.7910447761194029,0.9737942873477259,1.0,3/17,4.07%,NR4A1;SLIT2;MYH9
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.46375084405492145,0.7465575082264249,0.8,0.9736444833161241,1.0,2/8,19.62%,ABCA2;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31717433904367465,0.7464551379208088,0.935064935064935,0.9734805972170899,1.0,4/113,5.10%,EGF;TRPM4;SOX4;LGR5
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.48742545659941616,-0.7462816768934547,0.7948717948717948,1.0,1.0,1/6,5.99%,CRACR2B
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.35681986869976,-0.7461720861334706,0.9487179487179487,1.0,1.0,2/24,4.05%,KCNE1;CFTR
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.41187265174308274,-0.746044228333349,0.7837837837837838,1.0,1.0,3/8,34.97%,ATP6AP2;GRN;TMEM9
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.5107851667055507,0.7458534628824229,0.847457627118644,0.9739438631656838,1.0,2/5,20.24%,FTO;TDG
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.4499259990595318,0.7457472999379976,0.7547169811320755,0.9737658196343862,1.0,1/7,10.33%,SHMT1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.4066925461891273,-0.7456681468155046,0.7837837837837838,1.0,1.0,2/12,14.09%,UFL1;MT3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.4792542340971864,-0.7455423388685096,0.7692307692307693,1.0,1.0,1/7,5.63%,MUL1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3782377261780429,0.7454493874344154,0.8387096774193549,0.9738923661471423,1.0,7/20,21.32%,CDC7;CCNB1;BRD4;CCND1;ATAD5;CDC25B;RAB11A
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.28640229640524134,0.7453214545781633,0.9761904761904762,0.9737498425608636,1.0,22/326,9.31%,SERPINA10;C3;CHGB;IGF1;CHRM3;FAM20C;CSF2RA;CP;APP;DAB2IP;SFTPD;DENND3;IGFBP7;LAMB1;NOTUM;BAP1;VGF;SHISA5;VCAN;RPL3;ATP23;ITIH2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.414493928183477,-0.7452791215836382,0.8181818181818182,1.0,1.0,1/10,2.38%,TPP1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.4208957922755998,-0.7452497418713571,0.9047619047619048,1.0,1.0,2/9,9.66%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.4208957922755998,-0.7452497418713571,0.9047619047619048,1.0,1.0,2/9,9.66%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.3956046134415716,-0.7451091632399593,0.8823529411764706,1.0,1.0,3/18,6.23%,CYP4F3;CEL;HSD11B1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.47361691657317384,0.7448300360118246,0.8148148148148148,0.974070920336249,1.0,2/8,11.03%,ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.39252277829903925,0.7446988518612919,0.90625,0.973914281042812,1.0,1/25,3.14%,WAS
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.5153299974819264,0.7445629556051666,0.8431372549019608,0.9738037077371859,1.0,3/5,19.68%,TRPM4;GPR183;TRPM2
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.4938984734127187,0.7445609853572084,0.8421052631578947,0.9735058488142866,1.0,1/6,8.75%,ATP23
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.44783977393182717,-0.7444881513017396,0.7297297297297297,1.0,1.0,4/12,19.09%,EIF2S1;EIF2AK1;DDIT3;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2813050872560828,-0.7444795440385524,1.0,1.0,1.0,10/75,15.83%,CEBPA;TRIB3;CBFA2T3;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4082181927082217,0.7443971102530205,0.7681159420289855,0.9733813347498246,1.0,2/17,4.00%,ICAM1;THY1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.2836488566828583,-0.744255356264135,0.9230769230769231,1.0,1.0,26/129,16.42%,G0S2;REEP6;ERP29;CEL;ALDH1A1;CBR3;RETSAT;BLVRA;ACOT2;KMT5A;ECH1;TDO2;GCDH;EPHX1;PDHA1;HMGCL;ETFDH;IDH1;ACSS1;BPHL;ECHS1;CPT2;RDH11;SUCLA2;EHHADH;PRDX6
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.4750221449157775,0.744235119340013,0.7962962962962963,0.9732922256673062,1.0,3/8,28.77%,LMTK2;ARFGEF2;NSG1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.4773933908096551,0.744097103988429,0.7857142857142857,0.9731184108178669,1.0,2/7,15.17%,MAPK8IP1;HLA-E
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.44878126660526,0.7433838464729732,0.8412698412698413,0.9738414787206569,1.0,2/12,12.49%,CNTN4;EPHA4
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.4762985182433434,0.7432638061090099,0.819672131147541,0.9737099558090542,1.0,3/6,14.70%,SFTPD;CCL2;TAFA4
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3317904038017293,0.7432461034405824,0.8873239436619719,0.9734267916704809,1.0,10/63,21.32%,GOLGA8O;MAPRE2;HAUS7;GOLGA8A;KIFC2;NEK6;NCOR1;FLNA;TUBGCP6;RAB11A
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.3288462329071015,0.7427009449435883,0.9041095890410958,0.9737434502813473,1.0,13/89,13.48%,ST6GAL1;MTHFD2;PLAAT4;ACOT4;PLAAT3;ALDH1L1;SHMT1;ABCA2;PLAAT5;DBI;ABCB9;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.37244100140649083,0.7425008836055426,0.8181818181818182,0.973710814488287,1.0,7/27,26.46%,PPP1R16B;PRKCD;PPP1R7;CALM3;PIN1;DLC1;SPPL3
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.41836231603169505,-0.7424219783706666,0.7560975609756098,1.0,1.0,1/10,5.24%,GREM1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.3693669738305679,-0.7422487340812258,0.8529411764705882,1.0,1.0,4/17,18.06%,CEP131;CEP83;STIL;CEP192
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.4859155942765757,-0.741993288409153,0.9024390243902439,1.0,1.0,1/6,6.23%,HSD11B1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.44639084846204846,0.741968433204395,0.8245614035087719,0.9741117938795075,1.0,2/9,15.09%,SLC29A4;OAZ2
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3637001809626203,0.7415110885995688,0.8051948051948052,0.9743468942927254,1.0,4/34,19.19%,DAB2IP;CDC7;BRCA1;MAX
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.34141566875829166,-0.7414262102764542,0.9473684210526315,1.0,1.0,4/50,5.85%,AAAS;RAE1;RNF212;NUP50
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.4511520587466523,0.7413541550814368,0.8,0.9742612577426095,1.0,2/9,13.09%,GINS2;CDC7
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4168730674987011,0.741158148613936,0.8666666666666667,0.9742249806322076,1.0,3/16,9.32%,MTFR2;DNM1;MX1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.3976567840563606,-0.7411125957174325,0.8048780487804879,1.0,1.0,2/11,9.66%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3580696293455541,0.7397872153237673,0.8857142857142857,0.9756569062552974,1.0,8/36,16.65%,PID1;BCL2L1;SLC4A11;MAPT;BCL2;STOML2;HEBP2;PINK1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.48193481815617156,0.7396590817996678,0.8148148148148148,0.9754864716248428,1.0,2/5,26.71%,SLC2A13;SLC26A6
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.3658489191834174,0.739585301857136,0.7931034482758621,0.9752915114781573,1.0,9/25,27.37%,TRPM4;CDK6;PPARG;HDAC7;SEMA4D;NOCT;SUFU;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.2529522858579261,-0.7394736275753275,1.0,1.0,1.0,23/276,11.17%,NUP62CL;ERP29;COX18;ARF5;SRPRA;NXT2;RABL3;SNF8;NUP50;TBC1D4;VPS29;ARFIP2;STX16;TMED5;COPB2;RANBP6;RABL2A;SEC31B;DNAJC27;ARL1;C17ORF75;WDR11;RANBP17
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.35070264777278437,-0.7392640259583311,0.875,1.0,1.0,7/29,13.30%,HEY2;HES6;ASCL1;HEYL;BHLHE41;HES5;HEY1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.43055078296584576,-0.7388972894356041,0.7906976744186046,1.0,1.0,1/9,3.10%,GALT
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.449178966220798,0.7387482559055556,0.7666666666666667,0.9760217905506593,1.0,7/12,29.89%,ADAM19;ABCG1;ADAM17;PSEN1;DYRK1A;APH1B;ABCA7
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.32012371551136837,0.7386502336293214,0.9142857142857143,0.9758654669211265,1.0,8/70,15.03%,SLC39A14;IRS2;FOXO1;RAB15;SORBS1;HDAC9;PPARG;CPEB2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.4465205493120822,0.7384680069664241,0.7111111111111111,0.9751792524634377,1.0,1/6,8.21%,TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.4465205493120822,0.7384680069664241,0.7111111111111111,0.9751792524634377,1.0,1/6,8.21%,TMED10
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.4465205493120822,0.7384680069664241,0.7111111111111111,0.9751792524634377,1.0,1/6,8.21%,TMED10
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.4450048365427901,0.7382847395954011,0.75,0.975083086830844,1.0,3/11,11.98%,APP;SNCA;MAPT
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.35518743127119395,-0.7382062911825148,0.8108108108108109,1.0,1.0,2/31,1.60%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.4352882944587728,-0.7381656304367477,0.7727272727272727,1.0,1.0,3/9,20.02%,MCM6;MCM4;MCMDC2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.4282552353567315,-0.7379025548059233,0.7619047619047619,1.0,1.0,3/6,25.60%,VPS35;CAV2;DRD2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.35290368900832986,-0.7378309170210363,0.8157894736842105,1.0,1.0,4/37,7.23%,SPRY1;RGS2;APOE;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.42744920224705313,0.73781119928236,0.8166666666666667,0.975408309354783,1.0,5/14,25.00%,SMAD1;FGF2;KLF4;TJP1;BMPER
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.4630854610624211,0.7375696077043251,0.78,0.9753928623500047,1.0,4/8,31.14%,WNK1;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3963316496356836,0.7367920025244254,0.7631578947368421,0.976040610324507,1.0,9/25,22.87%,NLRC5;PARP9;GAS6;FADD;WNT5A;ADAM17;HIF1A;CSF1;TRIM44
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.4057059765316305,0.736335961004211,0.7818181818181819,0.976295082311574,1.0,4/23,18.08%,SLC7A2;SLC7A1;SLC1A6;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.45481304016019114,0.7362105632247623,0.8235294117647058,0.9761741743711414,1.0,2/12,2.71%,THBS1;SULF1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.44206444209289797,-0.7361920099400003,0.8157894736842105,1.0,1.0,3/8,6.53%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.4403944861942572,0.7361671339421327,0.7894736842105263,0.9759061018040064,1.0,3/9,15.62%,PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.3233166187501623,-0.7354295715851444,0.9393939393939394,1.0,1.0,1/35,0.88%,ATF5
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.465220864920762,0.7352228997761832,0.8421052631578947,0.9767281278273338,1.0,4/6,41.21%,PLK3;STX5;PLK5;GBF1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.3099632751170958,-0.7350175024700379,0.90625,1.0,1.0,3/40,9.79%,SAXO1;IL5;ENTR1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.38711703136827186,0.7346760153530622,0.819672131147541,0.9770906863045487,1.0,5/18,19.70%,RYR2;CACNA1C;SLC8A1;CALM3;PDE4D
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.46392476607602373,0.7346574231146372,0.8035714285714286,0.9768330866872192,1.0,1/8,15.55%,COBL
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.4870945448824312,0.7346369466314925,0.8070175438596491,0.976547633905095,1.0,1/8,4.63%,GLYATL2
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.4331136449608171,0.7346262436086319,0.819672131147541,0.9762518551413636,1.0,1/10,9.12%,CTNNB1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.5062081876654718,0.7346227181996547,0.8064516129032258,0.9759562576146198,1.0,1/5,16.22%,RNASE10
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.43747304481424465,0.7344859819851145,0.8392857142857143,0.9755229750958492,1.0,1/8,9.77%,ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.43747304481424465,0.7344859819851145,0.8392857142857143,0.9755229750958492,1.0,1/8,9.77%,ARHGEF10L
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3893270984058434,0.7342100716534374,0.7903225806451613,0.9755669869581546,1.0,5/24,24.04%,RHBDF1;RHBDF2;NDFIP2;PPM1F;DNAJC1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.46528725769820156,0.7341925854306742,0.8208955223880597,0.9752964255248123,1.0,4/9,38.30%,CREBBP;BAG6;SIRT1;KAT5
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.3744562213866083,0.7339897208500937,0.8235294117647058,0.9752566263921525,1.0,4/26,18.61%,BAP1;ARIH2;PINK1;MICALL2
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.40704652446078193,0.7333495397364684,0.8333333333333334,0.97550881777541,1.0,1/12,3.27%,SLC25A21
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.40704652446078193,0.7333495397364684,0.8333333333333334,0.97550881777541,1.0,1/12,3.27%,SLC25A21
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.46281381332536686,0.7330881263950183,0.7936507936507936,0.9755108784652872,1.0,1/7,8.29%,TYR
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.3749721661206481,0.7330588172210105,0.875,0.9752512163595368,1.0,9/34,14.81%,ANXA1;WDR62;GCM2;CDK6;TRAK1;TGFB2;MAPT;HAP1;LPAR1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.3753281833529901,0.7328274360973773,0.9193548387096774,0.9752603315807931,1.0,5/30,16.84%,PTPRC;TGFB2;JARID2;PUM1;TP53
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.35857289519705804,0.7326715331252415,0.8666666666666667,0.9751334291481344,1.0,7/42,16.18%,FA2H;CERS3;CYP4F22;ABCA2;ST6GALNAC3;SGMS1;CERS5
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3345800815344053,-0.7325433913806638,0.8787878787878788,1.0,1.0,5/28,15.75%,ACSM6;THEM4;ACOT2;ACOT6;SUCLA2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.38696321309299264,0.73234401944679,0.8490566037735849,0.9752157896812366,1.0,3/16,10.59%,PIEZO2;CTNNB1;TCAP
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3293715060914882,0.7323341803639523,0.9565217391304348,0.9749251663263443,1.0,10/64,20.52%,SEPTIN4;FAM107A;BIRC3;HDAC4;PRICKLE1;PHF23;PINK1;BRCA1;NDFIP2;PIAS1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.39349285818151647,0.7322424996183179,0.8695652173913043,0.9747671236014059,1.0,10/26,25.53%,PLSCR1;PUM1;IFI35;PRKCA;NMI;BMP6;SLC15A4;POLR3C;SCIMP;DHX9
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.48111156322309534,0.7318955229025681,0.8412698412698413,0.9748390707890978,1.0,3/5,39.97%,GSK3B;CSNK1A1;AMER1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.44038594211569215,-0.7313305174435062,0.7105263157894737,1.0,1.0,2/6,16.48%,BCL2L11;STK17B
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.40732834213624336,-0.7312859709735863,0.7857142857142857,1.0,1.0,2/11,13.68%,TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.3871171492917922,0.7310356990900234,0.8548387096774194,0.9755969622121459,1.0,3/19,13.96%,SEPTIN9;ZMYND10;HAP1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.4039645431599649,0.730938714752613,0.796875,0.9754318970174087,1.0,2/16,10.76%,FAP;ZDHHC7
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.4366432815796507,0.730425653318661,0.8363636363636363,0.9757715398264989,1.0,2/12,10.74%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.49395178197507256,0.7304190485344954,0.8181818181818182,0.9754847573238251,1.0,3/5,21.97%,TF;B2M;BMP6
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.2812100561796224,-0.7302324075459381,1.0,1.0,1.0,12/88,18.47%,CEP72;SSNA1;CETN2;HAUS1;IQCB1;CEP131;SCLT1;DYNLL1;MKS1;CEP83;CEP192;PLK1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.3585490151180698,-0.7301748775335324,0.8837209302325582,1.0,1.0,2/21,8.49%,RFC3;PRIMPOL
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4026155226130984,-0.7300206195622063,0.8378378378378378,1.0,1.0,2/14,10.35%,ABCD1;SLC25A33
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.36624089312967634,-0.7296375091020609,0.8947368421052632,1.0,1.0,2/14,19.23%,CLP1;NRDE2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.460078365719102,0.7296149986601492,0.7931034482758621,0.9762137055449784,1.0,2/8,19.41%,PPARG;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.40121196812963633,0.7294393458499768,0.85,0.9761077604387914,1.0,4/24,12.73%,ZIC1;BAG3;SMAD3;PRKCD
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.46499297909845627,0.7293651863114118,0.8490566037735849,0.9759219360720062,1.0,3/8,24.17%,LOXL1;LOXL2;SUMF1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.27619935682701224,0.7289537114772924,1.0,0.9760628519749451,1.0,42/352,16.02%,GOLGA8O;ARHGAP4;VAPB;CNTNAP1;DMTN;ATP8B4;THY1;WTIP;SH3KBP1;CFAP126;NEDD9;MTFR2;DPYSL2;PAK4;TMED10;PCLO;PLAAT3;KIF5C;PLEKHF1;PLD2;YTHDF1;ARHGEF7;AGTPBP1;CHMP1A;PACSIN1;CFAP61;PEX14;FGD5;USP6NL;GOLGA8A;FMNL3;STX4;RNF112;SYNE3;CCL2;OPTN;STOML2;SIPA1;BIN1;RAB30;ATL3;PALLD
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.4300515378976801,-0.7288415972260972,0.8421052631578947,1.0,1.0,3/11,15.01%,GTF2A2;TAF11;BDP1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.28800409245599157,-0.7284365653789499,0.972972972972973,1.0,1.0,14/105,12.26%,SRPRB;EIF4EBP1;SRPRA;NOP56;GEMIN4;EIF2S1;EXOSC4;IMP3;SPCS1;SERP1;EXOSC5;SLC30A5;YIF1A;LSM4
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.3720600465738079,-0.7275220524325064,0.9111111111111111,1.0,1.0,5/16,10.95%,SLC30A8;SLC39A10;SLC30A6;SLC30A5;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.4808095898871393,0.7274408981474021,0.8301886792452831,0.9774820040143792,1.0,1/5,7.28%,LARP6
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.42594156256788335,0.7270670521424922,0.8620689655172413,0.977625832543679,1.0,6/14,34.34%,PPARG;ABCG1;ITGAV;OSBPL8;PPARD;PNPLA2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.4765595793478916,0.7270423312133663,0.8064516129032258,0.9770386527778363,1.0,3/6,39.19%,AKAP8L;IWS1;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.4765595793478916,0.7270423312133663,0.8064516129032258,0.9770386527778363,1.0,3/6,39.19%,AKAP8L;IWS1;SETD2
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.43579044639417974,0.7265968189993769,0.7547169811320755,0.9772553439895443,1.0,1/8,4.01%,DYSF
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.3341045579305874,-0.7265689676078476,0.8,1.0,1.0,4/22,20.24%,VPS4B;HSPA1A;PLK1;CHMP3
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.4289906817141451,0.7264319402013777,0.7611940298507462,0.9768492273580602,1.0,4/11,14.12%,SYNJ2;INPP5A;INPP5J;IMPA1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4289906817141451,0.7264319402013777,0.7611940298507462,0.9768492273580602,1.0,4/11,14.12%,SYNJ2;INPP5A;INPP5J;IMPA1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.33788459856024694,0.7262395980103022,0.9090909090909091,0.9767156803418438,1.0,11/51,21.40%,BLM;EME2;CDKN1A;DONSON;CCND1;MRE11;TP53;CDK2;BRCA1;WAC;FBXO31
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.4473960527315276,0.7259813157061424,0.8448275862068966,0.9767000335200793,1.0,2/7,24.68%,CALM3;JPH2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.34451497825110783,0.725825723464848,0.8450704225352113,0.9765631485481518,1.0,3/42,6.09%,ZFP36;ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.49128634501300394,0.7257972334380456,0.8333333333333334,0.9762843567017901,1.0,1/8,3.39%,SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.42202981679759244,-0.7253715016217224,0.7142857142857143,1.0,1.0,2/7,4.51%,AGER;APOE
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3737894035841862,0.7250468489651134,0.8360655737704918,0.9768851118870914,1.0,6/32,13.96%,NEFL;KIF5A;KIF5C;TRAK1;RAB27B;HAP1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.31259545067792033,-0.7250167062757993,0.868421052631579,1.0,1.0,7/48,12.62%,TNFAIP3;TRIM21;MUL1;PTPN22;RNASEL;POLR3F;POLR3B
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.44292942640051647,-0.7248020253769707,0.7894736842105263,1.0,1.0,1/7,8.07%,GLUD1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4216707678979084,0.7246059947019842,0.859375,0.9771186296595401,1.0,2/12,8.07%,APP;LDLR
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.48846322198262687,-0.7230896796871904,0.8,1.0,1.0,1/5,10.17%,NCSTN
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.38801667995953737,-0.722457484336681,0.8378378378378378,1.0,1.0,7/21,26.87%,VPS11;AFG3L2;MIEF1;FIS1;GDAP1;VPS18;MFN2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.36662434718832315,0.722409870843154,0.9180327868852459,0.9792896174592999,1.0,2/41,2.41%,IPCEF1;MBP
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.376693686392243,-0.7223151735191395,0.8648648648648649,1.0,1.0,3/11,16.10%,LY96;TRIL;TIRAP
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.34811989307865676,-0.7220785737694707,0.8648648648648649,1.0,1.0,4/17,20.24%,VPS4B;HSPA1A;PLK1;CHMP3
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.2964275246590048,-0.7219305175556966,0.9310344827586207,1.0,1.0,3/48,3.03%,CEBPA;LEPR;SLC30A8
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.37844462507656645,-0.7216864154140604,0.85,1.0,1.0,2/12,6.16%,EDNRB;ASCL1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.3460340417242051,-0.7216085688538666,0.85,1.0,1.0,2/32,2.72%,PADI4;H2BC21
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2537248544421783,-0.7210140494709157,1.0,1.0,1.0,21/132,19.73%,TPX2;CEP72;SSNA1;FBXO5;CETN2;VPS4B;HAUS1;HMMR;PSMD10;PSMD12;CEP131;PSMB5;PSMD2;DYNLL1;CUL1;CEP192;PSME3;PLK1;PSMB4;PSMB6;TUBB
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.41327509317381994,-0.7205206140906247,0.78,1.0,1.0,2/9,8.78%,RGCC;DAG1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.3106622190230979,-0.7204554565125225,0.9615384615384616,1.0,1.0,9/65,19.77%,ELOC;PSMD10;PSMD12;PSMB5;PSMD2;PSME3;PSMB4;PSMB6;UBB
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.4643807229081977,0.7201040621244216,0.8363636363636363,0.9815838133229544,1.0,3/10,6.82%,ICAM1;THY1;CD99
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.3804731459805009,-0.7199521791630095,0.7666666666666667,1.0,1.0,1/15,4.84%,MCRS1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.3804731459805009,-0.7199521791630095,0.7666666666666667,1.0,1.0,1/15,4.84%,MCRS1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.31882503799137113,-0.7199435255251113,0.88,1.0,1.0,6/48,14.78%,TNFAIP3;FBXO5;PRR7;HSPA1A;UFL1;BAG2
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.40020191785794024,0.7193909924906007,0.7681159420289855,0.9821027042582102,1.0,1/12,7.52%,ECE1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.43386484434320427,-0.7193260856199032,0.7608695652173914,1.0,1.0,6/6,56.63%,NENF;PPARA;MKKS;BBS2;BBS4;SPX
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.4886348818473754,0.7191649094250041,0.8541666666666666,0.9820612667148089,1.0,1/5,10.32%,NFKBID
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.4118608721245155,-0.7187711235315875,0.7906976744186046,1.0,1.0,2/7,14.92%,WARS2;YARS2
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.37517318023793234,0.7186848561259594,0.859375,0.9822824975501203,1.0,8/32,22.42%,GLRA2;SYVN1;GLRA3;RCN3;TRPM2;UBXN6;MARCHF6;RNF185
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.37393083491432844,-0.718637061305059,0.8947368421052632,1.0,1.0,2/24,8.69%,ID2;PER3
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.41356230664937343,-0.7182746390186187,0.7555555555555555,1.0,1.0,2/6,30.68%,SENP2;SENP5
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.45771602426306146,0.7182050728762089,0.8070175438596491,0.982596873815034,1.0,1/7,16.84%,TP53
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.4049096231903216,0.7181629810809069,0.8064516129032258,0.9823446461126536,1.0,1/12,3.24%,NELL1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.41940409397346146,0.7180902211577322,0.8153846153846154,0.9821443613888544,1.0,5/11,23.60%,TJP3;TJP2;PDE2A;BMP6;TJP1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.33643647209674094,-0.7180827507380396,0.8857142857142857,1.0,1.0,4/24,16.87%,FIP1L1;CPSF1;CLP1;CPSF3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.33643647209674094,-0.7180827507380396,0.8857142857142857,1.0,1.0,4/24,16.87%,FIP1L1;CPSF1;CLP1;CPSF3
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.32115443898416374,0.7176507688614575,0.9642857142857143,0.9822824599526632,1.0,9/74,11.75%,ZDHHC9;ZDHHC22;PARD3;MYO1C;MICALL1;ZDHHC7;ZDHHC1;PEX14;NACAD
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.3415949061283846,-0.7173424282902567,0.8888888888888888,1.0,1.0,4/31,13.59%,MTIF2;MTIF3;UFL1;TEX264
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.32630533546973184,0.7166023435980048,0.9047619047619048,0.9831692580168362,1.0,9/46,16.42%,NUMBL;HES7;SERPINF1;CTNNB1;YAP1;B2M;TRIM32;NAP1L1;RGS14
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.4579866826228568,0.7161554053662024,0.890625,0.9834139003044678,1.0,3/6,29.54%,COL5A1;ADAM17;PLET1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.3699982253297365,-0.7160209458753702,0.8974358974358975,1.0,1.0,2/25,8.69%,ID2;PER3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3209062768780413,0.7160003922350446,0.9577464788732394,0.9826959868136894,1.0,9/82,17.91%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;TAB1;IKBKG;SKP1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3209062768780413,0.7160003922350446,0.9577464788732394,0.9826959868136894,1.0,9/82,17.91%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;TAB1;IKBKG;SKP1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3209062768780413,0.7160003922350446,0.9577464788732394,0.9826959868136894,1.0,9/82,17.91%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;TAB1;IKBKG;SKP1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4143171081774001,0.715942519123997,0.8548387096774194,0.9824650103558692,1.0,7/12,24.52%,CCND1;TP53;CDK2;PLK3;WAC;FBXO31;SDE2
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4758084086880858,0.7150677478528036,0.875,0.9831813747036937,1.0,3/8,18.65%,PTPRC;ELF1;CBFB
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.330777686157513,0.7147323443460349,0.8955223880597015,0.9832740642642259,1.0,16/62,15.95%,TLR2;SERPINE1;COLEC12;SFTPD;NOD1;TNFRSF14;MYD88;LYG1;SYK;TF;PRKCD;OPTN;HLA-E;GSDMD;IL12A;LYG2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.3565020910180396,0.7144897320304049,0.8793103448275862,0.9832462177024398,1.0,4/35,15.09%,BLM;CDKN1A;DONSON;MRE11
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.33466704599122843,-0.7143004376567665,0.8235294117647058,1.0,1.0,7/25,24.72%,KMT2A;MEN1;PRDM7;WDR82;TET3;PAXIP1;CTR9
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.3911634870614158,-0.7142773174646931,0.7727272727272727,1.0,1.0,1/12,2.08%,CST3
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.4579059334400688,0.7135206940861404,0.8571428571428571,0.9840787018593911,1.0,1/6,8.23%,CYP1B1
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.4120772356094341,0.7134783065784149,0.828125,0.9838338959003194,1.0,4/12,14.12%,SYNJ2;INPP5A;INPP5J;IMPA1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.36200463053148096,-0.7132478890178514,0.8863636363636364,1.0,1.0,10/19,30.55%,TTPA;CYP4F12;LRAT;CUBN;RBP1;VKORC1L1;CYP11A1;LGMN;GC;UBIAD1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.41051297924630814,0.7130948024498893,0.8113207547169812,0.983933155703628,1.0,5/15,11.99%,ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.38394666582975345,0.7127830197490529,0.8888888888888888,0.9839945361192332,1.0,2/14,8.84%,KCNB2;PVALEF
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.40384390810996273,-0.7127096189674944,0.9285714285714286,1.0,1.0,3/17,5.41%,TPX2;ANKRD53;RAE1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.364772065217204,0.7126619125600839,0.8135593220338984,0.9838290301072441,1.0,8/30,18.33%,DAB2IP;CARD19;NLRP12;NLRC3;MAPKBP1;PER1;RORA;OTUD7B
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.4672099763504204,-0.7125155133321219,0.9024390243902439,1.0,1.0,1/7,4.51%,APOE
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.42353032844254584,-0.7124952194833933,0.8604651162790697,1.0,1.0,5/12,22.22%,GLUD1;IDH1;IDH3G;ACO1;SIRT4
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.3226194842803306,0.7118143748772227,0.9090909090909091,0.9845226435219666,1.0,9/43,25.67%,DAB2IP;BAG3;OPTN;HSPH1;PACRG;HSPA4;HSPB1;HSPA5;PRKN
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.3088546152098317,-0.7116820701241701,0.96875,1.0,1.0,4/27,22.84%,NCOA4;ZFYVE16;GCC2;AP4M1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.41951929650602293,0.7116277370534085,0.8333333333333334,0.9844292141985369,1.0,2/11,11.54%,NAMPT;PARP9
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.31565094026139046,0.7113485790671223,0.9859154929577465,0.9844113893463444,1.0,10/86,11.61%,ABCA6;ACSL5;ABCA8;ABCA5;SLCO1A2;DIO1;HSD3B7;DHCR24;ABCA9;ABCA2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.3769879648757219,-0.710306497076151,0.8723404255319149,1.0,1.0,4/14,11.41%,TRIM21;TRIM68;EXOC7;FUCA2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.3879380533094291,0.7093071856429815,0.8983050847457628,0.9863641063141987,1.0,4/25,12.73%,ZIC1;BAG3;SMAD3;PRKCD
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.3115696166799397,0.7090702320039194,0.9305555555555556,0.9863457107761856,1.0,18/106,21.17%,SCN2A;SUV39H1;LMNA;NDRG1;PGK1;CPEB2;SLC8A3;HIPK2;FMN2;HIF3A;PINK1;BACH1;TP53;RORA;PLK3;ARNT;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4431826206179981,0.7088992674593965,0.8181818181818182,0.9862518460817855,1.0,1/10,8.71%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.4464265570665834,0.7088840163963717,0.8653846153846154,0.985976253685694,1.0,2/11,16.79%,TESPA1;IKBKG
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.32208407146804324,0.7088034686837305,0.9466666666666667,0.9857831193662098,1.0,15/79,16.79%,GPNMB;KIF14;PRKCG;AGAP2;MAG;SNCA;INPP5A;VSTM2L;CD200;CCL2;BCL2;SET;TOX3;PINK1;IKBKG
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.49991258563249374,-0.708495244646208,0.8717948717948718,1.0,1.0,1/5,5.83%,KRT10
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.4413915407210131,-0.7082719388082399,0.8181818181818182,1.0,1.0,1/5,6.16%,ASCL1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.4704170209440268,0.7082166031626105,0.8148148148148148,0.9861625484979557,1.0,1/5,3.39%,SLC39A14
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.4069585550230946,0.7079924720690263,0.8596491228070176,0.9860791318097376,1.0,1/11,3.62%,APP
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.391323696307978,-0.7077659283902235,0.9130434782608695,1.0,1.0,2/12,8.78%,SAXO1;DAG1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.4232834804493035,0.7076178645192257,0.8947368421052632,0.9861533507287333,1.0,6/12,30.33%,PCGF3;CDYL;BRCA1;RBM15B;LRIF1;PCGF5
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.33296239327195354,-0.7074217238227039,0.8064516129032258,1.0,1.0,3/25,7.00%,HSPG2;HPSE2;SDC3
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.33231690721632756,0.707297630516147,0.9253731343283582,0.9862686220904145,1.0,8/58,13.48%,EPHA2;TPST1;SULT4A1;ACOT4;AK3;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.48628915865067146,0.7070296567445333,0.9180327868852459,0.9862571467275293,1.0,3/6,26.67%,PACS2;AHCYL1;VMP1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4220617517232816,0.7065624591890926,0.8,0.9864749986995676,1.0,3/9,18.76%,NOS1AP;CALM3;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3995876912732667,0.7063877711471244,0.8840579710144928,0.9863950350254562,1.0,5/19,13.51%,SLIT2;DAB2IP;TGFB2;CYRIB;FBP1
prerank,MSigDB_Hallmark_2020__E2F Targets,0.2896023888703398,0.7062726698151149,0.987012987012987,0.9862432857396377,1.0,25/169,18.75%,CDKN2A;CCNB2;LMNB1;RPA1;SUV39H1;MTHFD2;POLD1;NAA38;SHMT1;BARD1;CDKN1A;PMS2;CDKN1B;CKS1B;DONSON;NAP1L1;MRE11;PPM1D;STMN1;TP53;DUT;HMGA1;TFRC;BRCA1;CDC25B
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.48559275746189495,-0.7062084835162544,0.8604651162790697,1.0,1.0,1/5,1.81%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.40139929623785536,0.7060091013995679,0.8125,0.9862797063730684,1.0,1/11,1.84%,THBS1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.4249349042225558,0.7059799829542701,0.8904109589041096,0.9857339016002665,1.0,2/12,13.62%,SLC20A2;SLC37A2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4249349042225558,0.7059799829542701,0.8904109589041096,0.9857339016002665,1.0,2/12,13.62%,SLC20A2;SLC37A2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.3692402331883972,0.7058745616654248,0.9090909090909091,0.9855517827003061,1.0,6/25,19.86%,ABCC4;SLCO1A2;SLC51A;SLC27A5;RXRA;ABCC3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.42561021714908776,-0.7057025978943751,0.6829268292682927,1.0,1.0,4/6,23.86%,BAD;AKT2;MTLN;VCP
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.31592259502579123,-0.7056937808672978,0.9615384615384616,1.0,1.0,10/51,24.02%,PSMD10;PSMD12;PSMB5;NQO1;PSMD2;PSME3;PSMB4;PSMB6;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.4339696697501848,0.7054624905433869,0.8524590163934426,0.985701079003455,1.0,1/7,9.69%,ASS1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3248215250686365,0.704910501509518,0.9714285714285714,0.9860141824050097,1.0,2/77,2.19%,KIF14;PSRC1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.44678429372703266,0.704767728699289,0.8253968253968254,0.9858799318450935,1.0,3/7,31.33%,RIN3;RAB5A;PICALM
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.35468358795279603,-0.7041651791348839,0.9090909090909091,1.0,1.0,3/22,7.23%,SELENOS;TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.31810079589147877,0.7040659437560624,0.9,0.98641460508548,1.0,4/41,8.23%,AWAT1;ALOX12;FAAH;CYP1B1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.28000582892957643,0.7040637839559598,0.9878048780487805,0.9861199770672346,1.0,34/186,24.36%,KIF14;PRAME;HECW2;ENC1;PML;CTNNB1;TBL1X;KCTD13;HECW1;SPSB1;AGAP3;SYVN1;UBXN11;SMURF1;RCN3;RFFL;RNF187;UBXN1;MTA1;RNF122;UBXN6;MARCHF6;TBL1XR1;BFAR;UBE4B;RNF185;DDB1;TRIM9;UBE2B;PSMB3;CUL3;USP44;FBXW5;ARRB1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.4623704628413412,-0.7039209192317789,0.7674418604651163,1.0,1.0,1/6,3.45%,FBLN5
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.33405936181536156,-0.7036015822337116,0.9512195121951219,1.0,1.0,3/26,18.24%,SF3A1;KHDC4;SRSF9
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.3758534902948687,-0.7035485749375837,0.8837209302325582,1.0,1.0,3/17,19.63%,APOE;ERLIN2;ERLIN1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.4458504044083193,0.7031912283908761,0.8484848484848485,0.9868554746585964,1.0,1/8,16.62%,CPNE7
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3631172270188842,-0.7029041681812395,0.926829268292683,1.0,1.0,3/15,7.30%,PGP;CBFA2T3;MST1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.38729598899145423,-0.702901194318517,0.868421052631579,1.0,1.0,1/12,10.63%,ACVR1C
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.3519715052560101,0.7028710878162815,0.9666666666666667,0.9869427450002325,1.0,10/34,23.60%,DAB2IP;GFAP;NCLN;SPTY2D1;PINK1;RAP1A;FAM110C;RAP1B;PTPN11;TJP1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.29502621008551144,0.7027570216552464,0.9863013698630136,0.9867675169279349,1.0,17/113,17.11%,TLR2;PRKCB;IRAK2;APP;NOD1;TRIM5;TRIM22;MYD88;PRKCH;STAT3;TERF2IP;ALK;TRIM32;SLCO3A1;TAB1;IKBKG;WNT5A
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.45696272865629384,-0.7027519300671102,0.82,1.0,1.0,1/6,3.10%,GALT
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.35768480140616515,0.7027253384880396,0.8285714285714286,0.986514023734995,1.0,7/29,14.08%,IRS2;CHST15;APOD;ALDOB;GALK1;FBP1;HK1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.3683701624899215,0.7024153191051081,0.8620689655172413,0.9865365969727716,1.0,5/25,11.45%,KCNIP4;FGF12;KCNH2;HOMER1;KCNAB3
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.446122936455938,0.7022573961355105,0.9180327868852459,0.9861187141705444,1.0,2/9,16.10%,CHMP1A;IST1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.446122936455938,0.7022573961355105,0.9180327868852459,0.9861187141705444,1.0,2/9,16.10%,CHMP1A;IST1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.2772469751841822,0.7015639604049684,0.9878048780487805,0.9865327663393517,1.0,21/241,13.08%,TEKT2;PTPRO;SHTN1;DMTN;CYS1;ABCC4;RHOD;RAP2B;EMP1;CDC14A;ARHGEF7;MAK;FSCN1;RP2;MINK1;FGD5;IFT122;P2RY12;CFAP20;ARF6;OPHN1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.33385083541069227,0.7008890609963311,0.9565217391304348,0.986983997150401,1.0,5/35,10.51%,PPARGC1B;PMEPA1;PADI2;PGR;YAP1
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.44832515177562715,-0.7008807960985576,0.7659574468085106,1.0,1.0,2/5,10.87%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.47163333463828716,0.7007293385763932,0.9354838709677419,0.9868465362462693,1.0,1/6,22.57%,UBR5
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.32276327117193815,-0.7006969346197739,0.84375,1.0,1.0,16/42,18.89%,C6;CYP4F3;PIK3C2G;NCMAP;ACKR2;ADH4;FRK;TSHR;FMO5;TTF1;KCNIP3;SPTLC3;UGT2B7;CYP4F12;PRLR;SLC3A1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3163159987771545,0.7004328606542666,0.9466666666666667,0.9869471765244149,1.0,11/67,19.57%,CHRM3;BAP1;B4GALT7;ST8SIA4;FBXL2;LCMT1;MSRA;PLOD2;PHEX;LOXL2;SLC35A1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4165241990223483,0.700421474202626,0.78,0.986670438566892,1.0,4/8,28.83%,CALM3;CBARP;GNB5;FMR1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.404234196589911,0.7004045229469237,0.8524590163934426,0.9863768740210523,1.0,3/13,20.80%,PPP1R16B;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.39701734252787785,-0.699938815245808,0.7297297297297297,1.0,1.0,1/6,23.86%,VCP
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.38461117075003565,0.6997806421395611,0.8035714285714286,0.9867425490742274,1.0,6/15,13.56%,MYH9;PIR;PDE1B;GAS6;PPARG;RELB
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3638000331322145,-0.699637048412238,0.868421052631579,1.0,1.0,4/21,15.09%,SUPT16H;ERCC6;CCNT1;HMGN1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),0.47831181646304605,0.6995510532216321,0.8545454545454545,0.9867072512947106,1.0,1/5,12.73%,PRKCD
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.33399200410571894,0.6988532685907988,0.9130434782608695,0.9871574912910652,1.0,12/44,28.01%,ZIC1;GLIS2;DLG5;IFT122;RORA;KIF7;TXNDC15;GLI1;SUFU;PTCH1;TTC23;CREBBP
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3131794539046854,-0.698691031122764,0.9142857142857143,1.0,1.0,7/36,15.62%,SFXN2;SLC3A2;SLC6A13;SLC36A1;SLC38A9;SLC25A22;SLC47A1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.28849568690252586,0.69828279550658,0.9726027397260274,0.9875124257124489,1.0,10/111,15.77%,GOLGA8O;ATP8B4;STK25;TMED10;ARHGEF7;USP6NL;GOLGA8A;OPTN;RAB30;ATL3
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.35256894596448346,0.6978516022244993,0.9137931034482759,0.9876024792541235,1.0,6/27,16.77%,BOC;CDK9;CTNNB1;HDAC9;CTNNA1;MAPK11
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.3366262027887625,-0.6978480309476686,0.9375,1.0,1.0,6/30,16.39%,OAT;GLUD1;SLC39A8;ART4;GLYATL1;ALDH18A1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.4212068947727312,-0.6977504204711277,0.7441860465116279,1.0,1.0,3/7,26.45%,BRPF1;BRPF3;MEAF6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3268534317110983,0.6974783340073362,0.8955223880597015,0.987658557332306,1.0,13/55,19.29%,ZIC1;TCP1;BAG3;LIMK2;SMAD3;YAP1;CCT4;PARP9;PRKCD;CCT8;WWTR1;TFRC;FLNA
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.45098417012072,0.6974101471660237,0.8620689655172413,0.9874263509617472,1.0,2/5,32.43%,TSG101;STAM
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.30157248721395213,-0.6967741975423595,1.0,1.0,1.0,14/58,20.96%,RFC3;POLD3;GTF2H5;GTF2H2;ERCC2;DNASE1L1;PNRC2;DNA2;XPA;ERCC3;MUS81;UBB;PARP1;MEI4
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.31827973097891493,-0.6967276782732291,0.9117647058823529,1.0,1.0,2/32,4.37%,RFC3;POLD3
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.43593386902428344,0.6966869325271771,0.8679245283018868,0.9878655387517508,1.0,4/11,17.56%,RDH13;CYP1B1;DHRS13;ALDH8A1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.4106100730661213,-0.6965857203218859,0.8,1.0,1.0,2/9,12.29%,GPLD1;GRAMD1B
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.40295449843396497,0.6963411115941108,0.890625,0.9879452130914211,1.0,6/15,25.09%,GAS6;HLA-DRB1;RARA;TNFSF4;PDCD1LG2;PRNP
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.4267111156073592,0.6956701127640085,0.8857142857142857,0.9883772100497995,1.0,3/10,17.96%,HIPK3;TP53;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3688661776677621,0.6955632035427605,0.8032786885245902,0.988219583686789,1.0,6/17,21.32%,CDC7;CCNB1;BRD4;CCND1;CDC25B;RAB11A
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.36942379903313494,-0.6954862424048736,0.8181818181818182,1.0,1.0,1/15,1.39%,STAB2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.4574956779222224,0.6952013182367659,0.9056603773584906,0.9883160130135016,1.0,1/7,0.95%,ANXA1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.4224094029776221,-0.695077269153017,0.8095238095238095,1.0,1.0,3/6,34.97%,ATP6AP2;GRN;TMEM9
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.4212790378936516,-0.6949150383629125,0.775,1.0,1.0,1/6,3.59%,AKR1C3
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.35872313339963957,-0.6948366775728854,0.8723404255319149,1.0,1.0,6/20,23.09%,POLR2K;POLR2C;POLR2D;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.35872313339963957,-0.6948366775728854,0.8723404255319149,1.0,1.0,6/20,23.09%,POLR2K;POLR2C;POLR2D;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.40365557534280827,-0.6946358117071194,0.8157894736842105,1.0,1.0,5/10,22.34%,CR1;GPLD1;SPG21;FPR3;SLA2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.31675445755430176,-0.6934749937411626,0.896551724137931,1.0,1.0,2/27,4.51%,EDNRB;APOE
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.39954856847851195,0.6933976826021943,0.7966101694915254,0.9898341521321882,1.0,2/13,10.74%,TBX20;TGFB2
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.34311681218851453,0.69253878402204,0.9285714285714286,0.9904207486029223,1.0,4/32,8.23%,AWAT1;ALOX12;FAAH;CYP1B1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.3347002531746232,0.6919508611192828,0.8870967741935484,0.9907261957832397,1.0,5/30,12.75%,EGF;RAB11FIP5;CTNNB1;ABCA2;STX4
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.2785863108698202,-0.6913760266495287,1.0,1.0,1.0,20/111,19.77%,CSDC2;EXOSC8;EXOSC4;VIM;EXOSC5;HSPA1A;PSMD10;PSMD12;IGF2BP3;CNOT7;PSMB5;CNOT1;PSMD2;RC3H1;ZFP36L2;PSME3;PSMB4;PCBP4;PSMB6;UBB
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.35839106667310644,0.6913704412537163,0.8382352941176471,0.9910382263693429,1.0,5/21,18.00%,KIF5A;HOOK1;KIF5C;TUBA1B;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.3591400148040361,0.6911559689462684,0.8923076923076924,0.9909409529498342,1.0,3/37,8.07%,PRKCG;AGAP2;LDLR
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.3842991285986987,0.6909758715157776,0.873015873015873,0.9908200760535254,1.0,5/23,11.60%,WAS;PAK3;ARHGAP18;FCHSD1;PLEKHG2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.32874652360436996,0.6907586951929946,0.9583333333333334,0.9907533370860285,1.0,21/46,29.35%,RAMP3;DNM1;SNCA;GRK2;MX1;SYK;SMURF1;TFRC;RAMP1;DNM2;LDLRAP1;GRK3;LMTK2;ARFGEF2;CLTC;SH3GLB1;NEDD4;KIF16B;NSG1;UVRAG;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.35320991209814084,-0.6905970741762446,0.926829268292683,1.0,1.0,3/23,7.23%,SELENOS;TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.4632848778564433,-0.6903237807438052,0.8409090909090909,1.0,1.0,1/6,4.68%,RGCC
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3266756306565165,0.6898506315842384,0.9104477611940298,0.9913724022094442,1.0,17/52,30.03%,MAP1LC3A;ATG9A;GABARAPL1;SMURF1;ELAPOR1;PACS2;RAB7A;ATG16L2;WDR45;TMEM41B;ULK1;ATG7;GABARAPL2;VMP1;ATG5;NSFL1C;ULK2
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.3895310782752591,0.6898269056982498,0.8163265306122449,0.9908200730560525,1.0,3/11,15.40%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.3895310782752591,0.6898269056982498,0.8163265306122449,0.9908200730560525,1.0,3/11,15.40%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.3192348818367844,0.68940844677468,0.9487179487179487,0.9909626726481106,1.0,5/46,8.83%,NSDHL;ABCA5;SOAT1;CYP1B1;CYP21A2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.36861456128033376,0.6893222526113708,0.8448275862068966,0.9907542754615783,1.0,3/14,7.80%,CIITA;LARP6;SCX
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.42917121812006775,0.6890721365445857,0.82,0.9907348984622708,1.0,1/7,8.86%,UGDH
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3824213774129084,-0.6890623298231472,0.8297872340425532,1.0,1.0,5/12,28.24%,RNF168;RNF8;LARP7;RECQL5;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3748025617225369,-0.6889421450579057,0.9069767441860465,1.0,1.0,2/19,4.51%,ERP29;APOE
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3789574110629391,0.6888099431595939,0.8135593220338984,0.9906885555731502,1.0,3/15,15.40%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.41804097638187715,0.688756874730153,0.9016393442622951,0.9904365986010784,1.0,5/11,21.20%,DYSF;SYK;IFI35;SBNO2;NMI
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3472689186900362,0.6887022434665431,0.8873239436619719,0.9902016412020933,1.0,5/31,14.45%,NEFL;SYBU;MAPT;HAP1;DCTN1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.2688757288067457,-0.6878739367325619,1.0,1.0,1.0,10/62,14.80%,GSTT2B;TPP1;RHCE;PCSK1;SPCS1;APEH;MMACHC;ERAP2;SPCS2;GSTM3
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.3904515886810285,-0.6877978359182436,0.9142857142857143,1.0,1.0,6/13,24.40%,ENTPD1;DCTPP1;NUDT15;ENPP3;ENTPD5;ITPA
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.45182191912059777,0.6876510687832479,0.8888888888888888,0.9909203009996261,1.0,1/8,4.89%,TRPM4
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.3430250667257103,0.6875133724919158,0.9230769230769231,0.990762807874583,1.0,5/26,12.81%,FABP3;MFSD2A;LDLR;SORBS1;MLXIPL
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.371796688605194,-0.6870607028004265,0.8444444444444444,1.0,1.0,1/14,1.39%,STAB2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.329681781039655,-0.6868358823468868,0.9473684210526315,1.0,1.0,8/27,13.60%,SLC25A5;MUL1;FZD9;HSPA1A;PRELID1;PSMD10;CLU;TRIAP1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.3523581737298631,0.686627213171811,0.8939393939393939,0.9913226202973541,1.0,4/26,11.57%,CENPP;MIS18A;CENPV;CENPH
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.3240744206921395,-0.6864510508859702,0.9473684210526315,1.0,1.0,1/25,0.81%,AR
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.4174498310900221,0.6860699638545239,0.8545454545454545,0.9915589472210405,1.0,1/6,14.43%,PHACTR1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.34855263343095444,0.6859571454662029,0.9333333333333333,0.9913845790794701,1.0,4/39,14.54%,TRAF3IP2;TRIM5;ARIH2;RNF152
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.4396836488672802,0.6858623929138323,0.8909090909090909,0.9909150746002955,1.0,2/9,12.73%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4396836488672802,0.6858623929138323,0.8909090909090909,0.9909150746002955,1.0,2/9,12.73%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.41923309504289186,0.685857267176381,0.8846153846153846,0.9906233716051231,1.0,1/10,5.88%,FAS
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.36062097749106264,-0.6855231759595162,0.8292682926829268,1.0,1.0,2/16,8.07%,OAT;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.34637579992900225,-0.6853983346147918,0.9428571428571428,1.0,1.0,3/24,4.68%,MEOX2;APOE;RGCC
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.441155097625449,0.6849709053456299,0.896551724137931,0.9911889590771676,1.0,1/6,4.37%,GAD2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.415318211592677,-0.6846520064252835,0.8292682926829268,1.0,1.0,3/9,19.09%,EIF2S1;DDIT3;EIF2AK3
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4146503705347373,0.6843927661320889,0.875,0.9912972182283912,1.0,1/7,12.37%,TRUB1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3306236311289368,-0.6841311481681073,0.8918918918918919,1.0,1.0,2/26,4.59%,GDF9;TWSG1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.4607087081027277,0.683747980181545,0.8923076923076924,0.9916338442547503,1.0,1/5,5.99%,TNFRSF14
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.4042864688002644,-0.6833463313844629,0.8604651162790697,1.0,1.0,1/7,5.88%,SERPINF2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.42349517785670737,-0.6833335123020778,0.7446808510638298,1.0,1.0,1/5,14.15%,USP19
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.36774233693609937,-0.6828236667149525,0.8541666666666666,1.0,1.0,2/11,16.20%,GNPDA2;NAGK
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.36774233693609937,-0.6828236667149525,0.8541666666666666,1.0,1.0,2/11,16.20%,GNPDA2;NAGK
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4009762686362549,-0.6827340506339002,0.7857142857142857,1.0,1.0,2/6,10.71%,APEH;VPS4B
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.31276916795064436,-0.6825829329607663,0.9696969696969697,1.0,1.0,8/43,14.25%,TTC29;CFAP53;ADCY10;TEKT5;SPAG17;TEKT1;DNAH5;SPEF2
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3099173526079279,0.6825242771264386,0.9714285714285714,0.9924908065247477,1.0,5/61,10.05%,SLC4A10;ABCC4;SLCO1A2;SLC4A9;SLC4A11
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.4591123228873977,0.68243985563594,0.8688524590163934,0.9922695723326003,1.0,1/5,21.36%,PMPCB
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2960970976577385,0.6813886481038706,0.9701492537313433,0.9930184421712722,1.0,9/79,17.10%,KHDRBS2;RBM24;SRRM4;MBNL2;CELF3;WTAP;KHDRBS3;RBFOX2;NOVA2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.32249049082142256,-0.6808736605328001,0.9117647058823529,1.0,1.0,3/39,8.49%,RFC3;POLD3;PRIMPOL
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.3399085364013731,0.6808067275625604,0.8983050847457628,0.9932333752685394,1.0,6/25,23.50%,CDKN1A;TP53;TINF2;EXOSC10;ACD;PIF1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.4205867307875402,-0.6804966049862198,0.8372093023255814,1.0,1.0,2/7,13.69%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.3585584313575972,0.6801908216919142,0.8787878787878788,0.9934750168405792,1.0,5/24,13.89%,SPAG1;DCX;RSPH4A;DNAJB13;CFAP74
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.27282974312529895,-0.6801249427651842,1.0,1.0,1.0,14/59,20.45%,PGP;PIGW;GDE1;GPLD1;PLA2G4C;ENPP6;PLA2G15;PRDX6;DPM2;GPCPD1;PLA2G4A;PIGF;GDPD1;CPNE3
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.3885369201832669,0.6799421397601116,0.9027777777777778,0.9934013011310591,1.0,1/12,2.85%,CD55
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.41333033730337615,-0.679253411159473,0.8297872340425532,1.0,1.0,1/8,13.44%,CLU
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.33081110575850003,0.6779488740689055,0.9041095890410958,0.9949233572700164,1.0,4/36,19.19%,DAB2IP;CDC7;BRCA1;MAX
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.41675242092850096,-0.6779328109436548,0.9333333333333333,1.0,1.0,1/7,17.25%,THBS4
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.39958634197441156,-0.6775946437829822,0.8421052631578947,1.0,1.0,1/8,5.43%,RNF2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.35389045790319096,0.6775632958659764,0.8805970149253731,0.9949699097804406,1.0,5/24,17.11%,SAMHD1;NLRC5;TTLL12;FADD;WNT5A
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.26294067220529327,-0.6772956722359086,0.972972972972973,1.0,1.0,8/69,11.14%,RBM23;BRDT;RRP1B;RPS26;RPS13;PQBP1;HSPA1A;ZPR1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.34754433424126724,0.6771667267296201,0.8771929824561403,0.9949594781082711,1.0,8/25,26.17%,NOS1AP;ATP2B4;CAV3;DNM2;HIF1A;SCARB1;HTR2B;GCH1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.32723441498142203,-0.6764315059041051,1.0,1.0,1.0,4/22,10.24%,POLD3;MCM9;PMS1;MSH4
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.342448586181314,0.6752829328356128,0.9206349206349206,0.9963926532884367,1.0,8/25,15.95%,TLR2;TNFRSF14;MYD88;LYG1;HLA-E;GSDMD;IL12A;LYG2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.4357180061152025,0.6752066439450379,0.9122807017543859,0.996154116727986,1.0,2/6,27.38%,DSEL;CHST14
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.3427866902575378,0.6750339088252498,0.9076923076923077,0.9959860166147686,1.0,11/30,27.89%,STEAP3;TF;TFRC;DNM2;ATP6V1B2;LMTK2;CLTC;ARHGAP1;ATP6V1C1;ATP6V1C2;ATP6V1G2
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.43003029432424156,-0.6741683114860314,0.7954545454545454,1.0,1.0,2/5,22.43%,TMEM167B;TRAPPC11
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.42029707312634496,0.6737957358608251,0.8867924528301887,0.9968888878206412,1.0,1/5,15.16%,CD70
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3225993172132754,0.6736660380218994,0.8983050847457628,0.9967307074533763,1.0,3/39,7.19%,RPA1;HROB;POLD1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.27250808566616075,0.6736395804985215,1.0,0.9964756287122023,1.0,28/135,21.81%,STEAP3;SEPTIN4;FAS;BCL6;BIRC3;ALPK2;CASP10;TP53I3;NDRG1;ACTN1;SRA1;TNFRSF10B;LCMT1;ALK;BCAR1;RARG;TOX3;PINK1;TP53;AMIGO2;DNAJA3;RTKN;PAX8;DDX42;RTN4;ACER3;LGALS1;ACTN4
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.4065715281931833,0.6735225378699854,0.9333333333333333,0.9962942571637011,1.0,2/12,17.75%,TLE6;MAP4
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.4091754575572306,0.6734950297469159,0.890625,0.9960194000908548,1.0,1/7,15.98%,RARG
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.4342253674860356,-0.6734411533228588,0.8297872340425532,1.0,1.0,2/6,35.24%,RPUSD4;PUS10
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.38633471648369,0.6732148319366077,0.9322033898305084,0.996025396749284,1.0,1/12,5.26%,ABCC4
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),-0.4134413218884765,-0.6727931599251552,0.9024390243902439,1.0,1.0,2/5,11.91%,CXCL13;CYP7B1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.36049616249937666,0.6726737495204653,0.9230769230769231,0.9961883983259958,1.0,4/19,11.54%,TRAF3IP2;CGAS;ZDHHC1;PARP9
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.40984710071354563,-0.6723239979691745,0.85,1.0,1.0,3/5,24.82%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.40984710071354563,-0.6723239979691745,0.85,1.0,1.0,3/5,24.82%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.40984710071354563,-0.6723239979691745,0.85,1.0,1.0,3/5,24.82%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.38964917038459335,-0.6722827851117428,0.9411764705882353,1.0,1.0,2/9,7.89%,DGKE;DGKB
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.42469906300380267,-0.6722471766749478,0.8222222222222222,1.0,1.0,1/7,1.82%,SELENOS
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.34561315390275743,-0.6719033673687184,0.918918918918919,1.0,1.0,3/17,10.14%,DHFR2;ALDH1L2;SLC46A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3655510604303508,0.6717396229149761,1.0,0.9966719088706593,1.0,8/23,19.70%,KCNQ1;RYR2;SLC9A1;ATP1B1;SLC8A1;CALM3;CAV3;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.3641811042396756,-0.6716777405114928,0.9117647058823529,1.0,1.0,6/15,22.42%,XG;TIRAP;THBS4;DNM1L;MCU;MDK
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.3215771739531292,-0.6716772981447166,0.9210526315789473,1.0,1.0,5/29,14.53%,THAP7;NOC2L;KMT2A;TADA2B;BRD7
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.34451526108087627,-0.6715868980551396,0.9487179487179487,1.0,1.0,2/17,8.82%,KPNA2;RGPD8
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2584933816260332,0.6709642158481701,1.0,0.9971417821360222,1.0,29/263,17.11%,YWHAH;TBC1D9;CNTN2;GRID2;CNTNAP1;CNTNAP2;SEPTIN5;SEPTIN4;SEPTIN8;SEPTIN9;TMED10;CTNNB1;SH3PXD2B;SCG5;PACSIN1;DUOXA1;USP6NL;RAB20;ARF6;STX4;PICK1;ATG9A;TBC1D1;SEPTIN10;STX1B;SMURF1;TBC1D10B;COPZ2;WNT5A
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.34319854811231065,0.67064372716567,0.95,0.9971140670331501,1.0,2/24,14.34%,TMED10;OPTN
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3831799595172163,0.6706411303592849,0.9107142857142857,0.9968227687372012,1.0,4/16,12.38%,GABBR2;CACNA1C;ORAI1;CAP2
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.31496699516298077,0.6704192029531182,0.9538461538461539,0.9967117698280695,1.0,17/50,31.08%,MAP1LC3A;ATG9A;GABARAPL1;ELAPOR1;PACS2;RAB7A;ATG16L2;WDR45;TMEM41B;ULK1;ATG7;GABARAPL2;VMP1;ATG5;NSFL1C;ULK2;RAB1A
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.4183491666082718,-0.6702987202949938,0.9215686274509803,1.0,1.0,2/5,13.41%,PTPN22;RUNX1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4426675345243207,-0.6698288368744119,0.8378378378378378,1.0,1.0,2/5,25.37%,CTR9;LEO1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4426675345243207,-0.6698288368744119,0.8378378378378378,1.0,1.0,2/5,25.37%,CTR9;LEO1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.4118821461426003,0.6697697870724096,0.8035714285714286,0.9969809975386918,1.0,3/9,13.05%,PADI2;APOD;CD200
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.36753717347593323,0.6696837908746662,0.8793103448275862,0.9967566687469378,1.0,1/13,6.89%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.3320864518182906,0.6693454406945025,0.9393939393939394,0.9967357720696864,1.0,12/56,21.22%,FYN;NECAB2;LIMK2;YAP1;PARP9;MAPT;STX4;WWTR1;TFRC;MAP1A;DDRGK1;RTN4
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.42072912278101626,-0.6692869257970585,0.8260869565217391,1.0,1.0,3/7,7.40%,EDNRB;EDNRA;PIK3C2A
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.31856188473728364,-0.6688587048985697,0.9393939393939394,1.0,1.0,4/34,12.01%,RPL23;PDCL3;HFE;RPL11
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3595535087824854,-0.6683665628785795,0.96875,1.0,1.0,1/22,3.02%,EIF4EBP1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.3986130795707633,-0.6682108621862193,0.9117647058823529,1.0,1.0,5/5,60.15%,ATP2C1;ACSL3;RACK1;CLN3;CNST
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.2745753654431824,0.6681245973739576,0.9672131147540983,0.9975878281607878,1.0,16/96,22.06%,APP;ADD2;DVL1;HDAC4;PEX14;CDKN1A;PRKCD;B2M;TMC8;HIPK2;STK3;CTSZ;BTBD1;LDLRAP1;AMFR;ZFPM1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.32575142025027737,0.6678758629784255,0.9846153846153847,0.997500084028579,1.0,9/40,25.67%,DAB2IP;DENND3;RNASEH2C;NEU4;SUPV3L1;SND1;EXOSC7;FBXO2;PRKN
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.4278854028910872,-0.6674092537954025,0.8222222222222222,1.0,1.0,3/6,25.03%,TNIP1;VCP;SART3
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4248896962910485,0.6671803637562087,0.8412698412698413,0.9977886687987767,1.0,2/8,23.66%,PLEKHA4;MLLT3
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.27584241908280616,-0.6671665046458066,0.967741935483871,1.0,1.0,9/79,12.62%,TNFAIP3;TRIM21;POLR2K;PTPN22;DHX33;PQBP1;POLR3F;POLR3E;POLR3B
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.3057298043208362,-0.6670800605641594,0.926829268292683,1.0,1.0,3/47,3.14%,SRPRB;TPP1;SRPRA
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.3910485299816715,-0.6668643994011325,0.8157894736842105,1.0,1.0,3/11,17.09%,CXXC4;WNT7A;STIL
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.30781790035263934,0.6663924639054184,0.971830985915493,0.9981769529761277,1.0,2/64,1.84%,IGF1;THBS1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.27604052597787715,-0.6663671733648638,0.972972972972973,1.0,1.0,8/41,20.54%,ERCC8;ABRAXAS1;ERCC6;CEBPG;RNF168;BRCC3;UBE2V2;RNF8
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.3964672943170591,0.6661606029878144,0.8043478260869565,0.9980724741318953,1.0,5/8,33.38%,ASXL1;GPS2;ASXL2;CITED2;SIRT1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3633817231455899,-0.6661466948696856,0.8529411764705882,1.0,1.0,5/13,23.01%,HUS1;RAD9B;MUS81;CHEK2;RAD17
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.3749438019855442,-0.6660489348223276,0.8333333333333334,1.0,1.0,1/12,2.26%,MSTO1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.37504029243782266,0.6659059929664696,0.9152542372881356,0.997984691063059,1.0,1/14,3.62%,APP
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.39078181406203827,0.6658982212379455,0.8666666666666667,0.9977007243666804,1.0,5/10,30.17%,CHDH;SLC44A1;SARDH;BHMT;DMGDH
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.3880179932716846,-0.6658493860663873,0.8292682926829268,1.0,1.0,2/11,7.09%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.32654866049664316,-0.6656737252864695,0.9117647058823529,1.0,1.0,1/30,1.09%,FAM47E
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.2817503364191315,-0.6636953160022252,1.0,1.0,1.0,5/38,11.95%,CST3;HSPG2;CALB1;NCSTN;TSPAN33
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.39871441292281284,-0.6636804350119548,0.86,1.0,1.0,1/5,1.91%,CD200R1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.34850634318448426,-0.6635325710648032,0.8333333333333334,1.0,1.0,5/18,17.51%,GTF2H5;GTF2H2;ERCC2;XPA;ERCC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.34850634318448426,-0.6635325710648032,0.8333333333333334,1.0,1.0,5/18,17.51%,GTF2H5;GTF2H2;ERCC2;XPA;ERCC3
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.35102547668448403,-0.6631955428476906,0.85,1.0,1.0,6/20,17.59%,ABCA13;CPTP;SLC46A1;TAP1;SLC19A1;SLC5A6
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.39685789556694556,0.6630746663116389,0.8840579710144928,0.9997876797343657,1.0,2/13,16.65%,PID1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.32079057826591345,-0.6629484751284923,0.9512195121951219,1.0,1.0,4/20,19.52%,CARF;MT3;BMP2;SESN2
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.4046341266897989,-0.6629399007262489,0.8157894736842105,1.0,1.0,2/8,12.74%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.3382899954070773,0.6617557586592513,0.9344262295081968,1.0,1.0,6/37,10.76%,RAMP3;DNM1;SNCA;GRK2;MX1;SYK
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.452835789406426,0.6608105469491347,0.8909090909090909,1.0,1.0,1/5,12.75%,STX4
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.3237265965321993,-0.6607451009017656,0.9736842105263158,1.0,1.0,4/17,20.65%,RNF2;RNF168;RNF8;UBE2A
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.39992325056947514,0.6604247601137204,0.8870967741935484,1.0,1.0,1/10,7.97%,MCUB
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.4522551672064574,0.6603489863066268,0.9375,1.0,1.0,1/6,7.76%,SNCA
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3329356419596461,-0.6602867306050546,0.9166666666666666,1.0,1.0,4/24,17.21%,HEYL;VPS11;CNOT1;CNOT9
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.29912052917093873,-0.6599058205358938,0.972972972972973,1.0,1.0,9/47,19.29%,SNF8;VPS29;CCDC22;ENTR1;WASHC2C;VPS35;SNX31;SNX17;VPS26C
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.27904626770687974,0.6598180906507348,0.987012987012987,1.0,1.0,24/112,26.58%,ATF3;RPA1;NUAK1;BAG3;MAPT;NPAS2;CAMK2B;HSPH1;NEK6;PINK1;YWHAE;NEK4;AMFR;CAMK2A;DNAJC2;ADCY8;DNAJB6;NUP160;CHORDC1;EIF4G1;MAPKAPK2;PRKN;NUP88;NUP35
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.3793636644243896,0.6596903148226222,0.9642857142857143,1.0,1.0,5/16,24.15%,SEC14L1;SLC25A29;SLC29A4;SLC44A1;SLC22A4
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.2993482044833462,-0.6596527224235331,0.9117647058823529,1.0,1.0,3/41,8.49%,RFC3;POLD3;PRIMPOL
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.3300750358648407,0.659435889827823,0.8867924528301887,1.0,1.0,5/23,21.17%,EIF5A;IFIH1;IL12A;MAPK11;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.35660077643963384,0.6578768539509157,0.8813559322033898,1.0,1.0,5/16,22.54%,CDK6;RARA;ZFPM1;TLR3;MAFB
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.44152028005765387,0.6578239239366969,0.8421052631578947,1.0,1.0,3/7,24.41%,STAC2;CACNB2;STAC
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.3878105633180685,0.6575946589586839,0.88,1.0,1.0,2/7,13.52%,ABCB9;B2M
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.396399593858023,-0.6569035216885692,0.8604651162790697,1.0,1.0,2/8,5.46%,APOE;APOM
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4242148122095962,0.6561519887249267,0.8448275862068966,1.0,1.0,3/8,10.74%,SOX4;TBX20;TGFB2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.4330897553601618,-0.6556500929303399,0.8478260869565217,1.0,1.0,3/5,7.40%,EDNRB;EDNRA;PIK3C2A
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.24422189795852167,-0.6547465239491882,1.0,1.0,1.0,19/134,19.16%,CSDC2;EXOSC8;EXOSC4;VIM;METTL3;EXOSC5;HSPA1A;PSMD10;PSMD12;IGF2BP3;PSMB5;PSMD2;RC3H1;ZFP36L2;PSME3;PSMB4;PCBP4;CIRBP;PSMB6
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3527366253669194,0.6537992125632833,0.9545454545454546,1.0,1.0,5/19,25.67%,WASHC1;PINK1;ZMIZ1;HIF1A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.36637581599075886,0.6533355748254268,0.9122807017543859,1.0,1.0,1/14,5.14%,CD44
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.397776125425638,-0.6533249047697185,0.8958333333333334,1.0,1.0,1/7,4.71%,FOXJ1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.3480606754735449,0.6533101235779485,0.9047619047619048,1.0,1.0,4/22,21.19%,TMBIM1;PARP9;TP53;CAMK2A
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.26141167075780863,0.6525008908505573,1.0,1.0,1.0,16/165,13.88%,EGF;CCNB2;LMNB1;INCENP;SUV39H1;GINS2;PML;SMAD3;CHMP1A;SLC7A1;POLQ;BARD1;TLE3;CDC7;CDKN1B;CKS1B
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.43661994289182376,0.6524547666382822,0.8596491228070176,1.0,1.0,1/5,17.05%,XRCC1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2714711919596986,-0.651966727725729,1.0,1.0,1.0,3/53,6.39%,FBXO5;RNF2;FBXO43
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.40074333891503827,-0.6518554701125373,0.8076923076923077,1.0,1.0,1/5,4.68%,RGCC
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.431759233872434,0.6517533717334033,0.8709677419354839,1.0,1.0,1/5,8.29%,TYR
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.29783364883160623,-0.6507297388223497,0.9473684210526315,1.0,1.0,6/28,18.19%,SETDB1;SMYD2;KMT2A;MEN1;WDR82;EZH2
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.39873457882162866,-0.650179986117795,0.8717948717948718,1.0,1.0,2/6,24.02%,FUZ;VANGL2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.45693187854999895,0.6499946554163752,0.9583333333333334,1.0,1.0,1/5,10.94%,HMGCLL1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.35800225583528583,-0.6499743129427672,0.8125,1.0,1.0,2/14,13.69%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3503133417491164,0.6495003515200005,0.9032258064516129,1.0,1.0,1/23,4.52%,SUV39H1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.4124228563292758,0.6491700942484832,0.9047619047619048,1.0,1.0,1/8,10.85%,GLI2
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.28328699111172523,-0.648859572174553,0.9655172413793104,1.0,1.0,11/49,16.84%,ATP10B;APOE;NPC2;CPTP;MTTP;PRELID1;TRIAP1;ATP8B3;PRELID2;PCTP;ATP11C
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.3540929632025236,0.6484513371475464,0.9130434782608695,1.0,1.0,3/19,10.85%,LAMB1;TGFB2;GLI2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3263741363245376,-0.6481636857431861,0.9761904761904762,1.0,1.0,2/17,13.00%,MAPK7;HTRA2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3102511201023396,-0.647831993436572,0.9285714285714286,1.0,1.0,3/23,8.40%,TRIB3;SELENOK;BAK1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.39272112131220627,0.6477122069747259,0.9193548387096774,1.0,1.0,3/15,15.84%,SERPINE1;GAS6;IL12A
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.3207126201171843,-0.6472626541603128,0.9411764705882353,1.0,1.0,3/24,7.90%,SLC6A13;SLC25A19;SLC36A1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3296145274360371,0.6471723649914912,0.90625,1.0,1.0,5/35,11.07%,BMP8A;PMEPA1;RBPMS;TGFB2;LDLRAD4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.399262427538785,0.6471557550388175,0.8928571428571429,1.0,1.0,4/7,35.16%,CAMK2A;CAMK2D;BMPR1A;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.3076272382025048,0.6462755084420038,1.0,1.0,1.0,8/30,24.72%,NELL1;PKDCC;P2RX7;SLC8A1;BMP6;ANO6;TGFB3;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.33342117154839623,-0.6462056373588013,0.9117647058823529,1.0,1.0,3/18,11.50%,RPL37;RPL23;ATR
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.346735909195095,-0.6458095951257323,0.8181818181818182,1.0,1.0,3/17,8.98%,TNNT1;TTN;VIM
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.346735909195095,-0.6458095951257323,0.8181818181818182,1.0,1.0,3/17,8.98%,TNNT1;TTN;VIM
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),-0.392072570784916,-0.6454332100736717,0.9069767441860465,1.0,1.0,1/5,4.71%,FOXJ1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.4486419327965279,0.6453545532799955,0.8297872340425532,1.0,1.0,1/5,4.37%,GAD2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3532551288400993,0.6447863775863751,0.9454545454545454,1.0,1.0,9/23,24.20%,DUSP1;HECW2;CCNB1;LCMT1;NEK6;CDK5RAP2;CDC27;CUL3;USP44
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.41433145429585705,0.644709465522867,0.875,1.0,1.0,1/5,22.64%,HYOU1
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.4079582460739238,-0.644590250156121,0.8148148148148148,1.0,1.0,2/5,19.00%,WASHC2C;CARMIL2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.3293445078887083,0.6445625665995987,0.9104477611940298,1.0,1.0,2/32,3.45%,TRPC3;CP
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.3822911343756764,-0.6430219607056893,0.9487179487179487,1.0,1.0,1/7,3.59%,AKR1C3
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3250200643417173,0.6420164537929762,0.9242424242424242,1.0,1.0,4/29,11.57%,CENPP;MIS18A;CENPV;CENPH
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.36777060935607525,0.6419863691224794,0.847457627118644,1.0,1.0,2/13,10.74%,TBX20;TGFB2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.40519582298707213,0.6417420110114946,0.9298245614035088,1.0,1.0,2/7,18.08%,SLC4A11;SLC7A8
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.4640237881296295,0.6414233558666419,0.9464285714285714,1.0,1.0,3/5,18.08%,SLC16A10;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.33106934256409226,0.64124789867911,0.9,1.0,1.0,3/18,15.40%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.3629624312770694,-0.640995410116984,0.9024390243902439,1.0,1.0,2/11,9.78%,ELOVL4;ELOVL2
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.325832454248407,-0.6405326462549621,0.96875,1.0,1.0,11/20,24.40%,NT5E;PRPSAP1;NT5C;GART;PPAT;GPX1;NUDT15;PNP;PRPS1;NT5C1A;ITPA
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.2949658532927959,-0.6404290495739678,0.8947368421052632,1.0,1.0,16/40,26.34%,GRPEL2;PEX10;TIMM23;ZFAND2B;TIMM50;AKT2;TIMM17A;DNAJC19;PEX1;SEC62;SEC61A1;TOMM70;SRP54;C2CD5;SEC63;GRPEL1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4144358017770941,0.6400119627943068,0.8333333333333334,1.0,1.0,2/8,10.90%,MYD88;STAT3
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.3442018749533988,0.639967554702781,0.9016393442622951,1.0,1.0,2/17,9.66%,PLSCR1;IKBKE
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.24771866496054679,0.639831155022312,1.0,1.0,1.0,49/351,23.24%,ANLN;GOLGA8O;TEKT2;MAP1LC3A;CYS1;ABCC4;MAPRE2;HAUS7;SH3PXD2B;CDC14A;YTHDF1;MAK;CHMP1A;RP2;IFT122;MAPT;CFAP20;GOLGA8A;ATG9A;TRAPPC14;CDS2;IST1;VPS37B;NEK6;GABARAPL1;ABCA3;IFT140;CILK1;NCOR1;RILPL1;FLNA;SNX10;TXNDC15;TUBGCP6;EXOC2;CFAP54;RAB11A;CFAP44;ELAPOR1;PACS2;RAB7A;ATG16L2;ASAP1;WDR45;WDR90;TTBK2;TMEM41B;RCC1;EHD4
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.38135868081819146,-0.6395572217992475,0.8936170212765957,1.0,1.0,4/7,28.96%,VPS11;PTPN23;RDX;EZR
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.315030913482114,0.6395274055613211,0.9838709677419355,1.0,1.0,3/30,14.34%,DAB2IP;BAG3;OPTN
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2909284544103003,0.639504510461136,0.9863013698630136,1.0,1.0,8/77,17.11%,DVL1;DAAM1;PRICKLE1;PRICKLE2;CELSR3;SMURF1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.3856236595226384,-0.6389734954101959,0.918918918918919,1.0,1.0,1/9,13.90%,CLP1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.21666134403568799,-0.6387840552060178,1.0,1.0,1.0,11/285,7.41%,CDC26;ERCC8;TNFAIP3;RNF6;IRF2BP1;TRIM21;MUL1;FBXO27;TRIM68;ANAPC13;RNF114
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.4261558755364679,0.6386291505417436,0.9230769230769231,1.0,1.0,2/5,21.97%,DKK3;BMP6
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.4218715401654512,0.6380872982989869,0.9361702127659575,1.0,1.0,2/5,22.83%,DKK3;H6PD
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.387754326525716,0.6378180606413115,0.8813559322033898,1.0,1.0,2/10,16.41%,SHMT1;SERINC5
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.29229941162448964,0.6374597381945479,0.9861111111111112,1.0,1.0,5/65,13.68%,MAP3K14;BIRC3;CHI3L1;RELB;TNFRSF10B
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.39321910050728515,0.6372492927419093,0.8833333333333333,1.0,1.0,4/7,37.66%,TJP1;F2R;NLGN2;CSF1R
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.32482679671372683,0.6368833298680812,0.9852941176470589,1.0,1.0,7/21,21.87%,TERF2IP;NEIL2;OGG1;TINF2;TDG;NEIL1;ACD
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.4313109701410002,0.6365048103457392,0.9629629629629629,1.0,1.0,1/6,10.32%,NFKBID
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.42976806517424093,0.6363527978394995,0.9032258064516129,1.0,1.0,2/6,6.80%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.36539802939835575,0.6361914910639472,0.9375,1.0,1.0,3/13,16.67%,ALOX12;PNPLA8;ELOVL5
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.36542961048914296,0.636169789371386,0.9122807017543859,1.0,1.0,8/15,32.35%,CLTB;NSG2;CALY;FCHO2;CLTC;NSG1;PICALM;HIP1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.29445953242374956,-0.6360826988554399,1.0,1.0,1.0,5/36,16.38%,DYNLRB2;DYNLRB1;CEP131;DYNC2I1;DYNLL1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.4160951737436508,0.6360664268983013,0.9245283018867925,1.0,1.0,4/7,27.48%,BIN1;YWHAE;SESTD1;CBARP
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.39120470026758186,0.6360313891470086,0.8679245283018868,1.0,1.0,1/7,12.73%,PRKCD
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.3923648820515336,0.636022604958056,0.9322033898305084,1.0,1.0,2/6,13.27%,OLAH;ACOT7
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.31539172845677854,0.6358801172946793,0.9859154929577465,1.0,1.0,4/32,11.72%,RAB15;SNCA;SYTL4;RAB27B
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.40978925437991087,0.6354947359570955,0.8888888888888888,1.0,1.0,1/5,13.83%,PER1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.4145237653067272,0.635479916214659,0.8775510204081632,1.0,1.0,3/6,17.51%,SFTPD;ABCA3;RCN3
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.4145237653067272,0.635479916214659,0.8775510204081632,1.0,1.0,3/6,17.51%,SFTPD;ABCA3;RCN3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.332976416152417,0.6354698357538763,0.9841269841269841,1.0,1.0,4/26,16.67%,ACSL5;HACD1;ELOVL7;ELOVL5
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.4060614578624526,-0.6353497074066581,0.8666666666666667,1.0,1.0,1/7,2.08%,CST3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.33707336828547796,-0.6353074512471975,0.9142857142857143,1.0,1.0,1/13,4.76%,NPC2
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.33274599337086597,0.634966700871515,0.9850746268656716,1.0,1.0,4/27,13.19%,TJP3;GALNT12;CAPN8;BACE2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.4022680099225434,-0.6346292588953847,0.918918918918919,1.0,1.0,8/8,59.79%,FGFR3;LRP5;LRP6;SFRP4;BMPR1B;SKI;BMPR2;FGFR2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.2160829208599624,-0.634525643001924,1.0,1.0,1.0,48/312,21.27%,CDC26;ERCC8;TNFAIP3;RNF6;FBXO45;ELOC;KCTD2;RNF114;VPS4B;PPP1R11;ZFAND2B;RAD23A;SPSB4;FEM1A;PSMD10;PSMD12;UBL7;FBXL22;WDR91;PSMB5;ANAPC15;KLHL8;RNF126;DCAF11;PSMD2;RC3H1;RNF5;RNF167;RNF34;RNF168;FEM1C;TRIM3;DDIT3;PSME3;PLK1;PSMB4;PSMB6;ATXN3;GID8;SKP2;UBE4A;RNF8;UBXN2A;SHARPIN;UBE2A;KBTBD7;NUB1;COPS3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.41957093996006695,0.6319430345659456,0.9166666666666666,1.0,1.0,2/6,31.08%,UBXN1;USP25
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.2984215087390212,0.6318939153104624,0.9710144927536232,1.0,1.0,5/30,18.82%,RARG;RAP1GAP2;NEB;VAV2;VAV1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.33397620263182515,0.6315910515385139,0.9344262295081968,1.0,1.0,7/22,23.73%,APP;CCNB1;CDC25B;PRKCA;MEIS2;USP2;CUL3
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.3899029017502166,0.631504122649158,0.9107142857142857,1.0,1.0,1/9,12.31%,EEF1A2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.23681466601375772,-0.6310695457778799,1.0,1.0,1.0,8/76,14.78%,AAAS;RAE1;NUP50;HSF1;HSPA1A;ATR;NUP54;BAG2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.2899695633234391,0.6309792613156887,0.971830985915493,1.0,1.0,18/60,21.17%,FOXO1;SOX4;HK2;STAT3;PYGL;MLXIPL;PPARG;BACE2;KLF7;PDK4;HK1;ADIPOR2;GCKR;STK11;CAV3;IGF1R;HECTD4;HIF1A
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.41439670748492274,0.6308666416489105,0.9473684210526315,1.0,1.0,2/7,15.17%,MAPK8IP1;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.35399532056088573,0.6304359469635548,0.8771929824561403,1.0,1.0,5/16,27.38%,DLG5;KIF7;TXNDC15;GLI1;TTC23
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.23906468244085152,-0.6304177183742548,1.0,1.0,1.0,15/67,21.44%,TRIB3;ARRDC4;BCL10;PEF1;RPS2;SPSB4;PSMD10;TBC1D7;DCUN1D2;HSPBP1;PLK1;UBB;MALT1;FANCM;TSPYL5
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.3241473764810958,-0.6303637163979258,0.8913043478260869,1.0,1.0,4/19,13.44%,HSPA1A;BBS10;TMEM35A;CLU
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.36144554745149454,0.6303237962458088,0.9523809523809523,1.0,1.0,1/13,3.77%,DAB2IP
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.323514016549898,0.6302189369920059,0.9710144927536232,1.0,1.0,9/35,21.51%,PSRC1;DCX;TPPP;RSPH4A;CFAP74;MTCL1;CDK5RAP2;LRGUK;JHY
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.3942964826660863,0.6291418426023218,0.8695652173913043,1.0,1.0,3/8,19.05%,APOD;KLF4;MAP2K5
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.309284390851839,0.6291225453402801,0.9661016949152542,1.0,1.0,12/31,25.12%,SLC39A14;SLC7A1;SLC1A6;SLC29A1;SLC7A8;LRSAM1;LRP2;SLC38A1;SLC12A7;SLC12A4;SLC22A4;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.34153148810139744,0.6291124222992496,0.9344262295081968,1.0,1.0,1/15,4.24%,NOS1AP
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.28749201334600155,0.6281623322778173,1.0,1.0,1.0,8/77,17.11%,DVL1;DAAM1;PRICKLE1;PRICKLE2;CELSR3;SMURF1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.36778757818589264,-0.6276431201291865,0.9767441860465116,1.0,1.0,1/7,3.47%,ZC3H8
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.41588807833356356,-0.626856932172146,0.9,1.0,1.0,1/5,11.26%,ZNF304
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.3541021596177423,-0.6265855276955632,0.8292682926829268,1.0,1.0,1/6,10.83%,HSPA1A
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.43566868057430685,0.6264376446975548,0.9215686274509803,1.0,1.0,2/5,31.43%,CTPS2;CTPS1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.36928618449753076,0.6264107418379501,0.9464285714285714,1.0,1.0,1/12,4.24%,NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.37755055890188904,-0.62632522787009,0.8918918918918919,1.0,1.0,1/10,9.62%,HSF1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.41986973833058133,0.6261179393378222,0.9259259259259259,1.0,1.0,2/5,12.36%,P2RY12;FLI1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.3128360784050048,0.6261078177264918,0.953125,1.0,1.0,5/29,20.87%,RPA1;CDC7;POLE3;CDK2;POLE2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.4153415702132224,-0.6259951749968594,0.8372093023255814,1.0,1.0,1/5,21.48%,MYOCD
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.3298829224017734,-0.6254805041626058,0.9117647058823529,1.0,1.0,4/12,24.82%,UFL1;TEX264;UFC1;UFM1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.40535399080697676,-0.6252939758606877,0.9375,1.0,1.0,1/5,7.74%,LY96
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.3244099581647969,-0.6248718808873174,0.8979591836734694,1.0,1.0,2/12,16.20%,GNPDA2;NAGK
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.3513664304052559,0.6244820929186345,0.9454545454545454,1.0,1.0,2/16,6.67%,SLC39A14;SLC39A11
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.31061933611087245,0.6242733479403201,0.9594594594594594,1.0,1.0,9/47,15.55%,WAS;CORO7;WASF1;FAM107A;TPPP;FGF13;MAPT;SPIRE1;COBL
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.31486270252311294,0.6242030928862329,0.9552238805970149,1.0,1.0,4/26,10.74%,ECE1;CACNA1C;CTNNB1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.29908148920215105,0.6241704154704529,0.9866666666666667,1.0,1.0,9/43,19.18%,PRKCG;FAM168A;NPAS2;SPIRE1;FMN2;XRCC1;SPIRE2;BRCA1;WRAP53
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.2745126936464863,-0.6237844751111554,1.0,1.0,1.0,15/66,20.95%,EIF2S1;RRAGC;ATP6V1G1;ATP6V1E2;ATP6V0D2;SLC38A9;ATP6V1F;RRAGA;MIOS;DAP;LARS1;EIF2AK3;SESN2;NPRL2;WDR24
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.3852888710887442,0.6233873280613671,0.8852459016393442,1.0,1.0,4/9,29.35%,TGFB2;TGFB3;HLA-F;TGFB1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.2864531033652487,0.6233539160080113,1.0,1.0,1.0,6/70,13.93%,APP;EIF4A3;LSM11;THOC6;GRSF1;DHX38
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.3249528769597823,0.6232146461309696,0.9672131147540983,1.0,1.0,6/29,23.21%,NUDT16;RNASEH2C;ENTPD2;SUPV3L1;SND1;EXOSC7
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.3091220847525794,0.622830985186915,0.984375,1.0,1.0,5/32,15.67%,CENPP;MIS18A;CENPH;SRCAP;SPTY2D1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.4246495120342854,0.6222128924353265,0.9047619047619048,1.0,1.0,1/6,12.90%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.4246495120342854,0.6222128924353265,0.9047619047619048,1.0,1.0,1/6,12.90%,PPARG
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3637610541828314,-0.622172398966548,0.9444444444444444,1.0,1.0,1/12,2.98%,COPS8
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.35672449735491574,0.6218677005168891,0.9047619047619048,1.0,1.0,10/13,44.09%,ATG7;UBA2;UBA5;UBA6;SAE1;ATG10;UBA3;UBA1;DESI1;UBA7
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.3664547961687944,0.6213812668243248,0.9433962264150944,1.0,1.0,2/12,14.63%,PDK4;BCL2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.38922515936446395,-0.620910484801906,0.9024390243902439,1.0,1.0,2/9,7.09%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.40534188716684294,0.620869584847978,0.8245614035087719,1.0,1.0,2/5,31.67%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.40534188716684294,0.620869584847978,0.8245614035087719,1.0,1.0,2/5,31.67%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.27737397181317325,-0.6208430018470898,1.0,1.0,1.0,15/65,20.95%,EIF2S1;RRAGC;ATP6V1G1;ATP6V1E2;ATP6V0D2;SLC38A9;ATP6V1F;RRAGA;MIOS;DAP;LARS1;EIF2AK3;SESN2;NPRL2;WDR24
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.40445456846368,0.620214790683118,0.9508196721311475,1.0,1.0,6/6,59.57%,XRCC4;XRCC6;MGMT;LIG1;LIG4;LIG3
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.37591528914736994,0.6192788866197106,0.921875,1.0,1.0,1/9,18.89%,ETS1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.36478413604918214,-0.6189146172899054,0.8863636363636364,1.0,1.0,4/6,25.59%,TEX264;FAM111A;VCP;SPRTN
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.39777008387281143,0.6185485391140221,0.8571428571428571,1.0,1.0,1/6,4.81%,MYH11
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.3201739789191981,-0.6180448505507856,0.8787878787878788,1.0,1.0,3/21,13.50%,HSF1;ATR;MEN1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3719849953017232,-0.6178054859196702,0.7837837837837838,1.0,1.0,1/9,9.63%,GPR37L1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.3582003275838719,-0.6176336643521462,1.0,1.0,1.0,2/13,18.98%,SLC25A22;SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.28144042850265005,-0.6175403665071522,0.9761904761904762,1.0,1.0,6/46,13.50%,TRIM21;TRIB3;APOE;HFE;RPL11;MEN1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.3195282122389196,0.6165868167049495,0.9552238805970149,1.0,1.0,8/30,16.33%,PAK3;ARHGAP18;FCHSD1;TPPP;PLEKHG2;MAPT;CAMSAP3;PFN2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.262265205980154,-0.6164666388260006,1.0,1.0,1.0,8/47,16.73%,NOC2L;EIF2S1;BAK1;METTL3;ATR;TRIAP1;GNGT1;SMPD1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.3796244225293111,-0.6164261207990964,0.8541666666666666,1.0,1.0,2/6,10.78%,CACNA1S;RYR1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.3796244225293111,-0.6164261207990964,0.8541666666666666,1.0,1.0,2/6,10.78%,CACNA1S;RYR1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.3757016716374242,0.6161828639792614,0.9642857142857143,1.0,1.0,6/16,17.11%,THBS1;CD200;TNIP2;MFHAS1;LRFN5;WNT5A
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.23333281793488062,0.6161570914696366,1.0,1.0,1.0,89/445,25.29%,PRAME;MARCHF1;UHRF2;TRIM5;TRIM61;HECW2;FBXW12;NEUROD2;ENC1;TRIM22;TRIM36;SH3RF3;CTNNB1;FBXO32;TRIM17;NEURL1;PEX14;ARIH2;DTX2;BARD1;KCTD13;HECW1;SPSB1;FBXL16;RNF112;SYVN1;FBXL2;RNF19A;TRIM32;TRIM47;RNF152;BCL2;UBE2H;FANCL;GAN;TRAIP;PDZRN3;HIF3A;SMURF1;PINK1;SKP1;RNF187;LRSAM1;FBXO24;DDB2;CBFB;ARIH1;BRCA1;FBXO41;RNF122;RAD18;BSPRY;MARCHF6;WAC;CDC27;RNF144A;RPS27A;RUSC1;AMFR;HIF1A;UBE2QL1;BFAR;ZNRF2;FBXO31;UBE4B;FBXL8;KLHL7;RNF185;UBR5;TRIM44;DDB1;UBE2B;UHRF1;RNF181;PSMB3;CUL3;UBE2E1;FBXW5;TRIM54;ARRB1;FBXO2;RNF220;SDE2;CBL;FBXL4;HLA-A;UVSSA;CCNF;KCTD10
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.4063590280155303,0.6160860422779983,0.9482758620689655,1.0,1.0,1/5,18.73%,BRCA1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.4184495984667894,0.6157410310094928,0.8775510204081632,1.0,1.0,3/5,37.09%,NPHP4;TCTN1;TMEM107
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.39313140212107156,0.6154679807184485,0.9230769230769231,1.0,1.0,2/7,13.70%,SLC4A11;PDPN
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.37929999625878524,-0.6154228876310036,0.9047619047619048,1.0,1.0,1/7,10.17%,NCSTN
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.3778531491374215,-0.615404519736935,0.8421052631578947,1.0,1.0,2/5,23.36%,FBL;TRMT112
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.2865859352142235,-0.6152156225178631,0.9705882352941176,1.0,1.0,3/24,11.96%,SPDL1;CENPA;LLGL1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.36383055874271997,0.6150879176980213,0.9655172413793104,1.0,1.0,2/16,4.89%,ASPN;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.30198862851758806,0.6149917106472262,0.9827586206896551,1.0,1.0,4/23,23.50%,TINF2;EXOSC10;ACD;PIF1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.30544036618512305,0.6147650501114098,0.9166666666666666,1.0,1.0,5/31,16.57%,CENPP;MIS18A;CENPH;CABIN1;H3-3A
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.34790455867224795,-0.6147088972784394,0.9375,1.0,1.0,1/13,5.09%,SETDB1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.3711710799453192,-0.6145891879500868,0.9069767441860465,1.0,1.0,10/10,62.91%,PRKDC;HMGB1;LIG3;LIG4;LIG1;DCAF1;RAG1;TCF3;HMGB2;XRCC4
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.3892606770265766,0.6138358542379168,0.8723404255319149,1.0,1.0,1/6,8.13%,SCARA3
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.3994392306522516,0.6137660873147738,0.9344262295081968,1.0,1.0,2/5,24.94%,COL5A1;EIF4G1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.3883277697023617,-0.6137025373209354,0.9523809523809523,1.0,1.0,2/7,25.99%,DNAAF1;DNAH11
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.33248936601174806,-0.613467381598102,0.9411764705882353,1.0,1.0,13/13,66.78%,PRKRA;TUT4;AGO4;TUT7;TARBP2;ADAR;AGO3;DROSHA;MRPL44;AGO2;DICER1;LIN28B;AGO1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.3747315313593237,-0.6131667861340679,0.8333333333333334,1.0,1.0,1/8,9.63%,GPR37L1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.337673503917033,-0.6130322652007227,0.9393939393939394,1.0,1.0,1/17,1.85%,AGER
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.34022983774885596,0.6129635302515181,0.9574468085106383,1.0,1.0,1/18,1.97%,SLC7A2
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.364244219306899,-0.6125932551224089,0.95,1.0,1.0,6/10,33.96%,NMD3;NPM1;ABCE1;SDAD1;RPS15;RAN
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.294586002407348,-0.6123032304853914,0.9696969696969697,1.0,1.0,9/46,18.67%,ERCC8;ABRAXAS1;ATR;NSMCE4A;ERCC6;CEBPG;RNF168;SPRED1;BRCC3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.2567297808495619,-0.6122214680690365,1.0,1.0,1.0,7/65,13.44%,AR;APOM;TFIP11;HSF1;HSPA1A;WASHC2C;CLU
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.3697410514064393,-0.612015084991112,0.9038461538461539,1.0,1.0,1/5,7.42%,AOX1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.28104171685848145,-0.6115862711565592,0.975,1.0,1.0,4/28,10.21%,APOE;DGKE;DGKB;GK
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.3855772300732314,0.6112402389487646,0.9354838709677419,1.0,1.0,1/7,19.35%,WHRN
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3571831305816423,0.6112349430161287,0.9310344827586207,1.0,1.0,2/15,19.18%,PARP9;WRAP53
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.2995898035094483,0.6110246830505838,0.9583333333333334,1.0,1.0,6/41,16.17%,APP;GRM5;FOXO3;CNDP1;MAPKAPK5;KLF4
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.33205082772237127,-0.6109855480871363,0.8285714285714286,1.0,1.0,8/8,66.81%,MLST8;NPRL3;MTOR;RPTOR;SMG1;CARD11;CLEC16A;LARP1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.3444572750423053,-0.609994868644438,0.8888888888888888,1.0,1.0,5/12,22.42%,TIRAP;THBS4;DNM1L;MCU;MDK
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.3444572750423053,-0.609994868644438,0.8888888888888888,1.0,1.0,5/12,22.42%,TIRAP;THBS4;DNM1L;MCU;MDK
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.3055071571729914,0.6095517138033993,0.9838709677419355,1.0,1.0,7/27,24.61%,PIGA;PGAP4;PIGB;PIGK;PIGQ;PIGH;PIGX
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.40540347293770973,0.6095234610305806,1.0,1.0,1.0,2/7,19.87%,HMGCLL1;BCAT1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.33185951160876526,0.6091894854821351,0.9384615384615385,1.0,1.0,5/19,25.74%,PPP1R16B;MFHAS1;YWHAE;ARPP19;ENSA
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.3477651519439807,0.6088030854905189,0.875,1.0,1.0,1/12,10.34%,CHMP1A
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.3148508838645071,-0.608776670985887,0.9117647058823529,1.0,1.0,5/12,23.87%,LY96;IPMK;DNM1L;PGAM5;CD14
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.4053039129321923,0.6081520784040283,0.9354838709677419,1.0,1.0,2/6,26.88%,ZBTB1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.3280733222487152,-0.6079315952356391,0.9722222222222222,1.0,1.0,1/11,7.20%,ZNF502
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.31100199681795226,-0.6077845125253976,0.975,1.0,1.0,4/16,13.26%,FICD;PLXNB3;RRP1B;TMED2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.28252124761475267,0.6074173156261627,1.0,1.0,1.0,3/62,10.51%,LMO2;KITLG;YAP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.25460225609176756,0.6073189642918516,1.0,1.0,1.0,29/143,23.99%,PIM3;APP;BTG3;CDK9;HECA;SMAD3;CDKN1C;TTLL12;SRA1;CDKN1B;CCNB1;CKS1B;IQGAP1;NEK6;SKP1;CDC25B;SCRIB;PRKCA;TFAP4;BTG1;CDC27;TTC28;MEIS2;DDB1;RCC1;USP2;PSMB3;UBE2E1;PIN1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.37262158009979823,0.6073112664823622,0.9344262295081968,1.0,1.0,1/12,6.09%,NUDT16
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.4173196614279038,0.6072619088416766,0.8823529411764706,1.0,1.0,1/5,13.51%,CCNB1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.3693656859987648,-0.6066688855766666,0.9555555555555556,1.0,1.0,2/8,5.46%,APOE;APOM
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.32818088927132594,0.6056061484303972,0.9166666666666666,1.0,1.0,2/12,15.09%,PML;MRE11
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.31777563413214677,0.6054646576855576,0.9482758620689655,1.0,1.0,2/19,14.11%,UGDH;NANS
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3426189451843116,0.6049385355951307,0.9545454545454546,1.0,1.0,5/14,26.13%,RYR2;DDRGK1;HSPA5;UBAC2;GABARAPL2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.2741383860298124,0.6045701662286416,0.9859154929577465,1.0,1.0,15/72,20.46%,BLM;HK2;NR6A1;ERCC6L;ALPL;CENPH;CDC7;TRIM32;NAP1L1;SET;PHF6;ATAD5;RFC4;FUBP1;HELLS
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.34681084546095964,0.604299090872416,0.9523809523809523,1.0,1.0,1/13,12.04%,TERF2IP
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.35575835072096235,0.6038608844493596,0.9482758620689655,1.0,1.0,2/10,9.59%,PADI2;ART3
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.3814929212485059,0.6025647612361978,0.9322033898305084,1.0,1.0,2/8,27.79%,MAPKAPK2;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.3190787405607155,-0.6024332349764756,0.9024390243902439,1.0,1.0,1/11,5.66%,SIRT6
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.36132434435571636,0.6012880694922829,0.9122807017543859,1.0,1.0,1/9,9.34%,PLAAT3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.31246923501788004,0.6010978400987816,0.9850746268656716,1.0,1.0,2/28,11.54%,WAS;PARP9
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.2628212010584156,0.6010491416996784,1.0,1.0,1.0,17/97,20.02%,THBS1;ATF3;DAB2IP;PDIA2;NIBAN1;BBC3;TNFRSF10B;SYVN1;BCL2;EIF2B5;MAP3K5;TP53;RCN3;SCAMP5;ITPR1;UBXN6;MARCHF6
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.3560111364211592,-0.6006249795412628,0.8888888888888888,1.0,1.0,6/6,64.41%,MAPK8;FNTA;C6ORF89;PRKD1;PRKD2;VEGFA
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.38526187482469587,0.6000730857666992,0.9649122807017544,1.0,1.0,1/5,10.90%,STAT3
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.299024288058468,0.6000459678887634,0.9726027397260274,1.0,1.0,4/25,14.96%,SLCO1A2;SLC17A5;SLC26A8;SLC13A4
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.3452310704680682,-0.6000342855921891,0.8653846153846154,1.0,1.0,3/8,29.04%,NR1H2;PROM2;NR1H3
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.34710317451204314,0.5999097891512921,0.9344262295081968,1.0,1.0,2/12,15.64%,EME2;MEIOB
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.37133798951872715,0.5995785401596414,0.9038461538461539,1.0,1.0,3/10,15.87%,MYO1C;GAB1;PIK3CD
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.27535945593228167,0.5992277030177661,1.0,1.0,1.0,6/46,10.33%,MTHFD2;GPT2;ACOT4;ASS1;ALDH1L1;SHMT1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.34516783068139645,0.5990867481901004,0.9272727272727272,1.0,1.0,7/18,36.45%,XPO5;SND1;PARN;DDX17;DIS3L2;LIN28B;DICER1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.34352575929287876,0.5987716353692377,0.9649122807017544,1.0,1.0,3/13,12.50%,CTU2;GTPBP3;TRMT9B
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.3040642367874426,0.597960773080945,0.9696969696969697,1.0,1.0,3/24,11.57%,CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.3040642367874426,0.597960773080945,0.9696969696969697,1.0,1.0,3/24,11.57%,CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.3704096991624747,0.596948997140613,0.9384615384615385,1.0,1.0,2/7,20.54%,GAS6;BTG1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.32233290464666475,0.5966077888075038,0.953125,1.0,1.0,1/17,8.05%,MGAT5
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.4039507209576433,-0.5954369272274296,0.9459459459459459,1.0,1.0,1/5,18.98%,SLC25A11
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.38348652374714,-0.5953536779562723,0.9743589743589743,1.0,1.0,1/6,18.98%,SLC25A11
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.34281788762440435,-0.5950393519941128,0.9318181818181818,1.0,1.0,1/8,9.14%,ATP6V1G1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.27153783613913046,-0.5950112049474773,1.0,1.0,1.0,8/48,13.58%,GAL3ST2;ADAMTS9;FBXO27;GANC;ST8SIA5;GANAB;GAL3ST4;AGA
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.30451163795073194,-0.5947810182839494,0.9459459459459459,1.0,1.0,5/14,23.87%,LY96;IPMK;DNM1L;PGAM5;CD14
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.31346349855463346,0.5945960293302168,0.9830508474576272,1.0,1.0,4/18,10.33%,MTHFD2;FTCD;ALDH1L1;SHMT1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.345502467986948,0.5944777323069474,0.9508196721311475,1.0,1.0,4/13,38.64%,DGKD;SMAP1;SCYL2;UBQLN2
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.41007137276234645,0.5936413952557609,0.9384615384615385,1.0,1.0,3/5,25.67%,GCKR;MIDN;PRKN
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3649158872531154,0.5932530122498221,0.9508196721311475,1.0,1.0,1/11,4.53%,HIC1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.36273272597050993,-0.5918731108311786,0.8723404255319149,1.0,1.0,1/6,5.82%,IL5
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.3490450800014035,-0.5917271099952571,0.9545454545454546,1.0,1.0,2/6,24.68%,YY1;MAP3K4
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.31969096670512037,0.5912153683663024,0.9848484848484849,1.0,1.0,8/21,26.31%,CHMP1A;NCAPD3;CCNB1;SET;PHF13;MCPH1;PHF8;AKAP8L
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.30025935120476926,-0.59108200151035,0.9318181818181818,1.0,1.0,6/17,29.01%,VPS11;CHMP3;PTPN23;RDX;EZR;SNX12
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.3466435853194778,-0.5900132068122532,0.9047619047619048,1.0,1.0,1/5,19.23%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.3466435853194778,-0.5900132068122532,0.9047619047619048,1.0,1.0,1/5,19.23%,NRDE2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3610320685446842,0.5894641388899294,0.9259259259259259,1.0,1.0,2/10,16.57%,CABIN1;H3-3A
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.3000963918603704,0.5892690977359858,0.971830985915493,1.0,1.0,4/24,29.48%,MORF4L2;MORF4L1;CREBBP;BAG6
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.3551537929702094,-0.5890173655130756,0.9302325581395349,1.0,1.0,1/5,10.12%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.3551537929702094,-0.5890173655130756,0.9302325581395349,1.0,1.0,1/5,10.12%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.3551537929702094,-0.5890173655130756,0.9302325581395349,1.0,1.0,1/5,10.12%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.3551537929702094,-0.5890173655130756,0.9302325581395349,1.0,1.0,1/5,10.12%,TACR1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.32275752211122966,0.5886012133106615,0.9583333333333334,1.0,1.0,1/12,5.45%,OXTR
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.3051176472069649,0.5884585345979237,0.9821428571428571,1.0,1.0,3/26,14.34%,DAB2IP;BAG3;OPTN
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.35074664641862824,-0.5883773345268346,0.9210526315789473,1.0,1.0,6/6,64.94%,CKB;CKMT2;SLC6A8;GAMT;GATM;CKM
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.3645337653133543,-0.5880258510757882,0.9210526315789473,1.0,1.0,7/7,63.56%,PRKRA;TSN;TARBP2;DROSHA;MRPL44;AGO2;DICER1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.3679593095832207,-0.5876567059971329,0.9019607843137255,1.0,1.0,1/5,8.78%,DAG1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.3679593095832207,-0.5876567059971329,0.9019607843137255,1.0,1.0,1/5,8.78%,DAG1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.3358514703442317,0.5875718186610047,0.9824561403508771,1.0,1.0,5/18,22.42%,SYVN1;MARCHF6;RPS27A;AMFR;RNF185
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.39126732162056266,0.5862920910374034,0.9622641509433962,1.0,1.0,2/5,29.32%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.39547552965464405,0.5852147198903298,0.9152542372881356,1.0,1.0,2/5,31.38%,DDRGK1;PLCG2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3336918044417084,0.5845645411866245,0.9701492537313433,1.0,1.0,3/15,16.42%,LDLR;SHANK1;RGS14
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.33025225425599536,0.5839800969995032,0.953125,1.0,1.0,2/14,11.24%,SAMHD1;GDA
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.3488175242042298,0.5835049775973342,0.9230769230769231,1.0,1.0,1/6,10.33%,SHMT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.35900886550031885,0.5832848982566603,0.9423076923076923,1.0,1.0,3/10,20.29%,PID1;TFRC;ADCK1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.3338352709512072,0.5822885552114853,0.9846153846153847,1.0,1.0,1/15,10.34%,CHMP1A
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.3209025103512779,-0.5815742733579055,0.972972972972973,1.0,1.0,2/17,5.24%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.3898863732028928,-0.5810326560205795,0.9411764705882353,1.0,1.0,3/5,24.40%,DCTPP1;ENPP3;ITPA
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),-0.3640047408373078,-0.5801616162479525,0.8837209302325582,1.0,1.0,2/5,17.54%,GPLD1;JAM2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.24457309302726374,0.5799197705000326,1.0,1.0,1.0,28/105,30.16%,CORO7;BAIAP3;HOOK1;WASHC1;DCTN1;TBC1D10B;HOOK2;TBC1D10A;GGA1;EMP2;TMEM87B;CCDC91;SORT1;RAB7A;LMTK2;SLC66A2;ARFRP1;CLTC;WDR81;ANKFY1;DENND5A;ERC1;ANKRD27;KIF16B;RAB6B;AP1G1;GAK;RAB5A
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.30130527083049186,-0.5794586024666925,1.0,1.0,1.0,3/20,10.03%,NUDT7;NT5E;AMPD3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.28674258251976753,-0.5793217464657006,0.9512195121951219,1.0,1.0,1/17,4.17%,RHOH
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.364524237459084,-0.5791234777172442,0.9047619047619048,1.0,1.0,1/7,8.30%,TFIP11
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.29931095523451307,0.5785339195604449,0.9508196721311475,1.0,1.0,7/31,24.18%,SMCR8;RNF152;TELO2;STK11;RRAGD;SESN1;SPAAR
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.36449686171289736,-0.5771285229027276,0.9285714285714286,1.0,1.0,5/5,63.56%,HES1;NOTCH1;RNF10;SKI;DICER1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.3907770392412807,0.5771216856286936,0.9056603773584906,1.0,1.0,1/5,13.95%,PRDM1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.33994074270337626,0.5769393992225144,0.9298245614035088,1.0,1.0,5/12,28.09%,HDAC4;FZD7;HDAC5;HDAC3;SOX6
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.3239387839016167,-0.576813826962532,0.9318181818181818,1.0,1.0,1/10,9.31%,METTL3
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.37170521161356884,-0.5767711379685229,0.9166666666666666,1.0,1.0,3/6,22.61%,PHGDH;SRR;PSPH
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.3270375776048208,-0.5766121912040576,0.9032258064516129,1.0,1.0,3/7,19.24%,SLC39A8;ART4;ARG1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.26623054561042303,0.5746447576271635,1.0,1.0,1.0,1/58,2.41%,LMO2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.29138190399231323,0.5746235749420087,0.9682539682539683,1.0,1.0,7/24,26.84%,HR;KDM6A;PHF2;KDM3A;PHF8;KDM6B;KDM4C
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.30118144599969454,-0.5745344452811915,0.975,1.0,1.0,5/15,23.97%,ASAH2B;SPTLC3;DHFR;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.29932457468608803,0.5729922796021464,0.9552238805970149,1.0,1.0,6/25,21.58%,CYP1B1;ABCA2;MTARC2;GCHFR;CYB5B;ACER3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.27320132731947006,-0.5724821941733935,1.0,1.0,1.0,8/29,23.86%,VAMP8;VTI1B;VIPAS39;ATG14;CHMP3;RUBCNL;CALM1;VCP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3158056282105973,0.5723823471632555,1.0,1.0,1.0,3/24,16.65%,FYN;GPR37;PINK1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.3665856736676633,-0.5712623752092951,0.9523809523809523,1.0,1.0,1/9,5.63%,MUL1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.3543446522775169,0.5711906992085495,0.90625,1.0,1.0,3/7,30.43%,LRP2;TGFBR3;NRP1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.35327407486197837,-0.5711394258356033,0.9122807017543859,1.0,1.0,2/6,25.01%,PTGIS;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.35327407486197837,-0.5711394258356033,0.9122807017543859,1.0,1.0,2/6,25.01%,PTGIS;SIRPA
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.24678021280562212,0.5706828546335114,1.0,1.0,1.0,23/127,23.90%,PLK2;WDR62;INCENP;CENPP;ERCC6L;CENPH;CCNB1;RANGAP1;KIFC2;NEK6;STMN1;SKA2;MAP4;DYNC1LI2;FLNA;CKAP5;DYNC1LI1;RAB11A;CENPU;RCC1;DCTN6;NUP160;KIF11
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.38555375885274196,0.5703657745433938,0.9622641509433962,1.0,1.0,2/5,26.67%,FTO;ALKBH5
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.38568891850324605,0.570178293261519,0.9482758620689655,1.0,1.0,2/6,27.79%,MAPKAPK2;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.37059706211330634,0.5701065301216977,0.9464285714285714,1.0,1.0,2/5,28.09%,FZD7;SOX6
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.3017797631030046,-0.5700245774287727,1.0,1.0,1.0,5/18,26.87%,AFG3L2;MIEF1;FIS1;GDAP1;MFN2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.3883767462531953,-0.5697050713259773,0.9795918367346939,1.0,1.0,1/5,8.09%,CAP1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.3360871747300115,0.5692815830303486,0.9454545454545454,1.0,1.0,3/8,18.83%,HDAC4;FBP1;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.3360871747300115,0.5692815830303486,0.9454545454545454,1.0,1.0,3/8,18.83%,HDAC4;FBP1;NCOR1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.24636137836558625,0.5692033653908974,1.0,1.0,1.0,9/90,15.19%,TRPM4;NNAT;LOXL1;HDAC4;HDAC9;BCL11A;RANGAP1;PLOD2;IFIH1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.3085417230130973,-0.5690977161772901,0.9743589743589743,1.0,1.0,5/10,28.97%,CTH;MPST;TST;BLMH;CPS1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.2988802794656413,-0.5678079036648358,1.0,1.0,1.0,4/19,20.57%,NEMP1;PLK1;TARDBP;UBXN2A
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.3158759130171313,0.567661177013517,0.9692307692307692,1.0,1.0,6/15,23.26%,MLXIPL;PNPLA8;GCKR;RORA;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.23358294618837294,-0.5673608814159739,1.0,1.0,1.0,5/84,7.64%,PADI4;COPS8;RAE1;CETN2;COPS7A
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3405532608927078,-0.5671650922098487,0.9333333333333333,1.0,1.0,2/11,21.20%,KMT2A;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3215994304085207,0.5662507560378268,0.9333333333333333,1.0,1.0,6/18,22.32%,EFNA1;ABCA2;EPHA4;SLC2A13;ABCG1;RANBP9
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.3610807786382171,0.5660847346892308,0.95,1.0,1.0,3/9,15.01%,SULT4A1;UST;CHST4
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.3924614771210053,-0.5657643035616936,0.9375,1.0,1.0,1/5,16.37%,PNRC2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3055410073770905,-0.565245514078199,0.972972972972973,1.0,1.0,3/15,18.94%,PIP4P1;RRAGA;LARS1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.2913885509089823,-0.563926023060584,1.0,1.0,1.0,4/18,14.18%,DGKE;DGKB;MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.2749621859899596,-0.5637733850764431,0.9767441860465116,1.0,1.0,6/36,13.62%,FBXO5;SMYD2;KMT5A;WDR76;USP51;NSMCE4A
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.36108545131093017,0.5635821122012277,0.9180327868852459,1.0,1.0,1/5,13.66%,KLF9
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.2968077616019472,0.5635097637449608,0.9818181818181818,1.0,1.0,3/22,9.32%,MTFR2;DNM1;MX1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.3727936575180635,0.5632366789132692,0.9272727272727272,1.0,1.0,2/5,29.80%,BCAT1;BCAT2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.24105818840346907,0.5613384975972151,1.0,1.0,1.0,19/114,23.95%,ELAVL4;RBMS1;ADARB2;RNASE1;RBPMS;RNASEH2C;WTAP;HNRNPH1;RBFOX2;LAGE3;FTO;RBM5;SUPV3L1;RBM6;CELF2;SND1;EXOSC7;BICD1;POLR2I
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.36992335080609046,-0.5613327181026703,0.96,1.0,1.0,1/5,11.92%,PVR
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.3638023075064825,0.5603877672722499,0.9344262295081968,1.0,1.0,1/6,26.65%,MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.3471893081337693,-0.5601270791487473,0.9574468085106383,1.0,1.0,2/6,21.20%,ADRA1A;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.32554377863729644,0.5600635068915986,0.967741935483871,1.0,1.0,5/10,36.41%,SKP1;UBE2S;RAB1A;FZR1;BTRC
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.26197259260281786,-0.559538442726808,0.975609756097561,1.0,1.0,5/27,15.80%,BCAP31;SEC24A;HFE;ERAP2;TAP1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.3071770999924117,0.5589137886304889,0.9538461538461539,1.0,1.0,2/19,11.98%,YTHDF1;MAPT
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.2768609703604097,0.5586602790477434,0.9857142857142858,1.0,1.0,7/39,18.38%,PID1;CYRIB;MAPT;PINK1;RHOT1;PDE2A;RHOT2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.28130197945086133,0.5582947189023354,1.0,1.0,1.0,1/29,5.53%,NUAK1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.277819589235421,-0.5557369854831568,0.9736842105263158,1.0,1.0,4/20,22.81%,SPDL1;CENPA;PLK1;DYNLT1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.19617442580669517,-0.5537734098562939,1.0,1.0,1.0,28/107,26.87%,VAMP8;SNF8;VPS4B;BECN1;VTI1B;MTERF3;FUNDC1;VIPAS39;DYNLL1;ATG14;PIK3R4;CHMP3;RUBCNL;PRKAB2;ACBD5;YOD1;PGAM5;VCP;TOMM70;CSNK2A2;VPS39;PIP4K2B;VTA1;ATG16L1;SNAP29;VPS28;CHMP2A;MFN2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.30609715623393147,0.5537384644967276,0.9696969696969697,1.0,1.0,4/21,14.63%,CD44;BCL2L1;TRIM32;BCL2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.35062771223941314,-0.5534017614849612,0.9795918367346939,1.0,1.0,1/7,10.17%,NCSTN
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.288924771824698,0.5529872852213943,0.9661016949152542,1.0,1.0,1/22,6.59%,TDRD5
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.32067021230297077,0.5529604162658046,0.9298245614035088,1.0,1.0,2/16,21.12%,MORF4L2;MORF4L1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.33857792391930475,0.5522824345819751,0.9666666666666667,1.0,1.0,5/11,25.09%,TMED10;ABCA2;RANBP9;FLOT2;PRNP
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.30637016020744584,0.5519925409902507,0.9454545454545454,1.0,1.0,2/16,14.63%,PDK4;BCL2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.32761822008739555,0.5512900830284313,0.9636363636363636,1.0,1.0,4/12,19.71%,SET;HMGA1;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.32761822008739555,0.5512900830284313,0.9636363636363636,1.0,1.0,4/12,19.71%,SET;HMGA1;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2875379615498117,0.551202838023971,0.9833333333333333,1.0,1.0,7/26,22.74%,YAP1;PAK1;CBFB;BRCA1;DDRGK1;DNAAF4;CARM1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.3467274237494894,0.550693998227547,0.9047619047619048,1.0,1.0,2/7,36.45%,AGO1;DICER1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.27238440630477334,0.5506657876436998,0.953125,1.0,1.0,3/26,15.09%,PML;MAPKAPK5;MRE11
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.2761938522307186,-0.5496262156519782,0.975,1.0,1.0,14/14,72.41%,TRNT1;INTS6L;INTS2;INTS14;PTCD1;ELAC2;INTS8;ERI1;INTS7;TOE1;SSB;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.2843087868472793,0.5494681757217884,1.0,1.0,1.0,7/23,20.74%,CTNNB1;ARF6;SMURF1;GGA1;FLNA;PIGK;EMP2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.33378424701545995,-0.5491586786367929,0.8918918918918919,1.0,1.0,1/6,13.88%,SLC25A22
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.32586255026931943,0.5468375810410995,0.9821428571428571,1.0,1.0,2/11,18.91%,SYNGR3;RXRA
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.2581529141533848,0.5466458958623973,1.0,1.0,1.0,2/39,7.64%,ZFP36;CDK9
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.33396766923946597,-0.5459391129169708,0.9318181818181818,1.0,1.0,2/8,17.25%,JUP;THBS4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.32823731902399517,-0.5457086808307853,1.0,1.0,1.0,7/7,67.19%,MYOCD;UQCC2;DDX5;NR1D2;MEF2C;GPC1;DDX17
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.3147626338128522,-0.5456026660866814,0.9722222222222222,1.0,1.0,7/12,37.93%,WNT5B;GPC3;SFRP4;DAAM2;TIAM1;CSNK1E;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.3190836049399795,-0.5450231658537604,1.0,1.0,1.0,3/11,18.00%,RIC3;TMEM35A;RANGRF
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.34648512358534067,-0.5449711342897021,0.9347826086956522,1.0,1.0,1/5,13.41%,RUNX1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.25047111556745455,0.5449541559982651,1.0,1.0,1.0,11/70,18.38%,CLIC4;NEXN;CENPV;MAPT;USP6NL;MTM1;CAMSAP3;PINK1;RHOT1;PDE2A;RHOT2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.30808950086058523,-0.5447405366927549,0.9,1.0,1.0,7/7,69.21%,PRPS1;CAD;TPK1;UMPS;DHODH;CTPS1;CTPS2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.2871839107353385,0.5443551063787307,0.9827586206896551,1.0,1.0,5/22,20.74%,MAP1B;MAPT;CAMSAP3;AEBP1;MAP1A
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.3272767498386201,-0.543023973000793,1.0,1.0,1.0,2/7,29.73%,PEX1;PEX12
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.32898078337531633,0.5429902953593008,0.9230769230769231,1.0,1.0,6/12,23.26%,MLXIPL;PNPLA8;GCKR;RORA;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.24632314122139393,0.5424127290072955,1.0,1.0,1.0,6/60,16.57%,ZFP36;WTIP;STAT3;PPARG;PUM1;H3-3A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.35351039008016083,0.5419277999812319,1.0,1.0,1.0,2/6,28.80%,PPM1F;CORO1C
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.32445420689900567,-0.5411667440644328,0.9302325581395349,1.0,1.0,3/7,25.87%,SEC62;SEC61A1;SEC63
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.3101594087446964,-0.5410687965915418,0.975,1.0,1.0,1/10,9.50%,VPS11
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.27353992666331767,0.5394309361974554,0.9841269841269841,1.0,1.0,3/26,20.99%,LSM11;ZNF473;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.31840536665271263,0.5381879866318503,1.0,1.0,1.0,2/13,20.65%,TFRC;TNFSF4
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.32427233611743866,-0.5380738999654983,0.9333333333333333,1.0,1.0,6/6,67.59%,LMOD1;FLII;TMOD1;TMOD3;TMOD2;PGM5
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.28714497655290444,0.5380234535716651,0.9846153846153847,1.0,1.0,3/19,15.13%,MCUB;STOML2;SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.344540299860569,0.5379071001162714,0.9310344827586207,1.0,1.0,1/6,8.54%,TENM4
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.29779528465508665,-0.5375057230775909,1.0,1.0,1.0,2/12,12.29%,GPLD1;GRAMD1B
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.28716985607614476,-0.5374952321699499,0.975609756097561,1.0,1.0,4/8,33.13%,RHOC;PLA2G5;FGFR3;PLIN5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.24849812736004054,-0.5374174775740627,1.0,1.0,1.0,3/18,13.00%,MAPK7;HSPA1A;HTRA2
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.2818611101428807,0.5372311004341784,0.9841269841269841,1.0,1.0,4/29,20.15%,IFT122;IFT140;ODAD4;SNX10
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.32343306023039925,-0.5369709127728935,0.9523809523809523,1.0,1.0,4/8,25.72%,MST1;GPX1;BRCA2;ZNF703
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.2989434905318449,0.5369086492978299,0.9473684210526315,1.0,1.0,1/13,9.22%,ACOT4
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.3571753986332574,-0.536800339356289,0.9285714285714286,1.0,1.0,6/6,64.30%,SLC4A7;PDZD7;LRTOMT;MYO6;JAG2;USH1C
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.34065153746587556,-0.5363857390063551,0.9782608695652174,1.0,1.0,3/6,25.49%,RMI2;MSH3;MSH2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.3412790340368,0.5358862193575933,0.9824561403508771,1.0,1.0,4/8,25.26%,ARNT;HIF1A;HMOX1;ANKRD2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.2911659624127682,-0.5355141095650217,0.9772727272727273,1.0,1.0,4/12,23.97%,ASAH2B;SPTLC3;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.2911659624127682,-0.5355141095650217,0.9772727272727273,1.0,1.0,4/12,23.97%,ASAH2B;SPTLC3;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.34039686613950904,-0.5352517459190054,0.9130434782608695,1.0,1.0,1/5,10.56%,HFE
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.30988810408335793,0.5338614535813646,0.9508196721311475,1.0,1.0,1/11,9.22%,ACOT4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.20834821431108094,0.5325480482836388,1.0,1.0,1.0,75/341,26.01%,UHRF2;TRIM5;TRIM61;TRPM4;HECW2;NEUROD2;ENC1;TRIM22;FBXO32;TRIM17;PEX14;ARIH2;DTX2;BARD1;KCTD13;HECW1;BCL11A;SPSB1;SYVN1;FBXL2;RANGAP1;TRIM32;TRIM47;RNF152;IFIH1;UBE2H;GAN;TRAIP;PDZRN3;HIF3A;SMURF1;PINK1;SKP1;RNF187;FBXO24;ARIH1;BRCA1;RAD18;BSPRY;MARCHF6;WAC;PIAS1;CDC27;RNF144A;RPS27A;DDRGK1;AMFR;HIF1A;KLHL7;TRIM44;UBE2I;DDB1;UBE2B;UHRF1;RNF181;CUL3;NUP160;UBE2E1;FBXW5;TRIM54;ARRB1;FBXO2;RNF220;SDE2;CBL;HLA-A;ATG7;UVSSA;CCNF;SUMO3;KCTD10;PRKN;UBE2R2;KLHL21;TRIM35
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.31903878922287265,0.532116508658947,0.9838709677419355,1.0,1.0,5/13,28.55%,P3H2;PLOD2;OGFOD1;EGLN3;ASPH
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.24798784606393648,0.530203519068272,1.0,1.0,1.0,7/60,17.84%,ATF3;EIF2B2;YTHDF1;EIF2B5;RPS6KB2;EIF3B;GLE1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.30894546026123004,0.530049773248066,0.9473684210526315,1.0,1.0,3/9,22.80%,SLC12A5;SLC12A7;SLC12A4
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.30894546026123004,0.530049773248066,0.9473684210526315,1.0,1.0,3/9,22.80%,SLC12A5;SLC12A7;SLC12A4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.2992375089822362,0.5298114433747628,0.9827586206896551,1.0,1.0,3/16,13.70%,SMAD3;FSCN1;PDPN
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.2536105979386099,-0.5297124652008811,1.0,1.0,1.0,2/28,10.71%,SNF8;VPS4B
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.2634580622363518,-0.529465979880715,0.9782608695652174,1.0,1.0,2/19,8.78%,FLG2;DAG1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.33046861689023593,0.528944594312058,0.9655172413793104,1.0,1.0,2/12,9.50%,ROBO2;BASP1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.27858047203939434,-0.528610912648733,1.0,1.0,1.0,2/16,11.50%,HSF1;ATR
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.34380970804598376,0.5281509804158633,0.9545454545454546,1.0,1.0,3/7,33.06%,BCAR1;NRP1;APPL1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.34380970804598376,0.5281509804158633,0.9545454545454546,1.0,1.0,3/7,33.06%,BCAR1;NRP1;APPL1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.2728934822514123,-0.528144721182139,0.975,1.0,1.0,5/24,19.66%,PIGW;GPLD1;PIGO;DPM2;PIGF
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.21910118691312375,-0.5279295735965115,1.0,1.0,1.0,8/58,17.13%,NOC2L;EIF2S1;BAK1;METTL3;ATR;TRIAP1;SMPD1;XPA
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.2768807362842032,-0.527813095043663,1.0,1.0,1.0,3/20,13.82%,SNF8;BECN1;WDR91
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.32099684514503857,0.5266412959785759,0.9571428571428572,1.0,1.0,5/9,23.83%,ETV6;ARIH2;WNT5A;YJEFN3;MECOM
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.3292595158612946,-0.5263951833514956,0.9428571428571428,1.0,1.0,1/5,9.00%,MICA
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.34016046412854894,0.5253629176190135,0.9285714285714286,1.0,1.0,1/7,14.98%,PLOD2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.3082204730369881,0.5234190771822588,0.9666666666666667,1.0,1.0,4/12,18.73%,SNCA;JARID2;SET;BRCA1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.29031910344607753,-0.5222759617653391,0.9583333333333334,1.0,1.0,5/13,28.24%,RNF168;RNF8;LARP7;RECQL5;NELFCD
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.30840141419183414,0.5221265628443139,0.9824561403508771,1.0,1.0,4/13,34.70%,TFRC;SLC15A4;SHLD1;HMCES
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.27386144370022025,0.5220233369961861,1.0,1.0,1.0,5/21,23.42%,TMTC1;POMGNT2;LARGE1;SDF2L1;DPY19L1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.2566678557594073,-0.5218187364401686,1.0,1.0,1.0,7/30,17.41%,CTSH;DAG1;NCSTN;NAPSA;RBMX;AFG3L2;HM13
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.2783363733546257,0.5217928175931056,0.9827586206896551,1.0,1.0,3/17,16.03%,TMTC1;POMGNT2;LARGE1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.3297605863618062,0.5191107546218333,0.9807692307692307,1.0,1.0,1/5,25.26%,PARN
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.2877035067115583,0.519095388973946,0.984375,1.0,1.0,10/18,37.69%,SGCG;SIX4;IGSF8;PGM5;MYH14;SGCZ;TBX2;MYOZ2;MYL6;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.32930815681125336,0.5184495344640369,1.0,1.0,1.0,3/8,27.17%,HDAC4;HDAC5;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.32931027056661766,0.5180663257848318,0.9019607843137255,1.0,1.0,2/5,32.32%,EIF4G1;IMPACT
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.2996596948884878,0.517686659031872,0.9714285714285714,1.0,1.0,3/15,19.05%,BCL2L1;BCL2;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.2996596948884878,0.517686659031872,0.9714285714285714,1.0,1.0,3/15,19.05%,BCL2L1;BCL2;MAP2K5
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.355628808101883,0.516568281472847,0.9411764705882353,1.0,1.0,2/5,29.38%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.355628808101883,0.516568281472847,0.9411764705882353,1.0,1.0,2/5,29.38%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.2671368864961656,-0.5163560216044856,1.0,1.0,1.0,1/12,14.91%,NAA11
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.31999978704070986,-0.5156915222765375,0.9354838709677419,1.0,1.0,2/6,18.04%,UFL1;MEOX1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.2764831561826818,0.5153728889682256,1.0,1.0,1.0,2/23,10.70%,NOTUM;HDAC4
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.29893593007161273,0.5144178056943578,1.0,1.0,1.0,5/14,33.42%,AK5;ENTPD2;ENTPD7;CMPK2;ENTPD6
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.2536168350720553,-0.5116612046112959,1.0,1.0,1.0,2/27,10.71%,SNF8;VPS4B
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.2784964636596216,-0.510114338808958,0.9782608695652174,1.0,1.0,3/11,25.87%,SEC62;SEC61A1;SEC63
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.34272017877480354,0.5100438507024169,0.9361702127659575,1.0,1.0,1/5,24.38%,NAA25
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.3045443906591656,0.5094859188906075,0.9838709677419355,1.0,1.0,3/11,23.20%,P2RY12;P2RX7;CIB2
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2430057388992321,-0.5091700000117753,0.975,1.0,1.0,7/21,26.68%,VPS4B;TMEM50B;CHMP3;TMEM50A;VCP;VTA1;CHMP2A
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.31143059633491954,-0.5089661185933447,0.918918918918919,1.0,1.0,7/7,68.87%,SPHK2;KDM5A;C6ORF89;PRKD1;PRKD2;VEGFA;CAMK2D
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.2701856099895098,0.5083413683627367,1.0,1.0,1.0,6/29,18.92%,IRS2;PDK1;FBP1;PDK4;RORA;PDK3
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.34706052278162725,0.5063675059372001,0.9636363636363636,1.0,1.0,1/6,9.69%,ASS1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.2452989199050402,-0.5061701856048976,1.0,1.0,1.0,4/24,22.81%,SPDL1;CENPA;PLK1;DYNLT1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.3203834754511633,-0.5057922609526985,0.9142857142857143,1.0,1.0,1/8,11.36%,ENTPD1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.276207839562443,-0.5053809940529245,0.9772727272727273,1.0,1.0,15/15,72.41%,INTS3;INTS4;INTS6L;INTS11;INTS2;INTS14;INTS9;INTS8;INTS7;TOE1;INTS1;INTS12;INTS10;INTS6;INTS5
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.2810752588583707,-0.5046972840792799,1.0,1.0,1.0,2/11,14.20%,PLIN3;PLIN2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.3308440423717232,0.5038866254776699,0.9649122807017544,1.0,1.0,4/9,23.04%,NTRK3;F3;VEGFD;CXCL12
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.2737636766360699,0.5032189583312049,0.9859154929577465,1.0,1.0,3/19,19.87%,ACAD8;AUH;BCAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.2737636766360699,0.5032189583312049,0.9859154929577465,1.0,1.0,3/19,19.87%,ACAD8;AUH;BCAT1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.3289835078666143,0.5031803555008784,0.9672131147540983,1.0,1.0,4/8,29.32%,HAP1;HDAC6;DRC1;MAP2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.2860610860262977,0.503176223879563,1.0,1.0,1.0,1/14,6.09%,NUDT16
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.25424692004400284,-0.5025774208383306,0.972972972972973,1.0,1.0,2/18,13.90%,FSTL3;LRRC17
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.3447261149397515,0.5025410436843663,0.98,1.0,1.0,3/5,33.93%,CAV3;NEDD4L;CAB39
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.276207839562443,-0.5022931810813703,1.0,1.0,1.0,15/15,72.41%,MEPCE;INTS3;MTREX;INTS4;INTS11;INTS2;INTS9;INTS8;ZCCHC8;INTS7;INTS1;INTS12;INTS10;INTS6;INTS5
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.26318426369905434,0.5015951003685055,1.0,1.0,1.0,3/23,17.37%,SLC26A8;PDPN;SLC1A6
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.31320507004611386,0.5013818309970035,1.0,1.0,1.0,3/8,24.55%,HMOX2;ABCC1;HMOX1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.31320507004611386,0.5013818309970035,1.0,1.0,1.0,3/8,24.55%,HMOX2;ABCC1;HMOX1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.332121755433857,0.5007770484014067,1.0,1.0,1.0,1/6,17.91%,SKP1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.312131363324496,-0.5000511896416094,0.9555555555555556,1.0,1.0,1/10,13.88%,SLC25A22
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.3002307397857964,-0.49950732013586185,1.0,1.0,1.0,1/5,16.01%,WNT7B
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.27158408478821233,0.4981245198367766,1.0,1.0,1.0,3/11,30.74%,PPP2R2D;UBE2S;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),0.3085929017206004,0.4973595020918891,0.9591836734693877,1.0,1.0,3/5,30.43%,B2M;ANXA2;NRP1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.3093091155842601,-0.4973056184602553,0.975609756097561,1.0,1.0,4/8,28.08%,MTRF1;JMJD4;SHFL;ETF1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.32247166132366833,0.49511157413357515,0.9811320754716981,1.0,1.0,2/7,23.61%,PAX8;SIX4
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.32247166132366833,0.49511157413357515,0.9811320754716981,1.0,1.0,2/7,23.61%,PAX8;SIX4
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.3117185522652493,-0.494295704801626,0.9777777777777777,1.0,1.0,6/6,68.84%,ERCC4;ATM;ERCC1;TERF2;SMG6;NBN
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.3017540517849503,0.49402855774161175,0.9696969696969697,1.0,1.0,2/8,27.31%,MESP1;FZD5
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.2913008471941507,0.49375003463192035,1.0,1.0,1.0,2/10,16.14%,IHO1;FMN2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.29373366866364425,-0.49314008140249754,0.9375,1.0,1.0,1/7,10.56%,HFE
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.3220555706931356,-0.4930775070992515,0.9411764705882353,1.0,1.0,2/5,29.04%,NR1H2;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.3171272648828789,0.49274208693870064,0.9454545454545454,1.0,1.0,2/6,20.25%,PDE4D;ADRA1D
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.3165825569913582,0.49192993623518566,0.9833333333333333,1.0,1.0,1/8,12.92%,EIF5A
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.2500526894567743,-0.4917304916670337,1.0,1.0,1.0,4/17,19.51%,MOGAT1;GK;PLA2G15;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.31492355978535996,-0.4916485954680653,0.9545454545454546,1.0,1.0,7/7,68.52%,MYOCD;SPX;GPER1;SPHK1;CTTN;SRF;F2R
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.30402793787426596,-0.49038190698228395,0.9761904761904762,1.0,1.0,4/6,33.96%,NMD3;NPM1;SDAD1;RAN
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.25357185253877623,0.4892237397098672,1.0,1.0,1.0,4/32,18.61%,BAP1;ARIH2;PINK1;MICALL2
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.304737372601225,-0.4889722541198229,1.0,1.0,1.0,2/6,20.23%,YME1L1;AFG1L
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.31489167847742455,-0.48697817577438063,0.975609756097561,1.0,1.0,5/5,68.52%,HS3ST5;GP1BA;PROCR;EPHB2;F2R
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.27540411947601534,-0.48663225635152985,0.9111111111111111,1.0,1.0,2/7,22.06%,SLC25A46;DNM1L
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.26737794399286074,0.4844778847182159,0.9850746268656716,1.0,1.0,1/18,7.64%,CDK9
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.242036084610452,0.4834545661942268,1.0,1.0,1.0,5/34,21.95%,SMCR8;GAS6;TELO2;RRAGD;RHEB
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.301372209158337,0.48318077692507294,0.9803921568627451,1.0,1.0,1/8,8.20%,GRK2
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.2315741339875772,-0.4803895632584489,1.0,1.0,1.0,1/35,2.95%,TRIM21
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.2950031376773304,0.48014112104111367,0.9622641509433962,1.0,1.0,3/7,30.98%,GCKR;CARMIL1;SLC2A9
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.271418664682152,0.4799220619824721,0.984375,1.0,1.0,7/17,30.95%,PCGF3;SKP1;DDB2;DDB1;BCOR;PCGF5;PCGF2
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.25540533697908757,-0.479256507811723,1.0,1.0,1.0,12/12,74.48%,NRDE2;TPR;NSUN2;NCBP2;CPSF6;SUPT6H;KHDRBS1;NUP153;SETD2;IWS1;AKAP8L;DHX9
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.31490761832447484,-0.4770546709244327,0.9523809523809523,1.0,1.0,6/6,68.52%,MYOCD;ENO1;SPHK1;CTTN;SRF;F2R
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.28212473664688903,0.47649197998543086,0.9827586206896551,1.0,1.0,5/11,33.74%,ACOT7;PANK3;ACAT1;SLC25A16;PPCDC
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.28212473664688903,0.47649197998543086,0.9827586206896551,1.0,1.0,5/11,33.74%,ACOT7;PANK3;ACAT1;SLC25A16;PPCDC
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.28212473664688903,0.47649197998543086,0.9827586206896551,1.0,1.0,5/11,33.74%,ACOT7;PANK3;ACAT1;SLC25A16;PPCDC
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.28956973075158743,0.4751013862185518,0.9655172413793104,1.0,1.0,2/11,19.12%,PEX14;PEX7
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.2717889152170776,0.4749238652151502,1.0,1.0,1.0,4/15,32.21%,SART1;PSIP1;WBP11;WBP4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.2670726298600303,-0.4731994506661637,0.9761904761904762,1.0,1.0,1/9,9.00%,MICA
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.26830189996949244,0.4728855533489533,0.9836065573770492,1.0,1.0,7/17,30.15%,ADAM17;SPPL2B;ADAM9;PSEN1;APH1B;TGFB1;RHBDD1
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.3281028548289128,0.47121155166498785,0.9811320754716981,1.0,1.0,5/5,67.20%,CHM;RABGGTB;FNTA;PGGT1B;RABGGTA
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.2975682087243566,0.46960535131223313,0.9473684210526315,1.0,1.0,1/7,17.11%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.2598203837274244,0.4668211981711757,0.9827586206896551,1.0,1.0,7/14,33.05%,ATAD5;DDRGK1;GLI1;CUL3;ZNF16;PLCG2;PAF1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.2673083562577939,0.46655350204829665,0.9655172413793104,1.0,1.0,4/12,34.70%,TFRC;TGFB1;SHLD1;HMCES
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.2798420573048497,0.46638956285627087,1.0,1.0,1.0,7/7,72.03%,DHX9;AGO1;AGO2;AGO3;AGO4;DDX3X;DHX36
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2688762349759511,0.46597964783516393,1.0,1.0,1.0,3/16,24.14%,BCLAF1;MED24;MED13
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.30053371947349483,-0.4631179035864947,0.9836065573770492,1.0,1.0,1/5,12.44%,PTGIS
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.2832393735624595,0.4630934179447155,0.9838709677419355,1.0,1.0,5/11,35.94%,SAR1A;SEC16A;CD81;TM9SF4;INSIG1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.24961900377205093,0.4621577339991442,0.9836065573770492,1.0,1.0,3/20,16.77%,ALOX12;ACOT7;LTC4S
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.2874715261958998,-0.4616787196816358,0.9814814814814815,1.0,1.0,6/6,71.27%,ADI1;ENOPH1;MRI1;APIP;BHMT2;BHMT
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.28818554594889284,0.4604572343113252,0.9672131147540983,1.0,1.0,4/8,30.41%,SPRED3;DYRK1A;BRMS1;NNMT
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.25308395215311263,0.46043685513435906,0.9841269841269841,1.0,1.0,4/12,29.05%,PDE4D;ADRA1D;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.323019829411215,0.4603105176436406,1.0,1.0,1.0,3/5,35.30%,PRKN;UBE2S;ITCH
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.22907336056563046,0.4602018968033641,0.9861111111111112,1.0,1.0,4/26,19.76%,ART3;PARP9;HPF1;PARP8
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.32293986636971034,0.46003572320131303,0.9827586206896551,1.0,1.0,5/5,67.71%,NUCKS1;XRCC5;XRCC6;NIPBL;ATM
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.31509129903537936,0.4597240607473755,1.0,1.0,1.0,2/5,35.55%,PRKN;VAPA
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.3003063109049643,0.4595991534378107,0.9833333333333333,1.0,1.0,1/6,13.21%,MACROD1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.2632953119551783,-0.45889303850738344,1.0,1.0,1.0,2/7,23.63%,ACTN2;EHD2
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.2667175008238385,-0.4583559993885322,1.0,1.0,1.0,1/15,5.07%,PIGW
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.28640850417615793,-0.4580820794548334,0.9795918367346939,1.0,1.0,6/6,71.37%,EHD2;ADGRB1;MAPK14;EHD1;RIPOR2;FLOT1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.292337336430626,0.45715626966102846,0.9629629629629629,1.0,1.0,1/6,18.07%,DOT1L
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.2806988943041705,-0.456497077001141,1.0,1.0,1.0,2/7,23.49%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.2598983199150091,0.4562085580479824,1.0,1.0,1.0,4/15,29.07%,GLE1;IGF1R;OGFOD1;HDAC6
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.2241161333311798,-0.4560575225026548,1.0,1.0,1.0,1/24,5.43%,RNF2
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2763985453410687,0.4560381722737961,0.9830508474576272,1.0,1.0,2/9,28.64%,ADAM9;FLOT1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.2864230029361142,-0.4550546543075031,0.9795918367346939,1.0,1.0,7/7,71.37%,EHD2;ADGRB1;CFLAR;MAPK14;EHD1;RIPOR2;FLOT1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.29131865350544156,0.45486627185242734,0.9814814814814815,1.0,1.0,6/6,70.88%,DHX9;SSB;DCP1A;YBX1;DDX1;DDX3X
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.2441631221629899,0.4547971442334052,1.0,1.0,1.0,5/12,33.51%,PARP8;PARP16;TNKS2;TNKS;PARP12
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.28238244248795713,0.4547507126262968,0.9454545454545454,1.0,1.0,3/6,37.35%,GTF3C5;GTF3C2;GTF3C1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.29894715529459404,-0.45451063480134724,0.9795918367346939,1.0,1.0,5/5,70.12%,NCK1;PPP1R15B;PTPN1;PPP1R15A;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.21173233184339357,-0.44974038318025483,1.0,1.0,1.0,2/27,12.01%,HFE;RPL11
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.2986940676250253,-0.44929679324750116,0.9795918367346939,1.0,1.0,5/5,70.14%,CD63;AP1M1;RAB32;AP3D1;AP1G1
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.2986940676250253,-0.44929679324750116,0.9795918367346939,1.0,1.0,5/5,70.14%,CD63;AP1M1;RAB32;AP3D1;AP1G1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.3130318817536065,0.44780948166112283,1.0,1.0,1.0,1/5,23.04%,CXCL12
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.2825427599720418,0.44501857755784124,0.9833333333333333,1.0,1.0,1/5,21.81%,ACTN4
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.2254899764791345,-0.4418399953628082,1.0,1.0,1.0,3/23,17.52%,HSPA13;HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.27561247216035634,-0.44099318864570014,0.96,1.0,1.0,5/5,72.45%,IL34;PTK2;CSF1R;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.2581199590092989,-0.4399604860828327,1.0,1.0,1.0,1/10,12.74%,ATP1A2
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.2691537342131898,0.43703138385731066,0.9841269841269841,1.0,1.0,4/10,28.65%,DSTN;MICAL1;WDR1;GSN
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.23935017534807593,0.4346767253943804,1.0,1.0,1.0,4/18,25.74%,PPP1R16B;MFHAS1;ARPP19;ENSA
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.2977049478103122,0.433410106095587,1.0,1.0,1.0,3/5,24.44%,DDRGK1;BFAR;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.26003149224625205,0.4325776237381385,1.0,1.0,1.0,1/10,18.89%,ETS1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.29098146544992365,-0.43243862163964764,0.9714285714285714,1.0,1.0,2/5,20.61%,ADIPOR1;APPL2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.26389435362304275,-0.43242957335189297,1.0,1.0,1.0,2/8,19.51%,PTGIS;PLA2G4A
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.2649341338035076,0.4319744385463561,1.0,1.0,1.0,2/8,26.53%,LRP2;CYP3A4
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.2046965587429596,-0.4312065655179874,1.0,1.0,1.0,5/27,25.57%,KIF20B;CEP131;TENM1;GCC2;PCM1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.25211171279856087,-0.427948913267527,0.9761904761904762,1.0,1.0,1/9,17.96%,DDIT3
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.2808168348282378,0.4265783226866874,0.9836065573770492,1.0,1.0,1/7,18.00%,ADGRE2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.27103371469069554,-0.42595667388015734,0.9743589743589743,1.0,1.0,7/7,72.91%,APPL2;CDC42;PPT1;CLN3;AXL;APPL1;ANKFY1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.2636294608959757,-0.42500934140114244,1.0,1.0,1.0,6/6,73.65%,NPM1;RPS15;RAN;LTV1;XPO1;NUP88
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.29226674488275617,0.42185670828969546,1.0,1.0,1.0,2/6,31.38%,SCIMP;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.23943876000405212,0.420522565748548,1.0,1.0,1.0,19/19,76.08%,TP53;MED24;MED13;SRF;PSMC6;MED16;PSMC3;MED14;PSMC5;PSMC2;MED4;MED1;PSMC4;DHX36;MED30;MED12;ESR1;SUB1;PAXIP1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.24846858705006836,-0.4197631414113867,1.0,1.0,1.0,8/8,75.17%,POLR2L;GTF3C6;GTF3C4;GTF3C3;GTF3C1;BRF1;GTF3C2;GTF3C5
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.2888186369533224,0.4185512776895021,1.0,1.0,1.0,2/5,29.77%,XRCC1;RAD21
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.1901252507698608,-0.4177889495054396,1.0,1.0,1.0,6/33,25.57%,KIF20B;CEP131;TENM1;ACTN2;EHD2;PCM1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.2715567154124845,0.4169047666071251,1.0,1.0,1.0,1/5,20.26%,SLC38A1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.25618632005349257,-0.4140441962191797,1.0,1.0,1.0,1/8,12.83%,RGN
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.2658326486883835,0.41374815318201263,1.0,1.0,1.0,1/6,21.00%,GNAI1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.2511155488133252,0.4136327984765969,1.0,1.0,1.0,2/5,26.22%,CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.26811413425351305,0.4119333907182959,1.0,1.0,1.0,2/9,23.50%,TP53;PIF1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.2664838459291553,0.41152896165422204,1.0,1.0,1.0,4/9,34.07%,ATP2B4;PRNP;GSK3B;MYOZ2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.2664838459291553,0.41152896165422204,1.0,1.0,1.0,4/9,34.07%,ATP2B4;PRNP;GSK3B;MYOZ2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.19990816033796488,-0.4105717589257876,1.0,1.0,1.0,3/28,17.52%,HSPA13;HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.22968096165134472,-0.4101969672495906,1.0,1.0,1.0,1/11,10.77%,SUPT16H
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.2536262026016492,0.4069480985807261,1.0,1.0,1.0,2/10,21.39%,TFAP4;POU2F3
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.2738948959711256,0.40636390172819176,0.9824561403508771,1.0,1.0,1/5,21.97%,BMP6
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.21227466072513673,-0.40441003241495416,1.0,1.0,1.0,13/13,78.79%,NUP54;NDC1;TPR;NUP133;NUP205;NUP107;NUP153;NUP93;NUP98;AHCTF1;SEH1L;NUP35;RTN4
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.2595667139096984,0.40049375696669537,1.0,1.0,1.0,5/5,74.05%,DEUP1;CEP152;CCDC78;E2F4;PLK4
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.24936768058538855,-0.4004423644677696,1.0,1.0,1.0,1/6,15.49%,CPT2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.267161572152921,0.3935510483356884,1.0,1.0,1.0,1/7,15.59%,GPR183
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.21877373297554556,-0.39288618082368854,1.0,1.0,1.0,10/10,78.14%,NABP2;BRCA2;NIPBL;RUVBL2;PIH1D1;POT1;MACROH2A2;LRWD1;MACROH2A1;ACD
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.22822415263845988,0.3911325791644354,1.0,1.0,1.0,4/13,29.89%,DDRGK1;BFAR;HSPA5;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.26177898553957263,0.39094756567101974,1.0,1.0,1.0,3/6,33.38%,WNT5A;PLCG2;SIRT1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.23345467539122,-0.3894083428573562,0.9714285714285714,1.0,1.0,2/10,19.52%,LARS1;SESN2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.23345467539122,-0.3894083428573562,0.9714285714285714,1.0,1.0,2/10,19.52%,LARS1;SESN2
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.26169265033407574,-0.38931774633094346,0.9777777777777777,1.0,1.0,5/5,73.84%,DHFR;MTHFS;QDPR;FPGS;GCH1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.23472584317470446,0.3863744829679738,1.0,1.0,1.0,1/9,16.84%,TP53
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.2296016411223047,0.38466832934909595,1.0,1.0,1.0,5/11,33.76%,UBXN1;RNF185;BAG6;USP25;RNFT1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.21122663981022086,0.38322330297418356,1.0,1.0,1.0,8/18,35.71%,MAPKAPK5;MAPK3;MAP2K7;TNKS2;NBN;TNKS;PRKCQ;MAPK1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.20800202582932392,0.3793127015146862,1.0,1.0,1.0,16/16,79.22%,TINF2;TNKS2;TNKS;NAF1;HNRNPA2B1;SMG6;TERF2;SMG5;PINX1;POT1;ATM;ERCC4;DHX36;TERF1;SLX4;PARP1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2177873048389528,-0.3766384927102242,1.0,1.0,1.0,3/9,26.19%,ADRA1A;DRD2;ADRA1B
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.22343062444710252,0.3765380172650576,1.0,1.0,1.0,4/10,34.05%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.22343062444710252,0.3765380172650576,1.0,1.0,1.0,4/10,34.05%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.2325835413726514,0.37371046133031305,1.0,1.0,1.0,2/8,26.05%,CPEB2;DPH6
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.2132286344078025,0.373179042222502,1.0,1.0,1.0,5/19,27.56%,BRCA1;RPS6KA4;ARRB1;RPS6KA5;MAPK3
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.2559728690018222,0.3715708921517337,1.0,1.0,1.0,5/5,74.41%,GHRHR;CHD7;SELENOT;GHRL;DRD2
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.20519138672715048,0.3689896490625303,1.0,1.0,1.0,4/20,23.97%,WAC;UBE2B;UHRF1;UBE2E1
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.21682558537228153,0.3648330098917162,1.0,1.0,1.0,1/7,19.16%,RBP2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.19996485151116597,0.36075045437355535,1.0,1.0,1.0,6/21,28.74%,MSRA;NOX4;MTHFR;AHCY;SMS;BHMT
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.21367467878734428,-0.35645208745154233,1.0,1.0,1.0,2/10,19.52%,LARS1;SESN2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.2090805564509735,0.3559306813522778,1.0,1.0,1.0,7/13,35.71%,MAPKAPK5;MAPK3;MAP2K7;TNKS2;TNKS;PRKCQ;MAPK1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.23041257080880997,0.35259348564634974,1.0,1.0,1.0,2/6,29.35%,MRTFB;TGFB1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.2080801944106926,-0.3459288358710439,1.0,0.9997961382764947,1.0,9/9,79.21%,UBB;UBA52;TUT4;ISG15;TUT7;CHFR;UBC;DIS3L2;RPS27A
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.20891131925281187,0.331751866901162,1.0,1.0,1.0,3/10,32.25%,PNPLA8;SLC27A1;HADHB
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.20535669080046565,0.32269511316456845,1.0,0.9999514235923468,1.0,10/10,79.47%,WAC;UBE2E1;PAF1;CDC73;RNF20;RNF40;DTX3L;LEO1;CTR9;RNF8
